0001564590-20-006427.txt : 20200225 0001564590-20-006427.hdr.sgml : 20200225 20200225165448 ACCESSION NUMBER: 0001564590-20-006427 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 115 CONFORMED PERIOD OF REPORT: 20191231 FILED AS OF DATE: 20200225 DATE AS OF CHANGE: 20200225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEVRO CORP CENTRAL INDEX KEY: 0001444380 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 562568057 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36715 FILM NUMBER: 20651646 BUSINESS ADDRESS: STREET 1: 1800 BRIDGE PARKWAY CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: 650-251-0005 MAIL ADDRESS: STREET 1: 1800 BRIDGE PARKWAY CITY: REDWOOD CITY STATE: CA ZIP: 94065 10-K 1 nvro-10k_20191231.htm 10-K nvro-10k_20191231.htm
false FY NVRO 0001444380 --12-31 Large Accelerated Filer true 0.00 3.50 P6M 2015-06-30 2017-05-31 P3Y 0.00 P6M P7Y4M24D P7Y3M18D P6Y8M12D P6Y3M18D P5Y1M6D P6Y2M12D 1.44 18.00 P3Y9M14D 32.51 48.44 P7Y10M6D 49.94 63.23 P4Y5M12D 63.39 76.81 P8Y3M7D 84.30 97.52 P7Y25D 1.44 97.52 P6Y3M14D P5Y8M12D P5Y6M P5Y6M 0.51 0.44 0.44 0.014 0.023 0.018 P6M P6M P6M 0.48 0.44 0.36 0.016 0.021 0.010 0.52 0.51 0.46 0.026 0.029 0.022 0.61 0.57 0.37 0.024 0.025 0.014 P2Y8M12D P2Y7M6D P4M24D 0001444380 2019-01-01 2019-12-31 xbrli:shares 0001444380 2020-02-14 iso4217:USD 0001444380 2019-06-28 0001444380 2019-12-31 0001444380 2018-12-31 iso4217:USD xbrli:shares 0001444380 2018-01-01 2018-12-31 0001444380 2017-01-01 2017-12-31 0001444380 us-gaap:CommonStockMember 2016-12-31 0001444380 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0001444380 us-gaap:RetainedEarningsMember 2016-12-31 0001444380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0001444380 2016-12-31 0001444380 us-gaap:CommonStockMember 2017-01-01 2017-12-31 0001444380 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-12-31 0001444380 us-gaap:RetainedEarningsMember 2017-01-01 2017-12-31 0001444380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-12-31 0001444380 us-gaap:CommonStockMember 2017-12-31 0001444380 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001444380 us-gaap:RetainedEarningsMember 2017-12-31 0001444380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001444380 2017-12-31 0001444380 us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0001444380 us-gaap:CommonStockMember 2018-01-01 2018-12-31 0001444380 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0001444380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-12-31 0001444380 us-gaap:CommonStockMember 2018-12-31 0001444380 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001444380 us-gaap:RetainedEarningsMember 2018-12-31 0001444380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001444380 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0001444380 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001444380 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001444380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001444380 us-gaap:CommonStockMember 2019-12-31 0001444380 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001444380 us-gaap:RetainedEarningsMember 2019-12-31 0001444380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001444380 us-gaap:AccountingStandardsUpdate201409Member 2019-01-01 2019-12-31 0001444380 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 2019-12-31 0001444380 nvro:DebtLiabilityComponentMember 2019-01-01 2019-12-31 0001444380 nvro:DebtEquityComponentMember 2019-01-01 2019-12-31 0001444380 nvro:PerformanceBasedRestrictedStockUnitsRSUMember 2019-01-01 2019-12-31 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2019-01-01 2019-12-31 0001444380 us-gaap:IPOMember 2014-11-01 2014-11-30 0001444380 us-gaap:OverAllotmentOptionMember 2014-11-01 2014-11-30 0001444380 2014-11-01 2014-11-30 0001444380 us-gaap:IPOMember 2014-11-30 0001444380 us-gaap:CommonStockMember us-gaap:IPOMember 2014-11-01 2014-11-30 0001444380 us-gaap:CommonStockMember 2015-06-01 2015-06-30 0001444380 us-gaap:OverAllotmentOptionMember 2015-06-01 2015-06-30 0001444380 2015-06-01 2015-06-30 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2016-06-30 xbrli:pure 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2016-06-01 2016-06-30 nvro:Subsidiary nvro:Business 0001444380 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember country:US 2019-01-01 2019-12-31 0001444380 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember country:US 2018-01-01 2018-12-31 0001444380 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember country:US 2017-01-01 2017-12-31 0001444380 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2019-01-01 2019-12-31 0001444380 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2018-01-01 2018-12-31 0001444380 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember 2017-01-01 2017-12-31 0001444380 us-gaap:CreditConcentrationRiskMember us-gaap:AccountsReceivableMember 2019-01-01 2019-12-31 0001444380 us-gaap:CreditConcentrationRiskMember us-gaap:AccountsReceivableMember 2018-01-01 2018-12-31 nvro:Customer 0001444380 us-gaap:CertificatesOfDepositMember 2019-12-31 0001444380 us-gaap:CertificatesOfDepositMember 2018-12-31 0001444380 nvro:CollateralizingPaymentChargesRelatedToCreditCardsMember 2018-12-31 0001444380 srt:MinimumMember 2019-01-01 2019-12-31 0001444380 srt:MaximumMember 2019-01-01 2019-12-31 0001444380 2016-01-01 2016-12-31 0001444380 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-12-31 0001444380 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member us-gaap:AccountingStandardsUpdate201409Member 2018-01-01 0001444380 us-gaap:AccountingStandardsUpdate201409Member 2018-01-01 0001444380 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member us-gaap:AccountingStandardsUpdate201409Member 2018-12-31 0001444380 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member us-gaap:AccountingStandardsUpdate201409Member 2018-12-31 0001444380 us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member us-gaap:AccountingStandardsUpdate201409Member 2018-01-01 2018-12-31 0001444380 us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member us-gaap:AccountingStandardsUpdate201409Member 2018-01-01 2018-12-31 0001444380 country:US 2019-01-01 2019-12-31 0001444380 country:US 2018-01-01 2018-12-31 0001444380 country:US 2017-01-01 2017-12-31 0001444380 us-gaap:NonUsMember 2019-01-01 2019-12-31 0001444380 us-gaap:NonUsMember 2018-01-01 2018-12-31 0001444380 us-gaap:NonUsMember 2017-01-01 2017-12-31 0001444380 2020-01-01 2019-12-31 0001444380 us-gaap:AccountingStandardsUpdate201602Member srt:MinimumMember 2019-12-31 0001444380 us-gaap:AccountingStandardsUpdate201602Member 2019-12-31 0001444380 srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0001444380 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0001444380 srt:MinimumMember us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 2019-12-31 0001444380 srt:MaximumMember us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 2019-12-31 0001444380 srt:MaximumMember us-gaap:AccountingStandardsUpdate201602Member 2019-12-31 0001444380 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2019-01-01 2019-12-31 0001444380 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001444380 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001444380 us-gaap:BondsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001444380 us-gaap:BondsMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001444380 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001444380 us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001444380 us-gaap:CorporateNoteSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001444380 us-gaap:CorporateNoteSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001444380 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001444380 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001444380 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001444380 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001444380 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001444380 us-gaap:CommercialPaperMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001444380 us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001444380 us-gaap:CorporateNoteSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001444380 us-gaap:CorporateNoteSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001444380 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001444380 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001444380 us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2019-12-31 0001444380 us-gaap:AgencySecuritiesMember 2019-12-31 0001444380 us-gaap:CommercialPaperMember 2019-12-31 0001444380 us-gaap:CorporateNoteSecuritiesMember 2019-12-31 0001444380 us-gaap:CommercialPaperMember 2018-12-31 0001444380 us-gaap:CorporateNoteSecuritiesMember 2018-12-31 0001444380 us-gaap:EquipmentMember 2019-12-31 0001444380 us-gaap:EquipmentMember 2018-12-31 0001444380 us-gaap:ComputerEquipmentMember 2019-12-31 0001444380 us-gaap:ComputerEquipmentMember 2018-12-31 0001444380 us-gaap:FurnitureAndFixturesMember 2019-12-31 0001444380 us-gaap:FurnitureAndFixturesMember 2018-12-31 0001444380 us-gaap:LeaseholdImprovementsMember 2019-12-31 0001444380 us-gaap:LeaseholdImprovementsMember 2018-12-31 0001444380 us-gaap:ConstructionInProgressMember 2019-12-31 0001444380 us-gaap:ConstructionInProgressMember 2018-12-31 0001444380 nvro:RedwoodOfficeAgreementMember 2019-01-01 2019-12-31 utr:sqft 0001444380 nvro:RedwoodOfficeAgreementMember 2015-03-31 0001444380 nvro:RedwoodOfficeAgreementAdditionalExpansionPremisesMember nvro:FirstAmendmentMember 2016-12-31 0001444380 nvro:RedwoodOfficeAgreementMember 2015-03-01 2015-03-31 0001444380 nvro:RedwoodOfficeAgreementAdditionalExpansionPremisesMember nvro:FirstAmendmentMember 2019-01-01 2019-12-31 0001444380 nvro:RedwoodOfficeAgreementAdditionalExpansionPremisesMember nvro:FirstAmendmentMember 2016-12-01 2016-12-31 0001444380 nvro:RedwoodOfficeAgreementAdditionalExpansionPremisesMember nvro:SecondAmendmentMember 2017-04-01 2017-04-30 0001444380 nvro:RedwoodOfficeAgreementAdditionalExpansionPremisesMember 2017-04-30 0001444380 nvro:FacilityLeaseAgreementOneMember 2014-08-01 2014-08-31 0001444380 nvro:FacilityLeaseAgreementOneMember 2015-05-30 2015-05-31 0001444380 nvro:FacilityLeaseAgreementTwoMember 2015-03-01 2015-03-31 0001444380 nvro:FacilityLeaseAgreementTwoMember 2017-02-01 2017-02-28 0001444380 nvro:FacilityLeaseAgreementThreeMember 2017-02-01 2017-02-28 0001444380 nvro:SupplyAgreementsMember 2019-12-31 0001444380 nvro:SupplyAgreementsMember 2019-01-01 2019-12-31 0001444380 us-gaap:ServiceAgreementsMember 2019-12-31 0001444380 nvro:MayoAndVglMember us-gaap:LicensingAgreementsMember 2019-01-01 2019-12-31 0001444380 nvro:MayoFoundationMember us-gaap:LicensingAgreementsMember 2019-01-01 2019-12-31 0001444380 nvro:MayoFoundationMember us-gaap:LicensingAgreementsMember srt:MinimumMember 2019-01-01 2019-12-31 0001444380 us-gaap:LicensingAgreementsMember 2019-01-01 2019-12-31 0001444380 us-gaap:LicensingAgreementsMember 2018-01-01 2018-12-31 0001444380 us-gaap:LicensingAgreementsMember 2017-01-01 2017-12-31 0001444380 nvro:MayoFoundationMember us-gaap:LicensingAgreementsMember 2014-11-01 2014-11-30 0001444380 us-gaap:LicensingAgreementsMember 2017-07-31 0001444380 us-gaap:LicensingAgreementsMember 2017-07-01 2017-07-31 nvro:ConvertibleNote 0001444380 us-gaap:IndemnificationGuaranteeMember 2019-12-31 nvro:Patent 0001444380 nvro:BostonScientificCorporationMember 2016-12-09 0001444380 nvro:BostonScientificCorporationMember 2019-12-31 0001444380 2019-08-01 2019-08-01 0001444380 nvro:PatentInfringementMember 2019-12-31 utr:D 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember nvro:OneHundredThirtyPercentApplicableConversionPriceMember 2016-06-01 2016-06-30 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember nvro:NinetyEightPercentApplicableConversionPriceMember 2016-06-01 2016-06-30 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember srt:MaximumMember 2016-06-01 2016-06-30 0001444380 nvro:DebtLiabilityComponentMember nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2019-12-31 0001444380 nvro:DebtLiabilityComponentMember nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2018-12-31 0001444380 nvro:DebtEquityComponentMember nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2019-12-31 0001444380 nvro:DebtEquityComponentMember nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2018-12-31 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2018-01-01 2018-12-31 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2017-01-01 2017-12-31 0001444380 us-gaap:WarrantMember nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2016-06-30 0001444380 us-gaap:WarrantMember srt:MinimumMember nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2016-06-30 0001444380 us-gaap:WarrantMember srt:MaximumMember nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2016-06-30 0001444380 us-gaap:IPOMember 2014-11-10 2014-11-11 0001444380 us-gaap:CommonStockMember 2014-11-11 0001444380 2014-11-10 0001444380 nvro:TwoThousandSevenPlanMember 2019-01-01 2019-12-31 0001444380 nvro:TwoThousandFourteenEquityIncentivePlanMember 2014-10-31 0001444380 nvro:TwoThousandFourteenEquityIncentivePlanMember 2019-01-01 2019-12-31 0001444380 nvro:TwoThousandFourteenEquityIncentivePlanMember srt:MaximumMember 2019-01-01 2019-12-31 0001444380 nvro:TwoThousandFourteenEquityIncentivePlanMember srt:MinimumMember 2019-01-01 2019-12-31 0001444380 nvro:TwoThousandFourteenEquityIncentivePlanMember nvro:IncentiveStockOptionsMember 2019-01-01 2019-12-31 0001444380 nvro:TwoThousandFourteenEquityIncentivePlanMember nvro:NonQualifiedStockOptionsMember 2019-01-01 2019-12-31 0001444380 nvro:TwoThousandFourteenEquityIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2019-01-01 2019-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2016-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-12-31 0001444380 nvro:EmployeeStockOptionAndRestrictedStockMember 2017-01-01 2017-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2017-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-12-31 0001444380 nvro:EmployeeStockOptionAndRestrictedStockMember 2018-01-01 2018-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2018-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001444380 nvro:EmployeeStockOptionAndRestrictedStockMember 2019-01-01 2019-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2019-12-31 0001444380 nvro:Range1Member 2019-01-01 2019-12-31 0001444380 nvro:Range2Member 2019-01-01 2019-12-31 0001444380 nvro:Range3Member 2019-01-01 2019-12-31 0001444380 nvro:Range4Member 2019-01-01 2019-12-31 0001444380 nvro:Range5Member 2019-01-01 2019-12-31 0001444380 nvro:Range6Member 2019-01-01 2019-12-31 0001444380 nvro:Range1Member 2019-12-31 0001444380 nvro:Range2Member 2019-12-31 0001444380 nvro:Range3Member 2019-12-31 0001444380 nvro:Range4Member 2019-12-31 0001444380 nvro:Range5Member 2019-12-31 0001444380 nvro:Range6Member 2019-12-31 0001444380 nvro:PerformanceBasedRestrictedStockUnitsRSUMember srt:ChiefExecutiveOfficerMember 2019-03-01 2019-03-31 0001444380 nvro:PerformanceBasedRestrictedStockUnitsRSUMember srt:ChiefExecutiveOfficerMember srt:MinimumMember 2019-03-01 2019-03-31 0001444380 nvro:PerformanceBasedRestrictedStockUnitsRSUMember srt:ChiefExecutiveOfficerMember srt:MaximumMember 2019-03-01 2019-03-31 0001444380 us-gaap:RestrictedStockUnitsRSUMember 2016-12-31 0001444380 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-12-31 0001444380 us-gaap:RestrictedStockUnitsRSUMember 2017-12-31 0001444380 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-12-31 0001444380 us-gaap:RestrictedStockUnitsRSUMember 2018-12-31 0001444380 us-gaap:RestrictedStockUnitsRSUMember 2019-12-31 0001444380 us-gaap:EmployeeStockMember 2014-10-31 0001444380 us-gaap:EmployeeStockMember 2018-12-31 0001444380 us-gaap:EmployeeStockMember 2018-01-01 2018-12-31 0001444380 nvro:EmployeeStockPurchasePlanMember 2019-01-01 2019-12-31 0001444380 nvro:EmployeeStockPurchasePlanMember 2018-01-01 2018-12-31 0001444380 nvro:EmployeeStockPurchasePlanMember 2017-01-01 2017-12-31 0001444380 nvro:EmployeeStockPurchasePlanMember 2019-12-31 0001444380 nvro:EmployeeStockPurchasePlanMember 2018-12-31 0001444380 nvro:EmployeeStockPurchasePlanMember 2017-12-31 0001444380 us-gaap:RestrictedStockUnitsRSUMember 2019-03-01 2019-03-31 0001444380 us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0001444380 us-gaap:CostOfSalesMember 2018-01-01 2018-12-31 0001444380 us-gaap:CostOfSalesMember 2017-01-01 2017-12-31 0001444380 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-12-31 0001444380 us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-12-31 0001444380 us-gaap:ResearchAndDevelopmentExpenseMember 2017-01-01 2017-12-31 0001444380 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0001444380 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-12-31 0001444380 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-01-01 2017-12-31 0001444380 us-gaap:DomesticCountryMember 2019-12-31 0001444380 us-gaap:StateAndLocalJurisdictionMember 2019-12-31 0001444380 us-gaap:DomesticCountryMember 2018-12-31 0001444380 us-gaap:StateAndLocalJurisdictionMember 2018-12-31 0001444380 us-gaap:DomesticCountryMember 2019-01-01 2019-12-31 0001444380 us-gaap:StateAndLocalJurisdictionMember 2019-01-01 2019-12-31 0001444380 us-gaap:DomesticCountryMember us-gaap:ResearchMember 2019-12-31 0001444380 us-gaap:CaliforniaFranchiseTaxBoardMember us-gaap:ResearchMember 2019-12-31 0001444380 us-gaap:RestrictedStockMember 2019-01-01 2019-12-31 0001444380 us-gaap:RestrictedStockMember 2018-01-01 2018-12-31 0001444380 us-gaap:RestrictedStockMember 2017-01-01 2017-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-12-31 0001444380 us-gaap:ConvertibleDebtSecuritiesMember 2019-01-01 2019-12-31 0001444380 us-gaap:ConvertibleDebtSecuritiesMember 2018-01-01 2018-12-31 0001444380 us-gaap:ConvertibleDebtSecuritiesMember 2017-01-01 2017-12-31 0001444380 us-gaap:WarrantMember 2019-01-01 2019-12-31 0001444380 us-gaap:WarrantMember 2018-01-01 2018-12-31 0001444380 us-gaap:WarrantMember 2017-01-01 2017-12-31 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2019-12-31 0001444380 2019-10-01 2019-12-31 0001444380 2019-07-01 2019-09-30 0001444380 2019-04-01 2019-06-30 0001444380 2019-01-01 2019-03-31 0001444380 2018-10-01 2018-12-31 0001444380 2018-07-01 2018-09-30 0001444380 2018-04-01 2018-06-30 0001444380 2018-01-01 2018-03-31

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

☒

Annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the year ended December 31, 2019

or

☐

Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission File Number: 001-36715

 

NEVRO CORP.

(Exact name of registrant as specified in its charter)

 

Delaware

56-2568057

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

1800 Bridge Parkway

Redwood City, California 94065

(Address of principal executive offices and zip code)

(650) 251-0005

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading Symbol

 

Name of exchange on which registered

Common Stock, par value $0.001 per share

 

NVRO

 

New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes  ☒    No  ☐

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Exchange Act of 1934 (the “Exchange Act”).    Yes  ☐    No  ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

  ☒

Accelerated filer

☐

 

 

 

 

Non-accelerated filer

  ☐

Smaller reporting company

☐

 

 

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

As of June 28, 2019, the last business day of the Registrant’s most recently completed second fiscal quarter, the aggregate market value of the common stock held by non-affiliates of the registrant was approximately $1,923 million based on the closing sale price for the registrant’s common stock on The New York Stock Exchange on that date of $64.83 per share.

As of February 14, 2020, there were 31,820,724 shares of the registrant’s Common Stock outstanding.

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant’s Proxy Statement for the registrant’s 2020 Annual Meeting of Stockholders are incorporated by reference into Part III of this Form 10-K to the extent stated herein. The Proxy Statement will be filed within 120 days of the registrant’s fiscal year ended December 31, 2019.  

 

 

 

 

NEVRO CORP.

TABLE OF CONTENTS

 

 

Page No.

PART I

 

 

 

 

Item 1.

Business

1

Item 1A.

Risk Factors

27

Item 1B.

Unresolved Staff Comments

63

Item 2.

Properties

63

Item 3.

Legal Proceedings

64

Item 4.

Mine Safety Disclosures

65

PART II

 

 

 

 

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

66

Item 6.

Selected Financial Data

68

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

68

Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

83

Item 8.

Financial Statements and Supplementary Data

84

Item 9.

Changes in and Disagreements with Accountants On Accounting and Financial Disclosure

122

Item 9A.

Controls and Procedures

122

Item 9B.

Other Information

123

 

 

PART III

 

 

 

 

Item 10.

Directors, Executive Officers and Corporate Governance

124

Item 11.

Executive Compensation

124

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

124

Item 13.

Certain Relationships and Related Transactions, and Director Independence

124

Item 14.

Principal Accountant Fees and Services

124

 

 

PART IV

 

 

 

 

Item 15.

Exhibits and Financial Statement Schedules

125

Item 16.

Form 10-K Summary

131

 

Signatures

132

 

 

 

 

 

PART I

ITEM 1. BUSINESS

Overview

We are a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain.  We have developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain, and have recently launched our newest product platform, Senza® Omnia™. Our proprietary paresthesia-free HF10 therapy, delivered by our Senza system, was demonstrated in our SENZA-RCT study to be superior to traditional SCS therapy, with HF10 therapy being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy.  Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. Our SENZA-RCT study, along with our European studies, represents what we believe is the most robust body of clinical evidence for any SCS therapy. We believe the superiority of HF10 therapy over traditional SCS therapies will allow us to capitalize on and expand the approximately $2.5 billion existing global SCS market by treating both back and leg pain without paresthesia.

We launched Senza commercially in the United States in May 2015, after receiving a label from the U.S. Food and Drug Administration (FDA) supporting the superiority of our HF10 therapy over traditional SCS.  The Senza system has been commercially available in certain European markets since November 2010 and in Australia since August 2011. We have experienced significant revenue growth in the United States since commercial launch. Senza is currently reimbursed by all of the major insurance providers. In early 2017, we initiated the launch of our surgical lead, marketed as the Surpass™ surgical lead, which is now widely available in the United States, certain European countries and Australia. In January 2018, we received FDA approval of our next generation Senza II SCS system, which later gained CE Mark and TGA approval in Australia.  In the fourth quarter of 2019, we received FDA approval of our latest generation product platform, Senza Omnia, which we have recently commercially launched in the United Sates.  We expect decisions on marketing applications in Europe and Australia in the first and second half of 2020, respectively. Senza Omnia’s key innovation is enhanced programming versatility, as it delivers our proprietary HF10 therapy, but is also capable of offering all frequencies from 2 to 10,000 Hz, either individually or paired with other waveforms. This frequency range includes the broadest mix of waveform types available in the industry. We believe versatility in programming is a key factor in physician product selection because it enables physicians to address a diverse patient population. The approval of Senza Omnia also includes an improved clinician programmer, patient remote control and patient charger.

The tables below set forth our revenue from U.S. and international sales the past three years on a quarterly basis and total revenue for each of the past five years.

 

 

Q1 2017

 

 

Q2 2017

 

 

Q3 2017

 

 

Q4 2017

 

 

Q1 2018

 

 

Q2 2018

 

 

Q3 2018

 

 

Q4 2018

 

 

Q1 2019

 

 

Q2 2019

 

 

Q3 2019

 

 

Q4 2019

 

Revenue from:

(in millions)

 

U.S. sales

$

53.1

 

 

$

63.0

 

 

$

66.3

 

 

$

81.1

 

 

$

70.6

 

 

$

79.9

 

 

$

79.6

 

 

$

91.6

 

 

$

65.8

 

 

$

78.1

 

 

$

84.2

 

 

$

97.9

 

International sales

 

15.3

 

 

 

15.0

 

 

 

16.0

 

 

 

16.9

 

 

 

17.0

 

 

 

16.2

 

 

 

16.0

 

 

 

16.3

 

 

 

16.3

 

 

 

15.5

 

 

 

16.0

 

 

 

16.5

 

Total revenue

$

68.4

 

 

$

78.0

 

 

$

82.3

 

 

$

98.0

 

 

$

87.6

 

 

$

96.1

 

 

$

95.6

 

 

$

107.9

 

 

$

82.1

 

 

$

93.6

 

 

$

100.2

 

 

$

114.4

 

 

 

2015

 

 

2016

 

 

2017

 

 

2018

 

 

2019

 

Revenue from:

(in millions)

 

U.S. sales

$

24.3

 

 

$

173.3

 

 

$

263.5

 

 

$

321.8

 

 

$

326.0

 

International sales

 

45.3

 

 

 

55.2

 

 

 

63.2

 

 

 

65.5

 

 

 

64.3

 

Total revenue

$

69.6

 

 

$

228.5

 

 

$

326.7

 

 

$

387.3

 

 

$

390.3

 

With a primary focus on treating leg pain, the global market for SCS therapy was estimated to be approximately $2.5 billion in 2019.  We believe the superiority of HF10 therapy over traditional SCS therapies will allow us to capitalize on the addressable trunk and limb chronic pain market, which is estimated to be less than 10% penetrated in the United States, as well as expand the SCS market by treating other pain-related indications, such as painful diabetic neuropathy and non-surgical back pain, among others. The United States represents approximately

1

 

80% of this global market due in part to governmental reimbursement restraints in international markets. We believe that due to factors such as an aging population and an increasing number of failed back surgeries, there is continuing opportunity for an SCS therapy that effectively treats back pain to increase the size of the existing SCS market over time.

We believe that we will continue to both take share of and expand the SCS therapy market due to the unique benefits of HF10 therapy, as well as the broad therapy versatility of our product platform.  HF10 therapy is paresthesia-free therapy and has demonstrated superior efficacy when compared to traditional SCS therapies. Traditional SCS therapy generates paresthesia, a sensation typically experienced as tingling, numbness and buzzing, which overlaps the pain area. Paresthesia is often considered unpleasant or uncomfortable.  Compared to traditional SCS therapy which typically operates at 50 Hz to 60 Hz, HF10 therapy delivers spinal cord stimulation at a lower amplitude and a higher frequency waveform of 10,000 Hz. In addition, HF10 therapy relies on consistent anatomical placement of the stimulation leads across patients, thus reducing procedure variability relative to traditional SCS therapy which requires individualized lead placement to properly map paresthesia coverage. We believe the ability of HF10 therapy to deliver pain relief without paresthesia provides a substantial benefit over traditional SCS therapy to patients and physicians. However, despite its shortcomings traditional SCS therapy has a long track record of safety and, together with our product platform, can be made available to the subgroup of patients who do not receive adequate relief with HF10 therapy alone.

We believe the clinical results from our SENZA-RCT study, along with our European studies, position us with superior and compelling efficacy data. The following charts provide a comparison of HF10 therapy in both pain reduction and responder rates against the other prospective Level 1 studies conducted.

 

1.

Al-Kaisy A, et. al. Sustained effectiveness of 10 kHz high-frequency spinal cord stimulation for patients with chronic, low back pain: 24-month results of a prospective multicenter study. Pain Med. 2014;15:347-354.  Internal data on file.

 

2.

Kapural, Leonardo et. al. Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: The SENZA-RCT Randomized Controlled Trial. Anesthesiology Vol. 123 No 4. October 2015.

 

3.

Kumar K et al., Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome, Pain (2007), doi:10.1016/j.pain.2007.07.028.  6-month data shown.

 

4.

St. Jude Medical Proclaim™ Implantable Pulse Generator Clinician's Manual, Models 3660, 3662, 3665, 3667. Published on www.sjm.com October 2016.

2

 

 

1.

Al-Kaisy A, et. al. Sustained effectiveness of 10 kHz high-frequency spinal cord stimulation for patients with chronic, low back pain: 24-month results of a prospective multicenter study. Pain Med. 2014;15:347-354.  Internal data on file.

 

2.

Kapural, Leonardo et. al. Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: The SENZA-RCT Randomized Controlled Trial. Anesthesiology Vol. 123 No 4. October 2015.

 

3.

Kumar K et al., Spinal cord stimulation versus conventional medical management for neuropathic pain: A multicentre randomised controlled trial in patients with failed back surgery syndrome, Pain (2007), doi:10.1016/j.pain.2007.07.028.  6-month data shown.

 

4.

St. Jude Medical Proclaim™ Implantable Pulse Generator Clinician's Manual, Models 3660, 3662, 3665, 3667. Published on www.sjm.com October 2016.

We believe we have built competitive advantages through our proprietary technology, clinical evidence base, strong track record of execution with over 55,000 patients implanted with Senza systems, extensive intellectual property and a proven management team with substantial neuromodulation experience. With the well-demonstrated superior efficacy of our HF10 therapy, we aim to continue to drive adoption and penetration in the U.S. market, which represents the largest opportunity in SCS, and expand patient access to HF10 therapy by investing in the development of evidence for new indications such as chronic painful neuropathies (including painful diabetic neuropathy) and non-surgical refractory back pain. On this front, we initiated two randomized controlled trials in 2018, SENZA-PDN and SENZA-NSRBP, which are evaluating HF10 therapy for the treatment of painful diabetic neuropathy and non-surgical refractory back pain, respectively.

The SENZA-PDN study is the largest randomized controlled trial (RCT) conducted in the field of spinal cord stimulation with 216 randomized patients. The study is evaluating HF10 therapy among patients diagnosed with painful diabetic neuropathy (PDN) and refractory to conventional medical management (CMM). Patients were randomized one to one to CMM alone or CMM with HF10 therapy. We presented three-month primary outcome data in January 2020 at the North American Neuromodulation Society (NANS) conference. The primary outcome was a composite of safety and efficacy, specifically including greater than or equal to 50% pain relief and no worsening in neurological deficit versus the baseline. 86% of patients in the HF10 therapy plus CMM arm met the three-month endpoint, compared with 5% in the CMM only arm. Patients in the SENZA-PDN study will be followed for 24 months. We plan to use data from the SENZA-PDN study, most likely the forthcoming data from the 12-month endpoint, if positive, to seek approval to add specific PDN language in our labeling and support expanded reimbursement payor coverage. The SENZA-PDN study is designed to provide long-term clinical data of critical end-points up to 24 months of follow-up.

Market Overview

Existing Treatments for Chronic Pain and Limitations

Chronic pain has been defined as pain that lasts longer than the time required for tissues to heal, which is often considered to be three months.  Patients who present with chronic pain are typically placed on a treatment progression plan. Initial medical management typically includes behavioral modification, exercise, physical therapy

3

 

and over-the-counter analgesics and non-steroidal anti-inflammatory drugs. When early stage medical management is not sufficient for the treatment of chronic leg and back pain, patients may progress to interventional techniques including steroid injections or nerve blocks. Patients who do not respond to these more conservative treatments are considered candidates for more advanced therapies.  These more advanced therapies include spine surgery, treatment with oral opioids and SCS.  Spine surgery, while a common invasive procedure, can result in complications such as Failed Back Surgery Syndrome (FBSS) a condition where pain persists despite the procedure, and spinal surgery often fails to treat certain types of chronic pain such as severe neuropathic back pain.  Oral opioids, while reducing the patient’s perception of pain, lack clinical evidence to support long-term usage and can cause multiple complications and side-effects including nausea, vomiting and dizziness.  Further, opioids present a high risk of addiction and abuse.    

Traditional Spinal Cord Stimulation and Limitations

SCS is a type of neuromodulation technology that utilizes an implantable, pacemaker-like device to deliver electrical impulses to the spinal cord to treat chronic pain.  Traditional SCS therapy is designed to induce paresthesia, a sensation typically experienced as tingling, numbness and buzzing, which overlaps the area of pain with the intent of masking pain perception. The electrical pulses are delivered by small electrodes on leads that are placed near the spinal cord and are connected to a battery-powered generator implanted under the skin. Traditional SCS therapy is currently indicated as a treatment for chronic pain of the trunk and limbs in patients who failed conventional medical management. Traditional SCS therapy is considered to be a minimally invasive and reversible therapy that may provide greater long-term benefits over more invasive surgical approaches or opioids. The most common use for traditional SCS therapy is for neuropathic pain conditions such as FBSS.

Traditional SCS therapy generally consists of two phases, an evaluation period, also called the trial period, which typically lasts several days, followed by a permanent implant for those patients who experience a successful trial period. The trial period involves a percutaneously placed insulated wire, called a lead, which a physician implants near the spinal cord using a needle. During the trial period, a temporary external system is used by patients and physicians for evaluating whether traditional SCS therapy is effective. If the trial period is successful, a permanent system is implanted in the patient. The success criterion is typically an approximate 50% reduction in pain during the evaluation period. For those patients that proceed to the permanent implant procedure, we believe that approximately 30% to 40% of U.S. procedures are completed using surgical leads and the remaining are completed using percutaneous leads.

A key part of the permanent system is the implantable pulse generator (IPG) which is a miniaturized version of the external stimulator. The IPG should provide the patient with multiple years of use and can be either rechargeable or non-rechargeable. Due to payor constraints in certain European countries, the transition from primary cell IPGs to rechargeable IPGs has been slow in those markets. In the United States and Australia, the majority of IPGs implanted are rechargeable.

Traditional SCS products have required paresthesia to provide pain relief, and consequently, paresthesia coverage has been used as a surrogate metric for successful pain relief. Paresthesia is often considered unpleasant or uncomfortable and is sometimes made worse by a shocking or jolting sensation with changes in posture. Unpleasant sensations can be caused by lead movement closer to the spinal cord or away from it as the patient moves, resulting in variation in paresthesia intensity. Paresthesia is also a constant reminder of the patient’s chronic condition. Due to the distraction of paresthesia, patients with traditional SCS devices are instructed not to drive or operate machinery when the device is active. Medtronic plc (Medtronic) has released a survey showing that 71% of patients find paresthesia uncomfortable at times. As such, innovation in the SCS market has historically focused on technologies that optimize traditional SCS therapy’s ability to create more precise paresthesia fields. Even with successful paresthesia coverage, patients still may not receive pain relief or often lose pain relief after a period of time.

Traditional SCS procedures also require physicians to perform the complex and often time-consuming process of paresthesia mapping. This mapping process requires a patient to be sedated for the lead placement, then awakened and repeatedly questioned in order for the physician to assess paresthesia coverage over the patient’s area of pain and reposition and reprogram the leads to redirect the paresthesia. This process creates variability in the procedure and a complicated anesthesia management process, impacting the physician’s schedule and patient comfort. The

4

 

primary objective of traditional SCS therapy is to create a stimulation program that covers the areas of pain without creating paresthesia beyond the pain areas, given that this can be uncomfortable and difficult to tolerate.

Traditional SCS technology involves the delivery of low frequency electrical impulses, or waveforms, to the spinal cord.  Recent developments in traditional SCS have resulted in alternative waveforms, some of which are variations of low frequency waveforms at sub-threshold amplitudes aimed at reducing the reliance on paresthesia.  For example, Abbott Laboratories has developed a SCS system that offers an alternate low frequency waveform called BurstDR.  Medtronic is promoting a programming approach called DTM™ (Differential Target Multiplexed) which involves frequencies up to 1,200 Hz. Additionally, Boston Scientific is now offering sub-threshold therapy at frequencies below 1.2 kHz.

Our Solution for Chronic Pain

HF10 Therapy

Our HF10 therapy is designed to deliver innovative neuromodulation solutions for treating chronic pain based on what we believe to be the best clinical evidence available. By overcoming many of the limitations of traditional SCS therapy, our HF10 therapy offers superior efficacy for patients and provides significant advantages to physicians and hospitals. We believe the advantages of our proprietary HF10 therapy over traditional SCS include:

 

•

Demonstrated superior efficacy data for both leg and back pain: In our SENZA-RCT pivotal study, HF10 therapy was demonstrated to provide significant and sustained back pain relief in addition to leg pain relief. HF10 therapy was shown in both number of patients that respond and in treatment efficacy to be superior to traditional SCS therapy as it was nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain. Our SENZA-RCT study, along with the previously completed European studies, represent what we believe is the most robust body of clinical evidence for any SCS therapy. We believe that the superior efficacy results and robust data provided in our pivotal clinical trials will drive increased adoption of our HF10 therapy among patients, payors and providers and may enable us to gain significant market share in the approximately $2.5 billion existing global SCS market in 2018, which is primarily based on treating leg pain. In addition, we believe our efficacy data in back pain will allow us to expand the SCS market under current reimbursement regimes by meeting demand from back pain patients who are largely untreated by traditional SCS therapies.

 

•

Paresthesia free pain relief for patients:  HF10 therapy offers the notable benefit to patients of achieving significant and sustained pain relief without paresthesia, thus enabling our patients to avoid the uncomfortable shocking or jolting sensations commonly associated with paresthesia, and removing a major barrier for many patients who may otherwise benefit from SCS therapy.

 

•

Anatomical lead placement for physicians. Since HF10 therapy relies on consistent anatomical lead placement, it removes the cumbersome process of paresthesia mapping that is required by traditional SCS therapy, reducing variability in the operating procedure and offering a significant benefit to both physicians and hospitals by reducing variability of procedures.

 

•

Ability to treat a broader group of chronic pain patients: Our HF10 therapy is a platform technology that we believe can provide treatment benefits for a broader group of chronic pain indications. We are currently investigating the use of HF10 therapy to address additional indications such as chronic upper limb and neck pain, painful neuropathies and non-surgical refractory back pain. Based on analysis from our SENZA-RCT and European studies, we believe HF10 therapy may be an attractive treatment option for some non-surgical refractory back pain patients due to its cost, reversibility and initial trial period. Due to the removal of paresthesia, we believe HF10 may also be an effective therapy for patients with chronic upper limb and neck pain as it does not create the intense discomfort that traditional SCS generates for patients with chronic upper limb and neck pain when leads are placed in the cervical spine.

5

 

Our Growth Strategy

Our mission is to be the neuromodulation leader in the treatment of chronic pain by developing innovative, evidence-based solutions. To accomplish this objective we intend to:

 

•

Earn market share through a successful launch of Senza Omnia: Senza Omnia offers the most versatile platform in SCS as it includes the broadest frequency range (2 to10,000 Hz), the most waveform capabilities and the unique ability to offer HF10 therapy. In 2020, we will continue to expand our commercialization of Omnia in the United States and, pending regulatory approvals, would plan to launch Omnia launches in both Europe and Australia. We intend to position Omnia as the most versatile product available in the market, and we believe that it will have broad appeal to clinicians offering SCS.

 

•

Expand the existing SCS market by treating back pain: We believe we are expanding the existing SCS market by delivering a system that provides meaningful treatment for chronic back pain, which we believe represents a significant opportunity in the global SCS market. With traditional SCS therapy, patients who experience predominant back pain are associated with lower levels of treatment success. Consequently, patients with back pain are typically not recommended for treatment with traditional SCS therapy due to the difficulty of achieving and maintaining pain coverage. In contrast to traditional SCS therapy, we believe HF10 therapy is positioned to expand the existing SCS market by effectively treating back pain in addition to leg pain.

 

•

Communicate the clinically demonstrated, superior efficacy of HF10 therapy to patients, physicians and payors globally: Given our robust clinical evidence that demonstrates the superior efficacy of our HF10 therapy, we believe we will be able to position our therapy with patients, providers and payors in a differentiated way. Given that our SENZA-RCT pivotal study has demonstrated superiority for both back and leg pain in a head-to-head comparison with traditional SCS, we are able to differentiate HF10 therapy by communicating its superior clinical benefits and advantages to patients, physicians and payors.

 

•

Invest in research and development to drive innovation: We are extending our novel and proprietary technologies into a series of product enhancements with the goal of improving the treatment of chronic pain. We also expect to continue developing enhancements to Senza to further increase performance and introduce new benefits including next generation IPGs, enhanced software, updated accessories and enhanced MRI capabilities.  We believe that further product enhancements if and when completed will drive continued adoption of our technology platform and further validate the advantages and benefits of our HF10 therapy.

 

•

Scale our business to achieve cost and production efficiencies: We plan to improve the efficiency of our third-party manufacturing processes, which we believe will lower our per unit manufacturing cost. We expect to continue to scale our manufacturing operations as we expand Senza sales volumes in the United States.

Growth Opportunities in Other Chronic Pain Indications

We plan to use our platform technology to generate evidence on HF10 therapy for use in other chronic pain indications, including chronic non-surgical back pain, and painful neuropathies. There can be no assurance that we will be successful in generating evidence for HF10 therapy in other indications or in receiving additional regulatory approvals and reimbursement coverage to promote Senza and HF10 therapy for use in other indications. Below are two areas where preliminary results have been promising:

Non-Surgical Back Pain

One of the most common uses for SCS is for neuropathic pain conditions such as FBSS. The incidence of patients that will develop FBSS following lumbar spinal surgery is estimated to be within the range of 10% to 40%. However, in addition to having applicability for treating FBSS patients, there is a potential for SCS to provide benefit for patients suffering from chronic pain who are not surgical candidates.  HF10 therapy could provide an attractive treatment option for these patients, as a subset analysis of non-surgical patients from our SENZA-RCT and European studies, respectively, found a decrease in back pain VAS scores from 7.2 to 2.5 (12 months, n=11) and 8.1

6

 

to 3.4 (24 months, n=14), as well as a decrease in leg pain VAS scores from 7.1 to 2.3 (12 months, n=11) and 5.9 to 2.8 (24 months, n=14). More recent results in patients who were not candidates for major spine surgery and treated with HF10 therapy in a study led by Dr. Adnan Al-Kaisy demonstrated similar promising results. In this study, patients experienced reduced back pain VAS and Oswestry Disability Index (ODI) scores from baseline of 87% and 63% respectively at 36 months (n=17). In addition to pain reduction and reduced disability, a reduction in opioid use was observed with 90% of the patients using opioids at the start of the study compared to 12% at the end of the study. The results of this study led to the initiation of the SENZA-NSRBP RCT which will compare HF10 therapy delivered in conjunction with conventional medical management (CMM) to CMM alone in non-surgical refractory back pain (NSRBP) patients.

Painful Neuropathies

The American Chronic Pain Association estimates that more than 15 million people in the United States and Europe have some degree of neuropathic pain. More than two out of every 100 people are estimated to have peripheral neuropathy, with the incidence rate increasing to eight in every 100 for people aged 55 or older. The diminished quality of life and increased disability associated with peripheral neuropathy results in significant workforce and healthcare costs. Various treatments currently exist, but have limited efficacy. As such, we have initiated an initial study to determine if HF10 therapy could help this patient group. Results of a prospective, multicenter feasibility study treating chronic intractable pain of the limbs from peripheral polyneuropathy using HF10 therapy demonstrated a decrease in mean VAS pain score from 7.5 at baseline (N=18) to 1.9 at three months post-implant (the primary endpoint), 2.8 at twelve months and 1.4 at twenty-four months.  Subject deemed responders was 78% at three months, 69% at twelve months and 88% at twenty-four months (presented at NANS in January 2019). The results from this study led to the initiation of the SENZA-PDN RCT.

We recently presented the preliminary outcome data from SENZA-PDN which demonstrated greater than or equal to 50% pain relief and no worsening in neurological deficit versus baseline, with 86% of patients in the HF10 therapy plus CMM arm reaching the endpoint, compared with 5% in the CMM only arm.

Clinical Data

To support development of our proprietary HF10 therapy, the technology was evaluated in preclinical studies and further studied in prospective clinical trials, some of which have been published. Key highlights of our SENZA-RCT pivotal study are as follows:

 

•

Our SENZA-RCT study results demonstrated the superiority of HF10 therapy to traditional SCS therapy on all primary and secondary endpoints through 24 months.

 

•

HF10 therapy was nearly twice as successful in treating back pain as traditional SCS therapy, with 84.3% of patients receiving HF10 therapy reporting 50% or more pain relief at three months, as compared to 43.8% of patients receiving traditional SCS therapy. The superiority of HF10 therapy for treating back pain was maintained through the 24-month follow-up period of the study.

 

•

HF10 therapy was 1.5 times as successful in treating leg pain as traditional SCS therapy, with 83.1% of patients receiving HF10 therapy, as compared to 55.5% of patients receiving traditional SCS therapy, reporting 50% or more pain relief at three months, results that were superior. The superiority of HF10 therapy for treating leg pain was maintained through the 24-month follow-up period of the study.

 

•

HF10 therapy provided a 69.2% reduction in back pain as measured by VAS, versus 44.2% for traditional SCS therapy, at three months, results that were superior. The superiority of HF10 therapy for reducing back pain was maintained through the 24-month follow-up period of the study.  HF10 therapy provided a 72.8% reduction in leg pain as measured by VAS, versus 51.5% for traditional SCS therapy, at three months, results that were superior. The superiority of HF10 therapy for reducing leg pain was maintained through the 24-month follow-up period of the study.  Superiority of HF10 therapy to traditional SCS therapy demonstrated for both back and leg pain at each designated study endpoint throughout 24 months.

7

 

 

•

Patients receiving HF10 therapy did not report paresthesia or uncomfortable stimulation at three months. In comparison, 46.5% of patients receiving traditional SCS therapy reported uncomfortable stimulation at three months.

 

•

Two-thirds of HF10 therapy patients had a VAS pain score of less than or equal to 2.5 on a scale of 0 to 10 for back pain at three months (which we define as achieving remitter status), which is nearly twice the number of traditional SCS therapy patients (35%) with a VAS pain score of less than or equal to 2.5, results that were statistically superior. The superiority of HF10 therapy for achieving remitter status for back pain was maintained through the 24-month follow-up period of the study.

 

•

Two-thirds of HF10 therapy patients had a VAS pain score of less than or equal to 2.5 on a scale of 0 to 10 for leg pain at three months, a much greater number than traditional SCS therapy patients (40%) with a VAS pain score of less than or equal to 2.5, results that were statistically superior. The superiority of HF10 therapy for achieving remitter status for leg pain was maintained through the 24-month follow-up period of the study.

 

•

Safety outcomes were consistent across the treatment groups, with the exception of uncomfortable paresthesia in traditional SCS patients, which was not in HF10 therapy patients.

The results from the clinical studies have been consistent across studies and across outcome measures. Our initial prospective multicenter European clinical study (the EU study) were consistent with our subsequent findings in our prospective, comparative, randomized, controlled U.S. pivotal study (SENZA-RCT study). In the two-year follow up of the EU study, average back pain VAS was reduced from 8.4 at baseline to 2.8 at 12 months to 3.3 at 24 months. Average leg pain was reduced from 5.4 VAS pain level at baseline to 2.0 at 12 months to 2.3 at 24 months. Additionally, for responder rates, 60% of the implanted patients had at least 50% back pain relief and 71% had at least 50% leg pain relief. Disability as measured by Oswestry Disability Index (ODI) improved by an average of 15 points at 24 months, a clinically and statistically significant improvement. The following table summarizes key outcomes for implanted subjects in our EU and SENZA-RCT studies.

 

 

Month 3

Month 6

Month 12

Month 24

 

EU

RCT

EU

RCT

EU

RCT

EU

RCT

Back pain responders

 

 

 

 

 

 

 

 

HF10 therapy (%)

82.9

84.3

73.6

76.4

70.1

78.7

60.0

76.5

Traditional SCS (%)

 

43.8

 

52.5

 

51.3

 

49.3

Superiority p-value

 

<0.001

 

0.001

 

<0.001

 

<0.001

Leg pain responders

 

 

 

 

 

 

 

 

HF10 therapy (%)

82.9

83.1

86.0

80.9

65.0

80.9

71.1

72.9

Traditional SCS (%)

 

55.0

 

55.0

 

50

 

49.3

Superiority p-value

 

<0.001

 

<0.001

 

<0.001

 

<0.001

Back pain reduction from Baseline

 

 

 

 

 

 

 

 

HF10 therapy (%)

71.3

69.2

67.7

62.4

64.9

66.4

59.6

66.9

Traditional SCS (%)

 

44.2

 

44.3

 

44.7

 

41.1

Superiority p-value

 

<0.001

 

<0.001

 

<0.001

 

<0.001

Leg pain reduction from Baseline

 

 

 

 

 

 

 

 

HF10 therapy (%)

75.3

72.8

73.4

66.9

61.6

69.5

61.6

65.1

Traditional SCS (%)

 

51.5

 

49.9

 

48.0

 

46.0

Superiority p-value

 

<0.001

 

0.002

 

<0.001

 

0.002

8

 

Our SENZA-RCT pivotal study was a prospective, randomized, multi-center study, conducted across 11 U.S. clinical trial sites, comparing the safety and effectiveness of Senza delivering HF10 therapy, which we refer to as the test to Boston Scientific’s FDA-approved Precision Plus system, delivering traditional SCS therapy, which we refer to as the control. Each included patient was required to have a leg and back pain VAS score of at least 5. Among the 198 chronic pain patients who were randomized for treatments, 171 had a successful therapy evaluation phase, or trial phase, and were implanted with an SCS system. The study was designed as a non-inferiority trial and met its primary and secondary endpoints. Statistical analysis also demonstrated the superior efficacy of HF10 therapy over traditional SCS therapy for all primary and secondary endpoints.

The 12-month outcomes for HF10 therapy in our SENZA-RCT pivotal study were published in Anesthesiology and are consistent with the outcomes from our European clinical study, the two year results of which have been published in the Pain Medicine journal of the American Academy of Pain Medicine. The 24-month SENZA-RCT results were presented in December 2015 at the annual meeting of the North American Neuromodulation Society, showing sustained superiority of HF10 therapy compared with traditional SCS in treating both back and leg pain over the 24-month follow-up period. The 24-month outcomes in our SENZA-RCT pivotal study were published in Neurosurgery.

Patients with chronic pain are generally classified by physicians based on the location of their pain, for example whether their worst pain is predominant back, predominant leg, mixed back and leg, upper limb, neck or other. The adoption of SCS to date has been driven primarily by the treatment of patients whose worst pain is in their legs and for whom other treatment approaches have failed. We believe that broader utilization of traditional SCS therapy has been restrained by the lack of prospective randomized clinical evidence supporting SCS broadly and, in particular, demonstrating an ability to treat back pain.

Safety Data (EU and RCT Studies)

Safety results of our SENZA-RCT pivotal study were generally consistent between the test and control groups. Study-related serious adverse events (SAEs) occurred in 4.0% of HF10 therapy subjects (n=4) compared with 7.2% of traditional SCS therapy subjects (n=7; p = 0.37). In addition to the SAEs described above, there were two deaths, one of which was study-related and resulted from a myocardial infarction of a subject randomized to traditional SCS therapy that occurred during the implant procedure. The other death occurred outside the study period in the test group and resulted from a malignant hepatic neoplasm. The most common study-related AEs were implant site pain (in 11.9% of HF10 therapy and 10.3% of traditional SCS therapy subjects) and uncomfortable paresthesia (in 11.3% of traditional SCS therapy subjects and in no HF10 therapy subjects). Lead migration leading to revision occurred in 3.0% of HF10 therapy and 5.2% of traditional SCS therapy participants. Importantly, neurological assessment revealed no stimulation-related neurological deficits in either treatment group. Also, there were no stimulation-related SAEs in either arm.

Safety results of our EU study demonstrated no evidence of neurologic deficit or dysfunction attributable to prolonged delivery of HF10 therapy. Further, investigators reported that adverse events were similar in nature and frequency to those seen with traditional SCS therapy. The most common adverse events in both arms of the study were implant site pain, infection and lead migration.

Our Senza System

The Senza system is approved to create electrical impulses from 2 Hz to 10,000 Hz, including our proprietary HF10 therapy, which allows for pain relief without paresthesia. HF10 therapy delivers proprietary waveforms at 10,000 Hz pulse rate with a statistically driven and clinically verified programming algorithm.

Senza, similar to other commercially available SCS systems, consists of leads, a trial stimulator, an IPG, surgical tools, a clinician laptop programmer, a patient remote control and a mobile charger. These components enable physicians to implant the leads and the IPG, and patients to operate the system.  Below is a depiction of our new Senza Omnia product, as well as the new patient remote control and charger.

 

9

 

Implantable Pulse Generator (IPG): The IPG contains a rechargeable battery and electronics that deliver electrical pulses to the lead. It can connect to one or two leads, and up to 16 electrodes. It is a programmable device and can deliver the required customized programs for each patient. The IPG is rechargeable and is placed surgically under the skin, usually above the buttock or the abdomen. The Senza, Senza II and Senza Omnia SCS systems are approved with “at least a 10 year battery life”.

 

Percutaneous Leads: The percutaneous leads vary in length and are thin, insulated medical wires in a cylindrical, flexible and steerable shape that conduct electrical pulses from the IPG to near the spinal cord. The insertion of the percutaneous leads can also be minimally invasive as they can be inserted in the epidural space through a needle.

 

Surpass Surgical Leads: The Surpass surgical leads are similar to our percutaneous leads but in a larger paddle-shaped format that provides a larger surface area that broadens exposure of the lead along the vertebrae. Our Surpass surgical leads received initial approval from the FDA in late 2016 with a further approval received in January 2017.  In April of 2017, the surgical lead received CE Mark and TGA in approval in Australia.  We believe

10

 

the Surpass leads give us access to up to approximately 30% to 40% of the U.S. SCS market that we previously did not address without a surgical lead.

 

Trial Stimulator: The trial stimulator contains electronics that deliver electrical pulses to the lead. It is an external device that is worn around the waist during the evaluation period that typically lasts several days. It is powered by batteries.

Surgical Tools: Surgical tools include percutaneous insertion needles that are used to introduce the lead into the epidural space, a variety of stylets that give physicians the ability to steer and deliver the lead to the desired location, anchors to secure the leads and tunneling tools that provide access from the lead insertion site to the location of the IPG.

Programmer:  The clinician laptop programmer contains proprietary software that allows the customized per patient programming of the IPG. It can non-invasively interrogate the IPG and transmit programming information and download diagnostic information.

Patient Remote Control: The patient remote control is a handheld device that allows patients to turn their stimulation on and off and change programs uploaded to their IPG.

Charger: The charger recharges the IPG from outside the body. To charge, the charging coil of the charger is placed over the location of the IPG and then initiated by pushing a button on the charger. The charger is mobile and can be worn around the waist using a belt when charging is needed, so that the patient can perform various tasks while charging. Charging sessions are usually performed daily and are expected to average approximately 45 minutes a day.

Third-Party Coverage and Reimbursement

In the United States, the primary purchasers of Senza are hospitals, outpatient surgery centers and physician offices. These purchasers bill various third-party payors, such as Medicare, Medicaid and private health insurance plans for the healthcare services associated with the SCS procedure. Government agencies and private payors determine whether to provide coverage for specific procedures. In the United States, the Centers for Medicare & Medicaid Services (CMS) administers the Medicare and Medicaid programs (the latter, along with applicable state governments). As the single largest payor, this program has a significant impact on other payors’ payment systems.

Generally, reimbursement for services performed at a hospital or outpatient surgery center are reported using billing codes issued by the American Medical Association (AMA) known as Current Procedural Terminology (CPT) codes. Physician reimbursement under Medicare generally is based on a fee schedule and determined by the relative values of the professional service rendered.  Hospital outpatient services, reported by CPT codes, are assigned to clinically relevant Ambulatory Payment Classifications (APCs) used to determine the Medicare payment amount for services provided. In addition, CMS and the National Center for Health Statistics (NCHS) are jointly responsible for overseeing changes and modifications to billing codes used by hospitals to report inpatient procedures, known as ICD-10-PCS codes on and after October 1, 2015. In the United States, CMS approved a transitional pass-through

11

 

payment for High-Frequency Stimulation under the Medicare hospital outpatient prospective payment system effective January 1, 2016 and expired December 31, 2017, assigning a new Healthcare Common Procedure Coding System (HCPCS) Level II billing code to describe High-Frequency Stimulation (C1822).  This pass-through payment for HF10 therapy was in addition to the established reimbursement for spinal cord stimulation implant procedures and devices.  CMS determined that the Senza SCS System delivering HF10 therapy met the criteria for a new transitional pass-through device category based on evidence submitted from our SENZA-RCT study. We believe that SCS procedures using Senza are adequately described by existing CPT, HCPCS II and ICD-10-PCS codes for the implantation of spinal cord stimulators and related leads performed in various sites of care.

Medicare reimbursement rates for the same or similar procedures vary due to geographic location, nature of the facility in which the procedure is performed (i.e., hospital outpatient department or outpatient surgery centers) and other factors. Although private payors’ coverage policies and reimbursement rates can differ significantly from payor to payor, the Medicare program is frequently used as a model for how private payors and other governmental payors develop their coverage and reimbursement policies for healthcare items and services, including SCS procedures. For example, certain regional Blue Cross Blue Shield plans previously denied coverage for Senza on the basis that high-frequency neuromodulation is investigational and/or experimental. We continue to engage in efforts to convince such payors of the advantages of HF10 therapy, however, there can be no assurances that we are successful in overturning any negative coverage decisions by private health insurance plans, should they arise. In addition, payors continually review new technologies for possible coverage and can, without notice, deny coverage for these new products and procedures. As a result, the coverage determination process is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of our products to each payor separately, with no assurance that coverage and adequate reimbursement will be obtained, or maintained if obtained.

Outside the United States, reimbursement levels vary significantly by country, and by region within some countries. Reimbursement is obtained from a variety of sources, including government-sponsored and private health insurance plans, and combinations of both. Some countries will require us to gather additional clinical data before granting broader coverage and reimbursement for our products. It is our intent to complete the requisite clinical studies and obtain coverage and reimbursement approval beyond what we have today in countries where it makes economic sense to do so.

Product Development and Research Development

Our objective is to continue to improve patient outcomes and further expand patient access to HF10 therapy through enhancements to Senza and the development of new indications. Research and development (R&D) expenses were $37.6 million, $48.5 million and $59.0 million, for the years ended December 31, 2017, 2018 and 2019, respectively.

Since the launch of the initial Senza system, we have introduced a number of product enhancements. These include a short-tip version of the lead, new lengths of the lead, a surgically placed paddle lead, an active anchor with improved performance over silicon anchors, a second generation active anchor with smaller volume, lead adaptors that allow use of competitor leads already implanted in patients, upgraded clinician programmer software, a number of next generation IPGs which are conditionally safe for MRI scans anywhere on the body, and our Surpass surgical lead to complement our percutaneous lead. We also expect to continue developing enhancements to further increase performance and introduce new benefits including next generation IPGs and enhanced MRI capabilities. There can be no assurance that we will be successful in these efforts or in receiving any required regulatory approvals.

Sales and Marketing

United States

In 2019, we continued to grow our U.S. sales organization, which represents our main channel to communicate with our customers. Our sales representatives target physician specialties involved in SCS treatment decisions, including neurosurgeons, physiatrists, interventional pain specialists and orthopedic spine surgeons. In addition, our commercial team plans to continue to create demand for Senza among additional stakeholders involved in the SCS treatment decision, including third-party payors, hospitals administrators and SCS patients and their

12

 

families. We have also developed a clinical support team in order to provide ongoing support to physicians and patients for the use of Senza.

International

We sell Senza in Europe and Australia through a combination of our direct sales force and a network of sales agents and independent distributors. We began our direct sales operations in the United Kingdom in late 2010 and to date have expanded our direct sales operations to Austria, Australia, Belgium, Germany, Luxembourg, Netherlands, Norway, Sweden and Switzerland. We utilize sales agents and independent distributors to sell in other countries.

Competition

We compete in the SCS market for chronic pain. We also compete with spine surgeries, in particular re-operations. Currently, our major competitors are Medtronic, Boston Scientific and Abbott Laboratories, who have obtained regulatory approval for SCS systems. We believe that the primary competitive factors in the market are:

 

•

Sales force experience and access

 

•

Published clinical efficacy data

 

•

Product support and service

 

•

Effective marketing and education

 

•

Company brand recognition

 

•

Clinical research leadership

 

•

Technological innovation, product enhancements and speed of innovation

 

•

Pricing and reimbursement

 

•

Product reliability, safety and durability

 

•

Ease of use

 

•

Physician advocacy and support

Many of our competitors have greater capital resources, more established operations, longer commercial histories and more extensive relationships with physicians. They also have wider product offerings within neuromodulation and in other product categories, providing them with greater supplier power and with more opportunities to interact with stakeholders involved in purchasing decisions. We also face competition to recruit and retain qualified sales and other personnel.

We expect our competitors to launch new products and release additional clinical evidence within the next few years. For example, Abbott Laboratories received FDA approval for a SCS system that offers an alternate low frequency waveform called BurstDR, and in February 2016, the company gained approval for a neuromodulation system that stimulates the dorsal root ganglion for treatment of focal pain and complex regional pain syndrome, in each case, using pivotal clinical studies for each therapy to support the FDA approval process.  Medtronic gained FDA approval for the Intellis™ spinal cord stimulator in September of 2017, and in January of 2020 announced the purchase a company called Stimgenics, which includes a proprietary SCS waveform called Differential Target Multiplexed (DTM). Additionally, Boston Scientific broadly launched the WaveWriter™ SCS system in January 2019 and also promotes the results of a sub-threshold therapy through their WHISPER, COMBO and HALO studies. Additionally, there are a number of emerging competitors at various stages of development. Stimwave has developed and is commercializing a minimally invasive stimulation system that employs an externally worn power source and radio frequency transmitter.  Nalu Medical, Inc. (Nalu Medical) and Neuspera Medical Inc. (Neuspera Medical) are also pursuing a similar approach as well.  Saluda is developing and testing a low frequency closed loop system for the treatment of chronic pain.

13

 

Intellectual Property

We actively seek to protect the intellectual property and proprietary technology that we believe is important to our business, which includes seeking and maintaining patents covering our technology and products, proprietary processes and any other inventions that are commercially or strategically important to the development of our business. We also rely upon trademarks to build and maintain the integrity of our brand, and we seek to protect the confidentiality of trade secrets that may be important to the development of our business. For more information, please see “Risk Factors—Risks Related to Intellectual Property.”

Patents, Trademarks and Proprietary Technology

As of December 31, 2019, we owned 198 issued patents globally, of which 129 were issued U.S. utility patents, 2 were issued U.S. design patents, 40 were issued Australian utility patents, one was an Australian design patent, 17 were issued European utility patents, one was a European design patent, 5 were issued German Utility Models, 4 were issued Japanese patents, one was an issued Korean utility patent, one was an issued Korean design patent, two were issued Chinese utility patents and one was an issued Chinese design patent. In general, our patents cover SCS systems that are configured to generate non-paresthesia producing therapy signals at frequencies between 1,500 Hz to 100,000 Hz, as well as additional aspects, algorithms and components of the Senza system and HF10 therapy. As of December 31, 2019, we held 150 patent applications pending globally, of which 95 were patent applications pending in the United States, and 55 were patent applications pending across Europe, Australia, Canada, Japan, China and Korea. We also have an exclusive license from the Mayo Foundation to two U.S. issued patents and one U.S. pending patent application. All of our current issued patents are projected to expire between 2028 and 2038.

As of December 31, 2019, our trademark portfolio contained 29 trademark registrations, of which there were 6 U.S. trademark registrations, 7 Australian trademark registrations, 8 European trademark registrations, one U.K. trademark registration, 2 Japanese trademark registrations, one Norwegian trademark registration, 2 Swiss trademark registration and 2 Turkish trademark registrations.  Our trademark portfolio also contained 67 pending applications, of which 12 are pending U.S. trademark applications and 55 are pending foreign trademark applications.

The term of individual patents depends on the legal term for patents in the countries in which they are granted. In most countries, including the United States, the patent term is generally 20 years from the earliest claimed filing date of a non-provisional or priority patent application. We cannot assure that patents will be issued from any of our pending applications or that, if patents are issued, they will be of sufficient scope or strength to provide meaningful protection for our technology. Notwithstanding the scope of the patent protection available to us, a competitor could develop treatment methods or devices that are not covered by our patents. Furthermore, numerous U.S. and foreign issued patents and patent applications owned by third parties exist in the fields in which we are developing products. Because patent applications can take many years to issue, there may be applications unknown to us, which applications may later result in issued patents that our existing or future products or proprietary technologies may be alleged to infringe.

There has been substantial litigation regarding patent and other intellectual property rights in the medical device industry. In the future, we may need to engage in litigation to enforce patents issued or licensed to us, to protect our trade secrets or know-how, to defend against claims of infringement of the rights of others or to determine the scope and validity of the proprietary rights of others. Litigation could be costly and could divert our attention from other functions and responsibilities. Adverse determinations in litigation could subject us to significant liabilities to third parties, could require us to seek licenses from third parties and could prevent us from manufacturing, selling or using Senza, any of which could severely harm our business.

We also rely upon trade secrets, know-how and continuing technological innovation, and may rely upon licensing opportunities in the future, to develop and maintain our competitive position. We seek to protect our proprietary rights through a variety of methods, including confidentiality agreements and proprietary information agreements with suppliers, employees, consultants and others who may have access to proprietary information, under which they are bound to assign to us inventions made during the term of their employment.

14

 

The Mayo License

In October 2006, we entered into a license agreement (the Mayo License) with the Venturi Group, LLC (VGL) and the Mayo Foundation for Medical Education and Research (the Mayo Foundation) pursuant to which the Mayo Foundation committed to confer with us exclusively to develop products for the treatment of autonomic and peripheral nervous system disorders, including pain, using devices to modulate nerve signaling, and non-exclusively to test such devices, and VGL committed to confer with us non-exclusively to develop such devices, and exclusively to test such devices. These commitments to confer expired in January 2011. We were granted a worldwide license to make, use, sell, offer for sale, and import products incorporating or using the know-how developed for and provided to us by the Mayo Foundation or VGL in the course of such development and testing activities, exclusively for product development and non-exclusively for product testing. Pursuant to the Mayo License, we are obligated to pay royalties in the low single digits to the Mayo Foundation, on a country-by-country and product-by-product basis, based on a percentage of net sales of licensed products, subject to reduction under certain circumstances. We are also required under the Mayo License to use commercially reasonable efforts to research, develop and commercialize licensed products.

The Mayo License terminates upon the expiration of (1) the last to expire of the licensed patents or (2) our obligation to pay royalties, whichever is later. We, the Mayo Foundation or VGL may terminate the Mayo License upon 60 days’ notice of a party’s material breach if such breach remains uncured after such 60-day period.

Manufacturing and Supply

We rely upon third-party suppliers for the manufacture and assembly of our Senza SCS system and its components, some of which are single- or sole-sources of the relevant product component. We are in the process of identifying and qualifying second-source alternatives for several of our critical single-source suppliers. Thus, in the event that our relationship with any of our single- or sole-source suppliers terminates in the future, we feel confident that sufficient production capacity is available to build products at the standards we require. We believe that existing third-party facilities will be adequate to meet our current and anticipated manufacturing needs.

We believe our manufacturing operations, and those of our suppliers, are in compliance with regulations mandated by the FDA. Manufacturing facilities that produce medical devices or their component parts intended for distribution world-wide are subject to regulation and periodic unannounced inspection by the FDA and other domestic and international regulatory agencies. For products distributed in the United States, we are required to manufacture any products that we sell in compliance with the FDA’s Quality System Regulation (QSR) which covers the methods used in, and the facilities used for, the design, testing, control, manufacturing, labeling, quality assurance, packaging, storage and shipping of our products. In international markets, we are required to obtain and maintain various quality assurance and quality management certifications. We have obtained the following international certifications: Quality Management System ISO13485, Full Quality Assurance Certification for the design and manufacture of spinal cord stimulator systems and accessories and a Design Examination certificate for Implantable Pulse Generator and Accessories. We are required to demonstrate continuing compliance with applicable regulatory requirements to maintain these certifications and will continue to be periodically inspected by international regulatory authorities for certification purposes.

Our material supply contracts are as follows:

Pro-Tech Design and Manufacturing

In July 2014, we entered into a supply agreement with Pro-Tech Design and Manufacturing, Inc. (Pro-Tech) pursuant to which Pro-Tech, as a single-source supplier, conducts the inspection, labeling, packaging and sterilization of our Senza SCS system. Our supply agreement expired in July 2019 and we are currently in discussions with Pro-Tech on a revised agreement.

Stellar (Cirtec) Technologies

On July 1, 2009, we entered into a manufacturing agreement with Stellar Technologies, Inc. (Stellar) our single-source supplier of our percutaneous leads, percutaneous lead extenders and surgical leads for our neurological

15

 

stimulator products. On June 30, 2014, the agreement’s initial term expired, and the agreement automatically renewed for the first time. On July 1, 2014, we entered into a first amendment to the manufacturing agreement with Stellar, which provides for an additional five year term commencing from the date of the amendment, after which the agreement automatically renews for successive one-year terms unless either party provides written notice of intent not to renew at least 30 days before the expiration of the then-current term. On January 28, 2016, we entered into a second amendment to this agreement, which provides for the purchase of certain supplementary products pursuant to the agreement. We refer to the manufacturing agreement as amended by the first and second amendments as the Stellar Agreement.

Either we or Stellar may terminate the Stellar Agreement at will upon one year’s advance notice, subject to certain remaining rights and payment obligations, including an early cancellation fee payable by us to Stellar. We may also terminate the Stellar Agreement if Stellar is unable to perform its obligations under the Stellar Agreement for 60 days or more, or if Stellar is unwilling to perform its obligations under the Stellar Agreement and does not cure such defect within 60 days of our providing written notice to cure. Stellar may terminate the Stellar Agreement in the event of our default of certain specified obligations, including our payment obligations, material violation of a warranty or law, our material breach, and our insolvency.

CCC Supply Agreement

We rely upon C.C.C. Del Uruguay S.A. (CCC), a subsidiary of Integer Holdings Corporation (formerly Greatbatch Ltd.), as one of our manufacturers of our IPGs. We currently have a multi-year supply agreement with CCC with regard to the manufacture and supply of our IPGs.  The agreement was effective as of November 11, 2016. On April 30, 2019, we entered into the first amendment to the supply agreement with CCC, incorporating new product models and adjusting unit cost.

The agreement continues for ten years unless terminated earlier. The term of the agreement automatically renews for additional two-year terms unless one party provides the other party with written notice of termination at least one year prior to the end of the initial term or the applicable renewal period. In the event of a change of control of CCC, the agreement may be terminated by us upon three years’ written notice to CCC, provided that such notice period shall be one year in the event CCC is acquired by certain competitors to us. In addition, the agreement may be terminated by mutual agreement of the parties, or by either party, with written notice, upon the other party’s cessation of business or other termination of its business operations, uncured material breach or insolvency of the other party. Upon termination of the agreement, CCC shall, subject to certain exceptions and unless otherwise agreed to by the parties, fulfill all purchase orders placed by us and accepted by CCC prior to the effective date of termination.

The agreement contains, among other provisions, customary representations and warranties by the parties, ordering and payment and shipping terms, customary provisions with respect to the ownership of any intellectual property created during the term of the agreement, certain indemnification rights in favor of both parties, limitations of liability and customary confidentiality provisions.

EaglePicher Medical Power Supply Agreement

In April 2009, we entered into a product supply and development agreement with EaglePicher Medical Power LLC (EaglePicher) our single-source supplier of the batteries and related products for our IPG. Pursuant to the agreement, EaglePicher must use its best efforts to supply these batteries and related products in sufficient quantity to meet our demand. The agreement also provides that, upon our written request, EaglePicher will conduct development of a modified version of these products to our specifications, if we so desire. The initial term of our supply agreement with EaglePicher expired in November 2010, and the term had been automatically renewing for successive one-year periods.

In March 2015, we entered into a first amendment to the product supply and development agreement with EaglePicher. The amendment committed us to specified minimum purchase amounts until the end of 2017 and adjusts EaglePicher’s production capacity and facilities commitments under the agreement as well as certain pricing, purchasing, delivery and cancellation terms. The amendment also extends the term of the agreement to December 31, 2019, with an additional two-year automatic renewal period unless we or EaglePicher provide notice

16

 

of intent not to renew prior to the commencement of such renewal term. The amendment further provides us with the right to place a final order with EaglePicher following termination of the agreement, as amended and modifies certain warranty and assignment terms and the parties’ limitations of liability.

In November 2015, we entered into a second amendment to the agreement, which increased our pre-existing specified minimum purchase amounts and increased EaglePicher’s production capacity commitments under the agreement, as well as specifying certain purchasing and purchase order protocols.  The amendment obligated EaglePicher to establish and qualify an additional battery production operation and commits us to fund approximately $1.0 million of such production operation paid in three milestone installments.  The amendment also establishes EaglePicher as our exclusive battery supplier through the initial five-year term of the agreement, ending December 31, 2019.

In September 2017, we entered into a third amendment to the agreement, which changed the renewal term of the agreement such that the agreement will automatically renew for a period of one year unless we or EaglePicher provides notice of intent to terminate the agreement six months prior to the commencement of such renewal term.  In 2019, we notified EaglePicher of our intent to not renew the agreement upon its expiration on December 31, 2019.  We are currently in discussions with EaglePicher on a revised agreement.

Vention (Nordson) Supply Agreement

In December 2015, we entered into a Manufacturing and Supply Agreement with Vention Medical Design and Development, Inc. (Vention) pursuant to which Vention agreed to manufacture and supply our IPGs. We are obligated to purchase from Vention specified minimum purchase quantities of IPGs for the duration of the Vention agreement.

The agreement continues for five years unless terminated earlier. The term of the agreement automatically renews for additional one-year terms unless one party provides the other party with written notice of termination at least one year prior to the end of the applicable renewal period. The agreement may be terminated by us for any reason upon 180 days’ written notice to Vention. In addition, the agreement may be terminated by mutual agreement of the parties, or by either party, with written notice, upon uncured material breach or insolvency of the other party. Upon termination of the agreement, Vention shall, upon our request, manufacture an additional 24 months of continuous supply of IPGs based on the preceding forecast average or such other amount as agreed upon by the parties.

In September 2017, we entered into a first amendment to the Manufacturing and Supply Agreement with Vention, which changed the unit costs of the products supplied by Vention.  In April 2018, we entered into a second amendment to the Manufacturing and Supply Agreement, which acknowledged that Vention changed its name to Nordson MEDICAL Design and Development, Inc (Nordson) and which changed the unit cost of the products supplied by Nordson.

Other Suppliers

We also have other suppliers, including some sole-source suppliers, for certain of our components, with whom we do not have agreements.

Product Liability and Insurance

The manufacture and sale of our products subjects us to the risk of financial exposure to product liability claims. Our products are used in situations in which there is a risk of serious injury or death. We carry insurance policies which we believe to be customary for similar companies in our industry. We cannot assure you that these policies will be sufficient to cover all or substantially all losses that we experience.

We endeavor to maintain executive and organization liability insurance in a form and with aggregate coverage limits that we believe are adequate for our business purposes, but our coverage limits may prove not to be adequate in some circumstances.

17

 

Government Regulations

United States

Our products and operations are subject to extensive and rigorous regulation by the FDA under the Federal Food, Drug, and Cosmetic Act (FFDCA) and its implementing regulations, guidance, and standards. The FDA regulates the research, testing, manufacturing, safety, labeling, storage, recordkeeping, promotion, distribution, and production of medical devices in the United States to ensure that medical products distributed domestically are safe and effective for their intended uses. The FDA also regulates the export of medical devices manufactured in the United States to international markets. Any violations of these laws and regulations could result in a material adverse effect on our business, financial condition and results of operations. In addition, if there is a change in law, regulation or judicial interpretation, we may be required to change our business practices, which could have a material adverse effect on our business, financial condition and results of operations.

Under the FFDCA, medical devices are classified into one of three classes—Class I, Class II or Class III—depending on the degree of risk associated with each medical device and the extent of control needed to ensure safety and effectiveness.

Class I devices are those for which safety and effectiveness can be assured by adherence to FDA’s “general controls” for medical devices, which include compliance with the applicable portions of the QSR facility registration and product listing, reporting of adverse medical events, and appropriate, truthful and non-misleading labeling, advertising, and promotional materials. Some Class I devices also require premarket clearance by the FDA through the 510(k) premarket notification process described below.

Class II devices are subject to FDA’s general controls, and any other “special controls” deemed necessary by FDA to ensure the safety and effectiveness of the device. These special controls can include performance standards, post-market surveillance, patient registries, and FDA guidance documents. While most Class I devices are exempt from the 510(k) premarket notification requirement, manufacturers of most Class II devices are required to submit to the FDA a premarket notification under Section 510(k) of the FDCA requesting permission to commercially distribute the device. The FDA’s permission to commercially distribute a device subject to a 510(k) premarket notification is generally known as 510(k) clearance. When a 510(k) is required, the manufacturer must submit to the FDA a premarket notification submission demonstrating that the device is “substantially equivalent” to a legally marketed device, which in some cases may require submission of clinical data. A legally marketed device is defined by statute to mean a device that was legally marketed prior to May 28, 1976, the date upon which the Medical Device Amendments of 1976 were enacted, or another commercially available, similar device that was cleared through the 510(k) process. Unless a specific exemption applies, 510(k) premarket notification submissions are subject to user fees. If the FDA determines that the device, or its intended use, is not substantially equivalent to a legally marketed device, the FDA will place the device, or the particular use of the device, into Class III, and the device sponsor must then fulfill much more rigorous premarketing requirements in the form of a premarket approval (PMA).

A Class III device includes devices deemed by the FDA to pose the greatest risk such as life-supporting or life-sustaining devices, or implantable devices, in addition to a device that has a new intended use or utilizes advanced technology that is not substantially equivalent to that of a legally marketed device. The safety and effectiveness of Class III devices cannot be assured solely by general and special controls. These devices almost always require formal clinical studies to demonstrate safety and effectiveness. Class III devices require PMA approval before they can be marketed although some pre-amendment Class III devices for which the FDA has not yet required a PMA are cleared through the 510(k) process.

PMA Approval

The Senza SCS system is a Class III device subject to review and approval through the PMA pathway. PMA applications must be supported by, among other things, valid scientific evidence, which typically requires extensive data, including technical, preclinical, clinical and manufacturing data, to demonstrate to the FDA’s satisfaction the safety and effectiveness of the device. A PMA application must also include, among other things, a complete description of the device and its components, a detailed description of the methods, facilities and controls used to

18

 

manufacture the device and proposed labeling. As with 510(k) submissions, unless subject to an exemption, PMA submissions are subject to user fees.

The FDA has 45 days from its receipt of a PMA to determine whether the application will be accepted for filing based on the agency’s threshold determination that it is sufficiently complete to permit substantive review. Once the submission is accepted for filing, the FDA begins an in-depth review. The FDA has 180-days to review a PMA application that has been filed by the FDA, although the review of an application more often occurs over a significantly longer period of time, and can take up to several years. During this review period, the FDA may request additional information or clarification of information already provided. An advisory panel of experts from outside the FDA may be convened to review and evaluate the application and provide recommendations to the FDA as to the approvability of the device. The FDA may or may not accept the panel’s recommendation. In addition, the FDA will conduct a pre-approval inspection of the applicant and/or its third-party manufacturers’ or suppliers’ manufacturing facility or facilities to ensure compliance with the QSR, which requires manufacturers to follow design, testing, control, documentation and other quality assurance procedures.

The timing of FDA review of an initial PMA application can vary substantially and, in some cases, require several years to complete. The FDA can delay, limit, or deny approval of a PMA application for many reasons, including:

 

•

it is not demonstrated that there is reasonable assurance that the device is safe or effective under the conditions of use prescribed, recommended or suggested in the proposed labeling;

 

•

the data from preclinical studies and clinical trials may be insufficient; and

 

•

the manufacturing process, methods, controls or facilities used for the manufacture, processing, packing or installation of the device do not meet applicable requirements.

If the FDA evaluations of both the PMA application and the manufacturing facilities are favorable, the FDA will either issue an approval order or an approvable letter, the latter of which usually contains a number of conditions that must be met in order to secure final approval of the PMA. If the FDA’s evaluation of the PMA or manufacturing facilities is not favorable, the FDA will deny approval of the PMA or issue a not approvable letter. A not approvable letter will outline the deficiencies in the application and, where practical, will identify what is necessary to make the PMA approvable. The FDA may also determine that additional clinical trials are necessary, in which case the PMA approval may be delayed for several months or years while the trials are conducted and the data is then submitted in an amendment to the PMA. Once granted, PMA approval may be withdrawn by the FDA if compliance with post approval requirements, conditions of approval or other regulatory standards is not maintained or problems are identified following initial marketing.  In May 2015, we received approval for our PMA application for the Senza SCS system.

Approval by the FDA of new PMA applications or PMA supplements may be required for modifications to the manufacturing process, labeling, device specifications, materials or design of a device that is approved through the PMA process. Certain other changes to an approved device also require the submission of a new PMA, such as when the design change causes a different intended use, mode of operation, and technical basis of operation, or when the design change is so significant that a new generation of the device will be developed, and the data that were submitted with the original PMA are not applicable for the change in demonstrating a reasonable assurance of safety and effectiveness. PMA supplements often require submission of the same type of information as an initial PMA application, except that the supplement is limited to information needed to support any changes from the device covered by the original PMA application and may not require as extensive clinical data.  For example, if we seek approval to expand the label of Senza to include additional pain indications, we anticipate that we will be required to submit and receive approval for a PMA supplement.

Clinical Studies

Clinical trials are almost always required to support a PMA and are sometimes required to support a 510(k) submission. In the United States, human clinical trials intended to support medical device clearance or approval require compliance with the FDA’s investigational device exemption (IDE) regulations. For a device that presents a “significant risk” to human health, the device sponsor is required to file an IDE application with the FDA and obtain

19

 

IDE approval prior to commencing the human clinical trial, as well as obtain approval of an Institutional Review Board (IRB) at each institution where the study will be conducted. If the device is considered a “non-significant risk,” IDE approval from FDA is not required. Instead, only approval from the IRB overseeing the investigation at each clinical trial site is required, though the sponsor must still comply with abbreviated IDE requirements, such as protection of human subjects and informed consent. Human clinical studies are generally required in connection with approval of Class III devices and may be required for Class I and II devices. An IDE application must be supported by appropriate data, such as animal and laboratory test results, showing that it is safe to test the device in humans and that the testing protocol is scientifically sound. The IDE will automatically become effective 30 days after receipt by the FDA unless the FDA notifies the company that the investigation may not begin. If the FDA determines that there are deficiencies or other concerns with an IDE for which it requires modification, the FDA may permit a clinical trial to proceed under a conditional approval.

If an IDE application is approved by the FDA, human clinical trials may begin at a specific number of investigational sites with a specific number of patients, as approved by the FDA. If the device presents a non-significant risk to the patient, a sponsor may begin the clinical trial after obtaining approval for the trial by one or more IRBs without separate approval from the FDA, but must still follow abbreviated IDE requirements, such as monitoring the investigation, ensuring that the investigators obtain informed consent, and labeling and record-keeping requirements. Acceptance of an IDE application for review does not guarantee that the FDA will allow the IDE to become effective and, if it does become effective, the FDA may or may not determine that the data derived from the trials support the safety and effectiveness of the device or warrant the continuation of clinical trials. An IDE supplement must be submitted to, and approved by, the FDA before a sponsor or investigator may make a change to the investigational plan that may affect its scientific soundness, study plan or the rights, safety or welfare of human subjects.

During a study, the sponsor is required to comply with the applicable FDA requirements, including, for example, trial monitoring, selecting clinical investigators and providing them with the investigational plan, ensuring IRB review, adverse event reporting, record keeping, and prohibitions on the promotion of investigational devices or on making safety or effectiveness claims for them. The clinical investigators in the clinical study are also subject to FDA regulations and must obtain patient informed consent, rigorously follow the investigational plan and study protocol, control the disposition of the investigational device, and comply with all reporting and recordkeeping requirements. Additionally, after a trial begins, we, the FDA or the IRB could suspend or terminate a clinical trial at any time for various reasons, including a belief that the risks to study subjects outweigh the anticipated benefits.

Continuing Regulation

After the FDA permits a device to enter commercial distribution, numerous regulatory requirements apply. These include: compliance with the QSR, which requires manufacturers to follow elaborate design, testing, control, documentation and other quality assurance procedures during the manufacturing process; labeling regulations; the FDA’s general prohibition against promoting products for unapproved or “off-label” uses; the reports of Corrections and Removals regulation, which requires manufacturers to report recalls and field actions to the FDA if initiated to reduce a risk of health posed by the device or to remedy a violation of the Federal Food, Drug and Cosmetic Act; and the Medical Device Reporting regulation, which requires that manufacturers report to the FDA if their device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if it were to reoccur. Manufacturers are also required to register and list their devices with the FDA, based on which the FDA will conduct inspections to ensure continued compliance with applicable regulatory requirements.

The FDA has broad post-market and regulatory and enforcement powers. Failure to comply with the applicable U.S. medical device regulatory requirements could result in, among other things, warning letters; fines; injunctions; consent decrees; civil penalties; repairs, replacements or refunds; recalls, corrections or seizures of products; total or partial suspension of production; the FDA’s refusal to grant future premarket clearances or approvals; withdrawals or suspensions of current product applications; and criminal prosecution. If any of these events were to occur, they could have a material adverse effect on our business, financial condition and results of operations.

20

 

International

Our international sales are subject to regulatory requirements in the countries in which our products are sold. The regulatory review process varies from country to country and may in some cases require the submission of clinical data. In addition, the FDA must be notified of, or approve the export to certain countries of devices that require a PMA, and not yet approved in the United States.

In the European Economic Area (EEA), which is comprised of the 27 Member States of the European Union (EU) plus Norway, Liechtenstein, Iceland and the United Kingdom (UK) (until the end of the transition period on December 31, 2020 provided for in the Withdrawal Agreement between the EU and UK), we need to comply with the requirements of the EU Active Implantable Medical Devices Directive (AIMDD) and appropriately affix the CE Mark on our products to attest to such compliance. To achieve compliance, our products must meet the “Essential Requirements” laid down in Annex I of the AIMDD relating to safety and performance. To demonstrate compliance with the Essential Requirements and obtain the right to affix the CE Mark we must undergo a conformity assessment procedure, which varies according to the type of medical device and its classification. Except for low risk medical devices (Class I with no measuring function and which are not sterile), where the manufacturer can issue an EC Declaration of Conformity based on a self-assessment of the conformity of its products with the Essential Requirements, a conformity assessment procedure requires the intervention of a Notified Body, which is an organization designated by a competent authority of an EEA country to conduct conformity assessments. Depending on the relevant conformity assessment procedure, the Notified Body would audit and examine the Technical File and the quality system for the manufacture, design and final inspection of our devices. The Notified Body issues a CE Certificate of Conformity following successful completion of a conformity assessment procedure conducted in relation to the medical device and its manufacturer and their conformity with the Essential Requirements. This Certificate entitles the manufacturer to affix the CE Mark to its medical devices after having prepared and signed a related EC Declaration of Conformity. The assessment of the conformity of Senza has been certified by our Notified Body (the British Standards Institution, or BSI).

As a general rule, demonstration of conformity of medical devices and their manufacturers with the Essential Requirements must be based, among other things, on the evaluation of clinical data supporting the safety and performance of the products during normal conditions of use. Specifically, a manufacturer must demonstrate that the device achieves its intended performance during normal conditions of use and that the known and foreseeable risks, and that any adverse events, are minimized and acceptable when weighed against the benefits of its intended performance, and that any claims made about the performance and safety of the device (e.g., product labeling and instructions for use) are supported by suitable evidence. This assessment must be based on clinical data, which can be obtained from (1) clinical studies conducted on the devices being assessed, (2) scientific literature from similar devices whose equivalence with the assessed device can be demonstrated or (3) both clinical studies and scientific literature. With respect to active implantable medical devices or Class III devices, the manufacturer must conduct clinical studies to obtain the required clinical data, unless reliance on existing clinical data from equivalent devices can be justified. The conduct of clinical studies in the EEA is governed by detailed regulatory obligations. These may include the requirement of prior authorization by the competent authorities of the country in which the study takes place and the requirement to obtain a positive opinion from a competent Ethics Committee. This process can be expensive and time-consuming. Additionally, Senza must continue to comply with the requirements of certain EU Directives.

We are subject to continued surveillance by our Notified Body and will be required to report any serious adverse incidents to the appropriate authorities. We also must comply with additional requirements of individual countries in which our products are marketed.

The assessment of the conformity of Senza with the AIMDD and the Radio and Telecommunications Terminal (R&TTE) Directive has been certified by the BSI.

In April 2017, the European Parliament passed the Medical Devices Regulation (Regulation 2017/745), which repeals and replaces the EU Medical Devices Directive and the Active Implantable Medical Devices Directive. Unlike directives, which must be implemented into the national laws of the EEA member States, the regulations would be directly applicable, i.e., without the need for adoption of EEA member State laws implementing them, in all EEA member States and are intended to eliminate current differences in the regulation of medical devices among

21

 

EEA member States. The Medical Devices Regulation, among other things, is intended to establish a uniform, transparent, predictable and sustainable regulatory framework across the EEA for medical devices and ensure a high level of safety and health while supporting innovation. The Medical Devices Regulation will however only become applicable three years after publication (in May 2020). Once applicable, the new regulations will among other things:

 

•

strengthen the rules on placing devices on the market and reinforce surveillance once they are available;

 

•

establish explicit provisions on manufacturers' responsibilities for the follow-up of the quality, performance and safety of devices placed on the market;

 

•

improve the traceability of medical devices throughout the supply chain to the end-user or patient through a unique identification number;

 

•

set up a central database to provide patients, healthcare professionals and the public with comprehensive information on products available in the EU; and

 

•

strengthen rules for the assessment of certain high-risk devices, such as implants, which may have to undergo an additional check by experts before they are placed on the market.

Once applicable, the Medical Devices Regulation may impose increased compliance obligations for us to access the EU market.  

Other Regulations

We are also subject to healthcare fraud and abuse regulation in the jurisdictions in which we will conduct our business. These laws include, without limitation, applicable anti-kickback, false claims, physician sunshine and patient privacy and security laws and regulations.

Anti-Kickback Statute: The federal Anti-Kickback Statute prohibits, among other things, persons or entities from knowingly and willfully soliciting, offering, receiving or paying any remuneration, directly or indirectly, overtly or covertly, in cash or in kind, in exchange for or to induce either the referral of an individual for, or the purchase, lease, order or recommendation of, any good, facility, item or service for which payment may be made, in whole or in part, under federal healthcare programs such as Medicare and Medicaid. The federal Anti-Kickback Statute is broad and prohibits many arrangements and practices that are lawful in businesses outside of the healthcare industry. The term “remuneration” includes kickbacks, bribes, or rebates and also has been broadly interpreted to include anything of value, including for example, gifts, discounts, the furnishing of supplies or equipment, credit arrangements, payments of cash, waivers of payments, ownership interests and providing anything at less than its fair market value. There are a number of statutory exceptions and regulatory safe harbors protecting certain business arrangements from prosecution under the federal Anti-Kickback Statute. These statutory exceptions and safe harbors set forth provisions that, if all their applicable requirements are met, will assure healthcare providers and other parties that they may not be prosecuted under the federal Anti-Kickback Statute. The failure of a transaction or arrangement to fit precisely within one or more applicable statutory exceptions or safe harbors does not necessarily mean that it is illegal or that prosecution will be pursued. However, conduct and business arrangements that do not fully satisfy all requirements of an applicable safe harbor may result in increased scrutiny by government enforcement authorities and will be evaluated on a case-by-case basis based on a cumulative review of all of its facts and circumstances. Further, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act which is discussed below. Penalties for violations of the Anti-Kickback Statute include, but are not limited to, criminal, civil and/or administrative penalties, damages, fines, disgorgement, individual imprisonment, possible exclusion from Medicare, Medicaid and other federal healthcare programs, and the curtailment or restructuring of operations.

Federal Civil False Claims Act: The federal civil False Claims Act prohibits, among other things, persons or entities from knowingly presenting or causing to be presented a false or fraudulent claim to, or the knowing use of false statements to obtain payment from or approval by, the federal government. In addition, private individuals have the ability to bring actions under the civil False Claims Act in the name of the government alleging false and

22

 

fraudulent claims presented to or paid by the government (or other violations of the statutes) and to share in any amounts paid by the entity to the government in fines or settlement. Such suits, known as qui tam actions, have increased significantly in the healthcare industry in recent years. Manufacturers can be held liable under these laws if they are deemed to “cause” the submission of false or fraudulent claims by, for example, providing inaccurate billing or coding information to customers or promoting a product off-label. Penalties for a federal civil False Claims Act violation include three times the actual damages sustained by the government, plus mandatory civil penalties for each separate false claim, the potential for exclusion from participation in federal healthcare programs and criminal liability.

Health Insurance Portability and Accountability Act of 1996: The federal Health Insurance Portability and Accountability Act (HIPAA) created several new federal crimes, including healthcare fraud and false statements relating to healthcare matters. The healthcare fraud statute prohibits knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, including private third-party payors. The false statements statute prohibits knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation.

In addition, HIPAA and its implementing regulations established uniform standards for certain covered entities, which are healthcare providers, health plans and healthcare clearinghouses, as well as their business associates, governing the conduct of specified electronic healthcare transactions and protecting the security and privacy of protected health information. HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, created four new tiers of civil monetary penalties and gave state attorneys general new authority to file civil actions for damages or injunctions in federal courts to enforce the federal HIPAA laws and seek attorneys’ fees and costs associated with pursuing federal civil actions.

EU Data Protection Laws: We are subject to laws and regulations in non-U.S. countries covering data privacy and the protection of health-related and other personal information. EU member states and other jurisdictions have adopted data protection laws and regulations, which impose significant compliance obligations. Laws and regulations in these jurisdictions apply broadly to the collection, use, storage, disclosure and security of personal information that identifies or may be used to identify an individual, such as names, contact information and sensitive personal data such as health data. These laws and regulations are subject to frequent revisions and differing interpretations, and have generally become more stringent over time.

For example, the EU General Data Protection Regulation (GDPR) became applicable on May 25, 2018, implementing more stringent operational requirements for processors and controllers of personal data, including, for example, expanded disclosures about how personal information is to be used, limitations on retention of information, increased requirements pertaining to health data and pseudonymised (i.e., key-coded) data, mandatory data breach notification requirements, more robust rights for individuals over their personal data and higher standards for data controllers to demonstrate that they have obtained valid consent for certain data processing activities. We are subject to evolving EU laws on data export, as we may transfer personal data from the EU to other jurisdictions. The GDPR also provides that EU member states may make their own further laws and regulations limiting the processing of genetic, biometric or health data, which could limit our ability to use and share personal data or could cause our costs could increase, and harm our business and financial condition.

Following Brexit, we will have to comply with the GDPR and the UK GDPR, each regime having the ability to fine up to the greater of €20 million/ £17 million or 4% of global turnover. The relationship between the UK and the EU in relation to certain aspects of data protection law remains unclear, e.g. how data transfers between EU member states. These changes will lead to additional costs and increase our overall risk.

In recent years, U.S. and European lawmakers and regulators have expressed concern over electronic marketing and the use of third-party cookies, web beacons and similar technology for online behavioral advertising. In the EU, informed consent is required for the placement of a cookie on a user’s device. The current EU laws that cover the use of cookies and similar technology and marketing online or by electronic means are under reform. A draft of the new ePrivacy Regulation is currently going through the European legislative process.  Unlike the current ePrivacy Directive, the ePrivacy Regulation will be directly implemented into the laws of each of the EU member

23

 

States, without the need for further enactment. When implemented, it is expected to alter rules on third-party cookies, web beacons and similar technology for online behavioral advertising and to impose stricter requirements on companies using these tools.  The current provisions of the draft ePrivacy Regulation also extend the strict opt-in marketing rules to business-to-business communications, and significantly increase penalties. While the text of the draft ePrivacy Regulation is still under development, a recent European court decision and regulators’ recent guidance are driving increased attention to cookies and tracking technologies. If regulators start to enforce the strict approach in recent guidance, this could lead to substantial costs, require significant systems changes, limit the effectiveness of our marketing activities, divert the attention of our technology personnel, adversely affect our margins, increase costs and subject us to additional liabilities.

Any failure or perceived failure by us to comply with privacy or security laws, policies, legal obligations or industry standards or any security incident that results in the unauthorized release or transfer of personally identifiable information may result in governmental enforcement actions and investigations including by European Data Protection Authorities, fines and penalties (for example, of up to 20,000,000 Euros or up to 4% of the total worldwide annual turnover of the preceding financial year (whichever is higher) under the GDPR and draft ePrivacy Regulation, and £17.5 million or 4% of the total worldwide annual turnover for breaches of the UK legislation), litigation and/or adverse publicity, including by consumer advocacy groups, and could cause our customers to lose trust in us, which could have an adverse effect on our reputation and business. Such failures could have a material adverse effect on our financial condition and operations. If the third parties we work with violate applicable laws, contractual obligations or suffer a security breach, such violations may also put us in breach of our obligations under privacy laws and regulations and/or could in turn have a material adverse effect on our business.

The Federal Physician Payments Sunshine Act: The federal Physician Payments Sunshine Act requires certain manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children’s Health Insurance Program, with certain exceptions, to report annually to CMS information related to “payments or other transfers of value” made to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), certain other health care professionals beginning in 2022, and teaching hospitals, and to report annually to CMS certain ownership and investment interests held by physicians and their immediate family members.

Analogous State and Foreign Law Equivalents:  We may be subject to state and foreign law equivalents of each of the above federal laws, such as anti-kickback and false claims laws which may apply to items or services reimbursed by any third-party payor, including commercial insurers; state laws that require device companies to comply with the industry’s voluntary compliance guidelines and the applicable compliance guidance promulgated by the federal government or otherwise restrict payments that may be made to healthcare providers and other potential referral sources; state laws that require device manufacturers to report information related to payments and other “transfers of value” to physicians and other healthcare providers or marketing expenditures; and state laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts. For example, the California Consumer Privacy Act, or CCPA, which went into effect January 1, 2020, among other things, creates new data privacy obligations for covered companies and provides new privacy rights to California residents, including the right to opt out of certain disclosures of their information. The CCPA also creates a private right of action with statutory damages for certain data breaches, thereby potentially increasing risks associated with a data breach. Although the law includes limited exceptions, including for “protected health information” maintained by a covered entity or business associate, it may regulate or impact our processing of personal information depending on the context.

Healthcare Reform: In March 2010 the Affordable Care Act (the ACA) was signed into law, which has the potential to substantially change healthcare financing and delivery by both governmental and private insurers, and significantly impact the medical device industry. The Affordable Care Act impacted existing government healthcare programs and resulted in the development of new programs. The Affordable Care Act’s provisions of importance include, but are not limited to, a deductible 2.3% excise tax on any entity that manufactures or imports medical devices offered for sale in the United States, with limited exceptions, effective January 1, 2013. The excise tax was subsequently suspended, effective January 1, 2016, and permanently repealed altogether, effective January 1, 2020.

24

 

Since its enactment, there have been judicial and congressional challenges to certain aspects of the ACA. By way of example, the Tax Cuts and Jobs Act of 2017 includes a provision repealing, effective January 1, 2019, the tax-based shared responsibility payment imposed by the ACA on certain individuals who fail to maintain qualifying health coverage for all or part of a year that is commonly referred to as the “individual mandate.” On December 14, 2018, a U.S. District Court Judge in the Northern District of Texas, ruled that the individual mandate is a critical and inseverable feature of the ACA, and therefore, because it was repealed as part of the Tax Act, the remaining provisions of the ACA are invalid as well. On December 18, 2019, the U.S. Court of Appeals for the 5th Circuit upheld the District Court’s decision that the individual mandate was unconstitutional but remanded the case back to the District Court to determine whether the remaining provisions of the ACA are invalid as well. It is unclear how these decisions, subsequent appeals, if any, and other efforts to challenge, repeal or replace the ACA will impact the law or our business.

In addition, other legislative changes have been proposed and adopted since the ACA was enacted. These changes included an aggregate reduction in Medicare payments to providers of up to 2% per fiscal year, which went into effect on April 1, 2013 and will remain in effect through 2025 unless additional Congressional action is taken. The Medicare Access and CHIP Reauthorization Act of 2015, enacted on April 16, 2015 (MACRA), repealed the formula by which Medicare made annual payment adjustments to physicians and replaced the former formula with fixed annual updates and a new system of incentive payments scheduled to begin in 2019 that are based on various performance measures and physicians’ participation in alternative payment models such as accountable care organizations.

Any regulatory or legislative developments in domestic or foreign markets that eliminates or reduces reimbursement rates for procedures performed with our products could harm our ability to sell our products or cause downward pressure on the prices of our products, either of which would affect our ability to generate the revenues necessary to support our business.

The Foreign Corrupt Practices Act: The Foreign Corrupt Practices Act (FCPA) prohibits any U.S. individual or business from paying, offering or authorizing payment or offering of anything of value, directly or indirectly, to any foreign official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the United States to comply with accounting provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations.

The UK Bribery Act. The UK Bribery Act prohibits giving, offering or promising bribes (which includes anything of value) to any person, including private persons, as well as requesting, agreeing to receive, or accepting bribes from any person. In addition, under the UK Bribery Act, companies which carry on a business or part of a business in the UK, as we do, may be held liable not only for bribes given, offered, promised, requested or accepted to any person, including private persons, by employees and persons associated with the company in order to obtain or retain business or a business advantage for the company, but also for failing to prevent the bribe in the first place. Liability for the offence of failing to prevent bribery is strict, with no element of a corrupt state of mind, but a defense of having in place adequate procedures designed to prevent bribery is available. Furthermore, under the UK Bribery Act there is no exception for facilitation payments.

Employees

As of December 31, 2019, we had 853 employees globally. We believe the success of our business depends, in part, on our ability to attract and retain qualified personnel. We are committed to developing our employees and providing them with opportunities to contribute to our growth and success. Our employees are not subject to a collective bargaining agreement, and we believe that we have good relations with our employees.

About Us

We were incorporated in Minnesota in March 2006 and reincorporated in Delaware in October 2006. We completed the initial public offering of our common stock in November 2014. Our common stock is currently listed

25

 

on the New York Stock Exchange (NYSE) under the symbol “NVRO.” Our principal executive offices are located at 1800 Bridge Parkway, Redwood City, California 94065. Our telephone number is (650) 251-0005. Our website address is www.nevro.com. The information on, or that can be accessed through, our website is not incorporated by reference into this Annual Report on Form 10-K, or Annual Report, or any other filings we make with the U.S. Securities and Exchange Commission, or SEC.

Available Information

We make available on or through our website certain reports and amendments to those reports that we file with, or furnish to, the SEC in accordance with the Securities Exchange Act of 1934, as amended, or the Exchange Act. These include our Annual Reports on Form 10-K, our Quarterly Reports on Form 10-Q and our Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act. We make this information available on or through our website free of charge as soon as reasonably practicable after we electronically file the information with, or furnish it to, the SEC. This information is also available by writing to us at the address on the cover of this Annual Report.  The SEC maintains a website that contains reports, proxy and information statements, and other information regarding our filings, at www.sec.gov. The information on, or that can be accessed through, our website is not incorporated by reference into this Annual Report or any other filings we make with the SEC.

26

 

ITEM 1A. RISK FACTORS

Our business involves significant risks, some of which are described below. You should carefully consider these risks, as well as the other information in this Annual Report, including our financial statements and the related notes and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” The occurrence of any of the events or developments described below could harm our business, financial condition, results of operations and growth prospects. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our business.

Risks Related to our Business

We are substantially dependent on continued market acceptance in the United States for our HF10 therapy, and the failure of our HF10 therapy to continue to gain market acceptance would negatively impact our business.

Since our inception, we have devoted substantially all of our efforts to the development and commercialization of Senza and HF10 therapy for the treatment of chronic leg and back pain. Prior to mid-2015, our revenue was derived nearly entirely from sales of Senza in Europe and Australia. Although we received approval of our PMA in May 2015, we are still in the relatively early stages of our commercialization efforts in the United States and have a limited history of commercializing our product in the United States. We have incurred significant costs, including costs to continue to build our sales force in order to sustain our commercial sales in the United States. If we are unable to continue to achieve significant market acceptance in the United States, our results of operations will be adversely affected as the United States is the principal market for Senza. If we are unsuccessful in our continuing efforts to commercialize our products, including, in particular Senza Omnia, or are unable to market our products as a result of a quality problem, failure to maintain or obtain additional regulatory approvals, unexpected or serious complications or other unforeseen negative effects related to our HF10 therapy or the other factors discussed in these risk factors, we would lose our only source of revenue, and our business will be materially adversely affected.

We may be unable to gain broader market acceptance for a number of reasons, including:

 

•

established competitors with strong relationships with customers, including physicians, hospitals and third-party suppliers;

 

•

limitations in our ability to demonstrate differentiation and advantages of our product compared to competing products and the relative safety, efficacy and ease of use of our product;

 

•

the limited size of our sales force and the learning curve required to gain experience selling our product;

 

•

the inability to obtain sufficient supply of the components for our Senza products or secure second-source suppliers if our main suppliers are unable to fulfill our orders;

 

•

insufficient financial or other resources to support our commercialization efforts necessary to reach profitability; and

 

•

the introduction and market acceptance of new, more effective or less expensive competing products and technologies.

Moreover, physicians and hospitals may not perceive the benefits of our products and may be unwilling to change from the SCS devices they are currently using. Communicating the benefits of Senza and HF10 therapy to these physicians and hospitals requires a significant commitment by our marketing team and sales organization. Physicians and hospitals may be slow to change their practices because of perceived risks arising from the use of new products. Physicians may not recommend or use Senza until there is more long-term commercial experience to convince them to alter their existing treatment methods, or until they receive additional recommendations from other physicians that our product is effective. We cannot predict when, if ever, physicians and hospitals may adopt use of our product. If we are unable to educate physicians and hospitals about the advantages of our HF10 therapy, do not continue to gain market acceptance of our product, or fail to significantly grow our market share, we will not be able to grow our revenue and our business and financial condition will be adversely affected.

27

 

We must continue to educate physicians and demonstrate to them the merits of our HF10 therapy compared to those of our competitors.

Physicians play a significant role in determining the course of a patient’s treatment and the type of product that will be used to treat a patient. An important part of our sales process includes the education of physicians on the safe and effective use of our HF10 therapy and our Senza products, particularly because Senza and high-frequency neuromodulation treatment is relatively new as compared to existing low-frequency traditional SCS systems.  As a result, our success depends, in large part, on effectively marketing our HF10 therapy to physicians, including the results of our pivotal SENZA-RCT study. In order for us to sell our products, we must successfully demonstrate to physicians the merits of our HF10 therapy compared to our competitors’ SCS systems for use in treating patients with chronic leg and back pain. Acceptance of our HF10 therapy depends on educating physicians as to the distinctive characteristics, perceived benefits, safety, ease of use and cost-effectiveness of Senza as compared to our competitors’ SCS systems, and communicating to physicians the proper application of our HF10 therapy. Physicians typically need to perform several procedures to become comfortable using HF10 therapy and Senza. If a physician experiences difficulties during an initial procedure or otherwise, that physician may be less likely to continue to use our product or to recommend it to other physicians. As a result, educating physicians on the proper use of Senza is critical to the success of our commercialization efforts. If we are not successful in educating physicians and convincing them of the merits of our HF10 therapy or educating them on the use of Senza, they may not use our Senza products and we may be unable to increase our sales, sustain our growth or achieve profitability.

In addition, we believe receiving support of our products from physicians is essential for market acceptance and adoption. If we do not receive support from physicians or long-term data does not show the benefits of using our HF10 therapy, physicians may not use Senza. In such circumstances, our results of operations would be materially adversely affected. It is also important for our growth that these physicians advocate for the benefits of our products in the broader marketplace. If physicians misuse or ineffectively use our products, it could result in unsatisfactory patient outcomes, patient injuries, negative publicity or lawsuits against us, any of which could have an adverse effect on our business.

We are currently, and may in the future become, involved in lawsuits to protect or enforce our intellectual property, which are expensive and time consuming, and ultimately unsuccessful, and could result in the diversion of significant resources, thereby hindering our ability to effectively grow sales of our Senza systems or commercialize future products, if any. If we are unable to obtain, maintain, protect, and enforce our intellectual property, our business will be negatively affected.

The market for medical devices is subject to rapid technological change and frequent litigation regarding patent and other intellectual property rights. It is possible that our patents or licenses may not withstand challenges made by others or protect our rights adequately.

Our success depends in large part on our ability to secure effective patent protection for our products and processes in the United States and internationally. We have filed and intend to continue to file patent applications for various aspects of our technology and trademark applications to protect our brand and business. We seek to obtain and maintain patents and other intellectual property rights to restrict the ability of others to market products or services that misappropriate our technology and/or infringe our intellectual property to compete with our products. We are currently involved in, and in the future may become involved in additional, lawsuits and/or proceedings to protect and enforce our intellectual property rights. These lawsuits and proceedings are expensive and require substantial attention of management.

However, we face the risks that:

 

•

We may fail to secure necessary patents, potentially permitting competitors to market competing products and make, use or sell products that are substantially the same as ours without incurring the sizeable development costs that we have incurred, which would adversely affect our ability to compete.

 

•

Patents may not issue from any of our currently pending or future patent applications.

 

•

Our already-granted patents and any future patents may not survive legal challenges, including challenges in the pending lawsuits with Boston Scientific and Stimwave, to their scope, validity or

28

 

 

enforceability, or provide significant protection for us, and they may be re-examined or invalidated, and/or may be found to be unenforceable or not cover competing products.

 

•

Even if our patents are determined by a court to be valid and enforceable, they may not be drafted or interpreted broadly enough to prevent others from marketing products and services similar to ours.  Similarly, others may simply design around our patents. For example, third parties may be able to make systems or devices that are similar to ours but that are not covered by the claims of our patents. Third parties may assert that we or our licensors were not the first to make the inventions covered by our issued patents or pending patent applications. The claims of our issued patents or patent applications when issued may not cover our commercial technology or the future products and services that we develop. We may not have freedom to operate unimpeded by the patent rights of others. Third parties may have dominating, blocking or other patents relevant to our technology of which we are not aware. In addition, because patent applications in the United States and many foreign jurisdictions are typically not published until 18 months after the filing of certain priority documents (or, in some cases, are not published until they issue as patents) and because publications in the scientific literature often lag behind actual discoveries, we cannot be certain that others have not filed patent applications for our technology or our contemplated technology. Any such patent applications may have priority over our patent applications or issued patents, which could further require us to obtain rights to issued patents covering such technologies. If another party has filed a U.S. patent application on inventions similar to ours, depending on when the timing of the filing date falls under certain patent laws, we may have to participate in a priority contest (such as an interference proceeding) declared by the USPTO, to determine priority of invention in the United States. There may be prior public disclosures that could invalidate our inventions or parts of our inventions of which we are not aware. Further, we may not develop additional proprietary technologies and, even if we do, they may not be patentable.

 

•

Patent law can be highly uncertain and involve complex legal and factual questions for which important principles remain unresolved. In the United States and in many foreign jurisdictions, policies regarding the breadth of claims allowed in patents can be inconsistent. The U.S. Supreme Court and the U.S. Court of Appeals for the Federal Circuit have made, and will likely continue to make, changes in how the patent laws of the United States are interpreted. Similarly, foreign courts have made, and will likely continue to make, changes in how the patent laws in their respective jurisdictions are interpreted. We cannot predict future changes in the interpretation of patent laws or changes to patent laws that might be enacted into law by U.S. and foreign legislative bodies. Those changes may materially affect our patents or patent applications, our ability to obtain patents or the patents and patent applications of our licensors. Future protection for our proprietary rights is uncertain because legal means afford only limited protection and may not adequately protect our rights or permit us to gain or keep our competitive advantage, which could adversely affect our financial condition and results of operations.

 

•

Monitoring unauthorized uses of our intellectual property is difficult and costly. From time to time, we seek to analyze our competitors’ products and services.  For example, in November 2016, we filed a complaint against Boston Scientific Corporation in order to enforce certain of our patents, the ruling of which is currently under appeal, and in February 2019, we filed a lawsuit for patent infringement and false advertisement against Stimwave.  We may in the future seek to enforce our patents or other proprietary rights against other potential infringements. However, the steps we have taken to protect our proprietary rights may not be adequate to prevent misappropriation of our intellectual property. We may not be able to detect unauthorized use of, or take appropriate steps to enforce, our intellectual property rights. Our competitors may also independently develop similar technology. Any inability to meaningfully protect our intellectual property could result in competitors offering products that incorporate our product features, which could reduce demand for our products. In addition, we may need to defend our patents from third-party challenges, including interferences, derivation proceedings, re-examination proceedings, post-grant review, inter partes review, third-party submissions, oppositions, nullity actions, or other patent proceedings. We may also need to initiate infringement claims or litigation. Adverse proceedings such as litigation or challenges to the validity of our patents can be expensive, time consuming and may divert the efforts of our technical and managerial personnel, which could in turn harm our business, whether or not we receive a determination favorable to us. In addition, in an infringement or other adverse proceeding, a court may decide that the patent we seek to enforce is invalid or unenforceable, or may refuse to stop the other party from using the technology at

29

 

 

issue on the grounds that the patent in question does not cover the technology in question. An adverse result in any litigation or proceeding could place one or more of our patents at risk of being invalidated, interpreted narrowly or found unenforceable. Some of our competitors may be able to devote significantly more resources to intellectual property litigation, and may have significantly broader patent portfolios to assert against us, if we assert our rights against them. Further, because of the substantial discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be disclosed or otherwise compromised during litigation.

 

•

We may not be able to accurately estimate or control our future operating expenses in relation to obtaining, enforcing and/or defending intellectual property, which could lead to cash shortfalls. Our operating expenses may fluctuate significantly in the future as a result of the costs of preparing, filing, prosecuting, defending and enforcing patent claims and other patent related costs, including litigation costs and the results of such litigation.

 

•

We may also be forced to enter into cross-license agreements with competitors in order to manufacture, use, sell, import and/or export products or services that are covered by our competitors’ intellectual property rights. If we need to use our intellectual property to enter such cross-license agreements, it may compromise the value of our intellectual property due to the fact that our competitors may be able to manufacture, use, sell, import and/or export our patented technology.

For additional information regarding risks related to our intellectual property, see “Risks Related to Intellectual Property.”

Our competitors are large, well-established companies with substantially greater resources than we have and have a long history of competing in the SCS market.

Our current and potential competitors are publicly traded, or are divisions of publicly traded, major medical device companies that have substantially greater financial, technical, sales and marketing resources than we have. The existing global SCS market in 2019 is estimated to be approximately $2.5 billion, with the United States comprising approximately 80% of the market. Given the size of the existing and potential market in the United States, we expect that as we work to increase our market position and penetration in the United States our competitors will take aggressive action to protect their current market position.  For example, in May 2015, a unit of Boston Scientific, one of our principal competitors, filed with the USPTO two petitions for inter partes review challenging the validity of our U.S. Patent No. 8,359,102 (the ‘102 patent), which the Patent Trial and Appeals Board (PTAB) at the USPTO denied in November 2015, and, in December 2016 and April 2018, filed lawsuits against us in the U.S. District Court for the District of Delaware alleging that we infringed their patents covering technology related to stimulation leads, batteries and telemetry units, and alleging theft of trade secrets and tortious interference with contract.  We will face significant competition in establishing our market share in the United States and may encounter unforeseen obstacles and competitive challenges in the United States.

In addition, we face a particular challenge overcoming the long-standing practices by some physicians of using the neuromodulation products of our larger, more established competitors. Physicians who have completed many successful implants using the neuromodulation products made by these competitors may be reluctant to try new products from a source with which they are less familiar. If these physicians do not try and subsequently adopt our product, then our revenue growth will slow or decline.

Further, a number of our competitors are currently conducting, or we anticipate will be conducting, clinical trials to demonstrate the results of their SCS systems. The results of these trials may be equivalent to, or potentially better than, the results of our pivotal U.S. trial.

If our competitors are better able to develop and market neuromodulation products that are safer, more effective, less costly, easier to use or otherwise more attractive than our Senza products, our business will be adversely impacted.

The medical device industry is highly competitive and subject to technological change. Our success depends, in part, upon our ability to establish a competitive position in the neuromodulation market by securing broad market

30

 

acceptance of our HF10 therapy and our Senza products for the treatment of approved chronic pain conditions. Any product we develop that achieves regulatory clearance or approval will have to compete for market acceptance and market share. We believe that the primary competitive factors in the neuromodulation market are demonstrated clinical effectiveness, product safety, reliability and durability, ease of use, product support and service, minimal side effects, pricing and contracting, and salesforce experience and relationships. We face significant competition in the United States and internationally, which we believe will continue to intensify as we grow our presence in the U.S. market. For example, our major competitors, Medtronic, Boston Scientific and Abbott Laboratories, each has approved neuromodulation systems in at least the United States, Europe, and Australia and have been established for several years.  Further, since the launch of our product, these major competitors have all launched new SCS systems: Medtronic launched the Intellis system, Boston Scientific launched the Spectra WaveWriter system and Abbott Laboratories launched the Proclaim system.  We believe these competitors will continue to launch new products, waveforms, and datasets to remain competitive. For example, in early 2020 Medtronic announced the acquisition of Stimgenics, a company that has developed a specific waveform with a purported mechanism of action, and the results of an RCT which had strong results versus traditional SCS. Launches such as these could result in a reduction of our differentiation in the marketplace.  In addition to these major competitors, we also face competition from companies such as Stimwave, Saluda and Nalu Medical, and may face competition from Neuspera Medical and Biotronik in the future. These companies are becoming more active in the SCS market.  For instance, in the first quarter of 2019, Stimwave received FDA clearance for 10kHz stimulation, expanding their previous clearance for low frequency therapy, and Nalu Medical received FDA clearance in the first quarter of 2019 for their SCS system and Saluda Medical received CE Mark in the third quarter of 2019 for their SCS system.  Additionally, there are other emerging competitors with active neuromodulation system development programs that may emerge in the future. Many of the companies developing or marketing competing products enjoy several advantages over us, including:

 

•

more experienced sales forces;

 

•

greater name recognition;

 

•

more established sales and marketing programs and distribution networks;

 

•

earlier regulatory approval;

 

•

long established relationships with physicians and hospitals;

 

•

significant patent portfolios, including issued U.S. and foreign patents and pending patent applications, as well as the resources to enforce patents against us or any of our third-party suppliers and distributors;

 

•

the ability to acquire and integrate our competitors and/or their technology;

 

•

demonstrated ability to develop product enhancements and new product offerings;

 

•

established history of product reliability, safety and durability;

 

•

the ability to offer rebates or bundle multiple product offerings to offer greater discounts or incentives;

 

•

greater financial and human resources for product development, sales, and marketing; and

 

•

greater experience in and resources for conducting R&D, clinical studies, manufacturing, preparing regulatory submissions, obtaining regulatory clearance or approval for products and marketing approved products.

Our competitors may develop and patent processes or products earlier than we do, obtain patents that may apply to us at any time, obtain regulatory clearance or approvals for competing products more rapidly than we do or develop more effective or less expensive products or technologies that render our technology or products obsolete or less competitive. We also face fierce competition in recruiting and retaining qualified sales, scientific, and management personnel, establishing clinical trial sites and enrolling patients in clinical studies. If our competitors are more successful than we are in these matters, our business may be harmed.

31

 

We have a history of significant losses. If we do not achieve and sustain profitability, our financial condition could suffer.

We have experienced significant net losses, and have no assurance that we will achieve profitability. We expect to continue to incur losses as we build our U.S. commercial operations and continue to investigate the use of our HF10 therapy to treat other chronic pain conditions. We incurred net losses of $103.7 million, $49.2 million and $36.7 million for the years ended December 31, 2019, 2018 and 2017, respectively. As of December 31, 2019, our accumulated deficit was $409.8 million. Our prior losses have had, and will continue to have, an adverse effect on our stockholders’ equity and working capital. If our revenue grows more slowly than we anticipate, or if our operating expenses are higher than we expect, we may not be able to achieve profitability and our financial condition could suffer. Our patent infringement lawsuits with Boston Scientific Corporation have caused us to, and may continue to cause us to, incur substantial legal expenses.  Even if we achieve profitability in the future, we may not be able to sustain profitability in subsequent periods.

Our ability to achieve profitability will depend, in part, on our ability to reduce the per unit manufacturing cost of our products.

Currently, the gross profit generated from the sale of our Senza products is not sufficient to cover our operating expenses. To achieve our operating and strategic goals, we will, among other things, need to reduce the per-unit manufacturing cost of Senza. This cannot be achieved without increasing the volume of components that we purchase in order to take advantage of volume-based pricing discounts, improving manufacturing efficiency or increasing our volume to leverage manufacturing overhead costs. If we are unable to improve manufacturing efficiency and reduce manufacturing overhead costs per unit, our ability to achieve profitability will be severely constrained. Any increase in manufacturing volumes is dependent upon a corresponding increase in sales. The occurrence of one or more factors that negatively impact the manufacturing or sales of Senza or reduce our manufacturing efficiency may prevent us from achieving our desired reduction in manufacturing costs, which would negatively affect our operating results and may prevent us from attaining profitability.

If third-party payors do not provide adequate coverage and reimbursement for the use of Senza, our revenue will be negatively impacted.

Our success in marketing our products depends and will depend in large part on whether U.S. and international government health administrative authorities, private health insurers and other organizations adequately cover and reimburse customers for the cost of our products.

In the United States, we expect to derive nearly all our sales from sales of our products to hospitals and outpatient surgery centers who typically bill various third-party payors, including Medicare, Medicaid, private commercial insurance companies, health maintenance organizations and other healthcare-related organizations, to cover all or a portion of the costs and fees associated with our products and bill patients for any applicable deductibles or co-payments. Access to adequate coverage and reimbursement for SCS procedures using Senza (and our other products in development) by third-party payors is essential to the acceptance of our products by our customers.

We believe that SCS procedures using our products are adequately described by existing CPT, HCPCS II and ICD-10-CM codes for the implantation of spinal cord stimulators and related leads performed in various sites of care, although such codes generally do not specifically describe procedures using either low-frequency or high-frequency stimulation. In the United States, CMS approved a transitional pass-through payment for High-Frequency Stimulation under the Medicare hospital outpatient prospective payment system effective as of January 1, 2016.  This pass-through payment (HCPCS C1822) for HF10 therapy was in addition to the established reimbursement for spinal cord stimulation devices; however, this additional pass-through payment ended on December 31, 2017.

We believe that some of our target customers may be unwilling to adopt Senza over more established or lower-cost therapeutic alternatives already available or that may subsequently become available. Further, any decline in the amount payors are willing to reimburse our customers for SCS procedures using Senza could make it

32

 

difficult for new customers to adopt Senza and could create additional pricing pressure for us, which could adversely affect our ability to invest in and grow our business.

Third-party payors, whether foreign or domestic, or governmental or commercial, are developing increasingly sophisticated methods of controlling healthcare costs. In addition, in the United States, no uniform policy of coverage and reimbursement for medical device products and services exists among third-party payors. Therefore, coverage and reimbursement for medical device products and services can differ significantly from payor to payor. Favorable reimbursement decisions from federal Medicare and certain commercial payors, such as Aetna, Cigna, Humana, Blue Cross Blue Shield and Kaiser, have contributed to our increase in revenue to date, while we continue to engage in efforts to educate payors on the advantages of HF10 therapy.  However, there can be no assurance that all private health insurance plans will cover the product.  A significant number of negative coverage and reimbursement decisions by private insurers may impair our ability or delay our ability to grow our revenue. In addition, payors continually review new technologies for possible coverage and can, without notice, deny coverage for these new products and procedures. As a result, the coverage determination process is often a time-consuming and costly process that will require us to provide scientific and clinical support for the use of our products to each payor separately, with no assurance that coverage and adequate reimbursement will be obtained, or maintained if obtained.

Reimbursement systems in international markets vary significantly by country and by region within some countries, and reimbursement approvals must be obtained on a country-by-country basis. In many international markets, a product must be approved for reimbursement before it can be approved for sale in that country. Further, many international markets have government-managed healthcare systems that control reimbursement for new devices and procedures. For example, the governmental healthcare system in France has not yet approved reimbursement of Senza. In most markets there are private insurance systems as well as government-managed systems. If sufficient coverage and reimbursement is not available for our current or future products, in either the United States or internationally, the demand for our products and our revenues will be adversely affected.

We do not expect our worldwide revenue growth to continue at historic rates.

Our worldwide revenue has increased from $23.5 million for the year ended December 31, 2013 to $390.3 million for the year ended December 31, 2019.  Since May 2015 when we commenced the commercial launch of Senza in the U.S., our worldwide revenue growth has been substantially driven by sales of Senza products in the United States.  Despite the significant growth in sales in the U.S. for many years following our launch, we do not expect to continue this historic rate of revenue growth in the U.S. or on a worldwide basis.  Further, due to a number of factors, including governmental reimbursement constraints in the European SCS market limiting the number of annual SCS implants, market pressure in Australia and our current penetration in these markets, we expect minimal, if any, growth in our international markets.

If we fail to develop and retain an effective direct sales force in the United States, our business could suffer.

As we increase our commercial and marketing efforts, we will need to retain, develop and grow the number of direct sales personnel that we employ. We continue to make a significant investment in recruiting and training sales representatives and clinical representatives. There is significant competition for sales personnel experienced in relevant medical device sales. Once hired, the training process is lengthy because it requires significant education for new sales representatives to achieve the level of clinical competency with our products expected by physicians. Upon completion of the training, our sales representatives typically require lead time in the field to grow their network of accounts and achieve the productivity levels we expect them to reach in any individual territory. Furthermore, the use of our products often requires or benefits from direct support from us. If we are unable to attract, motivate, develop and retain a sufficient number of qualified sales personnel, or if our sales representatives do not achieve the productivity levels we expect them to reach, our revenue will not grow at the rate we expect and our financial performance will suffer. For example, during the first half of 2018, we hired sales personnel at a slower rate that we had expected, which, among other factors, caused us to lower our expectations for full year 2018 worldwide revenue. Also, to the extent we hire personnel from our competitors, our new sales representatives will usually be subject to restrictive covenants with their former employers, including non-competition, non-solicitation and/or confidentiality provisions.  As a result, we may have to wait until applicable non-competition provisions have expired before deploying such personnel in restricted territories or incur costs to relocate personnel outside of such territories. We and certain of our new sales

33

 

representatives have been, continue to be, and may in the future be, subject to allegations that these new hires have violated the non-competition clauses, been improperly solicited or divulged to us proprietary or other confidential information of their former employers. Any of these risks may adversely affect our business.

If we fail to maintain FDA approval to market and sell Senza, or if such approval is impacted in the future, we will be unable to commercially distribute and market Senza in the United States. Further, we may not be able to obtain required regulatory approvals to expand the indications for which we may market and sell Senza.

We and our products are subject to extensive regulation in the U.S. and elsewhere, including by the FDA and its foreign counterparts.

The regulations to which we are subject are complex and have tended to become more stringent over time. Regulatory changes could result in restrictions on our ability to carry on or expand our operations, higher than anticipated costs or lower than anticipated sales. The FDA enforces these regulatory requirements through periodic unannounced inspections. We do not know whether we will pass any future FDA inspections.  While we have received FDA approval of our Senza PMA application, there can be no assurance that approval will be maintained. For example:

 

•

we may not be able to maintain to the FDA’s satisfaction that our product is safe and effective for its intended use;

 

•

we may fail to comply with the guidelines required by FDA and other agencies to maintain our PMA approval; and

 

•

the manufacturing processes and facilities we and our vendors use may not meet applicable requirements to maintain our PMA approval.

In addition, we may suffer from product liability or other issues that impact our ability to continue to market the Senza systems in the United States.

Failing to maintain FDA approval could result in unexpected and significant costs for us and consume management’s time and other resources. The FDA could ask us to improve or augment manufacturing processes, collect and provide data on the quality or safety of our product or issue us warning letters relating to matters that may result in removal of our product from the market. Additionally, we will be required to obtain FDA approval prior to making any modification to the device, and the FDA may revoke the approval or impose other restrictions if post-market data demonstrates safety issues or lack of effectiveness. If we are unable to obtain and maintain the necessary regulatory approvals, our financial condition may be adversely affected, and our ability to grow domestically and internationally would likely be limited.

Modifications to our products may require us to obtain new PMA approvals or approvals of a PMA supplement, and if we market modified products without obtaining necessary approvals, we may be required to cease marketing or recall the modified products until required approvals are obtained.

Certain modifications to a PMA-approved device may require approval of a new PMA or a PMA supplement, or alternatively a notification or other submission to the FDA. The FDA may not agree with our decisions regarding whether a new PMA or PMA supplement is necessary. We may make modifications to our approved devices in the future that we believe do not require approval of a new PMA or PMA supplement. If the FDA disagrees with our determination and requires us to submit a new PMA or PMA supplement for modifications to our previously approved products, we may be required to cease marketing or to recall the modified product until we obtain approval, and we may be subject to significant regulatory fines or penalties. In addition, the FDA may not approve our products for the indications that are necessary or desirable for successful commercialization or could require clinical trials to support any modifications. Any delay or failure in obtaining required approvals would adversely affect our ability to introduce new or enhanced products in a timely manner, which in turn would harm our future growth.

34

 

Traditional SCS has been available for over 50 years, while Senza has only been commercially available since 2010 and, as a result, we have a limited track record compared to our competitors.

Traditional SCS has been commercialized since 1967, while we only began commercializing Senza internationally in 2010 and in the United States since May 2015. Because we have a relatively limited commercial track record compared to our competitors and Senza has been implanted in patients for significantly less time than our competitors’ products, physicians may be slower to adopt or recommend Senza. Further, while we believe our international commercial experience and relatively recent U.S. commercial experience, and our European two-year study and U.S. pivotal study support the safety and effectiveness of our HF10 therapy, future studies or patient experience over a longer period of time may indicate that treatment with our HF10 therapy does not achieve non-inferiority status as compared to treatment with competitive products or that our HF10 therapy causes unexpected or serious complications or other unforeseen negative effects. Such results would likely slow the adoption of Senza and significantly reduce our sales, which would harm our business and adversely affect our results of operations.

Furthermore, if patients with traditional SCS implantations were to experience unexpected or serious complications or other unforeseen effects, the market for Senza may be adversely affected, even if such effects are not applicable to Senza.

Our success depends on physicians’ use of our HF10 therapy to treat chronic back pain.

Our success is dependent on physicians’ acceptance and use of our HF10 therapy to treat chronic back pain. We believe a significant limitation of current neuromodulation systems is the limited evidence supporting efficacy of traditional SCS for treating chronic back pain. Senza utilizes high-frequency stimulation technology capable of delivering waveform of up to 10,000 Hz for spinal cord stimulation that has been shown to be effective in the treatment of both leg and back pain. However, we may face challenges convincing physicians, many of whom have extensive experience with competitors’ SCS products and established relationships with other companies, to appreciate the benefits of HF10 therapy and, in particular, its ability to treat back pain as well as leg pain, and adopt it for treatment of their patients. If Senza is unable to gain acceptance by physicians for the treatment of back pain, our potential to expand the existing neuromodulation market will be significantly limited and our revenue potential will be negatively impacted.

Our international operations subject us to certain operating risks, which could adversely impact our results of operations and financial condition.

As of December 31, 2019, we sell Senza directly in the Netherlands, Austria, Switzerland, United Kingdom, Sweden, Australia, Belgium, Luxembourg, Norway and Germany and through distributors and agents located in Spain, Italy, Slovakia, Turkey, Kuwait and Ireland. The sale and shipment of Senza across international borders, as well as the purchase of components from international sources, subject us to United States and foreign governmental trade, import and export and customs regulations and laws.

Compliance with these regulations and laws is costly and exposes us to penalties for non-compliance. Other laws and regulations that can significantly impact us include various anti-bribery laws, including the U.S. Foreign Corrupt Practices Act, as well as export controls laws. Any failure to comply with applicable legal and regulatory obligations could impact us in a variety of ways that include, but are not limited to, significant criminal, civil and administrative penalties, including imprisonment of individuals, fines and penalties, denial of export privileges, seizure of shipments, restrictions on certain business activities and exclusion or debarment from government contracting.

Our international operations expose us and our distributors to risks inherent in operating in foreign jurisdictions. These risks include:

 

•

difficulties in enforcing our intellectual property rights and in defending against third-party threats and intellectual property enforcement actions against us, our distributors, or any of our third-party suppliers;

 

•

reduced or varied protection for intellectual property rights in some countries;

 

•

pricing pressure that we may experience internationally;

35

 

 

•

foreign currency exchange rate fluctuations;

 

•

a shortage of high-quality sales people and distributors;

 

•

third-party reimbursement policies that may require some of the patients who receive our products to directly absorb medical costs or that may necessitate the reduction of the selling prices of Senza;

 

•

relative disadvantages compared to competitors with established business and customer relationships;

 

•

the imposition of additional U.S. and foreign governmental controls or regulations;

 

•

economic instability;

 

•

changes in duties and tariffs, license obligations and other non-tariff barriers to international trade, including any retaliatory tariffs or other actions taken by foreign countries in response to the U.S. tariffs imposed and threatened by the United States presidential administration;

 

•

the imposition of restrictions on the activities of foreign agents, representatives and distributors;

 

•

scrutiny of foreign tax authorities that could result in significant fines, penalties and additional taxes being imposed on us;

 

•

laws and business practices favoring local companies;

 

•

longer payment cycles;

 

•

difficulties in maintaining consistency with our internal guidelines;

 

•

difficulties in enforcing agreements and collecting receivables through certain foreign legal systems;

 

•

the imposition of costly and lengthy new export licensing requirements;

 

•

the imposition of U.S. or international sanctions against a country, company, person or entity with whom we do business that would restrict or prohibit continued business with the sanctioned country, company, person or entity; and

 

•

the imposition of new trade restrictions.

If we experience any of these risks, our sales in non-U.S. jurisdictions may be harmed and our results of operations would suffer.

Changes in tax laws, tax rulings or trade policies may have a material adverse effect on our business, financial condition and results of operations.

Changes in laws and policy relating to taxes or trade may have an adverse effect on our business, financial condition and results of operations.

Recently enacted legislation has significantly changed U.S. federal income tax laws, the consequences of which could have a material impact on the value of our deferred tax assets and could increase our future U.S. income tax expense.  The legislation could be subject to potential amendments and technical corrections, and will be subject to further interpretation and implementing of regulations by the Treasury and Internal Revenue Service (IRS), any of which could mitigate or increase certain adverse effects of the legislation. In addition, it remains unclear how some of these U.S. federal income tax changes will affect state and local taxation.

In addition, changes in U.S. trade policies could materially and adversely impact our effective tax rate, increase our costs and reduce the competitiveness of our products.

We are dependent upon third-party manufacturers and suppliers, in some cases sole- or single-source suppliers, making us vulnerable to supply shortages and problems and price fluctuations, which could harm our business.

We rely on a limited number of suppliers who manufacture and assemble certain components of our products.

36

 

Our suppliers may encounter problems during manufacturing for a variety of reasons, including, for example, failure to follow specific protocols and procedures, failure to comply with applicable legal and regulatory requirements, equipment malfunction and environmental factors, failure to properly conduct their own business affairs and infringement of third-party intellectual property rights, any of which could delay or impede their ability to meet our requirements. Our reliance on these third-party suppliers also subjects us to other risks that could harm our business, including:

 

•

third parties may threaten or enforce their intellectual property rights against our suppliers, which may cause disruptions or delays in shipment, or may force our suppliers to cease conducting business with us;

 

•

we may not be able to obtain adequate supplies from one or more vendors in a timely manner or on commercially reasonable terms;

 

•

we are not a major customer of many of our suppliers, and these suppliers may therefore give other customers’ needs higher priority than ours;

 

•

our suppliers, especially new suppliers, may make errors in manufacturing that could negatively affect the efficacy or safety of our products, impacting our ability to maintain our PMA approval, or cause delays in shipment, impacting our ability to meet demand in the United States or international markets;

 

•

we may have difficulty locating and qualifying alternative suppliers;

 

•

switching components or suppliers may require product redesign and possibly submission to FDA, European Economic Area (EEA) Notified Bodies or other foreign regulatory bodies, which could significantly impede or delay our commercial activities;

 

•

one or more of our sole- or single-source suppliers may be unwilling or unable to supply components of our products, or may supply products that do not meet our product requirements;

 

•

other customers may use fair or unfair negotiation tactics and/or pressures to impede our use of the supplier;

 

•

the occurrence of a fire, natural disaster or other catastrophe impacting one or more of our suppliers may affect their ability to deliver products to us in a timely manner; and

 

•

our suppliers may encounter financial or other business hardships unrelated to our demand, which could inhibit their ability to fulfill our orders and meet our requirements.

We may not be able to quickly establish additional or alternative suppliers for commercialization in the United States if necessary, in part because we may need to undertake additional activities to qualify such suppliers as required by the regulatory approval process. Any interruption or delay in obtaining products from our third-party suppliers, or our inability to obtain products from qualified alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand of our customers and cause them to switch to competing products. Given our reliance on certain single-source suppliers, we are especially susceptible to supply shortages because we do not have alternate suppliers currently available.

We rely upon third-party, single-source, and in certain cases sole-source, suppliers for many of the components and materials used in our products, and for critical manufacturing and packaging services, and the loss of any of these suppliers could harm our business.

A number of the critical components used in our products are supplied to us from single-source, or in certain cases sole-source, suppliers, including leads, lead extenders, surgical leads, neurostimulator components and telemetry modules. Our ability to supply our products commercially depends, in part, on our ability to obtain a supply of these components that have been manufactured in accordance with regulatory requirements and in sufficient quantities for commercialization and clinical testing. In most cases, we have not entered into manufacturing, supply or quality agreements with our single-source and sole-source suppliers, some of which supply components critical to our products. We are not certain that our single-source or sole-source suppliers will be able to meet our demand for their products and services, either because of the nature of our agreements with those suppliers, or our limited experience with those suppliers, or due to our relative importance as a customer to those suppliers or

37

 

otherwise. It may be difficult for us to assess their ability to timely meet our demand in the future based on past performance. While our suppliers have generally met our demand for their products on a timely basis in the past, they may subordinate our needs in the future to the needs of their other customers.

Establishing additional or replacement suppliers for the components or processes used in Senza systems, if required, may not be accomplished quickly. If we are able to find a replacement supplier, such replacement supplier would need to be qualified and may require additional regulatory authority approval, which could result in further delay. While we seek to maintain adequate inventory of the single-source or sole-source components and materials used in our products, any interruption or delay in the supply of components or materials, or our inability to obtain components or materials from alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand of our customers and cause them to cancel orders.  In addition, from time to time, certain of our suppliers experience interruptions and variances in their manufacturing processes, including suppliers of our leads and batteries.  Because we are reliant on these single source suppliers, we are particularly susceptible to supply shortages and, if one of our suppliers were to experience an ongoing or continued manufacturing problem, and, in particular, our leads and battery suppliers, our ability to meet our forecasted commercial demand could be materially and negatively impacted.

If our third-party suppliers fail to deliver the required commercial quantities of materials, or the level of services we require, on a timely basis and at commercially reasonable prices, and we are unable to find one or more replacement suppliers capable of production at a substantially equivalent cost in substantially equivalent volumes and quality, and on a timely basis, the continued commercialization of Senza would be impeded, delayed, limited or prevented, which could harm our business, results of operations, financial condition and prospects.

We may not be able to establish or strengthen our brand.

We believe that establishing and strengthening the Nevro and Senza brands is critical to achieving widespread acceptance of HF10 therapy, particularly because of the highly competitive nature of the market for SCS products. Promoting and positioning our brand will depend largely on the success of our marketing efforts and our ability to provide physicians with a reliable product for successful treatment of chronic leg and back pain. Additionally, we believe the quality and reliability of our product is critical to building physician support of this new therapy in the United States and any negative publicity regarding the quality or reliability of Senza could significantly damage our reputation in the market. Further, given the established nature of our competitors, and our relatively recent commercial launch in the United States, it is likely that our future marketing efforts will require us to incur significant additional expenses. These brand promotion activities may not yield increased sales and, even if they do, any sales increases may not offset the expenses we incur to promote our brand. If we fail to successfully promote and maintain our brand, or if we incur substantial expenses in an unsuccessful attempt to promote and maintain our brand, our HF10 therapy may not be accepted by physicians, which would adversely affect our business, results of operations and financial condition.

If we fail to properly manage our anticipated growth, our business could suffer.

We have been growing rapidly in recent periods and have a relatively short history of operating as a commercial company. As an organization, we have only relatively recently commercially launched our product in the United States and commenced a sales representative training program. A commercial launch and training program of this size is a significant undertaking that requires substantial financial and managerial resources. We intend to continue to grow and may experience periods of rapid growth and expansion, which could place a significant additional strain on our limited personnel, information technology systems and other resources. In particular, the hiring of our direct sales force in the United States requires significant management, financial and other supporting resources. Any failure by us to manage our growth effectively could have an adverse effect on our ability to achieve our development and commercialization goals.

To achieve our revenue goals, we must successfully increase manufacturing output to meet expected customer demand. In the future, we may experience difficulties with manufacturing yields, quality control, component supply and shortages of qualified personnel, among other problems. These problems could result in delays in product availability and increases in expenses. Any such delay or increased expense could adversely affect our ability to generate revenue.

38

 

Future growth will also impose significant added responsibilities on management, including the need to identify, recruit, train and integrate additional employees. In addition, rapid and significant growth will place a strain on our administrative and operational infrastructure.

In order to manage our operations and growth we will need to continue to improve our operational and management controls, reporting and information technology systems and financial internal control procedures. If we are unable to manage our growth effectively, it may be difficult for us to execute our business strategy and our operating results and business could suffer.

If we fail to receive access to hospital facilities, our sales may decrease.

In the United States, in order for physicians to use Senza, the hospital facilities where these physicians treat patients typically require us to enter into purchasing contracts. The process of securing a satisfactory contract can be lengthy and time-consuming and require extensive negotiations and management time. In the European Union (EU), from time to time, certain institutions require us to engage in a contract bidding process in the event that such institutions are considering making purchase commitments that exceed specified cost thresholds, which vary by jurisdiction. These processes are only open at certain periods of time, and we may not be successful in the bidding process. If we do not receive access to hospital facilities via these contracting processes or otherwise, or if we are unable to secure contracts or tender successful bids, our sales may stagnate or decrease and our operating results may be harmed. Furthermore, we may expend significant effort in these time-consuming processes and still may not obtain a purchase contract from such hospitals.

We rely in part on a small group of third-party distributors to effectively distribute our products outside the United States.

We depend in part on medical device distributors for the marketing and sales of our products in certain territories in Europe. We depend on these distributors’ efforts to market our products, yet we are unable to control their efforts completely. These distributors typically sell a variety of other, non-competing products that may limit the resources they dedicate to selling Senza. In addition, we are unable to ensure that our distributors comply with all applicable laws regarding the sale of our products. If our distributors fail to effectively market and sell Senza in full compliance with applicable laws, our operating results and business may suffer. Recruiting and retaining qualified third-party distributors and training them in our technology and product offering requires significant time and resources. To develop and expand our distribution, we must continue to scale and improve our processes and procedures that support our distributors. Further, if our relationship with a successful distributor terminates, we may be unable to replace that distributor without disruption to our business. If we fail to maintain positive relationships with our distributors, fail to develop new relationships with other distributors, including in new markets, fail to manage, train or incentivize existing distributors effectively, or fail to provide distributors with competitive products on attractive terms, or if these distributors are not successful in their sales efforts, our revenue may decrease and our operating results, reputation and business may be harmed.

We may face product liability claims that could result in costly litigation and significant liabilities.

Manufacturing and marketing Senza, and clinical testing of our HF10 therapy, may expose us to product liability and other tort claims. Although we have, and intend to maintain, liability insurance, the coverage limits of our insurance policies may not be adequate and one or more successful claims brought against us may have a material adverse effect on our business and results of operations. For example, in 2014, the U.S. Supreme Court declined to hear an appeal where the U.S. Court of Appeals for the Ninth Circuit ruled that the Medical Device Amendments of 1976 to the FFDCA did not preempt state laws in a product liability case involving a medical device company. If other courts in the United States adopt similar rulings, we may be subject to increased litigation risk in connection with our products. Product liability claims could negatively affect our reputation, continued product sales, and our ability to obtain and maintain regulatory approval for our products.

39

 

If clinical studies for future indications do not produce results necessary to support regulatory clearance or approval in the United States or elsewhere, we will be unable to commercialize our products for these indications.

Clinical trials are necessary to support PMA applications and may be necessary to support PMA supplements for modified versions of our marketed device products. This would require the enrollment of large numbers of suitable subjects, which may be difficult to identify, recruit and maintain as participants in the clinical trial. Adverse outcomes in the post-approval studies could also result in restrictions or withdrawal of approval of the PMA. We will likely need to conduct additional clinical studies in the future to support new indications for our products or for approvals or clearances of new product lines, or for the approval of the use of our products in some foreign countries. For example, we are currently conducting clinical trials for Senza to explore the potential for HF10 therapy to treat certain chronic pain indications, including chronic upper limb and neck pain, painful neuropathies and non-surgical refractory back pain. We will likely need to conduct additional clinical studies in the future to support regulatory approval for the use of our products to treat some of these new indications. Clinical testing can take many years, is expensive and carries uncertain outcomes. The initiation and completion of any of these studies may be prevented, delayed, or halted for numerous reasons, including, but not limited to, the following:

 

•

the FDA, Institutional Review Boards (IRBs), Ethics Committees, EU Competent Authorities or other regulatory authorities do not approve a clinical study protocol, force us to modify a previously approved protocol, or place a clinical study on hold;

 

•

patients do not enroll in, or enroll at a lower rate than we expect, or do not complete a clinical study;

 

•

patients or investigators do not comply with study protocols;

 

•

the FDA may disagree with our interpretation of the data from our pre-clinical studies and clinical trials, or may find the clinical trial design, conduct or results inadequate to prove safety or efficacy, and may require us to pursue additional pre-clinical studies or clinical trials, which could further delay the clearance or approval of our products;

 

•

patients do not return for post-treatment follow-up at the expected rate;

 

•

patients experience serious or unexpected adverse side effects for a variety of reasons that may or may not be related to our products such as the advanced stage of co-morbidities that may exist at the time of treatment, causing a clinical study to be put on hold;

 

•

sites participating in an ongoing clinical study withdraw, requiring us to engage new sites;

 

•

difficulties or delays associated with establishing additional clinical sites;

 

•

third-party clinical investigators decline to participate in our clinical studies, do not perform the clinical studies on the anticipated schedule, or perform in a manner inconsistent with the investigator agreement, clinical study protocol, good clinical practices, other FDA, IRB or Ethics Committee requirements, and EEA Member State or other foreign regulations governing clinical trials;

 

•

third-party organizations do not perform data collection and analysis in a timely or accurate manner;

 

•

regulatory inspections of our clinical studies or manufacturing facilities require us to undertake corrective action or suspend or terminate our clinical studies;

 

•

changes in federal, state, or foreign governmental statutes, regulations or policies;

 

•

interim or final results are inconclusive or unfavorable as to immediate and long-term safety or efficacy;

 

•

the study design is inadequate to demonstrate safety and efficacy; or

 

•

the statistical endpoints are not met.

Clinical failure can occur at any stage of the testing. Our clinical studies may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical or non-clinical studies in addition to those we have planned. Our failure to adequately demonstrate the safety and effectiveness of any of our devices would prevent receipt of regulatory clearance or approval and, ultimately, the commercialization of that device or indication for use.

40

 

We could also encounter delays if the FDA concludes that our financial relationships with investigators results in a perceived or actual conflict of interest that may have affected the interpretation of a study, the integrity of the data generated at the applicable clinical trial site or the utility of the clinical trial itself. Principal investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and receive cash compensation and/or equity-based awards in connection with such services. If these relationships and any related compensation to or ownership interest by the clinical investigator carrying out the study result in perceived or actual conflicts of interest, or if the FDA concludes that the financial relationship may have affected interpretation of the study, the integrity of the data generated at the applicable clinical trial site may be questioned and the utility of the clinical trial itself may be jeopardized, which could result in the FDA refusing to accept the data as support for our future applications. Any such delay or rejection could prevent us from commercializing any of our products currently in development.

Even if our products are approved in the United States, Australia and the EEA, comparable regulatory authorities of additional foreign countries must also approve the manufacturing and marketing of our products in those countries. Approval procedures vary among jurisdictions and can involve requirements and administrative review periods different from, and greater than, those in the United States, Australia or the EEA, including additional preclinical studies or clinical trials. Any of these occurrences may harm our business, financial condition and prospects significantly.

If we fail to retain our key executives or recruit and hire new employees, our operations and financial results may be adversely effected while we attract other highly qualified personnel.

Our future success depends, in part, on our ability to continue to retain our executive officers and other key employees, and recruit and hire new employees. All of our executive officers and other employees are at-will employees, and therefore may terminate employment with us at any time with no advance notice. The replacement of any of our key personnel likely would involve significant time and costs, may significantly delay or prevent the achievement of our business objectives and may harm our business.

In addition, many of our employees have become, or will soon become, vested in a substantial amount of Company stock or be able to exercise a substantial number of stock options. Our employees may be more likely to leave us if the shares they own or the shares underlying their vested options have significantly appreciated in value relative to the original purchase prices of the shares or the exercise prices of the options, or if the exercise prices of the options that they hold are significantly below the market price of our common stock. Further, our employees’ ability to exercise those options and sell their stock in a public market may result in a higher than normal turnover rate.

Our future success also depends on our ability to retain executive officers and other key employees and attract new key employees. Many executive officers and other employees in the neuromodulation and medical device industry are subject to strict non-competition, non-solicitation and/or confidentiality agreements with their employers, including our main competitors Medtronic plc, Boston Scientific and Abbott Laboratories. Our competitors may allege breaches of, and seek to enforce, such non-competition, non-solicitation and/or confidentiality agreements or initiate litigation based on such agreements, particularly now that we have entered the U.S. market. Such litigation, whether or not meritorious, may impede our ability to attract, hire or utilize executive officers and other key employees who have been or are currently employed by our competitors.

Failure to protect our information technology infrastructure against cyber-based attacks, network security breaches, service interruptions, or data corruption could significantly disrupt our operations and adversely affect our business and operating results.

We rely on information technology and telephone networks and systems, including the Internet, to process and transmit sensitive electronic information and to manage or support a variety of business processes and activities, including sales, billing, marketing, procurement and supply chain, manufacturing and distribution. We use enterprise information technology systems to record, process and summarize financial information and results of operations for internal reporting purposes and to comply with regulatory, financial reporting, legal and tax requirements. Our information technology systems, some of which are managed by third-parties, may be susceptible to damage, disruptions or shutdowns due to computer viruses, attacks by computer hackers, failures during the process of

41

 

upgrading or replacing software, databases or components thereof, power outages, hardware failures, telecommunication failures, user errors or catastrophic events. Despite the precautionary measures we have taken to prevent breakdowns in our information technology and telephone systems, if our systems suffer severe damage, disruption or shutdown and we are unable to effectively resolve the issues in a timely manner, our business and operating results may suffer.

Risks Related to Intellectual Property

We currently are, and may in the future become, involved in lawsuits to defend ourselves against intellectual property disputes, which could be expensive and time consuming, and ultimately unsuccessful, and could result in the diversion of significant resources, and hinder our ability to commercialize our existing or future products.

Our success depends in part on not infringing the patents or violating the other proprietary rights of others. Intellectual property disputes can be costly to defend and may cause our business, operating results and financial condition to suffer. Significant litigation regarding patent rights occurs in the medical industry. Whether merited or not, it is possible that U.S. and foreign patents and pending patent applications controlled by third parties may be alleged to cover our products. We may also face allegations that our employees have misappropriated the intellectual property rights of their former employers or other third parties. For example, on December 9, 2016, Boston Scientific filed a patent infringement lawsuit alleging our manufacture, use and sale of the Senza system infringes certain of Boston Scientific’s patents covering technology related to stimulation leads, batteries and telemetry units. On April 27, 2018, Boston Scientific filed a second lawsuit alleging patent infringement, theft of trade secrets, and tortious interference with contract.

Our competitors in both the United States and abroad, many of which have substantially greater resources and have made substantial investments in patent portfolios and competing technologies, may have applied for or obtained or may in the future apply for and obtain, patents that will prevent, limit, or otherwise interfere with our ability to make, use, sell, and/or export our products. For example, our major competitors, Medtronic, Boston Scientific and Abbott Laboratories, each have significant patent portfolios covering systems, sub-systems, methods, and manufacturing processes. These competitors may have one or more patents for which they can threaten and/or initiate patent infringement actions against us and/or any of our third-party suppliers. Our ability to defend ourselves and/or our third-party suppliers may be limited by our financial and human resources, the availability of reasonable defenses, and the ultimate acceptance of our defenses by the courts or juries. Further, if such patents are successfully asserted against us, this may result in an adverse impact on our business, including injunctions, damages and/or attorneys’ fees. From time to time and in the ordinary course of business, we may develop non-infringement and/or invalidity positions with respect to third-party patents, which may or not be ultimately adjudicated as successful by a judge or jury if such patents were asserted against us.

We may receive in the future, particularly as a public company, communications from patent holders, including non-practicing entities, alleging infringement of patents or other intellectual property rights or misappropriation of trade secrets, or offering licenses to such intellectual property. Any claims that we assert against perceived infringers could also provoke these parties to assert counterclaims against us alleging that we infringe their intellectual property rights. At any given time, we may be involved as either a plaintiff or a defendant in a number of patent infringement actions, the outcomes of which may not be known for prolonged periods of time. We may also become involved in disputes with others regarding the ownership of intellectual property rights. For example, we jointly develop intellectual property with certain parties, and disagreements may therefore arise as to the ownership of the intellectual property developed pursuant to these relationships. If we are unable to resolve these disputes, we could lose valuable intellectual property rights.

The large number of patents, the rapid rate of new patent applications and issuances, the complexities of the technologies involved and the uncertainty of litigation significantly increase the risks related to any patent litigation. Any potential intellectual property litigation also could force us to do one or more of the following:

 

•

stop selling, making, using, or exporting products that use the disputed intellectual property;

 

•

obtain a license from the intellectual property owner to continue selling, making, exporting, or using products, which license may require substantial royalty payments and may not be available on reasonable terms, or at all;

42

 

 

•

incur significant legal expenses;

 

•

pay substantial damages or royalties to the party whose intellectual property rights we may be found to be infringing, potentially including treble damages if the court finds that the infringement was willful;

 

•

if a license is available from a third-party, we may have to pay substantial royalties, upfront fees or grant cross-licenses to intellectual property rights for our products and services;

 

•

pay the attorney fees and costs of litigation to the party whose intellectual property rights we may be found to be infringing;

 

•

find non-infringing substitute products, which could be costly and create significant delay due to the need for prior FDA authorization;

 

•

find alternative supplies for infringing products or processes, which could be costly and create significant delay due to the need for FDA regulatory clearance; and/or

 

•

redesign those products or processes that infringe any third-party intellectual property, which could be costly, disruptive, and/or infeasible.

From time to time, we may be subject to legal proceedings and claims with respect to intellectual property.  For more information regarding our ongoing litigation with Boston Scientific, as well as our lawsuit for patent infringement and false advertisement against Stimwave, see the section titled “Legal Proceedings” included under Part I, Item 3 of this Annual Report. Even if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses, and could distract our technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments, that we do not control. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of our common stock and the value of the 1.75% convertible senior notes due 2021 (the 2021 Notes). Additionally, because we often do not control the timing of the public announcements, there is the potential for these announcements to be made during market hours, necessitating a halt in the trading of our common stock for periods of time.  Finally, any uncertainties resulting from the initiation and continuation of any litigation could have a material adverse effect on our ability to raise the funds necessary to continue our operations.

If any of the foregoing occurs, we may have to withdraw existing products from the market or may be unable to commercialize one or more of our products, all of which could have a material adverse effect on our business, results of operations and financial condition. Any litigation or claim against us, even those without merit, may cause us to incur substantial costs, and could place a significant strain on our financial resources, divert the attention of management from our core business and harm our reputation. Further, as the number of participants in the neuromodulation industry grows, the possibility of intellectual property infringement claims against us increases.

In addition, we may indemnify our customers, suppliers and international distributors against claims relating to the infringement of the intellectual property rights of third parties relating to our products, methods, and/or manufacturing processes. Third parties may assert infringement claims against our customers, suppliers, or distributors. These claims may require us to initiate or defend protracted and costly litigation on behalf of our customers, suppliers or distributors, regardless of the merits of these claims. If any of these claims succeed, we may be forced to pay damages on behalf of our customers, suppliers, or distributors or may be required to obtain licenses for the products they use. If we cannot obtain all necessary licenses on commercially reasonable terms, our customers may be forced to stop using our products, or our suppliers may be forced to stop providing us with products.

Similarly, interference or derivation proceedings provoked by third parties or brought by the USPTO or any foreign patent authority may be necessary to determine the priority of inventions or other matters of inventorship with respect to our patents or patent applications. An unfavorable outcome in these or any other such proceedings could require us to cease using the related technology or to attempt to license rights to it from the prevailing party. Our business could be harmed if the prevailing party does not offer us a license on commercially reasonable terms, if any license is offered at all.

43

 

We may also become involved in other proceedings, such as re-examination or opposition proceedings, before the USPTO or its foreign counterparts relating to our intellectual property or the intellectual property rights of others. For example, two of our competitors, Boston Scientific and Medtronic, have filed oppositions in the EU with respect to certain of our patents. Boston Scientific has filed an entitlement action against us in the German courts. Defending our position in proceedings such as these will require management’s time and attention, as well as financial costs. Given the competitive environment in which we operate, we expect additional challenges to our intellectual property portfolio as we continue commercialization of Senza in the United States and abroad. An unfavorable outcome in these or any other such proceedings could cause us to lose valuable intellectual property rights and/or be unable to enforce our intellectual property rights, which could invite increased competition thereby materially harming our business.

Changes in patent law could diminish the value of patents in general, thereby impairing our ability to protect our existing and future products.

Patent reform legislation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents. On September 16, 2011, the Leahy-Smith America Invents Act (the Leahy-Smith Act) was signed into law. The Leahy-Smith Act includes a number of significant changes to U.S. patent law. These include provisions that affect the way patent applications are prosecuted, redefine prior art and may affect patent litigation. The changes also switched the United States patent system from a “first-to-invent” system to a “first-to-file” system. Under a “first-to-file” system, assuming the other requirements for patentability are met, the first inventor to file a patent application generally will be entitled to the patent on an invention regardless of whether another inventor had made the invention earlier. The USPTO recently developed new regulations and procedures to govern administration of the Leahy-Smith Act, and many of the substantive changes to patent law associated with the Leahy-Smith Act, in particular, the first-to-file provisions, only became effective on March 16, 2013. Accordingly, it is not clear what, if any, impact the Leahy-Smith Act will have on the operation of our business. The Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of our issued patents, all of which could have a material adverse effect on our business and financial condition.

In addition, patent reform legislation may pass in the future that could lead to additional uncertainties and increased costs surrounding the prosecution, enforcement and defense of our patents and applications. Furthermore, the U.S. Supreme Court and the U.S. Court of Appeals for the Federal Circuit have made, and will likely continue to make, changes in how the patent laws of the United States are interpreted. Similarly, foreign courts have made, and will likely continue to make, changes in how the patent laws in their respective jurisdictions are interpreted. We cannot predict future changes in the interpretation of patent laws or changes to patent laws that might be enacted into law by United States and foreign legislative bodies. Those changes may materially affect our patents or patent applications and our ability to obtain additional patent protection in the future.

Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.

The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. In addition, periodic maintenance fees on issued patents often must be paid to the USPTO and foreign patent agencies over the lifetime of the patent. While an unintentional lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Non-compliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents. If we fail to maintain the patents and patent applications covering our products or procedures, we may not be able to stop a competitor from marketing products that are the same as or similar to our own, which would have a material adverse effect on our business.

44

 

We may not be able to adequately protect our intellectual property rights throughout the world.

Filing, prosecuting and defending patents on our products in all countries throughout the world would be prohibitively expensive. The requirements for patentability may differ in certain countries, particularly developing countries, and the breadth of patent claims allowed can be inconsistent. In addition, the laws of some foreign countries may not protect our intellectual property rights to the same extent as laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories in which we have patent protection that may not be sufficient to terminate infringing activities.

We do not have patent rights in certain foreign countries in which a market may exist. Moreover, in foreign jurisdictions where we do have patent rights, proceedings to enforce such rights could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly, and our patent applications at risk of not issuing. Additionally, such proceedings could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and if we do prevail, the damages or other remedies awarded, if any, may not be commercially meaningful. Thus, we may not be able to stop a competitor from marketing and selling in foreign countries products that are the same as or similar to our products, and our competitive position in the international market would be harmed.

We may be subject to damages resulting from claims that we or our employees have wrongfully used or disclosed alleged trade secrets of our competitors or are in breach of non-competition or non-solicitation agreements with our competitors.

We could in the future be subject to claims that we or our employees have inadvertently or otherwise used or disclosed alleged trade secrets or other proprietary information of former employers or competitors. In addition, many of our executive officers and key employees, as well as our Lead Director, have worked for our major competitors (or companies acquired by these competitors), which include Boston Scientific, Medtronic and Abbott Laboratories. Although we have procedures in place that seek to prevent our employees and consultants from using the intellectual property, proprietary information, know-how or trade secrets of others in their work for us, we may in the future be subject to claims that we caused an employee to breach the terms of his or her non-competition or non-solicitation agreement, or that we or these individuals have, inadvertently or otherwise, used or disclosed the alleged trade secrets or other proprietary information of a former employer or competitor. Litigation may be necessary to defend against these claims. Even if we are successful in defending against these claims, litigation could result in substantial costs and could be a distraction to management. If our defense to those claims fails, in addition to paying monetary damages, a court could prohibit us from using technologies or features that are essential to our products, if such technologies or features are found to incorporate or be derived from the trade secrets or other proprietary information of the former employers. An inability to incorporate technologies or features that are important or essential to our products would have a material adverse effect on our business, and may prevent us from selling our products or from practicing our processes. In addition, we may lose valuable intellectual property rights or personnel. Moreover, any such litigation or the threat thereof may adversely affect our ability to hire employees or contract with independent sales representatives. A loss of key personnel or their work product could hamper or prevent our ability to commercialize our products, which could have an adverse effect on our business, results of operations and financial condition.

If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected.

Our registered or unregistered trademarks or trade names may be challenged, infringed, circumvented, declared generic or determined to be infringing on other marks. We may not be able to protect our rights in these trademarks and trade names, which we need in order to build name recognition with potential partners or customers in our markets of interest. In addition, third parties have registered trademarks similar and identical to our trademarks in foreign jurisdictions, and may in the future file for registration of such trademarks. If they succeed in registering or developing common law rights in such trademarks, and if we were not successful in challenging such third-party rights, we may not be able to use these trademarks to market our products in those countries. In any case,

45

 

if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected.

If we are unable to protect the confidentiality of our trade secrets, our business and competitive position may be harmed.

In addition to patent and trademark protection, we also rely on trade secrets, including unpatented know-how, technology and other proprietary information, to maintain our competitive position. We seek to protect our trade secrets, in part, by entering into non-disclosure and confidentiality agreements with parties who have access to them, such as our consultants and vendors, or our former or current employees. We also enter into confidentiality and invention or patent assignment agreements with our employees and consultants. Despite these efforts, however, any of these parties may breach the agreements and disclose our trade secrets and other unpatented or unregistered proprietary information, and once disclosed, we are likely to lose trade secret protection. Monitoring unauthorized uses and disclosures of our intellectual property is difficult, and we do not know whether the steps we have taken to protect our intellectual property will be effective. In addition, we may not be able to obtain adequate remedies for any such breaches. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret is difficult, expensive and time-consuming, and the outcome is unpredictable. In addition, some courts inside and outside the United States are less willing or unwilling to enforce trade secret protection.

Further, our competitors may independently develop knowledge, methods and know-how similar, equivalent, or superior to our proprietary technology. Competitors could purchase our products and attempt to replicate some or all of the competitive advantages we derive from our development efforts, willfully infringe our intellectual property rights, design around our protected technology or develop their own competitive technologies that fall outside of our intellectual property rights. In addition, our key employees, consultants, suppliers or other individuals with access to our proprietary technology and know-how may incorporate that technology and know-how into projects and inventions developed independently or with third parties. As a result, disputes may arise regarding the ownership of the proprietary rights to such technology or know-how, and any such dispute may not be resolved in our favor. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent them, or those to whom they communicate it, from using that technology or information to compete with us and our competitive position could be adversely affected. If our intellectual property is not adequately protected so as to protect our market against competitors’ products and methods, our competitive position could be adversely affected, as could our business.

Risks Related to our Financial and Operating Results

We may choose, or need, to obtain additional funds in the future, and these funds may not be available on acceptable terms or at all.

Our operations have consumed substantial amounts of cash since inception, and we anticipate our expenses will increase as we continue to build a commercial sales force in the United States, investigate the use of our HF10 therapy for the treatment of other chronic pain conditions, continue to otherwise grow our business, including potentially acquiring other businesses or technologies, manage the maturity of our convertible debt instruments, the 2021 Notes, and continue to operate as a public company. In particular, we believe that we will continue to expend substantial resources for the foreseeable future on the commercialization of Senza in the United States, as well as the growth of our sales and marketing efforts and sales representative training, seeking additional foreign regulatory approvals, the preparation and submission of regulatory filings and the clinical development of any other product candidates or indications we may choose to pursue. These expenditures will also include costs associated with manufacturing and supply as well as marketing and selling Senza in the United States and elsewhere, and any other future products approved for sale, R&D, conducting preclinical studies and clinical trials and obtaining regulatory approvals.

We believe that our growth will depend, in part, on our ability to fund our commercialization efforts, particularly in the United States, and our efforts to develop our Senza products and HF10 therapy for the treatment of additional chronic pain indications and develop technology complementary to our current product. In order to further enhance our R&D efforts, pursue product expansion opportunities or acquire a new business or products that are complementary to our business, we may choose to seek additional funds. If we are unable to raise funds on

46

 

favorable terms, or at all, the long-term growth of our business may be negatively impacted. As a result, we may be unable to compete effectively. Our cash requirements in the future may be significantly different from our current estimates and depend on many factors, including:

 

•

the costs of commercializing our products in the United States and elsewhere, including costs associated with product sales, marketing, manufacturing and distribution;

 

•

our ability to maintain the average sales price of our products;

 

•

the cost of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights, including, in particular, the costs of enforcing our patent rights in the action we filed against Boston Scientific and in defending against Boston Scientific’s action against us;

 

•

the R&D activities we intend to undertake in order to expand the chronic pain indications and product enhancements that we intend to pursue;

 

•

whether or not we pursue acquisitions or investments in businesses, products or technologies that are complementary to our current business;

 

•

the degree and rate of market acceptance of our products in the United States and elsewhere;

 

•

changes or fluctuations in our inventory supply needs and forecasts of our supply needs;

 

•

our need to implement additional infrastructure and internal systems;

 

•

our ability to hire additional personnel to support our operations as a public company; and

 

•

the emergence of competing technologies or other adverse market developments.

To finance these activities, we may seek funds through borrowings or through additional rounds of financing, including private or public equity or debt offerings and collaborative arrangements with corporate partners. We may be unable to raise funds on favorable terms, or at all.

The sale of additional equity or convertible debt securities could result in additional dilution to our stockholders. If we borrow additional funds or issue debt securities, these securities could have rights superior to holders of our common stock and the 2021 Notes and could contain covenants that will restrict our operations. We might have to obtain funds through arrangements with collaborative partners or others that may require us to relinquish rights to our technologies, product candidates, or products that we otherwise would not relinquish. If we do not obtain additional resources, our ability to capitalize on business opportunities will be limited, we may be unable to compete effectively and the growth of our business will be harmed.

Our operating results may vary significantly from quarter to quarter, which may negatively impact our stock price in the future.

Our quarterly revenue and results of operations may fluctuate from quarter to quarter due to, among others, the following reasons:

 

•

physician and payor acceptance of our products and HF10 therapy;

 

•

our success in initiating patient trials for HF10 therapy and converting those trials into permanent implants;

 

•

fluctuations in our expenses associated with inventory buildup or write-downs from analyzing our inventory for obsolescence or conformity with our product requirements;

 

•

fluctuations in the expenses related to initiating, pursuing and defending lawsuits;

 

•

buying patterns of our customers;

 

•

the timing, expense and results of our commercialization efforts in the United States and elsewhere, R&D activities, clinical trials and regulatory approvals;

 

•

the introduction of new products and technologies by our competitors;

47

 

 

•

the productivity of our sales representatives;

 

•

difficulties in collecting receivables related to our sales in the United States;

 

•

fluctuations in expenses as a result of expanding our commercial operations and operating as a public company;

 

•

supplier, manufacturing or quality problems with our products;

 

•

changes in our pricing policies or strategies or in the pricing policies or strategies of our competitors; and

 

•

changes in coverage amounts or government and third-party payors’ reimbursement policies.

Because of these and other factors, it is likely that in some future period our operating results will not meet investor expectations or those of public market analysts.

Any unanticipated change in revenues or operating results is likely to cause our stock price to fluctuate. New information may cause investors and analysts to revalue our business, which could cause a decline in our stock price.

We are required to maintain high levels of inventory, which could consume a significant amount of our resources, reduce our cash flows and lead to inventory impairment charges.

As a result of the need to maintain substantial levels of inventory, we are subject to the risk of inventory obsolescence and expiration, which may lead to inventory impairment charges. Our products consist of a substantial number of individual components. In order to market and sell Senza effectively, we often must maintain high levels of inventory. In particular, as we continue our commercial launch of Senza in the United States, we intend to maintain our high levels of inventory in order to meet our estimated demand and, as a result, incur significant expenditures associated with such levels of inventory. The manufacturing process requires lengthy lead times, during which components of our products may become obsolete, and we may over- or underestimate the amount needed of a given component, in which case we may expend extra resources or be constrained in the amount of end product that we can produce. As compared to direct manufacturers, our dependence on third-party manufacturers exposes us to greater lead times increasing our risk of inventory obsolescence comparatively, and we would be required to record an impairment charge, as we did in the first quarter of 2019. Furthermore, our products have a limited shelf life due to sterilization requirements, and part or all of a given product or component may expire and its value would become impaired. We have also experienced inventory write-downs as a result of inventory that did not meet our product requirements. In addition, as we release later generations of products that contain advancements or additional features, the earlier generations may become obsolete. If our estimates of required inventory are too high, we may be exposed to further inventory obsolescence risk. In the event that a substantial portion of our inventory becomes obsolete or expires, or in the event we experience a supply chain imbalance as described above, it could have a material adverse effect on our earnings and cash flows due to the resulting costs associated with the inventory impairment charges and costs required to replace such inventory.

The seasonality of our business creates variance in our quarterly revenue, which makes it difficult to compare or forecast our financial results.

Our revenue fluctuates on a seasonal basis, which affects the comparability of our results between periods. For example, due to the seasonality of buying patterns and implant volumes of distributors, hospitals and clinics, the industry generally experiences lower revenues in the first and third quarters of the year and higher revenues in the fourth quarter. We are now experiencing these industry trends to a greater degree than in our initial U.S. commercial launch phase. These seasonal variations are difficult to predict accurately, may vary amongst different markets, and at times may be entirely unpredictable, which introduce additional risk into our business as we rely upon forecasts of customer demand to build inventory in advance of anticipated sales.

48

 

We are subject to risks associated with currency fluctuations, and changes in foreign currency exchange rates could impact our results of operations.

A portion of our business is located outside the United States and, as a result, we generate revenue and incur expenses denominated in currencies other than the U.S. dollar, a majority of which is denominated in Euros, British Pounds and Australian Dollars. As a result, changes in the exchange rates between such foreign currencies and the U.S. dollar could materially impact our reported results of operations and distort period to period comparisons. Fluctuations in foreign currency exchange rates also impact the reporting of our receivables and payables in non-U.S. currencies. As a result of such foreign currency fluctuations, it could be more difficult to detect underlying trends in our business and results of operations. In addition, to the extent that fluctuations in currency exchange rates cause our results of operations to differ from our expectations or the expectations of our investors, the trading price of our common stock and the value of the 2021 Notes could be adversely affected.

In the future, we may engage in exchange rate hedging activities in an effort to mitigate the impact of exchange rate fluctuations. If our hedging activities are not effective, changes in currency exchange rates may have a more significant impact on our results of operations.

Our ability to use our net operating losses and tax credits to offset future taxable income and taxes may be subject to certain limitations.

In general, under Section 382 of the U.S. Internal Revenue Code of 1986, as amended (the Code), a corporation that undergoes an “ownership change” is subject to limitations on its ability to utilize its pre-change net operating loss (NOL) carryforwards and other tax attributes, such as research and development tax credits, to offset post-change taxable income and taxes.

As a result of our June 2015 underwritten public offering, we have experienced a Section 382 “ownership change.” We currently believe that this “ownership change” will not inhibit our ability to utilize our NOLs prior to expiration.  However, we may experience additional ownership changes as a result of subsequent changes in our stock ownership, some of which changes may be outside our control.  As a result, we may not be able to utilize a material portion of our NOLs and tax credits, even if we achieve profitability and generate sufficient taxable income in the future. If we are limited in our ability to use our NOLs and tax credits in future years as a result of ownership changes, we will pay more taxes than if we were able to fully utilize our NOLs and tax credits. This could materially and adversely affect our results of operations. As of December 31, 2019, we had federal NOLs of $398.5 million, of which $139.5 million was generated in fiscal year 2018 and thereafter, which can be carried forward indefinitely under the Tax Cuts and Jobs Act (the 2017 Tax Act), as well as state NOLs of $194.8 million, of which $22.1 million may be carried forward indefinitely.  If not utilized, the remaining federal NOLs will begin to expire in 2026 and the state NOLs will begin to expire in 2020.

Risks Related to Regulation of our Industry

Senza is subject to extensive governmental regulation, and our failure to comply with applicable requirements could cause our business to suffer.

The medical device industry is regulated extensively by governmental authorities, principally the FDA and corresponding state and foreign regulatory agencies and authorities, such as the EU legislative bodies and the EEA Member State Competent Authorities. The FDA and other U.S., EEA and foreign governmental agencies and authorities regulate and oversee, among other things, with respect to medical devices:

 

•

design, development and manufacturing;

 

•

testing, labeling, content and language of instructions for use and storage;

 

•

clinical trials;

 

•

product safety;

 

•

marketing, sales and distribution;

 

•

pre-market regulatory clearance and approval;

49

 

 

•

conformity assessment procedures;

 

•

record-keeping procedures;

 

•

advertising and promotion;

 

•

recalls and other field safety corrective actions;

 

•

post-market surveillance, including reporting of deaths or serious injuries and malfunctions that, if they were to recur, could lead to death or serious injury;

 

•

post-market studies; and

 

•

product import and export.

The laws and regulations to which we are subject are complex and have tended to become more stringent over time. Legislative or regulatory changes could result in restrictions on our ability to carry on or expand our operations, higher than anticipated costs or lower than anticipated sales.

Our failure to comply with U.S. federal and state regulations or EEA or other foreign regulations applicable in the countries where we operate could lead to the issuance of warning letters or untitled letters, the imposition of injunctions, suspensions or loss of regulatory clearance or approvals, product recalls, termination of distribution, product seizures or civil penalties. In the most extreme cases, criminal sanctions or closure of our manufacturing facilities are possible. If any of these risks materialize, our business would be adversely affected.

Our business is subject to extensive governmental regulation that could make it more expensive and time consuming for us to expand the potential indications for which Senza is approved or introduce new or improved products.

Our products must comply with regulatory requirements imposed by the FDA in the United States and similar agencies in foreign jurisdictions. These requirements involve lengthy and detailed laboratory and clinical testing procedures, sampling activities, extensive agency review processes, and other costly and time-consuming procedures. It often takes several years to satisfy these requirements, depending on the complexity and novelty of the product. We also are subject to numerous additional licensing and regulatory requirements relating to safe working conditions, manufacturing practices, environmental protection, fire hazard control and disposal of hazardous or potentially hazardous substances. Some of the most important requirements we must comply with include:

 

•

FFDCA and the FDA’s implementing regulations (Title 21 CFR);

 

•

European Union CE Mark requirements;

 

•

Medical Device Quality Management System Requirements (ISO 13485:2003);

 

•

Occupational Safety and Health Administration requirements; and

 

•

California Department of Health Services requirements.

Government regulation may impede our ability to conduct clinical studies and to manufacture and sell our existing and future products. Government regulation also could delay our marketing of new products for a considerable period of time and impose costly procedures on our activities. Foreign regulatory agencies may not approve Senza and any of our future products on a timely basis, if at all. Any delay in obtaining, or failure to obtain, such approvals could negatively impact our marketing of any future products and reduce our product revenues.

Our products remain subject to strict regulatory controls on manufacturing, marketing and use. We may be forced to modify or recall a product after release in response to regulatory action or unanticipated difficulties encountered in general use. Any such action could have a material effect on the reputation of our products and on our business and financial position.

50

 

Further, regulations may change, and any additional regulation could limit or restrict our ability to use any of our technologies, which could harm our business. For example, in December 2016, the 21st Century Cures Act, or Cures Act, was signed into law.  The Cures Act, among other things, is intended to modernize the regulation of medical devices and spur innovation, but its ultimate implementation remains unclear.  We could also be subject to new international, federal, state or local regulations that could affect our R&D programs and harm our business in unforeseen ways. If this happens, we may have to incur significant costs to comply with such laws and regulations, which will harm our results of operations.

We also cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative or executive action, either in the United States or abroad. For example, certain policies of the United States presidential administration may impact our business and industry.  Namely, the United States presidential administration has taken several executive actions, including the issuance of a number of Executive Orders, that could impose significant burdens on, or otherwise materially delay, the FDA’s ability to engage in routine regulatory and oversight activities such as implementing statutes through rulemaking, issuance of guidance, and review and approval of marketing applications.  It is difficult to predict how these Executive Orders will be implemented, and the extent to which they will impact the FDA’s ability to exercise its regulatory authority.  If these executive actions impose constraints on FDA’s ability to engage in oversight and implementation activities in the normal course, our business may be negatively impacted.

In April 2017, the European Parliament passed the Medical Devices Regulation (Regulation 2017/745), which repeals and replaces the EU Medical Devices Directive and the Active Implantable Medical Devices Directive. Unlike directives, which must be implemented into the national laws of the EEA member States, the regulations would be directly applicable, i.e., without the need for adoption of EEA member State laws implementing them, in all EEA member States and are intended to eliminate current differences in the regulation of medical devices among EEA member States.

The Medical Devices Regulation, among other things, is intended to establish a uniform, transparent, predictable and sustainable regulatory framework across the EEA for medical devices and ensure a high level of safety and health while supporting innovation. The Medical Devices Regulation will, however, only become fully applicable three years after publication (in May 2020). Once applicable, the Medical Devices Regulation will, among other things:

 

•

strengthen the rules on placing devices on the market and reinforce surveillance once they are available;

 

•

establish explicit provisions on manufacturers' responsibilities for the follow-up of the quality, performance and safety of devices placed on the market;

 

•

improve the traceability of medical devices throughout the supply chain to the end-user or patient through a unique identification number;

 

•

set up a central database to provide patients, healthcare professionals and the public with comprehensive information on products available in the EU; and

 

•

strengthen rules for the assessment of certain high-risk devices, such as implants, which may have to undergo an additional check by experts before they are placed on the market.

Once applicable, the Medical Devices Regulation may impose increased compliance obligations for us to access the EU market.

Senza is subject to extensive governmental regulation in foreign jurisdictions, such as Europe, and our failure to comply with applicable requirements could cause our business to suffer.

In the EEA, Senza must comply with the Essential Requirements laid down in Annex I to the EU Active Implantable Medical Devices Directive. Compliance with these requirements is a prerequisite to be able to affix the CE Mark to Senza, without which Senza cannot be marketed or sold in the EEA. To demonstrate compliance with the Essential Requirements and obtain the right to affix the CE Mark to Senza, we must undergo a conformity assessment procedure, which varies according to the type of medical device and its classification. Except for low risk medical devices (Class I with no measuring function and which are not sterile), where the manufacturer can

51

 

issue an EC Declaration of Conformity based on a self-assessment of the conformity of its products with the Essential Requirements, a conformity assessment procedure requires the intervention of a Notified Body, which is an organization designated by a competent authority of an EEA country to conduct conformity assessments. Depending on the relevant conformity assessment procedure, the Notified Body would audit and examine the Technical File and the quality system for the manufacture, design and final inspection of our devices. The Notified Body issues a CE Certificate of Conformity following successful completion of a conformity assessment procedure conducted in relation to the medical device and its manufacturer and their conformity with the Essential Requirements. This Certificate entitles the manufacturer to affix the CE Mark to its medical devices after having prepared and signed a related EC Declaration of Conformity.

As a general rule, demonstration of conformity of medical devices and their manufacturers with the Essential Requirements must be based, among other things, on the evaluation of clinical data supporting the safety and performance of the products during normal conditions of use. Specifically, a manufacturer must demonstrate that the device achieves its intended performance during normal conditions of use and that the known and foreseeable risks, and any adverse events, are minimized and acceptable when weighed against the benefits of its intended performance, and that any claims made about the performance and safety of the device (e.g., product labeling and instructions for use) are supported by suitable evidence. This assessment must be based on clinical data, which can be obtained from (1) clinical studies conducted on the devices being assessed, (2) scientific literature from similar devices whose equivalence with the assessed device can be demonstrated or (3) both clinical studies and scientific literature. With respect to active implantable medical devices or Class III devices, the manufacturer must conduct clinical studies to obtain the required clinical data, unless reliance on existing clinical data from equivalent devices can be justified. The conduct of clinical studies in the EEA is governed by detailed regulatory obligations. These may include the requirement of prior authorization by the competent authorities of the country in which the study takes place and the requirement to obtain a positive opinion from a competent Ethics Committee. This process can be expensive and time-consuming.

In order to continue to sell Senza in Europe, we must maintain our CE Mark and continue to comply with certain EU Directives. Our failure to continue to comply with applicable foreign regulatory requirements, including those administered by authorities of the EEA countries, could result in enforcement actions against us, including refusal, suspension or withdrawal of our CE Certificates of Conformity by the BSI, which could impair our ability to market products in the EEA in the future.

In addition, we are subject to the EU’s General Data Protection Regulation (GDPR).  GDPR imposes obligations on companies that operate in our industry with respect to the processing of personal data of European residents and the cross-border transfer of such data. The GDPR imposes onerous accountability obligations requiring data controllers and processors to maintain a record of their data processing and policies. If our or our partners’ or service providers’ privacy or data security measures fail to comply with the GDPR requirements, we may be subject to litigation, regulatory investigations, enforcement notices requiring us to change the way we use personal data and/or fines of up to 20 million Euros or up to 4% of the total worldwide annual turnover of the preceding financial year, whichever is higher, as well as compensation claims by affected individuals, negative publicity, reputational harm and a potential loss of business and goodwill. Following Brexit, we will have to comply with the GDPR and the UK GDPR, each regime having the ability to fine up to the greater of €20 million/ £17.5 million or 4% of global turnover. The relationship between the UK and the EU in relation to certain aspects of data protection law remains unclear, e.g. how data transfers between EU member states and the UK will be treated. These changes will lead to additional costs and increase our overall risk exposure. While we continue to address the implications of the recent changes to EU and UK data privacy regulations, data privacy remains an evolving landscape at both the domestic and international level, with new regulations coming into effect and continued legal challenges, and our efforts to comply with the evolving data protection rules may be unsuccessful. It is possible that these laws may be interpreted and applied in a manner that is inconsistent with our practices. Accordingly, we must devote significant resources to understanding and complying with this changing landscape.

In April 2017, the European Parliament passed the Medical Devices Regulation (Regulation 2017/745), which repeals and replaces the EU Medical Devices Directive and the Active Implantable Medical Devices Directive. Unlike directives, which must be implemented into the national laws of the EEA member States, the regulations would be directly applicable, i.e., without the need for adoption of EEA member State laws implementing them, in all EEA member States and are intended to eliminate current differences in the regulation of medical devices among

52

 

EEA member States. The Medical Devices Regulation, among other things, is intended to establish a uniform, transparent, predictable and sustainable regulatory framework across the EEA for medical devices and ensure a high level of safety and health while supporting innovation. The Medical Devices Regulation will however only become applicable three years after publication (in May 2020). Once applicable, the new regulations will among other things:

 

•

strengthen the rules on placing devices on the market and reinforce surveillance once they are available;

 

•

establish explicit provisions on manufacturers' responsibilities for the follow-up of the quality, performance and safety of devices placed on the market;

 

•

improve the traceability of medical devices throughout the supply chain to the end-user or patient through a unique identification number;

 

•

set up a central database to provide patients, healthcare professionals and the public with comprehensive information on products available in the EU; and

 

•

strengthen rules for the assessment of certain high-risk devices, such as implants, which may have to undergo an additional check by experts before they are placed on the market.

Once applicable, the Medical Devices Regulation may impose increased compliance obligations for us to access the EU market.

In the EEA, we are also subject to Directive 2006/114/EC concerning misleading and comparative advertising, and Directive 2005/29/EC on unfair commercial practices, as well as other EEA Member State legislation governing the advertising and promotion of medical devices. EEA Member State legislation may also restrict or impose limitations on our ability to advertise our products directly to the general public. In addition, voluntary EU and national Codes of Conduct provide guidelines on the advertising and promotion of our products and may impose limitations on our promotional activities with healthcare professionals.

The misuse or off-label use of our product may harm our image in the marketplace, result in injuries that lead to product liability suits, which could be costly to our business, or result in costly investigations and sanctions from the FDA and other regulatory bodies if we are deemed to have engaged in off-label promotion.

Senza has been approved for marketing in the United States, CE Marked in the EEA and approved by the TGA in Australia for specific treatments and anatomies. We may only promote or market the Senza SCS system for its specifically approved indications as described on the approved label. We train our marketing and sales force against promoting our products for uses outside of the approved indications for use, known as “off-label uses.” We cannot, however, prevent a physician from using our product off-label, when in the physician’s independent professional medical judgment he or she deems the use of the product in the non-approved indication as appropriate. There may be increased risk of injury to patients if physicians attempt to use our product off-label. Furthermore, the use of our product for indications other than those approved by the applicable regulatory body may not effectively treat such conditions, which could harm our reputation in the marketplace among physicians and patients.

Physicians may also misuse our product or use improper techniques if they are not adequately trained, potentially leading to injury and an increased risk of product liability. If our product is misused or used with improper technique, we may become subject to costly litigation by our customers or their patients. Product liability claims could divert management’s attention from our core business, be expensive to defend, and result in sizable damage awards against us that may not be covered by insurance. In addition, if the FDA determines that our promotional materials, training or physician support activities constitute promotion of an off-label use, it could request that we modify our training, promotional materials or physician support activities or subject us to regulatory or enforcement actions, including the issuance of an untitled letter, a warning letter, injunction, seizure, civil fine or criminal penalties. It is also possible that other federal, state or foreign enforcement authorities might take action if they consider our business activities to constitute promotion of an off-label use, which could result in significant penalties, including, but not limited to, criminal, civil and/or administrative penalties, damages, fines, disgorgement, exclusion from participation in government healthcare programs, and the curtailment of our operations. Further, regulators or legislators may also enhance the enforcement of, and attempt to curtail, any off-label use by physicians

53

 

of medical devices in the future. Any of these events could significantly harm our business and results of operations and cause our stock price to decline.

Our products may in the future be subject to notifications, recalls, or voluntary market withdrawals that could harm our reputation, business and financial results.

The FDA, EEA Competent Authorities and similar foreign governmental authorities have the authority to require the recall of commercialized products in the event of material deficiencies or defects in design or manufacture that could affect patient safety. In the case of the FDA, the authority to require a recall must be based on an FDA finding that there is a reasonable probability that the device would cause serious adverse health consequences or death. Manufacturers may, under their own initiative, conduct a product notification or recall to inform physicians of changes to instructions for use, or if a deficiency in a device is found or suspected. A government-mandated recall or voluntary recall by us or one of our distributors could occur as a result of component failures, manufacturing errors, design or labeling defects or other issues. Recalls, which include certain notifications and corrections as well as removals, of Senza could divert managerial and financial resources and could have an adverse effect on our financial condition, harm our reputation with customers, and reduce our ability to achieve expected revenue.

In addition, the manufacturing of our products is subject to extensive post-market regulation by the FDA and foreign regulatory authorities, and any failure by us or our contract manufacturers or suppliers to comply with regulatory requirements could result in recalls, facility closures, and other penalties. We and our suppliers and contract manufacturers are subject to the Quality System Regulation (QSR), and comparable foreign regulations which govern the methods used in, and the facilities and controls used for, the design, manufacture, quality assurance, labeling, packaging, sterilization, storage, shipping, and servicing of medical devices. These regulations are enforced through periodic inspections of manufacturing facilities. Any manufacturing issues at our or our suppliers’ or contract manufacturers’ facilities, including failure to comply with regulatory requirements, may result in warning or untitled letters, manufacturing restrictions, voluntary or mandatory recalls or corrections, fines, withdrawals of regulatory clearances or approvals, product seizures, injunctions, or the imposition of civil or criminal penalties, which would adversely affect our business results and prospects.

We are required to report certain malfunctions, deaths, and serious injuries associated with our products, which can result in voluntary corrective actions or agency enforcement actions.

Under the FDA medical device reporting regulations, medical device manufacturers are required to submit information to the FDA when they receive a report or become aware that a device has or may have caused or contributed to a death or serious injury or has or may have a malfunction that would likely cause or contribute to death or serious injury if the malfunction were to recur. All manufacturers placing medical devices on the market in the EEA are legally bound to report incidents involving devices they produce or sell to the regulatory agency, or competent authority, in whose jurisdiction the incident occurred. Under the EU Medical Devices Directive (Directive 93/42/EEC), an incident is defined as any malfunction or deterioration in the characteristics and/or performance of a device, as well as any inadequacy in the labeling or the instructions for use which, directly or indirectly, might lead to or might have led to the death of a patient, or user or of other persons or to a serious deterioration in their state of health.

Malfunction of our products could result in future voluntary corrective actions, such as recalls, including corrections, or customer notifications, or agency action, such as inspection or enforcement actions. If malfunctions do occur, we may be unable to correct the malfunctions adequately or prevent further malfunctions, in which case we may need to cease manufacture and distribution of the affected products, initiate voluntary recalls, and redesign the products. Regulatory authorities may also take actions against us, such as ordering recalls, imposing fines, or seizing the affected products. Any corrective action, whether voluntary or involuntary, will require the dedication of our time and capital, distract management from operating our business, and may harm our reputation and financial results.

54

 

A recall of our products, either voluntarily or at the direction of the FDA, an EEA Competent Authority or another governmental authority, or the discovery of serious safety issues with our products, could have a significant adverse impact on us.

The FDA and similar foreign governmental authorities such as the Competent Authorities of the EEA countries have the authority to require the recall of commercialized products in the event of material deficiencies or defects in design or manufacture or in the event that a product poses an unacceptable risk to health. Manufacturers may, under their own initiative, recall a product if any material deficiency in a device is found. A government-mandated or voluntary recall by us or one of our distributors could occur as a result of an unacceptable risk to health, component failures, manufacturing errors, design or labeling defects or other deficiencies and issues. Recalls of any of our products would divert managerial and financial resources and have an adverse effect on our reputation, results of operations and financial condition, which could impair our ability to produce our products in a cost-effective and timely manner in order to meet our customers’ demands. We may also be required to bear other costs or take other actions that may have a negative impact on our future sales and our ability to generate profits.

We may be subject to federal, state and foreign healthcare laws and regulations, and a finding of failure to comply with such laws and regulations could have a material adverse effect on our business.

We are subject to healthcare fraud and abuse regulation and enforcement by federal, state and foreign governments, which could significantly impact our business. In the United States, the laws that may affect our ability to operate include, but are not limited to:

 

•

the federal Anti-Kickback Statute, which prohibits, among other things, persons and entities from knowingly and willfully soliciting, receiving, offering or paying remuneration, directly or indirectly, in cash or in kind, in exchange for or to induce either the referral of an individual for, or the purchase, lease, order or recommendation of, any good, facility, item or service for which payment may be made, in whole or in part, under federal healthcare programs such as Medicare and Medicaid. A person or entity does not need to have actual knowledge of this statute or specific intent to violate it in order to have committed a violation;

 

•

federal civil and criminal false claims laws, including the False Claims Act, that prohibit, among other things, knowingly presenting, or causing to be presented, claims for payment or approval to the federal government that are false or fraudulent, knowingly making a false statement material to an obligation to pay or transmit money or property to the federal government or knowingly concealing or knowingly and improperly avoiding or decreasing an obligation to pay or transmit money or property to the federal government. In addition, a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act;

 

•

Health Insurance Portability and Accountability Act of 1996 (HIPAA), which created federal criminal laws that prohibit executing a scheme to defraud any federal healthcare benefit program or making false statements relating to healthcare matters submitted for payment. A person or entity does not need to have actual knowledge of these statutes or specific intent to violate them in order to have committed a violation;

 

•

HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, and their respective implementing regulations, which impose requirements on certain covered healthcare providers, health plans and healthcare clearinghouses as well as their business associates that perform services for them that involve individually identifiable health information, relating to the privacy, security and transmission of individually identifiable health information without appropriate authorization, including mandatory contractual terms as well as directly applicable privacy and security standards and requirements;

 

•

the federal physician sunshine requirements under the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, collectively, the ACA, which require certain manufacturers of drugs, devices, biologics, and medical supplies to report annually to the U.S. Department of Health and Human Services information related to payments and other transfers of value to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), certain

55

 

 

other healthcare professionals beginning in 2022, and teaching hospitals, and ownership and investment interests held by physicians and their immediate family members;

 

•

state and foreign law equivalents of each of the above federal laws, such as state anti-kickback and false claims laws that may apply to items or services reimbursed by any third-party payor, including commercial insurers; state laws that require device companies to comply with the industry’s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government, or otherwise restrict payments that may be made to healthcare providers and other potential referral sources; state laws that require device manufacturers to report information related to payments and other transfers of value to physicians and other healthcare providers or marketing expenditures; and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA; and

 

•

the California Consumer Privacy Act (CCPA), which took effect on January 1, 2020. The CCPA creates individual privacy rights for California consumers and increases the privacy and security obligations of entities handling certain personal information. The CCPA provides for civil penalties for violations, as well as a private right of action for data breaches that is expected to increase data breach litigation. The CCPA may increase our compliance costs and potential liability, and many similar laws have been proposed at the federal level and in other states. In the event that we are subject to or affected by HIPAA, the CCPA or other domestic privacy and data protection laws, any liability from failure to comply with the requirements of these laws could adversely affect our financial condition.

The scope and enforcement of each of these laws is uncertain and subject to rapid change in the current environment of healthcare reform, especially in light of the lack of applicable precedent and regulations. Federal and state enforcement bodies have increased their scrutiny of interactions between healthcare companies and healthcare providers, which has led to a number of investigations, prosecutions, convictions and settlements in the healthcare industry. Responding to investigations can be time-and resource-consuming and can divert management’s attention from the business. Additionally, as a result of these investigations, healthcare providers and entities may have to agree to additional onerous compliance and reporting requirements as part of a consent decree or corporate integrity agreement. Any such investigation or settlement could increase our costs or otherwise have an adverse effect on our business.

If our operations are found to be in violation of any of the laws described above or any other governmental regulations that apply to us now or in the future, we may be subject to penalties, including civil and criminal penalties, damages, fines, disgorgement, exclusion from governmental health care programs, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our financial results.

Healthcare legislative reform measures may have a material adverse effect on us.

In the United States, there have been and continue to be a number of legislative initiatives to contain healthcare costs. In March 2010, the ACA was signed into law, which included, among other things, a deductible 2.3% excise tax on any entity that manufactures or imports medical devices offered for sale in the United States, with limited exceptions, effective January 1, 2013. Subsequently, multiple moratoriums were implemented such that medical device sales in 2016 through 2019 are exempt from the medical device excise tax. The tax was subsequently repealed in December 2019. If the law were to be reinstated and if any efforts we undertake to offset the excise tax are unsuccessful as we sell the product in the United States, the increased tax burden could have an adverse effect on our results of operations and cash flows. Other elements of the ACA, including comparative effectiveness research, an independent payment advisory board and payment system reforms, including shared savings pilots and other provisions, may significantly affect the payment for, and the availability of, healthcare services and result in fundamental changes to federal healthcare reimbursement programs, any of which may materially affect numerous aspects of our business.

Since its enactment, there have been judicial and Congressional challenges to certain aspects of the ACA. By way of example, the Tax Cuts and Jobs Act of 2017, or the Tax Act, includes a provision repealing, effective January 1, 2019, the tax-based shared responsibility payment imposed by the ACA on certain individuals who fail to

56

 

maintain qualifying health coverage for all or part of a year that is commonly referred to as the “individual mandate.” On December 14, 2018, a U.S. District Court Judge in the Northern District of Texas, ruled that the individual mandate is a critical and inseverable feature of the ACA, and therefore, because it was repealed as part of the Tax Act, the remaining provisions of the ACA are invalid as well. On December 18, 2019, the U.S. Court of Appeals for the 5th Circuit upheld the District Court’s decision that the individual mandate was unconstitutional but remanded the case back to the District Court to determine whether the remaining provisions of the ACA are invalid as well. It is unclear how these decisions, subsequent appeals, if any, and other efforts to challenge, repeal or replace the ACA will impact the law or our business.  Any new limitations on, changes to, or uncertainty with respect to the ability of individuals to enroll in governmental reimbursement programs or other third-party payor insurance plans could impact demand for our product.

In addition, other legislative changes have been proposed and adopted in the United States since the ACA was enacted. These changes included an aggregate reduction in Medicare payments to providers of 2% per fiscal year, which went into effect on April 1, 2013 and will remain in effect through 2029 unless additional Congressional action is taken. On January 2, 2013, the American Taxpayer Relief Act of 2012, was signed into law which, among other things, further reduced Medicare payments to certain providers, including hospitals. The Medicare Access and CHIP Reauthorization Act of 2015, enacted on April 16, 2015 (MACRA), repealed the formula by which Medicare made annual payment adjustments to physicians and replaced the former formula with fixed annual updates and a new system of incentive payments scheduled to begin in 2019 that are based on various performance measures and physicians’ participation in alternative payment models such as accountable care organizations.

We expect that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that federal and state governments will pay for healthcare products and services, which could result in reduced demand for our products or additional pricing pressures.

Our future success depends on our ability to develop, receive regulatory clearance or approval for, additional chronic pain indications for Senza and introduce new products or product enhancements that will be accepted by the market in a timely manner.

It is important to our business that we build a pipeline of product offerings for treatment of chronic pain. As such, our success will depend in part on our ability to expand the chronic pain indications for which our products may be used and/or develop and introduce new products. However, we may not be able to successfully develop and obtain regulatory clearance or approval for expanded indications or product enhancements, or new products, or these products may not be accepted by physicians or the payors who financially support many of the procedures performed with our products.

The success of any new product offering or enhancement to an existing product will depend on a number of factors, including our ability to:

 

•

identify and anticipate physician and patient needs properly;

 

•

develop and introduce new products or product enhancements in a timely manner;

 

•

avoid infringing upon the intellectual property rights of third parties;

 

•

demonstrate, if required, the safety and efficacy of new products with data from preclinical and clinical studies;

 

•

obtain the necessary regulatory clearances or approvals for new products or product enhancements;

 

•

comply fully with FDA and foreign regulations on marketing of new devices or modified products;

 

•

provide adequate training to potential users of our products; and

 

•

receive adequate coverage and reimbursement for procedures performed with our products.

If we do not develop new products or product enhancements in time to meet market demand or if there is insufficient demand for these products or enhancements, or if our competitors introduce new products with functionalities that are superior to ours, our results of operations will suffer.

57

 

Risks Related to Our Securities

Our stock price may be volatile and as a result our stockholders may not be able to resell shares of our common stock at or above the price they paid and such volatility may also adversely impact the value of the 2021 Notes.

The trading price of our common stock could be highly volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control. These factors include those discussed in this “Risk Factors” section of this Annual Report and others such as:

 

•

achievement of expected product sales and profitability, including the effects of seasonality on our results of operations, as well as adjustments to our sales forecasts;

 

•

delays or setbacks in the commercialization of Senza or the expansion of indications for which Senza is approved;

 

•

announcements of new products by us or our competitors;

 

•

announcements or developments in any intellectual property infringement actions in which we may become involved, including our lawsuits with Boston Scientific;

 

•

manufacture, supply or distribution shortages;

 

•

fluctuations in our expenses associated with inventory buildup or write-downs from analyzing our inventory for obsolescence or conformity with our product requirements;

 

•

adverse actions taken by regulatory agencies with respect to our clinical trials, manufacturing supply chain or sales and marketing activities;

 

•

our operating results;

 

•

results from, or any delays in, clinical trial programs relating to our product candidates;

 

•

changes or developments in laws or regulations applicable to our products;

 

•

any adverse changes in our relationship with any manufacturers or suppliers;

 

•

the success of our efforts to acquire or develop additional products;

 

•

announcements concerning our competitors or the medical device industry in general;

 

•

actual or anticipated fluctuations in our operating results;

 

•

FDA or other U.S. or foreign regulatory actions affecting us or our industry or other healthcare reform measures in the United States;

 

•

changes in financial estimates or recommendations by securities analysts;

 

•

trading volume of our common stock;

 

•

trading activity in our common stock by the option counterparties to our convertible note hedge transactions to unwind or modify their hedge positions;

 

•

sales of our common stock by us, our executive officers and directors or our stockholders in the future;

 

•

general economic and market conditions and overall fluctuations in the United States equity markets; and

 

•

the loss of any of our key scientific or management personnel.

Because the 2021 Notes are convertible into shares of common stock, volatility or depressed market prices of our common stock could have a similar effect on the value of the 2021 Notes.  Holders who receive shares of our common stock upon conversion of the 2021 Notes will also be subject to the risk of volatility and depressed market prices of our common stock.  Similarly, the liquidity of the trading market in the 2021 Notes and the market price quoted for the 2021 Notes, may be adversely affected by changes in the overall market for this type of security and by changes in our financial performance or prospects or in the prospects for companies in our industry generally.

58

 

In addition, the stock markets in general, and the markets for medical device stocks in particular, have experienced volatility that may have been unrelated to the operating performance of the issuer. These broad market fluctuations may adversely affect the trading price or liquidity of our common stock and the value of the 2021 Notes. In the past, when the market price of a stock has been volatile, holders of that stock have sometimes instituted securities class action litigation against the issuer. If any of our stockholders were to bring such a lawsuit against us, we could incur substantial costs defending the lawsuit and the attention of our management would be diverted from the operation of our business, which could seriously harm our financial position. Any adverse determination in litigation could also subject us to significant liabilities.

Servicing our debt requires a significant amount of cash, and we may not have sufficient cash flow from our business to pay our substantial debt.

Our ability to make scheduled payments of the principal of, to pay interest on or to refinance our indebtedness, including the 2021 Notes, depends on our future performance, which is subject to economic, financial, competitive and other factors beyond our control. Our business may not continue to generate cash flow from operations in the future sufficient to service our debt and make necessary capital expenditures. If we are unable to generate such cash flow, we may be required to adopt one or more alternatives, such as selling assets, restructuring debt or obtaining additional equity capital on terms that may be onerous or highly dilutive. Our ability to refinance our indebtedness will depend on the capital markets and our financial condition at such time. We may not be able to engage in any of these activities or engage in these activities on desirable terms, which could result in a default on our debt obligations.

Recent and future regulatory actions and other events may adversely affect the value and liquidity of the 2021 Notes.

We expect that many investors in, and potential purchasers of, the 2021 Notes will employ, or seek to employ, a convertible arbitrage strategy with respect to the 2021 Notes. Investors would typically implement such a strategy by selling short the common stock underlying the 2021 Notes and dynamically adjusting their short position while continuing to hold the 2021 Notes. Investors may also implement this type of strategy by entering into swaps on our common stock in lieu of or in addition to short selling the common stock.

The SEC and other regulatory and self-regulatory authorities have implemented various rules and taken certain actions, and may in the future adopt additional rules and take other actions, that may impact those engaging in short selling activity involving equity securities (including our common stock). Such rules and actions include Rule 201 of SEC Regulation SHO, the adoption by the Financial Industry Regulatory Authority, Inc. and the national securities exchanges of a “Limit Up-Limit Down” program, the imposition of market-wide circuit breakers that halt trading of securities for certain periods following specific market declines, and the implementation of certain regulatory reforms required by the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 (the Dodd-Frank Act). Any governmental or regulatory action that restricts the ability of investors in, or potential purchasers of, the 2021 Notes to effect short sales of our common stock, borrow our common stock or enter into swaps on our common stock could adversely affect the value and the liquidity of the 2021 Notes.

If securities or industry analysts issue an adverse or misleading opinion regarding our stock, our stock price and trading volume could decline.

The trading market for our common stock is influenced by the research and reports that industry or securities analysts publish about us or our business. If any of the analysts who cover us issues an adverse or misleading opinion regarding us, our business model, our intellectual property or our stock performance, or if our clinical trials and operating results fail to meet the expectations of analysts, our stock price would likely decline. If one or more of these analysts cease coverage of us or fail to publish reports on us regularly, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline.

59

 

We incur significantly increased costs and devote substantial management time as a result of operating as a public company.

As a public company, we incur significant legal, accounting and other expenses that we did not incur as a private company. For example, we are subject to the reporting requirements of the Exchange Act, and are required to comply with the applicable requirements of the Sarbanes-Oxley Act of 2002 (Sarbanes-Oxley Act), and the Dodd-Frank Act, as well as rules and regulations subsequently implemented by the SEC and the NYSE, including the establishment and maintenance of effective disclosure and financial controls and changes in corporate governance practices. We expect that compliance with these requirements will increase our legal and financial compliance costs and will make some activities more time consuming and costly.

In addition, our management and other personnel divert attention from operational and other business matters to devote substantial time to these public company requirements. In particular, we incur significant expenses and devote substantial management effort toward ensuring compliance with the requirements of Section 404 of the Sarbanes-Oxley Act. We continue to hire additional accounting and financial staff with appropriate public company experience and technical accounting knowledge. We cannot predict or estimate the amount of additional costs we will incur in order to remain compliant with our public company reporting requirements or the timing of such costs. Additional compensation costs and any future equity awards will increase our compensation expense, which would increase our general and administrative expense and could adversely affect our profitability.

If we are unable to maintain effective internal control over financial reporting in the future, investors may lose confidence in the accuracy and completeness of our financial reports and the market price of our common stock and the value of the 2021 Notes could be adversely affected.

As a public company, we are required to maintain internal control over financial reporting and to report any material weaknesses in such internal control. Section 404 of the Sarbanes-Oxley Act requires that we evaluate and determine the effectiveness of our internal control over financial reporting and provide a management report on internal control over financial reporting.  Further, the Sarbanes-Oxley Act also requires that our internal control over financial reporting be attested to by our independent registered public accounting firm.

If we have a material weakness in our internal control over financial reporting, we may not detect errors on a timely basis and our financial statements may be materially misstated. The process of designing and implementing the internal control over financial reporting required to comply with this obligation is time consuming, costly and complicated. If we identify material weaknesses in our internal control over financial reporting, if we are unable to comply with the requirements of Section 404 in a timely manner, if we are unable to assert that our internal control over financial reporting are effective, or if our independent registered public accounting firm is unable to express an opinion as to the effectiveness of our internal control over financial reporting, investors may lose confidence in the accuracy and completeness of our financial reports and the market price of our common stock and the value of the 2021 Notes could be adversely affected, and we could become subject to investigations by the stock exchange on which our securities are listed, the SEC, or other regulatory authorities, which could require additional financial and management resources.

The accounting method for convertible debt securities that may be settled in cash, such as the 2021 Notes, could have a material effect on our reported financial results.

In May 2008, the Financial Accounting Standards Board (FASB) issued FASB Staff Position No. APB 14-1, Accounting for Convertible Debt Instruments That May Be Settled in Cash Upon Conversion (Including Partial Cash Settlement), which has subsequently been codified as Accounting Standards Codification 470-20, Debt with Conversion and Other Options (ASC 470-20). Under ASC 470-20, an entity must separately account for the liability and equity components of the convertible debt instruments (such as the 2021 Notes) that may be settled entirely or partially in cash upon conversion in a manner that reflects the issuer’s economic interest cost. The effect of ASC 470-20 on the accounting for the 2021 Notes is that the equity component is required to be included in the additional paid-in capital section of stockholders’ equity on our consolidated balance sheet, and the value of the equity component would be treated as debt discount for purposes of accounting for the debt component of the 2021 Notes. As a result, we are required to record a greater amount of non-cash interest expense in current periods presented as a result of the amortization of the discounted carrying value of the 2021 Notes to their face amount over the term of

60

 

the 2021 Notes. We will report lower net income in our financial results because ASC 470-20 will require interest to include both the current period’s amortization of the debt discount and the instrument’s non-convertible interest rate, which could adversely affect our reported or future financial results, the trading price of our common stock and the value of the 2021 Notes.

In addition, under certain circumstances, convertible debt instruments (such as the 2021 Notes) that may be settled entirely or partly in cash are currently accounted for utilizing the treasury stock method, the effect of which is that the shares issuable upon conversion of the 2021 Notes are not included in the calculation of diluted earnings per share except to the extent that the conversion value of the 2021 Notes exceeds their principal amount. Under the treasury stock method, for diluted earnings per share purposes, the transaction is accounted for as if the number of shares of common stock that would be necessary to settle such excess, if we elected to settle such excess in shares, are issued. We cannot be sure that the accounting standards in the future will continue to permit the use of the treasury stock method. If we are unable to use the treasury stock method in accounting for the shares issuable upon conversion of the 2021 Notes, then our diluted earnings per share would be adversely affected.

If we sell shares of our common stock in future financings, stockholders may experience immediate dilution and, as a result, our stock price and the value of the 2021 Notes may decline.

We may from time to time issue additional shares of common stock at a discount from the current trading price of our common stock. As a result, our stockholders would experience immediate dilution upon the purchase of any shares of our common stock sold at such discount. In addition, as opportunities present themselves, we may enter into financing or similar arrangements in the future, including the issuance of debt securities, preferred stock or common stock. If we issue common stock or securities convertible into common stock, our common stockholders would experience additional dilution and, as a result, our stock price and the value of the 2021 Notes may decline.

Sales of a substantial number of shares of our common stock in the public market could cause our stock price and the value of the 2021 Notes to fall.

If our existing stockholders sell, or indicate an intention to sell, substantial amounts of our common stock in the public market, the trading price of our common stock and the value of the 2021 Notes could decline. As of December 31, 2019, we had outstanding a total of approximately 31.5 million shares of common stock, and approximately 7.8 million shares of common stock that are either subject to outstanding options or reserved for future issuance under our equity incentive plans will become eligible for sale in the public market to the extent permitted by the provisions of various vesting schedules, and Rule 144 and Rule 701 under the Securities Act. If these additional shares of common stock are sold, or if it is perceived that they will be sold, in the public market, the trading price of our common stock and the value of the 2021 Notes could decline.

Provisions in our charter documents and under Delaware law could discourage a takeover that stockholders may consider favorable and may lead to entrenchment of management.

Our amended and restated certificate of incorporation and amended and restated bylaws contain provisions that could significantly reduce the value of our shares to a potential acquirer or delay or prevent changes in control or changes in our management without the consent of our board of directors. The provisions in our charter documents include the following:

 

•

no cumulative voting in the election of directors, which limits the ability of minority stockholders to elect director candidates;

 

•

the exclusive right of our board of directors to elect a director to fill a vacancy created by the expansion of the board of directors or the resignation, death or removal of a director, which prevents stockholders from being able to fill vacancies on our board of directors;

 

•

the required approval of at least a majority of the shares entitled to vote at an election of directors to remove a director for cause, and the prohibition on removal of directors without cause;

61

 

 

•

the ability of our board of directors to authorize the issuance of shares of preferred stock and to determine the price and other terms of those shares, including preferences and voting rights, without stockholder approval, which could be used to significantly dilute the ownership of a hostile acquirer;

 

•

the ability of our board of directors to alter our bylaws without obtaining stockholder approval;

 

•

the required approval of at least a majority of the shares entitled to vote at an election of directors to adopt, amend or repeal our bylaws or repeal the provisions of our amended and restated certificate of incorporation regarding the election and removal of directors;

 

•

a prohibition on stockholder action by written consent, which forces stockholder action to be taken at an annual or special meeting of our stockholders;

 

•

the requirement that a special meeting of stockholders may be called only by the board of directors, which may delay the ability of our stockholders to force consideration of a proposal or to take action, including the removal of directors; and

 

•

advance notice procedures that stockholders must comply with in order to nominate candidates to our board of directors or to propose matters to be acted upon at a stockholders’ meeting, which may discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of us.

In addition, our classified staggered board is being phased-out pursuant to our amended and restated certificate of incorporation, which was filed on May 24, 2019.  Pursuant to the amended and restated certificate of incorporation, each director who stands for election or re-election at and after the 2020 annual meeting of stockholders following the completion of such director’s then-current three-year term will be elected for a one-year term, expiring at the next year’s annual stockholder meeting. As a result, commencing with the 2022 annual meeting of stockholders, our directors will no longer be divided into classes, however until this time, certain directors will have multiple year terms which may delay the ability of stockholders to change the membership of a majority of directors.

In addition, these provisions would apply even if we were to receive an offer that some stockholders may consider beneficial.

We are also subject to the anti-takeover provisions contained in Section 203 of the Delaware General Corporation Law. Under Section 203, a corporation may not, in general, engage in a business combination with any holder of 15% or more of its capital stock unless the holder has held the stock for three years or, among other exceptions, the board of directors has approved the transaction.  The repurchase right under the 2021 Notes in connection with a fundamental change and any increase in the conversion rate in connection with a make-whole fundamental change could also discourage a potential acquirer.

Claims for indemnification by our directors and officers may reduce our available funds to satisfy successful third-party claims against us and may reduce the amount of money available to us.

Our amended and restated certificate of incorporation and amended and restated bylaws provide that we will indemnify our directors and officers to the fullest extent permitted by Delaware law.

62

 

In addition, as permitted by Section 145 of the Delaware General Corporation Law, our amended and restated bylaws and our indemnification agreements that we have entered into with our directors and officers provide that:

 

•

we will indemnify our directors and officers for serving us in those capacities or for serving other business enterprises at our request, to the fullest extent permitted by Delaware law. Delaware law provides that a corporation may indemnify such person if such person acted in good faith and in a manner such person reasonably believed to be in or not opposed to the best interests of the registrant and, with respect to any criminal proceeding, had no reasonable cause to believe such person’s conduct was unlawful;

 

•

we may, in our discretion, indemnify employees and agents in those circumstances where indemnification is permitted by applicable law;

 

•

we are required to advance expenses, as incurred, to our directors and officers in connection with defending a proceeding, except that such directors or officers shall undertake to repay such advances if it is ultimately determined that such person is not entitled to indemnification;

 

•

we will not be obligated pursuant to our amended and restated bylaws to indemnify a person with respect to proceedings initiated by that person against us or our other indemnitees, except with respect to proceedings authorized by our board of directors or brought to enforce a right to indemnification;

 

•

the rights conferred in our amended and restated bylaws are not exclusive, and we are authorized to enter into indemnification agreements with our directors, officers, employees and agents and to obtain insurance to indemnify such persons; and

 

•

we may not retroactively amend our amended and restated bylaw provisions to reduce our indemnification obligations to directors, officers, employees and agents.

We do not currently intend to pay dividends on our common stock, and, consequently, our stockholders’ ability to achieve a return on their investment will depend on appreciation in the price of our common stock.

We do not currently intend to pay any cash dividends on our common stock for the foreseeable future. We currently intend to invest our future earnings, if any, to fund our growth. Therefore, our stockholders are not likely to receive any dividends on our common stock for the foreseeable future. Since we do not intend to pay dividends, our stockholders’ ability to receive a return on their investment will depend on any future appreciation in the market value of our common stock. There is no guarantee that our common stock will appreciate or even maintain the price at which our stockholders have purchased it.

ITEM 1B. UNRESOLVED STAFF COMMENTS

None.

ITEM 2. PROPERTIES

Our corporate headquarters and R&D facilities are located in Redwood City, California, where we lease and currently occupy approximately 50,740 square feet of office and laboratory space. In December 2016, we amended the original lease for our corporate headquarters in order to increase the space we occupy by approximately 49,980 square feet of office space adjacent to our corporate headquarters.  Our obligations under the amended lease for the new space commenced on June 1, 2018. The term of the lease for our corporate headquarters and the new adjacent space ends on May 31, 2025.  In April 2017, we entered into a second amendment to the original lease for a temporary space of approximately 8,171 square feet of office space for the period from May 2017 until June 1, 2018, the commencement of the term for the additional adjacent space.  We believe our current headquarters, together with our additional adjacent space, is sufficient for our current and foreseeable business needs.  We also lease a small storage facility in Australia and a small amount of warehouse space in San Carlos, California.

For additional information, see Note 7. Commitments and Contingencies of Notes to Consolidated Financial Statements in Part II, Item 8 of this Annual Report.

63

 

On November 28, 2016, we filed a lawsuit for patent infringement against Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation (collectively, Boston Scientific). The lawsuit, filed in the U.S. District Court for the Northern District of California (the Court), asserts that Boston Scientific is infringing our patents covering inventions relating to our Senza system and HF10 therapy. The lawsuit seeks preliminary and permanent injunctive relief against further infringement as well as damages and attorney’s fees. On July 24, 2018, the Court issued an order on claim construction and summary judgment.  In the order, the Court ruled that six asserted method claims in three of the Company’s asserted patents were patent eligible and not invalid as indefinite.  Specifically, the claims upheld in the ruling were claims 11, 21 and 23 of U.S. Patent No. 8,359,102; claim 18 of U.S. Patent No. 8,792,988; and claims 1 and 5 of U.S. Patent No. 8,768,472.  Collectively, these six claims cover methods for delivering SCS therapy at frequencies between 1.5 kHz and 100 kHz.

The Court, however, found that Boston Scientific is not currently infringing the six upheld method claims.  Specifically, the Court found that Boston Scientific's sale of the Spectra WaveWriter systems for commercial use in the United States does not infringe the upheld method claims because the Spectra WaveWriter systems cannot be programmed to generate signals above 1.2 kHz.  With regard to the use of the Spectra WaveWriter and the Precision with MultiWave systems in patients that have completed the ACCELERATE clinical trial, the Court found such use to fall within the safe harbor provision of 35 U.S.C. § 271(e).  The Court further held that 35 U.S.C. § 271(f) does not apply to method claims, and therefore the sale of the Precision with MultiWave systems in Europe does not infringe the upheld method claims.  The Court also found that the asserted system claims in four of the Company's asserted patents were invalid as indefinite.  Specifically, the Court invalidated claims 18, 34, and 55 of U.S. Patent No. 9,327,125; claims 5 and 34 of U.S. Patent No. 9,333,357; claims 7, 12, 35, 37, and 58 of U.S. Patent No. 8,712,533; and claims 1 and 22 of U.S. Patent No. 9,480,842.

On July 27, 2018, the parties submitted a joint statement to the Court wherein Boston Scientific asserted to the Court that, with respect to whether any U.S. launch of a high-rate product (such as the Precision with MultiWave and Spectra WaveWriter models used in the ACCELERATE study or any other system that is programmable at any frequency in the range 1.5 to 100 kHz) is imminent, Boston Scientific, as of now, has not decided whether to launch such a product; has not established a timeline for when such a decision might be made, if ever; and has not determined what frequencies would be enabled if it were to decide to launch such a product in the future. Boston Scientific further confirmed its public statements that the ACCELERATE study had been extended into 2019, with an estimated study completion date between April 2019 and November 2019.  On the basis of the foregoing, the parties agreed to dismissal on ripeness grounds of Nevro’s declaratory judgment claims without prejudice, each side to bear its own fees and costs as to these claims, and jointly requested that the Court enter such a dismissal. The dismissal was thereafter entered as a court order on July 31, 2018.  Boston Scientific and Nevro are each appealing portions of the Court's July 24th ruling, and we have submitted our respective appeal briefs and replies to the U.S. Court of Appeals for the Federal Circuit.  The appeal was heard on December 2, 2019.  We are awaiting the ruling from the court.

On December 9, 2016, Boston Scientific filed a first lawsuit alleging our manufacture, use and sale of the Senza system infringes certain of Boston Scientific’s patents covering SCS technology related to stimulation leads, rechargeable batteries and telemetry. The lawsuit, filed in the U.S. District Court for the District of Delaware, seeks unspecified damages and attorney’s fees, as well as preliminary and permanent injunctive relief against further infringement. In relation to this lawsuit, we filed petitions for inter partes review at the U.S. Patent and Trademark Office (USPTO) against all the eight patents asserted by Boston Scientific.  As a result of those petitions, in February 2019, all of the asserted claims of Boston Scientific’s U.S. Patent Nos. 6,895,280 and 7,587,241 were found invalid by the Patent Trial and Appeal Board (PTAB) at the USPTO.  Boston Scientific has appealed these rulings.  Boston Scientific and Nevro have each submitted appeal briefs and replies to the U.S. Court of Appeals for the Federal Circuit, and are awaiting a hearing date.  This patent infringement lawsuit has been stayed since June 2018, pending completion of inter partes proceedings.

On April 27, 2018, Boston Scientific filed a second lawsuit alleging patent infringement, theft of trade secrets, and tortious interference with contract. The lawsuit, filed in the U.S. District Court for the District of Delaware, seeks unspecified damages and attorney’s fees, as well as preliminary and permanent injunctive relief against further infringement. In relation to this lawsuit, we filed petitions for inter partes review at the USPTO against seven of the

64

 

nine patents asserted by Boston Scientific. In January 2020, the PTAB initiated inter partes reviews in all seven of the challenged patents.

On August 23, 2018, the Oklahoma Police Pension and Retirement System filed a putative securities class action complaint against us and certain individual officers alleging violations of Sections 10(b) and 20(a) of the Exchange Act, and Rule 10b-5 of the Exchange Act.  The lawsuit, filed in the U.S. District Court for the Northern District of California, seeks unspecified damages and attorneys’ fees based on alleged misleading statements or omissions by us and the individual officers regarding our rights in technology underlying the Senza SCS systems and the termination of our former Vice President of Worldwide Sales. On November 3, 2018, a related shareholder derivative lawsuit was filed in the U.S. District Court for the Northern District of California seeking unspecified damages, injunctive relief and attorneys’ fees based on alleged violations of Section 14(a) of the Securities and Exchange Act of 1934, breach of fiduciary duties, unjust enrichment and waste of corporate assets. On August 1, 2019, U.S. District Judge Vince Chhabria granted the Company’s motion to dismiss the pending securities class action complaint, with leave to file an amended complaint within 21 days of the order.  The plaintiffs did not file an amended complaint, and on August 23, 2019, the securities class action was dismissed.  On September 6, 2019, the related shareholder derivative lawsuit was voluntarily dismissed.

On February 14, 2019, we filed a lawsuit for patent infringement against Stimwave asserting that Stimwave is infringing our patents covering inventions related to our HF10 therapy and the Senza system, as well as a claim for false advertising under the Lanham Action Section 43(a), 15 U.S.C. § 1125(a).  In relation to this lawsuit, on July 24, 2019, the court granted our motion for preliminary injunction, and has issued an order barring Stimwave, and all affiliated persons and entities, from infringing patent claims covering frequencies between 3 kHz and 10 kHz by programming Stimwave's SCS systems to deliver its recently introduced high-frequency, paresthesia-free SCS therapy.  Per our request, the court order does not enjoin Stimwave from providing follow-up care and programming for any patients who were already programmed with such high frequency therapy.  On July 25, 2019, Stimwave filed a Notice of Appeal to the U.S. Court of Appeals for the Federal Circuit.  Stimwave and Nevro have each submitted appeal briefs and replies to the appellate court, and we are awaiting a hearing date. During the appeal, the litigation in the District of Delaware will continue on the merits.

We are and may from time to time continue to be involved in various legal proceedings to defend our intellectual property, including several pending European patent oppositions at the European Patent Office initiated by our competitors Medtronic and Boston Scientific and an entitlement action filed by Boston Scientific in Germany.  In addition, we are and may from time to time also be involved in various legal proceedings of a character normally incident to the ordinary course of business, such as product liability and professional liability matters, which we do not deem to be material to our business and consolidated financial statements at this stage.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable

65

 

PART II

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information

Our common stock has been publicly traded on the NYSE under the symbol “NVRO” since the initial public offering (IPO) of our common stock on November 6, 2014. Prior to that time, there was no public market for our common stock.

Holders of Record

As of February 14, 2020, there were approximately 16 stockholders of record of our common stock, and the closing price per share of our common stock was $139.66. Since many of our shares of common stock are held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of stockholders represented by these record holders.

Dividends

We have never declared or paid cash dividends on our common stock. Because we currently intend to retain all future earnings to finance future growth, we do not anticipate paying any cash dividends in the near future.

Securities Authorized for Issuance under Equity Compensation Plans

The information required by this Item 5 regarding equity compensation plans is incorporated by reference from the information under the captions “Equity Compensation Plan Information” and “Security Ownership of Certain Beneficial Owners and Management” that will be contained in the Proxy Statement.

66

 

Stock Performance Graph

The following graph illustrates a comparison of the total cumulative stockholder return on our common stock since November 6, 2014, which is the date our common stock first began trading on the NYSE, to two indices: the S&P 500 Composite Index and the S&P Healthcare Equipment Index. The stockholder return shown in the graph below is not necessarily indicative of future performance, and we do not make or endorse any predictions as to future stockholder returns. This graph shall not be deemed “soliciting material” or be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any of our filings under the Securities Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.

 

 

 

 

 

December 31,

 

 

December 31,

 

 

December 31,

 

 

December 31,

 

 

December 31,

 

 

December 31,

 

$100 investment in stock or index

 

2014

 

 

2015

 

 

2016

 

 

2017

 

 

2018

 

 

2019

 

Nevro Corp. (NVRO)

 

$

100.00

 

 

$

174.58

 

 

$

187.90

 

 

$

178.54

 

 

$

100.57

 

 

$

303.96

 

S&P 500 (GSPC)

 

$

100.00

 

 

$

99.27

 

 

$

108.74

 

 

$

129.86

 

 

$

121.76

 

 

$

156.92

 

S&P Healthcare Equipment (SPSIHE)

 

$

100.00

 

 

$

108.78

 

 

$

122.27

 

 

$

158.93

 

 

$

173.62

 

 

$

212.51

 

 

Recent Sales of Unregistered Securities

None.

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

None.

67

 

ITEM 6. SELECTED FINANCIAL DATA

The following selected consolidated financial data is qualified in its entirety by, and should be read in conjunction with the consolidated financial statements and the notes thereto included in Part II, Item 8 and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in Part II, Item 7 of this Annual Report. The selected consolidated statements of operations data for each of the five years in the period ended December 31, 2019, and the consolidated balance sheet data as of December 31, 2019, 2018, 2017, 2016 and 2015 have been derived from our audited consolidated financial statements.

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

 

2016

 

 

2015

 

(in thousands, except per share data)

 

 

 

Selected Consolidated Statements of Operations Data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

390,255

 

 

$

387,289

 

 

$

326,674

 

 

$

228,504

 

 

$

69,606

 

Cost of revenue

 

 

121,905

 

 

 

113,965

 

 

 

98,981

 

 

 

75,433

 

 

 

28,120

 

Gross profit

 

 

268,350

 

 

 

273,324

 

 

 

227,693

 

 

 

153,071

 

 

 

41,486

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

59,017

 

 

 

48,459

 

 

 

37,560

 

 

 

33,729

 

 

 

21,382

 

Sales, general and administrative

 

 

305,812

 

 

 

266,608

 

 

 

219,712

 

 

 

142,423

 

 

 

82,471

 

Total operating expenses

 

 

364,829

 

 

 

315,067

 

 

 

257,272

 

 

 

176,152

 

 

 

103,853

 

Loss from operations

 

 

(96,479

)

 

 

(41,743

)

 

 

(29,579

)

 

 

(23,081

)

 

 

(62,367

)

Interest and other income (expense), net

 

 

(5,608

)

 

 

(6,694

)

 

 

(5,671

)

 

 

(5,806

)

 

 

(3,898

)

Loss on extinguishment of debt

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(1,268

)

 

 

—

 

Loss before income taxes

 

 

(102,087

)

 

 

(48,437

)

 

 

(35,250

)

 

 

(30,155

)

 

 

(66,265

)

Provision for income taxes

 

 

1,599

 

 

 

768

 

 

 

1,408

 

 

 

1,623

 

 

 

1,166

 

Net loss

 

$

(103,686

)

 

$

(49,205

)

 

$

(36,658

)

 

$

(31,778

)

 

$

(67,431

)

Net loss per share attributable to common

   stockholders, basic and diluted

 

$

(3.37

)

 

$

(1.64

)

 

$

(1.25

)

 

$

(1.12

)

 

$

(2.54

)

Shares used in computing basic and diluted

   net loss per common share

 

 

30,803,872

 

 

 

30,051,961

 

 

 

29,424,054

 

 

 

28,485,003

 

 

 

26,581,890

 

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

 

2016

 

 

2015

 

(in thousands, except per share data)

 

 

 

Selected Consolidated Balance Sheet Data:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

65,373

 

 

$

51,266

 

 

$

42,845

 

 

$

41,406

 

 

$

87,036

 

Short-term investments

 

$

172,429

 

 

$

213,281

 

 

$

226,467

 

 

$

234,951

 

 

$

106,634

 

Working capital

 

$

351,441

 

 

$

381,445

 

 

$

383,177

 

 

$

378,093

 

 

$

246,242

 

Total assets

 

$

469,645

 

 

$

463,116

 

 

$

454,056

 

 

$

430,583

 

 

$

291,183

 

Long-term debt

 

$

160,300

 

 

$

152,394

 

 

$

145,019

 

 

$

138,140

 

 

$

19,740

 

Total stockholders' equity

 

$

216,352

 

 

$

245,483

 

 

$

249,172

 

 

$

249,034

 

 

$

234,592

 

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

This Annual Report includes “forward-looking statements” within the meaning of the federal securities laws, particularly statements referencing our expectations relating to the productivity of our sales force, revenues, deferred revenues, cost of revenues, operating expenses, stock-based compensation and provision for income taxes; the growth of our customer base and customer demand for our products; the sufficiency of our cash balances and cash flows; the impact of recent changes in accounting standards; the impact of changes in the tax code as a result of recent federal tax legislation and uncertainty as to how some of those changes may be applied; market risk sensitive instruments; contractual obligations; and assumptions underlying any of the foregoing. In some cases, forward-looking statements can be identified by the use of terminology such as “may,” “will,” “expects,” “intends,” “plans,” “anticipates,” “estimates,” “potential,” or “continue,” or the negative thereof, or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements contained herein are

68

 

reasonable, these expectations or any of the forward-looking statements could prove to be incorrect, and actual results could differ materially from those projected or assumed in the forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to risks and uncertainties, including but not limited to the factors set forth in this Annual Report under Part I, Item 1A. Risk Factors. All forward-looking statements and reasons why results may differ included in this Annual Report are made as of the date of the filing of this Annual Report, and we assume no obligation to update any such forward-looking statements or reasons why actual results may differ.

The following discussion should be read in conjunction with our consolidated financial statements and notes thereto appearing in Part II, Item 8 of this Annual Report.

Overview

We are a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain.  We have developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain, and have recently launched our newest product platform, Senza Omnia. Our proprietary paresthesia-free HF10 therapy, delivered by our Senza system, was demonstrated in our SENZA-RCT study to be superior to traditional SCS therapy, with HF10 therapy being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy.  Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. Our SENZA-RCT study, along with our European studies, represents what we believe is the most robust body of clinical evidence for any SCS therapy. We believe the superiority of HF10 therapy over traditional SCS therapies will allow us to capitalize on and expand the approximately $2.5 billion existing global SCS market by treating both back and leg pain without paresthesia.

We launched Senza commercially in the United States in May 2015, after receiving a label from the U.S. Food and Drug Administration (FDA) supporting the superiority of our HF10 therapy over traditional SCS.  The Senza system has been commercially available in certain European markets since November 2010 and in Australia since August 2011. We have experienced significant revenue growth in the United States since commercial launch. Senza is currently reimbursed by all of the major insurance providers. In early 2017, we commenced a controlled commercial launch of our surgical lead, marketed as the Surpass surgical lead. In January 2018, we received FDA approval of our next generation Senza II SCS system.  In the fourth quarter of 2019, we received FDA approval of Senza® Omnia™, which we recently launched in the United States. The tables below set forth our revenue from U.S. and international sales the past three years on a quarterly basis and total revenue for each of the past five years.

 

 

Q1 2017

 

 

Q2 2017

 

 

Q3 2017

 

 

Q4 2017

 

 

Q1 2018

 

 

Q2 2018

 

 

Q3 2018

 

 

Q4 2018

 

 

Q1 2019

 

 

Q2 2019

 

 

Q3 2019

 

 

Q4 2019

 

Revenue from:

(in millions)

 

U.S. sales

$

53.1

 

 

$

63.0

 

 

$

66.3

 

 

$

81.1

 

 

$

70.6

 

 

$

79.9

 

 

$

79.6

 

 

$

91.6

 

 

$

65.8

 

 

$

78.1

 

 

$

84.2

 

 

$

97.9

 

International sales

 

15.3

 

 

 

15.0

 

 

 

16.0

 

 

 

16.9

 

 

 

17.0

 

 

 

16.2

 

 

 

16.0

 

 

 

16.3

 

 

 

16.3

 

 

 

15.5

 

 

 

16.0

 

 

 

16.5

 

Total revenue

$

68.4

 

 

$

78.0

 

 

$

82.3

 

 

$

98.0

 

 

$

87.6

 

 

$

96.1

 

 

$

95.6

 

 

$

107.9

 

 

$

82.1

 

 

$

93.6

 

 

$

100.2

 

 

$

114.4

 

 

 

2015

 

 

2016

 

 

2017

 

 

2018

 

 

2019

 

Revenue from:

(in millions)

 

U.S. sales

$

24.3

 

 

$

173.3

 

 

$

263.5

 

 

$

321.8

 

 

$

326.0

 

International sales

 

45.3

 

 

 

55.2

 

 

 

63.2

 

 

 

65.5

 

 

 

64.3

 

Total revenue

$

69.6

 

 

$

228.5

 

 

$

326.7

 

 

$

387.3

 

 

$

390.3

 

Since our inception, we have financed our operations primarily through equity and debt financings and borrowings under a debt facility. Our accumulated deficit as of December 31, 2019 was $409.8 million. A significant amount of our capital resources has been used to support the development of our Senza products and HF10 therapy, and we have also made a significant investment building our U.S. commercial infrastructure and sales force to support our commercialization efforts in the United States. We intend to continue to make significant investments in our U.S. commercial infrastructure, as well as in research and development (R&D) to develop Senza to treat other chronic pain indications, including conducting clinical trials to support our future regulatory

69

 

submissions. In order to further enhance our R&D efforts, pursue product expansion opportunities or acquire a new business or products that are complementary to our business, we may choose to raise additional funds, which may include future equity and debt financings.

We rely on third-party suppliers for all of the components of our Senza products, and for the assembly of these systems. Several of these suppliers are currently single-source suppliers. We have entered into and/or amended several supply agreements in an effort to reinforce our supply chain.  We are also required to maintain high levels of inventory, and, as a result, we are subject to the risk of inventory obsolescence and expiration, which may lead to inventory impairment charges. Additionally, as compared to direct manufacturers, our dependence on third-party manufacturers exposes us to greater lead times, increasing our risk of inventory obsolescence.

Important Factors Affecting our Results of Operations

We believe that the following factors have impacted and we expect will continue to impact our results of operations.

Importance of Physician Awareness and Acceptance of Our Products

We continue to invest in programs to educate physicians who treat chronic pain about the advantages of Senza. This requires significant commitment by our marketing team and sales organization, and can vary depending upon the physician’s practice specialization, personal preferences and geographic location. Further, we are competing with well-established companies in our industry that have strong existing relationships with many of these physicians. Educating physicians about the advantages of our Senza products, including our latest product, Senza Omnia, which we recently launched in the United States, and influencing these physicians to use these products to treat chronic pain, is required to grow our revenue.

Reimbursement and Coverage Decisions by Third-Party Payors

Healthcare providers in the United States generally rely on third-party payors, principally federal Medicare, state Medicaid and private health insurance plans, to cover and reimburse all or part of the cost of our products and the related implant procedure for patients. The revenue we are able to generate from sales of our products depends in large part on the availability of reimbursement from such payors. While we currently have a favorable reimbursement decision from federal Medicare, decisions of coverage and reimbursement for Senza and the related implant procedure from private health insurance providers can vary. In general, these decisions require that such payors perform analyses to determine if the procedure is medically necessary and if our technology is covered under their existing coverage policies. These payors may deny reimbursement if they determine that the device or procedure was not used in accordance with the payor’s coverage policy.  A significant component of our commercial efforts includes working with private payors to ensure positive coverage and reimbursement decisions for our products. Favorable reimbursement decisions from federal Medicare and certain commercial payors, such as Aetna, Cigna, Humana, Blue Cross Blue Shield and Kaiser, have contributed to our increase in revenue to date.  Although the largest commercial payors and federal Medicare cover Senza, there can be no assurance that all private health insurance plans will cover the product.  A significant number of negative coverage and reimbursement decisions by private insurers may impair our ability or delay our ability to grow our revenue.

Inventory Buildup and Supply Chain Management

Our products are composed of a substantial number of individual components and, in order to market and sell them effectively, we must maintain high levels of inventory. In particular, since our commercial launch of Senza in the United States, we have continued to add suppliers to fortify our supply chain and we have maintained increased levels of inventory. As a result, a significant amount of our cash used in operations has been associated with the maintaining these levels of inventory. There may also be times in which we determine that our inventory does not meet our product requirements, as was the case for the years ended December 31, 2019 and 2018, wherein we recorded a write-down of inventory of $1.6 million and $2.0 million, respectively. Further, the manufacturing process for our products requires lengthy lead times, during which components may become obsolete. We may also over- or underestimate the quantities of required components, in which case we may expend extra resources or be

70

 

constrained in the amount of end product that we can produce. In addition, as we release later generations of products that contain advancements or additional features, the earlier generations may become obsolete. These factors subject us to the risk of inventory obsolescence and expiration, which may lead to inventory impairment charges.  For the year ended December 31, 2019, we additionally recorded a charge of $3.6 million related to the cancellation of firm purchase commitments.

Investment in Research and Clinical Trials

We intend to continue investing in R&D to expand into new indications and chronic pain conditions, as well as develop product enhancements to improve outcomes and enhance the physician and patient experience. For example, we commenced controlled commercial launches of Surpass, our surgical lead product in early 2017 and Senza II SCS System in late 2017.  Most recently, we launched our next generation product platform, Senza Omnia, in the United States in November 2019.  We are continuing to invest in product improvements to Senza, including enhanced MRI capabilities and a next generation IPG. While R&D and clinical testing are time consuming and costly, we believe expanding into new indications, implementing product improvements and continuing to demonstrate HF10 efficacy, safety and cost effectiveness through clinical data are all critical to increasing the adoption of HF10 therapy.

Significant Investment in U.S. Sales Organization

We are continuing to make investments in building our U.S. commercial infrastructure and recruiting and training our U.S. sales force. This is a lengthy process that requires recruiting appropriate sales representatives, establishing and, on occasion, refining a commercial infrastructure in the United States and training our sales representatives. Following initial training for Senza, our sales representatives typically require lead time in the field to grow their network of accounts and produce sales results. Successfully recruiting and training a sufficient number of productive sales representatives has been required to achieve growth at the rate we expect.

Access to Hospital Facilities

In the United States, in order for physicians to use our products, the hospital facilities where these physicians treat patients often require us to enter into purchasing contracts directly with the hospital facilities or with the Group Purchasing Organizations of which the hospital facilities are members. This process can be lengthy and time-consuming and requires extensive negotiations and management time. In Europe, we may be required to engage in a contract bidding process in order to sell our products, where the bidding processes are only open at certain periods of time, and we may not be successful in the bidding process.

We Do Not Expect Our Worldwide Revenue Growth Rate to Continue at Historic Rates

Our worldwide revenue has increased from $18.2 million for the year ended December 31, 2012 to $390.3 million for the year ended December 31, 2019.  Since May 2015 when we commenced the commercial launch of Senza in the U.S., our worldwide revenue growth has been substantially driven by sales of Senza in the United States.  Over the past two years, our revenue growth in international markets has slowed significantly. Although we had experienced significant growth in sales in the United States for several years following our launch, we do not expect to continue that historic rate of revenue growth in the United States or on a worldwide basis.  Further, due to a number of factors, including governmental reimbursement constraints in the European SCS market limiting the number of annual SCS implants, market pressure in Australia and our current penetration in these markets, we expect minimal, if any, growth in our international markets.

Critical Accounting Policies, Significant Judgments and Use of Estimates

Our management’s discussion and analysis of financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP). The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an ongoing basis, we evaluate our critical accounting policies and estimates. We base our estimates on

71

 

historical experience and on various other assumptions that we believe to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions and conditions. We believe that the estimates, judgments and assumptions involved in the accounting for revenue recognition, inventory, stock-based compensation, income taxes and allowance for doubtful accounts have the greatest potential impact on our consolidated financial statements, so we consider these to be our critical accounting policies. We discuss below the critical accounting estimates associated with these policies. Historically, our estimates, judgments, and assumptions relative to our critical accounting policies have not differed materially from actual results. Our significant accounting policies are more fully described in Note 2, Summary of Significant Accounting Policies, of Notes to Consolidated Financial Statements in Part II, Item 8 of this Annual Report.

Revenue

On January 1, 2018, the Company adopted the new accounting standard ASC 606, Revenue from Contracts with Customers, using the modified retrospective method applied to contracts which were not completed as of that date.  Results for reporting periods beginning after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 605, Revenue Recognition. Under ASC 606, assuming all other revenue recognition criteria have been met, the Company will recognize revenue earlier for arrangements where the Company has satisfied its performance obligations but has not issued invoices.  These amounts are recorded as unbilled receivables, which are included in accounts receivable on the consolidated balance sheet, as the Company has an unconditional right to payment at the end of the applicable period.  

Revenue is recognized when obligations under the terms of a contract with customers are satisfied, which occurs with the transfer of control of the Company’s goods to its customers.  Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods.

For a majority of sales, where the Company’s sales representative delivers its product at the point of implantation at hospitals or medical facilities, the Company recognizes revenue upon completion of the procedure and authorization, which represents the point in time when control transfers to the customers.

For the remaining sales, which are sent from the Company’s distribution centers directly to hospitals and medical facilities, as well as distributor sales, where product is ordered in advance of an implantation, the transfer of control occurs at the time of shipment of the product.  These customers are obligated to pay within specified terms regardless of when or if they ever sell or use the products. The Company does not offer rights of return or price protection. To the extent the Company has a post-delivery obligation, such as programming devices that have been delivered as part of a direct-ship order, the Company defers revenue and the associated cost of goods sold associated with the post-delivery obligation only if the amounts are deemed material.

For further discussion on revenue recognition see Note 3, Revenue, of Notes to Consolidated Financial Statements in Part II, Item 8 of this Annual Report.

Inventory Valuation

We contract with third parties for the manufacturing and packaging of all of the components of our Senza products. We plan the manufacture of our systems based on estimates of market demand. The nature of our business requires that we maintain sufficient inventory on hand to meet the requirements of our customers. Inventories are stated at the lower of cost or net realizable value. Cost is determined using the standard cost method, which approximates the first-in, first-out basis. Net realizable value is determined as the prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation.

We regularly review inventory quantities compared to forecasted sales to record a provision for excess and obsolete inventory when appropriate. Inventory write-downs are recorded for excess and obsolete inventory. We estimate forecasted sales by considering:

 

•

product acceptance in the marketplace;

72

 

 

•

customer demand;

 

•

historical sales;

 

•

product obsolescence; and

 

•

technological innovations.

Any inventory write-downs are recorded in cost of revenue within the statements of operations during the period in which such write-downs are determined necessary by management.

Stock-Based Compensation

Stock-based compensation costs related to stock options granted to employees are measured at the date of grant based on the estimated fair value of the award, net of estimated forfeitures. We estimate the grant date fair value, and the resulting stock-based compensation expense, using the Black-Scholes option-pricing model.  The fair value is recognized on a straight-line basis over the requisite service period of the stock option award, which is generally the vesting term of four years, with the exception of performance based stock option awards, whose fair value is recognized as expenses when it is determined that achieving the performance metrics are probable.

The Black-Scholes option-pricing model requires the use of highly subjective assumptions which determine the fair value of stock-based awards. The assumptions used in our option-pricing model represent management’s best estimates. These estimates are complex, involve a number of variables, uncertainties and assumptions and the application of management’s judgment, so that they are inherently subjective. If factors change and different assumptions are used, our stock-based compensation expense could be materially different in the future. These assumptions are estimated as follows:

Risk-Free Interest Rate. We base the risk-free interest rate used in the Black-Scholes valuation model on the implied yield available on U.S. Treasury zero-coupon issues with an equivalent remaining term of the options for each option group.

Expected Term. The expected term represents the period that our stock-based awards are expected to be outstanding. We have historically used the Staff Accounting Bulletin (SAB) 110, simplified method to calculate the expected term, which is the average of the contractual term and vesting period for the period. Starting in late 2016, we have started to utilize our historical data for the calculation of expected term.

Volatility. We have historically determined the price volatility factor based on the historical volatilities of our peer group as we did not have a sufficient trading history for our common stock.  Starting in late 2016, we have started to incorporate our historical stock trading volatility with those of our peer group for the calculation of volatility.  Industry peers consist of several public companies in the medical device technology industry with comparable characteristics including enterprise value, risk profiles and position within the industry. We regularly evaluate our peer group to assess changes in circumstances where identified companies may no longer be similar to us, in which case, more suitable companies whose share prices are publicly available would be utilized in the calculation.

Dividend Yield. The expected dividend assumption is based on our current expectations about our anticipated dividend policy. We currently do not expect to issue any dividends.

In addition to assumptions used in the Black-Scholes option-pricing model, we must also estimate a forfeiture rate to calculate the stock-based compensation for our awards. We will continue to use judgment in evaluating the assumptions related to our stock-based compensation on a prospective basis. As we continue to accumulate additional data, we may have refinements to our estimates, which could materially impact our future stock-based compensation expense.

In 2015, we began issuing restricted stock units (RSUs).  We account for stock-based compensation for the RSUs at their fair value, based on the closing market price of our common stock on the grant date.  These costs are

73

 

recognized on a straight-line basis over the requisite service period, which is generally the vesting term of four years.

In 2016, we granted performance based RSUs to our former CEO that only vest upon the achievement of specific operational performance criteria.  The stock-based compensation for these performance based RSUs are recognized as expenses when it is determined that achieving the performance metrics are probable.

In 2019, we granted RSUs to our current CEO, which entitle him to receive a number of shares of our common stock based on our stock price performance compared to a specified target composite index over a three-year period.  The number of shares to be issued upon vesting ranges from zero to 3.5 times the number of RSUs granted, depending on the relative performance of our common stock compared to the targeted composite index.  The fair value of these grants is determined by using the Monte Carlo simulation model, which is based on a discounted cash flow approach, and requires inputs such as expected volatility of our stock price, expected volatility of the targeted composite index, correlation between the changes in our stock price and the target composite index, risk-free interest rate and expected dividends.  The expected volatility of our stock and the target composite index is based on the historical data. Correlation is based on the historical relationship between our stock price and the target composite index. The risk-free interest rate is based upon the treasury yield consistent with the vesting term of the grant. The expected dividend yield is zero.  Stock-based compensation for these restricted stock units is recognized over the specified performance measurement.

We estimate the fair value of the rights to purchase shares by employees under our Employee Stock Purchase Plan using the Black-Scholes option pricing formula. Our Employee Stock Purchase Plan provides for consecutive six-month offering periods and we use our own historical volatility data in the valuation.

Income Tax

We recognize deferred income taxes for temporary differences between the basis of assets and liabilities for financial statement and income tax purposes. We periodically evaluate the positive and negative evidence bearing upon realizability of our deferred tax assets. Based upon the weight of available evidence, which includes our historical operating performance, reported cumulative net losses since inception and difficulty in accurately forecasting our future results, we maintained a full valuation allowance on our net U.S. federal and state deferred tax assets as of December 31, 2019 and 2018. We intend to maintain a full valuation allowance on the federal and state deferred tax assets until sufficient positive evidence exists to support reversal of the valuation allowance.

As of December 31, 2019, we had federal net operating loss carryforwards (NOLs) of $398.5 million, of which $139.5 million was generated in fiscal year 2018 and thereafter, which can be carried forward indefinitely under the 2017 Tax Act, as well as state NOLs of 194.8 million, of which $22.1 million may be carried forward indefinitely.  If not utilized, the remaining federal NOLs will begin to expire in 2026 and the state NOLs will begin to expire 2020. We have no foreign NOL carryforwards.  We also have federal research tax credit carryforwards that will begin to expire in 2026 and California research tax credits that do not expire. Realization of these NOL and research tax credit carryforwards depends on future income, and there is a risk that our existing carryforwards could expire unused and be unavailable to reduce future income tax liabilities, which could materially and adversely affect our results of operations.

In addition, under Section 382 of the Internal Revenue Code of 1986, as amended (the Code) our ability to utilize NOL carryforwards or other tax attributes such as research tax credits, in any taxable year may be limited if we experience, or have experienced, a Section 382 “ownership change.” A Section 382 “ownership change” generally occurs if one or more stockholders or groups of stockholders, who own at least 5% of our stock, increase their ownership by a greater than 50 percentage point change (by value) over a rolling three-year period. Similar rules may apply under state tax laws.

No deferred tax assets have been recognized on our balance sheet related to our NOLs and tax credits, as they are fully reserved by a valuation allowance. We experienced a Section 382 “ownership change” as a result of our June 2015 underwritten public offering.  We currently estimate this “ownership change” will not inhibit our ability to utilize our NOLs.  However, we may, in the future, experience one or more additional Section 382 “ownership changes” as a result of subsequent changes in our stock ownership, some of which changes are outside our control.

74

 

If so, we may not be able to utilize a material portion of our NOLs and tax credits even if we achieve profitability and generate sufficient taxable income. If we are limited in our ability to use our NOLs and tax credits in future years in which we have taxable income, we will pay more taxes than if we were able to fully utilize our NOLs and tax credits. This could materially and adversely affect our results of operations.

We record unrecognized tax benefits as liabilities and adjust these liabilities when our judgment changes as a result of the evaluation of new information not previously available. Because of the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from our current estimate of the unrecognized tax benefit liabilities. These differences will be reflected as increases or decreases to income tax expense in the period in which new information is available. Our policy is to recognize interest and penalties related to income taxes as a component of income tax expense. A nominal amount of interest and penalties have been recognized in the statements of operations and comprehensive loss in 2019.  No interest or penalties related to income taxes have been recognized in the statements of operations and comprehensive loss in 2018 and 2017.

On December 22, 2017, the 2017 Tax Cuts and Jobs Act (the 2017 Tax Act) was enacted into law.  The recorded impact for the effects of the 2017 Tax Act is based on our current knowledge, assumptions and interpretations of available guidance.  We elected to account for Global Intangible Low-Taxed Income (GILTI) as a current period expense when incurred.  We will continue to monitor the issuance of additional regulatory or accounting guidance and record any necessary adjustments in the period for which additional guidance is issued.

Allowance for Doubtful Accounts

We must make estimates of the collectability of accounts receivable. In doing so, we analyze historical bad debt trends, customer credit worthiness, current economic trends and changes in customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts. Our accounts receivable balance was $82.8 million, net of allowance of $0.8 million, as of December 31, 2019 and $80.7 million, net of allowance of $0.8 million, as of December 31, 2018.

Components of Results of Operations

Revenue

Our revenue is generated primarily from sales to two types of customers: hospitals and outpatient medical facilities, with each being served primarily through a direct sales force. Sales to these entities are billed to, and paid by, the hospitals and outpatient medical facilities as part of their normal payment processes, with payment received by us in the form of an electronic transfer, check or credit card payment. Product sales to third-party distributors are billed to and paid by the distributors as part of their normal payment processes, with payment received by us in the form of an electronic transfer.

U.S. revenue is generally recognized after our sales representatives deliver our product at the point of implantation and upon the completion and authorization of the implant procedure.  In response to competitive practices and pressures, we have offered some volume price discounting for larger orders, where products are ordered in advance of an implantation and revenue is recognized when the transfer of control occurs at the time of shipment.

Revenue from sales of our Senza products fluctuate based on the selling price of the system, as the average sales price of a system varies geographically and by the type of system sold, and based on the mix of sales by geography. Our revenue from international sales can also be significantly impacted by fluctuations in foreign currency exchange rates, as our sales are denominated in the local currency in the countries in which we sell our products.

We expect our revenue to fluctuate from quarter to quarter due to a variety of factors, including seasonality.  For example, the industry generally experiences lower revenues in the first and third quarters of the year and higher revenues in the fourth quarter.  Our revenue has been impacted by these industry trends. Further, the impact of the buying patterns and implant volumes of hospitals and medical facilities, and third-party distributors may vary, and as a result could have an effect on our revenue from quarter to quarter. In addition, in the second quarter of 2015, we

75

 

commenced commercial sales of Senza in the United States.  Since then, we have recorded revenue of approximately $24.4 million, $173.3 million, $263.5 million, $321.8 million and $326.0 million for the years ended December 31, 2015, 2016, 2017, 2018 and 2019, respectively, for sales in the United States.  We anticipate that our total revenue will increase as we continue our commercialization in the United States.

Cost of Revenue

We utilize contract manufacturers for the production of Senza products. Cost of revenue consists primarily of acquisition costs of the components of Senza, manufacturing overhead, royalty payments, scrap and inventory excess and obsolescence charges, as well as distribution-related expenses, such as logistics and shipping costs, net of costs charged to customers.

We calculate gross margin as revenue less cost of revenue divided by revenue. Our gross margin has been and will continue to be affected by a variety of factors, but primarily by our average sales price and the costs to have our products manufactured. While costs are primarily incurred in U.S. dollars, international revenue may be impacted by the appreciation or depreciation of the U.S. dollar, which may impact our overall gross margin. Our gross margin is also affected by our ability to reduce manufacturing costs as a percentage of revenue.

Operating Expenses

Our operating expenses consist of R&D expense, and sales, general and administrative (SG&A) expense. Personnel costs are the most significant component of operating expenses and consist primarily of salaries, bonus incentives, benefits, stock-based compensation and sales commissions.

Research and Development. R&D costs are expensed as incurred. R&D expense consists primarily of personnel costs, including salary, employee benefits and stock-based compensation expenses for our R&D employees. R&D expense also includes costs associated with product design efforts, development prototypes, testing, clinical trial programs and regulatory activities, contractors and consultants, equipment and software to support our development, facilities and information technology. We expect product development expenses to increase in absolute dollars as we continue to develop product enhancements to Senza. Our R&D expenses may fluctuate from period to period due to the timing and extent of our R&D and clinical trial expenses.

Sales, General and Administrative. SG&A expense consists primarily of personnel costs, including salary, employee benefits and stock-based compensation expenses for our sales and marketing personnel, including sales commissions, and for administrative personnel that support our general operations, such as information technology, executive management, financial accounting, customer service and human resources personnel. We expense commissions at the time of the sale. SG&A expense also includes costs attributable to marketing, as well as travel, intellectual property and other legal fees, financial audit fees, insurance, fees for other consulting services, depreciation and facilities.

In the last three years, we significantly increased the size of our sales presence worldwide and have increased marketing spending in order to generate additional sales opportunities. Additionally, we have made substantial investments in our U.S. commercial infrastructure to support our commercialization efforts in the United States. We expect SG&A expenses to decrease as a percent of revenue as we engage in activities that leverage our existing sales and marketing personnel to support the commercialization of our products in the United States.

During 2017, 2018 and 2019, we had a significant increase in SG&A headcount and experienced significant legal expenses associated with our intellectual property litigation with Boston Scientific. We anticipate significant continued expenses associated with these legal activities. Additionally, we continue to incur significant expenses related to audit, legal, regulatory and tax-related services associated with maintaining compliance with exchange listing and SEC requirements, including compliance under the Sarbanes-Oxley Act of 2002 (the Sarbanes-Oxley Act), director and officer insurance premiums and investor relations costs associated with being a public company. Our SG&A expense may fluctuate from period to period due to the seasonality of our revenue and the timing and extent of our SG&A expense.

76

 

Interest Income and Interest Expense

Interest income consists primarily of interest income earned on our investments and interest expense consists of interest paid on our outstanding debt and the amortization of debt discount and debt issuance costs.

Other Income (Expense), Net

Other income (expense), net consists primarily of foreign currency transaction gains and losses and the gains and losses from the remeasurement of foreign-denominated balances to the U.S. dollar.

Provision for Income Taxes

The provision for income taxes consists primarily of income taxes in foreign jurisdictions in which we conduct business as well as states where we have determined we have state nexus. We maintain a full valuation allowance for substantially all of our deferred tax assets including net operating loss (NOL) carryforwards and federal and state tax credits.

Allowance for Doubtful Accounts

We make estimates as to the overall collectability of accounts receivable and provide an allowance for accounts receivable considered uncollectible. We specifically analyze accounts receivable based on historical bad debt experience, customer concentrations, customer credit-worthiness, the age of the receivable, current economic trends, and changes in customer payment terms when evaluating the adequacy of the allowance for doubtful accounts. We record the adjustment in general and administrative expense.

Recent Accounting Pronouncements

For recent accounting pronouncements, see Note 2, Summary of Significant Accounting Policies, of Notes to Consolidated Financial Statements in Part II, Item 8 of this Annual Report.

Comparison of the Years Ended December 31, 2019 and 2018

Revenue, Cost of Revenue, Gross Profit and Gross Margin

 

 

 

Years Ended December 31,

 

 

 

 

 

 

 

2019

 

 

2018

 

 

Change

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

390,255

 

 

$

387,289

 

 

$

2,966

 

Cost of revenue

 

 

121,905

 

 

 

113,965

 

 

 

7,940

 

Gross profit

 

$

268,350

 

 

$

273,324

 

 

$

(4,974

)

Gross margin

 

69%

 

 

71%

 

 

(2)%

 

 

Revenue. Revenue increased to $390.3 million in 2019 from $387.3 million in 2018, an increase of $3.0 million, or 1%, due to increased sales of the Senza systems in the United States and continued adoption of the Senza system in international markets. The increase in sales of the Senza system was further driven in part by our expanded sales force in the United States in 2019 and was partially offset by a small reduction in average selling prices.

Cost of Revenue, Gross Profit and Gross Margin. Cost of revenue increased to $121.9 million in 2019 from $114.0 million in 2018, an increase of $7.9 million, or 7%.  This increase was primarily due to a $5.2 million increase in the costs of manufactured product components, as well as a charge of $3.6 million related to the cancellation of firm purchase commitments. Gross profit decreased to $268.4 million in 2019 from $273.3 million in 2018, a decrease of $5.0 million, or 2%.  Gross profit as a percentage of revenue, or gross margin, decreased to 69% in 2019 compared to 71% in 2018.  The decrease in gross margin was primarily due to the write-down of inventory in 2019, as well as a small reduction in average selling prices.

77

 

Operating Expenses

 

 

 

Years Ended December 31,

 

 

 

 

 

 

 

2019

 

 

2018

 

 

 

 

 

 

 

Amount

 

 

% of

Total

Revenue

 

 

Amount

 

 

% of

Total

Revenue

 

 

Change

Amount

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

$

59,017

 

 

15%

 

 

$

48,459

 

 

13%

 

 

$

10,558

 

Sales, general and administrative

 

 

305,812

 

 

78%

 

 

 

266,608

 

 

69%

 

 

 

39,204

 

Total operating expenses

 

$

364,829

 

 

93%

 

 

$

315,067

 

 

81%

 

 

$

49,762

 

 

Research and Development (R&D) Expenses. R&D expenses increased to $59.0 million in 2019 from $48.5 million in 2018, an increase of $10.6 million, or 22%.  The increase was primarily due to an increase in headcount and related personnel and consulting costs of $5.0 million and clinical and development expenses of $4.7 million.

Sales, General and Administrative (SG&A) Expenses. SG&A expenses increased to $305.8 million in 2019 from $266.6 million in 2018, an increase of $39.2 million, or 15%.  This increase was primarily due to an increase in personnel costs of $39.0 million in relation to an increase in headcount to support of our continued U.S. commercialization and personnel costs related to the separation with our former Chief Executive Officer, increased travel, training and additional hardware expense of $4.2 million, which were partially offset by decreased legal and other professional services costs of $5.7 million.

Interest Income, Interest Expense, Other Income (Expense), Net, Loss on Extinguishment of Debt and Provision for Income Taxes

 

 

 

Years Ended December 31,

 

 

 

 

 

 

 

2019

 

 

2018

 

 

Change

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

$

6,020

 

 

$

4,871

 

 

$

1,149

 

Interest expense

 

 

(10,931

)

 

 

(10,401

)

 

 

(530

)

Other income (expense), net

 

 

(697

)

 

 

(1,164

)

 

 

467

 

Provision for income taxes

 

 

1,599

 

 

 

768

 

 

 

831

 

 

Interest Income. Interest income increased to $6.0 million in 2019 from $4.9 million in 2018, primarily as a result of an increase in our investment yield rate.

Interest Expense. Interest expense increased to $10.9 million in 2019 from $10.4 million in 2018, primarily as a result of an increase in the amortization of debt discount and debt issuance costs related to the issuance of the 2021 Notes.

Other Income (Expense), Net. Other income (expense), net was primarily comprised of foreign currency transaction gains and losses, and the gains and losses from the remeasurement of foreign-denominated balances. We recorded a net loss of $0.6 million in 2019 and $0.9 million in 2018 in relation to the two items previously mentioned.  Our remeasurement gains and losses are affected by changes in the foreign currency translation rates of the countries in which we conduct business.

Income Tax Expense. Income tax expense was $1.6 million in 2019 and $0.8 million in 2018. Our income tax expense is associated primarily with foreign and state income taxes. We continue to generate tax losses for U.S. federal and state tax purposes and have NOL carryforwards creating a deferred tax asset. We have a full valuation allowance on the majority of our deferred tax assets. The change in income tax expense was primarily due to changes in foreign income taxes on profits realized by our foreign subsidiaries.

78

 

Comparison of the Years Ended December 31, 2018 and 2017

Revenue, Cost of Revenue, Gross Profit and Gross Margin

 

 

 

Years Ended December 31,

 

 

 

 

 

 

 

2018

 

 

2017

 

 

Change

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

387,289

 

 

$

326,674

 

 

$

60,615

 

Cost of revenue

 

 

113,965

 

 

 

98,981

 

 

 

14,984

 

Gross profit

 

$

273,324

 

 

$

227,693

 

 

$

45,631

 

Gross margin

 

71%

 

 

70%

 

 

1%

 

 

Revenue. Revenue increased to $387.3 million in 2018 from $326.7 million in 2017, an increase of $60.6 million, or 19%, due to increased sales of the Senza system in the United States and continued adoption of the Senza systems in international markets where it had historically been sold. The increase in sales of the Senza systems was further driven in part by our expanded sales force in the United States in 2018.

Cost of Revenue, Gross Profit and Gross Margin. Cost of revenue increased to $114.0 million in 2018 from $99.0 million in 2017, an increase of $15.0 million, or 15%.  This increase was primarily due to a $14.4 million increase in the costs of manufactured product components as sales volumes increased. Gross profit increased to $273.3 million in 2018 from $227.7 million in 2017, an increase of $45.6 million, or 20%.  Gross profit as a percentage of revenue, or gross margin, increased to 71% in 2018 compared to 70% in 2017.  The increase in gross margin was partly due to lower inventory write-downs, but was partly offset by the negative impact on international revenue as a result of the appreciation of the U.S. dollar during 2018.

Operating Expenses

 

 

 

Years Ended December 31,

 

 

 

 

 

 

 

2018

 

 

2017

 

 

 

 

 

 

 

Amount

 

 

% of

Total

Revenue

 

 

Amount

 

 

% of

Total

Revenue

 

 

Change

Amount

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

$

48,459

 

 

13%

 

 

$

37,560

 

 

11%

 

 

$

10,899

 

Sales, general and administrative

 

 

266,608

 

 

69%

 

 

 

219,712

 

 

67%

 

 

 

46,896

 

Total operating expenses

 

$

315,067

 

 

81%

 

 

$

257,272

 

 

79%

 

 

$

57,795

 

 

Research and Development (R&D) Expenses. R&D expenses increased to $48.5 million in 2018 from $37.6 million in 2017, an increase of $10.9 million, or 29%.  The increase was primarily due to an increase in clinical and development expenses of $4.0 million, headcount and related personnel and consulting costs of $4.8 million and facilities-related and depreciation expenses of $1.2 million.

Sales, General and Administrative (SG&A) Expenses. SG&A expenses increased to $266.6 million in 2018 from $219.7 million in 2017, an increase of $46.9 million, or 21%.  This increase was primarily due to an increase in personnel costs of $31.8 million in relation to an increase in headcount for SG&A personnel in support of our continued U.S. commercial launch, increased legal and other professional services costs of $8.0 million, partially associated with legal expenses incurred in connection with the Boston Scientific litigations, increased travel, training and additional hardware expense of $4.5 million, increased other healthcare professional related expenses of $1.6 million and increased depreciation expenses of $0.9 million.

Interest Income, Interest Expense, Other Income (Expense), Net, Loss on Extinguishment of Debt and Provision for Income Taxes

 

79

 

 

 

Years Ended December 31,

 

 

 

 

 

 

 

2018

 

 

2017

 

 

Change

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

$

4,871

 

 

$

3,164

 

 

$

1,707

 

Interest expense

 

 

(10,401

)

 

 

(9,902

)

 

 

(499

)

Other income (expense), net

 

 

(1,164

)

 

 

1,067

 

 

 

(2,231

)

Provision for income taxes

 

 

768

 

 

 

1,408

 

 

 

(640

)

 

Interest Income. Interest income increased to $4.9 million in 2018 from $3.2 million in 2017, primarily as a result of an increase in our investment yield rate.

Interest Expense. Interest expense increased to $10.4 million in 2018 from $9.9 million in 2017, primarily as a result of an increase in the amortization of debt discount and debt issuance costs related to the issuance of the 2021 Notes.

Other Income (Expense), Net. Other income (expense), net was primarily comprised of foreign currency transaction gains and losses, and the gains and losses from the remeasurement of foreign-denominated balances. We recorded a net loss of $0.9 million in 2018 and a net gain of $1.3 million in 2017 in relation to the two items previously mentioned.  Our remeasurement gains and losses are affected by changes in the foreign currency translation rates of the countries in which we conduct business.

Income Tax Expense. Income tax expense was $0.8 million in 2018 and $1.4 million in 2017. Our income tax expense is associated primarily with foreign and state income taxes. We continue to generate tax losses for U.S. federal and state tax purposes and have NOL carryforwards creating a deferred tax asset. We have a full valuation allowance on the majority of our deferred tax assets. The change in income tax expense was primarily due to changes in foreign income taxes on profits realized by our foreign subsidiaries.

Liquidity, Capital Resources and Plan of Operations

Since our inception, we have financed our operations through private placements of preferred stock, the issuance of common stock in our IPO in November 2014 and our underwritten public offering in June 2015, borrowings under our credit facility, which we have subsequently repaid, and the June 2016 issuance of convertible senior notes due in 2021. At December 31, 2019, we had cash, cash equivalents and short-term investments of $237.8 million.  Based on our current operating plan, we expect that our cash and cash equivalents on hand, together with the anticipated funds from the collection of our receivables, will be sufficient to fund our operations through at least the next 12 months.

We expect to incur continued expenditures in the future in support of our commercial infrastructure and sales force. In addition, we intend to continue to make investments in the further development of our Senza product platform and HF10 therapy for the treatment of other chronic pain conditions, including ongoing R&D programs and conducting clinical trials. Further, we expect to expend significant cash resources pursuing and defending our ongoing intellectual property lawsuits with Stimwave and Boston Scientific. In order to further enhance our R&D efforts, pursue product expansion opportunities or acquire a new business or products that are complementary to our business, we may choose to raise additional funds.

We may continue to seek funds through equity or debt financings, or through other sources of financing. Adequate additional funding may not be available to us on acceptable terms or at all. Our failure to raise capital in the future could have a negative impact on our financial condition and our ability to pursue our business strategies. Should we choose to raise additional capital, the requirements will depend on many factors, including:

 

•

the costs related to the continued commercialization of our products in the United States and elsewhere, including product sales, marketing, manufacturing and distribution;

 

•

the cost of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights, including, in particular, the costs of enforcing our patent rights in the action we filed against Boston Scientific and in defending against Boston Scientific’s action against us;

80

 

 

•

the R&D activities we intend to undertake in order to expand the chronic pain indications and product enhancements that we intend to pursue;

 

•

whether or not we pursue acquisitions or investments in businesses, products or technologies that are complementary to our current business;

 

•

the degree and rate of market acceptance of our products in the United States and elsewhere;

 

•

changes or fluctuations in our inventory supply needs and forecasts of our supply needs;

 

•

our need to implement additional infrastructure and internal systems;

 

•

our ability to hire additional personnel to support our operations as a public company; and

 

•

the emergence of competing technologies or other adverse market developments.

Our success depends, in part, upon our ability to establish a competitive position in the neuromodulation market by securing broad market acceptance of our HF10 therapy and our Senza product platform for the treatment of chronic pain conditions. Any product we develop that achieves regulatory clearance or approval will have to compete for market acceptance and market share. We face significant competition in the United States and internationally, which we believe will intensify as we continue to commercialize in the United States.  For example, our major competitors, Medtronic, Boston Scientific and Abbott Laboratories, each have approved neuromodulation systems in at least the United States, Europe and Australia and have been established for several years. In addition to these major competitors, we may also face competition from other emerging competitors and smaller companies with active neuromodulation system development programs that may emerge in the future.

If we are unable to raise, or have access, to sufficient funds when needed, we may be required to delay, reduce, or terminate some or all of our commercial development plans.

The following table sets forth the primary sources and uses of cash for each of the periods presented below:

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

Net cash provided by (used in)

 

 

 

 

 

 

 

 

 

 

 

 

Operating activities

 

$

(50,225

)

 

$

(5,708

)

 

$

(14,273

)

Investing activities

 

 

32,330

 

 

 

6,433

 

 

 

4,069

 

Financing activities

 

 

32,093

 

 

 

7,754

 

 

 

11,199

 

Effect of exchange rate on cash flows

 

 

259

 

 

 

(258

)

 

 

444

 

Net increase (decrease) in cash, cash equivalents and restricted cash

 

$

14,457

 

 

$

8,221

 

 

$

1,439

 

 

Cash Used in Operating Activities. Net cash used in operating activities was $50.2 million, $5.7 million and $14.3 million for the years ended December 31, 2019, 2018 and 2017, respectively, primarily due to the net losses during the periods of $103.7 million, $49.2 million and $36.7 million, respectively. The cash used in operating activities for the year ended December 31, 2019 was affected by an increase in accounts receivable of $2.2 million and an increase in prepaids and other assets of $3.2 million.  These changes were offset by a net increase in accounts payable and accrued liabilities of $5.7 million and write-down of inventories of $1.5 million, as well as non-cash stock based compensation expense of $41.7 million, non-cash interest expense of $7.9 million, depreciation and amortization of $4.6 million and amortization of operating lease assets of $3.2 million. The cash used in operating activities for the year ended December 31, 2018 was affected by an increase in accounts receivable of $12.2 million and an increase in other assets of $2.6 million. These changes were offset by a net increase in accounts payable and accrued liabilities of $4.9 million and a decrease in inventory of $3.8 million, as well as non-cash stock based compensation expense of $36.6 million, non-cash interest expense of $7.4 million, depreciation and amortization of $3.9 million and a write-down of inventory of $2.0 million. The cash used in operating activities for the year ended December 31, 2017 was affected by a net increase of $14.4 million in accounts payable and accrued liabilities, as well as non-cash stock based compensation expense of $26.1 million, non-cash interest expense of $6.9 million and a write-down of inventories of $4.0 million.  These changes were offset by increases in our inventory balances of $16.3 million and accounts receivable of $13.9 million.

81

 

Cash Used in Investing Activities. Investing activities consisted primarily of changes in investment balances, including purchases and maturities of short-term investments, and purchases of property and equipment. For the year ended December 31, 2019, we had net proceeds from the sales and maturity of investments of $43.3 million, offset by purchases in property and equipment of $3.5 million.  Additionally, we purchased secured convertible notes totaling $7.5 million in the year ended December 31, 2019.  For the year ended December 31, 2018, we had net proceeds from the sales and maturity of investments of $14.7 million, which was offset by purchases in property and equipment of $8.2 million. For the year ended December 31, 2017, we had net proceeds from the sales and maturity of investments of $8.4 million, which was offset by purchases in property and equipment of $4.3 million.

Cash Provided by Financing Activities. Cash provided by financing activities was $32.1 million for the year ended December 31, 2019, primarily due to the cash received from the issuance of common stock to employees of $35.2 million pursuant to the exercise of employee stock options and our employee stock purchase plan, offset by $3.1 million for tax withholdings paid on behalf of employees for net share settlement.  Cash provided by financing activities was $7.8 million for the year ended December 31, 2018, primarily due to the cash received from the issuance of common stock to employees of $9.5 million pursuant to the exercise of employee stock options and our employee stock purchase plan.  Cash provided by financing activities was $11.2 million for the year ended December 31, 2017, primarily due to the cash received from the issuance of common stock to employees of $12.2 million pursuant to the exercise of employee stock options and our employee stock purchase plan.   

Contractual Obligations and Commitments

We have lease obligations primarily consisting of operating leases for our principal offices, which expire as set forth below, and for our warehouse space that expires in 2022.

In March 2015, we entered into a lease agreement for approximately 50,740 square feet of office space located in Redwood City, California for a period beginning in June 2015 and ending in May 2022, with initial annual payments of approximately $2.0 million, increasing to $2.4 million annually in the final year of the lease term.  In December 2016, we entered into a first amendment to the lease for an additional approximately 49,980 square feet of office space adjacent to the premises under the original lease (the Expansion Premises) with initial annual payments of $1.2 million, increasing to $2.9 million in the final year of the amended lease term.  The lease for the Expansion Premises commenced on June 1, 2018.  The first amendment also extends the lease term for the original premises to terminate on the same date as the amended lease, which is May 31, 2025.  In April 2017, we entered into a second amendment to the lease for a temporary space of approximately 8,171 square feet for a period beginning in May 2017, and which ended on June 1, 2018, the Commencement Date of the Expansion Premises.  See Note 7, Commitments and Contingencies, of Notes to Consolidated Financial Statements for additional information.

In August 2014, we entered into a facility lease for warehouse space beginning on August 21, 2014 through May 31, 2015.  In March 2015, we extended our warehouse lease through February 2017, at which time the lease terminated.

In February 2017, we entered into a separate non-cancellable facility lease for warehouse space beginning March 1, 2017 through February 28, 2022, under which we are obligated to pay approximately $0.4 million in lease payments over the term of the lease.

We have entered into supply agreements with certain of our suppliers that required certain minimum annual purchase agreements.  As of December 31, 2019, we had minimum annual purchase commitments of $6.2 million due in 2020.

We have also entered into a service agreement for which we are committed to pay $2.5 million in each of the next five years over the term of the service agreement, as well as a license agreement for which we are committed to pay $0.3 million over the remaining term of license agreement.

As of December 31, 2019, our contractual obligations related to the 2021 Notes are payments of $3.0 million due each year in 2020, as well as payments in interest and principal totaling $174.0 million due in 2021.

82

 

The following table summarizes our contractual obligations as of December 31, 2019 (in thousands):

 

 

 

Payment date by period

 

 

 

Total

 

 

Less than 1 year

 

 

1 to 3 years

 

 

4 to 5 years

 

 

More than 5 years

 

 

 

(in thousands)

 

Notes payable, including contractual interest

 

$

177,028

 

 

$

3,019

 

 

$

174,009

 

 

$

—

 

 

$

—

 

Lease obligations

 

 

28,863

 

 

 

4,924

 

 

 

10,331

 

 

 

11,209

 

 

 

2,399

 

Purchase obligations

 

 

19,032

 

 

 

8,804

 

 

 

5,214

 

 

 

5,014

 

 

 

—

 

Total

 

$

224,923

 

 

$

16,747

 

 

$

189,554

 

 

$

16,223

 

 

$

2,399

 

 

 

Off-Balance Sheet Arrangements

Through December 31, 2019, we did not have any relationships with unconsolidated organizations or financial partnerships, such as structured finance or special purpose entities that would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. For information regarding indemnification obligations, refer to Note 7, Commitments and Contingencies, of Notes to the Consolidated Financial Statements within Part II, Item 8 of this Annual Report.

Segment Information

We have one primary business activity and operate as one reportable segment.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Interest Rate Risk

We are exposed to limited market risk related to fluctuations in interest rates and market prices. Our primary exposure to market risk is interest rate sensitivity, which is affected by changes in the general level of U.S. interest rates. The primary objective of our investment activities is to preserve our capital to fund our operations.

We also seek to maximize income from our investments without assuming significant risk. To achieve our objectives, we maintain a portfolio of cash equivalents and investments in a variety of securities of high credit quality. As of December 31, 2019, we had cash and cash equivalents of $65.4 million, consisting of cash and money market funds, and short-term investments of $172.4 million, consisting of agency bonds, commercial paper and corporate notes. We maintained investments in money market funds that were not federally insured during the year ended December 31, 2019 and held cash in foreign banks of approximately $12.1 million at December 31, 2019 that was not federally insured. A portion of our investments may be subject to interest rate risk and could fall in value if market interest rates increase. However, because our investments are primarily short-term in duration, we believe that our exposure to interest rate risk is not significant. We do not enter into investments for trading or speculative purposes and have not used any derivative financial instruments to manage our interest rate risk exposure. A hypothetical 1% change in interest rates during any of the periods presented would not have had a material impact on our consolidated financial statements.

Foreign Currency Exchange Risk

To date, a portion of our revenue and operating expenses are incurred outside the United States and are denominated in foreign currencies and are subject to fluctuations due to changes in foreign currency exchange rates, particularly changes in the Australian dollar, the Euro and the United Kingdom pound sterling. Additionally, fluctuations in foreign currency exchange rates may cause us to recognize transaction gains and losses in our statement of operations. As a component of other income (expense), we recognized net foreign currency transaction losses of $0.6 million and $0.9 million for the year ended December 31, 2019 and 2018, respectively, and gains of $1.3 million for the year ended December 31, 2017. A hypothetical 10% favorable or unfavorable change in the weighted average foreign exchange rates for the year ended December 31, 2019 would have affected the Company’s net loss by approximately 7%. To date, we have not engaged in any foreign currency hedging transactions. As our

83

 

international operations grow, we will continue to reassess our approach to managing the risks relating to fluctuations in currency rates.

We do not believe that inflation and change in prices had a significant impact on our results of operations for any periods presented in our consolidated financial statements.

See Note 2, Summary of Significant Accounting Policies, of Notes to Consolidated Financial Statements for further information on foreign currency translation.

Market Risk and Market Interest Risk

In June 2016, we issued $172.5 million aggregate principal amount of 1.75% convertible senior notes due 2021.  The fair value of our convertible senior notes is subject to interest rate risk, market risk and other factors due to the convertible feature.  The fair value of the convertible senior notes will generally increase as our common stock price increases and will generally decrease as our common stock price declines in value.  The interest and market value changes affect the fair value of our convertible senior notes but do not impact our financial position, cash flows or results of operations due to the fixed nature of the debt obligation.  Additionally, we carry the convertible senior notes at face value less unamortized discount on our balance sheet, and we present the fair value for required disclosure purposes only.

See Note 8, Long-term Debt, of Notes to Consolidated Financial Statements for further information.

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The following consolidated financial statements, and the related notes thereto, of Nevro Corp. and the Report of the Company’s Independent Registered Public Accounting Firm are filed as a part of this Annual Report.

84

 

Report of Independent Registered Public Accounting Firm

 

 

To the Board of Directors and Stockholders of Nevro Corp.

 

 

Opinions on the Financial Statements and Internal Control over Financial Reporting

 

 

We have audited the accompanying consolidated balance sheets of Nevro Corp. and its subsidiaries (the “Company”) as of December 31, 2019 and 2018, and the related consolidated statements of operations and comprehensive loss, of stockholders’ equity and of cash flows for each of the three years in the period ended December 31, 2019, including the related notes (collectively referred to as the “consolidated financial statements”). We also have audited the Company's internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).  

 

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2019 and 2018, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2019 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.

 

 

Change in Accounting Principle

 

 

As discussed in Note 4 to the consolidated financial statements, the Company changed the manner in which it accounts for leases in 2019.

 

 

Basis for Opinions

 

 

The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management's Annual Report on Internal Control Over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.  

 

Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and

85

 

testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.

 

 

Definition and Limitations of Internal Control over Financial Reporting

 

 

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

 

Critical Audit Matters

 

 

The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.

 

 

Inventory Valuation - Excess and Obsolete Inventory

 

 

As described in Notes 2 and 6 to the consolidated financial statements, inventories are stated at the lower of cost or net realizable value. Management regularly reviews inventory quantities compared to forecasted sales to record a provision for excess and obsolete inventory when appropriate. Inventory write downs are recorded for excess and obsolete inventory. Management estimates forecasted sales by considering product acceptance in the marketplace, customer demand, historical sales, product obsolescence, and technological innovations. As of December 31, 2019, total inventories were $91.6 million.

 

The principal considerations for our determination that performing procedures relating to inventory valuation - excess and obsolete inventory is a critical audit matter are there was significant judgment by management to estimate the excess and obsolete inventory provision, including an analysis of forecasted sales. This in turn led to significant auditor judgment, subjectivity, and effort in performing procedures to test management’s estimates about forecasted sales and in evaluating the audit evidence obtained.


Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to inventory valuation and the excess and obsolete inventory provision, including controls over

86

 

development of the forecasted sales. These procedures also included, among others, testing management’s process for estimating the excess and obsolete inventory provision, including evaluating the appropriateness of the analysis of forecasted sales and testing the completeness, accuracy and relevance of underlying data used in the analysis. Evaluating management’s analysis of forecasted sales involved evaluating whether the assumptions used by management were reasonable considering management’s forecasting accuracy and whether these assumptions were consistent with evidence obtained in other areas of the audit.

 

 

 

 

/s/ PricewaterhouseCoopers LLP

San Jose, California

February 25, 2020

 

We have served as the Company’s auditor since 2008.

87

 

Nevro Corp.

Consolidated Balance Sheets

(in thousands, except share and per share data)

 

 

 

December 31,

 

 

December 31,

 

 

 

2019

 

 

2018

 

Assets

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

65,373

 

 

$

51,266

 

Short-term investments

 

 

172,429

 

 

 

213,281

 

Accounts receivable, net of allowance for doubtful accounts of $797

   and $824 at December 31, 2019 and 2018, respectively

 

 

82,833

 

 

 

80,656

 

Inventories

 

 

91,579

 

 

 

92,035

 

Prepaid expenses and other current assets

 

 

9,838

 

 

 

6,621

 

Total current assets

 

 

422,052

 

 

 

443,859

 

Property and equipment, net

 

 

11,766

 

 

 

12,801

 

Operating lease assets

 

 

21,533

 

 

 

—

 

Other assets

 

 

13,338

 

 

 

5,850

 

Restricted cash

 

 

956

 

 

 

606

 

Total assets

 

$

469,645

 

 

$

463,116

 

Liabilities and stockholders’ equity

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Accounts payable

 

$

16,048

 

 

$

23,505

 

Accrued liabilities

 

 

50,966

 

 

 

38,790

 

Other current liabilities

 

 

3,597

 

 

 

119

 

Total current liabilities

 

 

70,611

 

 

 

62,414

 

Long-term debt

 

 

160,300

 

 

 

152,394

 

Long-term operating lease liabilities

 

 

20,445

 

 

 

—

 

Other long-term liabilities

 

 

1,937

 

 

 

2,825

 

Total liabilities

 

 

253,293

 

 

 

217,633

 

Commitments and contingencies (Note 6)

 

 

 

 

 

 

 

 

Stockholders’ equity

 

 

 

 

 

 

 

 

Preferred stock, $0.001 par value, 10,000,000 shares authorized at

   December 31, 2019 and 2018, respectively; zero shares issued and

   outstanding at December 31, 2019 and 2018, respectively

 

 

—

 

 

 

—

 

Common stock, $0.001 par value, 290,000,000 shares authorized at

   December 31, 2019 and 2018, respectively; 31,544,361 and 30,263,536

   shares issued and outstanding at December 31, 2019 and 2018,

   respectively

 

 

32

 

 

 

30

 

Additional paid-in capital

 

 

626,401

 

 

 

552,612

 

Accumulated other comprehensive loss

 

 

(313

)

 

 

(1,077

)

Accumulated deficit

 

 

(409,768

)

 

 

(306,082

)

Total stockholders’ equity

 

 

216,352

 

 

 

245,483

 

Total liabilities and stockholders’ equity

 

$

469,645

 

 

$

463,116

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

88

 

Nevro Corp.

Consolidated Statements of Operations and Comprehensive Loss

(in thousands, except share and per share data)

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Revenue

 

$

390,255

 

 

$

387,289

 

 

$

326,674

 

Cost of revenue

 

 

121,905

 

 

 

113,965

 

 

 

98,981

 

Gross profit

 

 

268,350

 

 

 

273,324

 

 

 

227,693

 

Operating expenses

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

59,017

 

 

 

48,459

 

 

 

37,560

 

Sales, general and administrative

 

 

305,812

 

 

 

266,608

 

 

 

219,712

 

Total operating expenses

 

 

364,829

 

 

 

315,067

 

 

 

257,272

 

Loss from operations

 

 

(96,479

)

 

 

(41,743

)

 

 

(29,579

)

Interest income

 

 

6,020

 

 

 

4,871

 

 

 

3,164

 

Interest expense

 

 

(10,931

)

 

 

(10,401

)

 

 

(9,902

)

Other income (expense), net

 

 

(697

)

 

 

(1,164

)

 

 

1,067

 

Loss before income taxes

 

 

(102,087

)

 

 

(48,437

)

 

 

(35,250

)

Provision for income taxes

 

 

1,599

 

 

 

768

 

 

 

1,408

 

Net loss

 

 

(103,686

)

 

 

(49,205

)

 

 

(36,658

)

Other comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

Changes in foreign currency translation adjustment

 

 

449

 

 

 

(37

)

 

 

(360

)

Changes in unrealized gains (losses) on short-term investments, net

 

 

315

 

 

 

202

 

 

 

(204

)

Net change in other comprehensive loss

 

 

764

 

 

 

165

 

 

 

(564

)

Comprehensive loss

 

$

(102,922

)

 

$

(49,040

)

 

$

(37,222

)

Net loss per share, basic and diluted

 

$

(3.37

)

 

$

(1.64

)

 

$

(1.25

)

Weighted average number of common shares used to

   compute basic and diluted net loss per share

 

 

30,803,872

 

 

 

30,051,961

 

 

 

29,424,054

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

 

89

 

Nevro Corp.

Consolidated Statements of Stockholders’ Equity

(in thousands, except share data)

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

 

 

 

 

Accumulated

 

 

Total

 

 

 

Common Stock

 

 

Paid-In

 

 

Accumulated

 

 

Other Comprehensive

 

 

Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Income (Loss)

 

 

Equity

 

Balances at December 31, 2016

 

 

28,886,862

 

 

$

29

 

 

$

470,869

 

 

$

(221,186

)

 

$

(678

)

 

$

249,034

 

Exercise of common stock options

 

 

707,410

 

 

 

1

 

 

 

7,492

 

 

 

—

 

 

 

—

 

 

 

7,493

 

Issuance of common stock upon release of restricted stock units

 

 

83,121

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Shares withheld for tax obligations

 

 

(13,094

)

 

 

—

 

 

 

(991

)

 

 

—

 

 

 

—

 

 

 

(991

)

Issuance of common stock under employee stock purchase plan

 

 

73,262

 

 

 

—

 

 

 

4,697

 

 

 

—

 

 

 

—

 

 

 

4,697

 

Vesting of early exercised stock options

 

 

—

 

 

 

—

 

 

 

7

 

 

 

—

 

 

 

—

 

 

 

7

 

Stock based compensation

 

 

—

 

 

 

—

 

 

 

26,154

 

 

 

—

 

 

 

—

 

 

 

26,154

 

Net loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(36,658

)

 

 

—

 

 

 

(36,658

)

Other comprehensive loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(564

)

 

 

(564

)

Balances at December 31, 2017

 

 

29,737,561

 

 

 

30

 

 

 

508,228

 

 

 

(257,844

)

 

 

(1,242

)

 

 

249,172

 

Adoption of accounting standard (Note 3)

 

 

—

 

 

 

—

 

 

 

—

 

 

 

967

 

 

 

—

 

 

 

967

 

Exercise of common stock options

 

 

247,768

 

 

 

—

 

 

 

3,976

 

 

 

—

 

 

 

—

 

 

 

3,976

 

Issuance of common stock upon release of restricted stock units

 

 

196,274

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Shares withheld for tax obligations

 

 

(28,107

)

 

 

—

 

 

 

(1,742

)

 

 

—

 

 

 

—

 

 

 

(1,742

)

Issuance of common stock under employee stock purchase plan

 

 

110,040

 

 

 

—

 

 

 

5,520

 

 

 

—

 

 

 

—

 

 

 

5,520

 

Stock based compensation

 

 

—

 

 

 

—

 

 

 

36,630

 

 

 

—

 

 

 

—

 

 

 

36,630

 

Net loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(49,205

)

 

 

—

 

 

 

(49,205

)

Other comprehensive loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

165

 

 

 

165

 

Balances at December 31, 2018

 

 

30,263,536

 

 

 

30

 

 

 

552,612

 

 

 

(306,082

)

 

 

(1,077

)

 

 

245,483

 

Exercise of common stock options

 

 

828,722

 

 

 

1

 

 

 

28,606

 

 

 

—

 

 

 

—

 

 

 

28,607

 

Issuance of common stock upon release of restricted stock units

 

 

325,839

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

Shares withheld for tax obligations

 

 

(38,696

)

 

 

—

 

 

 

(3,057

)

 

 

—

 

 

 

—

 

 

 

(3,057

)

Issuance of common stock under employee stock purchase plan

 

 

164,960

 

 

 

1

 

 

 

6,544

 

 

 

—

 

 

 

—

 

 

 

6,545

 

Stock based compensation

 

 

—

 

 

 

—

 

 

 

41,696

 

 

 

—

 

 

 

—

 

 

 

41,696

 

Net loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

(103,686

)

 

 

—

 

 

 

(103,686

)

Other comprehensive loss

 

 

—

 

 

 

—

 

 

 

—

 

 

 

—

 

 

 

764

 

 

 

764

 

Balances at December 31, 2019

 

 

31,544,361

 

 

$

32

 

 

$

626,401

 

 

$

(409,768

)

 

$

(313

)

 

$

216,352

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

 

90

 

Nevro Corp.

Consolidated Statements of Cash Flows

(in thousands)

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Cash flows from operating activities

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(103,686

)

 

$

(49,205

)

 

$

(36,658

)

Adjustments to reconcile net loss to net cash used in operating activities

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

4,563

 

 

 

3,887

 

 

 

2,507

 

Amortization of operating lease assets

 

 

3,237

 

 

 

—

 

 

 

—

 

Stock-based compensation expense

 

 

41,697

 

 

 

36,637

 

 

 

26,143

 

Accretion of discount on short-term investments

 

 

(2,037

)

 

 

(1,257

)

 

 

(116

)

Provision for (recovery of) doubtful accounts

 

 

(27

)

 

 

(501

)

 

 

293

 

Write-down of inventory

 

 

1,456

 

 

 

2,005

 

 

 

3,984

 

Non-cash interest expense

 

 

7,912

 

 

 

7,382

 

 

 

6,884

 

Unrealized gains (losses) on foreign currency transactions

 

 

(450

)

 

 

1,188

 

 

 

(799

)

Changes in operating assets and liabilities

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable

 

 

(2,153

)

 

 

(12,214

)

 

 

(13,899

)

Inventories

 

 

(938

)

 

 

3,846

 

 

 

(16,297

)

Prepaid expenses and other current assets

 

 

(3,222

)

 

 

(767

)

 

 

(501

)

Other assets

 

 

514

 

 

 

(2,601

)

 

 

(892

)

Accounts payable

 

 

(7,472

)

 

 

5,170

 

 

 

2,162

 

Accrued liabilities

 

 

13,205

 

 

 

(242

)

 

 

12,269

 

Other long-term liabilities

 

 

(2,824

)

 

 

964

 

 

 

647

 

Net cash used in operating activities

 

 

(50,225

)

 

 

(5,708

)

 

 

(14,273

)

Cash flows from investing activities

 

 

 

 

 

 

 

 

 

 

 

 

Purchases of short-term investments

 

 

(211,006

)

 

 

(213,723

)

 

 

(287,938

)

Proceeds from sales of short-term investments

 

 

—

 

 

 

—

 

 

 

5,993

 

Proceeds from maturity of short-term investments

 

 

254,308

 

 

 

228,373

 

 

 

290,341

 

Investment in private company

 

 

(7,500

)

 

 

—

 

 

 

—

 

Purchases of property and equipment

 

 

(3,472

)

 

 

(8,217

)

 

 

(4,327

)

Net cash provided by investing activities

 

 

32,330

 

 

 

6,433

 

 

 

4,069

 

Cash flows from financing activities

 

 

 

 

 

 

 

 

 

 

 

 

Minimum tax withholding paid on behalf of employees for net share settlement

 

 

(3,057

)

 

 

(1,742

)

 

 

(991

)

Proceeds from issuance of common stock to employees

 

 

35,150

 

 

 

9,496

 

 

 

12,190

 

Net cash provided by financing activities

 

 

32,093

 

 

 

7,754

 

 

 

11,199

 

Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

 

259

 

 

 

(258

)

 

 

444

 

Net increase in cash, cash equivalents and restricted cash

 

 

14,457

 

 

 

8,221

 

 

 

1,439

 

Cash, cash equivalents and restricted cash

 

 

 

 

 

 

 

 

 

 

 

 

Cash, cash equivalents and restricted cash at beginning of year

 

 

51,872

 

 

 

43,651

 

 

 

42,212

 

Cash, cash equivalents and restricted cash at end of year

 

$

66,329

 

 

$

51,872

 

 

$

43,651

 

Supplemental disclosures of cash flow information

 

 

 

 

 

 

 

 

 

 

 

 

Cash paid for income taxes

 

$

1,338

 

 

$

1,847

 

 

$

687

 

Cash paid for interest

 

$

3,019

 

 

$

3,019

 

 

$

3,019

 

Significant non-cash transactions

 

 

 

 

 

 

 

 

 

 

 

 

Purchases of property and equipment in accounts payable

 

$

285

 

 

$

245

 

 

$

592

 

Vesting of early-exercised stock options

 

$

—

 

 

$

—

 

 

$

7

 

 

The accompanying notes are an integral part of these consolidated financial statements.

91

 

Nevro Corp.

Notes to Consolidated Financial Statements

1. Formation and Business of the Company

The Company was incorporated in Minnesota on March 10, 2006 to manufacture and market innovative active implantable medical devices for the treatment of neurological disorders initially focusing on the treatment of chronic pain. Subsequently, the Company was reincorporated in Delaware on October 4, 2006 and relocated to California.

Since inception, the Company has incurred net losses and negative cash flows from operations. During the year ended December 31, 2019, the Company incurred a net loss of $103.7 million and used $50.2 million of cash in operations. At December 31, 2019, the Company had an accumulated deficit of $409.8 million and does not expect to experience positive cash flows from operations in the immediate future. The Company has financed operations to date primarily through private placements of equity securities, borrowings under a debt agreement, the issuance of common stock in its November 2014 initial public offering and its June 2015 underwritten public offering, as well as its June 2016 underwritten public offering of convertible senior notes due in 2021. The Company’s ability to continue to meet its obligations and to achieve its business objectives for the foreseeable future is dependent upon, amongst other things, generating sufficient revenues and its ability to continue to control expenses to meet its obligations as they become due. Failure to increase sales of its products, manage discretionary expenditures or raise additional financing, if required, may adversely impact the Company’s ability to achieve its intended business objectives.

Public Offerings

In November 2014, the Company completed its initial public offering (IPO) of shares of its common stock and as a result, the following transactions were recorded in the Company’s consolidated financial statements during the fourth quarter of 2014:

 

•

the sale of 8,050,000 shares of common stock, including 1,050,000 from the exercise by the underwriters of their overallotment option, at an offering price of $18.00 per share, for net proceeds of $131.6 million, after deducting the underwriters’ discounts, commissions and offering costs paid by us; and

 

•

immediately prior to the completion of the IPO, all the outstanding shares of the Company’s redeemable convertible preferred stock and convertible preferred stock were converted into 15,208,048 shares of common stock.

In June 2015, the Company completed an underwritten public offering of its common stock, which included shares of its common stock held by certain of its stockholders, and issued 2,470,587 shares of common stock, including 705,882 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares.  The Company received cash proceeds of approximately $118.4 million, net of underwriting discounts and commissions and offering costs paid by the Company.

In June 2016, the Company issued $150.0 million aggregate principal amount of 1.75% convertible senior notes due 2021 in a registered underwritten public offering and an additional $22.5 million aggregate principal amount of such notes pursuant to the exercise in full of the over-allotment options of the underwriters (the 2021 Notes). The interest rates are fixed at 1.75% per annum and are payable semi-annually in arrears on June 1 and December 1 of each year, commencing on December 1, 2016.  The total net proceeds from the debt offering, after deducting transaction costs, were approximately $166.2 million.

2. Summary of Significant Accounting Policies

Basis of Presentation

These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (U.S. GAAP). The consolidated financial statements include the Company’s accounts and those of its four wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated.

92

 

Segments

The chief operating decision maker for the Company is the Chief Executive Officer. The Chief Executive Officer reviews financial information presented on a consolidated basis, accompanied only by information about revenue by geographic region, for purposes of allocating resources and evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level, other than revenue. Accordingly, the Company has determined that it has a single reportable and operating segment structure. The Company and its Chief Executive Officer evaluate performance based primarily on revenue in the geographic locations in which the Company operates. 

Until 2015, the Company had derived most of its revenue from sales to customers in Australia and Europe.  In May 2015, the U.S. Food and Drug Administration (FDA) approved the Company’s premarket approval (PMA) application to market Senza in the United States and the Company launched sales in the United States in 2015. Revenue by geography is based on the billing address of the customer. The United States is the only country that accounts for 10% or more of the revenue during the periods presented:

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

United States

 

 

84

%

 

 

83

%

 

 

81

%

 

Long-lived assets and operating income outside the United States are not material; therefore, disclosures have been limited to revenue.

Foreign Currency Translation

The Company’s consolidated financial statements are prepared in U.S. dollars (USD). Its foreign subsidiaries use their local currency as their functional currency and maintain their records in the local currency. Accordingly, the assets and liabilities of these subsidiaries are translated into USD using the current exchange rates in effect at the balance sheet date and equity accounts are translated into USD using historical rates. Revenues and expenses are translated using the monthly average exchange rates during the period when the transaction occurs. The resulting foreign currency translation adjustments from this process are recorded in accumulated other comprehensive income (loss) in the consolidated balance sheets. Unrealized foreign exchange gains and losses from the remeasurement of assets and liabilities denominated in currencies other than the functional currency of the reporting entity are recorded in other income (expense), net. The Company recorded net unrealized foreign currency transaction gains of $1.0 million during the year ended December 31, 2019, losses of $0.6 million during the year ended December 31, 2018 and gains of $0.8 million during the year ended December 31, 2017. Additionally, realized gains and losses resulting from transactions denominated in currencies other than the local currency are recorded in other income (expense), net. The Company recorded realized foreign currency transaction losses of $1.6 million during the year ended December 31, 2019, losses of $0.4 million during the year ended December 31, 2018 and gains of $0.5 million during the year ended December 31, 2017.

To the extent that the Company’s international operations grow, the effect of fluctuations in currency rates will become greater, and the Company will continue to reassess its approach to managing this risk. In addition, currency fluctuations or a weakening U.S. dollar can increase the costs of the Company’s international expansion. To date, the Company has not entered into any foreign currency hedging contracts. Based on its current international structure, the Company does not plan on engaging in hedging activities in the near future.

Use of Estimates

The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant accounting estimates and management judgments reflected in the consolidated financial statements include items such as allowances for doubtful accounts; warranty obligations; stock-based compensation; depreciation and amortization lives; inventory valuation; valuation

93

 

of investments and accounting for income taxes. Estimates are based on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.

Concentration of Credit Risk and Other Risks and Uncertainties

Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents and investments. The majority of the Company’s cash is held by one financial institution in the United States in excess of federally insured limits. The Company maintained investments in money market funds that were not federally insured during the years ended December 31, 2019 and 2018, and held cash in foreign banks of approximately $12.1 million and $4.1 million at December 31, 2019 and 2018, respectively, that was not federally insured. The Company has not experienced any losses on its deposits of cash and cash equivalents.

The Company’s convertible note hedge transactions, entered into in connection with the 2021 Notes, subject the Company to credit risk such that the counterparties may be unable to fulfill the terms of the transactions.  The associated risk is mitigated by limiting the counterparties to major financial institutions.

In the international markets in which the Company participates, the Company uses both a direct sales force and distributors to sell its products, while in the United States the Company utilizes a direct sales force. The Company performs ongoing credit evaluations of some of its direct customers and distributors, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.

There were no customers that accounted for 10% or more of the Company’s revenue for each of the years ended December 31, 2019, 2018 and 2017.  Additionally, there were no customers that accounted for 10% or more of the Company’s accounts receivable balance as of December 31, 2019 and 2018.

The Company is subject to risks common to medical device companies including, but not limited to, new technological innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, product liability, uncertainty of market acceptance of products and the need to obtain additional financing. The Company is dependent on third party manufacturers and suppliers, in some cases sole- or single-source suppliers.

There can be no assurance that the Company’s products or services will continue to be accepted in the marketplace, nor can there be any assurance that any future products or services can be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that such products or services will be successfully marketed, if at all.

The Company expects to incur operating losses in the near term and may need to obtain additional financing. There can be no assurance that such financing will be available or will be at terms acceptable by the Company.

Fair Value of Financial Instruments

Carrying amounts of certain of the Company’s financial instruments, including cash equivalents, short term investments, accounts receivable, accounts payable and accrued liabilities approximate fair value due to their relatively short maturities.

Cash and Cash Equivalents

The Company considers all highly liquid investments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents. Cash and cash equivalents include money market funds in the amount of $52.4 million and $15.6 million as of December 31, 2019 and 2018, respectively. At December 31, 2019 and 2018, the Company’s cash equivalents were held in institutions in the United States and include deposits in a money market fund which were unrestricted as to withdrawal or use.

94

 

Restricted Cash

Restricted cash as of December 31, 2019 and 2018 includes certificates of deposit of $0.6 million representing collateral for the Company’s Redwood City, CA building lease pursuant to an agreement dated March 5, 2015.  Restricted cash as of December 31, 2019 additionally includes certificates of deposit of $0.4 million collateralizing payment of charges related to the Company’s credit cards.

Investment Securities

The Company classifies its investment securities as available-for-sale. The Company classifies these investment securities as short-term or long-term based on the nature of the investment, its maturity date and its availability for use in current operations. Those investments with original maturities greater than three months at the date of purchase and remaining maturities of less than 12 months are considered short-term investments. Those investments with remaining maturities greater than 12 months are also classified as short-term investments as management considers them to be available for current operations if needed. The Company’s investment securities are recorded at fair value based on the fair value hierarchy.  Money market funds are classified within Level 1 of the fair value hierarchy, and commercial paper and corporate notes are classified within Level 2 of the fair value hierarchy. Unrealized gains and losses, deemed temporary in nature, are reported as a separate component of accumulated other comprehensive income (loss).

A decline in the fair value of any security below cost that is deemed other than temporary results in a charge to earnings and the corresponding establishment of a new cost basis for the security. Premiums (discounts) are amortized (accreted) over the life of the related security as an adjustment to yield using the straight-line interest method. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of securities sold.

Inventories

Inventories are stated at the lower of cost or net realizable value. Cost is determined using the standard cost method which approximates the first-in, first-out basis. Net realizable value is determined as the prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company regularly reviews inventory quantities compared to forecasted sales to record a provision for excess and obsolete inventory when appropriate. Inventory write-downs are recorded for excess and obsolete inventory. The Company estimates forecasted sales by considering product acceptance in the marketplace, customer demand, historical sales, product obsolescence and technological innovations.

The Company’s policy is to write down inventory that has become obsolete, inventory that has a cost basis in excess of its expected lower of cost or net realizable value, and inventory in excess of expected requirements. The estimate of excess quantities is judgmental and primarily dependent on the Company’s estimates of future demand for a particular product. If the estimate of future demand is inaccurate based on actual sales, the Company may increase the write-down for excess inventory for that component and record a charge to inventory impairment in the accompanying consolidated statements of operations and comprehensive loss. The Company periodically evaluates the carrying value of inventory on hand for potential excess amount over demand using the same lower of cost or net realizable value approach as that has been used to value the inventory. The Company also periodically evaluates inventory quantities in consideration of actual loss experience. As a result of these evaluations, for the year ended December 31, 2019, the Company recognized total write-downs of $1.6 million for its inventories.  For the years ended December 31, 2018 and 2017, the Company recognized total write-downs of $2.0 million and $4.0 million for its inventories. The Company’s estimation of the future demand for a particular component of the Company’s products may vary and may result in changes in estimates in any particular period.

Shipping and Handling Costs

Shipping and handling costs are expensed as incurred and are included in cost of revenue.

95

 

Revenue Recognition

The Company has revenue arrangements that generally consist of a single performance obligation, although, in some instances, revenue arrangements may consist of two performance obligations. The Company recognizes revenue at the point in time when it transfers control of promised goods to its customers.  Revenue is measured as the amount of consideration it expects to receive in exchange for transferring goods.

See Note 3 for further discussion on Revenue Recognition.

Allowance for Doubtful Accounts

The Company makes estimates of the collectability of accounts receivable. In doing so, the Company analyzes historical bad debt trends, customer credit worthiness, current economic trends and changes in customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts.

Property and Equipment

Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation of property and equipment, other than leasehold improvements, is computed using the straight-line method over the assets’ estimated useful lives of three to five years. Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the life of the lease. Upon retirement or sale, the cost and related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is reflected in operations. Maintenance and repairs are charged to operations as incurred.

Impairment of Long-Lived Assets

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group might not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net cash flows to the related asset group’s carrying value. If an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. There were no impairment charges, or changes in estimated useful lives, recorded through December 31, 2019.

Income Taxes

The Company records income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s consolidated financial statements or income tax returns. In estimating future tax consequences, expected future events other than enactments or changes in the tax law or rates are considered. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized.

The Company operates in various tax jurisdictions and is subject to audit by various tax authorities. To date, taxes paid have been predominantly due to income taxes in foreign and state jurisdictions in which we conduct business. The Company provides for tax contingencies whenever it is deemed probable that a tax asset has been impaired or a tax liability has been incurred for events such as tax claims or changes in tax laws. Tax contingencies are based upon their technical merits, relative tax law, and the specific facts and circumstances as of each reporting period. Changes in facts and circumstances could result in material changes to the amounts recorded for such tax contingencies.

The Company records uncertain tax positions on the basis of a two-step process whereby (1) a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. The Company’s policy is to recognize interest and penalties related to income taxes as a component of income tax expense. A nominal amount of interest and penalties have been recognized in the

96

 

statements of operations and comprehensive loss in 2019. No interest or penalties related to income taxes have been recognized in the statements of operations and comprehensive loss in 2018 and 2017.

On December 22, 2017, the 2017 Tax Cuts and Jobs Act (the 2017 Tax Act) was enacted into law.  The recorded impact for the effects of the 2017 Tax Act is based on the Company’s current knowledge, assumptions and interpretations of available guidance.  The Company elected to account for Global Intangible Low-Tax Income (GILTI) as a current period expense when incurred.  The Company will continue to monitor the issuance of additional regulatory or accounting guidance and record any necessary adjustments in the period for which additional guidance is issued.

Other Comprehensive Income (Loss)

Other comprehensive income (loss) represents all changes in stockholders’ equity except those resulting from distributions to stockholders. The Company’s unrealized gains on short-term available-for-sale investment securities and foreign currency translation adjustments represent the components of other comprehensive income (loss) that are excluded from the reported net loss and are presented in the consolidated statements of operations and comprehensive loss.

Research and Development

Research and development expenses, including new product development, regulatory compliance, and clinical research, are charged to operations as incurred in the consolidated statements of operations and comprehensive loss. Such costs include personnel-related costs, including stock-based compensation, supplies, services, depreciation, allocated facilities and information services, clinical trial and related clinical manufacturing expenses, fees paid to investigative sites, and other indirect costs.

Stock-Based Compensation

The Company accounts for stock-based compensation arrangements with employees in accordance with Accounting Standards Codification (ASC) 718, Compensation—Stock Compensation. ASC 718 requires the recognition of compensation expense, using a fair value-based method, for costs related to all share-based payments including stock options.

In March 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-09, Stock Compensation (Topic 718): Improvements to Employee Shared-Based Payment Accounting, which the Company adopted on January 1, 2017.  Under ASU 2016-09, entities are permitted to make an accounting policy election to either estimate forfeitures on share-based payment awards, as previously required, or to recognize forfeitures as they occur. The Company has elected to continue to estimate forfeitures expected to occur to determine the amount of compensation cost recognized in each period.  ASU 2016-09 also requires that entities recognize, on a prospective basis, all excess tax benefits and tax deficiencies as income tax expense or benefit in the income statement as discrete items in the reporting period in which they occur. The adoption did not result in a cumulative-effect adjustment to accumulated deficit as of January 1, 2017 using the modified retrospective method. Additionally, under ASU 2016-09, excess tax benefits are classified as an operating activity in the statement of cash flows. The Company has elected the presentation of excess tax benefits in the statement of cash flows using the prospective transition method.

The Company’s determination of the fair value of stock options, other than performance-based awards, on the date of grant utilizes the Black-Scholes option-pricing model, and is impacted by its common stock price as well as changes in assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the expected term that options will remain outstanding, the expected common stock price volatility over the term of the option awards, risk-free interest rates and expected dividends.

The fair value of stock options is recognized over the period during which an optionee is required to provide services in exchange for the option award, known as the requisite service period (usually the vesting period), on a straight-line basis. Stock-based compensation expense recognized at fair value includes the impact of estimated

97

 

forfeitures. The Company estimates future forfeitures at the date of grant and revises the estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

The Company estimates the fair value of the rights to purchase shares by employees under the Employee Stock Purchase Plan using the Black-Scholes option pricing formula. The Employee Stock Purchase Plan provides for consecutive six-month offering periods and the Company uses its own historical volatility data in the valuation.

Equity instruments issued to non-employees are recorded at their fair value on the measurement date and are subject to periodic adjustments as the underlying equity instruments vest. The fair value of options granted to consultants is expensed when vested. The non-employee stock-based compensation expense was not material for all periods presented.

The Company accounts for stock-based compensation for the restricted stock units at their fair value, based on the closing market price of the Company’s common stock on the grant date.  These costs are recognized on a straight-line basis over the requisite service period, which is generally the vesting term of four years.

The Company also issues stock options and restricted stock units with vesting based upon achievement of specific operational performance criteria. The fair value for these performance-based awards is recognized over the period during which the goals are to be achieved.  Stock-based compensation expense recognized at fair value includes the impact of estimated probability that the goals would be achieved, which is assessed prior to the requisite service period for the specific goals.

The Company additionally grants restricted stock units with vesting based on its stock price performance compared to a specified target composite index over a certain period.  The fair value of these grants is determined by using the Monte Carlo simulation model, which is based on a discounted cash flow approach, and requires inputs such as expected volatility of our stock price, expected volatility of the targeted composite index, correlation between the changes in our stock price and the target composite index, risk-free interest rate and expected dividends.  The expected volatility of our stock and the target composite index is based on the historical data. Correlation is based on the historical relationship between our stock price and the target composite index. The risk-free interest rate is based upon the treasury yield consistent with the vesting term of the grant. The expected dividend yield is zero. Stock-based compensation for these restricted stock units is recognized over the specified performance measurement period.

Upon adoption of ASU 2016-09 as described above, excess tax benefits or deficiencies from share-based award activity are reflected in the consolidated statements of operations as a component of the provision for income taxes, whereas they were previously recognized as additional paid-in capital.

Net Loss per Share of Common Stock

Basic net loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, restricted stock units and common stock options are considered to be potentially dilutive securities. Because the Company has reported a net loss in all periods presented, diluted net loss per common share is the same as basic net loss per common share for those periods.

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires the measurement and recognition of expected credit losses for financial assets held. The FASB has also issued several updates to ASU 2016-13.  These ASU’s are effective for public entities for annual periods beginning after December 15, 2019, with early adoption permitted. The Company has not determined the potential effects of the guidance on its consolidated financial statements.

98

 

In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This ASU eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences related to changes in ownership of equity method investments and foreign subsidiaries. ASU 2019-12 also simplifies aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU 2019-12 is effective for public entities for annual periods beginning after December 15, 2020, with early adoption permitted. The Company has not determined the potential effects of the guidance on its consolidated financial statements.

3. Revenue

Adoption of ASC 606

On January 1, 2018, the Company adopted the new accounting standard ASC 606, Revenue from Contracts with Customers, using the modified retrospective method applied to contracts which were not completed as of that date.  Results for reporting periods beginning after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 605, Revenue Recognition. Under ASC 606, assuming all other revenue recognition criteria have been met, the Company will recognize revenue earlier for arrangements where the Company has satisfied its performance obligations but has not issued invoices.  These amounts are recorded as unbilled receivables, which are included in accounts receivable on the consolidated balance sheet, as the Company has an unconditional right to payment at the end of the applicable period.  

The Company recognized the cumulative effect of initially applying ASC 606 as an adjustment to the opening balance of accumulated deficit.  The cumulative effect of the changes made to the consolidated balance sheet as of January 1, 2018 for the adoption of ASC 606 were as follows (in thousands):

 

 

 

Balance at

 

 

Adjustments Due

 

 

Balance at

 

 

 

December 31, 2017

 

 

to ASC 606

 

 

January 1, 2018

 

Balance Sheet:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable, net

 

$

67,287

 

 

$

1,447

 

 

$

68,734

 

Prepaid expenses and other current assets

 

 

6,463

 

 

 

(476

)

 

 

5,987

 

Accumulated other comprehensive loss

 

 

(1,242

)

 

 

4

 

 

 

(1,238

)

Accumulated deficit

 

 

(257,844

)

 

 

967

 

 

 

(256,877

)

 

In accordance with ASC 606, the disclosure of the impact of adoption on the Consolidated Balance Sheet was as follows (in thousands):

 

 

December 31, 2018

 

 

 

Balance

 

 

Balance Without

 

 

 

 

 

 

 

As Reported

 

 

ASC 606 Adoption

 

 

Effect of Change

 

Balance Sheet:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable, net

 

$

80,656

 

 

$

78,142

 

 

$

2,514

 

Inventories

 

 

92,035

 

 

 

92,126

 

 

 

(91

)

Prepaid expenses and other current assets

 

 

6,621

 

 

 

7,514

 

 

 

(893

)

In accordance with ASC 606, the disclosure of the impact of adoption on the Consolidated Statements of Operations was as follows (in thousands):

 

 

Year Ended December 31, 2018

 

 

 

 

 

 

 

Balance Without

 

 

 

 

 

 

 

Balance As Reported

 

 

ASC 606 Adoption

 

 

Effect of Change

 

Statement of Operations:

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

387,289

 

 

$

386,212

 

 

$

1,077

 

Cost of revenue

 

 

113,965

 

 

 

113,441

 

 

 

524

 

 

99

 

Revenue Recognition

Revenue is recognized when obligations under the terms of a contract with customers are satisfied, which occurs with the transfer of control of the Company’s goods to its customers.  Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods.

For a majority of sales, where the Company’s sales representative delivers its product at the point of implantation at hospitals or medical facilities, the Company recognizes revenue upon completion of the procedure and authorization, which represents the point in time when control transfers to the customers.

For the remaining sales, which are sent from the Company’s distribution centers directly to hospitals and medical facilities, as well as distributor sales, where product is ordered in advance of an implantation, the transfer of control occurs at the time of shipment of the product.  These customers are obligated to pay within specified terms regardless of when or if they ever sell or use the products. The Company does not offer rights of return or price protection. To the extent the Company has a post-delivery obligation, such as programming devices that have been delivered as part of a direct-ship order, the Company defers revenue and the associated cost of goods sold associated with the post-delivery obligation only if the amounts are deemed material.

Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The expected costs associated with warranty obligations continue to be recognized as expense when the products are sold (see Note 7). The Company periodically provides incentive offers, in the form of rebates, to customers based on their aggregate levels of purchases.  Product revenue is recorded net of such incentive offers.

The following table presents revenue by geography, based on the billing address of the customer (in thousands):

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

United States

 

$

326,012

 

 

$

321,781

 

 

$

263,462

 

International

 

 

64,243

 

 

 

65,508

 

 

 

63,212

 

Total revenue

 

$

390,255

 

 

$

387,289

 

 

$

326,674

 

 

Practical Expedients and Exemptions

The Company recognizes revenue upon the transfer of control of the product and there are no material future performance obligations beyond such transfer.  As a result, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company does not capitalize incremental costs when the amortization period of the asset is less than a year.

4. Lease Accounting

Adoption of ASC 842

On January 1, 2019, the Company adopted the new accounting standard ASC 842, Leases, which requires entities to recognize assets and liabilities for leases with lease terms of more than 12 months on the balance sheet.  

The Company adopted the new lease standard using the transition method that allowed entities to initially apply ASC 842 at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption (the optional transition method). The Company elected the package of transitional practical expedients, such that, for leases existing prior to the adoption of ASC 842, the Company will not need to

100

 

reassess whether contracts are leases, will retain historical lease classification and historical initial direct costs classification. The Company also elected the hindsight practical expedient to determine the lease term for existing leases.  Operating lease assets and operating lease liabilities are recognized based on the present value of minimum lease payments over the remaining lease term.  The Company uses its incremental borrowing rate based on information available when determining the lease liabilities.  Lease cost is recognized on a straight-line basis over the expected lease term.

Adoption of the new lease standard resulted in the recording of operating lease assets of $24.8 million and operating lease liabilities of $26.2 million.  The impact of the changes made to the consolidated balance sheet as of January 1, 2019 from the adoption of ASC 842 were as follows (in thousands):

 

 

 

Balance at

 

 

Adjustments Due

 

 

Balance at

 

 

 

December 31, 2018

 

 

to ASC 842

 

 

January 1, 2019

 

Balance Sheet:

 

 

 

 

 

 

 

 

 

 

 

 

Operating lease assets

 

$

—

 

 

$

24,771

 

 

$

24,771

 

Other current liabilities

 

 

119

 

 

 

2,389

 

 

 

2,508

 

Long-term operating lease liabilities

 

 

—

 

 

 

23,805

 

 

 

23,805

 

Other long-term liabilities

 

 

2,825

 

 

 

(1,423

)

 

 

1,402

 

The Company has operating leases for office space, warehouse, research and development facilities and equipment. Leases with terms of 12 months or less are not recorded on the balance sheet, as the related lease expenses are recognized on a straight-line basis over the lease term.  The Company accounts for lease components (such as fixed payments) separately from nonlease components (such as common area expenses).  As of December 31, 2019, the Company has leases with remaining terms of less than 3 year to 6 years, some of which may include options to extend the lease term for up to 5 years.

The weighted average lease terms and discounts rates are as follows:

 

 

 

December 31, 2019

 

Operating Lease Term and Discount Rate

 

 

 

 

Weighted-average remaining lease term

 

5.31 years

 

Weighted-average discount rate

 

7.0%

 

As of December 31, 2019, the maturity of lease liabilities are as follows (in thousands):

 

 

 

Operating Leases

 

2020

 

$

4,924

 

2021

 

 

5,073

 

2022

 

 

5,258

 

2023

 

 

5,522

 

2024

 

 

5,687

 

Thereafter

 

 

2,399

 

Total lease payments

 

 

28,863

 

Less: Interest

 

 

(4,920

)

Present value of lease liabilities

 

$

23,943

 

Supplemental lease cost information are as follows (in thousands):

 

 

 

Year Ended

 

 

 

December 31, 2019

 

Operating lease cost

 

$

4,936

 

Supplemental balance sheet information are as follows (in thousands):

 

101

 

 

 

December 31, 2019

 

Operating Leases:

 

 

 

 

Operating lease assets

 

$

21,533

 

 

 

 

 

 

Other current liabilities

 

$

3,498

 

Long term operating lease liabilities

 

 

20,445

 

Total operating lease liabilities

 

$

23,943

 

Supplemental cash flow information are as follows (in thousands):

 

 

 

Year Ended

 

 

 

December 31, 2019

 

Cash paid for amounts included in the measurement of lease liabilities:

 

 

 

 

Operating cash flow from operating leases

 

$

3,970

 

See Note 7 for further details of the Company’s lease commitments.

5. Fair Value Measurements

Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.

The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:

 

•

Level 1 — Observable inputs, such as quoted prices in active markets for identical assets or liabilities.

 

•

Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

•

Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

102

 

Cash Equivalents and Short Term Investments

The Company’s cash equivalents includes investments in money market funds that are classified as Level 1 of the fair value hierarchy. To value its money market funds, the Company values the funds at $1 stable net asset value, which is the quoted price in active markets for identical assets that the Company has the ability to access. The Company’s cash equivalents and short-term investments also includes commercial paper and corporate notes, which have been classified within Level 2 of the fair value hierarchy because of the sufficient observable inputs for revaluation. The Company’s Level 2 investments are valued using third-party pricing sources. The pricing services utilize industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades of any broker/dealer quotes on the same or similar investments, issuer credit spreads, benchmark investments, prepayment/default projections based on historical data and other observable inputs. The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis, by level, within the fair value hierarchy (in thousands):

 

Balance as of December 31, 2019

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds (i)

 

$

52,359

 

 

$

—

 

 

$

—

 

 

$

52,359

 

Agency bonds (iii)

 

 

—

 

 

 

17,246

 

 

 

—

 

 

 

17,246

 

Commercial paper (iii)

 

 

—

 

 

 

12,449

 

 

 

—

 

 

 

12,449

 

Corporate notes (iii)

 

 

—

 

 

 

142,734

 

 

 

—

 

 

 

142,734

 

Total assets

 

$

52,359

 

 

$

172,429

 

 

$

—

 

 

$

224,788

 

 

Balance as of December 31, 2018

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds (i)

 

$

15,572

 

 

$

—

 

 

$

—

 

 

$

15,572

 

Commercial paper (ii)

 

 

—

 

 

 

119,602

 

 

 

—

 

 

 

119,602

 

Corporate notes (ii)

 

 

—

 

 

 

111,532

 

 

 

—

 

 

 

111,532

 

Total assets

 

$

15,572

 

 

$

231,134

 

 

$

—

 

 

$

246,706

 

 

(i)

Included in cash and cash equivalents on the consolidated balance sheets.

(ii)

Included in either cash and cash equivalents or short-term investments on the consolidated balance sheets.

(iii)

Included in short-term investments on the consolidated balance sheets.

Convertible Senior Notes

As of December 31, 2019, the fair value of the 1.75% convertible senior notes due 2021 was $232.6 million.  The fair value was determined on the basis of market prices observable for similar instruments and is considered Level 2 in the fair value hierarchy.

103

 

6. Balance Sheet Components

Investments

The fair value of the Company’s cash equivalents and short-term investments approximates their respective carrying amounts due to their short-term maturity. The following is a summary of the gross unrealized gains and unrealized losses on the Company’s investment securities (in thousands):

 

 

 

December 31, 2019

 

 

 

Amortized

Cost

 

 

Gross

Unrealized

Holding

Gains

 

 

Gross

Unrealized

Holding

Losses

 

 

Aggregate

Fair Value

 

Investment Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Agency bonds

 

$

17,209

 

 

$

37

 

 

$

—

 

 

$

17,246

 

Commercial paper

 

 

12,425

 

 

 

24

 

 

 

—

 

 

 

12,449

 

Corporate notes

 

 

142,588

 

 

 

150

 

 

 

(4

)

 

 

142,734

 

Total securities

 

$

172,222

 

 

$

211

 

 

$

(4

)

 

$

172,429

 

 

 

 

December 31, 2018

 

 

 

Amortized

Cost

 

 

Gross

Unrealized

Holding

Gains

 

 

Gross

Unrealized

Holding

Losses

 

 

Aggregate

Fair Value

 

Investment Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

$

119,692

 

 

$

—

 

 

$

(90

)

 

$

119,602

 

Corporate notes

 

 

111,652

 

 

 

—

 

 

 

(120

)

 

 

111,532

 

Total securities

 

$

231,344

 

 

$

—

 

 

$

(210

)

 

$

231,134

 

Realized gains or losses from the sale of investments and other-than-temporary impairments, if any, on available-for-sale securities are reported in other income (expense), net as incurred. The cost of securities sold was determined based on the specific identification method. The amount of realized gains and realized losses on investments for the periods presented have not been material.

The amortized costs and estimated fair values of the Company’s available-for-sale securities by contractual maturities as of December 31, 2019 were as follows (in thousands):

 

 

 

Amortized Cost

 

 

Fair Value

 

Amounts maturing within one year

 

$

156,783

 

 

$

156,985

 

Amounts after one year through five years

 

 

15,439

 

 

 

15,444

 

Total investment securities

 

$

172,222

 

 

$

172,429

 

 

Inventories (in thousands)

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Raw materials

 

$

26,354

 

 

$

37,453

 

Finished goods

 

 

65,225

 

 

 

54,582

 

Total inventories

 

$

91,579

 

 

$

92,035

 

 

104

 

Property and Equipment, Net (in thousands)

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Laboratory equipment

 

$

5,733

 

 

$

2,874

 

Computer equipment and software

 

 

9,909

 

 

 

8,751

 

Furniture and fixtures

 

 

3,898

 

 

 

3,903

 

Leasehold improvements

 

 

4,226

 

 

 

4,218

 

Construction in process

 

 

1,006

 

 

 

1,811

 

Total

 

 

24,772

 

 

 

21,557

 

Less: Accumulated depreciation and amortization

 

 

(13,006

)

 

 

(8,756

)

Property and equipment, net

 

$

11,766

 

 

$

12,801

 

 

Depreciation and amortization expense for the years ended December 31, 2019, 2018 and 2017 was $4.6 million, $3.9 million and $2.5 million, respectively.

Accrued Liabilities (in thousands)

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Accrued payroll and related expenses

 

$

36,056

 

 

$

26,792

 

Accrued professional fees

 

 

1,633

 

 

 

1,595

 

Accrued taxes

 

 

2,353

 

 

 

2,506

 

Accrued clinical and research expenses

 

 

2,157

 

 

 

1,105

 

Accrued interest

 

 

243

 

 

 

243

 

Accrued warranty

 

 

1,178

 

 

 

1,236

 

Accrued other

 

 

7,346

 

 

 

5,313

 

Total accrued liabilities

 

$

50,966

 

 

$

38,790

 

 

7. Commitments and Contingencies

Operating Leases

In March 2015, the Company entered into a lease agreement for approximately 50,740 square feet of office space located in Redwood City, California for a period beginning in June 2015 through May 2022 with initial annual payments of approximately $2.0 million, increasing to $2.4 million annually during the final year of the lease term. In December 2016, the Company entered into an amendment for an additional approximately 49,980 square feet of office space adjacent to the premises under the original lease (the Expansion Premises), with initial annual payments of $1.2 million, increasing to $2.9 million in the final year of the amended lease term.  The lease for the Expansion Premises commenced on June 1, 2018.   The amendment also extends the lease term for the original premises to terminate on the same date as the amended lease, which is May 31, 2025.  In April 2017, the Company entered into a second amendment to the lease for a temporary space of 8,171 square feet for a period beginning in May 2017 and which ended on June 1, 2018, the Commencement Date of the Expansion Premises.

In August 2014, the Company entered into a new facility lease for warehouse space beginning on August 21, 2014 through May 31, 2015, under which it was obligated to pay approximately $100,000 in lease payments over the term of the lease. In March 2015, the Company extended the warehouse lease through February 2017 under which it was obligated to pay approximately $0.3 million in lease payments over the remaining term of the lease.

In February 2017, the Company entered into a separate non-cancellable facility lease for warehouse space beginning March 1, 2017 through February 28, 2022, under which the Company is obligated to pay approximately $0.4 million in lease payments over the term of the lease.

See Note 4 for further discussion on Lease Accounting.

105

 

Warranty Obligations

The Company warrants that its products will operate substantially in conformity with product specifications and provides a limited one- to five-year warranty.  Activities related to warranty obligations were as follows (in thousands):

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Beginning Balance

 

$

1,236

 

 

$

708

 

Provision for warranty

 

 

1,942

 

 

 

2,334

 

Utilization

 

 

(2,000

)

 

 

(1,806

)

Ending Balance

 

$

1,178

 

 

$

1,236

 

 

Supply Agreements

The Company has entered into supply agreements with certain of the Company’s suppliers that required certain minimum annual purchase agreements.  As of December 31, 2019, the Company had minimum annual purchase commitments of $6.2 million due in 2020. For the year ended December 31, 2019, the Company recorded a charge of $3.6 million related to the cancellation of firm purchase commitments for inventory related items.

The Company also entered into a service agreement in January 2020 for which it is committed to pay $2.5 million annually in each of the next five years.

License Agreements

In March 2006, the Company entered into an amended and restated license agreement with the Mayo Foundation for Medical Education and Research (Mayo) and Venturi Group LLC (VGL), which provides the Company access to the certain know how and licensed patents owned by Mayo and VGL for treatment of central, autonomic and peripheral nervous system disorders, including pain, using devices to modulate nerve signaling. The licenses granted are exclusive and the Company has the right to sub-license. The agreement will terminate upon the last to expire patent application, unless terminated earlier. The agreement can be terminated any time after three years from March 2006 by Mayo or VGL.

Per terms of the license, the Company is required to pay royalties based on the greater of earned royalty or minimum royalty. The earned royalty will be based on a percentage of net sales of licensed products either by the Company or the sub-licensee. The minimum royalty payment will be based on royalty periods as defined in the agreement.

In March 2011, the Company entered into a Phase II License Agreement with Mayo which provides the Company access to the certain know how and licensed patents owned by Mayo. The licenses granted are exclusive and the Company has the right to sub-license. The agreement will terminate upon the last to expire patent application, unless terminated earlier.

Per terms of the license, the Company is required to:

 

•

Pay a retainer fee of $40,000 per annum starting March 2011 and ending February 2013;

 

•

Pay royalties based on the greater of earned royalty or minimum royalty. The earned royalty is based on a percentage of net sales of licensed products either by the Company or the sub-licensee. The minimum annual royalty payment is $200,000.

Royalties paid during the years ended December 31, 2019, 2018 and 2017 were $3.2 million, $3.1 million and $2.5 million, respectively.

106

 

In November 2014, the Company issued Mayo 20,833 shares of common stock owed in connection with the IPO pursuant to the terms of the license, and recorded noncash research and development expense of $0.5 million for the fair value of the shares on the date of issuance.

In July 2017, the Company entered into a license agreement for which it is committed to pay $0.3 million over the remaining term of this license agreement, which ends in 2022.

Contingent Consideration

In February 2019, the Company entered into an agreement with a privately-held company to, among other things, provide the privately-held company financing in the form of a secured convertible note.  Through December 31, 2019, the Company has provided financing totaling $8.5 million in the form of two secured convertible notes. The Company has the obligation to provide additional funding of up to $3.0 million in the form of an additional secured convertible note and takes effect only after the Company exercises its option to make a further investment in the privately-held company that is based on certain development targets.  The agreement additionally provides the Company with the exclusive right, but not the obligation, to acquire the privately-held company.  As of December 31, 2019, the value of the secured convertible notes, measured at amortized cost, is $7.9 million, while the value of certain rights in relation to the agreement, measured at cost and monitored for impairment on an ongoing basis, is $1.0 million.  These amounts are reported in Other Assets on the Condensed Consolidated Balance Sheet.  The accretion of amortized cost is recorded in Interest Income, while any changes in value from impairment assessment are recorded in Other Income (Expense) in the Consolidated Statements of Operations and Comprehensive Income.  The Company concluded that the privately-held company is a variable interest entity; however, the Company is not the primary beneficiary as it does not retain power to direct the activities that most significantly impact its economic performance.

Contingencies

From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. There have been no contingent liabilities requiring accrual at December 31, 2019 and 2018.

Indemnification

The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, including, among other circumstances, in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to the Company’s technology. The term of these indemnification agreements is generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future, but have not yet been made.

The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has director and officer insurance coverage that reduces the Company’s exposure and enables the Company to recover a portion of any future amounts paid. The Company believes the estimated fair value of these indemnification agreements in excess of applicable insurance coverage is minimal.

The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. No liability associated with such indemnifications has been recorded to date.

107

 

Legal Matters

On November 28, 2016, the Company filed a lawsuit for patent infringement against Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation (collectively, Boston Scientific). The lawsuit, filed in the U.S. District Court for the Northern District of California (the Court), asserts that Boston Scientific is infringing seven of the Company’s patents covering inventions relating to the Senza system and HF10 therapy. The lawsuit seeks preliminary and permanent injunctive relief against further infringement as well as damages and attorney’s fees. On July 24, 2018, the Court issued an order on claim construction and summary judgment.  In the order, the Court ruled that six asserted method claims in three of the Company’s asserted patents were patent eligible and not invalid as indefinite.  Specifically, the claims upheld in the ruling were claims 11, 21 and 23 of U.S. Patent No. 8,359,102; claim 18 of U.S. Patent No. 8,792,988; and claims 1 and 5 of U.S. Patent No. 8,768,472.  Collectively, these six claims cover methods for delivering SCS therapy at frequencies between 1.5 kHz and 100 kHz.

The Court, however, found that Boston Scientific is not currently infringing the six upheld method claims.  Specifically, the Court found that Boston Scientific's sale of the Spectra WaveWriter systems for commercial use in the United States does not infringe the upheld method claims because the Spectra WaveWriter systems cannot be programmed to generate signals above 1.2 kHz.  With regard to the use of the Spectra WaveWriter and the Precision with MultiWave systems in patients that have completed the ACCELERATE clinical trial, the Court found such use to fall within the safe harbor provision of 35 U.S.C. § 271(e).  The Court further held that 35 U.S.C. § 271(f) does not apply to method claims, and therefore the sale of the Precision with MultiWave systems in Europe does not infringe the upheld method claims.  The Court also found that the asserted system claims in four of the Company's asserted patents were invalid as indefinite.  Specifically, the Court invalidated claims 18, 34, and 55 of U.S. Patent No. 9,327,125; claims 5 and 34 of U.S. Patent No. 9,333,357; claims 7, 12, 35, 37, and 58 of U.S. Patent No. 8,712,533; and claims 1 and 22 of U.S. Patent No. 9,480,842.  

On July 27, 2018, the parties submitted a joint statement to the Court wherein Boston Scientific asserted to the Court that, with respect to whether any U.S. launch of a high-rate product (such as the Precision with MultiWave and Spectra WaveWriter models used in the ACCELERATE study or any other system that is programmable at any frequency in the range 1.5 to 100 kHz) is imminent, Boston Scientific, as of now, has not decided whether to launch such a product; has not established a timeline for when such a decision might be made, if ever; and has not determined what frequencies would be enabled if it were to decide to launch such a product in the future. Boston Scientific further confirmed its public statements that the ACCELERATE study had been extended into 2019, with an estimated study completion date between April 2019 and November 2019.  On the basis of the foregoing, the parties agreed to dismissal on ripeness grounds of Nevro’s declaratory judgment claims without prejudice, each side to bear its own fees and costs as to these claims, and jointly requested that the Court enter such a dismissal. The dismissal was thereafter entered as a court order on July 31, 2018.  The Company and Boston Scientific are each appealing portions of the Court’s July 24th ruling, and have submitted their respective appeal briefs and replies to the U.S. Court of Appeals for the Federal Circuit.  The appeal was heard on December 2, 2019. The Company is awaiting the ruling from the appeals court.

On December 9, 2016, Boston Scientific filed a patent infringement lawsuit alleging the Company’s manufacture, use and sale of the Senza system infringes ten of Boston Scientific’s patents covering spinal cord stimulation technology related to stimulation leads, rechargeable batteries and telemetry. The lawsuit, filed in the U.S. District Court for the District of Delaware, seeks unspecified damages and attorney’s fees, as well as preliminary and permanent injunctive relief against further infringement. During this litigation, Boston Scientific unilaterally dismissed their assertions with regard to two of the ten patents.  In relation to this lawsuit, the Company filed petitions for inter partes review at the U.S. Patent and Trademark Office (USPTO) against all the eight remaining patents asserted by Boston Scientific.  As a result of those petitions, in February 2019, all of the asserted claims of Boston Scientific’s U.S. Patent Nos. 6,895,280 and 7,587,241 were found invalid by the Patent Trial and Appeal Board (PTAB) at the USPTO. Boston Scientific has appealed these rulings.  The Company and Boston Scientific have submitted their respective appeal briefs and replies to the U.S. Court of Appeals for the Federal Circuit, and are awaiting a hearing date. This patent infringement lawsuit has been stayed pending completion of the inter partes proceedings since June 2018. As of this time, the Company is unable to determine an outcome or potential range of loss.

108

 

On April 27, 2018, Boston Scientific filed a second patent lawsuit alleging patent infringement, theft of trade secrets and tortious interference with contract. The lawsuit, filed in the U.S. District Court for the District of Delaware, seeks unspecified damages and attorney’s fees, as well as preliminary and permanent injunctive relief against further infringement. In relation to this lawsuit, the Company filed petitions for inter partes review at the U.S. Patent and Trademark Office USPTO against seven of the nine patents asserted by Boston Scientific. In January 2020, the PTAB initiated inter partes reviews in all seven of the challenged patents. As of this time, the Company is unable to determine an outcome or potential range of loss.

On August 23, 2018, the Oklahoma Police Pension and Retirement System filed a putative securities class action complaint against the Company and certain individual officers alleging violations of Sections 10(b) and 20(a) of the Exchange Act, and Rule 10b-5 of the Exchange Act.  The lawsuit, filed in the U.S. District Court for the Northern District of California, seeks unspecified damages and attorneys’ fees based on alleged misleading statements or omissions by the Company and the individual officers regarding the Company’s rights in technology underlying the Senza SCS systems and the termination of the Company’s former Vice President of Worldwide Sales. On November 3, 2018, a related shareholder derivative lawsuit was filed in the United States District Court for the Northern District of California seeking unspecified damages, injunctive relief and attorneys’ fees based on alleged violations of Section 14(a) of the Securities and Exchange Act of 1934, breach of fiduciary duties, unjust enrichment and waste of corporate assets. On August 1, 2019, U.S. District Judge Vince Chhabria granted the Company’s motion to dismiss the pending securities class action complaint, with leave to file an amended complaint within 21 days of the order. The plaintiffs did not file an amended complaint, and on August 23, 2019, the securities class action was dismissed.  On September 6, 2019, the related shareholder derivative lawsuit was voluntarily dismissed

On February 14, 2019, the Company filed a lawsuit for patent infringement against Stimwave Technologies, Inc. (Stimwave) asserting that Stimwave is infringing the Company’s patents covering inventions related to its HF10 therapy and the Senza system, as well as a claim for false advertising under the Lanham Action Section 43(a), 15 U.S.C. § 1125(a).  In relation to this lawsuit, on July 24, 2019, the court granted Nevro's motion for preliminary injunction, and has issued an order barring Stimwave, and all affiliated persons and entities, from infringing patent claims covering frequencies between 3 kHz and 10 kHz by programming Stimwave's SCS systems to deliver its recently introduced high-frequency, paresthesia-free SCS therapy.  Per Nevro's request, the court order does not enjoin Stimwave from providing follow-up care and programming for any patients who were already programmed with such high frequency therapy.  On July 25, 2019, Stimwave filed a Notice of Appeal to the U.S. Court of Appeals for the Federal Circuit.  The Company and Stimwave have submitted their respective appeal briefs and replies to the appellate court, and are awaiting a hearing date. During the appeal, the litigation in the District of Delaware will continue on the merits.

As of December 31, 2019, the Company did not record a liability, as an outcome or potential loss range cannot be reasonably determined. 

The Company is and may from time to time continue to be involved in various legal proceedings to defend its intellectual property, including several pending European patent oppositions at the European Patent Office (EPO) initiated by the Company’s competitors Medtronic and Boston Scientific and an entitlement action filed by Boston Scientific in Germany.  In addition, the Company is and may from time to time also be involved in various legal proceedings of a character normally incident to the ordinary course of business, such as product liability and professional liability matters, which the Company does not deem to be material to its business and consolidated financial statements at this stage.

8. Long-term Debt

1.75% Convertible Senior Notes and Convertible Note Hedge and Warrant Transactions

In June 2016, the Company issued $150.0 million aggregate principal amount of 1.75% convertible senior notes due in June 2021 in a registered underwritten public offering and an additional $22.5 million aggregate principal amount of such notes pursuant to the exercise in full of the over-allotment options of the underwriters (the 2021 Notes). The interest rates are fixed at 1.75% per annum and are payable semi-annually in arrears on June 1 and

109

 

December 1 of each year, commencing on December 1, 2016.  The total net proceeds from the debt offering, after deducting initial purchase discounts and debt issuance costs, were approximately $166.2 million.

Each $1,000 principal amount of the 2021 Notes will initially be convertible into 10.3770 shares of the Company’s common stock, which is equivalent to an initial conversion price of approximately $96.37 per share, subject to adjustment upon the occurrence of specified events. The 2021 Notes will be convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding December 1, 2020, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on September 30, 2016 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period (the measurement period) in which the trading price (as defined in the indenture to the 2021 Notes) per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on each such trading day; or (3) upon the occurrence of specified corporate events.  On or after December 1, 2020 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their 2021 Notes at any time, regardless of the foregoing circumstances.  Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock, at the Company’s election.  If the Company undergoes a fundamental change prior to the maturity date, holders of the notes may require the Company to repurchase for cash all or any portion of their notes at a repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. In addition, if specific corporate events occur prior to the applicable maturity date, the Company will increase the conversion rate for a holder who elects to convert their notes in connection with such a corporate event in certain circumstances.  It is the Company’s current intent and policy to settle conversions through combination settlement with a specified dollar amount per $1,000 principal amount of notes of $1,000.  During the three months ended December 31, 2019, the conditions allowing holders of the 2021 Notes to convert have not been met. The 2021 Notes are therefore not convertible during the three months ended March 31, 2020 and are classified as long-term debt. Should the sale price condition be met in a future quarter, the 2021 Notes will be convertible at the holders’ option during the immediately following quarter. As of December 31, 2019, the if-converted value of the 2021 Notes did not exceed the principal value of those notes.

In accounting for the issuance of the convertible senior notes, the Company separated the 2021 Notes into liability and equity components.  The carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was $32.9 million and was determined by deducting the fair value of the liability component from the par value of the 2021 Notes. The equity component is not remeasured as long as it continues to meet the conditions for equity classification. The excess of the principal amount of the liability component over its carrying amount (debt discount) is amortized to interest expense over the term of the 2021 Notes expense at an effective interest rate of 6.29% over the contractual terms of the notes.

In accounting for the debt issuance costs of $6.2 million related to the 2021 Notes, the Company allocated the total amount incurred to the liability and equity components of the 2021 Notes based on their relative values. Issuance costs attributable to the liability component were $5.0 million and will be amortized to interest expense using the effective interest method over the contractual terms of the 2021 Notes.  Issuance costs attributable to the equity component were netted with the equity component in stockholders’ equity.

110

 

The net carrying amount of the liability component of the 2021 Notes was as follows (in thousands):

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Principal

 

$

172,500

 

 

$

172,500

 

Unamortized discount

 

 

(10,462

)

 

 

(17,305

)

Unamortized issuance cost

 

 

(1,738

)

 

 

(2,801

)

Net carrying amount

 

$

160,300

 

 

$

152,394

 

 

The net carrying amount of the equity component of the 2021 Notes was as follows (in thousands):

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Debt discount related to value of conversion option

 

$

32,945

 

 

$

32,945

 

Debt issuance cost

 

 

(1,179

)

 

 

(1,179

)

Net carrying amount

 

$

31,766

 

 

$

31,766

 

 

The following table sets forth the interest expense recognized related to the 2021 Notes (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Contractual interest expense

 

$

3,019

 

 

$

3,019

 

 

$

3,019

 

Amortization of debt discount

 

 

6,843

 

 

 

6,432

 

 

 

6,046

 

Amortization of debt issuance costs

 

 

1,063

 

 

 

943

 

 

 

833

 

Total interest expense related to the 2021 Notes

 

$

10,925

 

 

$

10,394

 

 

$

9,898

 

 

In connection with the offering of the 2021 Notes, the Company entered into convertible note hedge transactions with certain bank counterparties in which the Company has the option to purchase initially (subject to adjustment for certain specified events) a total of approximately 1.8 million shares of the Company’s common stock at a price of approximately $96.37 per share. The total cost of the convertible note hedge transactions was $45.1 million.  In addition, the Company sold warrants to certain bank counterparties whereby the holders of the warrants have the option to purchase initially (subject to adjustment for certain specified events) a total of approximately 1.8 million shares of the Company’s common stock at a price of $127.28 per share. The Company received $33.1 million in cash proceeds from the sale of these warrants.  Taken together, the purchase of the convertible note hedges and the sale of warrants are intended to offset any actual dilution from the conversion of these notes and to effectively increase the overall conversion price from $96.37 to $127.28 per share. As these transactions meet certain accounting criteria, the convertible note hedges and warrants are recorded in stockholders’ equity and are not accounted for as derivatives. The net cost of $12.0 million incurred in connection with the convertible note hedge and warrant transactions was recorded as a reduction to additional paid-in capital on the consolidated balance sheet.

9. Convertible Preferred Stock

Prior to its initial public offering, the Company had outstanding 15,208,048 shares of convertible preferred stock. Each share of preferred stock was convertible to one share of common stock. Upon the closing of the Company’s initial public offering on November 11, 2014, all shares of outstanding redeemable convertible preferred stock were automatically converted to 15,208,048 shares of the Company’s common stock.

111

 

10. Stock-Based Compensation

Common stock reserved for future issuance as of December 31, 2019 was as follows:

 

 

 

December 31,

 

 

 

2019

 

Outstanding stock options and restricted stock units

 

 

2,934,517

 

Reserved for grants of future stock options and restricted stock units

 

 

3,680,784

 

Reserved for employee stock purchase plan

 

 

1,161,645

 

Total common stock reserved for future issuance

 

 

7,776,946

 

 

Stock Plans

The Company’s Board of Directors (Board) and stockholders previously approved the 2007 Stock Option Plan (the 2007 Plan). In October 2014, the Board adopted the 2014 Equity Incentive Award Plan (the 2014 Plan and, together with the 2007 Plan, the Stock Plans).  As of the effective date of the 2014 Plan, the Company suspended the 2007 Plan and no additional awards may be granted under the 2007 Plan. Any shares of common stock covered by awards granted under the 2007 Plan that terminate after the effective date of the 2014 Plan by expiration, forfeiture, cancellation or other means without the issuance of such shares, will be added to the 2014 Plan reserve.

Under the 2014 Plan, 1,854,166 shares of common stock were initially reserved for issuance, plus the number of shares remaining available for future awards under the 2007 Plan, as of the pricing of the IPO. The number of shares initially reserved for issuance under the 2014 Plan is subject to increase by (i) the number of shares represented by awards outstanding under the 2007 Plan that are forfeited or lapse unexercised and which following the pricing date are not issued under the 2007 Plan, and (ii) an annual increase on January 1 of each year.

Under the 2014 Plan, the Company may grant awards such as incentive stock options, nonstatutory stock options, restricted stock units and stock appreciation rights. Incentive stock options (ISO) may be granted only to Company employees (including directors who are also employees). Nonqualified stock options (NSO) may be granted to Company employees, directors and consultants.

Stock Options

Options under the 2014 Plan may be granted for periods of up to ten years and at prices no less than 100% of the estimated fair market value of the shares on the date of grant as determined by the Board, provided, however, that the exercise price of an ISO or an NSO granted to a 10% stockholder shall not be less than 110% of the estimated fair market value of the shares on the date of grant. Upon the exercise of options, the Company issues new common stock from its authorized shares. The vesting provisions of individual options vary but are generally over four years, with the exception of performance based stock options.

Pursuant to the 2014 Plan, the Company granted performance based stock options to the Company’s former CEO in March 2016. This performance based stock option award is subject to the CEO’s continued service to the Company through each applicable vesting date. If a performance metric is not met within the time limits specified in the award agreements, the shares subject to vesting under the vesting tranche for that performance metric will be cancelled.  Upon the former CEO’s resignation from the Company in March 2019, the unvested shares subject to this award as of the separation date have been cancelled.

A summary of shares available for grant under the Stock Plans is as follows:

112

 

 

 

Shares Available

 

 

 

for Grant

 

Balance at December 31, 2016

 

 

2,202,239

 

Additional shares reserved

 

 

1,155,474

 

Shares forfeited for tax

 

 

13,094

 

Options and restricted stock granted

 

 

(1,002,063

)

Options and restricted stock cancelled

 

 

97,502

 

Balance at December 31, 2017

 

 

2,466,246

 

Additional shares reserved

 

 

1,189,502

 

Shares forfeited for tax

 

 

28,107

 

Options and restricted stock granted

 

 

(805,653

)

Options and restricted stock cancelled

 

 

102,560

 

Balance at December 31, 2018

 

 

2,980,762

 

Additional shares reserved

 

 

1,210,541

 

Allowance for PSU for overperformance

 

 

(277,778

)

Shares forfeited for tax

 

 

38,696

 

Options and restricted stock granted

 

 

(1,077,178

)

Options and restricted stock cancelled

 

 

527,963

 

Balance at December 31, 2019

 

 

3,403,006

 

A summary of stock option activity under the Stock Plans is as follows:

 

 

 

Options Outstanding

 

 

Weighted Average

 

 

 

 

 

 

Number of

 

 

Weighted Average

 

 

Remaining

 

Aggregate

 

 

 

Options

 

 

Exercise Price

 

 

Contractual Term

 

Intrinsic Value

 

 

 

 

 

 

 

 

 

 

 

(in years)

 

(in thousands)

 

Outstanding at December 31, 2016

 

 

2,821,227

 

 

$

29.85

 

 

7.4

 

$

123,425

 

Options granted

 

 

503,690

 

 

$

74.71

 

 

 

 

 

 

 

Options exercised

 

 

(707,410

)

 

$

10.59

 

 

 

 

$

50,971

 

Options cancelled

 

 

(57,535

)

 

$

46.83

 

 

 

 

 

 

 

Outstanding at December 31, 2017

 

 

2,559,972

 

 

$

43.62

 

 

7.3

 

$

71,120

 

Options granted

 

 

236,900

 

 

$

47.96

 

 

 

 

 

 

 

Options exercised

 

 

(247,768

)

 

$

16.05

 

 

 

 

$

15,468

 

Options cancelled

 

 

(19,364

)

 

$

44.70

 

 

 

 

 

 

 

Outstanding at December 31, 2018

 

 

2,529,740

 

 

$

46.72

 

 

6.7

 

$

21,866

 

Options granted

 

 

244,075

 

 

$

56.71

 

 

 

 

 

 

 

Options exercised

 

 

(828,722

)

 

$

34.52

 

 

 

 

$

42,695

 

Options cancelled

 

 

(298,908

)

 

$

66.22

 

 

 

 

 

 

 

Outstanding at December 31, 2019

 

 

1,646,185

 

 

$

50.80

 

 

6.3

 

$

109,870

 

Options exercisable as of December 31, 2019

 

 

1,117,773

 

 

$

46.70

 

 

5.1

 

$

79,186

 

Options vested, exercisable or expected to

   vest as of December 31, 2019

 

 

1,612,455

 

 

$

50.66

 

 

6.2

 

$

107,839

 

 

The aggregate intrinsic value of options exercised is the difference between the estimated fair market value of the Company’s common stock at the date of exercise and the exercise price for in-the-money options. The aggregate intrinsic value of outstanding options is the difference between the closing price as of the date outstanding and the exercise price of the underlying stock options. The weighted-average grant-date fair value of options granted during the years ended December 31, 2019, 2018 and 2017 was $27.91, $23.27 and $32.35 per share, respectively. The total fair value of options vested during the years ended December 31, 2019, 2018 and 2017 was approximately $8.3 million, $14.0 million and $13.3 million, respectively, based on the grant date fair value.

113

 

The options outstanding and vested under the Stock Plans by exercise price, at December 31, 2019, were as follows:

 

 

 

Options Outstanding

 

 

Options Vested

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number

 

 

Contractual Term

 

Weighted Average

 

 

Number

 

 

Weighted Average

 

Exercise Price

 

Outstanding

 

 

(in years)

 

Exercise Price

 

 

Exercisable

 

 

Exercise Price

 

$1.44 — $18.00

 

 

334,087

 

 

3.79

 

$

10.25

 

 

 

334,087

 

 

$

10.25

 

$32.51 — $48.44

 

 

391,304

 

 

7.85

 

$

43.43

 

 

 

159,456

 

 

$

42.13

 

$49.94 — $63.23

 

 

365,966

 

 

4.45

 

$

57.78

 

 

 

352,632

 

 

$

57.73

 

$63.39 — $76.81

 

 

393,930

 

 

8.27

 

$

70.58

 

 

 

155,991

 

 

$

73.09

 

$84.30 — $97.52

 

 

160,898

 

 

7.07

 

$

88.62

 

 

 

115,607

 

 

$

89.07

 

$1.44 — $97.52

 

 

1,646,185

 

 

6.29

 

$

50.80

 

 

 

1,117,773

 

 

$

46.70

 

 

Restricted Stock Units

In 2015, the Company began granting restricted stock units (RSUs) under the 2014 Plan.  Holders of RSUs do not have stockholder rights.  Upon the release of RSUs, the Company issues new common stock from its authorized shares. RSUs generally vest four years from the date of grant.

Pursuant to the 2014 Plan, the Company granted performance based RSUs to the former CEO in March 2016. The performance based RSUs are subject to the former CEO’s continued service to the Company through each applicable vesting date. If a performance metric is not met within the time limits specified in the RSU agreement, the shares subject to vesting under the vesting tranche for that performance metric will be cancelled. Upon the former CEO’s resignation from the Company in March 2019, the unvested shares subject to this award as of the separation date have been cancelled.

In March 2019, the Company granted RSUs to the current CEO, subject to his continued service to the company and based on the total shareholder return of the Company’s common stock price compared to a targeted composite index over a three-year period.  The number of shares to be issued upon vesting of these RSUs range from 0 to 3.5 times the target number of shares granted, depending on the Company’s performance against the targeted composite index.

A summary of RSUs activity under the Stock Plans was as follows:

 

 

 

Number of

 

 

Weighted Average

 

 

Aggregate

 

 

 

Restricted

 

 

Grant Date

 

 

Intrinsic Value

 

 

 

Stock Units

 

 

Fair Value

 

 

(in thousands)

 

Outstanding at December 31, 2016

 

 

345,555

 

 

$

70.39

 

 

$

25,108

 

Restricted stock granted

 

 

498,373

 

 

$

82.60

 

 

 

 

 

Restricted stock released

 

 

(83,121

)

 

$

69.90

 

 

$

1,175

 

Restricted stock cancelled

 

 

(39,967

)

 

$

81.57

 

 

 

 

 

Outstanding at December 31, 2017

 

 

720,840

 

 

$

78.26

 

 

$

49,767

 

Restricted stock granted

 

 

568,753

 

 

$

68.09

 

 

 

 

 

Restricted stock released

 

 

(196,274

)

 

$

77.43

 

 

$

968

 

Restricted stock cancelled

 

 

(83,196

)

 

$

81.73

 

 

 

 

 

Outstanding at December 31, 2018

 

 

1,010,123

 

 

$

72.41

 

 

$

39,284

 

Restricted stock granted

 

 

833,103

 

 

$

59.56

 

 

 

 

 

Restricted stock released

 

 

(325,839

)

 

$

70.69

 

 

$

4,064

 

Restricted stock cancelled

 

 

(229,055

)

 

$

70.23

 

 

 

 

 

Outstanding at December 31, 2019

 

 

1,288,332

 

 

$

64.92

 

 

$

151,431

 

Restricted stock expected to vest as of

   December 31, 2019

 

 

1,190,393

 

 

$

59.42

 

 

$

139,919

 

 

114

 

The aggregate intrinsic value of RSUs released is calculated using the fair market value of the Company’s common stock at the date of release. The aggregate intrinsic value of outstanding RSUs is calculated based on the closing price of the Company’s common stock as of the date outstanding.

2014 Employee Stock Purchase Plan

In October 2014, the Board adopted the 2014 Employee Stock Purchase Plan (the ESPP). A total of 196,666 shares of common stock were initially available for future issuance under the 2014 Employee Stock Purchase Plan, subject to an annual increase on January 1 of each year. The ESPP provides eligible employees with an opportunity to purchase shares of the Company’s common stock through payroll deductions of up to 15% of their eligible compensation, subject to plan limitations.  Under the ESPP, the purchase price of the Company stock is equal to 85% of the lower of its fair market value at the start and end of a six-month purchase period.

A summary of ESPP activity was as follows:

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Additional shares reserved

 

 

302,635

 

 

 

297,375

 

 

 

288,868

 

Shares issued

 

 

164,960

 

 

 

110,040

 

 

 

73,262

 

Shares available for future issuance

 

 

1,161,645

 

 

 

1,023,970

 

 

 

836,635

 

Employee contributions for shares issued (in thousands)

 

$

6,544

 

 

$

5,521

 

 

$

4,697

 

 

Early Exercises

Stock options previously granted under the 2007 Plan allowed the Board of Directors to grant awards to provide employee option holders the right to elect to exercise unvested options in exchange for restricted common stock. There were no unvested shares at December 31, 2019, 2018 and 2017 which were subject to a repurchase right held by the Company. Additionally, as of December 31, 2019 and 2018, there was no cash received related to unvested shares, respectively. Amounts recorded are transferred into common stock and additional paid-in-capital as the shares vest.

Employee Stock-Based Compensation

The Company estimated the fair value of stock options granted to employees and shares purchased by employees under the ESPP using the Black-Scholes option valuation model. The fair value is amortized on a straight-line basis over the requisite service period of the awards, with the exception of performance based stock options whose fair value is recorded as expenses based on the probability that the performance metrics will be achieved. The following assumptions were used in estimating the fair value:

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Stock Options:

 

 

 

 

 

 

 

 

 

 

 

 

Expected term (in years)

 

5.7

 

 

5.5

 

 

5.5

 

Expected volatility

 

51% — 52%

 

 

44% — 51%

 

 

44% — 46%

 

Risk-free interest rate

 

1.4% — 2.6%

 

 

2.3% — 2.9%

 

 

1.8% — 2.2%

 

Dividend Yield

 

0%

 

 

 

0%

 

 

 

0%

 

ESPP:

 

 

 

 

 

 

 

 

 

 

 

 

Expected term (in years)

 

0.5

 

 

0.5

 

 

0.5

 

Expected volatility

 

48% — 61%

 

 

44% — 57%

 

 

36% — 37%

 

Risk-free interest rate

 

1.6% — 2.4%

 

 

2.1% — 2.5%

 

 

1.0% — 1.4%

 

Dividend Yield

 

0%

 

 

 

0%

 

 

0%

 

 

Expected Term. The expected term of stock-based awards represents the weighted-average period that the stock-based awards are expected to remain outstanding. The Company has historically opted to use the “simplified method” for estimating the expected term of the awards, whereby the expected term equals the arithmetic average of

115

 

the vesting term and the original contractual term of the awards.  Starting in late 2016, the Company started to utilize its own historical data for the calculation of expected term.

Expected Volatility. The Company has historically determined the share price volatility for stock-based awards based on an analysis of the historical volatilities of a peer group of publicly traded medical device companies.  Starting in late 2016, the Company has started to incorporate its own stock trading volatility with those of its peer group for the calculation of volatility.  In evaluating similarity, the Company considered factors such as industry, stage of life cycle and size.

Risk-Free Interest Rate. The risk-free interest rate is based on the U.S. Treasury yield in effect at the time of the grant for zero-coupon U.S. Treasury notes with remaining terms similar to the expected term of the stock-based awards.

Dividend Rate. The expected dividend was assumed to be zero as the Company has never paid dividends and has no current plans to do so.

Expected Forfeiture Rate. The Company is required to estimate forfeitures at the time of grant, and revise those estimates in subsequent periods if actual forfeitures differ from those estimates. The Company uses historical data to estimate pre-vesting option forfeitures and record stock-based compensation expense only for those awards that are expected to vest. To the extent actual forfeitures differ from the estimates, the difference will be recorded as a cumulative adjustment in the period that the estimates are revised.

The Company accounts for RSUs at their fair value, based on the closing market price of the Company’s common stock on the grant date. The fair value is amortized on a straight-line basis over the requisite service period of the awards, which is generally the vesting term of four years.

In 2016, the Company granted performance based RSUs to its former CEO that only vest upon the achievement of specific operational performance criteria.  The stock-based compensation for these performance based RSUs are recognized as expenses when it is determined that achieving the performance metrics are probable. Upon the former CEO’s resignation from the Company in March 2019, the unvested shares subject to this award as of the separation date have been cancelled.

In connection with the former CEO’s resignation in March 2019, the Company amended the terms of his then vested nonqualified stock options such that they remain exercisable through the second anniversary of his separation date.  This modification resulted in a charge of $1.6 million in stock-based compensation.  

In 2019, the Company granted performance based RSUs to its current CEO that only vest based on the total shareholder return of the Company common stock price relative to that of a specified targeted index.  The fair value of these performance based RSUs is based on the Monte Carlo simulation model using the following assumptions:

 

 

 

Years Ended December 31,

 

 

 

2019

 

Index volatility

 

36%

 

Company volatility

 

45%

 

Risk-free interest rate

 

2.4%

 

Correlation with index

 

0.28

 

Dividend Yield

 

0%

 

 

116

 

A summary of pre-tax stock-based compensation expense by line items in the consolidated statements of operations was as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Cost of revenue

 

$

3,061

 

 

$

2,656

 

 

$

1,878

 

Research and development

 

 

6,323

 

 

 

5,871

 

 

 

4,601

 

Sales, general and administrative

 

 

32,313

 

 

 

28,110

 

 

 

19,664

 

Total stock-based compensation expense

 

$

41,697

 

 

$

36,637

 

 

$

26,143

 

 

A summary of pre-tax stock-based compensation expense by category was as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Stock options

 

$

10,312

 

 

$

13,765

 

 

$

13,412

 

Restricted stock units

 

 

28,845

 

 

 

21,006

 

 

 

11,197

 

Employee stock purchase plan

 

 

2,540

 

 

 

1,866

 

 

 

1,534

 

Total stock-based compensation expense

 

$

41,697

 

 

$

36,637

 

 

$

26,143

 

 

As of December 31, 2019, total stock-based compensation expense not yet recognized, net of estimated forfeitures, were as follows:

 

 

 

Unrecognized

 

 

Weighted-Average

 

 

 

Compensation

 

 

Amortization Period

 

 

 

(in thousands)

 

 

(in years)

 

Stock options

 

$

14,720

 

 

 

2.7

 

Restricted stock units

 

 

62,680

 

 

 

2.6

 

Employee stock purchase plan

 

 

1,262

 

 

 

0.4

 

 

11. Income Taxes

The components of the Company’s income / (loss) before income taxes were as follows:

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

 

 

(in thousands)

 

Domestic

 

$

(106,010

)

 

$

(52,755

)

 

$

(39,370

)

Foreign

 

 

3,923

 

 

 

4,318

 

 

 

4,120

 

Total loss before income taxes

 

$

(102,087

)

 

$

(48,437

)

 

$

(35,250

)

 

117

 

The components of the expense / (benefit) for income taxes are as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Current:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

(103

)

 

$

—

 

 

$

—

 

State

 

 

187

 

 

 

220

 

 

 

170

 

Foreign

 

 

1,644

 

 

 

1,477

 

 

 

1,238

 

Total current income tax expense / (benefit)

 

 

1,728

 

 

 

1,697

 

 

 

1,408

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

 

—

 

 

 

—

 

 

 

—

 

State

 

 

—

 

 

 

—

 

 

 

—

 

Foreign

 

 

(129

)

 

 

(929

)

 

 

—

 

Total deferred income tax expense / (benefit)

 

 

(129

)

 

 

(929

)

 

 

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total income tax expense / (benefit)

 

$

1,599

 

 

$

768

 

 

$

1,408

 

 

Income tax expense differs from the amount computed by applying the statutory federal income tax rate as follows:

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Tax at statutory federal rate

 

 

21.0

%

 

 

21.0

%

 

 

34.0

%

State tax, net of federal benefit

 

 

(0.1

)%

 

 

(0.4

)%

 

 

(0.4

)%

Foreign rate differential

 

 

(0.7

)%

 

 

(1.0

)%

 

 

0.5

%

Tax credits

 

 

3.0

%

 

 

2.8

%

 

 

4.5

%

Excess tax benefits related to stock-based compensation

 

 

3.8

%

 

 

2.0

%

 

 

21.5

%

Effect of Tax Cuts and Jobs Act of 2017

 

 

—

%

 

 

—

%

 

 

(121.1

)%

Change in valuation allowance

 

 

(26.4

)%

 

 

(21.2

)%

 

 

61.4

%

Other

 

 

(2.2

)%

 

 

(4.9

)%

 

 

(4.4

)%

Total

 

 

(1.6

)%

 

 

(1.7

)%

 

 

(4.0

)%

 

The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities are as follows:

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

 

 

(in thousands)

 

Net operating loss carryforwards

 

$

94,680

 

 

$

68,552

 

Tax credits

 

 

17,095

 

 

 

12,451

 

Depreciation

 

 

463

 

 

 

339

 

Stock-based compensation

 

 

9,372

 

 

 

10,770

 

Accruals and reserves

 

 

9,569

 

 

 

7,507

 

Lease liabilities

 

 

5,887

 

 

 

—

 

Other

 

 

1,096

 

 

 

2,057

 

Deferred tax assets

 

 

138,162

 

 

 

101,676

 

 

 

 

 

 

 

 

 

 

Right of use asset

 

 

(5,294

)

 

 

—

 

Deferred tax liabilities

 

 

(5,294

)

 

 

—

 

 

 

 

 

 

 

 

 

 

Valuation allowance

 

 

(131,807

)

 

 

(100,747

)

 

 

 

 

 

 

 

 

 

Net deferred tax assets

 

$

1,061

 

 

$

929

 

118

 

Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, substantially all of the net deferred tax assets have been offset by a valuation allowance. The valuation allowance increased by $31.1 million and $12.6 million for the years ended December 31, 2019 and 2018, respectively.

As of December 31, 2019, the Company had federal net operating loss carryforwards (NOLs) of approximately $398.5 million, of which $139.5 million was generated in fiscal year 2018 and thereafter, which can be carried forward indefinitely under the 2017 Tax Act, as well as state NOLs of approximately $194.8 million, of which $22.1 million may be carried forward indefinitely. If not utilized, the remaining federal NOLs will begin to expire in 2026, and the remaining state NOLs will begin to expire in 2020.

As of December 31, 2019, the Company had research and development credit carryforwards of approximately $13.7 million and $9.2 million for federal and California state income tax purposes, respectively. The federal credit carryforward begins expiring in 2026, and the state credits carry forward indefinitely.

Under Section 382 of the Internal Revenue Code of 1986, as amended, the Company’s ability to utilize NOLs or other tax attributes such as research tax credits, in any taxable year may be limited if the Company experiences, or has experienced, a Section 382 “ownership change.” A Section 382 “ownership change” generally occurs if one or more stockholders or groups of stockholders, who own at least 5% of the Company’s stock, increase their ownership by a greater than 50 percentage point change (by value) over a rolling three-year period. Similar rules may apply under state tax laws. As a result of the Company’s June 2015 underwritten public offering, the Company experienced a Section 382 “ownership change.”  The Company currently estimates that this “ownership change” will not inhibit its ability to utilize its NOLs. However, the Company may, in the future, experience one or more additional Section 382 “ownership changes” as a result of subsequent changes in its stock ownership, some of which changes are outside the Company’s control.  If so, the Company may not be able to utilize a material portion of its NOLs and tax credits, even if the Company achieves profitability.

The Company had unrecognized tax benefits (UTBs) of approximately $7.4 million as of December 31, 2019. The following table summarizes the activity related to UTBs (in thousands):

 

Balance at December 31, 2016

 

$

3,384

 

Increases related to current year tax provisions

 

 

790

 

Increases related to prior year tax provisions

 

 

193

 

Decreases related to prior year tax provisions

 

 

(134

)

Balance at December 31, 2017

 

 

4,233

 

Increases related to current year tax provisions

 

 

893

 

Increases related to prior year tax provisions

 

 

80

 

Decreases related to prior year tax provisions

 

 

(6

)

Balance at December 31, 2018

 

 

5,200

 

Increases related to current year tax provisions

 

 

1,611

 

Increases related to prior year tax provisions

 

 

572

 

Decreases related to prior year tax provisions

 

 

—

 

Balance at December 31, 2019

 

$

7,383

 

 

If these UTBs were recognized, approximately $7.4 million would affect the effective tax rate before consideration of the valuation allowance. The Company does not expect any material changes to the estimated amount of liability associated with its uncertain tax positions within the next twelve months.

In accordance with ASC 740, Income Taxes, the Company is classifying interest and penalties as a component of tax expense. There was a nominal amount of interest and penalties accrued at December 31, 2019.  There were no interest or penalties accrued at December 31, 2018 and December 31, 2017.

The Company files U.S. federal and state income tax and foreign income tax returns with varying statues of limitations. The Company’s U.S. federal and state tax years from inception in 2006 will remain open to examination

119

 

due to the carryover of the unused NOLs and tax credits. The Company does not have any tax audits or other proceedings pending.

12. Net Loss Per Share

The following table summarizes the computation of basic and diluted net loss per share (in thousands, except share and per share data):

 

 

 

 

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Net loss

 

$

(103,686

)

 

$

(49,205

)

 

$

(36,658

)

Weighted average shares outstanding

 

 

30,803,872

 

 

 

30,051,961

 

 

 

29,424,360

 

Less: weighted average shares subject to repurchase

 

 

—

 

 

 

—

 

 

 

(306

)

Weighted average shares used to compute basic and

   diluted net loss per share

 

 

30,803,872

 

 

 

30,051,961

 

 

 

29,424,054

 

Net loss per share, basic and diluted

 

$

(3.37

)

 

$

(1.64

)

 

$

(1.25

)

Basic net loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and potentially dilutive securities outstanding for the period, determined using the treasury-stock method, if inclusion of these is dilutive. Because the Company has reported a net loss for all periods presented, diluted net loss per common share is the same as basic net loss per common share for those periods.

The following potentially dilutive securities outstanding at the end of the periods presented have been excluded from the computation of diluted shares outstanding:

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Unreleased restricted stock

 

 

1,288,332

 

 

 

1,010,123

 

 

 

720,840

 

Options to purchase common stock

 

 

1,646,185

 

 

 

2,529,740

 

 

 

2,559,972

 

Convertible senior notes

 

 

1,790,033

 

 

 

1,790,033

 

 

 

1,790,033

 

Warrants related to the issuance of convertible senior notes

 

 

1,790,033

 

 

 

1,790,033

 

 

 

1,790,033

 

Total

 

 

6,514,583

 

 

 

7,119,929

 

 

 

6,860,878

 

 

Additionally, since the Company expects to settle the principal amount of its outstanding convertible senior notes in cash, the Company uses the treasury stock method for calculating any potential dilutive effect of the conversion spread on diluted net income per share, if applicable. The conversion spread will have a dilutive impact on diluted net income per share of common stock when the average market price of the Company’s common stock for a given period exceeds the conversion price of $96.37 per share for the 2021 Notes. Although this condition was met in the three months ended December 31, 2019, the Company excluded the potential shares issuable upon conversion of the 2021 Notes in the calculation of diluted earnings per share, as their inclusion would have been anti-dilutive due to the net loss position of the Company during this period. In connection with the issuance of the 2021 Notes, the Company entered into convertible bond hedges. The convertible bond hedges are not included for purposes of calculating the number of diluted shares outstanding, as their effect would be anti-dilutive. The convertible bond hedges are generally expected, but not guaranteed, to reduce the potential dilution and/or offset the cash payments the Company is required to make upon conversion of the 2021 Notes.

13. Employee Benefit Plan.

In 2007, the Company adopted a 401(K) plan for its employees whereby eligible employees may contribute up to the maximum amount permitted by the Internal Revenue Code of 1986, as amended.  In June 2016, the Company adopted a policy to match a portion of employee contributions for all qualified employees participating in the 401(k)

120

 

plan.  For the years ended December 31, 2019, 2018 and 2017, the Company recorded expenses of $3.1 million, $2.5 million and $2.2 million for matching contributions, respectively.

14. Selected Quarterly Financial Information (Unaudited)

 

 

 

Three Months Ended

 

 

 

December 31,

 

 

September 30,

 

 

June 30,

 

 

March 31,

 

 

 

2019

 

 

2019

 

 

2019

 

 

2019

 

 

 

(in thousands, except per share data)

 

Total revenue

 

$

114,374

 

 

$

100,162

 

 

$

93,571

 

 

$

82,148

 

Gross profit

 

$

81,258

 

 

$

69,940

 

 

$

63,943

 

 

$

53,209

 

Loss from operations

 

$

(11,681

)

 

$

(15,984

)

 

$

(26,560

)

 

$

(42,254

)

Net loss

 

$

(13,742

)

 

$

(17,847

)

 

$

(28,021

)

 

$

(44,076

)

Net loss per share, basic and diluted

 

$

(0.44

)

 

$

(0.58

)

 

$

(0.91

)

 

$

(1.45

)

Shares used in computing net loss per common

   share, basic and diluted

 

 

31,233,416

 

 

 

30,929,938

 

 

 

30,677,567

 

 

 

30,363,623

 

 

 

 

Three Months Ended

 

 

 

December 31,

 

 

September 30,

 

 

June 30,

 

 

March 31,

 

 

 

2018

 

 

2018

 

 

2018

 

 

2018

 

 

 

(in thousands, except per share data)

 

Total revenue

 

$

107,944

 

 

$

95,630

 

 

$

96,080

 

 

$

87,635

 

Gross profit

 

$

76,154

 

 

$

67,248

 

 

$

67,921

 

 

$

62,001

 

Loss from operations

 

$

(8,603

)

 

$

(9,237

)

 

$

(8,201

)

 

$

(15,702

)

Net loss

 

$

(9,607

)

 

$

(11,265

)

 

$

(10,620

)

 

$

(17,713

)

Net loss per share, basic and diluted

 

$

(0.32

)

 

$

(0.37

)

 

$

(0.35

)

 

$

(0.59

)

Shares used in computing net loss per common

   share, basic and diluted

 

 

30,214,454

 

 

 

30,123,188

 

 

 

30,028,985

 

 

 

29,836,277

 

 

121

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the Exchange Act) refers to controls and procedures that are designed to provide reasonable assurance that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their control objectives.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2019, the end of the period covered by this Annual Report. Based upon such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of such date.

Management’s Annual Report on Internal Control Over Financial Reporting

Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed by, or under the supervision of, our Chief Executive Officer and Chief Financial Officer, and effected by our Board of Directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:

 

•

Pertain to the maintenance of records that accurately and fairly reflect in reasonable detail the transactions and dispositions of the assets of our company;

 

•

Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and

 

•

Provide reasonable assurances regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material adverse effect on our financial statements.

Our management assessed our internal control over financial reporting as of December 31, 2019, the end the period covered by this Annual Report. Management based its assessment on criteria established in “Internal Control—Integrated Framework (2013)” issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on management's assessment of our internal control over financial reporting, management concluded that, as of December 31, 2019, our internal control over financial reporting was effective.

Internal control over financial reporting has inherent limitations. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. Internal control over financial reporting also can be circumvented by collusion or

122

 

improper management override. Because of such limitations, there is a risk that material misstatements will not be prevented or detected on a timely basis by internal control over financial reporting. However, these inherent limitations are known features of the financial reporting process. Therefore, it is possible to design into the process safeguards to reduce, though not eliminate, this risk.

The effectiveness of the Company’s internal control over financial reporting as of December 31, 2019 has been audited by PricewaterhouseCoopers LLP, an independent registered public accounting firm, as stated in their report which appears in Part II, Item 8 of this Annual Report.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the most recent fiscal quarter covered by this Annual Report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION

None.

123

 

PART III

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

Executive Officers, Significant Employee and Non-Employee Directors of the Registrant

The information required by this Item 10 is hereby incorporated by reference from the information under the captions “Executive Officers,” “Election of Directors”, “Corporate Governance” and “Section 16(a) Beneficial Ownership Reporting Compliance” that will be contained in the Proxy Statement for our 2020 Annual Meeting of Stockholders (or the Proxy Statement).

We have adopted a written code of conduct and ethics that applies to our principal executive officer, principal financial officer, principal accounting officer or controller, or persons serving similar functions. The text of our code of business conduct and ethics has been posted on our website at http://www.nevro.com. We intend to satisfy the disclosure requirements under Item 5.05 of the SEC Form 8-K regarding an amendment to, or waiver from, a provision of our Code of Conduct by posting such information on our website at the website address specified above.

ITEM 11. EXECUTIVE COMPENSATION

The information required by this Item 11 is incorporated by reference from the information under the captions “Director Compensation,” “Executive Compensation” and “Corporate Governance” that will be contained in the Proxy Statement.

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The information required by this Item 12 is incorporated by reference from the information under the captions “Equity Compensation Plan Information” and “Security Ownership of Certain Beneficial Owners and Management” that will be contained in the Proxy Statement.

The information required by this Item 13 is incorporated by reference from the information under the captions “Certain Relationships and Related Transactions” and “Corporate Governance” that will be contained in the Proxy Statement.

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

The information required by this Item 14 is incorporated by reference from the information under the caption “Ratification of Appointment of Independent Registered Public Accounting Firm” that will be contained in the Proxy Statement.

124

 

PART IV

ITEM 15. EXHIBITS and FINANCIAL STATEMENT SCHEDULES

(a)The following documents are filed as part of this Annual Report:

1.

Consolidated Financial Statements:

Reference is made to the Index to consolidated financial statements of Nevro Corp. under Item 8 of Part II hereof.

2.

Financial Statement Schedule:

All schedules are omitted because they are not applicable or the amounts are immaterial or the required information is presented in the consolidated financial statements and notes thereto in Part II, Item 8 above.

3.

Exhibits

See Exhibit Index below.

Exhibit Index

 

Exhibit

Number

 

Exhibit Description

 

Incorporated

by

Reference

Form

 

Date

 

Number

 

Filed Herewith

 

 

 

 

 

 

 

 

 

 

 

    3.1

 

Amended and Restated Certificate of Incorporation of Nevro Corp.

 

8-K

 

11/12/2014

 

3.1

 

 

 

 

 

 

 

 

 

 

 

 

 

    3.1(b)

 

Certificate of Amendment to Amended and Restated Certificate of Incorporation of Nevro Corp.

 

8-K

 

5/24/2019

 

3.1

 

 

 

 

 

 

 

 

 

 

 

 

 

    3.2

 

Amended and Restated Bylaws of Nevro Corp.

 

8-K

 

11/12/2014

 

3.1

 

 

 

 

 

 

 

 

 

 

 

 

 

    3.2(b)

 

Amendment to Amended and Restated Bylaws of Nevro Corp.

 

8-K

 

5/24/2019

 

3.2

 

 

 

 

 

 

 

 

 

 

 

 

 

    4.1

 

Reference is made to exhibits 3.1 and 3.2.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    4.2

 

Form of Common Stock Certificate.

 

S-1/A

 

10/27/2014

 

4.2

 

 

 

 

 

 

 

 

 

 

 

 

 

    4.3

 

Indenture, dated as of June 13, 2016, by and between the Company and Wilmington Trust, National Association.

 

8-K

 

6/13/2016

 

4.1

 

 

 

 

 

 

 

 

 

 

 

 

 

    4.4

 

First Supplemental Indenture, dated as of June 13, 2016, by and between the Company and Wilmington Trust, National Association.

 

8-K

 

6/13/2016

 

4.2

 

 

 

 

 

 

 

 

 

 

 

 

 

    4.5

 

Form of 1.75% Convertible Senior Note Due 2021.

 

8-K

 

6/13/2016

 

4.3

 

 

 

 

 

 

 

 

 

 

 

 

 

    4.6

 

Description of Nevro Corp.’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

  10.1†

 

Amended and Restated License Agreement, dated October 2, 2006, by and among the Company and Mayo Foundation for Medical Education and Research, Venturi Group, LLC.

 

S-1/A

 

10/15/2014

 

10.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

125

 

Exhibit

Number

 

Exhibit Description

 

Incorporated

by

Reference

Form

 

Date

 

Number

 

Filed Herewith

  10.2(a)†

 

Stellar Manufacturing Agreement, dated as of July 1, 2009, by and between the Company and Stellar Technologies, Inc.

 

S-1/A

 

10/15/2014

 

10.2(a)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.2(b)†

 

First Amendment to Stellar Manufacturing Agreement, dated as of July 1, 2014, by and between the Company and Stellar Technologies, Inc.

 

S-1/A

 

10/15/2014

 

10.2(b)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.2(c)†

 

Second Amendment to Stellar Manufacturing Agreement, dated as of January 28, 2016, by and between the Company and Stellar Technologies, Inc.

 

10-K

 

2/29/2016

 

10.2(c)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.3†

 

Supply Agreement, dated as of July 23, 2014 by and between the Company and Pro-Tech Design and Manufacturing, Inc.

 

S-1/A

 

10/15/2014

 

10.3

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.4(a)†

 

Supply Agreement, dated April 1, 2012, by and between the Company and CCC del Uruguay S.A.

 

S-1/A

 

10/15/2014

 

10.4(a)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.4(b)†

 

Amendment to Supply Agreement, dated as of March 20, 2013, by and between the Company and CCC del Uruguay S.A.

 

S-1/A

 

10/15/2014

 

10.4(b)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.5(a)†

 

Product Supply and Development Agreement, dated as of April 15, 2009, by and between the Company and EaglePicher Medical Power LLC.

 

S-1/A

 

10/15/2014

 

10.5

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.5(b)†

 

First Amendment to the Product Supply and Development Agreement, dated as of March 4, 2015, by and between the Company and EaglePicher Medical Power LLC.

 

10-K

 

3/18/2015

 

10.5(b)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.5(c)†

 

Second Amendment to the Product Supply and Development Agreement, dated as of October 23, 2015, by and between the Company and EaglePicher Medical Power LLC.

 

10-K

 

2/29/2016

 

10.5(c)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.5(d)

 

Third Amendment to the Product Supply and Development Agreement, dated as of September 15, 2017, by and between the Company and EaglePicher Medical Power LLC.

 

10-Q

 

11/6/2017

 

10.1

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.6(a)

 

Amended and Restated Registration Rights Agreement, dated February 8, 2013, by and among the Company and the investors listed therein.

 

S-1

 

10/03/2014

 

10.6(a)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.6(b)

 

Amendment to Amended and Restated Registration Rights Agreement, dated March 5, 2013, by and among the Company and the investors listed therein.

 

S-1

 

10/03/2014

 

10.6(b)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.6(c)

 

Second Amendment to Amended and Restated Registration Rights Agreement, dated October 24, 2014, by and among the Company and the investors listed therein.

 

S-1/A

 

11/04/14

 

10.6(c)

 

 

 

 

 

 

 

 

 

 

 

 

 

126

 

Exhibit

Number

 

Exhibit Description

 

Incorporated

by

Reference

Form

 

Date

 

Number

 

Filed Herewith

  10.7(a)

 

Multi-Tenant Space Lease, dated as of March 15, 2010, by and between Deerfield Campbell LLC and the Company.

 

S-1

 

10/03/2014

 

10.7(a)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.7(b)

 

First Amendment to Lease, dated as of October 18, 2012, by and between Deerfield Campbell LLC and the Company.

 

S-1

 

10/03/2014

 

10.7(b)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.7(c)

 

Second Amendment to Lease, dated as of February 18, 2015, by and between Deerfield Campbell LLC and the Company.

 

10-K

 

3/18/2015

 

10.7(c)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.8(a)#

 

Nevro Corp. 2007 Stock Incentive Plan, as amended as of March 5, 2013.

 

S-1

 

10/03/2014

 

10.8(a)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.8(b)#

 

Form of Incentive Stock Option Agreement (ISO) under the 2007 Stock Incentive Plan, as amended.

 

S-1

 

10/03/2014

 

10.8(b)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.8(c)#

 

Form of Non-Incentive Stock Option Agreement (NSO) under the 2007 Stock Incentive Plan, as amended.

 

S-1

 

10/03/2014

 

10.8(c)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.8(d)#

 

Form of Stock Purchase Right Grant Notice and Restricted Stock Purchase Agreement under the 2007 Stock Incentive Plan, as amended.

 

S-1

 

10/03/2014

 

10.8(d)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.9(a)#

 

Nevro Corp. 2014 Equity Incentive Award Plan.

 

S-8

 

11/12/2014

 

99.2(a)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.9(b)#

 

Form of Stock Option Grant Notice and Stock Option Agreement under the 2014 Equity Incentive Award Plan.

 

S-1/A

 

10/10/2014

 

10.9(b)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.9(c)#

 

Form of Restricted Stock Award Agreement and Restricted Stock Award Grant Notice under the 2014 Equity Incentive Award Plan.

 

S-1/A

 

10/10/2014

 

10.9(c)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.9(d)#

 

Form of Restricted Stock Unit Award Agreement and Restricted Stock Unit Award Grant Notice under the 2014 Equity Incentive Award Plan.

 

S-1/A

 

10/10/2014

 

10.9(d)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.10#

 

Nevro Corp. 2014 Employee Stock Purchase Plan.

 

S-8

 

11/12/2014

 

99.3

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.11#

 

Form of Indemnification Agreement for directors and officers.

 

S-1/A

 

10/10/2014

 

10.11

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.12#

 

Amended and Restated Company Bonus Plan.

 

10-Q

 

5/7/2018

 

10.1

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.13#

 

Nevro Corp. Non-Employee Director Compensation Program, as amended.

 

10-Q

 

8/8/2019

 

10.2

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.14#

 

Employment Agreement by and between D. Keith Grossman and the Company, effective as of March 19, 2019.

 

10-Q

 

5/9/2019

 

10.1

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.15#

 

Offer Letter, dated as of October 9, 2012, by and between Rami Elghandour and the Company.

 

S-1

 

10/03/2014

 

10.13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

127

 

Exhibit

Number

 

Exhibit Description

 

Incorporated

by

Reference

Form

 

Date

 

Number

 

Filed Herewith

  10.15(b)#

 

Employment Agreement, effective as of June 1, 2016, by and between Rami Elghandour and the Company.

 

10-Q

 

5/9/2016

 

10.3

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.15(c)#

 

Separation Agreement, dated March 18, 2019, by and between Rami Elghandour and the Company.

 

10-Q

 

5/9/2019

 

10.2

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.16#

 

Offer Letter, dated as of May 12, 2010, by and between Andrew H. Galligan and the Company.

 

S-1

 

10/03/2014

 

10.14

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.17(a)

 

Amended and Restated Stockholders’ Agreement, dated February 8, 2013, by and among the Company and the stockholders listed therein.

 

S-1

 

10/03/2014

 

10.15(a)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.17(b)

 

Amendment to Amended and Restated Stockholders’ Agreement, dated March 5, 2013, by and among the Company and the stockholders listed therein.

 

S-1

 

10/03/2014

 

10.15(b)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.17(c)

 

Second Amendment to Amended and Restated Stockholders’ Agreement, dated October 24, 2014, by and among the Company and the investors listed therein.

 

S-1/A

 

11/04/14

 

10.18(c)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.18(a)#

 

Form of Amended and Restated Change in Control Severance Agreement for certain executive officers.

 

10-Q

 

5/9/2016

 

10.4

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.18(b)#

 

Amended and Restated Change in Control Severance Agreement, dated as of June 5, 2019, by and between Andrew Galligan and the Company.

 

10-Q

 

8/8/2019

 

10.1

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.18(c)#

 

Amended and Restated Change in Control Severance Agreement, dated as of July 22, 2019, by and between Doug Alleavitch and the Company.

 

10-Q

 

11/6/2019

 

10.1

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.18(d)#

 

Amended and Restated Change in Control Severance Agreement, dated as of July 22, 2019, by and between Patrick Schmitz and the Company.

 

10-Q

 

11/6/2019

 

10.3

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.18(e)#

 

Amended and Restated Change in Control Severance Agreement, dated as of August 3, 2016, by and between Christofer Christoforou and the Company.

 

10-K

 

2/22/2018

 

10.18(e)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.18(f)#

 

Amended and Restated Change in Control Severance Agreement, dated as of July 22, 2019, by and between Kashif Rashid and the Company.

 

10-Q

 

11/6/2019

 

10.2

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.18(g)#

 

Change in Control Severance Agreement, dated as of September 16, 2019, by and between Niamh Pellegrini and the Company.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

  10.19(a)†

 

Supply Agreement, dated March 13, 2015, by and between the Company and Centro de Construccion de Cardioestimuladores del Uruguay S.A.

 

10-K/A

 

5/29/2015

 

10.22

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

128

 

Exhibit

Number

 

Exhibit Description

 

Incorporated

by

Reference

Form

 

Date

 

Number

 

Filed Herewith

  10.19(b)†

 

Supply Agreement, effective as of November 11, 2016, by and between the Company and Centro de Construccion de Cardioestimuladores del Uruguay S.A.

 

10-K

 

2/23/2017

 

10.22(b)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.19(c)†

 

First Amendment to Supply Agreement, effective as of April 30, 2019, by and between the Company and Centro de Construccion de Cardioestimuladores del Uruguay S.A.

 

10-Q

 

8/8/2019

 

10.3

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.20(a)

 

Lease Agreement, dated as of March 5, 2015, by and between the Company and Westport Office Park, LLC.

 

10-K

 

3/18/2015

 

10.23

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.20(b)

 

First Amendment to Lease, effective as of December 9, 2016, by and between the Company and Westport Office Park, LLC.

 

10-K

 

2/23/2017

 

10.23(b)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.20(c)

 

Second Amendment to Lease, effective as of April 13, 2017, by and between the Company and Westport Office Park, LLC.

 

10-Q

 

8/7/2017

 

10.1

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.20(d)

 

Third Amendment to Lease, effective as of December 6, 2017, by and between the Company and Westport Office Park, LLC.

 

10-K

 

2/22/2018

 

10.21(d)

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.21#

 

Offer Letter, dated as of March 30, 2015, by and between the Company and Doug Alleavitch.

 

8-K

 

4/9/2015

 

10.1

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.21(b)#

 

Transition and Separation Agreement, dated as of January 7, 2020, by and between the Company and Doug Alleavitch.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

  10.22(a)†

 

Manufacturing and Supply Agreement, dated as of December 18, 2015, by and between the Company and Vention Medical Design and Development, Inc.

 

10-K

 

2/29/2016

 

10.25

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.22(b)†

 

First Amendment to the Manufacturing and Supply Agreement, dated as of September 30, 2017, by and between the Company and Vention Medical Design and Development, Inc.

 

10-Q

 

11/6/2017

 

10.2

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.22(c)†

 

Second Amendment to the Manufacturing and Supply Agreement, dated April 2018, by and between the Company and Nordson MEDICAL Design and Development, Inc., fka Vention Medical Design and Development, Inc.

 

10-Q

 

8/2/2018

 

10.2

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.23

 

Settlement Agreement, dated March 19, 2019, by and among Broadfin Capital, LLC and certain of its affiliates named therein and the Company.

 

8-K

 

3/20/2019

 

10.1

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.24

 

Letter Agreement, dated June 7, 2016, between Morgan Stanley & Co. International plc and the Company, regarding the Base Warrants.

 

8-K

 

6/13/2016

 

10.1

 

 

 

 

 

 

 

 

 

 

 

 

 

129

 

Exhibit

Number

 

Exhibit Description

 

Incorporated

by

Reference

Form

 

Date

 

Number

 

Filed Herewith

  10.25

 

Letter Agreement, dated June 7, 2016, between Bank of America, N.A. and the Company, regarding the Base Warrants.

 

8-K

 

6/13/2016

 

10.2

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.26

 

Letter Agreement, dated June 7, 2016, between Goldman, Sachs & Co. and the Company, regarding the Base Warrants.

 

8-K

 

6/13/2016

 

10.3

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.27

 

Letter Agreement, dated June 7, 2016, between Morgan Stanley & Co. International plc and the Company, regarding the Base Call Option Transaction.

 

8-K

 

6/13/2016

 

10.4

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.28

 

Letter Agreement, dated June 7, 2016, between Bank of America, N.A. and the Company, regarding the Base Call Option Transaction.

 

8-K

 

6/13/2016

 

10.5

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.29

 

Letter Agreement, dated June 7, 2016, between Goldman, Sachs & Co. and the Company, regarding the Base Call Option Transaction.

 

8-K

 

6/13/2016

 

10.6

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.30

 

Letter Agreement, dated June 8, 2016, between Morgan Stanley & Co. International plc and the Company, regarding the Additional Warrants.

 

8-K

 

6/13/2016

 

10.7

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.31

 

Letter Agreement, dated June 8, 2016, between Bank of America, N.A. and the Company, regarding the Additional Warrants.

 

8-K

 

6/13/2016

 

10.8

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.32

 

Letter Agreement, dated June 8, 2016, between Goldman, Sachs & Co. and the Company, regarding the Additional Warrants.

 

8-K

 

6/13/2016

 

10.9

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.33

 

Letter Agreement, dated June 8, 2016, between Morgan Stanley & Co. International plc and the Company, regarding the Additional Call Option Transaction.

 

8-K

 

6/13/2016

 

10.10

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.34

 

Letter Agreement, dated June 8, 2016, between Bank of America, N.A. and the Company, regarding the Additional Call Option Transaction.

 

8-K

 

6/13/2016

 

10.11

 

 

 

 

 

 

 

 

 

 

 

 

 

  10.35

 

Letter Agreement, dated June 8, 2016, between Goldman, Sachs & Co. and the Company, regarding the Additional Call Option Transaction.

 

8-K

 

6/13/2016

 

10.12

 

 

 

 

 

 

 

 

 

 

 

 

 

  21.1

 

List of Subsidiaries.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

  23.1

 

Consent of Independent Registered Public Accounting Firm.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

  24.1

 

Power of Attorney (included on signature page to this Annual Report on Form 10-K).

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

  31.1

 

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

  31.2

 

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

X

130

 

Exhibit

Number

 

Exhibit Description

 

Incorporated

by

Reference

Form

 

Date

 

Number

 

Filed Herewith

 

 

 

 

 

 

 

 

 

 

 

  32.1**

 

Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

101.INS

 

XBRL Instance.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

101.SCH

 

XBRL Taxonomy Extension Schema.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

101.CAL

 

XBRL Taxonomy Extension Calculation Linkbase.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

101.LAB

 

XBRL Taxonomy Extension Label Linkbase.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

101.PRE

 

XBRL Taxonomy Extension Presentation Linkbase.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

101.DEF

 

XBRL Taxonomy Extension Definition Linkbase.

 

 

 

 

 

 

 

X

 

 

 

 

 

 

 

 

 

 

 

104

 

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

 

 

 

 

 

 

 

 

†

Confidential treatment has been granted for certain information contained in this exhibit. Such information

has been omitted and filed separately with the Securities and Exchange Commission.

#

Indicates management contract or compensatory plan.

**

The certification attached as Exhibit 32.1 that accompanies this Form 10-K is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Nevro Corp. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Form 10-K, irrespective of any general incorporation language contained in such filing.

 

ITEM 16. FORM 10-K SUMMARY

None.

 

131

 

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

February 25, 2020:

 

NEVRO CORP.

 

 

 

By:

 

/s/ D. Keith Grossman

 

 

D. Keith Grossman

President and Chief Executive Officer

 

POWER OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of D. Keith Grossman and Andrew H. Galligan his or her true and lawful attorney-in-fact and agent, with full power of substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitutes or substitute, may lawfully do or cause to be done by virtue hereof.

IN WITNESS WHEREOF, each of the undersigned has executed this Power of Attorney as of the date indicated opposite his/her name.

Pursuant to the requirements of the Securities Act, this report has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

Title

Date

 

 

 

/s/ D. Keith Grossman

Chief Executive Officer

February 25, 2020

D. Keith Grossman

(Principal Executive Officer)

 

 

 

 

/s/ ANDREW H. GALLIGAN

Chief Financial Officer

February 25, 2020

Andrew H. Galligan

(Principal Financial and

Accounting Officer)

 

 

 

 

/s/ MICHAEL DEMANE

Lead Director

February 25, 2020

Michael DeMane

 

 

 

 

 

/s/ FRANK FISCHER

Director

February 25, 2020

Frank Fischer

 

 

 

 

 

/s/ WILFRED E. JAEGER

Director

February 25, 2020

Wilfred E. Jaeger, M.D.

 

 

 

 

 

/s/ SHAWN T MCCORMICK

Director

February 25, 2020

Shawn T McCormick

 

 

 

 

 

/s/ KEVIN O’BOYLE

Director

February 25, 2020

Kevin O’Boyle

 

 

 

 

 

/s/ KAREN PRANGE

Director

February 25, 2020

Karen Prange

 

 

132

 

Signature

Title

Date

 

 

 

/s/ BRAD H. VALE

Director

February 25, 2020

Brad H. Vale, Ph.D., D.V.M

 

 

 

 

 

/s/ ELIZABETH WEATHERMAN

Director

February 25, 2020

Elizabeth Weatherman

 

 

 

133

 EX-4.6 2 nvro-ex46_607.htm EX-4.6 nvro-ex46_607.htm

Exhibit 4.6

DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT
TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

As of February 25, 2020, Nevro Corp. had one class of common stock registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

 

The following description of our common stock is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to our restated certificate of incorporation (the “Certificate of Incorporation”) and our amended and restated bylaws (the “Bylaws”), each of which is incorporated herein by reference as an exhibit to the Annual Report on Form 10-K filed with the Securities and Exchange Commission, of which this Exhibit 4.6 is a part. We encourage you to read our Certificate of Incorporation, our Bylaws and the applicable provisions of the General Corporation Law of the State of Delaware (the “DGCL”) for additional information.

 

Authorized Capital Stock

Our authorized capital stock consists of 300,000,000 shares, with a par value of $0.001 per share, of which 290,000,000 shares are designated as common stock and 10,000,000 shares are designated as preferred stock.

Each holder of our common stock is entitled to one vote for each share on all matters submitted to a vote of the stockholders, including the election of directors. Our stockholders do not have cumulative voting rights in the election of directors. Accordingly, holders of a majority of the voting shares are able to elect all of the directors. In addition, the affirmative vote of holders of a majority of the voting power of all of the then outstanding voting stock will be required to take certain actions, including amending certain provisions of our amended and restated certificate of incorporation, such as the provisions relating to amending our amended and restated bylaws, exclusive forum for certain legal proceedings and director liability. Subject to preferences that may be applicable to any then outstanding preferred stock, holders of our common stock are entitled to receive dividends, if any, as may be declared from time to time by our board of directors out of legally available funds. In the event of our liquidation, dissolution or winding up, holders of our common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then outstanding shares of preferred stock. Holders of our common stock have no preemptive, conversion, subscription or other rights, and there are no redemption or sinking fund provisions applicable to our common stock. The rights, preferences and privileges of the holders of our common stock are subject to and may be adversely affected by the rights of the holders of shares of any series of our preferred stock that we may designate in the future.

We have certain outstanding securities that may be converted, exercised or exchanged into shares of our common stock.

Registration Rights

Certain holders of unregistered common stock purchased in private placements, or their permitted transferees, are entitled to rights with respect to the registration of such shares under the Securities Act of 1933, as amended (the “Securities Act”). These rights are provided under the terms of an investors’ rights agreement between us and the holders of these shares, or the investors’ rights agreement, and include demand registration rights and piggyback registration rights. All fees, costs and expenses of underwritten registrations will be borne by us and all selling expenses, including underwriting discounts and selling commissions, will be borne by the holders of the shares being registered.

The registration rights terminate with respect to the registration rights of a particular stockholder when the holder can sell all of the holder’s shares in any three-month period under Rule 144 or another similar exemption under the Securities Act.

 

 

Listing

Our common stock is listed on the New York Stock Exchange under the symbol “NVRO.”

Transfer Agent and Registrar

The transfer agent and registrar for our common stock is EQ Shareowner Services.

Anti-Takeover Effects of Delaware Law and Our Certificate of Incorporation and Bylaws

Some provisions of Delaware law and our amended and restated certificate of incorporation and our amended and restated bylaws contain provisions that could make the following transactions more difficult: acquisition of us by means of a tender offer; acquisition of us by means of a proxy contest or otherwise; or removal of our incumbent officers and directors. It is possible that these provisions could make it more difficult to accomplish or could deter transactions that stockholders may otherwise consider to be in their best interest or in our best interests, including transactions that might result in a premium over the market price for our shares.

These provisions, summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors. We believe that the benefits of increased protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us outweigh the disadvantages of discouraging these proposals because negotiation of these proposals could result in an improvement of their terms.

Limits on Ability of Stockholders to Act by Written Consent or Call a Special Meeting

Our amended and restated bylaws provide that a special meeting of stockholders may be called at any time by the board of directors, but such special meetings may not be called by the stockholders or any other person or persons.

Our amended and restated certificate of incorporation eliminates the right of stockholders to act by written consent without a meeting.

Requirements for Advance Notification of Stockholder Nominations and Proposals

Our amended and restated bylaws establish advance notice procedures with respect to stockholder proposals and the nomination of candidates for election as directors, other than nominations made by or at the direction of our board of directors or a committee of our board of directors. These provisions may have the effect of precluding the conduct of certain business at a meeting if the proper procedures are not followed. These provisions may also discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer’s own slate of directors or otherwise attempting to obtain control of our company.

Board-related provisions

Our board of directors is currently divided into three classes. However, commencing with the 2022 annual meeting of stockholders, our board of directors shall no longer be divided into classes. Because our stockholders do not have cumulative voting rights, our stockholders holding a majority of the shares of common stock outstanding will be able to elect all of our directors. Our amended and restated certificate of incorporation provides for the removal of any of our directors only for cause and requires at least a majority of the voting power of all then outstanding shares of voting stock. Our amended and restated certificate of incorporation provides that the authorized number of directors may be changed only by resolution of the board of directors. Any vacancy on our board of directors may only be filled by a resolution of the board of directors unless the board of directors determines that such vacancies shall be filled by the stockholders.

 

 

Delaware Anti-Takeover Statute

We are subject to Section 203 of the Delaware General Corporation Law, which prohibits persons deemed “interested stockholders” from engaging in a “business combination” with a publicly-held Delaware corporation for three years following the date these persons become interested stockholders unless the business combination is, or the transaction in which the person became an interested stockholder was, approved in a prescribed manner or another prescribed exception applies. Generally, an “interested stockholder” is a person who, together with affiliates and associates, owns, or within three years prior to the determination of interested stockholder status did own, 15% or more of a corporation’s voting stock. Generally, a “business combination” includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. The existence of this provision may have an anti-takeover effect with respect to transactions not approved in advance by the board of directors, such as discouraging takeover attempts that might result in a premium over the market price of our common stock.

Limitations of Liability and Indemnification Matters

Our amended and restated certificate of incorporation contains provisions that limit the liability of our directors for monetary damages to the fullest extent permitted by Delaware law. Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as directors, except liability for:

 

•

any breach of the director’s duty of loyalty to us or our stockholders;

 

•

any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;

 

•

unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the Delaware General Corporation Law; and

 

•

any transaction from which the director derived an improper personal benefit.

Our amended and restated certificate of incorporation and amended and restated bylaws provide that we are required to indemnify our directors and officers, in each case to the fullest extent permitted by Delaware law. Our amended and restated bylaws also provide that we are obligated to advance expenses incurred by a director or officer in advance of the final disposition of any action or proceeding, and permit us to secure insurance on behalf of any officer, director, employee or other agent for any liability arising out of his or her actions in that capacity regardless of whether we would otherwise be permitted to indemnify him or her under Delaware law. We have entered and expect to continue to enter into agreements to indemnify our directors, executive officers and other employees as determined by our board of directors. With specified exceptions, these agreements provide for indemnification for related expenses including, among other things, attorneys’ fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding. We believe that these bylaw provisions and indemnification agreements are necessary to attract and retain qualified persons as directors and officers. We also maintain directors’ and officers’ liability insurance.

The limitation of liability and indemnification provisions in our amended and restated certificate of incorporation and amended and restated bylaws may discourage stockholders from bringing a lawsuit against our directors and officers for breach of their fiduciary duty. They may also reduce the likelihood of derivative litigation against our directors and officers, even though an action, if successful, might benefit us and our stockholders. Further, a stockholder’s investment may be adversely affected to the extent that we pay the costs of settlement and damage.

 

 EX-10.18(G) 3 nvro-ex1018g_523.htm EX-10.18(G) nvro-ex1018g_523.htm

Exhibit 10.18(g)

NEVRO CORP.

CHANGE IN CONTROL SEVERANCE AGREEMENT

This Change in Control Severance Agreement (the “Agreement”) is made and entered into by and between Niamh Pellegrini (“Executive”) and Nevro Corp. (the “Company”).  This Agreement is effective as of the latest date set forth by the signatures of the parties hereto below (the “Effective Date”).

R E C I T A L S

A.The Board of Directors of the Company (the “Board”) recognizes that the possibility of an acquisition of the Company or an involuntary termination can be a distraction to Executive and can cause Executive to consider alternative employment opportunities.  The Board has determined that it is in the best interests of the Company and its stockholders to assure that the Company will have the continued dedication and objectivity of Executive, notwithstanding the possibility, threat or occurrence of such an event.

B.The Board believes that it is in the best interests of the Company and its stockholders to provide Executive with an incentive to continue Executive’s employment and to motivate Executive to maximize the value of the Company upon a Change in Control (as defined below) for the benefit of its stockholders.

C.The Board believes that it is imperative to provide Executive with severance benefits upon certain terminations of Executive’s service to the Company that enhance Executive’s financial security and provide incentive and encouragement to Executive to remain with the Company notwithstanding the possibility of such an event.

D. Unless otherwise defined herein, capitalized terms used in this Agreement are defined in Section 9 below.

The parties hereto agree as follows:

1.Term of Agreement.  This Agreement shall become effective as of the Effective Date and terminate upon the date that all obligations of the parties hereto with respect to this Agreement have been satisfied.

2.At-Will Employment.  The Company and Executive acknowledge that Executive’s employment is and shall continue to be “at-will,” as defined under applicable law.  If Executive’s employment terminates for any reason, Executive shall not be entitled to any payments, benefits, damages, awards or compensation other than as provided by this Agreement.

3.Covered Termination Other Than During a Change in Control Period.  If Executive experiences a Covered Termination other than during a Change in Control Period, and if Executive

 

 

US-DOCS\108656691.1

 

delivers to the Company a general release of all claims against the Company and its affiliates (a “Release of Claims”) that becomes effective and irrevocable within sixty (60) days, or such shorter period of time specified by the Company, following such Covered Termination, then in addition to any accrued but unpaid salary, bonus, benefits, vacation and expense reimbursement payable in accordance with applicable law, the Company shall provide Executive with the following:

(a)Severance.  Executive shall be entitled to receive a severance payment equal to six (6) months of Executive’s base salary at the rate in effect immediately prior to the Termination Date payable in a cash lump sum, less applicable withholdings, on the first payroll date following the date the Release of Claims becomes effective and irrevocable.

(b)Continued Healthcare.  If Executive elects to receive continued healthcare coverage pursuant to the provisions of the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), the Company shall directly pay, or reimburse Executive for, the premium for Executive and Executive’ s covered dependents through the earlier of (i) the six (6) month anniversary of the Termination Date and (ii) the date Executive and Executive’s covered dependents, if any, become eligible for healthcare coverage under another employer’s plan(s).  After the Company ceases to pay premiums pursuant to the preceding sentence, Executive may, if eligible, elect to continue healthcare coverage at Executive’s expense in accordance the provisions of COBRA.

4.Covered Termination During a Change in Control Period.  If Executive experiences a Covered Termination during a Change in Control Period, and if Executive delivers a Release of Claims that becomes effective and irrevocable within sixty (60) days, or such shorter period of time specified by the Company, following such Covered Termination, then in addition to any accrued but unpaid salary, bonus, benefits, vacation and expense reimbursement payable in accordance with applicable law, the Company shall provide Executive with the following:

(a)Severance.  Executive shall be entitled to receive an amount equal to the sum of (i) eighteen (18) months of Executive’s annual base salary and (ii) 1.5 times Executive’s target annual bonus assuming achievement of performance goals at target, in each case, at the rate in effect immediately prior to the Termination Date, payable in a cash lump sum, less applicable withholdings, on the first payroll date following the date the Release of Claims becomes effective and irrevocable.

(b)Continued Healthcare.  If Executive elects to receive continued healthcare coverage pursuant to the provisions of COBRA, the Company shall directly pay, or reimburse Executive for, the premium for Executive and Executive’s covered dependents through the earlier of (i) the eighteen (18) month anniversary of the Termination Date and (ii) the date Executive and Executive’s covered dependents, if any, become eligible for healthcare coverage under another employer’s plan(s).  After the Company ceases to pay premiums pursuant to the preceding sentence, Executive may, if eligible, elect to continue healthcare coverage at Executive’s expense in accordance the provisions of COBRA.

-2-

 

US-DOCS\108656691.1

 

(c)Equity Awards.  Each outstanding and unvested equity award, including, without limitation, each stock option and restricted stock award, held by Executive shall automatically become vested and, if applicable, exercisable and any forfeiture restrictions or rights of repurchase thereon shall immediately lapse, in each case, with respect to one hundred percent (100%) of that number of unvested shares underlying Executive’s equity awards as of the Termination Date.  

5.Certain Reductions.  Notwithstanding anything herein to the contrary, the Company shall reduce Executive’s severance benefits under this Agreement, in whole or in part, by any other severance benefits, pay in lieu of notice, or other similar benefits payable to Executive by the Company in connection with Executive’s termination, including but not limited to payments or benefits pursuant to (a) any applicable legal requirement, including, without limitation, the Worker Adjustment and Retraining Notification Act, or (b) any Company agreement, arrangement, policy or practice relating to Executive’s termination of employment with the Company.  The benefits provided under this Agreement are intended to satisfy, to the greatest extent possible, any and all statutory obligations that may arise out of Executive’s termination of employment.  Such reductions shall be applied on a retroactive basis, with severance benefits previously paid being recharacterized as payments pursuant to the Company’s statutory obligation.

6.Deemed Resignation.  Upon termination of Executive’s employment for any reason, Executive shall be deemed to have resigned from all offices and directorships, if any, and then held with the Company or any of its affiliates, and, at the Company’s request, Executive shall execute such documents as are necessary or desirable to effectuate such resignations.

7.Other Terminations.  If Executive’s service with the Company is terminated by the Company or by Executive for any or no reason other than as a Covered Termination, then Executive shall not be entitled to any benefits hereunder other than accrued but unpaid salary, bonus, vacation and expense reimbursement in accordance with applicable law and to elect any continued healthcare coverage as may be required under COBRA or similar state law.  

8.Limitation on Payments. Notwithstanding anything in this Agreement to the contrary, if any payment or distribution Executive would receive pursuant to this Agreement or otherwise (“Payment”) would (a) constitute a “parachute payment” within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended (the “Code”), and (b) but for this sentence, be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment shall either be (i) delivered in full, or (ii) delivered as to such lesser extent which would result in no portion of such Payment being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax, results in the receipt by Executive on an after-tax basis, of the largest payment, notwithstanding that all or some portion the Payment may be taxable under Section 4999 of the Code. The accounting firm engaged by the Company for general audit purposes as of the day prior to the effective date of the Change in Control shall perform the foregoing calculations.  The Company shall bear all expenses with respect to the determinations by such accounting firm required to be made hereunder.  The accounting firm shall provide its calculations to the Company and Executive within fifteen (15) calendar days after the date on which Executive’s right to a Payment is triggered (if requested at that

-3-

 

US-DOCS\108656691.1

 

time by the Company or Executive) or such other time as requested by the Company or Executive.  Any good faith determinations of the accounting firm made hereunder shall be final, binding and conclusive upon the Company and Executive.  Any reduction in payments and/or benefits pursuant to this Section 8 will occur in the following order: (1) reduction of cash payments; (2) cancellation of accelerated vesting of equity awards other than stock options; (3) cancellation of accelerated vesting of stock options; and (4) reduction of other benefits payable to Executive.

9.Definition of Terms.  The following terms referred to in this Agreement shall have the following meanings:

(a)Cause.  “Cause” means (i) Executive’s gross negligence or willful misconduct in the performance of the duties and services required of Executive pursuant to this Agreement or Executive’s employment or offer letter agreement with the Company (the “Employment Agreement”); (ii) Executive’s conviction of a felony or crime involving moral turpitude; (iii) Executive’s willful refusal to perform the duties and responsibilities required of Executive under this Agreement or the Employment Agreement which remains uncorrected for thirty (30) days following written notice to Executive by the Company of such breach; (iv) Executive’s material breach of any material provision of this Agreement, the Employment Agreement, the Confidential Information Agreement (as defined below) or corporate code or policy which remains uncorrected for thirty (30) days following written notice to Executive by the Company of such breach; or (v) Executive violates the Foreign Corrupt Practices Act or other applicable United States law.  For purposes of this Section 9(a), an act or failure to act shall be considered “willful” only if done or omitted to be done without a good faith reasonable belief that such act or failure to act was in the best interests of the Company.

The foregoing definition shall not be deemed to be inclusive of all the acts or omissions that the Company (or any parent or subsidiary or acquiror or successor) may consider as reasonable grounds for Executive’s dismissal or discharge.

(b)Change in Control.  “Change in Control” means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events:

(i)A transaction or series of transactions (other than an offering of Common Stock to the general public through a registration statement filed with the Securities and Exchange Commission) whereby any “person” or related “group” of “persons” (as such terms are used in Sections 13(d) and 14(d)(2) of the Securities Exchange Act of 1934, as amended) (other than the Company, any of its subsidiaries, an employee benefit plan maintained by the Company or any of its subsidiaries or a “person” that, prior to such transaction, directly or indirectly controls, is controlled by, or is under common control with, the Company) directly or indirectly acquires beneficial ownership (within the meaning of Rule 13d-3 under the Securities Exchange Act of 1934, as amended) of securities of the Company possessing more than fifty percent (50%) of the total combined voting power of the Company’s securities outstanding immediately after such acquisition;

(ii)During any period of two (2) consecutive years, individuals who, at the beginning of such period, constitute the Board together with any new director(s) (other than a

-4-

 

US-DOCS\108656691.1

 

director designated by a person who shall have entered into an agreement with the Company to effect a transaction described in Sections 9(b)(i) or 9(b)(iii) hereof) whose election by the Board or nomination for election by the Company’s stockholders was approved by a vote of at least two-thirds (2/3) of the directors then still in office who either were directors at the beginning of the two (2)-year period or whose election or nomination for election was previously so approved, cease for any reason to constitute a majority thereof; or

(iii)The consummation by the Company (whether directly involving the Company or indirectly involving the Company through one or more intermediaries) of (x) a merger, consolidation, reorganization, or business combination or (y) a sale or other disposition of all or substantially all of the Company’s assets in any single transaction or series of related transactions or (z) the acquisition of assets or stock of another entity, in each case other than a transaction:

(1)which results in the Company’s voting securities outstanding immediately before the transaction continuing to represent (either by remaining outstanding or by being converted into voting securities of the Company or the person that, as a result of the transaction, controls, directly or indirectly, the Company or owns, directly or indirectly, all or substantially all of the Company’s assets or otherwise succeeds to the business of the Company (the Company or such person, the “Successor Entity”)) directly or indirectly, at least a majority of the combined voting power of the Successor Entity’s outstanding voting securities immediately after the transaction, and

(2)after which no person or group beneficially owns voting securities representing fifty percent (50%) or more of the combined voting power of the Successor Entity; provided, however, that no person or group shall be treated for purposes of this Section 9(b)(iii)(2) as beneficially owning fifty percent (50%)  or more of the combined voting power of the Successor Entity solely as a result of the voting power held in the Company prior to the consummation of the transaction.

A transaction shall not constitute a Change in Control if its sole purpose is to change the state of the Company’s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such transaction.  Notwithstanding the foregoing, a “Change in Control” must also constitute a “change in control event,” as defined in Treasury Regulation §1.409A-3(i)(5).

(c)Change in Control Period.  “Change in Control Period” means the period of time commencing three (3) months prior to a Change in Control and ending twenty-four (24) months following the Change in Control.

(d)Constructive Termination.  “Constructive Termination” means Executive’s resignation from employment with the Company that is effective within one-hundred twenty (120) days after the occurrence, without Executive’s written consent, of any of the following: (i) a material diminution in Executive’s base compensation that is not proportionately applicable to other officers and key employees of the Company generally; (ii) a material diminution in Executive’s job responsibilities or duties inconsistent in any material respect with Executive’s position, authority or

-5-

 

US-DOCS\108656691.1

 

responsibilities in effect immediately prior to such change, provided, that any change made solely as the result of the Company becoming a subsidiary or business unit of a larger company in a Change in Control shall not provide for Executive’s Constructive Termination hereunder; or (iii) the failure by any successor entity or corporation following a Change in Control to assume the obligations under this Agreement.  Notwithstanding the foregoing, a resignation shall not constitute a “Constructive Termination” unless the condition giving rise to such resignation continues uncured by the Company more than thirty (30) days following Executive’s written notice of such condition provided to the Company within ninety (90) days of the first occurrence of such condition and such resignation is effective within thirty (30) days following the end of such notice period.

(e)Covered Termination.  “Covered Termination” means Executive’s Constructive Termination or the termination of Executive’s employment by the Company other than for Cause.

(f)Termination Date.  “Termination Date” means the date Executive experiences a Covered Termination.

10.Successors.

(a)Company’s Successors.  Except as set forth above, any successor to the Company (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets shall assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession.  For all purposes under this Agreement, the term “Company” shall include any successor to the Company’s business and/or assets which executes and delivers the assumption agreement described in this Section 10(a) or which becomes bound by the terms of this Agreement by operation of law.

(b)Executive’s Successors.  The terms of this Agreement and all rights of Executive hereunder shall inure to the benefit of, and be enforceable by, Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.

11.Notices.  Notices and all other communications contemplated by this Agreement shall be in writing and shall be deemed to have been duly given when personally delivered or one day following mailing via Federal Express or similar overnight courier service.  In the case of Executive, mailed notices shall be addressed to Executive at Executive’s home address that the Company has on file for Executive.  In the case of the Company, mailed notices shall be addressed to its corporate headquarters, and all notices shall be directed to the attention of its Chief Executive Officer.

12.Confidentiality; Non-Disparagement.

(a)Confidentiality.  Executive hereby expressly confirms Executive’s continuing obligations to the Company pursuant to Executive’s Proprietary Information and Inventions Agreement with the Company (the “Confidential Information Agreement”).

-6-

 

US-DOCS\108656691.1

 

(b)Non-Disparagement.  Executive agrees that Executive shall not disparage, criticize or defame the Company, its affiliates and their respective affiliates, directors, officers, agents, partners, stockholders or employees, either publicly or privately.  The Company agrees that it shall not, and it shall instruct its officers and members of its Board to not, disparage, criticize or defame Executive, either publicly or privately.  Nothing in this Section 12(b) shall have application to any evidence or testimony required by any court, arbitrator or government agency.

13.Dispute Resolution.  To ensure the timely and economical resolution of disputes that arise in connection with this Agreement, Executive and the Company agree that any and all disputes, claims, or causes of action arising from or relating to the enforcement, breach, performance or interpretation of this Agreement, Executive’s employment, or the termination of Executive’s employment, shall be resolved to the fullest extent permitted by law by final, binding and confidential arbitration in San Mateo County, California through Judicial Arbitration & Mediation Services/Endispute (“JAMS”) in conformity with the then-existing JAMS employment arbitration rules and California law.  By agreeing to this arbitration procedure, both Executive and the Company waive the right to resolve any such dispute through a trial by jury or judge or administrative proceeding.  The arbitrator shall: (a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a written arbitration decision, to include the arbitrator’s essential findings and conclusions and a statement of the award.  The Company shall pay all JAMS’s arbitration fees in excess of the amount of court fees that would be required if the dispute were decided in a court of law.  Nothing in this Agreement is intended to prevent either Executive or the Company from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration.  Notwithstanding the foregoing, Executive and the Company each have the right to resolve any issue or dispute over intellectual property rights by Court action instead of arbitration.

14.Miscellaneous Provisions.

(a)Section 409A.  

(i)Separation from Service.  Notwithstanding any provision to the contrary in this Agreement, no amount deemed deferred compensation subject to Section 409A of the Code shall be payable pursuant to Sections 3 or 4 above unless Executive’s termination of employment constitutes a “separation from service” with the Company within the meaning of Section 409A of the Code and the Department of Treasury regulations and other guidance promulgated thereunder (“Separation from Service”) and, except as provided under Section 14(a)(ii) of this Agreement, any such amount shall not be paid, or in the case of installments, commence payment, until the sixtieth (60th) day following Executive’s Separation from Service.  Any installment payments that would have been made to Executive during the sixty (60) day period immediately following Executive’s Separation from Service but for the preceding sentence shall be paid to Executive on the sixtieth (60th) day following Executive’s Separation from Service and the remaining payments shall be made as provided in this Agreement.

(ii)Specified Employee.  Notwithstanding any provision to the contrary in this Agreement, if Executive is deemed at the time of Executive’s separation from service to be a

-7-

 

US-DOCS\108656691.1

 

“specified employee” for purposes of Section 409A(a)(2)(B)(i) of the Code, to the extent delayed commencement of any portion of the benefits to which Executive is entitled under this Agreement is required in order to avoid a prohibited distribution under Section 409A(a)(2)(B)(i) of the Code, such portion of Executive’s benefits shall not be provided to Executive prior to the earlier of (A) the expiration of the six (6)-month period measured from the date of Executive’s Separation from Service or (B) the date of Executive’s death.  Upon the first business day following the expiration of the applicable Code Section 409A(a)(2)(B)(i) period, all payments deferred pursuant to this Section 14(a)(ii) shall be paid in a lump sum to Executive, and any remaining payments due under this Agreement shall be paid as otherwise provided herein.

(iii)Expense Reimbursements.  To the extent that any reimbursements payable pursuant to this Agreement are subject to the provisions of Section 409A of the Code, any such reimbursements payable to Executive pursuant to this Agreement shall be paid to Executive no later than December 31st of the year following the year in which the expense was incurred, the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year, and Executive’s right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit.

(iv)Installments.  For purposes of Section 409A of the Code (including, without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)), Executive’s right to receive any installment payments under this Agreement shall be treated as a right to receive a series of separate payments and, accordingly, each such installment payment shall at all times be considered a separate and distinct payment.

(b)Waiver.  No provision of this Agreement shall be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by Executive and by an authorized officer of the Company (other than Executive).  No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party shall be considered a waiver of any other condition or provision or of the same condition or provision at another time.

(c)Whole Agreement.  This Agreement and the Confidential Information Agreement represent the entire understanding of the parties hereto with respect to the subject matter hereof and supersede all prior promises, arrangements and understandings regarding same, whether written or written, including, without limitation, any severance or change in control benefits in Executive’s offer letter agreement or employment agreement or previously approved by the Board.  

(d)Choice of Law.  The validity, interpretation, construction and performance of this Agreement shall be governed by the laws of the State of California.

(e)Severability.  The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision hereof, which shall remain in full force and effect.

-8-

 

US-DOCS\108656691.1

 

(f)Counterparts.  This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together will constitute one and the same instrument.

(Signature page follows)

-9-

 

US-DOCS\108656691.1

 

IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case of the Company by its duly authorized officer, as of the day and year set forth below.

 

 

 

 

NEVRO CORP.

 

 

By:

/s/ Andrew Galligan

 

 

Title:

CFO

 

 

Date:

9/16/2019

 

 

 

 

 

EXECUTIVE

 

 

/s/ Niamh Pellegrini

 

 

Niamh Pellegrini

 

 

Date:

9/16/2019

 

-10-

 

US-DOCS\108656691.1

 EX-10.21(B) 4 nvro-ex1021b_524.htm EX-10.21(B) nvro-ex1021b_524.htm

Exhibit 10.21(b)

TRANSITION AND SEPARATION AGREEMENT

 

This Transition and Separation Agreement (this “Agreement”) is entered into as of January 7, 2020 between Doug Alleavitch (“Executive”) and Nevro Corp., a Delaware corporation (the “Company”), effective as of the eighth day following the date Executive signs this Agreement (the “Effective Date”) with reference to the following facts:

 

 

A.Executive’s employment with the Company will end effective January 17, 2020 (the “Separation Date”).

 

B.Executive and the Company want to ensure the smooth transition of Executive’s duties and responsibilities to the Company and to establish the obligations of the parties including, without limitation, all amounts due and owing to the Executive.

 

NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth, the parties agree as follows:

 

1.Separation.  The Company and Executive agree that Executive’s employment with the Company shall end effective as of the Separation Date.  Executive hereby agrees to execute such further document(s) as shall be determined by the Company as necessary or desirable to give effect to the termination of Executive’s status as an employee of the Company and each of its subsidiaries; provided, that such documents shall not be inconsistent with any of the terms of this Agreement.

2.Transition Consulting Services.

(a)Consulting Period.  During the period (the “Consulting Period”) commencing on the Separation Date and ending on the six (6)-month anniversary thereof (the “Consulting Period End Date”), Executive shall be available to provide services to the Company, on a non-exclusive basis, as a consultant and shall provide transition services (the “Transition Services”) on an as-needed, as-requested basis in Executive’s areas of expertise and work experience and responsibility.  During the Consulting Period, Executive reaffirms Executive’s commitment to remain in compliance with that certain Proprietary Information and Inventions Agreement by and between Executive and the Company (the “Confidentiality Agreement”), including, without limitation, the non-solicitation covenants set forth therein.

(b)Consulting Fees.  In exchange for the performance of the Transition Services during the Consulting Period, Executive will continue to vest in shares of Company common stock underlying the equity awards set forth on Exhibit A attached hereto (the “Equity Awards”) in accordance with their original vesting schedules, subject to Executive continuing to provide, or remaining available to provide, the Transition Services to the Company.  On the earlier of (i) the date Executive ceases to provide, or remain available to provide, the Transition Services or (ii) the Consulting Period End Date, the Equity Awards shall cease vesting and any unvested portion shall thereupon be forfeited.  Executive acknowledges and agrees that to the extent any option constitutes an “incentive stock option” within the meaning of the Internal Revenue Code of 1986, as amended (the “Code”) and remains unexercised as of the three (3)-month anniversary of the Separation Date, such option shall thereupon cease to qualify for favorable tax treatment as “incentive stock option”.  Ordinary income recognized upon exercise of any such option that is exercised after the three (3)-month anniversary of the Separation Date will be subject to withholding taxes.  Executive further acknowledges that any vested option that remains unexercised

 

 

on the three (3)-month anniversary of Executive’s cessation of services (including upon the Consulting Period End Date) shall thereupon terminate.

(c)Benefits.  As an independent contractor, Executive understands and agrees that, while performing any services for the Company after the Separation Date, Executive shall not be eligible to participate in or accrue benefits under any Company benefit plan for which status as an employee of the Company is a condition of such participation or accrual.  To the extent that Executive was deemed eligible to participate, as an employee, in any Company benefit plan, Executive hereby waives Executive’s participation.

(d)Independent Contractor Status.  Executive and the Company acknowledge and agree that, during the Consulting Period, Executive shall be an independent contractor.  During the Consulting Period and thereafter, Executive shall not be an agent or employee of the Company and shall not be authorized to act on behalf of the Company. Personal income and self-employment taxes for Equity Awards that vest during the Consulting Period shall be the sole responsibility of Executive.  Executive agrees to indemnify and hold the Company and the other entities released herein harmless for any tax claims or penalties resulting from any failure by Executive to make required personal income and self-employment tax payments with respect to such Equity Awards.

3.Final Paycheck; Payment of Accrued Wages and Expenses.  

(a)Final Paycheck.  As soon as administratively practicable on or after the Separation Date, the Company will pay Executive all accrued but unpaid base salary and all accrued and unused paid time off earned through the Separation Date, subject to standard payroll deductions and withholdings.  Executive is entitled to these payments regardless of whether Executive executes this Agreement.

(b)Business Expenses.  The Company shall reimburse Executive for all outstanding expenses incurred prior to the Separation Date which are consistent with the Company’s policies in effect from time to time with respect to travel, entertainment and other business expenses, subject to the Company’s requirements with respect to reporting and documenting such expenses.  Executive is entitled to these reimbursements regardless of whether Executive executes this Agreement.

4.Separation Benefits. Without admission of any liability, fact or claim, the Company hereby agrees, subject to Executive’s execution of this Agreement and this Agreement becoming effective and irrevocable within thirty (30) days following the Separation Date, as well as Executive’s performance of Executive’s continuing obligations pursuant to this Agreement and the Confidentiality Agreement, including, without limitation, the non-solicitation and other restrictive covenants set forth therein, to provide Executive with the severance benefits as follows:

(a)Severance Payments.  Executive shall be entitled to receive an amount equal to $167,500.08, which constitutes six months of Executive’s base salary at the rate in effect immediately prior to the Separation Date.  Such amount shall be paid in a single cash lump sum, less applicable withholdings, on the first payroll date following the Effective Date.

(b)Continued Healthcare.  If Executive elects to receive continue health coverage pursuant to the provisions of the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), the Company shall directly pay, or reimburse Executive for, the premium for Executive and Executive’s covered dependents through the earlier of (i) the six (6)

2

 

US-DOCS\112428602.1

 

month anniversary of the Separation Date and (ii) the date Executive and Executive’s covered dependents, if any, become eligible for healthcare coverage under another employer’s plan(s).  After the Company ceases to pay premiums pursuant to the preceding sentence, Executive may, if eligible, elect to continue healthcare coverage at the Executive’s expense in accordance with the provisions of COBRA.

(c)Taxes.  Executive understands and agrees that all payments under this Section 4 will be subject to appropriate tax withholding and other deductions.  To the extent any taxes may be payable by Executive for the benefits provided to Executive by this Section 4 beyond those withheld by the Company, Executive agrees to pay them himself and to indemnify and hold the Company and the other entities released herein harmless for any tax claims or penalties, and associated attorneys’ fees and costs, resulting from any failure by Executive to make required payments.  To the extent that any reimbursements payable pursuant to this Agreement are subject to the provisions of Section 409A of the Code, such reimbursements shall be paid to Executive no later than December 31 of the year following the year in which the expense was incurred, the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year, and Executive’s right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit.

(d)2019 Bonus Payment.  Because the Separation Date will occur before the Company calculates and pays out bonuses for the 2019 calendar year, Employee agrees and acknowledges that Employee will not earn a bonus payment for the 2019 calendar year, pursuant to the terms and conditions of the Company’s bonus plan.  Notwithstanding the foregoing, as further consideration for this Agreement, Employee will remain eligible for Employee’s bonus amount for the 2019 calendar year, which if awarded by the Company, will be paid in a single cash lump sum, less applicable withholdings, at the same time as the annual bonuses for the 2019 calendar year are generally paid to other Company employees.

(e)Sole Separation Benefit.  Executive agrees that the payments provided by this Section 4 are not required under the Company’s normal policies and procedures and are provided as a severance solely in connection with this Agreement.  Executive acknowledges and agrees that the payments referenced in this Section 4 constitute adequate and valuable consideration, in and of themselves, for the promises contained in this Agreement.  

5.Full Payment.  Executive acknowledges that the payment and arrangements herein shall constitute full and complete satisfaction of any and all amounts properly due and owing to Executive as a result of Executive’s employment with the Company and separation therefrom.  Executive further acknowledges that, other than the Confidentiality Agreement, this Agreement shall supersede each agreement entered into between Executive and the Company regarding Executive’s employment, including, without limitation, any offer letter, employment agreement, severance and/or change in control agreement, and each such agreement other than the agreements evidencing Executive’s Equity Awards shall be deemed terminated and of no further effect as of the Separation Date.

6.Executive’s Release of the Company.  Executive understands that by agreeing to the release provided by this Section 6, Executive is agreeing not to sue, or otherwise file any claim against, the Company or any of its employees or other agents for any reason whatsoever based on anything that has occurred as of the date Executive signs this Agreement.

(a)Released Claims.  On behalf of Executive and Executive’s heirs, assigns, executors, administrators, trusts, spouse and estate, Executive hereby releases and forever

3

 

US-DOCS\112428602.1

 

discharges the “Releasees” hereunder, consisting of the Company, and each of its owners, affiliates, subsidiaries, predecessors, successors, assigns, agents, directors, officers, partners, employees and insurers, and all persons acting by, through, under or in concert with them, or any of them, of and from any and all manner of action or actions, cause or causes of action, in law or in equity, suits, debts, liens, contracts, agreements, promises, liability, claims, demands, damages, loss, cost or expense, of any nature whatsoever, known or unknown, fixed or contingent (hereinafter called “Claims”), which Executive now has or may hereafter have against the Releasees, or any of them, by reason of any matter, cause, or thing whatsoever from the beginning of time to the date hereof, including, without limiting the generality of the foregoing, any Claims arising out of, based upon or relating to Executive’s hire, employment, remuneration or resignation by the Releasees, or any of them, Claims arising under federal, state or local laws relating to employment, Claims of any kind that may be brought in any court or administrative agency, including any Claims arising under Title VII of the Civil Rights Act of 1964, as amended, 42 U.S.C. §  2000, et seq.; Americans with Disabilities Act, as amended, 42 U.S.C. § 12101 et seq.; the Rehabilitation Act of 1973, as amended, 29 U.S.C. § 701 et seq.; Age Discrimination in Employment Act, as amended, 29 U.S.C. § 621, et seq.; Civil Rights Act of 1866, and Civil Rights Act of 1991; 42 U.S.C. § 1981, et seq.; Equal Pay Act, as amended, 29 U.S.C. § 206(d); regulations of the Office of Federal Contract Compliance, 41 C.F.R. Section 60, et seq.; The Family and Medical Leave Act, as amended, 29 U.S.C. § 2601 et seq.; the Fair Labor Standards Act of 1938, as amended, 29 U.S.C. § 201 et seq.; the Employee Separation Income Security Act, as amended, 29 U.S.C. § 1001 et seq.; the Worker Adjustment and Retraining Notification Act, as amended, 29 U.S.C.  § 2101 et seq.; the California Fair Employment and Housing Act, as amended, Cal. Lab. Code § 12940 et seq.; the California Equal Pay Law, as amended, Cal. Lab. Code §§ 1197.5(a),199.5; the Moore-Brown-Roberti Family Rights Act of 1991, as amended, Cal. Gov’t Code §§12945.2, 19702.3; California Labor Code §§ 1101, 1102; the California WARN Act, California Labor Code §§ 1400 et. seq; California Labor Code §§ 1102.5(a),(b); claims for wages under the California Labor Code and any other federal, state or local laws of similar effect; the employment and civil rights laws of California; Claims for breach of contract; Claims arising in tort, including, without limitation, Claims of wrongful dismissal or discharge, discrimination, harassment, retaliation, fraud, misrepresentation, defamation, libel, infliction of emotional distress, violation of public policy, and/or breach of the implied covenant of good faith and fair dealing; and Claims for damages or other remedies of any sort, including, without limitation, compensatory damages, punitive damages, injunctive relief and attorney’s fees.  

(b)Unreleased Claims.  Notwithstanding the generality of the foregoing, Executive does not release the following claims:

(i)Claims for unemployment compensation or any state disability insurance benefits pursuant to the terms of applicable state law;

(ii)Claims for workers’ compensation insurance benefits under the terms of any worker’s compensation insurance policy or fund of the Company;

(iii)Claims to continued participation in certain of the Company’s group benefit plans pursuant to the terms and conditions of COBRA;

(iv)Claims to any benefit entitlements vested as the date of Executive’s employment Separation, pursuant to written terms of any Company employee benefit plan;

4

 

US-DOCS\112428602.1

 

(v)Claims for indemnification under any indemnification agreement, the Company’s Bylaws, California Labor Code Section 2802 or any other applicable law; and

(vi)Executive’s right to bring to the attention of the Equal Employment Opportunity Commission claims of discrimination; provided, however, that Executive does release Executive’s right to secure any damages for alleged discriminatory treatment.

(c)Acknowledgement.  In accordance with the Older Workers Benefit Protection Act of 1990, Executive has been advised of the following:

(i)Executive should consult with an attorney before signing this Agreement;

(ii)Executive has been given at least twenty-one (21) days to consider this Agreement; and

(iii)Executive has seven (7) days after signing this Agreement to revoke it.  If Executive wishes to revoke this Agreement, Executive must deliver notice of Executive’s revocation in writing, no later than 5:00 p.m. PT on the seventh (7th) day following Executive’s execution of this Agreement to Kashif Rashid, 1800 Bridge Parkway, Redwood City, CA 94065; or email: Kashif.Rashid@nevro.com. Executive understands that if Executive revokes this Agreement, it will be null and void in its entirety, and Executive will not be entitled to any payments or benefits provided in this Agreement, other than as provided in Section 3 hereof.

(d)EXECUTIVE ACKNOWLEDGES THAT EXECUTIVE HAS BEEN ADVISED OF AND IS FAMILIAR WITH THE PROVISIONS OF CALIFORNIA CIVIL CODE SECTION 1542, WHICH PROVIDES AS FOLLOWS:

“A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.”

BEING AWARE OF SAID CODE SECTION, EXECUTIVE HEREBY EXPRESSLY WAIVES ANY RIGHTS EXECUTIVE MAY HAVE THEREUNDER, AS WELL AS UNDER ANY OTHER STATUTES OR COMMON LAW PRINCIPLES OF SIMILAR EFFECT.

7.Non-Disparagement, Transition, Transfer of Company Property and Limitations on Service.  

(a)Non-Disparagement.  Executive agrees that Executive shall not disparage, criticize or defame the Company, its affiliates and their respective affiliates, directors, officers, agents, partners, stockholders, employees, products, services, technology or business, either publicly or privately.  Nothing in this Section 7(a) shall have application to any evidence or testimony required by any court, arbitrator or government agency.

(b)Transfer of Company Property.  Executive shall return to the Company within ten (10) business days following the Separation Date all equipment of the Company in Executive’s possession or control, including, without limitation, Executive’s laptop computer, along with all other equipment and originals and copies of correspondence, drawings, manuals,

5

 

US-DOCS\112428602.1

 

letters, notes, notebooks, reports, programs, plans, proposals, financial documents or any other documents concerning the Company’s customers, business plans, marketing strategies, products, processes or business of any kind and/or which contain proprietary information or trade secrets which are in the possession or control of Executive or Executive’s agents or representatives.

8.Executive Representations.  Executive warrants and represents that (a) Executive  has not filed or authorized the filing of any complaints, charges or lawsuits against the Company or any affiliate of the Company with any governmental agency or court, and that if, unbeknownst to Executive, such a complaint, charge or lawsuit has been filed on Executive’s behalf, Executive will immediately cause it to be withdrawn and dismissed, (b) Executive has reported all hours worked as of the date of this Agreement and has been paid all compensation, wages, bonuses, commissions and/or benefits to which Executive may be entitled and no other compensation, wages, bonuses, commissions and/or benefits are due to him, except as provided in this Agreement, (c) Executive has no known workplace injuries or occupational diseases and has been provided and/or has not been denied any leave requested under the Family and Medical Leave Act or any similar state law, (d) the execution, delivery and performance of this Agreement by Executive does not and will not conflict with, breach, violate or cause a default under any agreement, contract or instrument to which Executive is a party or any judgment, order or decree to which Executive is subject and (e) upon the execution and delivery of this Agreement by the Company and Executive, this Agreement will be a valid and binding obligation of Executive, enforceable in accordance with its terms.  

9.No Assignment by Executive.  Executive warrants and represents that no portion of any of the matters released herein, and no portion of any recovery or settlement to which Executive might be entitled, has been assigned or transferred to any other person, firm or corporation not a party to this Agreement, in any manner, including by way of subrogation or operation of law or otherwise.  If any claim, action, demand or suit should be made or instituted against the Company or any other Releasee because of any actual assignment, subrogation or transfer by Executive, Executive agrees to indemnify and hold harmless the Company and all other Releasees against such claim, action, suit or demand, including necessary expenses of investigation, attorneys’ fees and costs.  In the event of Executive’s death, this Agreement shall inure to the benefit of Executive and Executive’s executors, administrators, heirs, distributees, devisees and legatees.  None of Executive’s rights or obligations may be assigned or transferred by Executive, other than Executive’s rights to payments hereunder, which may be transferred only upon Executive’s death by will or operation of law.  

10.Governing Law.  This Agreement shall be construed and enforced in accordance with, and the rights of the parties shall be governed by, the laws of the State of California or, where applicable, United States federal law, in each case, without regard to any conflicts of laws provisions or those of any state other than California.

11.Arbitration; Venue.  All controversies, claims and disputes arising out of or relating to this Agreement shall be resolved by final and binding arbitration before a single neutral arbitrator in San Mateo County, California, in accordance with the Employment Dispute Resolution Rules of the American Arbitration Association (“AAA”), which can be found at https://www.adr.org/sites/default/files/EmploymentRules_Web.pdf. The arbitration shall be commenced by filing a demand for arbitration with the AAA within fourteen (14) days after the filing party has given notice of such breach to the other party.  The arbitrator shall award the prevailing party attorneys’ fees and expert fees, if any.  Notwithstanding the foregoing, it is acknowledged that it will be impossible to measure in money the damages that would be suffered if the parties fail to comply with any of the obligations imposed on them under Section 7(a) and Section 14 hereof, and that in the event of any such failure, an aggrieved person will be irreparably damaged and will not have an adequate remedy at law.  Any such person shall, therefore, be entitled to injunctive relief, including specific performance, to enforce such

6

 

US-DOCS\112428602.1

 

obligations, and if any action shall be brought in equity to enforce any of the provisions of Section 7(a) or Section 14 of this Agreement, none of the parties hereto shall raise the defense that there is an adequate remedy at law.  Any action seeking such injunctive relief, along with any other action relating to this Agreement that is excluded from the first sentence of this Section 11, shall be instituted and prosecuted exclusively in the federal or state courts located in the San Mateo County, California, and the each of the Company and Executive waive any right to change of venue.

12.Miscellaneous.  This Agreement, collectively with the Confidentiality Agreement and the agreements evidencing Equity Awards, comprise the entire agreement between the parties with regard to the subject matter hereof and supersedes, in their entirety, any other agreements between Executive and the Company with regard to the subject matter hereof.  The Company and Executive acknowledge that the separation of Executive’s employment with the Company is intended to constitute an involuntary separation from service for the purposes of Section 409A of the Code, and the related Department of Treasury regulations.  Executive acknowledges that there are no other agreements, written, oral or implied, and that Executive may not rely on any prior negotiations, discussions, representations or agreements.  This Agreement may not be changed or modified, in whole or in part, except by an instrument in writing signed by Executive and the Chief Executive Officer or other duly authorized officer of the Company.  This Agreement may be executed in separate counterparts, each of which is deemed to be an original and all of which taken together constitute one and the same agreement.  

13.Company Assignment and Successors.  The Company shall assign its rights and obligations under this Agreement to any successor to all or substantially all of the business or the assets of the Company (by merger or otherwise).  This Agreement shall be binding upon and inure to the benefit of the Company and its successors, assigns, personnel and legal representatives.

14.Maintaining Confidential Information.  Executive reaffirms Executive’s obligations under the Confidentiality Agreement.  Executive acknowledges and agrees that the payments provided in Section 4 and the vesting in Section 2 shall be subject to Executive’s continued compliance with Executive’s obligations under the Confidentiality Agreement.  For the avoidance of doubt and notwithstanding anything herein to the contrary, nothing in this Agreement will be construed to prohibit Executive from filing a charge with, reporting possible violations to, or participating or cooperating with any governmental agency or entity, including but not limited to the EEOC, the Department of Justice, the Securities and Exchange Commission, Congress or any agency Inspector General, or making other disclosures that are protected under the whistleblower, anti-discrimination or anti-retaliation provisions of federal, state or local law or regulation.  Executive does not need the prior authorization of the Company to make any such reports or disclosures, and Executive is not required to notify the Company that Executive has made such reports or disclosures. Furthermore, in accordance with 18 U.S.C. § 1833, notwithstanding anything to the contrary in this Agreement: (i) Executive shall not be in breach of this Agreement, and shall not be held criminally or civilly liable under any federal or state trade secret law (x) for the disclosure of a trade secret that is made in confidence to a federal, state, or local government official or to an attorney solely for the purpose of reporting or investigating a suspected violation of law, or (y) for the disclosure of a trade secret that is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal; and (ii) if Executive files a lawsuit for retaliation by the Company for reporting a suspected violation of law, Executive may disclose the trade secret to Executive’s attorney, and may use the trade secret information in the court proceeding, if Executive files any document containing the trade secret under seal, and does not disclose the trade secret, except pursuant to court order.

15.Executive’s Cooperation.  After the Separation Date, Executive shall cooperate with the Company and its affiliates, upon the Company’s reasonable request, with respect to any internal investigation or administrative, regulatory or judicial proceeding involving matters within the scope of

7

 

US-DOCS\112428602.1

 

Executive’s duties and responsibilities to the Company or its affiliates during Executive’s employment with the Company (including, without limitation, Executive being available to the Company upon reasonable notice for interviews and factual investigations, appearing at the Company’s reasonable request to give testimony without requiring service of a subpoena or other legal process, and turning over to the Company all relevant Company documents which are or may have come into Executive’s possession during Executive’s employment); provided, however, that any such request by the Company shall not be unduly burdensome or interfere with Executive’s personal schedule or ability to engage in gainful employment and, only following the Consulting Period End Date, with the Company to compensate Executive for Executive’s reasonable expenses incurred in connection with such cooperation and for Executive’s time spent in connection therewith (based on Executive’s 2019 base salary with the Company on a pro rata basis for the time actually spent on such cooperation).   

IN WITNESS WHEREOF, the undersigned have caused this Agreement to be duly executed and delivered as of the date indicated next to their respective signatures below.

 

 

 

 

 

DATED: January 7th, 2020

 

/s/ Doug Alleavitch

 

 

Doug Alleavitch

 

 

 

 

 

 

NEVRO CORP.

DATED: January 7, 2020

 

 

 

 

 

By:

/s/ Andrew Galligan

 

 

Name:

Andrew Galligan

 

 

Title:

CFO

 

8

 

US-DOCS\112428602.1

 EX-21.1 5 nvro-ex211_9.htm EX-21.1 nvro-ex211_9.htm

Exhibit 21.1

 

List of Subsidiaries of

Nevro Corp.

 

 

 

Subsidiary

 

Jurisdiction of Incorporation or Organization

 

 

 

Nevro Medical Sarl

 

Switzerland

Nevro Medical Limited

 

United Kingdom

Nevro Medical Pty Ltd.

 

Australia

Nevro Germany GmbH

 

Germany

 

 EX-23.1 6 nvro-ex231_10.htm EX-23.1 nvro-ex231_10.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-211864) and Form S-8 (Nos. 333-229778, 333-223159, 333-216206, 333-209816, 333-202857 and 333-200145) of Nevro Corp. of our report dated February 25, 2020 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

 

 

/s/ PricewaterhouseCoopers LLP
San Jose, California
February 25, 2020

 

 

 EX-31.1 7 nvro-ex311_7.htm EX-31.1 nvro-ex311_7.htm

Exhibit 31.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER

PURSUANT TO

SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)

I, D. Keith Grossman, certify that:

1.

I have reviewed this Annual Report on Form 10-K of Nevro Corp.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 25, 2020

 

/s/ D. Keith Grossman

D. Keith Grossman

Chief Executive Officer

(Principal Executive Officer)

 

 EX-31.2 8 nvro-ex312_11.htm EX-31.2 nvro-ex312_11.htm

Exhibit 31.2

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER

PURSUANT TO

SECURITIES EXCHANGE ACT RULES 13A-14(A) AND 15D-14(A)

I, Andrew H. Galligan, certify that:

1.

I have reviewed this Annual Report on Form 10-K of Nevro Corp.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 25, 2020

 

 

/s/ Andrew H. Galligan 

Andrew H. Galligan

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 EX-32.1 9 nvro-ex321_6.htm EX-32.1 nvro-ex321_6.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Nevro Corp. (the “Company”) on Form 10-K for the fiscal year ended December 31, 2019, as filed with the Securities and Exchange Commission (the “Report”), D. Keith Grossman, Chief Executive Officer of the Company, and Andrew H. Galligan, Chief Financial Officer of the Company, respectively, do each hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

•

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

•

The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 25, 2020

 

/s/ D. Keith Grossman 

D. Keith Grossman

Chief Executive Officer

(principal executive officer)

 

/s/ Andrew H. Galligan 

Andrew H. Galligan

Chief Financial Officer

(principal financial and accounting officer)

 

 GRAPHIC 10 g1qh3m4b2c4f000007.jpg GRAPHIC begin 644 g1qh3m4b2c4f000007.jpg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g1qh3m4b2c4f000004.jpg GRAPHIC begin 644 g1qh3m4b2c4f000004.jpg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g1qh3m4b2c4f000005.jpg GRAPHIC begin 644 g1qh3m4b2c4f000005.jpg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end GRAPHIC 13 g1qh3m4b2c4f000001.jpg GRAPHIC begin 644 g1qh3m4b2c4f000001.jpg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g1qh3m4b2c4f000006.jpg GRAPHIC begin 644 g1qh3m4b2c4f000006.jpg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end GRAPHIC 15 g1qh3m4b2c4f000002.jpg GRAPHIC begin 644 g1qh3m4b2c4f000002.jpg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g1qh3m4b2c4f000003.jpg GRAPHIC begin 644 g1qh3m4b2c4f000003.jpg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end EX-101.SCH 17 nvro-20191231.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - Consolidated Balance Sheets link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - Consolidated Balance Sheets (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - Consolidated Statements of Stockholders' Equity link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:presentationLink link:definitionLink 100060 - Disclosure - Formation and Business of the Company link:calculationLink link:presentationLink link:definitionLink 100070 - Disclosure - Summary of Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Revenue link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Lease Accounting link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Fair Value Measurements link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Balance Sheet Components link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Long-term Debt link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - Convertible Preferred Stock link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Stock-Based Compensation link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Income Taxes link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - Net Loss Per Share link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - Employee Benefit Plan link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Selected Quarterly Financial Information link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - Summary of Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - Summary of Significant Accounting Policies (Tables) link:calculationLink link:presentationLink link:definitionLink 100220 - Disclosure - Revenue (Tables) link:calculationLink link:presentationLink link:definitionLink 100230 - Disclosure - Lease Accounting (Tables) link:calculationLink link:presentationLink link:definitionLink 100240 - Disclosure - Fair Value Measurements (Tables) link:calculationLink link:presentationLink link:definitionLink 100250 - Disclosure - Balance Sheet Components (Tables) link:calculationLink link:presentationLink link:definitionLink 100260 - Disclosure - Commitments and Contingencies (Tables) link:calculationLink link:presentationLink link:definitionLink 100270 - Disclosure - Long-term Debt (Tables) link:calculationLink link:presentationLink link:definitionLink 100280 - Disclosure - Stock-Based Compensation (Tables) link:calculationLink link:presentationLink link:definitionLink 100290 - Disclosure - Income Taxes (Tables) link:calculationLink link:presentationLink link:definitionLink 100300 - Disclosure - Net Loss Per Share (Tables) link:calculationLink link:presentationLink link:definitionLink 100310 - Disclosure - Selected Quarterly Financial Information (Tables) link:calculationLink link:presentationLink link:definitionLink 100320 - Disclosure - Formation and Business of the Company - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100330 - Disclosure - Formation and Business of the Company - Additional Information - Public Offering (Detail) link:calculationLink link:presentationLink link:definitionLink 100340 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100350 - Disclosure - Summary of Significant Accounting Policies - Schedule of Revenue by Major Customers by Geographic Area (Detail) link:calculationLink link:presentationLink link:definitionLink 100360 - Disclosure - Revenue - Cumulative Effect of Changes to Consolidated Balance Sheet (Detail) link:calculationLink link:presentationLink link:definitionLink 100370 - Disclosure - Revenue - Impact of Adoption on Consolidated Balance Sheet (Detail) link:calculationLink link:presentationLink link:definitionLink 100380 - Disclosure - Revenue - Impact of Adoption on Consolidated Statement of Operations (Detail) link:calculationLink link:presentationLink link:definitionLink 100390 - Disclosure - Revenue - Summary of Revenue by Geography on Billing Address of Customer (Detail) link:calculationLink link:presentationLink link:definitionLink 100400 - Disclosure - Revenue - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100410 - Disclosure - Revenue - Additional Information (Detail1) link:calculationLink link:presentationLink link:definitionLink 100410 - Disclosure - Revenue - Additional Information (Detail1) link:calculationLink link:presentationLink link:definitionLink 100420 - Disclosure - Lease Accounting - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100430 - Disclosure - Lease Accounting - Schedule of Impact of Changes Made to the Consolidated Balance Sheet from the Adoption of ASC 842 (Detail) link:calculationLink link:presentationLink link:definitionLink 100440 - Disclosure - Lease Accounting - Schedule of Weighted Average Lease Terms and Discounts Rates (Detail) link:calculationLink link:presentationLink link:definitionLink 100450 - Disclosure - Lease Accounting - Schedule of Maturity of Lease Liabilities (Detail) link:calculationLink link:presentationLink link:definitionLink 100460 - Disclosure - Lease Accounting - Supplemental Lease Cost Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100470 - Disclosure - Lease Accounting - Summary of Operating Lease Assets and Liabilities (Detail) link:calculationLink link:presentationLink link:definitionLink 100480 - Disclosure - Lease Accounting - Schedule of Supplemental Cash Flow Information Related to Lease (Detail) link:calculationLink link:presentationLink link:definitionLink 100490 - Disclosure - Fair Value Measurements - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100500 - Disclosure - Fair Value Measurements - Financial Instruments Measured at Fair Value on Recurring Basis (Detail) link:calculationLink link:presentationLink link:definitionLink 100510 - Disclosure - Balance Sheet Components - Summary of Gross Unrealized Gains and Unrealized Losses of Investment Securities Excluding Investments in Money Market Funds (Detail) link:calculationLink link:presentationLink link:definitionLink 100520 - Disclosure - Balance Sheet Components - Summary of Contractual Maturities of Investment Securities (Detail) link:calculationLink link:presentationLink link:definitionLink 100530 - Disclosure - Balance Sheet Components - Components of Inventories (Detail) link:calculationLink link:presentationLink link:definitionLink 100540 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Detail) link:calculationLink link:presentationLink link:definitionLink 100550 - Disclosure - Balance Sheet Components - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100560 - Disclosure - Balance Sheet Components - Summary of Accrued Liabilities (Detail) link:calculationLink link:presentationLink link:definitionLink 100570 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100580 - Disclosure - Commitments and Contingencies - Schedule of Activities Related to Warranty Obligations (Detail) link:calculationLink link:presentationLink link:definitionLink 100590 - Disclosure - Long-term Debt - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100600 - Disclosure - Long-term Debt - Net Carrying Amount of Liability Component of Convertible Debt (Detail) link:calculationLink link:presentationLink link:definitionLink 100610 - Disclosure - Long-term Debt - Net Carrying Amount of Equity Component of Convertible Debt (Detail) link:calculationLink link:presentationLink link:definitionLink 100620 - Disclosure - Long-term Debt - Interest Expense Recognized Related to Convertible Notes (Detail) link:calculationLink link:presentationLink link:definitionLink 100630 - Disclosure - Convertible Preferred Stock - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100640 - Disclosure - Stock-Based Compensation - Summary of Common Stock Reserved for Future Issuance (Detail) link:calculationLink link:presentationLink link:definitionLink 100650 - Disclosure - Stock-Based Compensation - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100660 - Disclosure - Stock-Based Compensation - Summary of Shares Available for Grant (Detail) link:calculationLink link:presentationLink link:definitionLink 100670 - Disclosure - Stock-Based Compensation - Summary of Activity under Stock Plans (Detail) link:calculationLink link:presentationLink link:definitionLink 100680 - Disclosure - Stock-Based Compensation - Summary of Options Outstanding and Vested Under Stock Plans by Exercise Price (Detail) link:calculationLink link:presentationLink link:definitionLink 100690 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Units Under Stock Plan (Detail) link:calculationLink link:presentationLink link:definitionLink 100700 - Disclosure - Stock-Based Compensation - Schedule of Employee Stock Purchase Plan Activity (Detail) link:calculationLink link:presentationLink link:definitionLink 100710 - Disclosure - Stock-Based Compensation - Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation Model (Detail) link:calculationLink link:presentationLink link:definitionLink 100720 - Disclosure - Stock-Based Compensation - Schedule of Fair Value of Performance Based RUSs based on Monte Carlo Simulation Model (Detail) link:calculationLink link:presentationLink link:definitionLink 100730 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense by Line Items in Consolidated Statements of Operations (Detail) link:calculationLink link:presentationLink link:definitionLink 100740 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Detail) link:calculationLink link:presentationLink link:definitionLink 100750 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense Not Yet Recognized (Detail) link:calculationLink link:presentationLink link:definitionLink 100760 - Disclosure - Income Taxes - Components of Loss before Income Taxes (Detail) link:calculationLink link:presentationLink link:definitionLink 100770 - Disclosure - Income Taxes - Components of Expense/(Benefit) for Income Taxes (Detail) link:calculationLink link:presentationLink link:definitionLink 100780 - Disclosure - Income Taxes - Income Tax Expense by Applying Statutory Federal Income Tax Rate (Detail) link:calculationLink link:presentationLink link:definitionLink 100790 - Disclosure - Income Taxes - Tax Effects of Temporary Differences and Carryforwards That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Detail) link:calculationLink link:presentationLink link:definitionLink 100800 - Disclosure - Income Taxes - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100810 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Detail) link:calculationLink link:presentationLink link:definitionLink 100820 - Disclosure - Net Loss Per Share - Computation of Basic and Diluted Net Loss per Share (Detail) link:calculationLink link:presentationLink link:definitionLink 100830 - Disclosure - Net Loss Per Share - Computation of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Shares (Detail) link:calculationLink link:presentationLink link:definitionLink 100840 - Disclosure - Net Loss Per Share - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100850 - Disclosure - Employee Benefit Plan - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100860 - Disclosure - Selected Quarterly Financial Information - Schedule of Selected Quarterly Financial Information (Detail) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 18 nvro-20191231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 19 nvro-20191231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 20 nvro-20191231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Well-known Seasoned Issuer Entity Well Known Seasoned Issuer Entity Current Reporting Status Entity Current Reporting Status Entity Voluntary Filers Entity Voluntary Filers Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Shell Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Entity Public Float Entity Public Float Entity Interactive Data Current Entity Interactive Data Current Title of 12(b) Security Security12b Title Security Exchange Name Security Exchange Name Entity File Number Entity File Number Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Document Annual Report Document Annual Report Document Transition Report Document Transition Report Documents Incorporated by Reference [Text Block] Documents Incorporated By Reference [Text Block] Statement Of Financial Position [Abstract] Assets Assets [Abstract] Current assets Assets Current [Abstract] Cash and cash equivalents Cash And Cash Equivalents At Carrying Value Short-term investments Available For Sale Securities Debt Securities Current Accounts receivable, net of allowance for doubtful accounts of $797 and $824 at December 31, 2019 and 2018, respectively Accounts Receivable Net Current Inventories Inventory Net Prepaid expenses and other current assets Prepaid Expense And Other Assets Current Total current assets Assets Current Property and equipment, net Property Plant And Equipment Net Operating lease assets Operating Lease Right Of Use Asset Other assets Other Assets Noncurrent Restricted cash Restricted Cash And Cash Equivalents Noncurrent Total assets Assets Liabilities and stockholders’ equity Liabilities And Stockholders Equity [Abstract] Current liabilities Liabilities Current [Abstract] Accounts payable Accounts Payable Current Accrued liabilities Accrued Liabilities Current Other current liabilities Other Liabilities Current Total current liabilities Liabilities Current Long-term debt Long Term Debt Noncurrent Long-term operating lease liabilities Operating Lease Liability Noncurrent Other long-term liabilities Other Liabilities Noncurrent Total liabilities Liabilities Commitments and contingencies (Note 6) Commitments And Contingencies Stockholders’ equity Stockholders Equity [Abstract] Preferred stock, $0.001 par value, 10,000,000 shares authorized at December 31, 2019 and 2018, respectively; zero shares issued and outstanding at December 31, 2019 and 2018, respectively Preferred Stock Value Common stock, $0.001 par value, 290,000,000 shares authorized at December 31, 2019 and 2018, respectively; 31,544,361 and 30,263,536 shares issued and outstanding at December 31, 2019 and 2018, respectively Common Stock Value Additional paid-in capital Additional Paid In Capital Common Stock Accumulated other comprehensive loss Accumulated Other Comprehensive Income Loss Net Of Tax Accumulated deficit Retained Earnings Accumulated Deficit Total stockholders’ equity Stockholders Equity Total liabilities and stockholders’ equity Liabilities And Stockholders Equity Accounts receivable, allowance for doubtful accounts Allowance For Doubtful Accounts Receivable Current Preferred stock, par value Preferred Stock Par Or Stated Value Per Share Preferred stock, shares authorized Preferred Stock Shares Authorized Preferred stock, shares issued Preferred Stock Shares Issued Preferred stock, shares outstanding Preferred Stock Shares Outstanding Common stock, par value Common Stock Par Or Stated Value Per Share Common stock, shares authorized Common Stock Shares Authorized Common stock, shares issued Common Stock Shares Issued Common stock, shares outstanding Common Stock Shares Outstanding Income Statement [Abstract] Revenue Revenue From Contract With Customer Excluding Assessed Tax Cost of revenue Cost Of Goods And Services Sold Gross profit Gross Profit Operating expenses Operating Expenses [Abstract] Research and development Research And Development Expense Sales, general and administrative Selling General And Administrative Expense Total operating expenses Operating Expenses Loss from operations Operating Income Loss Interest income Investment Income Interest Interest expense Interest Expense Other income (expense), net Other Nonoperating Income Expense Loss before income taxes Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Provision for income taxes Income Tax Expense Benefit Net loss Net Income Loss Other comprehensive loss: Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract] Changes in foreign currency translation adjustment Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent Changes in unrealized gains (losses) on short-term investments, net Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent Net change in other comprehensive loss Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent Comprehensive loss Comprehensive Income Net Of Tax Net loss per share, basic and diluted Earnings Per Share Basic And Diluted Weighted average number of common shares used to compute basic and diluted net loss per share Weighted Average Number Of Share Outstanding Basic And Diluted Statement Of Stockholders Equity [Abstract] Statement [Table] Statement [Table] Equity Components Statement Equity Components [Axis] Equity Component Equity Component [Domain] Common Stock [Member] Common Stock [Member] Additional Paid-In Capital [Member] Additional Paid In Capital [Member] Accumulated Deficit [Member] Retained Earnings [Member] Accumulated Other Comprehensive Income (Loss) [Member] Accumulated Other Comprehensive Income [Member] Statement [Line Items] Statement [Line Items] Beginning balances Beginning balances, shares Shares Outstanding Adoption of accounting standard New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification Exercise of common stock options Stock Issued During Period Value Stock Options Exercised Exercise of common stock options, shares Stock Issued During Period Shares Stock Options Exercised Issuance of common stock upon release of restricted stock units Stock Issued During Period Shares Restricted Stock Award Gross Shares withheld for tax obligations Adjustments Related To Tax Withholding For Share Based Compensation Shares withheld for tax obligations, shares Shares Paid For Tax Withholding For Share Based Compensation Issuance of common stock under employee stock purchase plan Stock Issued During Period Value Employee Stock Purchase Plan Issuance of common stock under employee stock purchase plan, shares Stock Issued During Period Shares Employee Stock Purchase Plans Vesting of early exercised stock options Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options Stock based compensation Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value Net loss Other comprehensive loss Ending balances Ending balances, shares Amortization of operating lease asset. Unrealized gains and losses on foreign currency translation. Investment in private company. The amount related to shares of stock that were vested over the period per the terms of the related stock option agreements. Statement Of Cash Flows [Abstract] Cash flows from operating activities Net Cash Provided By Used In Operating Activities [Abstract] Net loss Profit Loss Adjustments to reconcile net loss to net cash used in operating activities Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Depreciation and amortization Depreciation Depletion And Amortization Amortization of operating lease assets Amortization Of Operating Lease Asset Stock-based compensation expense Share Based Compensation Accretion of discount on short-term investments Accretion Amortization Of Discounts And Premiums Investments Provision for (recovery of) doubtful accounts Provision For Doubtful Accounts Write-down of inventory Inventory Write Down Non-cash interest expense Amortization Of Financing Costs And Discounts Unrealized gains (losses) on foreign currency transactions Unrealized Gains And Losses On Foreign Currency Translation Changes in operating assets and liabilities Increase Decrease In Operating Capital [Abstract] Accounts receivable Increase Decrease In Accounts Receivable Inventories Increase Decrease In Inventories Prepaid expenses and other current assets Increase Decrease In Prepaid Deferred Expense And Other Assets Other assets Increase Decrease In Other Operating Assets Accounts payable Increase Decrease In Accounts Payable Accrued liabilities Increase Decrease In Accrued Liabilities Other long-term liabilities Increase Decrease In Other Noncurrent Liabilities Net cash used in operating activities Net Cash Provided By Used In Operating Activities Cash flows from investing activities Net Cash Provided By Used In Investing Activities [Abstract] Purchases of short-term investments Payments To Acquire Available For Sale Securities Debt Proceeds from sales of short-term investments Proceeds From Sale Of Short Term Investments Proceeds from maturity of short-term investments Proceeds From Sale And Maturity Of Available For Sale Securities Investment in private company Investment In Private Company Purchases of property and equipment Payments To Acquire Property Plant And Equipment Net cash provided by investing activities Net Cash Provided By Used In Investing Activities Cash flows from financing activities Net Cash Provided By Used In Financing Activities [Abstract] Minimum tax withholding paid on behalf of employees for net share settlement Payments Related To Tax Withholding For Share Based Compensation Proceeds from issuance of common stock to employees Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options Net cash provided by financing activities Net Cash Provided By Used In Financing Activities Effect of exchange rate changes on cash, cash equivalents and restricted cash Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations Net increase in cash, cash equivalents and restricted cash Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect Cash, cash equivalents and restricted cash Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract] Cash, cash equivalents and restricted cash at beginning of year Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations Cash, cash equivalents and restricted cash at end of year Supplemental disclosures of cash flow information Supplemental Cash Flow Information [Abstract] Cash paid for income taxes Income Taxes Paid Net Cash paid for interest Interest Paid Net Significant non-cash transactions Noncash Investing And Financing Items [Abstract] Purchases of property and equipment in accounts payable Capital Expenditures Incurred But Not Yet Paid Vesting of early-exercised stock options Vesting Of Early Exercised Stock Options Organization Consolidation And Presentation Of Financial Statements [Abstract] Formation and Business of the Company Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block] Accounting Policies [Abstract] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Revenue From Contract With Customer [Abstract] Revenue Revenue From Contract With Customer [Text Block] Leases [Abstract] Lease Accounting Leases Of Lessee Disclosure [Text Block] Fair Value Disclosures [Abstract] Fair Value Measurements Fair Value Disclosures [Text Block] Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments And Contingencies Disclosure [Text Block] Debt Disclosure [Abstract] Long-term Debt Debt Disclosure [Text Block] Equity [Abstract] Convertible Preferred Stock Preferred Stock [Text Block] Stock-Based Compensation Shareholders Equity And Share Based Payments [Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Earnings Per Share [Abstract] Net Loss Per Share Earnings Per Share [Text Block] Postemployment Benefits [Abstract] Employee Benefit Plan Compensation And Employee Benefit Plans [Text Block] Quarterly Financial Information Disclosure [Abstract] Selected Quarterly Financial Information Quarterly Financial Information [Text Block] Warranty Obligations Standard Product Warranty Policy Basis of Presentation Basis Of Accounting Policy Policy [Text Block] Segments Segment Reporting Policy Policy [Text Block] Foreign Currency Translation Foreign Currency Transactions And Translations Policy [Text Block] Use of Estimates Use Of Estimates Concentration of Credit Risk and Other Risks and Uncertainties Concentration Risk Credit Risk Fair Value of Financial Instruments Fair Value Of Financial Instruments Policy Cash and Cash Equivalents Cash And Cash Equivalents Policy [Text Block] Restricted Cash Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy Investment Securities Investment Policy [Text Block] Inventories Inventory Policy [Text Block] Revenue recognition shipping and handling costs. Shipping and Handling Costs Revenue Recognition Shipping And Handling Costs Policy [Text Block] Revenue Recognition Revenue Recognition Policy [Text Block] Allowance for Doubtful Accounts Receivables Trade And Other Accounts Receivable Allowance For Doubtful Accounts Policy Property and Equipment Property Plant And Equipment Policy [Text Block] Impairment of Long-Lived Assets Impairment Or Disposal Of Long Lived Assets Policy [Text Block] Income Taxes Income Tax Policy [Text Block] Other Comprehensive Income (Loss) Comprehensive Income Policy Policy [Text Block] Research and Development Research And Development Expense Policy Stock-Based Compensation Share Based Compensation Option And Incentive Plans Policy Net Loss per Share of Common Stock Earnings Per Share Policy [Text Block] Recent Accounting Pronouncements New Accounting Pronouncements Policy Policy [Text Block] Adoption of ASC 842 Lessee Leases Policy [Text Block] Schedule of Revenue by Major Customers by Geographic Area Schedule Of Revenue By Major Customers By Reporting Segments Table [Text Block] Disaggregation Of Revenue [Table] Disaggregation Of Revenue [Table] Adjustments for New Accounting Pronouncements Adjustments For New Accounting Pronouncements [Axis] Type of Adoption Type Of Adoption [Member] ASC 606 [Member] Accounting Standards Update201409 [Member] Disaggregation Of Revenue [Line Items] Disaggregation Of Revenue [Line Items] Cumulative Effect of Changes to Consolidated Balance Sheet New Accounting Pronouncement Early Adoption Table [Text Block] Schedule of Impact of Changes Made to the Consolidated Balance Sheet from the Adoption of ASC 842 Schedule Of New Accounting Pronouncements And Changes In Accounting Principles [Text Block] Summary of Revenue by Geography on Billing Address of Customer Disaggregation Of Revenue Table [Text Block] ASC 842 [Member] Accounting Standards Update201602 [Member] Schedule of weighted average lease terms and discounts rates. Schedule of Weighted Average Lease Terms and Discounts Rates Schedule Of Weighted Average Lease Terms And Discounts Rates Table [Text Block] Schedule of Maturity of Lease Liabilities Lessee Operating Lease Liability Maturity Table [Text Block] Supplemental Lease Cost Information Lease Cost Table [Text Block] Schedule of operating lease assets and operating lease liabilities. Schedule Of Operating Lease Assets and Liabilities Schedule Of Operating Lease Assets And Operating Lease Liabilities Table [Text Block] Schedule of cash flow information related to operating lease. Schedule of Supplemental Cash Flow Information Related to Lease Schedule Of Cash Flow Information Related To Operating Lease Tables [Text Block] Financial Instruments Measured at Fair Value on Recurring Basis Fair Value Assets Measured On Recurring Basis [Text Block] Summary of Gross Unrealized Gains and Unrealized Losses of Investment Securities Excluding Investments in Money Market Funds Debt Securities Available For Sale Table [Text Block] Summary of Contractual Maturities of Investment Securities Investments Classified By Contractual Maturity Date Table [Text Block] Components of Inventories Schedule Of Inventory Current Table [Text Block] Schedule of Property and Equipment, Net and Depreciation and Amortization Expense Property Plant And Equipment [Text Block] Summary of Accrued Liabilities Schedule Of Accrued Liabilities Table [Text Block] Schedule of Activities Related to Warranty Obligations Schedule Of Product Warranty Liability Table [Text Block] Debt Instrument [Table] Debt Instrument [Table] Long-term Debt, Type Longterm Debt Type [Axis] Long-term Debt, Type Longterm Debt Type [Domain] Debt liability component. Debt, Liability Component [Member] Debt Liability Component [Member] Debt equity component. Debt, Equity Component [Member] Debt Equity Component [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Net Carrying Amount of Convertible Debt Convertible Debt Table [Text Block] Interest expense recognized related to convertible notes. Interest Expense Recognized Related to Convertible Notes Interest Expense Recognized Related To Convertible Notes Table [Text Block] Schedule of common stock reserved for future issuance. Award Type Award Type [Axis] Award Type Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain] Performance Based Restricted Stock Units RSU. Performance Based RSUs [Member] Performance Based Restricted Stock Units R S U [Member] Summary of Common Stock Reserved for Future Issuance Schedule Of Common Stock Reserved For Future Issuance Table [Text Block] Summary of Shares Available for Grant Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value Table [Text Block] Summary of Activity under Stock Plans Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Summary of Options Outstanding and Vested under Stock Plans by Exercise Price Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Text Block] Summary of Restricted Stock Units under the Stock Plan Schedule Of Share Based Compensation Restricted Stock Units Award Activity Table [Text Block] Schedule of Employee Stock Purchase Plan Activity Schedule Of Share Based Compensation Employee Stock Purchase Plan Activity Table [Text Block] Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation and Monte Carlo Simulation Model Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block] Summary of Stock-Based Compensation Expense by Line Items in Consolidated Statements of Operations Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block] Summary of Stock-Based Compensation Expense Schedule Of Compensation Cost For Share Based Payment Arrangements Allocation Of Share Based Compensation Costs By Plan Table [Text Block] Summary of Stock-Based Compensation Expense Not Yet Recognized Schedule Of Unrecognized Compensation Cost Nonvested Awards Table [Text Block] Components of Loss before Income Taxes Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block] Components of Expense/(Benefit) for Income Taxes Schedule Of Components Of Income Tax Expense Benefit Table [Text Block] Income Tax Expense by Applying Statutory Federal Income Tax Rate Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block] Tax Effects of Temporary Differences and Carryforwards that Give Rise to Significant Portions of Deferred Tax Assets and Liabilities Summary Of Operating Loss Carryforwards [Text Block] Summary of Unrecognized Tax Benefits Schedule Of Unrecognized Tax Benefits Roll Forward Table [Text Block] Computation of Basic and Diluted Net Loss per Share Schedule Of Earnings Per Share Basic And Diluted Table [Text Block] Computation of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Shares Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Schedule of Selected Quarterly Financial Information Schedule Of Quarterly Financial Information Table [Text Block] Debt instrument maturity year. Organization consolidation and presentation of financial statements. Organization consolidation and presentation of financial statements. Organization Consolidation And Presentation Of Financial Statements [Table] Organization Consolidation And Presentation Of Financial Statements [Table] Debt Instrument Debt Instrument [Axis] Debt Instrument, Name Debt Instrument Name [Domain] One point seven five percent senior convertible note due twenty twenty one. 1.75% Convertible Senior Notes due 2021 [Member] One Point Seven Five Percent Senior Convertible Note Due Twenty Twenty One [Member] Formation and Business of the Company [Line Items] Organization Consolidation And Presentation Of Financial Statements [Line Items] Net loss Cash used in operations Accumulated deficit Debt instrument due year Debt Instrument Maturity Year Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table] Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table] Sale of Stock Subsidiary Sale Of Stock [Axis] Sale of Stock Sale Of Stock Name Of Transaction [Domain] IPO [Member] I P O [Member] Over Allotment Option [Member] Over Allotment Option [Member] Subsidiary, Sale of Stock [Line Items] Subsidiary Sale Of Stock [Line Items] Common stock, shares issued Stock Issued During Period Shares New Issues Net proceeds from common stock Proceeds From Issuance Initial Public Offering Common stock, shares issued price per share Shares Issued Price Per Share Shares issued upon conversion of redeemable convertible preferred stock and convertible preferred stock Conversion Of Stock Shares Issued1 Debt instrument additional aggregate principal amount. Aggregate principal amount of convertible senior notes Debt Instrument Face Amount Debt instrument interest rate Debt Instrument Interest Rate Stated Percentage Additional aggregate principal amount of convertible senior notes Debt Instrument Additional Aggregate Principal Amount Debt instrument frequency of payment Debt Instrument Frequency Of Periodic Payment Net proceeds from the debt offering after deducting transaction costs Proceeds From Debt Net Of Issuance Costs Number of wholly owned subsidiaries. Extended line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. A summary of information pertaining to the "Summary Of Significant Accounting Policies" disclosure as a whole for which no other established GAAP taxonomy identified hypercube is available." Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Concentration Risk Type Concentration Risk By Type [Axis] Concentration Risk Type Concentration Risk Type [Domain] Customer Concentration Risk [Member] Customer Concentration Risk [Member] Credit Concentration Risk [Member] Credit Concentration Risk [Member] Concentration Risk Benchmark Concentration Risk By Benchmark [Axis] Concentration Risk Benchmark Concentration Risk Benchmark [Domain] Revenue [Member] Sales Revenue Net [Member] Accounts Receivable [Member] Accounts Receivable [Member] Restricted Cash and Cash Equivalents Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Axis] Cash and Cash Equivalents Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Member] Certificates of Deposit [Member] Certificates Of Deposit [Member] Collateralizing payment charges related to credit cards. Collateralizing Payment Charges Related to Credit Cards [Member] Collateralizing Payment Charges Related To Credit Cards [Member] Statistical Measurement Range [Axis] Statistical Measurement Range [Member] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] RSU's [Member] Restricted Stock Units R S U [Member] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Number of wholly owned subsidiaries Number Of Wholly Owned Subsidiaries Number of business activities Number Of Operating Segments Concentration Risk [Table] Concentration Risk [Table] Geographic Concentration Risk [Member] Geographic Concentration Risk [Member] Geographical Statement Geographical [Axis] Geographical Segment Geographical [Domain] United States [Member] UNITED STATES Concentration Risk [Line Items] Concentration Risk [Line Items] Revenue Concentration Risk Percentage1 Net unrealized foreign currency transaction gains (losses) Foreign Currency Transaction Gain Loss Unrealized Realized foreign currency transaction gains (losses) Foreign Currency Transaction Gain Loss Realized Cash held in foreign banks Cash Uninsured Amount Concentration risk number of customers exceeding threshold Concentration risk, percentage Number of customers accounted 10% or more concentration risk Concentration Risk Number Of Customers Exceeding Threshold Money market funds Money Market Funds At Carrying Value Inventory write down cash and non cash. Write down of inventory Inventory Write Down Cash And Non Cash Estimated useful life of property and equipment Property Plant And Equipment Useful Life Impairment charges Asset Impairment Charges Interest or penalties recognized Income Tax Examination Penalties And Interest Expense Employee stock purchase plan offering period. Employee stock purchase plan offering period Employee Stock Purchase Plan Offering Period Vesting term Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 Dividend Yield Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate Revenue Initial Application Period Cumulative Effect Transition [Abstract] Revenue Initial Application Period Cumulative Effect Transition [Table] Revenue Initial Application Period Cumulative Effect Transition [Table] Initial Application Period Cumulative Effect Transition Initial Application Period Cumulative Effect Transition [Axis] Initial Application Period Cumulative Effect Transition Initial Application Period Cumulative Effect Transition [Domain] Adjustments Due to ASC 606 [Member] Difference Between Revenue Guidance In Effect Before And After Topic606 [Member] Revenue Initial Application Period Cumulative Effect Transition [Line Items] Revenue Initial Application Period Cumulative Effect Transition [Line Items] Accounts receivable, net Balance Without ASC 606 Adoption [Member] Calculated Under Revenue Guidance In Effect Before Topic606 [Member] International [Member] Non Us [Member] Total revenue Unsatisfied performance obligations description Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Table] Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Start Date [Axis] Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items] Unsatisfied performance obligations period Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 Lessee Lease Description [Table] Lessee Lease Description [Table] Lessee Lease Description [Line Items] Lessee Lease Description [Line Items] Lease term Lessee Operating Lease Term Of Contract Operating lease liabilities Operating Lease Liability Restatement Restatement [Axis] Restatement Restatement [Domain] Adjustments due to ASC 842 [Member] Restatement Adjustment [Member] Lessee operating lease remaining term of contract. Operating lease, remaining term Lessee Operating Lease Remaining Term Of Contract Options to extend the lease term Lessee Operating Lease Renewal Term Existence of option to extend the lease Lessee Operating Lease Existence Of Option To Extend Option to extend the lease term, description Lessee Operating Lease Option To Extend Weighted-average remaining lease term Operating Lease Weighted Average Remaining Lease Term1 Weighted-average discount rate Operating Lease Weighted Average Discount Rate Percent 2020 Lessee Operating Lease Liability Payments Due Next Twelve Months 2021 Lessee Operating Lease Liability Payments Due Year Two 2022 Lessee Operating Lease Liability Payments Due Year Three 2023 Lessee Operating Lease Liability Payments Due Year Four 2024 Lessee Operating Lease Liability Payments Due Year Five Thereafter Lessee Operating Lease Liability Payments Due After Year Five Total lease payments Lessee Operating Lease Liability Payments Due Less: Interest Lessee Operating Lease Liability Undiscounted Excess Amount Present value of lease liabilities Operating lease cost Operating Lease Cost Operating lease assets and liabilities abstract. Operating Leases: Operating Lease Assets And Liabilities [Abstract] Other current liabilities Operating Lease Liability Current Long term operating lease liabilities Total operating lease liabilities Cash paid for amounts included in the measurement of lease liabilities abstract. Cash paid for amounts included in the measurement of lease liabilities: Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract] Operating cash flow from operating leases Operating Lease Payments Money market funds net asset value per share. Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table] Measurement Frequency Fair Value By Measurement Frequency [Axis] Measurement Frequency Fair Value Measurement Frequency [Domain] Fair Value Measurements Recurring [Member] Fair Value Measurements Recurring [Member] Fair Value Hierarchy and NAV Fair Value By Fair Value Hierarchy Level [Axis] Fair Value Hierarchy and NAV Fair Value Measurements Fair Value Hierarchy [Domain] Level 1 [Member] Fair Value Inputs Level1 [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items] Net asset value of market funds Money Market Funds Net Asset Value Per Share Investment Type Investment Type [Axis] Investments Investment Type Categorization [Member] Money Market Funds [Member] Money Market Funds [Member] Bonds [Member] Bonds [Member] Commercial Paper [Member] Commercial Paper [Member] Corporate Notes [Member] Corporate Note Securities [Member] Level 2 [Member] Fair Value Inputs Level2 [Member] Level 3 [Member] Fair Value Inputs Level3 [Member] Total assets Assets Fair Value Disclosure Fair value of notes Debt Instrument Fair Value Investments Debt And Equity Securities [Abstract] Schedule Of Available For Sale Securities [Table] Schedule Of Available For Sale Securities [Table] Agency Bonds [Member] Agency Securities [Member] Schedule of Available-for-sale Securities [Line Items] Schedule Of Available For Sale Securities [Line Items] Amortized Cost Available For Sale Debt Securities Amortized Cost Basis Gross Unrealized Holding Gains Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax Gross Unrealized Holding Losses Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax Aggregate Fair Value Available For Sale Securities Debt Securities Amortized Cost, Amounts maturing within one year Available For Sale Securities Debt Maturities Within One Year Amortized Cost Amortized Cost, Amounts maturing after one year through five years Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost Fair Value, Amounts maturing within one year Available For Sale Securities Debt Maturities Within One Year Fair Value Fair Value, Amounts after one year through five years Available For Sale Securities Debt Maturities After One Through Five Years Fair Value Fair Value, Total investment securities Inventory Disclosure [Abstract] Raw materials Inventory Raw Materials Net Of Reserves Finished goods Inventory Finished Goods Net Of Reserves Total inventories Property Plant And Equipment [Abstract] Schedule Of Property Plant And Equipment [Table] Schedule Of Property Plant And Equipment [Table] Property, Plant and Equipment, Type Property Plant And Equipment By Type [Axis] Property, Plant and Equipment, Type Property Plant And Equipment Type [Domain] Laboratory Equipment [Member] Equipment [Member] Computer Equipment and Software [Member] Computer Equipment [Member] Furniture and Fixtures [Member] Furniture And Fixtures [Member] Leasehold Improvements [Member] Leasehold Improvements [Member] Construction in Process [Member] Construction In Progress [Member] Property, Plant and Equipment [Line Items] Property Plant And Equipment [Line Items] Property and equipment, gross Property Plant And Equipment Gross Less: Accumulated depreciation and amortization Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Property and equipment, net Depreciation and amortization expense Carrying value as of the balance sheet date of obligations incurred through that date and payable for clinical and research expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Payables And Accruals [Abstract] Accrued payroll and related expenses Employee Related Liabilities Current Accrued professional fees Accrued Professional Fees Current Accrued taxes Accrued Income Taxes Current Accrued clinical and research expenses Accrued Clinical And Research Expenses Current Accrued interest Interest Payable Current Accrued warranty Standard Product Warranty Accrual Current Accrued other Other Accrued Liabilities Current Total accrued liabilities Lease commencement period. Lease effective date. Operating leases expiration date. Lease commencement date description. Operating leases future minimum payments due in final year of lease term. Other Commitments [Table] Other Commitments [Table] Lease Arrangement, Type Lease Arrangement Type [Axis] Lease Arrangement, Type Lease Arrangement Type [Domain] Redwood office agreement. Redwood Office Agreement [Member] Redwood Office Agreement [Member] Redwood office agreement additional expansion premises. Redwood Office Agreement Additional Expansion Premises [Member] Redwood Office Agreement Additional Expansion Premises [Member] Scenario Statement Scenario [Axis] Scenario Scenario Unspecified [Domain] First amendment. Amendment 1 [Member] First Amendment [Member] Second amendment. Amendment 2 [Member] Second Amendment [Member] Facility lease agreement one. Facility Lease Agreement, Original [Member] Facility Lease Agreement One [Member] Facility lease agreement two. Facility Lease Agreement, Extended [Member] Facility Lease Agreement Two [Member] Facility lease agreement three. Non-cancellable Facility Lease [Member] Facility Lease Agreement Three [Member] Collaborative Arrangement and Arrangement Other than Collaborative Type Of Arrangement [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Arrangements And Nonarrangement Transactions [Member] Supply Agreements [Member] Supply Agreements [Member] Supply Agreements [Member] Finite-Lived Intangible Assets by Major Class Finite Lived Intangible Assets By Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name Finite Lived Intangible Assets Major Class Name [Domain] Service Agreement [Member] Service Agreements [Member] Counterparty Name Counterparty Name [Axis] Counterparty Name Repurchase Agreement Counterparty Name [Domain] Mayo And VGL. Mayo And VGL [Member] Mayo And Vgl [Member] Licensing Agreements [Member] Licensing Agreements [Member] Mayo Foundation. Mayo Foundation [Member] Mayo Foundation [Member] Loss Contingency Nature Loss Contingencies By Nature Of Contingency [Axis] Loss Contingency, Nature Loss Contingency Nature [Domain] Indemnification Agreement [Member] Indemnification Guarantee [Member] Related Party Transaction Related Party Transaction [Axis] Related Party Transaction Related Party Transaction [Domain] Boston scientific corporation. Boston Scientific Corporation [Member] Boston Scientific Corporation [Member] Patent infringement. Patent Infringement [Member] Patent Infringement [Member] Other Commitments [Line Items] Other Commitments [Line Items] Lease agreement, commencement period Lease Commencement Period Area of office space Area Of Land Lease agreement, effective date Lease Effective Date Lease agreement, expiration period Operating Leases Expiration Date Lease expense, payment due Operating Leases Future Minimum Payments Due Current Annual lease expense payable in final year of lease term Operating Leases Future Minimum Payments Due In Final Year Of Lease Term Commencement date description Lease Commencement Date Description Lease commencement date Operations Commenced Date1 Lease agreement, expiration date Lease Expiration Date1 Lease agreement, lease expense Lease And Rental Expense Standard product warranty, description Standard Product Warranty Description Beginning Balance Provision for warranty Standard Product Warranty Accrual Warranties Issued Utilization Standard Product Warranty Accrual Payments Ending Balance Purchase commitment, amount due in 2020 Purchase Obligation Due In Next Twelve Months Purchase commitments for inventory related charge Inventory Firm Purchase Commitment Loss Service agreement commitment amount year one. Service agreement commitment amount year two. Service agreement commitment amount year three. Service agreement commitment amount year four. Service agreement commitment amount year five. 2020 Service Agreement Commitment Amount Year One 2021 Service Agreement Commitment Amount Year Two 2022 Service Agreement Commitment Amount Year Three 2023 Service Agreement Commitment Amount Year Four 2024 Service Agreement Commitment Amount Year Five License agreement, terms Research And Development Arrangement Contract To Perform For Others Description And Terms Retainer fees Annual royalty payment Royalty Expense Noncash research and development expense. Noncash research and development expense Non Cash Research And Development Expense License agreement expiration year. License agreement commitment amount. License agreement commitment amount License Agreement Commitment Amount License agreement expiration year License Agreement Expiration Year Contingent consideration payment secured by convertible notes. Additional contingent consideration payment secured by convertible notes. Number of secured convertible notes. Secured convertible note receivable measured at amortized cost. Value of certain rights measured at cost. Contingent consideration payment secured by convertible notes Contingent Consideration Payment Secured By Convertible Notes Additional contingent consideration payment secured by convertible notes Additional Contingent Consideration Payment Secured By Convertible Notes Number of secured convertible notes Number Of Secured Convertible Notes Secured convertible note, measured at amortized cost Secured Convertible Note Receivable Measured At Amortized Cost Value of certain rights measured at cost Value Of Certain Rights Measured At Cost Contingent liabilities Loss Contingency Accrual At Carrying Value Patent infringement lawsuit allegation against number of patents. Patent infringement lawsuit allegation against number of patents Patent Infringement Lawsuit Allegation Against Number Of Patents Litigation amendment period. Litigation amendment period Litigation Amendment Period The month and year (YYYY-MM) that the debt instrument maturity is due. Debt Instruments [Abstract] Debt Conversion Description Debt Conversion By Unique Description [Axis] Debt Conversion, Name Debt Conversion Name [Domain] One hundred thirty percent applicable conversion price. 130% for Applicable Conversion Price [Member] One Hundred Thirty Percent Applicable Conversion Price [Member] Ninety eight percent applicable conversion price. 98% Applicable Conversion Price [Member] Ninety Eight Percent Applicable Conversion Price [Member] Warrant [Member] Warrant [Member] Debt instrument due year Debt Instrument Maturity Month And Year Percentage of principal amount of convertible notes is equal to repurchase price. Debt instrument conversions settlement amount. Convertible notes principal amount Debt Conversion Converted Instrument Amount1 Convertible notes, shares issued Debt Conversion Converted Instrument Shares Issued1 Convertible notes, type of equity security issued Debt Instrument Convertible Type Of Equity Security Convertible notes, conversion price Debt Instrument Convertible Conversion Price1 Debt instrument convertible trading days Debt Instrument Convertible Threshold Trading Days Debt instrument convertible consecutive trading days Debt Instrument Convertible Threshold Consecutive Trading Days1 Debt instrument convertible, percentage of conversion price Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger Percentage of closing sale price of common stock Debt Instrument Redemption Price Percentage Percentage of repurchase price, which is equal to principal amount of convertible notes Percentage Of Principal Amount Of Convertible Notes Is Equal To Repurchase Price Debt instrument combination settlement Debt Instrument Conversions Settlement Amount Debt conversion, converted instrument amount Debt Instrument Convertible Carrying Amount Of The Equity Component Debt instrument, effective interest rate Debt Instrument Interest Rate Effective Percentage Debt issuance costs attributable to the liability and equity component, total amount Deferred Finance Costs Net Debt issuance costs attributable to the liability component Deferred Finance Costs Noncurrent Gross Convertible Longterm Notes Payable Current And Noncurrent [Abstract] Principal Debt Instrument Carrying Amount Unamortized discount Debt Instrument Unamortized Discount Unamortized issuance cost Net carrying amount Long Term Debt Debt instrument convertible equity discount related to value of conversion option. Debt instrument convertible equity component issuance cost. Debt discount related to value of conversion option Debt Instrument Convertible Equity Discount Related To Value Of Conversion Option Debt issuance cost Debt Instrument Convertible Equity Component Issuance Cost Net carrying amount Contractual interest expense Interest Expense Debt Excluding Amortization Amortization of debt discount Amortization Of Debt Discount Premium Amortization of debt issuance costs Amortization Of Financing Costs Total interest expense related to the 2021 Notes Interest Expense Debt Note hedges transaction costs. Adjustments to additional paid in capital hedge and warrant transactions net cost. Note hedges number of shares contracted to buy. Purchase price per common stock. Conversion price per share. Number of shares purchased under convertible note hedge transactions Note Hedges Number Of Shares Contracted To Buy Purchase price of the shares issued under convertible note hedge transactions Purchase Price Per Common Stock Total cost of the convertible note hedge transactions Note Hedges Transaction Costs Number of shares issued for warrants under convertible note hedge transactions Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Purchase price of the shares issued under convertible note hedge transactions Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Proceeds from issuance of warrants Proceeds From Issuance Of Warrants Overall conversion price Conversion Price Per Share Net cost of reduction to additional paid-in capital Adjustments To Additional Paid In Capital Hedge And Warrant Transactions Net Cost Schedule Of Stock By Class [Table] Schedule Of Stock By Class [Table] Class of Stock [Line Items] Class Of Stock [Line Items] Convertible preferred stock converted to common stock Conversion Of Stock Shares Converted1 Common stock shares issued for each convertible preferred stock Convertible Preferred Stock Shares Issued Upon Conversion Convertible preferred stock outstanding Common stock options and restricted stock units outstanding. Common stock reserved for future issuance under stock option and restricted stock unit grants. Common stock reserved for future issuance under employee stock purchase plan. Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] Outstanding stock options and restricted stock units Common Stock Options And Restricted Stock Units Outstanding Reserved for grants of future stock options and restricted stock units Common Stock Reserved For Future Issuance Under Stock Option And Restricted Stock Unit Grants Reserved for employee stock purchase plan Common Stock Reserved For Future Issuance Under Employee Stock Purchase Plan Total common stock reserved for future issuance Common Stock Capital Shares Reserved For Future Issuance Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table] Plan Name Plan Name [Axis] Plan Name Plan Name [Domain] 2007 Plan. 2007 Plan [Member] Two Thousand Seven Plan [Member] 2014 Equity Incentive Plan. 2014 Plan [Member] Two Thousand Fourteen Equity Incentive Plan [Member] Vesting Vesting [Axis] Vesting Vesting [Domain] Share-based Compensation Award, Tranche One [Member] Share Based Compensation Award Tranche One [Member] Incentive Stock Options. ISO [Member] Incentive Stock Options [Member] Non Qualified Stock Options. NSO [Member] Non Qualified Stock Options [Member] Title of Individual Title Of Individual [Axis] Title of Individual Title Of Individual With Relationship To Entity [Domain] CEO [Member] Chief Executive Officer [Member] Employee Stock [Member] Employee Stock [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share Based Compensation Arrangement By Share Based Payment Award [Line Items] Additional awards authorized under plan Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized Common stock reserved for future issuance Plan modification description Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms Percentage of shareholder options granted. Stock options expiration period Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period Option purchase price, percentage of fair value Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent Percentage of shareholder granted option Percentage Of Shareholder Options Granted Share based compensation arrangement by share based payment award number of shares forfeited for tax. Share based compensation arrangement by share based payment award equity instruments options and other than options grants in period. Share based compensation arrangement by share based payment award equity instruments options and other than options forfeited and expirations in period. Number of allowance for PSU for over performance. Stock Options [Member] Employee Stock Option [Member] Employee stock option and restricted stock. Employee Stock Option and Restricted Stock [Member] Employee Stock Option And Restricted Stock [Member] Shares Available for Grant, Beginning balances Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Shares Available for Grant, Additional shares reserved Shares Available for Grant, Allowance for PSU for over performance Share Based Compensation Arrangement By Share Based Payment Award Number Of Allowance For P S U For Over Performance Shares Available for Grant, Shares forfeited for tax Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Forfeited For Tax Shares Available for Grant, Options and other than options granted Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options And Other Than Options Grants In Period Shares Available for Grant, Options and other than options forfeited or cancelled Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options And Other Than Options Forfeited And Expirations In Period Shares Available for Grant, Ending balances Share-based compensation arrangement by share-based payment award, options outstanding, weighted average exercise price, and additional disclosures. Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Exercise Price And Additional Disclosures [Abstract] Number of Options, Outstanding Beginning balances Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Number of Options, Options granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Number of Options, Options exercised Number of Options, Options cancelled Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Number of Options, Outstanding Ending balances Number of Options, Options exercisable Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Number of Options, Options vested, exercisable or expected to vest Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number Weighted Average Exercise Price, Beginning balances Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Weighted Average Exercise Price, Options granted Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price Weighted Average Exercise Price, Options exercised Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price Weighted Average Exercise Price, Options cancelled Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price Weighted Average Exercise Price, Ending balances Weighted Average Exercise Price, Options exercisable Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Weighted Average Exercise Price, Options vested, exercisable or expected to vest Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price Options Outstanding, Weighted-Average Remaining Contractual Term Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 Options exercisable, Weighted-Average Remaining Contractual Term Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 Options vested, exercisable or expected to vest, Weighted Average Remaining Contractual Term Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 Options Outstanding, Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Options exercised, Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value Options exercisable, Aggregate Intrinsic Value Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 Options vested, exercisable or expected to vest, Aggregate Intrinsic Value Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value Weighted-average grant-date fair value of options granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value Fair value of options vested Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table] Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table] Exercise Price Range Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Axis] Exercise Price Range Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Domain] Range 1 [Member] $1.44 — $18.00 [Member] Range1 [Member] Range 2 [Member] $32.51 — $48.44 [Member] Range2 [Member] Range 3 [Member] $49.94 — $63.23 [Member] Range3 [Member] Range 4 [Member] $63.39 — $76.81 [Member] Range4 [Member] Range 5 [Member] $84.30 — $97.52 [Member] Range5 [Member] Range 6 [Member] $1.44 — $97.52 [Member] Range6 [Member] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items] Options Outstanding, Exercise Price Lower Range Limit Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Options Outstanding, Exercise Price Upper Range Limit Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Number of Options Outstanding Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options Options Outstanding, Weighted Average Remaining Contractual Life (in Years) Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 Options Outstanding, Weighted Average Exercise Price Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 Options Vested, Number Exercisable Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options Options Vested, Weighted Average Exercise Price Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 Targeted composite index period. Targeted number of shares granted ratio. Targeted composite index period Targeted Composite Index Period Targeted number of shares granted ratio Targeted Number Of Shares Granted Ratio Share based compensation arrangement by share based payment award equity instruments other than options expected to vest. Restricted Stock Units [Member] Number of Restricted Stock Units, Outstanding Beginning Balance Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Number of Restricted Stock Units, Restricted stock granted Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Number of Restricted Stock Units, Restricted stock released Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Number of Restricted Stock Units, Restricted stock cancelled Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Number of Restricted Stock Units, Outstanding Ending Balance Number of Restricted Stock Units, Restricted stock expected to vest Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest Share-based compensation arrangement by share-based payment award, equity instruments other than options, shares expected to vest, weighted average grant date fair value. Weighted Average Grant Date Fair Value Outstanding, Beginning Balance Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Granted Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Released Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Cancelled Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value Outstanding, Ending Balance Weighted Average Grant Date Fair Value, Restricted stock expected to vest Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest Weighted Average Grant Date Fair Value Sharebased compensation arrangement by sharebased payment award equity instruments other than options aggregate intrinsic value expected to vest. Aggregate Intrinsic Value Outstanding Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding Aggregate Intrinsic Value, Released Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested Aggregate Intrinsic Value, Expected to vest Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Expected To Vest Number of shares available for sale Maximum employee subscription rate Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate Employee stock purchase plan offering period Share based compensation arrangement by share based payment award value issued in period. Employee Stock Purchase Plan [Member] ESPP [Member] Employee Stock Purchase Plan [Member] Additional shares reserved Shares issued Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period Shares available for future issuance Employee contributions for shares issued Share Based Compensation Arrangement By Share Based Payment Award Value Issued In Period Stock options unvested shares Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares Cash received from unvested shares Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Expected term (in years) Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 Expected volatility, minimum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum Expected volatility, maximum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum Risk-free interest rate, minimum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum Risk-free interest rate, maximum Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum Stock-based compensation expense Allocated Share Based Compensation Expense Share based compensation arrangement by share based payment award fair value assumptions index volatility rate. Share based compensation arrangement by share-based payment award, fair value assumptions volatility rate. Share based compensation arrangement by share based payment award fair value assumptions correlation wirh index rate. Index volatility Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Index Volatility Rate Company volatility Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Volatility Rate Risk-free interest rate Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Correlation with index Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Correlation With Index Rate Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table] Income Statement Location Income Statement Location [Axis] Income Statement Location Income Statement Location [Domain] Cost of Revenue [Member] Cost Of Sales [Member] Research and Development [Member] Research And Development Expense [Member] Selling, General and Administrative [Member] Selling General And Administrative Expenses [Member] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Employee Stock Purchase Plan [Member] Unrecognized Compensation Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options Unrecognized Compensation Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Weighted-Average Amortization Period (in years) Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 Domestic Income Loss From Continuing Operations Before Income Taxes Domestic Foreign Income Loss From Continuing Operations Before Income Taxes Foreign Current: Current Income Tax Expense Benefit Continuing Operations [Abstract] Federal Current Federal Tax Expense Benefit State Current State And Local Tax Expense Benefit Foreign Current Foreign Tax Expense Benefit Total current income tax expense / (benefit) Current Income Tax Expense Benefit Deferred: Deferred Income Tax Expense Benefit Continuing Operations [Abstract] Federal Deferred Federal Income Tax Expense Benefit State Deferred State And Local Income Tax Expense Benefit Foreign Deferred Foreign Income Tax Expense Benefit Total deferred income tax expense / (benefit) Deferred Income Tax Expense Benefit Total income tax expense / (benefit) Tax at statutory federal rate Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate State tax, net of federal benefit Effective Income Tax Rate Reconciliation State And Local Income Taxes Foreign rate differential Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential Tax credits Effective Income Tax Rate Reconciliation Tax Credits Excess tax benefits related to stock-based compensation Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost Effect of Tax Cuts and Jobs Act of 2017 Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate Change in valuation allowance Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance Other Effective Income Tax Rate Reconciliation Other Adjustments Total Effective Income Tax Rate Continuing Operations Deferred tax assets depreciation. Deferred tax assets lease liabilities. Deferred tax liabilities right of use asset. Net operating loss carryforwards Deferred Tax Assets Operating Loss Carryforwards Tax credits Deferred Tax Assets Tax Credit Carryforwards Depreciation Deferred Tax Assets Depreciation Stock-based compensation Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost Accruals and reserves Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Lease liabilities Deferred Tax Assets Lease Liabilities Other Deferred Tax Assets Other Deferred tax assets Deferred Tax Assets Gross Right of use asset Deferred Tax Liabilities Right Of Use Asset Deferred tax liabilities Deferred Income Tax Liabilities Valuation allowance Deferred Tax Assets Valuation Allowance Net deferred tax assets Deferred Tax Assets Net Income taxes. Income taxes. Income Taxes [Table] Income Taxes [Table] Income Tax Authority Income Tax Authority [Axis] Income Tax Authority Income Tax Authority [Domain] Federal [Member] Domestic Country [Member] State and Local Jurisdiction [Member] State And Local Jurisdiction [Member] Tax Credit Carryforward Tax Credit Carryforward [Axis] Tax Credit Carryforward, Name Tax Credit Carryforward Name [Domain] Research and Development Credit Carryforwards [Member] Research [Member] Income Tax Authority, Name Income Tax Authority Name [Axis] Income Tax Authority, Name Income Tax Authority Name [Domain] California state [Member] California Franchise Tax Board [Member] Income Taxes [Line Items] Income Taxes [Line Items] Increase in valuation allowance Valuation Allowance Deferred Tax Asset Change In Amount Federal and state net operating loss carry forwards expiration year. Net operating loss carryforward Operating Loss Carryforwards Net operating loss expiration date Federal And State Net Operating Loss Carry Forwards Expiration Year Tax credit carry forwards Tax Credit Carryforward Amount Unrecognized tax benefits Unrecognized Tax Benefits Beginning balance Increases related to current year tax provisions Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions Increases related to prior year tax provisions Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions Decreases related to prior year tax provisions Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions Ending balance Accrued interest and penalties Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Net loss Weighted average shares outstanding Weighted Average Number Of Shares Outstanding Basic Less: weighted average shares subject to repurchase Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation Weighted average shares used to compute basic and diluted net loss per share Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Antidilutive Securities Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities, Name Antidilutive Securities Name [Domain] Unreleased Restricted Stock [Member] Restricted Stock [Member] Options to Purchase Common Stock [Member] Convertible Senior Notes [Member] Convertible Debt Securities [Member] Warrants Related to the Issuance of Convertible Senior Notes [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Potentially dilutive securities excluded from computation of diluted shares outstanding Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Schedule Of Earnings Per Share Diluted By Common Class [Table] Schedule Of Earnings Per Share Diluted By Common Class [Table] Earnings Per Share Diluted [Line Items] Earnings Per Share Diluted [Line Items] Compensation And Retirement Disclosure [Abstract] Expense for matching contributions Defined Contribution Plan Employer Discretionary Contribution Amount Gross profit Loss from operations Net loss per share, basic and diluted Shares used in computing net loss per common share, basic and diluted EX-101.PRE 21 nvro-20191231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 22 R46.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Lease Accounting - Schedule of Maturity of Lease Liabilities (Detail)
$ in Thousands
Dec. 31, 2019
USD ($)
Leases [Abstract]  
2020 $ 4,924
2021 5,073
2022 5,258
2023 5,522
2024 5,687
Thereafter 2,399
Total lease payments 28,863
Less: Interest (4,920)
Present value of lease liabilities $ 23,943

XML 23 R42.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Revenue - Additional Information (Detail1)
Dec. 31, 2019
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2020-01-01  
Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]  
Unsatisfied performance obligations period 1 year
XML 24 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 25 R69.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation - Summary of Options Outstanding and Vested Under Stock Plans by Exercise Price (Detail)
 12 Months Ended
Dec. 31, 2019
$ / shares
shares
$1.44 — $18.00 [Member]  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Options Outstanding, Exercise Price Lower Range Limit $ 1.44
Options Outstanding, Exercise Price Upper Range Limit $ 18.00
Number of Options Outstanding | shares 334,087
Options Outstanding, Weighted Average Remaining Contractual Life (in Years) 3 years 9 months 14 days
Options Outstanding, Weighted Average Exercise Price $ 10.25
Options Vested, Number Exercisable | shares 334,087
Options Vested, Weighted Average Exercise Price $ 10.25
$32.51 — $48.44 [Member]  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Options Outstanding, Exercise Price Lower Range Limit 32.51
Options Outstanding, Exercise Price Upper Range Limit $ 48.44
Number of Options Outstanding | shares 391,304
Options Outstanding, Weighted Average Remaining Contractual Life (in Years) 7 years 10 months 6 days
Options Outstanding, Weighted Average Exercise Price $ 43.43
Options Vested, Number Exercisable | shares 159,456
Options Vested, Weighted Average Exercise Price $ 42.13
$49.94 — $63.23 [Member]  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Options Outstanding, Exercise Price Lower Range Limit 49.94
Options Outstanding, Exercise Price Upper Range Limit $ 63.23
Number of Options Outstanding | shares 365,966
Options Outstanding, Weighted Average Remaining Contractual Life (in Years) 4 years 5 months 12 days
Options Outstanding, Weighted Average Exercise Price $ 57.78
Options Vested, Number Exercisable | shares 352,632
Options Vested, Weighted Average Exercise Price $ 57.73
$63.39 — $76.81 [Member]  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Options Outstanding, Exercise Price Lower Range Limit 63.39
Options Outstanding, Exercise Price Upper Range Limit $ 76.81
Number of Options Outstanding | shares 393,930
Options Outstanding, Weighted Average Remaining Contractual Life (in Years) 8 years 3 months 7 days
Options Outstanding, Weighted Average Exercise Price $ 70.58
Options Vested, Number Exercisable | shares 155,991
Options Vested, Weighted Average Exercise Price $ 73.09
$84.30 — $97.52 [Member]  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Options Outstanding, Exercise Price Lower Range Limit 84.30
Options Outstanding, Exercise Price Upper Range Limit $ 97.52
Number of Options Outstanding | shares 160,898
Options Outstanding, Weighted Average Remaining Contractual Life (in Years) 7 years 25 days
Options Outstanding, Weighted Average Exercise Price $ 88.62
Options Vested, Number Exercisable | shares 115,607
Options Vested, Weighted Average Exercise Price $ 89.07
$1.44 — $97.52 [Member]  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]  
Options Outstanding, Exercise Price Lower Range Limit 1.44
Options Outstanding, Exercise Price Upper Range Limit $ 97.52
Number of Options Outstanding | shares 1,646,185
Options Outstanding, Weighted Average Remaining Contractual Life (in Years) 6 years 3 months 14 days
Options Outstanding, Weighted Average Exercise Price $ 50.80
Options Vested, Number Exercisable | shares 1,117,773
Options Vested, Weighted Average Exercise Price $ 46.70
XML 26 R61.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Long-term Debt - Net Carrying Amount of Liability Component of Convertible Debt (Detail) - 1.75% Convertible Senior Notes due 2021 [Member] - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Jun. 30, 2016
Debt Instrument [Line Items]      
Unamortized issuance cost     $ (5,000)
Debt, Liability Component [Member]      
Debt Instrument [Line Items]      
Principal $ 172,500 $ 172,500  
Unamortized discount (10,462) (17,305)  
Unamortized issuance cost (1,738) (2,801)  
Net carrying amount $ 160,300 $ 152,394  
XML 27 R65.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation - Summary of Common Stock Reserved for Future Issuance (Detail)
Dec. 31, 2019
shares
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Outstanding stock options and restricted stock units 2,934,517
Reserved for grants of future stock options and restricted stock units 3,680,784
Reserved for employee stock purchase plan 1,161,645
Total common stock reserved for future issuance 7,776,946
XML 28 R23.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Revenue (Tables)
 12 Months Ended
Dec. 31, 2019
Disaggregation Of Revenue [Line Items]  
Summary of Revenue by Geography on Billing Address of Customer

The following table presents revenue by geography, based on the billing address of the customer (in thousands):

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

United States

 

$

326,012

 

 

$

321,781

 

 

$

263,462

 

International

 

 

64,243

 

 

 

65,508

 

 

 

63,212

 

Total revenue

 

$

390,255

 

 

$

387,289

 

 

$

326,674

 
ASC 606 [Member]  
Disaggregation Of Revenue [Line Items]  
Cumulative Effect of Changes to Consolidated Balance Sheet The cumulative effect of the changes made to the consolidated balance sheet as of January 1, 2018 for the adoption of ASC 606 were as follows (in thousands):

 

 

 

Balance at

 

 

Adjustments Due

 

 

Balance at

 

 

 

December 31, 2017

 

 

to ASC 606

 

 

January 1, 2018

 

Balance Sheet:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable, net

 

$

67,287

 

 

$

1,447

 

 

$

68,734

 

Prepaid expenses and other current assets

 

 

6,463

 

 

 

(476

)

 

 

5,987

 

Accumulated other comprehensive loss

 

 

(1,242

)

 

 

4

 

 

 

(1,238

)

Accumulated deficit

 

 

(257,844

)

 

 

967

 

 

 

(256,877

)
Schedule of Impact of Changes Made to the Consolidated Balance Sheet from the Adoption of ASC 842

In accordance with ASC 606, the disclosure of the impact of adoption on the Consolidated Balance Sheet was as follows (in thousands):

 

 

December 31, 2018

 

 

 

Balance

 

 

Balance Without

 

 

 

 

 

 

 

As Reported

 

 

ASC 606 Adoption

 

 

Effect of Change

 

Balance Sheet:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable, net

 

$

80,656

 

 

$

78,142

 

 

$

2,514

 

Inventories

 

 

92,035

 

 

 

92,126

 

 

 

(91

)

Prepaid expenses and other current assets

 

 

6,621

 

 

 

7,514

 

 

 

(893

)

In accordance with ASC 606, the disclosure of the impact of adoption on the Consolidated Statements of Operations was as follows (in thousands):

 

 

Year Ended December 31, 2018

 

 

 

 

 

 

 

Balance Without

 

 

 

 

 

 

 

Balance As Reported

 

 

ASC 606 Adoption

 

 

Effect of Change

 

Statement of Operations:

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

387,289

 

 

$

386,212

 

 

$

1,077

 

Cost of revenue

 

 

113,965

 

 

 

113,441

 

 

 

524

 
XML 29 R27.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Commitments and Contingencies (Tables)
 12 Months Ended
Dec. 31, 2019
Commitments And Contingencies Disclosure [Abstract]  
Schedule of Activities Related to Warranty Obligations Activities related to warranty obligations were as follows (in thousands):

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Beginning Balance

 

$

1,236

 

 

$

708

 

Provision for warranty

 

 

1,942

 

 

 

2,334

 

Utilization

 

 

(2,000

)

 

 

(1,806

)

Ending Balance

 

$

1,178

 

 

$

1,236

 
XML 30 FilingSummary.xml IDEA: XBRL DOCUMENT 3.19.3.a.u2 html 257 517 1 true 87 0 false 11 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Consolidated Balance Sheets Sheet http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 100040 - Statement - Consolidated Statements of Stockholders' Equity Sheet http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity Consolidated Statements of Stockholders' Equity Statements 5 false false R6.htm 100050 - Statement - Consolidated Statements of Cash Flows Sheet http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 100060 - Disclosure - Formation and Business of the Company Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompany Formation and Business of the Company Notes 7 false false R8.htm 100070 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 100080 - Disclosure - Revenue Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenue Revenue Notes 9 false false R10.htm 100090 - Disclosure - Lease Accounting Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccounting Lease Accounting Notes 10 false false R11.htm 100100 - Disclosure - Fair Value Measurements Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 11 false false R12.htm 100110 - Disclosure - Balance Sheet Components Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponents Balance Sheet Components Notes 12 false false R13.htm 100120 - Disclosure - Commitments and Contingencies Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 13 false false R14.htm 100130 - Disclosure - Long-term Debt Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebt Long-term Debt Notes 14 false false R15.htm 100140 - Disclosure - Convertible Preferred Stock Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureConvertiblePreferredStock Convertible Preferred Stock Notes 15 false false R16.htm 100150 - Disclosure - Stock-Based Compensation Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensation Stock-Based Compensation Notes 16 false false R17.htm 100160 - Disclosure - Income Taxes Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxes Income Taxes Notes 17 false false R18.htm 100170 - Disclosure - Net Loss Per Share Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShare Net Loss Per Share Notes 18 false false R19.htm 100180 - Disclosure - Employee Benefit Plan Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureEmployeeBenefitPlan Employee Benefit Plan Notes 19 false false R20.htm 100190 - Disclosure - Selected Quarterly Financial Information Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureSelectedQuarterlyFinancialInformation Selected Quarterly Financial Information Notes 20 false false R21.htm 100200 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 21 false false R22.htm 100210 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 22 false false R23.htm 100220 - Disclosure - Revenue (Tables) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueTables Revenue (Tables) Tables http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenue 23 false false R24.htm 100230 - Disclosure - Lease Accounting (Tables) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingTables Lease Accounting (Tables) Tables http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccounting 24 false false R25.htm 100240 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurements 25 false false R26.htm 100250 - Disclosure - Balance Sheet Components (Tables) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsTables Balance Sheet Components (Tables) Tables http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponents 26 false false R27.htm 100260 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingencies 27 false false R28.htm 100270 - Disclosure - Long-term Debt (Tables) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtTables Long-term Debt (Tables) Tables http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebt 28 false false R29.htm 100280 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensation 29 false false R30.htm 100290 - Disclosure - Income Taxes (Tables) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTables Income Taxes (Tables) Tables http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxes 30 false false R31.htm 100300 - Disclosure - Net Loss Per Share (Tables) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShare 31 false false R32.htm 100310 - Disclosure - Selected Quarterly Financial Information (Tables) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureSelectedQuarterlyFinancialInformationTables Selected Quarterly Financial Information (Tables) Tables http://www.nevro.com/20191231/taxonomy/role/DisclosureSelectedQuarterlyFinancialInformation 32 false false R33.htm 100320 - Disclosure - Formation and Business of the Company - Additional Information (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail Formation and Business of the Company - Additional Information (Detail) Details 33 false false R34.htm 100330 - Disclosure - Formation and Business of the Company - Additional Information - Public Offering (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail Formation and Business of the Company - Additional Information - Public Offering (Detail) Details 34 false false R35.htm 100340 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail Summary of Significant Accounting Policies - Additional Information (Detail) Details 35 false false R36.htm 100350 - Disclosure - Summary of Significant Accounting Policies - Schedule of Revenue by Major Customers by Geographic Area (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueByMajorCustomersByGeographicAreaDetail Summary of Significant Accounting Policies - Schedule of Revenue by Major Customers by Geographic Area (Detail) Details 36 false false R37.htm 100360 - Disclosure - Revenue - Cumulative Effect of Changes to Consolidated Balance Sheet (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueCumulativeEffectOfChangesToConsolidatedBalanceSheetDetail Revenue - Cumulative Effect of Changes to Consolidated Balance Sheet (Detail) Details 37 false false R38.htm 100370 - Disclosure - Revenue - Impact of Adoption on Consolidated Balance Sheet (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedBalanceSheetDetail Revenue - Impact of Adoption on Consolidated Balance Sheet (Detail) Details 38 false false R39.htm 100380 - Disclosure - Revenue - Impact of Adoption on Consolidated Statement of Operations (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedStatementOfOperationsDetail Revenue - Impact of Adoption on Consolidated Statement of Operations (Detail) Details 39 false false R40.htm 100390 - Disclosure - Revenue - Summary of Revenue by Geography on Billing Address of Customer (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail Revenue - Summary of Revenue by Geography on Billing Address of Customer (Detail) Details 40 false false R41.htm 100400 - Disclosure - Revenue - Additional Information (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail Revenue - Additional Information (Detail) Details 41 false false R42.htm 100410 - Disclosure - Revenue - Additional Information (Detail1) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail1 Revenue - Additional Information (Detail1) Details 42 false false R43.htm 100420 - Disclosure - Lease Accounting - Additional Information (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingAdditionalInformationDetail Lease Accounting - Additional Information (Detail) Details 43 false false R44.htm 100430 - Disclosure - Lease Accounting - Schedule of Impact of Changes Made to the Consolidated Balance Sheet from the Adoption of ASC 842 (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfImpactOfChangesMadeToConsolidatedBalanceSheetFromAdoptionOfASC842Detail Lease Accounting - Schedule of Impact of Changes Made to the Consolidated Balance Sheet from the Adoption of ASC 842 (Detail) Details 44 false false R45.htm 100440 - Disclosure - Lease Accounting - Schedule of Weighted Average Lease Terms and Discounts Rates (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesDetail Lease Accounting - Schedule of Weighted Average Lease Terms and Discounts Rates (Detail) Details 45 false false R46.htm 100450 - Disclosure - Lease Accounting - Schedule of Maturity of Lease Liabilities (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfMaturityOfLeaseLiabilitiesDetail Lease Accounting - Schedule of Maturity of Lease Liabilities (Detail) Details 46 false false R47.htm 100460 - Disclosure - Lease Accounting - Supplemental Lease Cost Information (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingSupplementalLeaseCostInformationDetail Lease Accounting - Supplemental Lease Cost Information (Detail) Details 47 false false R48.htm 100470 - Disclosure - Lease Accounting - Summary of Operating Lease Assets and Liabilities (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail Lease Accounting - Summary of Operating Lease Assets and Liabilities (Detail) Details 48 false false R49.htm 100480 - Disclosure - Lease Accounting - Schedule of Supplemental Cash Flow Information Related to Lease (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetail Lease Accounting - Schedule of Supplemental Cash Flow Information Related to Lease (Detail) Details 49 false false R50.htm 100490 - Disclosure - Fair Value Measurements - Additional Information (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail Fair Value Measurements - Additional Information (Detail) Details 50 false false R51.htm 100500 - Disclosure - Fair Value Measurements - Financial Instruments Measured at Fair Value on Recurring Basis (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail Fair Value Measurements - Financial Instruments Measured at Fair Value on Recurring Basis (Detail) Details 51 false false R52.htm 100510 - Disclosure - Balance Sheet Components - Summary of Gross Unrealized Gains and Unrealized Losses of Investment Securities Excluding Investments in Money Market Funds (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail Balance Sheet Components - Summary of Gross Unrealized Gains and Unrealized Losses of Investment Securities Excluding Investments in Money Market Funds (Detail) Details 52 false false R53.htm 100520 - Disclosure - Balance Sheet Components - Summary of Contractual Maturities of Investment Securities (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail Balance Sheet Components - Summary of Contractual Maturities of Investment Securities (Detail) Details 53 false false R54.htm 100530 - Disclosure - Balance Sheet Components - Components of Inventories (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail Balance Sheet Components - Components of Inventories (Detail) Details 54 false false R55.htm 100540 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail Balance Sheet Components - Schedule of Property and Equipment, Net (Detail) Details 55 false false R56.htm 100550 - Disclosure - Balance Sheet Components - Additional Information (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail Balance Sheet Components - Additional Information (Detail) Details 56 false false R57.htm 100560 - Disclosure - Balance Sheet Components - Summary of Accrued Liabilities (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail Balance Sheet Components - Summary of Accrued Liabilities (Detail) Details 57 false false R58.htm 100570 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 58 false false R59.htm 100580 - Disclosure - Commitments and Contingencies - Schedule of Activities Related to Warranty Obligations (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfActivitiesRelatedToWarrantyObligationsDetail Commitments and Contingencies - Schedule of Activities Related to Warranty Obligations (Detail) Details 59 false false R60.htm 100590 - Disclosure - Long-term Debt - Additional Information (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail Long-term Debt - Additional Information (Detail) Details 60 false false R61.htm 100600 - Disclosure - Long-term Debt - Net Carrying Amount of Liability Component of Convertible Debt (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail Long-term Debt - Net Carrying Amount of Liability Component of Convertible Debt (Detail) Details 61 false false R62.htm 100610 - Disclosure - Long-term Debt - Net Carrying Amount of Equity Component of Convertible Debt (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail Long-term Debt - Net Carrying Amount of Equity Component of Convertible Debt (Detail) Details 62 false false R63.htm 100620 - Disclosure - Long-term Debt - Interest Expense Recognized Related to Convertible Notes (Detail) Notes http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail Long-term Debt - Interest Expense Recognized Related to Convertible Notes (Detail) Details 63 false false R64.htm 100630 - Disclosure - Convertible Preferred Stock - Additional Information (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail Convertible Preferred Stock - Additional Information (Detail) Details 64 false false R65.htm 100640 - Disclosure - Stock-Based Compensation - Summary of Common Stock Reserved for Future Issuance (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail Stock-Based Compensation - Summary of Common Stock Reserved for Future Issuance (Detail) Details 65 false false R66.htm 100650 - Disclosure - Stock-Based Compensation - Additional Information (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail Stock-Based Compensation - Additional Information (Detail) Details 66 false false R67.htm 100660 - Disclosure - Stock-Based Compensation - Summary of Shares Available for Grant (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail Stock-Based Compensation - Summary of Shares Available for Grant (Detail) Details 67 false false R68.htm 100670 - Disclosure - Stock-Based Compensation - Summary of Activity under Stock Plans (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail Stock-Based Compensation - Summary of Activity under Stock Plans (Detail) Details 68 false false R69.htm 100680 - Disclosure - Stock-Based Compensation - Summary of Options Outstanding and Vested Under Stock Plans by Exercise Price (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail Stock-Based Compensation - Summary of Options Outstanding and Vested Under Stock Plans by Exercise Price (Detail) Details 69 false false R70.htm 100690 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Units Under Stock Plan (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail Stock-Based Compensation - Summary of Restricted Stock Units Under Stock Plan (Detail) Details 70 false false R71.htm 100700 - Disclosure - Stock-Based Compensation - Schedule of Employee Stock Purchase Plan Activity (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail Stock-Based Compensation - Schedule of Employee Stock Purchase Plan Activity (Detail) Details 71 false false R72.htm 100710 - Disclosure - Stock-Based Compensation - Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation Model (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail Stock-Based Compensation - Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation Model (Detail) Details 72 false false R73.htm 100720 - Disclosure - Stock-Based Compensation - Schedule of Fair Value of Performance Based RUSs based on Monte Carlo Simulation Model (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail Stock-Based Compensation - Schedule of Fair Value of Performance Based RUSs based on Monte Carlo Simulation Model (Detail) Details 73 false false R74.htm 100730 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense by Line Items in Consolidated Statements of Operations (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail Stock-Based Compensation - Summary of Stock-Based Compensation Expense by Line Items in Consolidated Statements of Operations (Detail) Details 74 false false R75.htm 100740 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Detail) Details 75 false false R76.htm 100750 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense Not Yet Recognized (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail Stock-Based Compensation - Summary of Stock-Based Compensation Expense Not Yet Recognized (Detail) Details 76 false false R77.htm 100760 - Disclosure - Income Taxes - Components of Loss before Income Taxes (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail Income Taxes - Components of Loss before Income Taxes (Detail) Details 77 false false R78.htm 100770 - Disclosure - Income Taxes - Components of Expense/(Benefit) for Income Taxes (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail Income Taxes - Components of Expense/(Benefit) for Income Taxes (Detail) Details 78 false false R79.htm 100780 - Disclosure - Income Taxes - Income Tax Expense by Applying Statutory Federal Income Tax Rate (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail Income Taxes - Income Tax Expense by Applying Statutory Federal Income Tax Rate (Detail) Details 79 false false R80.htm 100790 - Disclosure - Income Taxes - Tax Effects of Temporary Differences and Carryforwards That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail Income Taxes - Tax Effects of Temporary Differences and Carryforwards That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Detail) Details 80 false false R81.htm 100800 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 81 false false R82.htm 100810 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail Income Taxes - Summary of Unrecognized Tax Benefits (Detail) Details 82 false false R83.htm 100820 - Disclosure - Net Loss Per Share - Computation of Basic and Diluted Net Loss per Share (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail Net Loss Per Share - Computation of Basic and Diluted Net Loss per Share (Detail) Details 83 false false R84.htm 100830 - Disclosure - Net Loss Per Share - Computation of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Shares (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail Net Loss Per Share - Computation of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Shares (Detail) Details 84 false false R85.htm 100840 - Disclosure - Net Loss Per Share - Additional Information (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail Net Loss Per Share - Additional Information (Detail) Details 85 false false R86.htm 100850 - Disclosure - Employee Benefit Plan - Additional Information (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureEmployeeBenefitPlanAdditionalInformationDetail Employee Benefit Plan - Additional Information (Detail) Details 86 false false R87.htm 100860 - Disclosure - Selected Quarterly Financial Information - Schedule of Selected Quarterly Financial Information (Detail) Sheet http://www.nevro.com/20191231/taxonomy/role/DisclosureSelectedQuarterlyFinancialInformationScheduleOfSelectedQuarterlyFinancialInformationDetail Selected Quarterly Financial Information - Schedule of Selected Quarterly Financial Information (Detail) Details 87 false false All Reports Book All Reports nvro-10k_20191231.htm nvro-20191231.xsd nvro-20191231_cal.xml nvro-20191231_def.xml nvro-20191231_lab.xml nvro-20191231_pre.xml nvro-ex1018g_523.htm nvro-ex1021b_524.htm nvro-ex211_9.htm nvro-ex231_10.htm nvro-ex311_7.htm nvro-ex312_11.htm nvro-ex321_6.htm nvro-ex46_607.htm g1qh3m4b2c4f000001.jpg g1qh3m4b2c4f000002.jpg g1qh3m4b2c4f000003.jpg g1qh3m4b2c4f000004.jpg g1qh3m4b2c4f000005.jpg g1qh3m4b2c4f000006.jpg g1qh3m4b2c4f000007.jpg http://xbrl.sec.gov/country/2017-01-31 http://fasb.org/srt/2019-01-31 http://fasb.org/us-gaap/2019-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true XML 31 nvro-10k_20191231_htm.xml IDEA: XBRL DOCUMENT 0001444380 2019-01-01 2019-12-31 0001444380 2020-02-14 0001444380 2019-06-28 0001444380 2019-12-31 0001444380 2018-12-31 0001444380 2018-01-01 2018-12-31 0001444380 2017-01-01 2017-12-31 0001444380 us-gaap:CommonStockMember 2016-12-31 0001444380 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0001444380 us-gaap:RetainedEarningsMember 2016-12-31 0001444380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0001444380 2016-12-31 0001444380 us-gaap:CommonStockMember 2017-01-01 2017-12-31 0001444380 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-12-31 0001444380 us-gaap:RetainedEarningsMember 2017-01-01 2017-12-31 0001444380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-12-31 0001444380 us-gaap:CommonStockMember 2017-12-31 0001444380 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001444380 us-gaap:RetainedEarningsMember 2017-12-31 0001444380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001444380 2017-12-31 0001444380 us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0001444380 us-gaap:CommonStockMember 2018-01-01 2018-12-31 0001444380 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0001444380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-12-31 0001444380 us-gaap:CommonStockMember 2018-12-31 0001444380 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001444380 us-gaap:RetainedEarningsMember 2018-12-31 0001444380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001444380 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0001444380 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001444380 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001444380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001444380 us-gaap:CommonStockMember 2019-12-31 0001444380 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001444380 us-gaap:RetainedEarningsMember 2019-12-31 0001444380 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001444380 us-gaap:AccountingStandardsUpdate201409Member 2019-01-01 2019-12-31 0001444380 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 2019-12-31 0001444380 nvro:DebtLiabilityComponentMember 2019-01-01 2019-12-31 0001444380 nvro:DebtEquityComponentMember 2019-01-01 2019-12-31 0001444380 nvro:PerformanceBasedRestrictedStockUnitsRSUMember 2019-01-01 2019-12-31 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2019-01-01 2019-12-31 0001444380 us-gaap:IPOMember 2014-11-01 2014-11-30 0001444380 us-gaap:OverAllotmentOptionMember 2014-11-01 2014-11-30 0001444380 2014-11-01 2014-11-30 0001444380 us-gaap:IPOMember 2014-11-30 0001444380 us-gaap:CommonStockMember us-gaap:IPOMember 2014-11-01 2014-11-30 0001444380 us-gaap:CommonStockMember 2015-06-01 2015-06-30 0001444380 us-gaap:OverAllotmentOptionMember 2015-06-01 2015-06-30 0001444380 2015-06-01 2015-06-30 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2016-06-30 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2016-06-01 2016-06-30 0001444380 country:US us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2019-01-01 2019-12-31 0001444380 country:US us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2018-01-01 2018-12-31 0001444380 country:US us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2017-01-01 2017-12-31 0001444380 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-12-31 0001444380 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2018-01-01 2018-12-31 0001444380 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2017-01-01 2017-12-31 0001444380 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2019-01-01 2019-12-31 0001444380 us-gaap:AccountsReceivableMember us-gaap:CreditConcentrationRiskMember 2018-01-01 2018-12-31 0001444380 us-gaap:CertificatesOfDepositMember 2019-12-31 0001444380 us-gaap:CertificatesOfDepositMember 2018-12-31 0001444380 nvro:CollateralizingPaymentChargesRelatedToCreditCardsMember 2018-12-31 0001444380 srt:MinimumMember 2019-01-01 2019-12-31 0001444380 srt:MaximumMember 2019-01-01 2019-12-31 0001444380 2016-01-01 2016-12-31 0001444380 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-12-31 0001444380 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 0001444380 us-gaap:AccountingStandardsUpdate201409Member 2018-01-01 0001444380 us-gaap:AccountingStandardsUpdate201409Member us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-12-31 0001444380 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-12-31 0001444380 us-gaap:AccountingStandardsUpdate201409Member us-gaap:CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member 2018-01-01 2018-12-31 0001444380 us-gaap:AccountingStandardsUpdate201409Member us-gaap:DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member 2018-01-01 2018-12-31 0001444380 country:US 2019-01-01 2019-12-31 0001444380 country:US 2018-01-01 2018-12-31 0001444380 country:US 2017-01-01 2017-12-31 0001444380 us-gaap:NonUsMember 2019-01-01 2019-12-31 0001444380 us-gaap:NonUsMember 2018-01-01 2018-12-31 0001444380 us-gaap:NonUsMember 2017-01-01 2017-12-31 0001444380 2020-01-01 2019-12-31 0001444380 srt:MinimumMember us-gaap:AccountingStandardsUpdate201602Member 2019-12-31 0001444380 us-gaap:AccountingStandardsUpdate201602Member 2019-12-31 0001444380 srt:RestatementAdjustmentMember us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0001444380 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0001444380 srt:MinimumMember us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 2019-12-31 0001444380 srt:MaximumMember us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 2019-12-31 0001444380 srt:MaximumMember us-gaap:AccountingStandardsUpdate201602Member 2019-12-31 0001444380 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-01-01 2019-12-31 0001444380 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2019-12-31 0001444380 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2019-12-31 0001444380 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:BondsMember 2019-12-31 0001444380 us-gaap:FairValueMeasurementsRecurringMember us-gaap:BondsMember 2019-12-31 0001444380 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2019-12-31 0001444380 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2019-12-31 0001444380 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateNoteSecuritiesMember 2019-12-31 0001444380 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateNoteSecuritiesMember 2019-12-31 0001444380 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001444380 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001444380 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001444380 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2018-12-31 0001444380 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2018-12-31 0001444380 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2018-12-31 0001444380 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CommercialPaperMember 2018-12-31 0001444380 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateNoteSecuritiesMember 2018-12-31 0001444380 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateNoteSecuritiesMember 2018-12-31 0001444380 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001444380 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001444380 us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2019-12-31 0001444380 us-gaap:AgencySecuritiesMember 2019-12-31 0001444380 us-gaap:CommercialPaperMember 2019-12-31 0001444380 us-gaap:CorporateNoteSecuritiesMember 2019-12-31 0001444380 us-gaap:CommercialPaperMember 2018-12-31 0001444380 us-gaap:CorporateNoteSecuritiesMember 2018-12-31 0001444380 us-gaap:EquipmentMember 2019-12-31 0001444380 us-gaap:EquipmentMember 2018-12-31 0001444380 us-gaap:ComputerEquipmentMember 2019-12-31 0001444380 us-gaap:ComputerEquipmentMember 2018-12-31 0001444380 us-gaap:FurnitureAndFixturesMember 2019-12-31 0001444380 us-gaap:FurnitureAndFixturesMember 2018-12-31 0001444380 us-gaap:LeaseholdImprovementsMember 2019-12-31 0001444380 us-gaap:LeaseholdImprovementsMember 2018-12-31 0001444380 us-gaap:ConstructionInProgressMember 2019-12-31 0001444380 us-gaap:ConstructionInProgressMember 2018-12-31 0001444380 nvro:RedwoodOfficeAgreementMember 2019-01-01 2019-12-31 0001444380 nvro:RedwoodOfficeAgreementMember 2015-03-31 0001444380 nvro:FirstAmendmentMember nvro:RedwoodOfficeAgreementAdditionalExpansionPremisesMember 2016-12-31 0001444380 nvro:RedwoodOfficeAgreementMember 2015-03-01 2015-03-31 0001444380 nvro:FirstAmendmentMember nvro:RedwoodOfficeAgreementAdditionalExpansionPremisesMember 2019-01-01 2019-12-31 0001444380 nvro:FirstAmendmentMember nvro:RedwoodOfficeAgreementAdditionalExpansionPremisesMember 2016-12-01 2016-12-31 0001444380 nvro:SecondAmendmentMember nvro:RedwoodOfficeAgreementAdditionalExpansionPremisesMember 2017-04-01 2017-04-30 0001444380 nvro:RedwoodOfficeAgreementAdditionalExpansionPremisesMember 2017-04-30 0001444380 nvro:FacilityLeaseAgreementOneMember 2014-08-01 2014-08-31 0001444380 nvro:FacilityLeaseAgreementOneMember 2015-05-30 2015-05-31 0001444380 nvro:FacilityLeaseAgreementTwoMember 2015-03-01 2015-03-31 0001444380 nvro:FacilityLeaseAgreementTwoMember 2017-02-01 2017-02-28 0001444380 nvro:FacilityLeaseAgreementThreeMember 2017-02-01 2017-02-28 0001444380 nvro:SupplyAgreementsMember 2019-12-31 0001444380 nvro:SupplyAgreementsMember 2019-01-01 2019-12-31 0001444380 us-gaap:ServiceAgreementsMember 2019-12-31 0001444380 nvro:MayoAndVglMember us-gaap:LicensingAgreementsMember 2019-01-01 2019-12-31 0001444380 nvro:MayoFoundationMember us-gaap:LicensingAgreementsMember 2019-01-01 2019-12-31 0001444380 nvro:MayoFoundationMember srt:MinimumMember us-gaap:LicensingAgreementsMember 2019-01-01 2019-12-31 0001444380 us-gaap:LicensingAgreementsMember 2019-01-01 2019-12-31 0001444380 us-gaap:LicensingAgreementsMember 2018-01-01 2018-12-31 0001444380 us-gaap:LicensingAgreementsMember 2017-01-01 2017-12-31 0001444380 nvro:MayoFoundationMember us-gaap:LicensingAgreementsMember 2014-11-01 2014-11-30 0001444380 us-gaap:LicensingAgreementsMember 2017-07-31 0001444380 us-gaap:LicensingAgreementsMember 2017-07-01 2017-07-31 0001444380 us-gaap:IndemnificationGuaranteeMember 2019-12-31 0001444380 nvro:BostonScientificCorporationMember 2016-12-09 0001444380 nvro:BostonScientificCorporationMember 2019-12-31 0001444380 2019-08-01 2019-08-01 0001444380 nvro:PatentInfringementMember 2019-12-31 0001444380 nvro:OneHundredThirtyPercentApplicableConversionPriceMember nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2016-06-01 2016-06-30 0001444380 nvro:NinetyEightPercentApplicableConversionPriceMember nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2016-06-01 2016-06-30 0001444380 srt:MaximumMember nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2016-06-01 2016-06-30 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember nvro:DebtLiabilityComponentMember 2019-12-31 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember nvro:DebtLiabilityComponentMember 2018-12-31 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember nvro:DebtEquityComponentMember 2019-12-31 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember nvro:DebtEquityComponentMember 2018-12-31 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2018-01-01 2018-12-31 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2017-01-01 2017-12-31 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember us-gaap:WarrantMember 2016-06-30 0001444380 srt:MinimumMember nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember us-gaap:WarrantMember 2016-06-30 0001444380 srt:MaximumMember nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember us-gaap:WarrantMember 2016-06-30 0001444380 us-gaap:IPOMember 2014-11-10 2014-11-11 0001444380 us-gaap:CommonStockMember 2014-11-11 0001444380 2014-11-10 0001444380 nvro:TwoThousandSevenPlanMember 2019-01-01 2019-12-31 0001444380 nvro:TwoThousandFourteenEquityIncentivePlanMember 2014-10-31 0001444380 nvro:TwoThousandFourteenEquityIncentivePlanMember 2019-01-01 2019-12-31 0001444380 srt:MaximumMember nvro:TwoThousandFourteenEquityIncentivePlanMember 2019-01-01 2019-12-31 0001444380 srt:MinimumMember nvro:TwoThousandFourteenEquityIncentivePlanMember 2019-01-01 2019-12-31 0001444380 nvro:IncentiveStockOptionsMember nvro:TwoThousandFourteenEquityIncentivePlanMember 2019-01-01 2019-12-31 0001444380 nvro:NonQualifiedStockOptionsMember nvro:TwoThousandFourteenEquityIncentivePlanMember 2019-01-01 2019-12-31 0001444380 nvro:TwoThousandFourteenEquityIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2019-01-01 2019-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2016-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-12-31 0001444380 nvro:EmployeeStockOptionAndRestrictedStockMember 2017-01-01 2017-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2017-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-12-31 0001444380 nvro:EmployeeStockOptionAndRestrictedStockMember 2018-01-01 2018-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2018-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001444380 nvro:EmployeeStockOptionAndRestrictedStockMember 2019-01-01 2019-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2019-12-31 0001444380 nvro:Range1Member 2019-01-01 2019-12-31 0001444380 nvro:Range2Member 2019-01-01 2019-12-31 0001444380 nvro:Range3Member 2019-01-01 2019-12-31 0001444380 nvro:Range4Member 2019-01-01 2019-12-31 0001444380 nvro:Range5Member 2019-01-01 2019-12-31 0001444380 nvro:Range6Member 2019-01-01 2019-12-31 0001444380 nvro:Range1Member 2019-12-31 0001444380 nvro:Range2Member 2019-12-31 0001444380 nvro:Range3Member 2019-12-31 0001444380 nvro:Range4Member 2019-12-31 0001444380 nvro:Range5Member 2019-12-31 0001444380 nvro:Range6Member 2019-12-31 0001444380 srt:ChiefExecutiveOfficerMember nvro:PerformanceBasedRestrictedStockUnitsRSUMember 2019-03-01 2019-03-31 0001444380 srt:MinimumMember srt:ChiefExecutiveOfficerMember nvro:PerformanceBasedRestrictedStockUnitsRSUMember 2019-03-01 2019-03-31 0001444380 srt:MaximumMember srt:ChiefExecutiveOfficerMember nvro:PerformanceBasedRestrictedStockUnitsRSUMember 2019-03-01 2019-03-31 0001444380 us-gaap:RestrictedStockUnitsRSUMember 2016-12-31 0001444380 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-12-31 0001444380 us-gaap:RestrictedStockUnitsRSUMember 2017-12-31 0001444380 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-12-31 0001444380 us-gaap:RestrictedStockUnitsRSUMember 2018-12-31 0001444380 us-gaap:RestrictedStockUnitsRSUMember 2019-12-31 0001444380 us-gaap:EmployeeStockMember 2014-10-31 0001444380 us-gaap:EmployeeStockMember 2018-12-31 0001444380 us-gaap:EmployeeStockMember 2018-01-01 2018-12-31 0001444380 nvro:EmployeeStockPurchasePlanMember 2019-01-01 2019-12-31 0001444380 nvro:EmployeeStockPurchasePlanMember 2018-01-01 2018-12-31 0001444380 nvro:EmployeeStockPurchasePlanMember 2017-01-01 2017-12-31 0001444380 nvro:EmployeeStockPurchasePlanMember 2019-12-31 0001444380 nvro:EmployeeStockPurchasePlanMember 2018-12-31 0001444380 nvro:EmployeeStockPurchasePlanMember 2017-12-31 0001444380 us-gaap:RestrictedStockUnitsRSUMember 2019-03-01 2019-03-31 0001444380 us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0001444380 us-gaap:CostOfSalesMember 2018-01-01 2018-12-31 0001444380 us-gaap:CostOfSalesMember 2017-01-01 2017-12-31 0001444380 us-gaap:ResearchAndDevelopmentExpenseMember 2019-01-01 2019-12-31 0001444380 us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-12-31 0001444380 us-gaap:ResearchAndDevelopmentExpenseMember 2017-01-01 2017-12-31 0001444380 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-01-01 2019-12-31 0001444380 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2018-01-01 2018-12-31 0001444380 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-01-01 2017-12-31 0001444380 us-gaap:DomesticCountryMember 2019-12-31 0001444380 us-gaap:StateAndLocalJurisdictionMember 2019-12-31 0001444380 us-gaap:DomesticCountryMember 2018-12-31 0001444380 us-gaap:StateAndLocalJurisdictionMember 2018-12-31 0001444380 us-gaap:DomesticCountryMember 2019-01-01 2019-12-31 0001444380 us-gaap:StateAndLocalJurisdictionMember 2019-01-01 2019-12-31 0001444380 us-gaap:DomesticCountryMember us-gaap:ResearchMember 2019-12-31 0001444380 us-gaap:CaliforniaFranchiseTaxBoardMember us-gaap:ResearchMember 2019-12-31 0001444380 us-gaap:RestrictedStockMember 2019-01-01 2019-12-31 0001444380 us-gaap:RestrictedStockMember 2018-01-01 2018-12-31 0001444380 us-gaap:RestrictedStockMember 2017-01-01 2017-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-12-31 0001444380 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-12-31 0001444380 us-gaap:ConvertibleDebtSecuritiesMember 2019-01-01 2019-12-31 0001444380 us-gaap:ConvertibleDebtSecuritiesMember 2018-01-01 2018-12-31 0001444380 us-gaap:ConvertibleDebtSecuritiesMember 2017-01-01 2017-12-31 0001444380 us-gaap:WarrantMember 2019-01-01 2019-12-31 0001444380 us-gaap:WarrantMember 2018-01-01 2018-12-31 0001444380 us-gaap:WarrantMember 2017-01-01 2017-12-31 0001444380 nvro:OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember 2019-12-31 0001444380 2019-10-01 2019-12-31 0001444380 2019-07-01 2019-09-30 0001444380 2019-04-01 2019-06-30 0001444380 2019-01-01 2019-03-31 0001444380 2018-10-01 2018-12-31 0001444380 2018-07-01 2018-09-30 0001444380 2018-04-01 2018-06-30 0001444380 2018-01-01 2018-03-31 shares iso4217:USD iso4217:USD shares pure nvro:Subsidiary nvro:Business nvro:Customer utr:sqft nvro:ConvertibleNote nvro:Patent utr:D false FY NVRO 0001444380 --12-31 Large Accelerated Filer true 0.00 3.50 P6M 2015-06-30 2017-05-31 P3Y 0.00 P6M P7Y4M24D P7Y3M18D P6Y8M12D P6Y3M18D P5Y1M6D P6Y2M12D 1.44 18.00 P3Y9M14D 32.51 48.44 P7Y10M6D 49.94 63.23 P4Y5M12D 63.39 76.81 P8Y3M7D 84.30 97.52 P7Y25D 1.44 97.52 P6Y3M14D P5Y8M12D P5Y6M P5Y6M 0.51 0.44 0.44 0.014 0.023 0.018 P6M P6M P6M 0.48 0.44 0.36 0.016 0.021 0.010 0.52 0.51 0.46 0.026 0.029 0.022 0.61 0.57 0.37 0.024 0.025 0.014 P2Y8M12D P2Y7M6D P4M24D 10-K true 2019-12-31 2019 false 001-36715 NEVRO CORP. DE 56-2568057 1800 Bridge Parkway Redwood City CA 94065 650 251-0005 Common Stock, par value $0.001 per share NYSE Yes No Yes Yes false false false 1923000000 31820724 Portions of the registrant’s Proxy Statement for the registrant’s 2020 Annual Meeting of Stockholders are incorporated by reference into Part III of this Form 10-K to the extent stated herein. The Proxy Statement will be filed within 120 days of the registrant’s fiscal year ended December 31, 2019. 65373000 51266000 172429000 213281000 797000 824000 82833000 80656000 91579000 92035000 9838000 6621000 422052000 443859000 11766000 12801000 21533000 13338000 5850000 956000 606000 469645000 463116000 16048000 23505000 50966000 38790000 3597000 119000 70611000 62414000 160300000 152394000 20445000 1937000 2825000 253293000 217633000 0.001 0.001 10000000 10000000 0 0 0 0 0.001 0.001 290000000 290000000 31544361 31544361 30263536 30263536 32000 30000 626401000 552612000 -313000 -1077000 -409768000 -306082000 216352000 245483000 469645000 463116000 390255000 387289000 326674000 121905000 113965000 98981000 268350000 273324000 227693000 59017000 48459000 37560000 305812000 266608000 219712000 364829000 315067000 257272000 -96479000 -41743000 -29579000 6020000 4871000 3164000 10931000 10401000 9902000 -697000 -1164000 1067000 -102087000 -48437000 -35250000 1599000 768000 1408000 -103686000 -49205000 -36658000 449000 -37000 -360000 315000 202000 -204000 764000 165000 -564000 -102922000 -49040000 -37222000 -3.37 -1.64 -1.25 30803872 30051961 29424054 28886862 29000 470869000 -221186000 -678000 249034000 707410 1000 7492000 7493000 83121 13094 991000 991000 73262 4697000 4697000 7000 7000 26154000 26154000 -36658000 -36658000 -564000 -564000 29737561 30000 508228000 -257844000 -1242000 249172000 967000 967000 247768 3976000 3976000 196274 28107 1742000 1742000 110040 5520000 5520000 36630000 36630000 -49205000 -49205000 165000 165000 30263536 30000 552612000 -306082000 -1077000 245483000 828722 1000 28606000 28607000 325839 38696 3057000 3057000 164960 1000 6544000 6545000 41696000 41696000 -103686000 -103686000 764000 764000 31544361 32000 626401000 -409768000 -313000 216352000 -103686000 -49205000 -36658000 4563000 3887000 2507000 3237000 41697000 36637000 26143000 2037000 1257000 116000 -27000 -501000 293000 1456000 2005000 3984000 7912000 7382000 6884000 450000 -1188000 799000 2153000 12214000 13899000 938000 -3846000 16297000 3222000 767000 501000 -514000 2601000 892000 -7472000 5170000 2162000 13205000 -242000 12269000 -2824000 964000 647000 -50225000 -5708000 -14273000 211006000 213723000 287938000 5993000 254308000 228373000 290341000 7500000 3472000 8217000 4327000 32330000 6433000 4069000 3057000 1742000 991000 35150000 9496000 12190000 32093000 7754000 11199000 259000 -258000 444000 14457000 8221000 1439000 51872000 43651000 42212000 66329000 51872000 43651000 1338000 1847000 687000 3019000 3019000 3019000 285000 245000 592000 7000 <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1. Formation and Business of the Company</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company was incorporated in Minnesota on March 10, 2006 to manufacture and market innovative active implantable medical devices for the treatment of neurological disorders initially focusing on the treatment of chronic pain. Subsequently, the Company was reincorporated in Delaware on October 4, 2006 and relocated to California.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Since inception, the Company has incurred net losses and negative cash flows from operations. During the year ended December 31, 2019, the Company incurred a net loss of $103.7 million and used $50.2 million of cash in operations. At December 31, 2019, the Company had an accumulated deficit of $409.8 million and does not expect to experience positive cash flows from operations in the immediate future. The Company has financed operations to date primarily through private placements of equity securities, borrowings under a debt agreement, the issuance of common stock in its November 2014 initial public offering and its June 2015 underwritten public offering, as well as its June 2016 underwritten public offering of convertible senior notes due in 2021. The Company’s ability to continue to meet its obligations and to achieve its business objectives for the foreseeable future is dependent upon, amongst other things, generating sufficient revenues and its ability to continue to control expenses to meet its obligations as they become due. Failure to increase sales of its products, manage discretionary expenditures or raise additional financing, if required, may adversely impact the Company’s ability to achieve its intended business objectives.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Public Offerings</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2014, the Company completed its initial public offering (IPO) of shares of its common stock and as a result, the following transactions were recorded in the Company’s consolidated financial statements during the fourth quarter of 2014:</p> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">•</span></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">the sale of 8,050,000 shares of common stock, including 1,050,000 from the exercise by the underwriters of their overallotment option, at an offering price of $18.00 per share, for net proceeds of $131.6 million, after deducting the underwriters’ discounts, commissions and offering costs paid by us; and</span></p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">•</span></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">immediately prior to the completion of the IPO, all the outstanding shares of the Company’s redeemable convertible preferred stock and convertible preferred stock were converted into 15,208,048 shares of common stock.</span></p></td></tr></table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2015, the Company completed an underwritten public offering of its common stock, which included shares of its common stock held by certain of its stockholders, and issued 2,470,587 shares of common stock, including 705,882 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares.  The Company received cash proceeds of approximately $118.4 million, net of underwriting discounts and commissions and offering costs paid by the Company.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the Company issued $150.0 million aggregate principal amount of 1.75% convertible senior notes due 2021 in a registered underwritten public offering and an additional $22.5 million aggregate principal amount of such notes pursuant to the exercise in full of the over-allotment options of the underwriters (the 2021 Notes). The interest rates are fixed at 1.75% per annum and are payable semi-annually in arrears on June 1 and December 1 of each year, commencing on December 1, 2016.  The total net proceeds from the debt offering, after deducting transaction costs, were approximately $166.2 million.</p> -103700000 -50200000 -409800000 2021 8050000 1050000 18.00 131600000 15208048 2470587 705882 118400000 150000000.0 0.0175 2021 22500000 semi-annually in arrears on June 1 and December 1 of each year, commencing on December 1, 2016 166200000 <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2. Summary of Significant Accounting Policies</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Basis of Presentation</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (U.S. GAAP). The consolidated financial statements include the Company’s accounts and those of its four wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Segments</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The chief operating decision maker for the Company is the Chief Executive Officer. The Chief Executive Officer reviews financial information presented on a consolidated basis, accompanied only by information about revenue by geographic region, for purposes of allocating resources and evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level, other than revenue. Accordingly, the Company has determined that it has a single reportable and operating segment structure. The Company and its Chief Executive Officer evaluate performance based primarily on revenue in the geographic locations in which the Company operates. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Until 2015, the Company had derived most of its revenue from sales to customers in Australia and Europe.  In May 2015, the U.S. Food and Drug Administration (FDA) approved the Company’s premarket approval (PMA) application to market Senza in the United States and the Company launched sales in the United States in 2015. Revenue by geography is based on the billing address of the customer. The United States is the only country that accounts for 10% or more of the revenue during the periods presented:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-lived assets and operating income outside the United States are not material; therefore, disclosures have been limited to revenue.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Foreign Currency Translation</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s consolidated financial statements are prepared in U.S. dollars (USD). Its foreign subsidiaries use their local currency as their functional currency and maintain their records in the local currency. Accordingly, the assets and liabilities of these subsidiaries are translated into USD using the current exchange rates in effect at the balance sheet date and equity accounts are translated into USD using historical rates. Revenues and expenses are translated using the monthly average exchange rates during the period when the transaction occurs. The resulting foreign currency translation adjustments from this process are recorded in accumulated other comprehensive income (loss) in the consolidated balance sheets. Unrealized foreign exchange gains and losses from the remeasurement of assets and liabilities denominated in currencies other than the functional currency of the reporting entity are recorded in other income (expense), net. The Company recorded net unrealized foreign currency transaction gains of $1.0 million during the year ended December 31, 2019, losses of $0.6 million during the year ended December 31, 2018 and gains of $0.8 million during the year ended December 31, 2017. Additionally, realized gains and losses resulting from transactions denominated in currencies other than the local currency are recorded in other income (expense), net. The Company recorded realized foreign currency transaction losses of $1.6 million during the year ended December 31, 2019, losses of $0.4 million during the year ended December 31, 2018 and gains of $0.5 million during the year ended December 31, 2017.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the extent that the Company’s international operations grow, the effect of fluctuations in currency rates will become greater, and the Company will continue to reassess its approach to managing this risk. In addition, currency fluctuations or a weakening U.S. dollar can increase the costs of the Company’s international expansion. To date, the Company has not entered into any foreign currency hedging contracts. Based on its current international structure, the Company does not plan on engaging in hedging activities in the near future.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant accounting estimates and management judgments reflected in the consolidated financial statements include items such as allowances for doubtful accounts; warranty obligations; stock-based compensation; depreciation and amortization lives; inventory valuation; valuation </p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of investments and</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> accounting for income taxes</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Estimates are based on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.</span></p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Other Risks and Uncertainties</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents and investments. The majority of the Company’s cash is held by one financial institution in the United States in excess of federally insured limits. The Company maintained investments in money market funds that were not federally insured during the years ended December 31, 2019 and 2018, and held cash in foreign banks of approximately $12.1 million and $4.1 million at December 31, 2019 and 2018, respectively, that was not federally insured. The Company has not experienced any losses on its deposits of cash and cash equivalents.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s convertible note hedge transactions, entered into in connection with the 2021 Notes, subject the Company to credit risk such that the counterparties may be unable to fulfill the terms of the transactions.  The associated risk is mitigated by limiting the counterparties to major financial institutions. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the international markets in which the Company participates, the Company uses both a direct sales force and distributors to sell its products, while in the United States the Company utilizes a direct sales force. The Company performs ongoing credit evaluations of some of its direct customers and distributors, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were no customers that accounted for <span>10%</span> or more of the Company’s revenue for each of the years ended December 31, 2019, 2018 and 2017.  Additionally, there were no customers that accounted for <span>10%</span> or more of the Company’s accounts receivable balance as of December 31, 2019 and 2018.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is subject to risks common to medical device companies including, but not limited to, new technological innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, product liability, uncertainty of market acceptance of products and the need to obtain additional financing. The Company is dependent on third party manufacturers and suppliers, in some cases sole- or single-source suppliers.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There can be no assurance that the Company’s products or services will continue to be accepted in the marketplace, nor can there be any assurance that any future products or services can be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that such products or services will be successfully marketed, if at all.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company expects to incur operating losses in the near term and may need to obtain additional financing. There can be no assurance that such financing will be available or will be at terms acceptable by the Company.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Fair Value of Financial Instruments</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Carrying amounts of certain of the Company’s financial instruments, including cash equivalents, short term investments, accounts receivable, accounts payable and accrued liabilities approximate fair value due to their relatively short maturities.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Cash and Cash Equivalents</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers all highly liquid investments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents. Cash and cash equivalents include money market funds in the amount of $52.4 million and $15.6 million as of December 31, 2019 and 2018, respectively. At December 31, 2019 and 2018, the Company’s cash equivalents were held in institutions in the United States and include deposits in a money market fund which were unrestricted as to withdrawal or use.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Restricted Cash</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash as of December 31, 2019 and 2018 includes certificates of deposit of $0.6 million representing collateral for the Company’s Redwood City, CA building lease pursuant to an agreement dated March 5, 2015.  Restricted cash as of December 31, 2019 additionally includes certificates of deposit of $0.4 million collateralizing payment of charges related to the Company’s credit cards.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Investment Securities</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company classifies its investment securities as available-for-sale. The Company classifies these investment securities as short-term or long-term based on the nature of the investment, its maturity date and its availability for use in current operations. Those investments with original maturities greater than three months at the date of purchase and remaining maturities of less than 12 months are considered short-term investments. Those investments with remaining maturities greater than 12 months are also classified as short-term investments as management considers them to be available for current operations if needed. The Company’s investment securities are recorded at fair value based on the fair value hierarchy.  Money market funds are classified within Level 1 of the fair value hierarchy, and commercial paper and corporate notes are classified within Level 2 of the fair value hierarchy. Unrealized gains and losses, deemed temporary in nature, are reported as a separate component of accumulated other comprehensive income (loss).</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A decline in the fair value of any security below cost that is deemed other than temporary results in a charge to earnings and the corresponding establishment of a new cost basis for the security. Premiums (discounts) are amortized (accreted) over the life of the related security as an adjustment to yield using the straight-line interest method. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of securities sold.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Inventories</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories are stated at the lower of cost or net realizable value. Cost is determined using the standard cost method which approximates the first-in, first-out basis. Net realizable value is determined as the prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company regularly reviews inventory quantities compared to forecasted sales to record a provision for excess and obsolete inventory when appropriate. Inventory write-downs are recorded for excess and obsolete inventory. The Company estimates forecasted sales by considering product acceptance in the marketplace, customer demand, historical sales, product obsolescence and technological innovations.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s policy is to write down inventory that has become obsolete, inventory that has a cost basis in excess of its expected lower of cost or net realizable value, and inventory in excess of expected requirements. The estimate of excess quantities is judgmental and primarily dependent on the Company’s estimates of future demand for a particular product. If the estimate of future demand is inaccurate based on actual sales, the Company may increase the write-down for excess inventory for that component and record a charge to inventory impairment in the accompanying consolidated statements of operations and comprehensive loss. The Company periodically evaluates the carrying value of inventory on hand for potential excess amount over demand using the same lower of cost or net realizable value approach as that has been used to value the inventory. The Company also periodically evaluates inventory quantities in consideration of actual loss experience. As a result of these evaluations, for the year ended December 31, 2019, the Company recognized total write-downs of $1.6 million for its inventories.  For the years ended December 31, 2018 and 2017, the Company recognized total write-downs of $2.0 million and $4.0 million for its inventories. The Company’s estimation of the future demand for a particular component of the Company’s products may vary and may result in changes in estimates in any particular period.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Shipping and Handling Costs</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shipping and handling costs are expensed as incurred and are included in cost of revenue.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Revenue Recognition</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has revenue arrangements that generally consist of a single performance obligation, although, in some instances, revenue arrangements may consist of two performance obligations. The Company recognizes revenue at the point in time when it transfers control of promised goods to its customers.  Revenue is measured as the amount of consideration it expects to receive in exchange for transferring goods.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 3 for further discussion on Revenue Recognition.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Allowance for Doubtful Accounts</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company makes estimates of the collectability of accounts receivable. In doing so, the Company analyzes historical bad debt trends, customer credit worthiness, current economic trends and changes in customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Property and Equipment</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation of property and equipment, other than leasehold improvements, is computed using the straight-line method over the assets’ estimated useful lives of three to five years. Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the life of the lease. Upon retirement or sale, the cost and related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is reflected in operations. Maintenance and repairs are charged to operations as incurred.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Impairment of Long-Lived Assets</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group might not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net cash flows to the related asset group’s carrying value. If an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. There were no impairment charges, or changes in estimated useful lives, recorded through December 31, 2019.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Income Taxes</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s consolidated financial statements or income tax returns. In estimating future tax consequences, expected future events other than enactments or changes in the tax law or rates are considered. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company operates in various tax jurisdictions and is subject to audit by various tax authorities. To date, taxes paid have been predominantly due to income taxes in foreign and state jurisdictions in which we conduct business. The Company provides for tax contingencies whenever it is deemed probable that a tax asset has been impaired or a tax liability has been incurred for events such as tax claims or changes in tax laws. Tax contingencies are based upon their technical merits, relative tax law, and the specific facts and circumstances as of each reporting period. Changes in facts and circumstances could result in material changes to the amounts recorded for such tax contingencies.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records uncertain tax positions on the basis of a two-step process whereby (1) a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. The Company’s policy is to recognize interest and penalties related to income taxes as a component of income tax expense. A nominal amount of interest and penalties have been recognized in the </p> <p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">statements of operations and comprehensive loss in 2019. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> interest or penalties related to income taxes have been recognized in the statements of operations and comprehensive loss in </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">201</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and 201</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 22, 2017, the 2017 Tax Cuts and Jobs Act (the 2017 Tax Act) was enacted into law.  The recorded impact for the effects of the 2017 Tax Act is based on the Company’s current knowledge, assumptions and interpretations of available guidance.  The Company elected to account for Global Intangible Low-Tax Income (GILTI) as a current period expense when incurred.  The Company will continue to monitor the issuance of additional regulatory or accounting guidance and record any necessary adjustments in the period for which additional guidance is issued.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Other Comprehensive Income (Loss)</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive income (loss) represents all changes in stockholders’ equity except those resulting from distributions to stockholders. The Company’s unrealized gains on short-term available-for-sale investment securities and foreign currency translation adjustments represent the components of other comprehensive income (loss) that are excluded from the reported net loss and are presented in the consolidated statements of operations and comprehensive loss.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Research and Development</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses, including new product development, regulatory compliance, and clinical research, are charged to operations as incurred in the consolidated statements of operations and comprehensive loss. Such costs include personnel-related costs, including stock-based compensation, supplies, services, depreciation, allocated facilities and information services, clinical trial and related clinical manufacturing expenses, fees paid to investigative sites, and other indirect costs.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock-Based Compensation</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for stock-based compensation arrangements with employees in accordance with Accounting Standards Codification (ASC) 718, <span style="font-style:italic;">Compensation—Stock Compensation.</span> ASC 718 requires the recognition of compensation expense, using a fair value-based method, for costs related to all share-based payments including stock options.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-09, <span style="font-style:italic;">Stock Compensation (Topic 718): Improvements to Employee Shared-Based Payment Accounting</span>, which the Company adopted on January 1, 2017.  Under ASU 2016-09, entities are permitted to make an accounting policy election to either estimate forfeitures on share-based payment awards, as previously required, or to recognize forfeitures as they occur. The Company has elected to continue to estimate forfeitures expected to occur to determine the amount of compensation cost recognized in each period.  ASU 2016-09 also requires that entities recognize, on a prospective basis, all excess tax benefits and tax deficiencies as income tax expense or benefit in the income statement as discrete items in the reporting period in which they occur. The adoption did not result in a cumulative-effect adjustment to accumulated deficit as of January 1, 2017 using the modified retrospective method. Additionally, under ASU 2016-09, excess tax benefits are classified as an operating activity in the statement of cash flows. The Company has elected the presentation of excess tax benefits in the statement of cash flows using the prospective transition method.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s determination of the fair value of stock options, other than performance-based awards, on the date of grant utilizes the Black-Scholes option-pricing model, and is impacted by its common stock price as well as changes in assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the expected term that options will remain outstanding, the expected common stock price volatility over the term of the option awards, risk-free interest rates and expected dividends.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of stock options is recognized over the period during which an optionee is required to provide services in exchange for the option award, known as the requisite service period (usually the vesting period), on a straight-line basis. Stock-based compensation expense recognized at fair value includes the impact of estimated </p> <p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">forfeitures. The Company estimates future forfeitures at the date of grant and revises the estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates the fair value of the rights to purchase shares by employees under the Employee Stock Purchase Plan using the Black-Scholes option pricing formula. The Employee Stock Purchase Plan provides for consecutive <span style="-sec-ix-hidden:F_000468">six-month</span> offering periods and the Company uses its own historical volatility data in the valuation.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equity instruments issued to non-employees are recorded at their fair value on the measurement date and are subject to periodic adjustments as the underlying equity instruments vest. The fair value of options granted to consultants is expensed when vested. The non-employee stock-based compensation expense was not material for all periods presented.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for stock-based compensation for the restricted stock units at their fair value, based on the closing market price of the Company’s common stock on the grant date.  These costs are recognized on a straight-line basis over the requisite service period, which is generally the vesting term of four years.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also issues stock options and restricted stock units with vesting based upon achievement of specific operational performance criteria. The fair value for these performance-based awards is recognized over the period during which the goals are to be achieved.  Stock-based compensation expense recognized at fair value includes the impact of estimated probability that the goals would be achieved, which is assessed prior to the requisite service period for the specific goals.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company additionally grants restricted stock units with vesting based on its stock price performance compared to a specified target composite index over a certain period.  The fair value of these grants is determined by using the Monte Carlo simulation model, which is based on a discounted cash flow approach, and requires inputs such as expected volatility of our stock price, expected volatility of the targeted composite index, correlation between the changes in our stock price and the target composite index, risk-free interest rate and expected dividends.  The expected volatility of our stock and the target composite index is based on the historical data. Correlation is based on the historical relationship between our stock price and the target composite index. The risk-free interest rate is based upon the treasury yield consistent with the vesting term of the grant. The expected dividend yield is zero. Stock-based compensation for these restricted stock units is recognized over the specified performance measurement period. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon adoption of ASU 2016-09 as described above, excess tax benefits or deficiencies from share-based award activity are reflected in the consolidated statements of operations as a component of the provision for income taxes, whereas they were previously recognized as additional paid-in capital.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Net Loss per Share of Common Stock</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, restricted stock units and common stock options are considered to be potentially dilutive securities. Because the Company has reported a net loss in all periods presented, diluted net loss per common share is the same as basic net loss per common share for those periods.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires the measurement and recognition of expected credit losses for financial assets held. The FASB has also issued several updates to ASU 2016-13.  These ASU’s are effective for public entities for annual periods beginning after December 15, 2019, with early adoption permitted. The Company has not determined the potential effects of the guidance on its consolidated financial statements.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, the FASB issued </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ASU No. 2019-12,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income Taxes (Topic 740): Simplifying the</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounting for Income Taxes. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This ASU </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences related to changes in ownership of equity method investments and foreign subsidiaries. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ASU 2019-12</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> also simplifies aspects of accounting for franchise taxes and enacted changes in tax laws or rates</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ASU 2019-12 is effective for public entities for annual periods beginning after December 15, 2020, with early adoption permitted. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has not determined the potential effects of the guidance on its consolidated financial statements.</span></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Basis of Presentation</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (U.S. GAAP). The consolidated financial statements include the Company’s accounts and those of its four wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated.</p> 4 <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Segments</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The chief operating decision maker for the Company is the Chief Executive Officer. The Chief Executive Officer reviews financial information presented on a consolidated basis, accompanied only by information about revenue by geographic region, for purposes of allocating resources and evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level, other than revenue. Accordingly, the Company has determined that it has a single reportable and operating segment structure. The Company and its Chief Executive Officer evaluate performance based primarily on revenue in the geographic locations in which the Company operates. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Until 2015, the Company had derived most of its revenue from sales to customers in Australia and Europe.  In May 2015, the U.S. Food and Drug Administration (FDA) approved the Company’s premarket approval (PMA) application to market Senza in the United States and the Company launched sales in the United States in 2015. Revenue by geography is based on the billing address of the customer. The United States is the only country that accounts for 10% or more of the revenue during the periods presented:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-lived assets and operating income outside the United States are not material; therefore, disclosures have been limited to revenue.</p> 1 The United States is the only country that accounts for 10% or more of the revenue during the periods presented: <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">83</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> 0.84 0.83 0.81 <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Foreign Currency Translation</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s consolidated financial statements are prepared in U.S. dollars (USD). Its foreign subsidiaries use their local currency as their functional currency and maintain their records in the local currency. Accordingly, the assets and liabilities of these subsidiaries are translated into USD using the current exchange rates in effect at the balance sheet date and equity accounts are translated into USD using historical rates. Revenues and expenses are translated using the monthly average exchange rates during the period when the transaction occurs. The resulting foreign currency translation adjustments from this process are recorded in accumulated other comprehensive income (loss) in the consolidated balance sheets. Unrealized foreign exchange gains and losses from the remeasurement of assets and liabilities denominated in currencies other than the functional currency of the reporting entity are recorded in other income (expense), net. The Company recorded net unrealized foreign currency transaction gains of $1.0 million during the year ended December 31, 2019, losses of $0.6 million during the year ended December 31, 2018 and gains of $0.8 million during the year ended December 31, 2017. Additionally, realized gains and losses resulting from transactions denominated in currencies other than the local currency are recorded in other income (expense), net. The Company recorded realized foreign currency transaction losses of $1.6 million during the year ended December 31, 2019, losses of $0.4 million during the year ended December 31, 2018 and gains of $0.5 million during the year ended December 31, 2017.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">To the extent that the Company’s international operations grow, the effect of fluctuations in currency rates will become greater, and the Company will continue to reassess its approach to managing this risk. In addition, currency fluctuations or a weakening U.S. dollar can increase the costs of the Company’s international expansion. To date, the Company has not entered into any foreign currency hedging contracts. Based on its current international structure, the Company does not plan on engaging in hedging activities in the near future.</p> 1000000.0 -600000 800000 -1600000 -400000 500000 <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant accounting estimates and management judgments reflected in the consolidated financial statements include items such as allowances for doubtful accounts; warranty obligations; stock-based compensation; depreciation and amortization lives; inventory valuation; valuation </p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">of investments and</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> accounting for income taxes</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">. Estimates are based on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.</span></p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Other Risks and Uncertainties</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents and investments. The majority of the Company’s cash is held by one financial institution in the United States in excess of federally insured limits. The Company maintained investments in money market funds that were not federally insured during the years ended December 31, 2019 and 2018, and held cash in foreign banks of approximately $12.1 million and $4.1 million at December 31, 2019 and 2018, respectively, that was not federally insured. The Company has not experienced any losses on its deposits of cash and cash equivalents.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s convertible note hedge transactions, entered into in connection with the 2021 Notes, subject the Company to credit risk such that the counterparties may be unable to fulfill the terms of the transactions.  The associated risk is mitigated by limiting the counterparties to major financial institutions. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the international markets in which the Company participates, the Company uses both a direct sales force and distributors to sell its products, while in the United States the Company utilizes a direct sales force. The Company performs ongoing credit evaluations of some of its direct customers and distributors, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There were no customers that accounted for <span>10%</span> or more of the Company’s revenue for each of the years ended December 31, 2019, 2018 and 2017.  Additionally, there were no customers that accounted for <span>10%</span> or more of the Company’s accounts receivable balance as of December 31, 2019 and 2018.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is subject to risks common to medical device companies including, but not limited to, new technological innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, product liability, uncertainty of market acceptance of products and the need to obtain additional financing. The Company is dependent on third party manufacturers and suppliers, in some cases sole- or single-source suppliers.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There can be no assurance that the Company’s products or services will continue to be accepted in the marketplace, nor can there be any assurance that any future products or services can be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that such products or services will be successfully marketed, if at all.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company expects to incur operating losses in the near term and may need to obtain additional financing. There can be no assurance that such financing will be available or will be at terms acceptable by the Company.</p> 12100000 4100000 2021 0 0 0 0.10 0.10 0.10 0 0 0.10 0.10 <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Fair Value of Financial Instruments</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Carrying amounts of certain of the Company’s financial instruments, including cash equivalents, short term investments, accounts receivable, accounts payable and accrued liabilities approximate fair value due to their relatively short maturities.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Cash and Cash Equivalents</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company considers all highly liquid investments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents. Cash and cash equivalents include money market funds in the amount of $52.4 million and $15.6 million as of December 31, 2019 and 2018, respectively. At December 31, 2019 and 2018, the Company’s cash equivalents were held in institutions in the United States and include deposits in a money market fund which were unrestricted as to withdrawal or use.</p> 52400000 15600000 <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Restricted Cash</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted cash as of December 31, 2019 and 2018 includes certificates of deposit of $0.6 million representing collateral for the Company’s Redwood City, CA building lease pursuant to an agreement dated March 5, 2015.  Restricted cash as of December 31, 2019 additionally includes certificates of deposit of $0.4 million collateralizing payment of charges related to the Company’s credit cards.</p> 600000 600000 400000 <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Investment Securities</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company classifies its investment securities as available-for-sale. The Company classifies these investment securities as short-term or long-term based on the nature of the investment, its maturity date and its availability for use in current operations. Those investments with original maturities greater than three months at the date of purchase and remaining maturities of less than 12 months are considered short-term investments. Those investments with remaining maturities greater than 12 months are also classified as short-term investments as management considers them to be available for current operations if needed. The Company’s investment securities are recorded at fair value based on the fair value hierarchy.  Money market funds are classified within Level 1 of the fair value hierarchy, and commercial paper and corporate notes are classified within Level 2 of the fair value hierarchy. Unrealized gains and losses, deemed temporary in nature, are reported as a separate component of accumulated other comprehensive income (loss).</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A decline in the fair value of any security below cost that is deemed other than temporary results in a charge to earnings and the corresponding establishment of a new cost basis for the security. Premiums (discounts) are amortized (accreted) over the life of the related security as an adjustment to yield using the straight-line interest method. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of securities sold.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Inventories</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories are stated at the lower of cost or net realizable value. Cost is determined using the standard cost method which approximates the first-in, first-out basis. Net realizable value is determined as the prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company regularly reviews inventory quantities compared to forecasted sales to record a provision for excess and obsolete inventory when appropriate. Inventory write-downs are recorded for excess and obsolete inventory. The Company estimates forecasted sales by considering product acceptance in the marketplace, customer demand, historical sales, product obsolescence and technological innovations.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s policy is to write down inventory that has become obsolete, inventory that has a cost basis in excess of its expected lower of cost or net realizable value, and inventory in excess of expected requirements. The estimate of excess quantities is judgmental and primarily dependent on the Company’s estimates of future demand for a particular product. If the estimate of future demand is inaccurate based on actual sales, the Company may increase the write-down for excess inventory for that component and record a charge to inventory impairment in the accompanying consolidated statements of operations and comprehensive loss. The Company periodically evaluates the carrying value of inventory on hand for potential excess amount over demand using the same lower of cost or net realizable value approach as that has been used to value the inventory. The Company also periodically evaluates inventory quantities in consideration of actual loss experience. As a result of these evaluations, for the year ended December 31, 2019, the Company recognized total write-downs of $1.6 million for its inventories.  For the years ended December 31, 2018 and 2017, the Company recognized total write-downs of $2.0 million and $4.0 million for its inventories. The Company’s estimation of the future demand for a particular component of the Company’s products may vary and may result in changes in estimates in any particular period.</p> 1600000 2000000.0 4000000.0 <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Shipping and Handling Costs</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shipping and handling costs are expensed as incurred and are included in cost of revenue.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Revenue Recognition</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has revenue arrangements that generally consist of a single performance obligation, although, in some instances, revenue arrangements may consist of two performance obligations. The Company recognizes revenue at the point in time when it transfers control of promised goods to its customers.  Revenue is measured as the amount of consideration it expects to receive in exchange for transferring goods.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 3 for further discussion on Revenue Recognition.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Adoption of ASC 606</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 1, 2018, the Company adopted the new accounting standard ASC 606, <span style="font-style:italic;">Revenue from Contracts with Customers</span>, using the modified retrospective method applied to contracts which were not completed as of that date.  Results for reporting periods beginning after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 605, <span style="font-style:italic;">Revenue Recognition</span>.<span style="color:#000000;"> Under ASC 606, assuming all other revenue recognition criteria have been met, the Company will recognize revenue earlier for arrangements where the Company has satisfied its performance obligations but has not issued invoices.  These amounts are recorded as unbilled receivables, which are included in accounts receivable on the consolidated balance sheet, as the Company has an unconditional right to payment at the end of the applicable period.  </span></p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Revenue Recognition</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue is recognized when obligations under the terms of a contract with customers are satisfied, which occurs with the transfer of control of the Company’s goods to its customers.  Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For a majority of sales, where the Company’s sales representative delivers its product at the point of implantation at hospitals or medical facilities, the Company recognizes revenue upon completion of the procedure and authorization, which represents the point in time when control transfers to the customers.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the remaining sales, which are sent from the Company’s distribution centers directly to hospitals and medical facilities, as well as distributor sales, where product is ordered in advance of an implantation, the transfer of control occurs at the time of shipment of the product.  These customers are obligated to pay within specified terms regardless of when or if they ever sell or use the products. The Company does not offer rights of return or price protection.<span style="color:#FF0000;"> </span>To the extent the Company has a post-delivery obligation, such as programming devices that have been delivered as part of a direct-ship order, the Company defers revenue and the associated cost of goods sold associated with the post-delivery obligation only if the amounts are deemed material.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The expected costs associated with warranty obligations continue to be recognized as expense when the products are sold (see Note 7). The Company periodically provides incentive offers, in the form of rebates, to customers based on their aggregate levels of purchases.  Product revenue is recorded net of such incentive offers.</p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Practical Expedients and Exemptions</p><p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes revenue upon the transfer of control of the product and there are no material future performance obligations beyond such transfer.  As a result, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company does not capitalize incremental costs when the amortization period of the asset is less than a year.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Allowance for Doubtful Accounts</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company makes estimates of the collectability of accounts receivable. In doing so, the Company analyzes historical bad debt trends, customer credit worthiness, current economic trends and changes in customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Property and Equipment</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation of property and equipment, other than leasehold improvements, is computed using the straight-line method over the assets’ estimated useful lives of three to five years. Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the life of the lease. Upon retirement or sale, the cost and related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is reflected in operations. Maintenance and repairs are charged to operations as incurred.</p> P3Y P5Y <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Impairment of Long-Lived Assets</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group might not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net cash flows to the related asset group’s carrying value. If an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. There were no impairment charges, or changes in estimated useful lives, recorded through December 31, 2019.</p> 0 <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Income Taxes</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s consolidated financial statements or income tax returns. In estimating future tax consequences, expected future events other than enactments or changes in the tax law or rates are considered. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company operates in various tax jurisdictions and is subject to audit by various tax authorities. To date, taxes paid have been predominantly due to income taxes in foreign and state jurisdictions in which we conduct business. The Company provides for tax contingencies whenever it is deemed probable that a tax asset has been impaired or a tax liability has been incurred for events such as tax claims or changes in tax laws. Tax contingencies are based upon their technical merits, relative tax law, and the specific facts and circumstances as of each reporting period. Changes in facts and circumstances could result in material changes to the amounts recorded for such tax contingencies.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records uncertain tax positions on the basis of a two-step process whereby (1) a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. The Company’s policy is to recognize interest and penalties related to income taxes as a component of income tax expense. A nominal amount of interest and penalties have been recognized in the </p> <p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">statements of operations and comprehensive loss in 2019. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> interest or penalties related to income taxes have been recognized in the statements of operations and comprehensive loss in </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">201</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and 201</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 22, 2017, the 2017 Tax Cuts and Jobs Act (the 2017 Tax Act) was enacted into law.  The recorded impact for the effects of the 2017 Tax Act is based on the Company’s current knowledge, assumptions and interpretations of available guidance.  The Company elected to account for Global Intangible Low-Tax Income (GILTI) as a current period expense when incurred.  The Company will continue to monitor the issuance of additional regulatory or accounting guidance and record any necessary adjustments in the period for which additional guidance is issued.</p> 0 0 0 <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Other Comprehensive Income (Loss)</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other comprehensive income (loss) represents all changes in stockholders’ equity except those resulting from distributions to stockholders. The Company’s unrealized gains on short-term available-for-sale investment securities and foreign currency translation adjustments represent the components of other comprehensive income (loss) that are excluded from the reported net loss and are presented in the consolidated statements of operations and comprehensive loss.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Research and Development</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses, including new product development, regulatory compliance, and clinical research, are charged to operations as incurred in the consolidated statements of operations and comprehensive loss. Such costs include personnel-related costs, including stock-based compensation, supplies, services, depreciation, allocated facilities and information services, clinical trial and related clinical manufacturing expenses, fees paid to investigative sites, and other indirect costs.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock-Based Compensation</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for stock-based compensation arrangements with employees in accordance with Accounting Standards Codification (ASC) 718, <span style="font-style:italic;">Compensation—Stock Compensation.</span> ASC 718 requires the recognition of compensation expense, using a fair value-based method, for costs related to all share-based payments including stock options.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-09, <span style="font-style:italic;">Stock Compensation (Topic 718): Improvements to Employee Shared-Based Payment Accounting</span>, which the Company adopted on January 1, 2017.  Under ASU 2016-09, entities are permitted to make an accounting policy election to either estimate forfeitures on share-based payment awards, as previously required, or to recognize forfeitures as they occur. The Company has elected to continue to estimate forfeitures expected to occur to determine the amount of compensation cost recognized in each period.  ASU 2016-09 also requires that entities recognize, on a prospective basis, all excess tax benefits and tax deficiencies as income tax expense or benefit in the income statement as discrete items in the reporting period in which they occur. The adoption did not result in a cumulative-effect adjustment to accumulated deficit as of January 1, 2017 using the modified retrospective method. Additionally, under ASU 2016-09, excess tax benefits are classified as an operating activity in the statement of cash flows. The Company has elected the presentation of excess tax benefits in the statement of cash flows using the prospective transition method.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s determination of the fair value of stock options, other than performance-based awards, on the date of grant utilizes the Black-Scholes option-pricing model, and is impacted by its common stock price as well as changes in assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the expected term that options will remain outstanding, the expected common stock price volatility over the term of the option awards, risk-free interest rates and expected dividends.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of stock options is recognized over the period during which an optionee is required to provide services in exchange for the option award, known as the requisite service period (usually the vesting period), on a straight-line basis. Stock-based compensation expense recognized at fair value includes the impact of estimated </p> <p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">forfeitures. The Company estimates future forfeitures at the date of grant and revises the estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates.</span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimates the fair value of the rights to purchase shares by employees under the Employee Stock Purchase Plan using the Black-Scholes option pricing formula. The Employee Stock Purchase Plan provides for consecutive <span style="-sec-ix-hidden:F_000468">six-month</span> offering periods and the Company uses its own historical volatility data in the valuation.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Equity instruments issued to non-employees are recorded at their fair value on the measurement date and are subject to periodic adjustments as the underlying equity instruments vest. The fair value of options granted to consultants is expensed when vested. The non-employee stock-based compensation expense was not material for all periods presented.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for stock-based compensation for the restricted stock units at their fair value, based on the closing market price of the Company’s common stock on the grant date.  These costs are recognized on a straight-line basis over the requisite service period, which is generally the vesting term of four years.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also issues stock options and restricted stock units with vesting based upon achievement of specific operational performance criteria. The fair value for these performance-based awards is recognized over the period during which the goals are to be achieved.  Stock-based compensation expense recognized at fair value includes the impact of estimated probability that the goals would be achieved, which is assessed prior to the requisite service period for the specific goals.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company additionally grants restricted stock units with vesting based on its stock price performance compared to a specified target composite index over a certain period.  The fair value of these grants is determined by using the Monte Carlo simulation model, which is based on a discounted cash flow approach, and requires inputs such as expected volatility of our stock price, expected volatility of the targeted composite index, correlation between the changes in our stock price and the target composite index, risk-free interest rate and expected dividends.  The expected volatility of our stock and the target composite index is based on the historical data. Correlation is based on the historical relationship between our stock price and the target composite index. The risk-free interest rate is based upon the treasury yield consistent with the vesting term of the grant. The expected dividend yield is zero. Stock-based compensation for these restricted stock units is recognized over the specified performance measurement period. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Upon adoption of ASU 2016-09 as described above, excess tax benefits or deficiencies from share-based award activity are reflected in the consolidated statements of operations as a component of the provision for income taxes, whereas they were previously recognized as additional paid-in capital.</p> P4Y 0 <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Net Loss per Share of Common Stock</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, restricted stock units and common stock options are considered to be potentially dilutive securities. Because the Company has reported a net loss in all periods presented, diluted net loss per common share is the same as basic net loss per common share for those periods.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Accounting Pronouncements</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires the measurement and recognition of expected credit losses for financial assets held. The FASB has also issued several updates to ASU 2016-13.  These ASU’s are effective for public entities for annual periods beginning after December 15, 2019, with early adoption permitted. The Company has not determined the potential effects of the guidance on its consolidated financial statements.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, the FASB issued </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ASU No. 2019-12,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income Taxes (Topic 740): Simplifying the</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounting for Income Taxes. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This ASU </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences related to changes in ownership of equity method investments and foreign subsidiaries. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ASU 2019-12</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> also simplifies aspects of accounting for franchise taxes and enacted changes in tax laws or rates</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ASU 2019-12 is effective for public entities for annual periods beginning after December 15, 2020, with early adoption permitted. </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has not determined the potential effects of the guidance on its consolidated financial statements.</span></p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">3. Revenue</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Adoption of ASC 606</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 1, 2018, the Company adopted the new accounting standard ASC 606, <span style="font-style:italic;">Revenue from Contracts with Customers</span>, using the modified retrospective method applied to contracts which were not completed as of that date.  Results for reporting periods beginning after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 605, <span style="font-style:italic;">Revenue Recognition</span>.<span style="color:#000000;"> Under ASC 606, assuming all other revenue recognition criteria have been met, the Company will recognize revenue earlier for arrangements where the Company has satisfied its performance obligations but has not issued invoices.  These amounts are recorded as unbilled receivables, which are included in accounts receivable on the consolidated balance sheet, as the Company has an unconditional right to payment at the end of the applicable period.  </span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognized the cumulative effect of initially applying ASC 606 as an adjustment to the opening balance of accumulated deficit.  The cumulative effect of the changes made to the consolidated balance sheet as of January 1, 2018 for the adoption of ASC 606 were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adjustments Due</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">to ASC 606</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">January 1, 2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67,287</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,447</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68,734</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,463</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(476</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,987</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated other comprehensive loss</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,242</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,238</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated deficit</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(257,844</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">967</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(256,877</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with ASC 606, the disclosure of the impact of adoption on the Consolidated Balance Sheet was as follows (in thousands):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance Without</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As Reported</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ASC 606 Adoption</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Effect of Change</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,656</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78,142</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,514</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92,035</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92,126</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(91</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,621</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,514</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(893</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with ASC 606, the disclosure of the impact of adoption on the Consolidated Statements of Operations was as follows (in thousands):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31, 2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance Without</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance As Reported</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ASC 606 Adoption</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Effect of Change</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Statement of Operations:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">387,289</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">386,212</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,077</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113,965</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113,441</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">524</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Revenue Recognition</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue is recognized when obligations under the terms of a contract with customers are satisfied, which occurs with the transfer of control of the Company’s goods to its customers.  Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For a majority of sales, where the Company’s sales representative delivers its product at the point of implantation at hospitals or medical facilities, the Company recognizes revenue upon completion of the procedure and authorization, which represents the point in time when control transfers to the customers.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the remaining sales, which are sent from the Company’s distribution centers directly to hospitals and medical facilities, as well as distributor sales, where product is ordered in advance of an implantation, the transfer of control occurs at the time of shipment of the product.  These customers are obligated to pay within specified terms regardless of when or if they ever sell or use the products. The Company does not offer rights of return or price protection.<span style="color:#FF0000;"> </span>To the extent the Company has a post-delivery obligation, such as programming devices that have been delivered as part of a direct-ship order, the Company defers revenue and the associated cost of goods sold associated with the post-delivery obligation only if the amounts are deemed material.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The expected costs associated with warranty obligations continue to be recognized as expense when the products are sold (see Note 7). The Company periodically provides incentive offers, in the form of rebates, to customers based on their aggregate levels of purchases.  Product revenue is recorded net of such incentive offers.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents revenue by geography, based on the billing address of the customer (in thousands):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">326,012</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">321,781</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">263,462</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">International</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64,243</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,508</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63,212</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">390,255</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">387,289</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">326,674</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Practical Expedients and Exemptions</p><p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company recognizes revenue upon the transfer of control of the product and there are no material future performance obligations beyond such transfer.  As a result, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company does not capitalize incremental costs when the amortization period of the asset is less than a year.</p> The cumulative effect of the changes made to the consolidated balance sheet as of January 1, 2018 for the adoption of ASC 606 were as follows (in thousands): <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adjustments Due</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">to ASC 606</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">January 1, 2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67,287</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,447</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68,734</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,463</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(476</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,987</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated other comprehensive loss</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,242</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,238</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated deficit</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(257,844</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">967</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(256,877</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> 67287000 1447000 68734000 6463000 -476000 5987000 -1242000 4000 -1238000 -257844000 967000 -256877000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with ASC 606, the disclosure of the impact of adoption on the Consolidated Balance Sheet was as follows (in thousands):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance Without</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As Reported</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ASC 606 Adoption</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Effect of Change</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts receivable, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,656</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78,142</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,514</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventories</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92,035</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92,126</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(91</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses and other current assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,621</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,514</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(893</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with ASC 606, the disclosure of the impact of adoption on the Consolidated Statements of Operations was as follows (in thousands):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:53.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended December 31, 2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance Without</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance As Reported</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ASC 606 Adoption</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.06%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Effect of Change</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Statement of Operations:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">387,289</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">386,212</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,077</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113,965</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113,441</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.06%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">524</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 80656000 78142000 2514000 92035000 92126000 -91000 6621000 7514000 -893000 387289000 386212000 1077000 113965000 113441000 524000 <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents revenue by geography, based on the billing address of the customer (in thousands):</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">326,012</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">321,781</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">263,462</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">International</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64,243</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,508</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63,212</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">390,255</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">387,289</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">326,674</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 326012000 321781000 263462000 64243000 65508000 63212000 390255000 387289000 326674000 The Company recognizes revenue upon the transfer of control of the product and there are no material future performance obligations beyond such transfer.  As a result, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company does not capitalize incremental costs when the amortization period of the asset is less than a year. P1Y <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">4. Lease Accounting</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Adoption of ASC 842</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 1, 2019, the Company adopted the new accounting standard ASC 842, <span style="font-style:italic;">Leases</span>, which requires entities to recognize assets and liabilities for leases with lease terms of more than 12 months on the balance sheet.  </p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company adopted the new lease standard using the transition method that allowed entities to initially apply ASC 842 at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption (the optional transition method). The Company elected the package of transitional practical expedients, such that, for leases existing prior to the adoption of ASC 842, the Company will not need to </p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">reassess whether contracts are leases, will retain historical lease classification and historical initial direct costs classification. The Company also elected the hindsight practical expedient to determine the lease term for existing leases.</span><span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">  Operating lease assets and operating lease liabilities are recognized based on the present value of minimum lease payments over the remaining lease term.  The Company uses its incremental borrowing rate based on information available when determining the lease liabilities.  Lease cost is recognized on a straight-line basis over the expected lease term.</span></p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adoption of the new lease standard resulted in the recording of operating lease assets of $24.8 million and operating lease liabilities of $26.2 million.  The impact of the changes made to the consolidated balance sheet as of January 1, 2019 from the adoption of ASC 842 were as follows (in thousands):</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adjustments Due</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">to ASC 842</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">January 1, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,771</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,771</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other current liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,389</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,508</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term operating lease liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,805</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,805</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other long-term liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,825</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,423</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,402</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has operating leases for office space, warehouse, research and development facilities and equipment. Leases with terms of 12 months or less are not recorded on the balance sheet, as the related lease expenses are recognized on a straight-line basis over the lease term.  The Company accounts for lease components (such as fixed payments) separately from nonlease components (such as common area expenses).  As of December 31, 2019, the Company has leases with remaining terms of less than 3 year to 6 years, some of which may include options to extend the lease term for up to 5 years.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted average lease terms and discounts rates are as follows:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating Lease Term and Discount Rate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.31 years</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.0%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2019, t<span style="color:#000000;">he maturity of lease liabilities are as follows (in thousands):</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,924</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,073</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,258</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,522</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,687</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,399</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease payments</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,863</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Interest</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,920</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.84%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Present value of lease liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,943</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental lease cost information are as follows (in thousands):</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease cost</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,936</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental balance sheet information are as follows (in thousands):</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,533</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other current liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,498</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long term operating lease liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,445</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.84%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating lease liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,943</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental cash flow information are as follows (in thousands):</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for amounts included in the measurement of lease liabilities:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flow from operating leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,970</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 7 for further details of the Company’s lease commitments.</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Adoption of ASC 842</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 1, 2019, the Company adopted the new accounting standard ASC 842, <span style="font-style:italic;">Leases</span>, which requires entities to recognize assets and liabilities for leases with lease terms of more than 12 months on the balance sheet.  </p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company adopted the new lease standard using the transition method that allowed entities to initially apply ASC 842 at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption (the optional transition method). The Company elected the package of transitional practical expedients, such that, for leases existing prior to the adoption of ASC 842, the Company will not need to </p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">reassess whether contracts are leases, will retain historical lease classification and historical initial direct costs classification. The Company also elected the hindsight practical expedient to determine the lease term for existing leases.</span><span style="color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">  Operating lease assets and operating lease liabilities are recognized based on the present value of minimum lease payments over the remaining lease term.  The Company uses its incremental borrowing rate based on information available when determining the lease liabilities.  Lease cost is recognized on a straight-line basis over the expected lease term.</span></p> P12M <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adoption of the new lease standard resulted in the recording of operating lease assets of $24.8 million and operating lease liabilities of $26.2 million.  The impact of the changes made to the consolidated balance sheet as of January 1, 2019 from the adoption of ASC 842 were as follows (in thousands):</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Adjustments Due</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance at</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:47.2%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">to ASC 842</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">January 1, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,771</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,771</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other current liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,389</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,508</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term operating lease liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,805</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,805</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.2%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other long-term liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,825</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,423</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.74%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,402</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 24800000 26200000 24771000 24771000 119000 2389000 2508000 23805000 23805000 2825000 -1423000 1402000 As of December 31, 2019, the Company has leases with remaining terms of less than 3 year to 6 years, some of which may include options to extend the lease term for up to 5 years. P3Y P6Y P5Y <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The weighted average lease terms and discounts rates are as follows:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating Lease Term and Discount Rate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.31 years</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7.0%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> P5Y3M21D 0.070 <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2019, t<span style="color:#000000;">he maturity of lease liabilities are as follows (in thousands):</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,924</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,073</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,258</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,522</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,687</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Thereafter</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,399</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease payments</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,863</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Interest</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,920</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.84%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Present value of lease liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,943</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 4924000 5073000 5258000 5522000 5687000 2399000 28863000 4920000 23943000 <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental lease cost information are as follows (in thousands):</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease cost</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,936</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 4936000 <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental balance sheet information are as follows (in thousands):</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,533</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other current liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,498</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long term operating lease liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,445</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.84%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating lease liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,943</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 21533000 3498000 20445000 23943000 <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental cash flow information are as follows (in thousands):</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Year Ended</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.84%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.44%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for amounts included in the measurement of lease liabilities:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.84%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flow from operating leases</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,970</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 3970000 <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">5. Fair Value Measurements</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:</p> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">•</span></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">Level 1 — Observable inputs, such as quoted prices in active markets for identical assets or liabilities.</span></p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">•</span></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">•</span></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></p></td></tr></table></div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Cash Equivalents and Short Term Investments</span></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s cash equivalents includes investments in money market funds that are classified as Level 1 of the fair value hierarchy. To value its money market funds, the Company values the funds at $1 stable net asset value, which is the quoted price in active markets for identical assets that the Company has the ability to access. The Company’s cash equivalents and short-term investments also includes commercial paper and corporate notes, which have been classified within Level 2 of the fair value hierarchy because of the sufficient observable inputs for revaluation. The Company’s Level 2 investments are valued using third-party pricing sources. The pricing services utilize industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades of any broker/dealer quotes on the same or similar investments, issuer credit spreads, benchmark investments, prepayment/default projections based on historical data and other observable inputs. The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis, by level, within the fair value hierarchy (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds (i)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52,359</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52,359</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds (iii)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,246</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,246</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper (iii)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,449</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,449</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes (iii)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142,734</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142,734</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52,359</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">172,429</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">224,788</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds (i)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,572</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,572</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper (ii)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119,602</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119,602</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes (ii)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,532</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,532</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,572</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">231,134</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">246,706</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:81.2%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"> </p> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)</span></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Included in cash and cash equivalents on the consolidated balance sheets.</p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)</span></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Included in either cash and cash equivalents or short-term investments on the consolidated balance sheets.</p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)</span></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Included in short-term investments on the consolidated balance sheets.</p></td></tr></table></div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Convertible Senior Notes</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2019, the fair value of the 1.75% convertible senior notes due 2021 was $232.6 million.  The fair value was determined on the basis of market prices observable for similar instruments and is considered Level 2 in the fair value hierarchy.</p> 1 The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis, by level, within the fair value hierarchy (in thousands): <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds (i)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52,359</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52,359</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds (iii)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,246</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,246</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper (iii)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,449</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,449</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes (iii)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142,734</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142,734</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">52,359</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">172,429</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">224,788</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance as of December 31, 2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Level 3</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Money market funds (i)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,572</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,572</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper (ii)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119,602</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119,602</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes (ii)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,532</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,532</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,572</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">231,134</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">246,706</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:81.2%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"> </p> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(i)</span></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Included in cash and cash equivalents on the consolidated balance sheets.</p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(ii)</span></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Included in either cash and cash equivalents or short-term investments on the consolidated balance sheets.</p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(iii)</span></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Included in short-term investments on the consolidated balance sheets.</p></td></tr></table></div> 52359000 52359000 17246000 17246000 12449000 12449000 142734000 142734000 52359000 172429000 224788000 15572000 15572000 119602000 119602000 111532000 111532000 15572000 231134000 246706000 0.0175 2021 232600000 <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">6. Balance Sheet Components</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Investments</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The fair value of the Company’s cash equivalents and short-term investments approximates their respective carrying amounts due to their short-term maturity. The following is a summary of the gross unrealized gains and unrealized losses on the Company’s investment securities (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Investment Securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,209</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,246</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,425</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,449</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142,588</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142,734</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">172,222</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">211</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">172,429</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Investment Securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119,692</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(90</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119,602</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,652</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(120</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,532</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total securities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">231,344</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(210</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">231,134</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Realized gains or losses from the sale of investments and other-than-temporary impairments, if any, on available-for-sale securities are reported in other income (expense), net as incurred. The cost of securities sold was determined based on the specific identification method. The amount of realized gains and realized losses on investments for the periods presented have not been material.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amortized costs and estimated fair values of the Company’s available-for-sale securities by contractual maturities as of December 31, 2019 were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts maturing within one year</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">156,783</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">156,985</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts after one year through five years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,439</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,444</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total investment securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">172,222</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">172,429</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Inventories (in thousands)</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Raw materials</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,354</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,453</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finished goods</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,225</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,582</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total inventories</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,579</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92,035</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Property and Equipment, Net (in thousands)</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,733</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,874</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment and software</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,909</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,751</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and fixtures</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,898</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,903</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,226</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,218</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction in process</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,006</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,811</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,772</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,557</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Accumulated depreciation and amortization</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,006</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,756</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,766</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,801</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization expense for the years ended December 31, 2019, 2018 and 2017 was $4.6 million, $3.9 million and $2.5 million, respectively.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Accrued Liabilities (in thousands)</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued payroll and related expenses</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,056</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,792</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional fees</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,633</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,595</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,353</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,506</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued clinical and research expenses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,157</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,105</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">243</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">243</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued warranty</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,178</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,236</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued other</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,346</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,313</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,966</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,790</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> The following is a summary of the gross unrealized gains and unrealized losses on the Company’s investment securities (in thousands): <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Investment Securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Agency bonds</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,209</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,246</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,425</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,449</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142,588</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">150</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">142,734</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">172,222</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">211</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">172,429</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.42%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31, 2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cost</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gains</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Gross</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrealized</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Holding</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Losses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Investment Securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commercial paper</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119,692</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(90</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">119,602</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Corporate notes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,652</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(120</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">111,532</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Total securities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">231,344</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(210</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">231,134</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 17209000 37000 17246000 12425000 24000 12449000 142588000 150000 4000 142734000 172222000 211000 4000 172429000 119692000 90000 119602000 111652000 120000 111532000 231344000 210000 231134000 <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The amortized costs and estimated fair values of the Company’s available-for-sale securities by contractual maturities as of December 31, 2019 were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortized Cost</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts maturing within one year</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">156,783</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">156,985</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts after one year through five years</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,439</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,444</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total investment securities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">172,222</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">172,429</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 156783000 156985000 15439000 15444000 172222000 172429000 <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Inventories (in thousands)</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Raw materials</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,354</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">37,453</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finished goods</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">65,225</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54,582</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total inventories</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,579</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92,035</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 26354000 37453000 65225000 54582000 91579000 92035000 <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Property and Equipment, Net (in thousands)</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Laboratory equipment</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,733</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,874</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Computer equipment and software</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,909</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,751</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Furniture and fixtures</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,898</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,903</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Leasehold improvements</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,226</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,218</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Construction in process</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,006</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,811</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24,772</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,557</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Accumulated depreciation and amortization</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,006</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,756</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property and equipment, net</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,766</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,801</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 5733000 2874000 9909000 8751000 3898000 3903000 4226000 4218000 1006000 1811000 24772000 21557000 13006000 8756000 11766000 12801000 4600000 3900000 2500000 <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Accrued Liabilities (in thousands)</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued payroll and related expenses</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,056</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,792</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued professional fees</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,633</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,595</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,353</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,506</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued clinical and research expenses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,157</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,105</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">243</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">243</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued warranty</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,178</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,236</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued other</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,346</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,313</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total accrued liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,966</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,790</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 36056000 26792000 1633000 1595000 2353000 2506000 2157000 1105000 243000 243000 1178000 1236000 7346000 5313000 50966000 38790000 <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">7. Commitments and Contingencies</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2015, the Company entered into a lease agreement for approximately 50,740 square feet of office space located in Redwood City, California for a period beginning in <span style="-sec-ix-hidden:F_000641">June 2015</span> through May 2022 with initial annual payments of approximately $2.0 million, increasing to $2.4 million annually during the final year of the lease term. In December 2016, the Company entered into an amendment for an additional approximately 49,980 square feet of office space adjacent to the premises under the original lease (the Expansion Premises), with initial annual payments of $1.2 million, increasing to $2.9 million in the final year of the amended lease term.  <span style="color:#000000;">The lease for the Expansion Premises commenced on June 1, 2018. </span><span style="color:#000000;">  </span>The amendment also extends the lease term for the original premises to terminate on the same date as the amended lease, which is May 31, 2025.  In April 2017, the Company entered into a second amendment to the lease for a temporary space of 8,171 square feet for a period beginning in <span style="-sec-ix-hidden:F_000649">May 2017</span> and which ended on June 1, 2018, the Commencement Date of the Expansion Premises.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In August 2014, the Company entered into a new facility lease for warehouse space beginning on August 21, 2014 through May 31, 2015, under which it was obligated to pay approximately $100,000 in lease payments over the term of the lease. In March 2015, the Company extended the warehouse lease through February 2017 under which it was obligated to pay approximately $0.3 million in lease payments over the remaining term of the lease.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2017, the Company entered into a separate non-cancellable facility lease for warehouse space beginning March 1, 2017 through February 28, 2022, under which the Company is obligated to pay approximately $0.4 million in lease payments over the term of the lease.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">See Note 4 for further discussion on Lease Accounting.</p> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Warranty Obligations</span></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company warrants that its products will operate substantially in conformity with product specifications and provides a limited one- to five-year warranty.  Activities related to warranty obligations were as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning Balance</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,236</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">708</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provision for warranty</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,942</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,334</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Utilization</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,806</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending Balance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,178</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,236</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Supply Agreements</p> <p id="OLE_LINK1" style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has entered into supply agreements with certain of the Company’s suppliers that required certain minimum annual purchase agreements.  As of December 31, 2019, the Company had minimum annual purchase commitments of $6.2 million due in 2020. For the year ended December 31, 2019, the Company recorded a charge of $3.6 million related to the cancellation of firm purchase commitments for inventory related items.</p> <p id="OLE_LINK2" style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also entered into a service agreement in January 2020 for which it is committed to pay $<span>2.5 million</span> annually in each of the next five years. </p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">License Agreements</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2006, the Company entered into an amended and restated license agreement with the Mayo Foundation for Medical Education and Research (Mayo) and Venturi Group LLC (VGL), which provides the Company access to the certain know how and licensed patents owned by Mayo and VGL for treatment of central, autonomic and peripheral nervous system disorders, including pain, using devices to modulate nerve signaling. The licenses granted are exclusive and the Company has the right to sub-license. The agreement will terminate upon the last to expire patent application, unless terminated earlier. The agreement can be terminated any time after three years from March 2006 by Mayo or VGL.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Per terms of the license, the Company is required to pay royalties based on the greater of earned royalty or minimum royalty. The earned royalty will be based on a percentage of net sales of licensed products either by the Company or the sub-licensee. The minimum royalty payment will be based on royalty periods as defined in the agreement.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2011, the Company entered into a Phase II License Agreement with Mayo which provides the Company access to the certain know how and licensed patents owned by Mayo. The licenses granted are exclusive and the Company has the right to sub-license. The agreement will terminate upon the last to expire patent application, unless terminated earlier.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Per terms of the license, the Company is required to:</p> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">•</span></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">Pay a retainer fee of $40,000 per annum starting March 2011 and ending February 2013</span>;</p></td></tr></table></div> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"> </p></td> <td style="width:5.24%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:'Times New Roman';font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">•</span></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:'Times New Roman';font-size:10pt;"><span style="font-family:Times New Roman;">Pay royalties based on the greater of earned royalty or minimum royalty. The earned royalty is based on a percentage of net sales of licensed products either by the Company or the sub-licensee. The minimum annual royalty payment is $200,000.</span></p></td></tr></table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Royalties paid during the years ended December 31, 2019, 2018 and 2017 were $3.2 million, $3.1 million and $2.5 million, respectively.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In November 2014, the Company issued Mayo 20,833 shares of common stock owed in connection with the IPO pursuant to the terms of the license, and recorded noncash research and development expense of $0.5 million for the fair value of the shares on the date of issuance.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In July 2017, the Company entered into a license agreement for which it is committed to pay $0.3 million over the remaining term of this license agreement, which ends in 2022.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Contingent Consideration</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In February 2019, the Company entered into an agreement with a privately-held company to, among other things, provide the privately-held company financing in the form of a secured convertible note.  Through December 31, 2019, the Company has provided financing totaling $8.5 million in the form of two secured convertible notes. The Company has the obligation to provide additional funding of up to $3.0 million in the form of an additional secured convertible note and takes effect only after the Company exercises its option to make a further investment in the privately-held company that is based on certain development targets.  The agreement additionally provides the Company with the exclusive right, but not the obligation, to acquire the privately-held company.  As of December 31, 2019, the value of the secured convertible notes, measured at amortized cost, is $7.9 million, while the value of certain rights in relation to the agreement, measured at cost and monitored for impairment on an ongoing basis, is $1.0 million.  These amounts are reported in Other Assets on the Condensed Consolidated Balance Sheet.  The accretion of amortized cost is recorded in Interest Income, while any changes in value from impairment assessment are recorded in Other Income (Expense) in the Consolidated Statements of Operations and Comprehensive Income.  The Company concluded that the privately-held company is a variable interest entity; however, the Company is not the primary beneficiary as it does not retain power to direct the activities that most significantly impact its economic performance.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Contingencies</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. There have been no contingent liabilities requiring accrual at December 31, 2019 and 2018.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Indemnification</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, including, among other circumstances, in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to the Company’s technology. The term of these indemnification agreements is generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future, but have not yet been made.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has director and officer insurance coverage that reduces the Company’s exposure and enables the Company to recover a portion of any future amounts paid. The Company believes the estimated fair value of these indemnification agreements in excess of applicable insurance coverage is minimal.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. No liability associated with such indemnifications has been recorded to date.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Legal Matters</span></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 28, 2016, the Company filed a lawsuit for patent infringement against Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation (collectively, Boston Scientific). The lawsuit, filed in the U.S. District Court for the Northern District of California (the Court), asserts that Boston Scientific is infringing seven of the Company’s patents covering inventions relating to the Senza system and HF10 therapy. The lawsuit seeks preliminary and permanent injunctive relief against further infringement as well as damages and attorney’s fees. On July 24, 2018, the Court issued an order on claim construction and summary judgment.  In the order, the Court ruled that six asserted method claims in three of the Company’s asserted patents were patent eligible and not invalid as indefinite.  Specifically, the claims upheld in the ruling were claims 11, 21 and 23 of U.S. Patent No. 8,359,102; claim 18 of U.S. Patent No. 8,792,988; and claims 1 and 5 of U.S. Patent No. 8,768,472.  Collectively, these six claims cover methods for delivering SCS therapy at frequencies between 1.5 kHz and 100 kHz.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Court, however, found that Boston Scientific is not currently infringing the six upheld method claims.  Specifically, the Court found that Boston Scientific's sale of the Spectra WaveWriter systems for commercial use in the United States does not infringe the upheld method claims because the Spectra WaveWriter systems cannot be programmed to generate signals above 1.2 kHz.  With regard to the use of the Spectra WaveWriter and the Precision with MultiWave systems in patients that have completed the ACCELERATE clinical trial, the Court found such use to fall within the safe harbor provision of 35 U.S.C. § 271(e).  The Court further held that 35 U.S.C. § 271(f) does not apply to method claims, and therefore the sale of the Precision with MultiWave systems in Europe does not infringe the upheld method claims.  The Court also found that the asserted system claims in four of the Company's asserted patents were invalid as indefinite.  Specifically, the Court invalidated claims 18, 34, and 55 of U.S. Patent No. 9,327,125; claims 5 and 34 of U.S. Patent No. 9,333,357; claims 7, 12, 35, 37, and 58 of U.S. Patent No. 8,712,533; and claims 1 and 22 of U.S. Patent No. 9,480,842.  </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 27, 2018, the parties submitted a joint statement to the Court wherein Boston Scientific asserted to the Court that, with respect to whether any U.S. launch of a high-rate product (such as the Precision with MultiWave and Spectra WaveWriter models used in the ACCELERATE study or any other system that is programmable at any frequency in the range 1.5 to 100 kHz) is imminent, Boston Scientific, as of now, has not decided whether to launch such a product; has not established a timeline for when such a decision might be made, if ever; and has not determined what frequencies would be enabled if it were to decide to launch such a product in the future. Boston Scientific further confirmed its public statements that the ACCELERATE study had been extended into 2019, with an estimated study completion date between April 2019 and November 2019.  On the basis of the foregoing, the parties agreed to dismissal on ripeness grounds of Nevro’s declaratory judgment claims without prejudice, each side to bear its own fees and costs as to these claims, and jointly requested that the Court enter such a dismissal. The dismissal was thereafter entered as a court order on July 31, 2018.  The Company and Boston Scientific are each appealing portions of the Court’s July 24<sup style="font-size:85%;line-height:120%;vertical-align:top">th</sup> ruling, and have submitted their respective appeal briefs and replies to the U.S. Court of Appeals for the Federal Circuit.  The appeal was heard on December 2, 2019. The Company is awaiting the ruling from the appeals court.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 9, 2016, Boston Scientific filed a patent infringement lawsuit alleging the Company’s manufacture, use and sale of the Senza system infringes ten of Boston Scientific’s patents covering spinal cord stimulation technology related to stimulation leads, rechargeable batteries and telemetry. The lawsuit, filed in the U.S. District Court for the District of Delaware, seeks unspecified damages and attorney’s fees, as well as preliminary and permanent injunctive relief against further infringement.<span style="color:#000000;"> During this litigation, Boston Scientific unilaterally dismissed their assertions with regard to two of the ten patents.  </span>In relation to this lawsuit, the Company filed petitions for <span style="font-style:italic;">inter partes</span> review at the U.S. Patent and Trademark Office (USPTO) against all the eight remaining patents asserted by Boston Scientific.  As a result of those petitions, in February 2019, all of the asserted claims of Boston Scientific’s U.S. Patent Nos. 6,895,280 and 7,587,241 were found invalid by the Patent Trial and Appeal Board (PTAB) at the USPTO. Boston Scientific has appealed these rulings.  The Company and Boston Scientific have submitted their respective appeal briefs and replies to the U.S. Court of Appeals for the Federal Circuit, and are awaiting a hearing date. This patent infringement lawsuit has been stayed pending completion of the <span style="font-style:italic;">inter partes</span> proceedings since June 2018. As of this time,<span style="color:#000000;"> </span>the Company is unable to determine an outcome or potential range of loss. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On April 27, 2018, Boston Scientific filed a </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">second </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">patent lawsuit alleging patent infri</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ngement, theft of trade secrets</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and tortious interference with contract. The lawsuit, filed in the </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">U.S. </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">District Court for the District of Delaware, seeks unspecified damages and attorney’s fees, as well as preliminary and permanent injunctive relief against further infringement. </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In relation to this lawsuit, the Company filed petitions for </span><span style="font-style:italic;">inter partes</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> review at the U.S. Patent and Trademark Office USPTO against </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">seven of the nine </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">patents asserted by Boston Scientific.</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In January 2020, the PTAB initiated inter partes reviews in all seven of the challenged patents.</span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of this time, the Company is unable to determine an outcome or potential range of loss.</span></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On August 23, 2018, the Oklahoma Police Pension and Retirement System filed a putative securities class action complaint against the Company and certain individual officers alleging violations of Sections 10(b) and 20(a) of the Exchange Act, and Rule 10b-5 of the Exchange Act.  The lawsuit, filed in the U.S. District Court for the Northern District of California, seeks unspecified damages and attorneys’ fees based on alleged misleading statements or omissions by the Company and the individual officers regarding the Company’s rights in technology underlying the Senza SCS systems and the termination of the Company’s former Vice President of Worldwide Sales.<span style="font-size:12pt;color:#000000;"> </span>On November 3, 2018, a related shareholder derivative lawsuit was filed in the United States District Court for the Northern District of California seeking unspecified damages, injunctive relief and attorneys’ fees based on alleged violations of Section 14(a) of the Securities and Exchange Act of 1934, breach of fiduciary duties, unjust enrichment and waste of corporate assets. On August 1, 2019, U.S. District Judge Vince Chhabria granted the Company’s motion to dismiss the pending securities class action complaint, with leave to file an amended complaint within 21 days of the order. The plaintiffs did not file an amended complaint, and on August 23, 2019, the securities class action was dismissed.  On September 6, 2019, the related shareholder derivative lawsuit was voluntarily dismissed</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.24%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On February 14, 2019, the Company filed a lawsuit for patent infringement against Stimwave Technologies, Inc. (Stimwave) asserting that Stimwave is infringing the Company’s patents covering inventions related to its HF10 therapy and the Senza system, as well as a claim for false advertising under the Lanham Action Section 43(a), 15 U.S.C. § 1125(a).  In relation to this lawsuit, on July 24, 2019, the court granted Nevro's motion for preliminary injunction, and has issued an order barring Stimwave, and all affiliated persons and entities, from infringing patent claims covering frequencies between 3 kHz and 10 kHz by programming Stimwave's SCS systems to deliver its recently introduced high-frequency, paresthesia-free SCS therapy.  Per Nevro's request, the court order does not enjoin Stimwave from providing follow-up care and programming for any patients who were already programmed with such high frequency therapy.  On July 25, 2019, Stimwave filed a Notice of Appeal to the U.S. Court of Appeals for the Federal Circuit.  The Company and Stimwave have submitted their respective appeal briefs and replies to the appellate court, and are awaiting a hearing date. During the appeal, the litigation in the District of Delaware will continue on the merits.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2019, <span style="color:#000000;">the Company did not record a liability, as an outcome or potential loss range cannot be reasonably determined</span>. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company is and may from time to time continue to be involved in various legal proceedings to defend its intellectual property, including several pending European patent oppositions at the European Patent Office (EPO) initiated by the Company’s competitors Medtronic and Boston Scientific and an entitlement action filed by Boston Scientific in Germany.  In addition, the Company is and may from time to time also be involved in various legal proceedings of a character normally incident to the ordinary course of business, such as product liability and professional liability matters, which the Company does not deem to be material to its business and consolidated financial statements at this stage.<span style="color:#000000;"> </span></p> 2015-03 50740 2022-05 2000000.0 2400000 49980 1200000 2900000 The lease for the Expansion Premises commenced on June 1, 2018. 2025-05-31 8171 2018-06-01 2018-06-01 2014-08 2014-08-21 2015-05-31 100000 2015-03 2017-02 300000 2017-03-01 2022-02-28 400000 limited one- to five-year warranty Activities related to warranty obligations were as follows (in thousands): <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Beginning Balance</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,236</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">708</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Provision for warranty</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,942</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,334</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Utilization</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,000</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,806</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Ending Balance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,178</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,236</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 1236000 708000 1942000 2334000 2000000 1806000 1178000 1236000 6200000 3600000 2500000 2500000 2500000 2500000 2500000 The agreement will terminate upon the last to expire patent application, unless terminated earlier. The agreement can be terminated any time after three years from March 2006 by Mayo or VGL. 40000 200000 3200000 3100000 2500000 20833 500000 300000 2022 8500000 2 3000000.0 7900000 1000000.0 0 0 0 10 8 P21D 0 <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">8. Long-term Debt</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">1.75% Convertible Senior Notes and Convertible Note Hedge and Warrant Transactions</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the Company issued $150.0 million aggregate principal amount of 1.75% convertible senior notes due in June 2021 in a registered underwritten public offering and an additional $22.5 million aggregate principal amount of such notes pursuant to the exercise in full of the over-allotment options of the underwriters (the 2021 Notes). The interest rates are fixed at 1.75% per annum and are payable semi-annually in arrears on June 1 and </p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 1 of each year, commencing on December 1, 2016</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.  The total net proceeds from the debt offering, after deducting initial purchase discounts and debt issuance costs, were approximately $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">166.2</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million.</span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Each $1,000 principal amount of the 2021 Notes will initially be convertible into 10.3770 shares of the Company’s common stock, which is equivalent to an initial conversion price of approximately $96.37 per share, subject to adjustment upon the occurrence of specified events. The 2021 Notes will be convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding December 1, 2020, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on September 30, 2016 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period (the measurement period) in which the trading price (as defined in the indenture to the 2021 Notes) per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on each such trading day; or (3) upon the occurrence of specified corporate events.  On or after December 1, 2020 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their 2021 Notes at any time, regardless of the foregoing circumstances.  Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock, at the Company’s election.  If the Company undergoes a fundamental change prior to the maturity date, holders of the notes may require the Company to repurchase for cash all or any portion of their notes at a repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. In addition, if specific corporate events occur prior to the applicable maturity date, the Company will increase the conversion rate for a holder who elects to convert their notes in connection with such a corporate event in certain circumstances.  It is the Company’s current intent and policy to settle conversions through combination settlement with a specified dollar amount per $1,000 principal amount of notes of $1,000.  During the three months ended December 31, 2019, the conditions allowing holders of the 2021 Notes to convert have not been met. The 2021 Notes are therefore not convertible during the three months ended March 31, 2020 and are classified as long-term debt. Should the sale price condition be met in a future quarter, the 2021 Notes will be convertible at the holders’ option during the immediately following quarter. As of December 31, 2019, the if-converted value of the 2021 Notes did not exceed the principal value of those notes.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accounting for the issuance of the convertible senior notes, the Company separated the 2021 Notes into liability and equity components.  The carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was $32.9 million and was determined by deducting the fair value of the liability component from the par value of the 2021 Notes. The equity component is not remeasured as long as it continues to meet the conditions for equity classification. The excess of the principal amount of the liability component over its carrying amount (debt discount) is amortized to interest expense over the term of the 2021 Notes expense at an effective interest rate of 6.29% over the contractual terms of the notes.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accounting for the debt issuance costs of $6.2 million related to the 2021 Notes, the Company allocated the total amount incurred to the liability and equity components of the 2021 Notes based on their relative values. Issuance costs attributable to the liability component were $5.0 million and will be amortized to interest expense using the effective interest method over the contractual terms of the 2021 Notes.  Issuance costs attributable to the equity component were netted with the equity component in stockholders’ equity.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The net carrying amount of the liability component of the 2021 Notes was as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.32%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Principal</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">172,500</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">172,500</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized discount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,462</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,305</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized issuance cost</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,738</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,801</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net carrying amount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">160,300</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">152,394</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The net carrying amount of the equity component of the 2021 Notes was as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.32%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt discount related to value of conversion option</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,945</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,945</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt issuance cost</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,179</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,179</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net carrying amount</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,766</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,766</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth the interest expense recognized related to the 2021 Notes (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.06%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.56%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contractual interest expense</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.56%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of debt discount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,843</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,432</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,046</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of debt issuance costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,063</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">943</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">833</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total interest expense related to the 2021 Notes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,925</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,394</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,898</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the offering of the 2021 Notes, the Company entered into convertible note hedge transactions with certain bank counterparties in which the Company has the option to purchase initially (subject to adjustment for certain specified events) a total of approximately 1.8 million shares of the Company’s common stock at a price of approximately $96.37 per share. The total cost of the convertible note hedge transactions was $45.1 million.  In addition, the Company sold warrants to certain bank counterparties whereby the holders of the warrants have the option to purchase initially (subject to adjustment for certain specified events) a total of approximately 1.8 million shares of the Company’s common stock at a price of $127.28 per share. The Company received $33.1 million in cash proceeds from the sale of these warrants.  Taken together, the purchase of the convertible note hedges and the sale of warrants are intended to offset any actual dilution from the conversion of these notes and to effectively increase the overall conversion price from $96.37 to $127.28 per share. As these transactions meet certain accounting criteria, the convertible note hedges and warrants are recorded in stockholders’ equity and are not accounted for as derivatives. The net cost of $12.0 million incurred in connection with the convertible note hedge and warrant transactions was recorded as a reduction to additional paid-in capital on the consolidated balance sheet.</p> 150000000.0 0.0175 2021-06 22500000 semi-annually in arrears on June 1 and December 1 of each year, commencing on December 1, 2016 166200000 1000 10.3770 common stock 96.37 20 30 1.30 5 10 0.98 1 1000 32900000 0.0629 6200000 5000000.0 <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The net carrying amount of the liability component of the 2021 Notes was as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.32%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Principal</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">172,500</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">172,500</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized discount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,462</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,305</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unamortized issuance cost</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,738</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2,801</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net carrying amount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">160,300</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">152,394</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 172500000 172500000 10462000 17305000 1738000 2801000 160300000 152394000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The net carrying amount of the equity component of the 2021 Notes was as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.32%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt discount related to value of conversion option</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,945</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,945</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt issuance cost</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,179</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,179</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net carrying amount</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,766</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,766</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 32945000 32945000 1179000 1179000 31766000 31766000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table sets forth the interest expense recognized related to the 2021 Notes (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.06%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.78%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.56%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Contractual interest expense</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.56%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of debt discount</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,843</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,432</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,046</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of debt issuance costs</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,063</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">943</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">833</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.56%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total interest expense related to the 2021 Notes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,925</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,394</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.78%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,898</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 3019000 3019000 3019000 6843000 6432000 6046000 1063000 943000 833000 10925000 10394000 9898000 1800000 96.37 45100000 1800000 127.28 33100000 96.37 127.28 12000000.0 <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">9. Convertible Preferred Stock</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prior to its initial public offering, the Company had outstanding 15,208,048 shares of convertible preferred stock. Each share of preferred stock was convertible to one share of common stock. Upon the closing of the Company’s initial public offering on November 11, 2014, all shares of outstanding redeemable convertible preferred stock were automatically converted to 15,208,048 shares of the Company’s common stock.</p> 15208048 1 15208048 <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">10. Stock-Based Compensation</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock reserved for future issuance as of December 31, 2019 was as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.8%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.8%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding stock options and restricted stock units</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,934,517</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reserved for grants of future stock options and restricted stock units</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,680,784</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reserved for employee stock purchase plan</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,161,645</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total common stock reserved for future issuance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,776,946</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock Plans</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company’s Board of Directors (Board) and stockholders previously approved the 2007 Stock Option Plan (the 2007 Plan). In October 2014, the Board adopted the 2014 Equity Incentive Award Plan (the 2014 Plan and, together with the 2007 Plan, the Stock Plans).  As of the effective date of the 2014 Plan, the Company suspended the 2007 Plan and no additional awards may be granted under the 2007 Plan. Any shares of common stock covered by awards granted under the 2007 Plan that terminate after the effective date of the 2014 Plan by expiration, forfeiture, cancellation or other means without the issuance of such shares, will be added to the 2014 Plan reserve.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the 2014 Plan, 1,854,166 shares of common stock were initially reserved for issuance, plus the number of shares remaining available for future awards under the 2007 Plan, as of the pricing of the IPO. The number of shares initially reserved for issuance under the 2014 Plan is subject to increase by (i) the number of shares represented by awards outstanding under the 2007 Plan that are forfeited or lapse unexercised and which following the pricing date are not issued under the 2007 Plan, and (ii) an annual increase on January 1 of each year.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the 2014 Plan, the Company may grant awards such as incentive stock options, nonstatutory stock options, restricted stock units and stock appreciation rights. Incentive stock options (ISO) may be granted only to Company employees (including directors who are also employees). Nonqualified stock options (NSO) may be granted to Company employees, directors and consultants.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Stock Options</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options under the 2014 Plan may be granted for periods of up to ten years and at prices no less than 100% of the estimated fair market value of the shares on the date of grant as determined by the Board, provided, however, that the exercise price of an ISO or an NSO granted to a 10% stockholder shall not be less than 110% of the estimated fair market value of the shares on the date of grant. Upon the exercise of options, the Company issues new common stock from its authorized shares. The vesting provisions of individual options vary but are generally over four years, with the exception of performance based stock options.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the 2014 Plan, the Company granted performance based stock options to the Company’s former CEO in March 2016. This performance based stock option award is subject to the CEO’s continued service to the Company through each applicable vesting date. If a performance metric is not met within the time limits specified in the award agreements, the shares subject to vesting under the vesting tranche for that performance metric will be cancelled.  Upon the former CEO’s resignation from the Company in March 2019, the unvested shares subject to this award as of the separation date have been cancelled.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of shares available for grant under the Stock Plans is as follows:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares Available</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">for Grant</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2016</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,202,239</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,155,474</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares forfeited for tax</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,094</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options and restricted stock granted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,002,063</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options and restricted stock cancelled</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97,502</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,466,246</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,189,502</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares forfeited for tax</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,107</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options and restricted stock granted</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(805,653</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options and restricted stock cancelled</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102,560</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2018</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,980,762</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,210,541</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for PSU for overperformance</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(277,778</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares forfeited for tax</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,696</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options and restricted stock granted</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,077,178</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options and restricted stock cancelled</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">527,963</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,403,006</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of stock option activity under the Stock Plans is as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options Outstanding</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual Term</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2016</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,821,227</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29.85</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000821">7.4</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">123,425</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">503,690</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74.71</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(707,410</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.59</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,971</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(57,535</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46.83</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2017</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,559,972</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43.62</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000822">7.3</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71,120</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">236,900</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47.96</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(247,768</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.05</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,468</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,364</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44.70</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2018</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,529,740</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46.72</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000823">6.7</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,866</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">244,075</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56.71</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(828,722</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34.52</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,695</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(298,908</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66.22</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,646,185</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50.80</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000824">6.3</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109,870</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercisable as of December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,117,773</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46.70</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000825">5.1</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79,186</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options vested, exercisable or expected to</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   vest as of December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,612,455</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50.66</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000826">6.2</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">107,839</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aggregate intrinsic value of options exercised is the difference between the estimated fair market value of the Company’s common stock at the date of exercise and the exercise price for in-the-money options. The aggregate intrinsic value of outstanding options is the difference between the closing price as of the date outstanding and the exercise price of the underlying stock options. The weighted-average grant-date fair value of options granted during the years ended December 31, 2019, 2018 and 2017 was $27.91, $23.27 and $32.35 per share, respectively. The total fair value of options vested during the years ended December 31, 2019, 2018 and 2017 was approximately $8.3 million, $14.0 million and $13.3 million, respectively, based on the grant date fair value.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The options outstanding and vested under the Stock Plans by exercise price, at December 31, 2019, were as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="8" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options Outstanding</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options Vested</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%; border-top:solid 0.75pt #000000;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.94%; border-top:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.94%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.94%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual Term</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Exercise Price</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.94%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercisable</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000842">$1.44 — $18.00</span></p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">334,087</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.94%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000860">3.79</span></p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.25</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">334,087</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.25</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000843">$32.51 — $48.44</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">391,304</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.94%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000861">7.85</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43.43</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">159,456</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42.13</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000844">$49.94 — $63.23</span></p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">365,966</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.94%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000862">4.45</span></p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57.78</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">352,632</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57.73</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000845">$63.39 — $76.81</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">393,930</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.94%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000863">8.27</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70.58</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">155,991</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73.09</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.26%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000846">$84.30 — $97.52</span></p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">160,898</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000864">7.07</span></p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88.62</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115,607</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89.07</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.26%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000847">$1.44 — $97.52</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,646,185</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000865">6.29</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50.80</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,117,773</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46.70</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Restricted Stock Units</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2015, the Company began granting restricted stock units (RSUs) under the 2014 Plan.  Holders of RSUs do not have stockholder rights.  Upon the release of RSUs, the Company issues new common stock from its authorized shares. RSUs generally vest four years from the date of grant.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the 2014 Plan, the Company granted performance based RSUs to the former CEO in March 2016. The performance based RSUs are subject to the former CEO’s continued service to the Company through each applicable vesting date. If a performance metric is not met within the time limits specified in the RSU agreement, the shares subject to vesting under the vesting tranche for that performance metric will be cancelled. Upon the former CEO’s resignation from the Company in March 2019, the unvested shares subject to this award as of the separation date have been cancelled. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In March 2019, the Company granted RSUs to the current CEO, subject to his continued service to the company and based on the total shareholder return of the Company’s common stock price compared to a targeted composite index over a <span style="-sec-ix-hidden:F_000884">three-year</span> period.  The number of shares to be issued upon vesting of these RSUs range from <span style="-sec-ix-hidden:F_000885_2">0 to 3.5 times</span> the target number of shares granted, depending on the Company’s performance against the targeted composite index.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of RSUs activity under the Stock Plans was as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Restricted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant Date</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock Units</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2016</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">345,555</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70.39</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,108</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock granted</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">498,373</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82.60</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock released</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(83,121</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69.90</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,175</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock cancelled</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(39,967</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81.57</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">720,840</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78.26</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49,767</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock granted</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">568,753</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68.09</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock released</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(196,274</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77.43</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">968</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock cancelled</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(83,196</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81.73</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,010,123</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72.41</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,284</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock granted</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">833,103</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59.56</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock released</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(325,839</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70.69</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,064</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock cancelled</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(229,055</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70.23</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,288,332</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64.92</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151,431</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock expected to vest as of</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,190,393</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59.42</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">139,919</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aggregate intrinsic value of RSUs released is calculated using the fair market value of the Company’s common stock at the date of release. The aggregate intrinsic value of outstanding </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">RSUs</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> is calculated based on the closing price of the Company’s common stock as of the date outstanding.</span></p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2014 Employee Stock Purchase Plan</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In October 2014, the Board adopted the 2014 Employee Stock Purchase Plan (the ESPP). A total of 196,666 shares of common stock were initially available for future issuance under the 2014 Employee Stock Purchase Plan, subject to an annual increase on January 1 of each year. The ESPP provides eligible employees with an opportunity to purchase shares of the Company’s common stock through payroll deductions of up to 15% of their eligible compensation, subject to plan limitations.  Under the ESPP, the purchase price of the Company stock is equal to 85% of the lower of its fair market value at the start and end of a <span style="-sec-ix-hidden:F_000926">six-month</span> purchase period.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of ESPP activity was as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.46%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">302,635</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">297,375</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">288,868</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares issued</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">164,960</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110,040</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73,262</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares available for future issuance</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,161,645</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,023,970</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">836,635</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee contributions for shares issued (in thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,544</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,521</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,697</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Early Exercises</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options previously granted under the 2007 Plan allowed the Board of Directors to grant awards to provide employee option holders the right to elect to exercise unvested options in exchange for restricted common stock. There were no unvested shares at December 31, 2019, 2018 and 2017 which were subject to a repurchase right held by the Company. Additionally, as of December 31, 2019 and 2018, there was no cash received related to unvested shares, respectively. Amounts recorded are transferred into common stock and additional paid-in-capital as the shares vest.</p> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Employee Stock-Based Compensation</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company estimated the fair value of stock options granted to employees and shares purchased by employees under the ESPP using the Black-Scholes option valuation model. The fair value is amortized on a straight-line basis over the requisite service period of the awards, with the exception of performance based stock options whose fair value is recorded as expenses based on the probability that the performance metrics will be achieved. The following assumptions were used in estimating the fair value:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.1%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock Options:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000944">5.7</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000945">5.5</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000946">5.5</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000947">51% — 52%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000948">44% — 51%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000949">44% — 46%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000953">1.4% — 2.6%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000954">2.3% — 2.9%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000955">1.8% — 2.2%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend Yield</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ESPP:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000962">0.5</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000963">0.5</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000964">0.5</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000965">48% — 61%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000966">44% — 57%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000967">36% — 37%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000971">1.6% — 2.4%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000972">2.1% — 2.5%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000973">1.0% — 1.4%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend Yield</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Expected Term<span style="font-style:normal;">. The expected term of stock-based awards represents the weighted-average period that the stock-based awards are expected to remain outstanding. The Company has historically opted to use the “simplified method” for estimating the expected term of the awards, whereby the expected term equals the arithmetic average of </span></p> <p style="margin-bottom:0pt;margin-top:0pt;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><span style="font-style:normal;">the vesting term and the original contractual term of the awards.</span><span style="font-style:normal;">  Starting in late 2016, the Company started to utilize its own historical data for the calculation of expected term.</span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Expected Volatility<span style="font-style:normal;">. The Company has historically determined the share price volatility for stock-based awards based on an analysis of the historical volatilities of a peer group of publicly traded medical device companies.  Starting in late 2016, the Company has started to incorporate its own stock trading volatility with those of its peer group for the calculation of volatility.  In evaluating similarity, the Company considered factors such as industry, stage of life cycle and size. </span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Risk-Free Interest Rate.<span style="font-style:normal;"> The risk-free interest rate is based on the U.S. Treasury yield in effect at the time of the grant for zero-coupon U.S. Treasury notes with remaining terms similar to the expected term of the stock-based awards.</span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Dividend Rate.<span style="font-style:normal;"> The expected dividend was assumed to be zero as the Company has never paid dividends and has no current plans to do so.</span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Expected Forfeiture Rate.<span style="font-style:normal;"> The Company is required to estimate forfeitures at the time of grant, and revise those estimates in subsequent periods if actual forfeitures differ from those estimates. The Company uses historical data to estimate pre-vesting option forfeitures and record stock-based compensation expense only for those awards that are expected to vest. To the extent actual forfeitures differ from the estimates, the difference will be recorded as a cumulative adjustment in the period that the estimates are revised.</span></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accounts for RSUs at their fair value, based on the closing market price of the Company’s common stock on the grant date. The fair value is amortized on a straight-line basis over the requisite service period of the awards, which is generally the vesting term of four years.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2016, the Company granted performance based RSUs to its former CEO that only vest upon the achievement of specific operational performance criteria.  The stock-based compensation for these performance based RSUs are recognized as expenses when it is determined that achieving the performance metrics are probable. Upon the former CEO’s resignation from the Company in March 2019, the unvested shares subject to this award as of the separation date have been cancelled.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the former CEO’s resignation in March 2019, the Company amended the terms of his then vested nonqualified stock options such that they remain exercisable through the second anniversary of his separation date.  This modification resulted in a charge of $1.6 million in stock-based compensation.  </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2019, the Company granted performance based RSUs to its current CEO that only vest based on the total shareholder return of the Company common stock price relative to that of a specified targeted index.  The fair value of these performance based RSUs is based on the Monte Carlo simulation model using the following assumptions:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.64%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.64%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.64%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.64%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Index volatility</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.64%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.64%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Company volatility</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.64%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.64%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.64%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.4%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.64%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Correlation with index</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.64%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.28</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.64%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend Yield</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.64%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of pre-tax stock-based compensation expense by line items in the consolidated statements of operations was as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,061</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,656</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,878</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,323</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,871</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,601</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales, general and administrative</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,313</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,110</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,664</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stock-based compensation expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,697</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,637</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,143</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of pre-tax stock-based compensation expense by category was as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,312</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,765</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,412</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,845</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,006</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,197</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee stock purchase plan</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,540</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,866</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,534</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stock-based compensation expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,697</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,637</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,143</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2019, total stock-based compensation expense not yet recognized, net of estimated forfeitures, were as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Compensation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization Period</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,720</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001014">2.7</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62,680</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001015">2.6</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee stock purchase plan</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,262</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001016">0.4</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Common stock reserved for future issuance as of December 31, 2019 was as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.8%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.8%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Outstanding stock options and restricted stock units</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,934,517</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.3%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reserved for grants of future stock options and restricted stock units</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,680,784</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reserved for employee stock purchase plan</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,161,645</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.3%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total common stock reserved for future issuance</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.88%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,776,946</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 2934517 3680784 1161645 7776946 0 1854166 The number of shares initially reserved for issuance under the 2014 Plan is subject to increase by (i) the number of shares represented by awards outstanding under the 2007 Plan that are forfeited or lapse unexercised and which following the pricing date are not issued under the 2007 Plan, and (ii) an annual increase on January 1 of each year. P10Y 1 0.10 0.10 1.10 P4Y <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of shares available for grant under the Stock Plans is as follows:</p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Shares Available</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.82%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">for Grant</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2016</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,202,239</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,155,474</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares forfeited for tax</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,094</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options and restricted stock granted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,002,063</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options and restricted stock cancelled</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97,502</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,466,246</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,189,502</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares forfeited for tax</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,107</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options and restricted stock granted</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(805,653</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options and restricted stock cancelled</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">102,560</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2018</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,980,762</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,210,541</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for PSU for overperformance</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(277,778</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares forfeited for tax</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,696</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options and restricted stock granted</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,077,178</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options and restricted stock cancelled</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">527,963</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,403,006</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 2202239 1155474 13094 1002063 97502 2466246 1189502 28107 805653 102560 2980762 1210541 277778 38696 1077178 527963 3403006 <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of stock option activity under the Stock Plans is as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.6%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options Outstanding</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual Term</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2016</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,821,227</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29.85</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000821">7.4</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">123,425</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">503,690</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74.71</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(707,410</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.59</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,971</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(57,535</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46.83</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2017</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,559,972</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43.62</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000822">7.3</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">71,120</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">236,900</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">47.96</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(247,768</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16.05</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,468</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(19,364</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44.70</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2018</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,529,740</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46.72</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000823">6.7</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,866</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options granted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">244,075</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">56.71</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercised</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(828,722</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34.52</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42,695</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options cancelled</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(298,908</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">66.22</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.34%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,646,185</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50.80</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.18%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000824">6.3</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.22%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:9.18%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">109,870</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options exercisable as of December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,117,773</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46.70</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000825">5.1</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">79,186</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.34%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options vested, exercisable or expected to</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   vest as of December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,612,455</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50.66</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000826">6.2</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.22%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">107,839</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 2821227 29.85 123425000 503690 74.71 707410 10.59 50971000 57535 46.83 2559972 43.62 71120000 236900 47.96 247768 16.05 15468000 19364 44.70 2529740 46.72 21866000 244075 56.71 828722 34.52 42695000 298908 66.22 1646185 50.80 109870000 1117773 46.70 79186000 1612455 50.66 107839000 27.91 23.27 32.35 8300000 14000000.0 13300000 <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The options outstanding and vested under the Stock Plans by exercise price, at December 31, 2019, were as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="8" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:39.82%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options Outstanding</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Options Vested</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%; border-top:solid 0.75pt #000000;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.94%; border-top:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.94%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Remaining</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.26%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.94%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contractual Term</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Exercise Price</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.94%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercisable</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.94%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000842">$1.44 — $18.00</span></p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">334,087</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.94%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000860">3.79</span></p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.25</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">334,087</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.25</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000843">$32.51 — $48.44</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">391,304</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.94%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000861">7.85</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">43.43</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">159,456</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42.13</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000844">$49.94 — $63.23</span></p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">365,966</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.94%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000862">4.45</span></p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57.78</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">352,632</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">57.73</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.26%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000845">$63.39 — $76.81</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">393,930</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.94%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000863">8.27</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70.58</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">155,991</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73.09</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.26%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000846">$84.30 — $97.52</span></p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">160,898</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000864">7.07</span></p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">88.62</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">115,607</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.94%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89.07</p></td> <td style="background-color:#CFF2FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:30.26%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000847">$1.44 — $97.52</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,646,185</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:12.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000865">6.29</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50.80</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.94%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,117,773</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.98%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.94%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">46.70</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 334087 10.25 334087 10.25 391304 43.43 159456 42.13 365966 57.78 352632 57.73 393930 70.58 155991 73.09 160898 88.62 115607 89.07 1646185 50.80 1117773 46.70 <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of RSUs activity under the Stock Plans was as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Aggregate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Restricted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Grant Date</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Intrinsic Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Stock Units</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Fair Value</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2016</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">345,555</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70.39</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25,108</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock granted</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">498,373</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82.60</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock released</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(83,121</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69.90</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,175</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock cancelled</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(39,967</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81.57</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">720,840</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">78.26</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">49,767</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock granted</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">568,753</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68.09</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock released</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(196,274</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">77.43</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">968</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock cancelled</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(83,196</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81.73</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,010,123</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">72.41</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">39,284</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock granted</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">833,103</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59.56</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock released</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(325,839</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70.69</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,064</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock cancelled</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(229,055</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">70.23</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Outstanding at December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,288,332</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">64.92</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:10.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151,431</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock expected to vest as of</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   December 31, 2019</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,190,393</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">59.42</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">139,919</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 345555 70.39 25108000 498373 82.60 83121 69.90 1175000 39967 81.57 720840 78.26 49767000 568753 68.09 196274 77.43 968000 83196 81.73 1010123 72.41 39284000 833103 59.56 325839 70.69 4064000 229055 70.23 1288332 64.92 151431000 1190393 59.42 139919000 196666 0.15 0.85 <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of ESPP activity was as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.46%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:62.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.5%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additional shares reserved</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">302,635</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">297,375</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">288,868</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares issued</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">164,960</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">110,040</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">73,262</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares available for future issuance</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,161,645</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,023,970</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">836,635</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:62.02%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee contributions for shares issued (in thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,544</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,521</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,697</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 302635 297375 288868 164960 110040 73262 1161645 1023970 836635 6544000 5521000 4697000 0 0 0 0 0 The following assumptions were used in estimating the fair value: <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:54.1%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:43.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Stock Options:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000944">5.7</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000945">5.5</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000946">5.5</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000947">51% — 52%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000948">44% — 51%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000949">44% — 46%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000953">1.4% — 2.6%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000954">2.3% — 2.9%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000955">1.8% — 2.2%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend Yield</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">ESPP:</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected term (in years)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000962">0.5</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000963">0.5</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000964">0.5</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected volatility</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000965">48% — 61%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000966">44% — 57%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000967">36% — 37%</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000971">1.6% — 2.4%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000972">2.1% — 2.5%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_000973">1.0% — 1.4%</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:43.06%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend Yield</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.14%;white-space:nowrap;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.14%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 0 0 0 0 0 0 P4Y 1600000 The fair value of these performance based RSUs is based on the Monte Carlo simulation model using the following assumptions: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.64%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.64%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:61.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.64%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.64%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Index volatility</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.64%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.64%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Company volatility</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.64%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.64%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Risk-free interest rate</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.64%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.4%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.64%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Correlation with index</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.64%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.28</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:61.64%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Dividend Yield</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:34.64%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> 0.36 0.45 0.024 0.0028 0 <p style="margin-top:2pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of pre-tax stock-based compensation expense by line items in the consolidated statements of operations was as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cost of revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,061</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,656</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,878</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,323</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,871</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,601</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales, general and administrative</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">32,313</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,110</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,664</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stock-based compensation expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,697</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,637</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,143</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 3061000 2656000 1878000 6323000 5871000 4601000 32313000 28110000 19664000 41697000 36637000 26143000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A summary of pre-tax stock-based compensation expense by category was as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.1%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,312</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,765</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,412</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.48%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">28,845</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,006</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,197</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee stock purchase plan</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,540</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,866</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,534</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.48%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stock-based compensation expense</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41,697</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">36,637</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.38%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,143</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 10312000 13765000 13412000 28845000 21006000 11197000 2540000 1866000 1534000 41697000 36637000 26143000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2019, total stock-based compensation expense not yet recognized, net of estimated forfeitures, were as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Unrecognized</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Weighted-Average</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Compensation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Amortization Period</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:67.08%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in years)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock options</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,720</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001014">2.7</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Restricted stock units</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62,680</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001015">2.6</span></p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:67.08%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Employee stock purchase plan</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,262</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="-sec-ix-hidden:F_001016">0.4</span></p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 14720000 62680000 1262000 <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">11. Income Taxes</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of the Company’s income / (loss) before income taxes were as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Domestic</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(106,010</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(52,755</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(39,370</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,923</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,318</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,120</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total loss before income taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(102,087</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,437</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(35,250</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of the expense / (benefit) for income taxes are as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(103</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">187</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">170</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,644</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,477</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,238</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current income tax expense / (benefit)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,728</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,697</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,408</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(129</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(929</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred income tax expense / (benefit)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(129</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(929</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total income tax expense / (benefit)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,599</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">768</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,408</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax expense differs from the amount computed by applying the statutory federal income tax rate as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax at statutory federal rate</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State tax, net of federal benefit</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.4</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.4</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign rate differential</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.7</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.5</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax credits</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.0</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.8</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.5</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Excess tax benefits related to stock-based compensation</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.8</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.5</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effect of Tax Cuts and Jobs Act of 2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(121.1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in valuation allowance</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26.4</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21.2</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61.4</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2.2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4.9</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4.4</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.6</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.7</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities are as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating loss carryforwards</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94,680</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68,552</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax credits</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,095</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,451</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">463</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">339</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,372</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,770</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accruals and reserves</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,569</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,507</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,887</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,096</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,057</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">138,162</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,676</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right of use asset</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,294</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,294</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(131,807</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(100,747</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,061</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">929</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, substantially all of the net deferred tax assets have been offset by a valuation allowance. The valuation allowance increased by $31.1 million and $12.6 million for the years ended December 31, 2019 and 2018, respectively.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2019, the Company had federal net operating loss carryforwards (NOLs) of approximately $398.5 million, of which $139.5 million was generated in fiscal year 2018 and thereafter, which can be carried forward indefinitely under the 2017 Tax Act, as well as state NOLs of approximately $194.8 million, of which $22.1 million may be carried forward indefinitely. If not utilized, the remaining federal NOLs will begin to expire in 2026, and the remaining state NOLs will begin to expire in 2020.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2019, the Company had research and development credit carryforwards of approximately $13.7 million and $9.2 million for federal and California state income tax purposes, respectively. The federal credit carryforward begins expiring in 2026, and the state credits carry forward indefinitely.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under Section 382 of the Internal Revenue Code of 1986, as amended, the Company’s ability to utilize NOLs or other tax attributes such as research tax credits, in any taxable year may be limited if the Company experiences, or has experienced, a Section 382 “ownership change.” A Section 382 “ownership change” generally occurs if one or more stockholders or groups of stockholders, who own at least 5% of the Company’s stock, increase their ownership by a greater than 50 percentage point change (by value) over a rolling three-year period. Similar rules may apply under state tax laws. As a result of the Company’s June 2015 underwritten public offering, the Company experienced a Section 382 “ownership change.”  The Company currently estimates that this “ownership change” will not inhibit its ability to utilize its NOLs. However, the Company may, in the future, experience one or more additional Section 382 “ownership changes” as a result of subsequent changes in its stock ownership, some of which changes are outside the Company’s control.  If so, the Company may not be able to utilize a material portion of its NOLs and tax credits, even if the Company achieves profitability.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company had unrecognized tax benefits (UTBs) of approximately $7.4 million as of December 31, 2019. The following table summarizes the activity related to UTBs (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2016</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,384</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to current year tax provisions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">790</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to prior year tax provisions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">193</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases related to prior year tax provisions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(134</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,233</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to current year tax provisions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">893</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to prior year tax provisions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases related to prior year tax provisions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,200</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to current year tax provisions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,611</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to prior year tax provisions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">572</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases related to prior year tax provisions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,383</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If these UTBs were recognized, approximately $7.4 million would affect the effective tax rate before consideration of the valuation allowance. The Company does not expect any material changes to the estimated amount of liability associated with its uncertain tax positions within the next twelve months.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In accordance with ASC 740, <span style="font-style:italic;">Income Taxes</span>, the Company is classifying interest and penalties as a component of tax expense. There was a nominal amount of interest and penalties accrued at December 31, 2019.  There were no interest or penalties accrued at December 31, 2018 and December 31, 2017.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company files U.S. federal and state income tax and foreign income tax returns with varying statues of limitations. The Company’s U.S. federal and state tax years from inception in 2006 will remain open to examination </p> <p style="margin-top:12pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">due to the carryover of the unused NOLs and tax credits. The Company does not have any tax audits or other proceedings pending.</span></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of the Company’s income / (loss) before income taxes were as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Domestic</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(106,010</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(52,755</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(39,370</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,923</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,318</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,120</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total loss before income taxes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(102,087</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(48,437</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(35,250</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> -106010000 -52755000 -39370000 3923000 4318000 4120000 -102087000 -48437000 -35250000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of the expense / (benefit) for income taxes are as follows (in thousands):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(103</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">187</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">170</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,644</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,477</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,238</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total current income tax expense / (benefit)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,728</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,697</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,408</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred:</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Federal</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(129</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(929</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total deferred income tax expense / (benefit)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(129</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(929</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total income tax expense / (benefit)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,599</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">768</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,408</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> -103000 187000 220000 170000 1644000 1477000 1238000 1728000 1697000 1408000 -129000 -929000 -129000 -929000 1599000 768000 1408000 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax expense differs from the amount computed by applying the statutory federal income tax rate as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax at statutory federal rate</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">34.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">State tax, net of federal benefit</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.4</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.4</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Foreign rate differential</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.7</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0.5</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax credits</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.0</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.8</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4.5</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Excess tax benefits related to stock-based compensation</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.8</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21.5</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Effect of Tax Cuts and Jobs Act of 2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(121.1</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Change in valuation allowance</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26.4</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(21.2</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">61.4</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(2.2</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4.9</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4.4</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.6</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.7</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4.0</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)%</p></td> </tr> </table></div> 0.210 0.210 0.340 -0.001 -0.004 -0.004 -0.007 -0.010 0.005 -0.030 -0.028 -0.045 0.038 0.020 0.215 -1.211 -0.264 -0.212 0.614 -0.022 -0.049 -0.044 -0.016 -0.017 -0.040 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities are as follows:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:30.38%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net operating loss carryforwards</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94,680</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68,552</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Tax credits</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,095</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,451</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">463</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">339</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,372</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,770</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accruals and reserves</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,569</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,507</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease liabilities</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,887</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,096</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,057</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax assets</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">138,162</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101,676</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right of use asset</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,294</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred tax liabilities</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,294</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Valuation allowance</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(131,807</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(100,747</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:27.35pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net deferred tax assets</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,061</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">929</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 94680000 68552000 17095000 12451000 463000 339000 9372000 10770000 9569000 7507000 5887000 1096000 2057000 138162000 101676000 5294000 5294000 131807000 100747000 1061000 929000 31100000 12600000 398500000 139500000 194800000 22100000 2026 2020 13700000 9200000 7400000 The following table summarizes the activity related to UTBs (in thousands): <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:60%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2016</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,384</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to current year tax provisions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">790</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to prior year tax provisions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">193</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases related to prior year tax provisions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(134</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,233</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to current year tax provisions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">893</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to prior year tax provisions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases related to prior year tax provisions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(6</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,200</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to current year tax provisions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,611</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.22%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Increases related to prior year tax provisions</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.94%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">572</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Decreases related to prior year tax provisions</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.22%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Balance at December 31, 2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.94%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.82%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,383</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 3384000 790000 193000 134000 4233000 893000 80000 6000 5200000 1611000 572000 7383000 0 0 0 <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">12. Net Loss Per Share</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the computation of basic and diluted net loss per share (in thousands, except share and per share data):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(103,686</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,205</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(36,658</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares outstanding</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,803,872</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,051,961</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,424,360</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: weighted average shares subject to repurchase</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(306</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares used to compute basic and</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   diluted net loss per share</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,803,872</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,051,961</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,424,054</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, basic and diluted</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3.37</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.64</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.25</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic net loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and potentially dilutive securities outstanding for the period, determined using the treasury-stock method, if inclusion of these is dilutive. Because the Company has reported a net loss for all periods presented, diluted net loss per common share is the same as basic net loss per common share for those periods.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following potentially dilutive securities outstanding at the end of the periods presented have been excluded from the computation of diluted shares outstanding:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unreleased restricted stock</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,288,332</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,010,123</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">720,840</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options to purchase common stock</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,646,185</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,529,740</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,559,972</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Convertible senior notes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,790,033</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,790,033</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,790,033</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants related to the issuance of convertible senior notes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,790,033</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,790,033</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,790,033</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,514,583</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,119,929</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,860,878</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:5.24%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, since the Company expects to settle the principal amount of its outstanding convertible senior notes in cash, the Company uses the treasury stock method for calculating any potential dilutive effect of the conversion spread on diluted net income per share, if applicable. The conversion spread will have a dilutive impact on diluted net income per share of common stock when the average market price of the Company’s common stock for a given period exceeds the conversion price of $96.37 per share for the 2021 Notes.<span style="color:#000000;"> Although this condition was met in the three months ended December 31, 2019, the Company excluded the potential shares issuable upon conversion of the 2021 Notes in the calculation of diluted earnings per share, as their inclusion would have been anti-dilutive due to the net loss position of the Company during this period.</span> In connection with the issuance of the 2021 Notes, the Company entered into convertible bond hedges. The convertible bond hedges are not included for purposes of calculating the number of diluted shares outstanding, as their effect would be anti-dilutive. The convertible bond hedges are generally expected, but not guaranteed, to reduce the potential dilution and/or offset the cash payments the Company is required to make upon conversion of the 2021 Notes.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the computation of basic and diluted net loss per share (in thousands, except share and per share data):</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Years Ended December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(103,686</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(49,205</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(36,658</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares outstanding</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,803,872</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,051,961</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,424,360</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: weighted average shares subject to repurchase</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">—</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(306</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average shares used to compute basic and</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   diluted net loss per share</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,803,872</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,051,961</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,424,054</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, basic and diluted</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(3.37</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.64</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.25</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> </table></div> -103686000 -49205000 -36658000 30803872 30051961 29424360 306 30803872 30051961 29424054 -3.37 -1.64 -1.25 <p style="margin-top:12pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following potentially dilutive securities outstanding at the end of the periods presented have been excluded from the computation of diluted shares outstanding:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="10" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:40.02%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.76%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2017</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Unreleased restricted stock</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,288,332</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,010,123</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">720,840</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options to purchase common stock</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,646,185</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,529,740</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,559,972</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:57.6%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Convertible senior notes</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,790,033</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,790,033</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.34%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,790,033</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants related to the issuance of convertible senior notes</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,790,033</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,790,033</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,790,033</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:57.6%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,514,583</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,119,929</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.34%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6,860,878</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 1288332 1010123 720840 1646185 2529740 2559972 1790033 1790033 1790033 1790033 1790033 1790033 6514583 7119929 6860878 96.37 <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">13. Employee Benefit Plan.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:5.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2007, the Company adopted a 401(K) plan for its employees whereby eligible employees may contribute up to the maximum amount permitted by the Internal Revenue Code of 1986, as amended.  In June 2016, the Company adopted a policy to match a portion of employee contributions for all qualified employees participating in the 401(k) </p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">plan.  For the year</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> ended December 31,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> 201</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">,</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">201</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">201</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the Company recorded expense</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> of $</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.1</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, $</span>2.5<span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and $</span>2.2<span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> million </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">for</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> matching contributions</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, respectively</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p> 3100000 2500000 2200000 <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">14. Selected Quarterly Financial Information (Unaudited)</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.46%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.32%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.46%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.32%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except per share data)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">114,374</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,162</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93,571</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82,148</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross profit</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81,258</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69,940</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63,943</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,209</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11,681</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,984</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26,560</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(42,254</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,742</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,847</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(28,021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(44,076</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, basic and diluted</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.44</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.58</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.91</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.45</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares used in computing net loss per common</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   share, basic and diluted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,233,416</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,929,938</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,677,567</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,363,623</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.46%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.32%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.46%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.32%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except per share data)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">107,944</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95,630</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96,080</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87,635</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross profit</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,154</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67,248</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67,921</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62,001</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,603</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,237</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,201</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,702</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,607</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11,265</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,620</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,713</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, basic and diluted</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.32</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.37</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.35</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.59</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares used in computing net loss per common</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   share, basic and diluted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,214,454</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,123,188</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,028,985</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,836,277</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:9pt;"> </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.46%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.32%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.46%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.32%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except per share data)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">114,374</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,162</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">93,571</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">82,148</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross profit</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">81,258</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69,940</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">63,943</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">53,209</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11,681</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,984</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(26,560</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(42,254</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,742</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,847</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(28,021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(44,076</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, basic and diluted</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.44</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.58</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.91</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1.45</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares used in computing net loss per common</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   share, basic and diluted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31,233,416</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,929,938</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,677,567</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,363,623</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.46%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.32%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March 31,</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.46%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.18%; border-bottom:solid 0.75pt transparent;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2018</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="14" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:47.32%;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(in thousands, except per share data)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total revenue</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">107,944</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">95,630</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">96,080</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">87,635</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gross profit</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">76,154</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67,248</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">67,921</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">62,001</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,603</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,237</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(8,201</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(15,702</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,607</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11,265</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(10,620</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(17,713</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share, basic and diluted</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.32</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.37</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.35</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.59</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.46%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shares used in computing net loss per common</p> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">   share, basic and diluted</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,214,454</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,123,188</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">30,028,985</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">29,836,277</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> 114374000 100162000 93571000 82148000 81258000 69940000 63943000 53209000 -11681000 -15984000 -26560000 -42254000 -13742000 -17847000 -28021000 -44076000 -0.44 -0.58 -0.91 -1.45 31233416 30929938 30677567 30363623 107944000 95630000 96080000 87635000 76154000 67248000 67921000 62001000 -8603000 -9237000 -8201000 -15702000 -9607000 -11265000 -10620000 -17713000 -0.32 -0.37 -0.35 -0.59 30214454 30123188 30028985 29836277 Included in cash and cash equivalents on the consolidated balance sheets. Included in either cash and cash equivalents or short-term investments on the consolidated balance sheets. Included in short-term investments on the consolidated balance sheets. XML 32 R19.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Employee Benefit Plan
 12 Months Ended
Dec. 31, 2019
Postemployment Benefits [Abstract]  
Employee Benefit Plan

13. Employee Benefit Plan.

In 2007, the Company adopted a 401(K) plan for its employees whereby eligible employees may contribute up to the maximum amount permitted by the Internal Revenue Code of 1986, as amended.  In June 2016, the Company adopted a policy to match a portion of employee contributions for all qualified employees participating in the 401(k)

plan.  For the years ended December 31, 2019, 2018 and 2017, the Company recorded expenses of $3.1 million, $2.5 million and $2.2 million for matching contributions, respectively.
XML 33 R11.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Fair Value Measurements
 12 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Fair Value Measurements

5. Fair Value Measurements

Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.

The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows:

 

•

Level 1 — Observable inputs, such as quoted prices in active markets for identical assets or liabilities.

 

•

Level 2 — Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

•

Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Cash Equivalents and Short Term Investments

The Company’s cash equivalents includes investments in money market funds that are classified as Level 1 of the fair value hierarchy. To value its money market funds, the Company values the funds at $1 stable net asset value, which is the quoted price in active markets for identical assets that the Company has the ability to access. The Company’s cash equivalents and short-term investments also includes commercial paper and corporate notes, which have been classified within Level 2 of the fair value hierarchy because of the sufficient observable inputs for revaluation. The Company’s Level 2 investments are valued using third-party pricing sources. The pricing services utilize industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades of any broker/dealer quotes on the same or similar investments, issuer credit spreads, benchmark investments, prepayment/default projections based on historical data and other observable inputs. The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis, by level, within the fair value hierarchy (in thousands):

 

Balance as of December 31, 2019

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds (i)

 

$

52,359

 

 

$

—

 

 

$

—

 

 

$

52,359

 

Agency bonds (iii)

 

 

—

 

 

 

17,246

 

 

 

—

 

 

 

17,246

 

Commercial paper (iii)

 

 

—

 

 

 

12,449

 

 

 

—

 

 

 

12,449

 

Corporate notes (iii)

 

 

—

 

 

 

142,734

 

 

 

—

 

 

 

142,734

 

Total assets

 

$

52,359

 

 

$

172,429

 

 

$

—

 

 

$

224,788

 

 

Balance as of December 31, 2018

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds (i)

 

$

15,572

 

 

$

—

 

 

$

—

 

 

$

15,572

 

Commercial paper (ii)

 

 

—

 

 

 

119,602

 

 

 

—

 

 

 

119,602

 

Corporate notes (ii)

 

 

—

 

 

 

111,532

 

 

 

—

 

 

 

111,532

 

Total assets

 

$

15,572

 

 

$

231,134

 

 

$

—

 

 

$

246,706

 

 

(i)

Included in cash and cash equivalents on the consolidated balance sheets.

(ii)

Included in either cash and cash equivalents or short-term investments on the consolidated balance sheets.

(iii)

Included in short-term investments on the consolidated balance sheets.

Convertible Senior Notes

As of December 31, 2019, the fair value of the 1.75% convertible senior notes due 2021 was $232.6 million.  The fair value was determined on the basis of market prices observable for similar instruments and is considered Level 2 in the fair value hierarchy.
XML 34 R15.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Convertible Preferred Stock
 12 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Convertible Preferred Stock

9. Convertible Preferred Stock

Prior to its initial public offering, the Company had outstanding 15,208,048 shares of convertible preferred stock. Each share of preferred stock was convertible to one share of common stock. Upon the closing of the Company’s initial public offering on November 11, 2014, all shares of outstanding redeemable convertible preferred stock were automatically converted to 15,208,048 shares of the Company’s common stock.
XML 35 R36.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Summary of Significant Accounting Policies - Schedule of Revenue by Major Customers by Geographic Area (Detail)
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Revenue [Member] | Geographic Concentration Risk [Member] | United States [Member]      
Concentration Risk [Line Items]      
Revenue 84.00% 83.00% 81.00%
XML 36 R32.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Selected Quarterly Financial Information (Tables)
 12 Months Ended
Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Selected Quarterly Financial Information

 

 

 

Three Months Ended

 

 

 

December 31,

 

 

September 30,

 

 

June 30,

 

 

March 31,

 

 

 

2019

 

 

2019

 

 

2019

 

 

2019

 

 

 

(in thousands, except per share data)

 

Total revenue

 

$

114,374

 

 

$

100,162

 

 

$

93,571

 

 

$

82,148

 

Gross profit

 

$

81,258

 

 

$

69,940

 

 

$

63,943

 

 

$

53,209

 

Loss from operations

 

$

(11,681

)

 

$

(15,984

)

 

$

(26,560

)

 

$

(42,254

)

Net loss

 

$

(13,742

)

 

$

(17,847

)

 

$

(28,021

)

 

$

(44,076

)

Net loss per share, basic and diluted

 

$

(0.44

)

 

$

(0.58

)

 

$

(0.91

)

 

$

(1.45

)

Shares used in computing net loss per common

   share, basic and diluted

 

 

31,233,416

 

 

 

30,929,938

 

 

 

30,677,567

 

 

 

30,363,623

 

 

 

 

Three Months Ended

 

 

 

December 31,

 

 

September 30,

 

 

June 30,

 

 

March 31,

 

 

 

2018

 

 

2018

 

 

2018

 

 

2018

 

 

 

(in thousands, except per share data)

 

Total revenue

 

$

107,944

 

 

$

95,630

 

 

$

96,080

 

 

$

87,635

 

Gross profit

 

$

76,154

 

 

$

67,248

 

 

$

67,921

 

 

$

62,001

 

Loss from operations

 

$

(8,603

)

 

$

(9,237

)

 

$

(8,201

)

 

$

(15,702

)

Net loss

 

$

(9,607

)

 

$

(11,265

)

 

$

(10,620

)

 

$

(17,713

)

Net loss per share, basic and diluted

 

$

(0.32

)

 

$

(0.37

)

 

$

(0.35

)

 

$

(0.59

)

Shares used in computing net loss per common

   share, basic and diluted

 

 

30,214,454

 

 

 

30,123,188

 

 

 

30,028,985

 

 

 

29,836,277

 
XML 37 R53.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Balance Sheet Components - Summary of Contractual Maturities of Investment Securities (Detail) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Investments Debt And Equity Securities [Abstract]    
Amortized Cost, Amounts maturing within one year $ 156,783  
Amortized Cost, Amounts maturing after one year through five years 15,439  
Amortized Cost 172,222 $ 231,344
Fair Value, Amounts maturing within one year 156,985  
Fair Value, Amounts after one year through five years 15,444  
Fair Value, Total investment securities $ 172,429 $ 231,134
XML 38 R57.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Balance Sheet Components - Summary of Accrued Liabilities (Detail) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Payables And Accruals [Abstract]      
Accrued payroll and related expenses $ 36,056 $ 26,792  
Accrued professional fees 1,633 1,595  
Accrued taxes 2,353 2,506  
Accrued clinical and research expenses 2,157 1,105  
Accrued interest 243 243  
Accrued warranty 1,178 1,236 $ 708
Accrued other 7,346 5,313  
Total accrued liabilities $ 50,966 $ 38,790  
XML 39 R84.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Net Loss Per Share - Computation of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Shares (Detail) - shares
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities excluded from computation of diluted shares outstanding 6,514,583 7,119,929 6,860,878
Unreleased Restricted Stock [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities excluded from computation of diluted shares outstanding 1,288,332 1,010,123 720,840
Options to Purchase Common Stock [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities excluded from computation of diluted shares outstanding 1,646,185 2,529,740 2,559,972
Convertible Senior Notes [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities excluded from computation of diluted shares outstanding 1,790,033 1,790,033 1,790,033
Warrants Related to the Issuance of Convertible Senior Notes [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Potentially dilutive securities excluded from computation of diluted shares outstanding 1,790,033 1,790,033 1,790,033
XML 40 R74.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation - Summary of Stock-Based Compensation Expense by Line Items in Consolidated Statements of Operations (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]      
Stock-based compensation expense $ 41,697 $ 36,637 $ 26,143
Cost of Revenue [Member]      
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]      
Stock-based compensation expense 3,061 2,656 1,878
Research and Development [Member]      
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]      
Stock-based compensation expense 6,323 5,871 4,601
Selling, General and Administrative [Member]      
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]      
Stock-based compensation expense $ 32,313 $ 28,110 $ 19,664
XML 41 R70.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation - Summary of Restricted Stock Units Under Stock Plan (Detail) - Restricted Stock Units [Member] - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of Restricted Stock Units, Outstanding Beginning Balance 1,010,123 720,840 345,555  
Number of Restricted Stock Units, Restricted stock granted 833,103 568,753 498,373  
Number of Restricted Stock Units, Restricted stock released (325,839) (196,274) (83,121)  
Number of Restricted Stock Units, Restricted stock cancelled (229,055) (83,196) (39,967)  
Number of Restricted Stock Units, Outstanding Ending Balance 1,288,332 1,010,123 720,840  
Number of Restricted Stock Units, Restricted stock expected to vest 1,190,393      
Weighted Average Grant Date Fair Value Outstanding, Beginning Balance $ 72.41 $ 78.26 $ 70.39  
Weighted Average Grant Date Fair Value, Granted 59.56 68.09 82.60  
Weighted Average Grant Date Fair Value, Released 70.69 77.43 69.90  
Weighted Average Grant Date Fair Value, Cancelled 70.23 81.73 81.57  
Weighted Average Grant Date Fair Value Outstanding, Ending Balance 64.92 $ 72.41 $ 78.26  
Weighted Average Grant Date Fair Value, Restricted stock expected to vest $ 59.42      
Aggregate Intrinsic Value Outstanding $ 151,431 $ 39,284 $ 49,767 $ 25,108
Aggregate Intrinsic Value, Released 4,064 $ 968 $ 1,175  
Aggregate Intrinsic Value, Expected to vest $ 139,919      
XML 42 R80.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes - Tax Effects of Temporary Differences and Carryforwards That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Detail) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Income Tax Disclosure [Abstract]    
Net operating loss carryforwards $ 94,680 $ 68,552
Tax credits 17,095 12,451
Depreciation 463 339
Stock-based compensation 9,372 10,770
Accruals and reserves 9,569 7,507
Lease liabilities 5,887  
Other 1,096 2,057
Deferred tax assets 138,162 101,676
Right of use asset (5,294)  
Deferred tax liabilities (5,294)  
Valuation allowance (131,807) (100,747)
Net deferred tax assets $ 1,061 $ 929
XML 43 R78.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes - Components of Expense/(Benefit) for Income Taxes (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Current:      
Federal $ (103)    
State 187 $ 220 $ 170
Foreign 1,644 1,477 1,238
Total current income tax expense / (benefit) 1,728 1,697 1,408
Deferred:      
Foreign (129) (929)  
Total deferred income tax expense / (benefit) (129) (929)  
Total income tax expense / (benefit) $ 1,599 $ 768 $ 1,408
XML 44 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Current assets    
Cash and cash equivalents $ 65,373 $ 51,266
Short-term investments 172,429 213,281
Accounts receivable, net of allowance for doubtful accounts of $797 and $824 at December 31, 2019 and 2018, respectively 82,833 80,656
Inventories 91,579 92,035
Prepaid expenses and other current assets 9,838 6,621
Total current assets 422,052 443,859
Property and equipment, net 11,766 12,801
Operating lease assets 21,533  
Other assets 13,338 5,850
Restricted cash 956 606
Total assets 469,645 463,116
Current liabilities    
Accounts payable 16,048 23,505
Accrued liabilities 50,966 38,790
Other current liabilities 3,597 119
Total current liabilities 70,611 62,414
Long-term debt 160,300 152,394
Long-term operating lease liabilities 20,445  
Other long-term liabilities 1,937 2,825
Total liabilities 253,293 217,633
Commitments and contingencies (Note 6)
Stockholders’ equity    
Preferred stock, $0.001 par value, 10,000,000 shares authorized at December 31, 2019 and 2018, respectively; zero shares issued and outstanding at December 31, 2019 and 2018, respectively
Common stock, $0.001 par value, 290,000,000 shares authorized at December 31, 2019 and 2018, respectively; 31,544,361 and 30,263,536 shares issued and outstanding at December 31, 2019 and 2018, respectively 32 30
Additional paid-in capital 626,401 552,612
Accumulated other comprehensive loss (313) (1,077)
Accumulated deficit (409,768) (306,082)
Total stockholders’ equity 216,352 245,483
Total liabilities and stockholders’ equity $ 469,645 $ 463,116
XML 45 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities      
Net loss $ (103,686) $ (49,205) $ (36,658)
Adjustments to reconcile net loss to net cash used in operating activities      
Depreciation and amortization 4,563 3,887 2,507
Amortization of operating lease assets 3,237    
Stock-based compensation expense 41,697 36,637 26,143
Accretion of discount on short-term investments (2,037) (1,257) (116)
Provision for (recovery of) doubtful accounts (27) (501) 293
Write-down of inventory 1,456 2,005 3,984
Non-cash interest expense 7,912 7,382 6,884
Unrealized gains (losses) on foreign currency transactions (450) 1,188 (799)
Changes in operating assets and liabilities      
Accounts receivable (2,153) (12,214) (13,899)
Inventories (938) 3,846 (16,297)
Prepaid expenses and other current assets (3,222) (767) (501)
Other assets 514 (2,601) (892)
Accounts payable (7,472) 5,170 2,162
Accrued liabilities 13,205 (242) 12,269
Other long-term liabilities (2,824) 964 647
Net cash used in operating activities (50,225) (5,708) (14,273)
Cash flows from investing activities      
Purchases of short-term investments (211,006) (213,723) (287,938)
Proceeds from sales of short-term investments     5,993
Proceeds from maturity of short-term investments 254,308 228,373 290,341
Investment in private company (7,500)    
Purchases of property and equipment (3,472) (8,217) (4,327)
Net cash provided by investing activities 32,330 6,433 4,069
Cash flows from financing activities      
Minimum tax withholding paid on behalf of employees for net share settlement (3,057) (1,742) (991)
Proceeds from issuance of common stock to employees 35,150 9,496 12,190
Net cash provided by financing activities 32,093 7,754 11,199
Effect of exchange rate changes on cash, cash equivalents and restricted cash 259 (258) 444
Net increase in cash, cash equivalents and restricted cash 14,457 8,221 1,439
Cash, cash equivalents and restricted cash      
Cash, cash equivalents and restricted cash at beginning of year 51,872 43,651 42,212
Cash, cash equivalents and restricted cash at end of year 66,329 51,872 43,651
Supplemental disclosures of cash flow information      
Cash paid for income taxes 1,338 1,847 687
Cash paid for interest 3,019 3,019 3,019
Significant non-cash transactions      
Purchases of property and equipment in accounts payable $ 285 $ 245 592
Vesting of early-exercised stock options     $ 7
XML 46 R10.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Lease Accounting
 12 Months Ended
Dec. 31, 2019
Leases [Abstract]  
Lease Accounting

4. Lease Accounting

Adoption of ASC 842

On January 1, 2019, the Company adopted the new accounting standard ASC 842, Leases, which requires entities to recognize assets and liabilities for leases with lease terms of more than 12 months on the balance sheet.  

The Company adopted the new lease standard using the transition method that allowed entities to initially apply ASC 842 at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption (the optional transition method). The Company elected the package of transitional practical expedients, such that, for leases existing prior to the adoption of ASC 842, the Company will not need to

reassess whether contracts are leases, will retain historical lease classification and historical initial direct costs classification. The Company also elected the hindsight practical expedient to determine the lease term for existing leases.  Operating lease assets and operating lease liabilities are recognized based on the present value of minimum lease payments over the remaining lease term.  The Company uses its incremental borrowing rate based on information available when determining the lease liabilities.  Lease cost is recognized on a straight-line basis over the expected lease term.

Adoption of the new lease standard resulted in the recording of operating lease assets of $24.8 million and operating lease liabilities of $26.2 million.  The impact of the changes made to the consolidated balance sheet as of January 1, 2019 from the adoption of ASC 842 were as follows (in thousands):

 

 

 

Balance at

 

 

Adjustments Due

 

 

Balance at

 

 

 

December 31, 2018

 

 

to ASC 842

 

 

January 1, 2019

 

Balance Sheet:

 

 

 

 

 

 

 

 

 

 

 

 

Operating lease assets

 

$

—

 

 

$

24,771

 

 

$

24,771

 

Other current liabilities

 

 

119

 

 

 

2,389

 

 

 

2,508

 

Long-term operating lease liabilities

 

 

—

 

 

 

23,805

 

 

 

23,805

 

Other long-term liabilities

 

 

2,825

 

 

 

(1,423

)

 

 

1,402

 

The Company has operating leases for office space, warehouse, research and development facilities and equipment. Leases with terms of 12 months or less are not recorded on the balance sheet, as the related lease expenses are recognized on a straight-line basis over the lease term.  The Company accounts for lease components (such as fixed payments) separately from nonlease components (such as common area expenses).  As of December 31, 2019, the Company has leases with remaining terms of less than 3 year to 6 years, some of which may include options to extend the lease term for up to 5 years.

The weighted average lease terms and discounts rates are as follows:

 

 

 

December 31, 2019

 

Operating Lease Term and Discount Rate

 

 

 

 

Weighted-average remaining lease term

 

5.31 years

 

Weighted-average discount rate

 

7.0%

 

As of December 31, 2019, the maturity of lease liabilities are as follows (in thousands):

 

 

 

Operating Leases

 

2020

 

$

4,924

 

2021

 

 

5,073

 

2022

 

 

5,258

 

2023

 

 

5,522

 

2024

 

 

5,687

 

Thereafter

 

 

2,399

 

Total lease payments

 

 

28,863

 

Less: Interest

 

 

(4,920

)

Present value of lease liabilities

 

$

23,943

 

Supplemental lease cost information are as follows (in thousands):

 

 

 

Year Ended

 

 

 

December 31, 2019

 

Operating lease cost

 

$

4,936

 

Supplemental balance sheet information are as follows (in thousands):

 

 

 

December 31, 2019

 

Operating Leases:

 

 

 

 

Operating lease assets

 

$

21,533

 

 

 

 

 

 

Other current liabilities

 

$

3,498

 

Long term operating lease liabilities

 

 

20,445

 

Total operating lease liabilities

 

$

23,943

 

Supplemental cash flow information are as follows (in thousands):

 

 

 

Year Ended

 

 

 

December 31, 2019

 

Cash paid for amounts included in the measurement of lease liabilities:

 

 

 

 

Operating cash flow from operating leases

 

$

3,970

 

See Note 7 for further details of the Company’s lease commitments.
XML 47 R14.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Long-term Debt
 12 Months Ended
Dec. 31, 2019
Debt Disclosure [Abstract]  
Long-term Debt

8. Long-term Debt

1.75% Convertible Senior Notes and Convertible Note Hedge and Warrant Transactions

In June 2016, the Company issued $150.0 million aggregate principal amount of 1.75% convertible senior notes due in June 2021 in a registered underwritten public offering and an additional $22.5 million aggregate principal amount of such notes pursuant to the exercise in full of the over-allotment options of the underwriters (the 2021 Notes). The interest rates are fixed at 1.75% per annum and are payable semi-annually in arrears on June 1 and

December 1 of each year, commencing on December 1, 2016.  The total net proceeds from the debt offering, after deducting initial purchase discounts and debt issuance costs, were approximately $166.2 million.

Each $1,000 principal amount of the 2021 Notes will initially be convertible into 10.3770 shares of the Company’s common stock, which is equivalent to an initial conversion price of approximately $96.37 per share, subject to adjustment upon the occurrence of specified events. The 2021 Notes will be convertible at the option of the holders at any time prior to the close of business on the business day immediately preceding December 1, 2020, only under the following circumstances: (1) during any calendar quarter commencing after the calendar quarter ending on September 30, 2016 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (2) during the five business day period after any ten consecutive trading day period (the measurement period) in which the trading price (as defined in the indenture to the 2021 Notes) per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on each such trading day; or (3) upon the occurrence of specified corporate events.  On or after December 1, 2020 until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their 2021 Notes at any time, regardless of the foregoing circumstances.  Upon conversion, the Company will pay or deliver, as the case may be, cash, shares of the Company’s common stock or a combination of cash and shares of the Company’s common stock, at the Company’s election.  If the Company undergoes a fundamental change prior to the maturity date, holders of the notes may require the Company to repurchase for cash all or any portion of their notes at a repurchase price equal to 100% of the principal amount of the notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. In addition, if specific corporate events occur prior to the applicable maturity date, the Company will increase the conversion rate for a holder who elects to convert their notes in connection with such a corporate event in certain circumstances.  It is the Company’s current intent and policy to settle conversions through combination settlement with a specified dollar amount per $1,000 principal amount of notes of $1,000.  During the three months ended December 31, 2019, the conditions allowing holders of the 2021 Notes to convert have not been met. The 2021 Notes are therefore not convertible during the three months ended March 31, 2020 and are classified as long-term debt. Should the sale price condition be met in a future quarter, the 2021 Notes will be convertible at the holders’ option during the immediately following quarter. As of December 31, 2019, the if-converted value of the 2021 Notes did not exceed the principal value of those notes.

In accounting for the issuance of the convertible senior notes, the Company separated the 2021 Notes into liability and equity components.  The carrying amount of the liability component was calculated by measuring the fair value of a similar debt instrument that does not have an associated convertible feature. The carrying amount of the equity component representing the conversion option was $32.9 million and was determined by deducting the fair value of the liability component from the par value of the 2021 Notes. The equity component is not remeasured as long as it continues to meet the conditions for equity classification. The excess of the principal amount of the liability component over its carrying amount (debt discount) is amortized to interest expense over the term of the 2021 Notes expense at an effective interest rate of 6.29% over the contractual terms of the notes.

In accounting for the debt issuance costs of $6.2 million related to the 2021 Notes, the Company allocated the total amount incurred to the liability and equity components of the 2021 Notes based on their relative values. Issuance costs attributable to the liability component were $5.0 million and will be amortized to interest expense using the effective interest method over the contractual terms of the 2021 Notes.  Issuance costs attributable to the equity component were netted with the equity component in stockholders’ equity.

The net carrying amount of the liability component of the 2021 Notes was as follows (in thousands):

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Principal

 

$

172,500

 

 

$

172,500

 

Unamortized discount

 

 

(10,462

)

 

 

(17,305

)

Unamortized issuance cost

 

 

(1,738

)

 

 

(2,801

)

Net carrying amount

 

$

160,300

 

 

$

152,394

 

 

The net carrying amount of the equity component of the 2021 Notes was as follows (in thousands):

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Debt discount related to value of conversion option

 

$

32,945

 

 

$

32,945

 

Debt issuance cost

 

 

(1,179

)

 

 

(1,179

)

Net carrying amount

 

$

31,766

 

 

$

31,766

 

 

The following table sets forth the interest expense recognized related to the 2021 Notes (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Contractual interest expense

 

$

3,019

 

 

$

3,019

 

 

$

3,019

 

Amortization of debt discount

 

 

6,843

 

 

 

6,432

 

 

 

6,046

 

Amortization of debt issuance costs

 

 

1,063

 

 

 

943

 

 

 

833

 

Total interest expense related to the 2021 Notes

 

$

10,925

 

 

$

10,394

 

 

$

9,898

 

 

In connection with the offering of the 2021 Notes, the Company entered into convertible note hedge transactions with certain bank counterparties in which the Company has the option to purchase initially (subject to adjustment for certain specified events) a total of approximately 1.8 million shares of the Company’s common stock at a price of approximately $96.37 per share. The total cost of the convertible note hedge transactions was $45.1 million.  In addition, the Company sold warrants to certain bank counterparties whereby the holders of the warrants have the option to purchase initially (subject to adjustment for certain specified events) a total of approximately 1.8 million shares of the Company’s common stock at a price of $127.28 per share. The Company received $33.1 million in cash proceeds from the sale of these warrants.  Taken together, the purchase of the convertible note hedges and the sale of warrants are intended to offset any actual dilution from the conversion of these notes and to effectively increase the overall conversion price from $96.37 to $127.28 per share. As these transactions meet certain accounting criteria, the convertible note hedges and warrants are recorded in stockholders’ equity and are not accounted for as derivatives. The net cost of $12.0 million incurred in connection with the convertible note hedge and warrant transactions was recorded as a reduction to additional paid-in capital on the consolidated balance sheet.
XML 48 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 49 R18.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Net Loss Per Share
 12 Months Ended
Dec. 31, 2019
Earnings Per Share [Abstract]  
Net Loss Per Share

12. Net Loss Per Share

The following table summarizes the computation of basic and diluted net loss per share (in thousands, except share and per share data):

 

 

 

 

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Net loss

 

$

(103,686

)

 

$

(49,205

)

 

$

(36,658

)

Weighted average shares outstanding

 

 

30,803,872

 

 

 

30,051,961

 

 

 

29,424,360

 

Less: weighted average shares subject to repurchase

 

 

—

 

 

 

—

 

 

 

(306

)

Weighted average shares used to compute basic and

   diluted net loss per share

 

 

30,803,872

 

 

 

30,051,961

 

 

 

29,424,054

 

Net loss per share, basic and diluted

 

$

(3.37

)

 

$

(1.64

)

 

$

(1.25

)

Basic net loss per share is computed by dividing net loss by the weighted-average number of common shares outstanding for the period. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and potentially dilutive securities outstanding for the period, determined using the treasury-stock method, if inclusion of these is dilutive. Because the Company has reported a net loss for all periods presented, diluted net loss per common share is the same as basic net loss per common share for those periods.

The following potentially dilutive securities outstanding at the end of the periods presented have been excluded from the computation of diluted shares outstanding:

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Unreleased restricted stock

 

 

1,288,332

 

 

 

1,010,123

 

 

 

720,840

 

Options to purchase common stock

 

 

1,646,185

 

 

 

2,529,740

 

 

 

2,559,972

 

Convertible senior notes

 

 

1,790,033

 

 

 

1,790,033

 

 

 

1,790,033

 

Warrants related to the issuance of convertible senior notes

 

 

1,790,033

 

 

 

1,790,033

 

 

 

1,790,033

 

Total

 

 

6,514,583

 

 

 

7,119,929

 

 

 

6,860,878

 

 

Additionally, since the Company expects to settle the principal amount of its outstanding convertible senior notes in cash, the Company uses the treasury stock method for calculating any potential dilutive effect of the conversion spread on diluted net income per share, if applicable. The conversion spread will have a dilutive impact on diluted net income per share of common stock when the average market price of the Company’s common stock for a given period exceeds the conversion price of $96.37 per share for the 2021 Notes. Although this condition was met in the three months ended December 31, 2019, the Company excluded the potential shares issuable upon conversion of the 2021 Notes in the calculation of diluted earnings per share, as their inclusion would have been anti-dilutive due to the net loss position of the Company during this period. In connection with the issuance of the 2021 Notes, the Company entered into convertible bond hedges. The convertible bond hedges are not included for purposes of calculating the number of diluted shares outstanding, as their effect would be anti-dilutive. The convertible bond hedges are generally expected, but not guaranteed, to reduce the potential dilution and/or offset the cash payments the Company is required to make upon conversion of the 2021 Notes.
ZIP 50 0001564590-20-006427-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-20-006427-xbrl.zip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
YWU3PB+P$QO.01/46VZ>M[=L G<*8"YD2S(EDB?! MBN3D;3@.O?9\Q:[R4LR&;W'CAM[J6-;]67[?2.9[VS;WVM0F[#&Q(7[^/,S< M@VD?J[6O7?\F\\>L[BA^M@--N[+2T@ V!S0_)SH"Z9/7+ ,D,"(#)I]^D<95 M!LZ['Q.F_MR "-6L&X+( M3I'\JJ2L)YM0J2::UN@@F"Z7W2AMI]3P:;,E;<@%!KU#D3$98X6UU)XO8N]S* M(S##O\42"VTST*,9X8H1V 2+B,R:?2=CUU. M\_/+[R"Z5JMT*;R\[^'_B&2/MOU5>J%D9^<9_8J0]UIANQ?91[9GR4&?%(?]^X #QQB\T3BCG&,813PK.77C4Z M^5_^=6*,':>@L\O/9^ZTHP%5!K]:2'OVGNXE=_)QN_\F$U762GC%W,5;Y93$ MG6P>JOQDL[D3.P]V-S/D*1B*;(>1>RI&35D*T\>$'3_#?PL#SBZQGX$YO[ZK M: /DM[4^)1S-H@P)=?+Z;N1G/..27G S/C@0HCL;?)D*>LP*Y LW(]SPGJ. MV>\?6 4Y,MY<8&V,9-96TRX63FI%,EYW9QB:F O M(ERV?IP.US^3Y%F,UC^5!?GUKL0B2IR*^_(^)H@AT[C+4Y3F/=$W1!9U7\3A M8KZWJK51[T[.V!S?H-O.QN]8IF]9/)A];]IVAEX4R4 MD&TTO+!$?6_T22NS=!FWE\]AK761TD5 &YQ6J@7L>@D)T[I$Y*OR+_Q\Y(?- M#UF;1I>C92YM;CGL$-@6UWRLQUZO-L-QQ*]E3PE?H:.S;KTSI:/,DNK7E6%7 M ?Q:BMI6;4?KK'DF08P5HO2S'"!,/LG'8OZYYW3##8C4WO]9/K&$8]R15V>" MK:GZ9OL9(B!!Z'%7N':,N?@1Y2:\BLJ9 3>C 0$3.BAO@IWGFX3YQ9>0FD_! MWB@A8OI096VU(7V"7;F1ZH,X0/;M0"%NQ9S7WT$S?W@6_JIWII>EH5.'/!,>FES6B-Q C MNGFP.7;[@)FD(;ZW+@\AJ1[PZ'Y=MNM=MM\_I[-]O0:'YBT2 B#N1M&(L4 T MZ&5O85]A[)XS3RA3JYRNLK L7S[6NYPW"#KSWI=[SQHHLAD&66(^Q9Z. M/D\/:6V#JTRR]7 FO1V.;#%7K]'B:8$_V*CAHRA:O7 M5;MFH$.DOA;#@4VDZJ)>N%=8H]?)<]NIKF8R(S%G/'+B6V6DIF>E7[, 0$S^ MN6B3X\Q_Y+/(K%:MQ7YL?T:2X>,'^R$FANDW_#%;$^Y6%N'B2]&X9(/0SEM9 M]0X.%3*5O-LE@6]^"F>NLR7&G6ZY$G.+3ZUA;-HV5ZQ"^ W>-4G4TWSHS]-W=I*E(+RLRLB_SQ=F M9GX[N3E$V33K 7N=CN #V6_8@&T(QJ3DY" S]X=.H*:37+<<_3B-XB24Y,ZL M(^&J.U75-PS*ND=@(0,>$/[JOM@&9)P/MX(,LOL*.7\FI M&3R(&@M@I$&;7]7BBJZA(G8#^2-9V#8X#=J,N;S)0\9I%DOB'$(IF;P2[F&V M2&V0.!O3#OL0(4,B =T/9]5'V >6KVTD+WG_DYF;\O?H#8:C=1&CW- M2OBHCD36-F[8X8THTFG5VGCM-->'8FSI$M,20$<1T!'M9ZEY]8Z#GU)T)W7? M:]JTN:\M+WC_,QSWC[W$]S XCE_]O@^A5Y$K0#V3E M^QVJ_HQ>0ZJM:?>;1^3&K\!G^:K:F[2PA(XF'1SK2?%PKW-SIF 6%.\@;#4W M2&IS;A";[JJ;2A4IHQB@I$?>DY"#J$F%"C[+SVM5+=YYI**AV2Y^=O<1BUAY M9V]8RR >E :F8J9U#JU%G([.+89^=^)\C''?,0:%?'!6R&P-N"7!W6-76)/L M.,T>CI3.1Y=YO,9!-P7S?QN0X#MWF)@X:0YB$061I!$BSQ8A)Y-YI0GM*LTW M3AXB5SDRV;X1&_\H&+Z']V12J@D<%3U)'UP *2/R$!)CLZB%IV(A#\+ F/P( M)BW5)X6J:7X_O7>1U5U= MI10U67V^L1\[01BKE @PPJC?;>DBEAF+>&%!"$M*'DF>;ISI+0RE/.2ID+*' ME 2DFH+X[]!?*E5"TN6%5G79MLV]H/PWYY.XZ8I0[J0HC*X[[H\X4YA.*CG> M*#B5G#&L.(K$:+:*$5:P$@R-BD*Q43E' *3R M56YTZ_)K;3$==90H*U-MEC MOR_;#1>I+ 7O=ER&U>)XC=YI.^SY !E^OCLM7$X@LE[-KN /];<=(%]GT(,A M/# CIOC&J&:@/\!M(R,(;6.]D(TDD; @)35IU#8U.I=E7)S84U0[==:\\ M??5#B/4G7Z3()^]1LT1'(1H6I?J8Z44^>M;:&:%AWX3)07XS%9[UTY%[;0>G MAQA^@J_+Y3L^QJUWX%TXI5>9M&O^F4LT7Y";NNZYQU'68].^,[W-.<7*U2?Z M,YDKMF]K!9(+>CC7B?S4XG0K]L]TD$8TVCFQ2SH$]MQF<^NF@P M?UT([[R;F,^DMHWQ'D4O"S9I@OB>:6\^,UT%U,B>R50.GT=="U)WL=?7B,[T4S9H55PPOM@PQ (0C$N EZ16F0&U%M M!JZ![="8>WXG%#-; FU:[<6Z"M"NPM3&0_(>O$>U9S,PF\(ZT4%-)SM_Z_6_, M%:26YQ!UGW.O_[.RCP8P.44;9=-A/MLXPSH7W+KVJKG&L@] 9TJ+KO2+^_B% MCQ9,;=X.B3F"F*]4#-!S>+)WS@NG;OAW7 E*AAB[6 2WQ>U@AX%K@ZCVE7NX M4IP7%QC)'0Z!6 W@,RWUN,M#F875@8N(#C(5K:2ITX'@GFO4C)JM[2DTI/X' MMYM>KQ>L=@J[E5U\1>%@\];E03<^1R[3W"0'0S1C]9GXYF:H]AMS6T= MHPMQ1SB>Z*R?E,:[CU%)1.;H43!>E _''5?@SGZ#EMU;SN"U6"?2Z!8'W$)FI AXM8"80P\,][ES::%T+.1.(:"![#;*;1,@3X[=>&&X M#NC3U!Y2OHX]*J:IS;/(H&E@W$R:C=$E?;X#2M8\I;F79 M*Z!CAB2:VH(C@ MGUT0JNZ73S^\(6$.&.7EU0VR'(9,DU;&B]5'7M'[U756]-[/1O9OVJ%6S<@L MD^VA?W+KQL2DW0 ?J;[&0\;R@5-5@B:')E:RP4>?FU?>-#.G;&UGDK1WU5NQ MVZ7Q5<31=B+P8_SO;")4A_']JC$/-WB!9<2&ZFA*,/9HI6EX^_)U\ M )/:RE#+M6AE6QZE\,W5"?5U-O_B,2SGLM+P1U)6*#DADP?#*5]P&@LGAF3/ M^P89$\UG\(&L.:1LL8R3J.8OW.^TQ%/BT-2*Z"$UG,I3IX040'84!C5MHCG0 MV!;^2]ORZ, M\2:('3*HQ_3AV,6,9U^^"_5X#<_?)?;HF*F?SQ&,#HB(699P+16PMMH:BC4K M,\@K[TO4)84/3#B2)'NB+ 75'I TQB[$7""SCU1=>93)0JVPS(<]'Z"(J!![ M0X;O&=;A ? .0S_$5M:.%X@@S_FE1F\-5(,"Y:L:U7\Y_\X@ 62)\*[E\50/ M>JCM!U>9/;=PKKQ"'OF@QJ4F8R[2?$V"IV -[\/F-D1V(*E!6)Y<@R2:V;\- MU5VYMZQS-P"2ZPN.<3>G(R''9EAANJ48I,M3-[',K;0<;9!"8S+PR5+45 M@/S&B@I#PW+18*@Q<+-[MX1YRO/AN'=R<+ RS9CJ';TUGB4?]711T_,1H;ED M92B10!S@67T*X;>:<<=,7."Q*NC50GR,,Y2-J!,PI# M+=N,N?"RVEH^GT($''/X+CK!) VIIV;6O4Z5E&F<8@64L^?ON90DF0:P2.0' MK"8C(LM:LC_**)';G$B)]G.>'<59^?N#:.5_4,SU 8?*SSU!OJLZBE*_,^(D M,0A?Q3PXC]@WDB2G1?*=9,[_5]'2!>!"UKNFX8P4EUK!Y#;;#B;6Y!'+2DPMEZXZI$4I3S%3M*>BVC6W"%GZ7HG0(BC8(&U3"2'<'RX!#QAJLU1 M_2G%UU[C5# :\&%Q'_N\5.*\%U%H-1I/>."RJ$N&>'[C3;CA8G?7MT/B'';4 MQL9QZIY;R'%XN$NC+188R0E>B.^.OV1#Z?#R'3R: S_%<>?,%<@XL0RT-2^(;#\Z#+N9KF"C2OB&4X M08%0RID(K1(X<0]$3N0V&[TJ7:YL$R%RZI+DIW+?VP(0GQKEU_0CRA/>HU4& MY9ARD2HJ?06H3B7=WD2\YKTW=S@VA[8;@I%[R.144E;'U"%-83 @A46,>!-R M!E%Y)?(W3W[HYV&.[R%!"OLN ':;'#!Y3UT2Z1#'""OZB>>L6'WWG__Q^6__ M\ 7V('](0-6OOM\H9>9) M1FG)QY461NUG-=_'$GCZ&#![L9ZID/]5J'=H7.0OZ.)S X%=%OSX M(R-6AKHR4D_%Y7&[+2V&F+1N7)@1SYU[,Y8>V&>8Q<^=7%H MZ#$_\D+=KZ^S4'=F8)=*W?]-C'G&66R^MO9,-?7M,_[3R!\8E]1,B&)_4@H> MCE6S]$-B?,ZH\L=%.R&-A=>;3EP40Y;E,,6Y;"/5SE,PB75>_9>V@2M^A@//(6H\U& M^38(F8KD\!N#WLPIKTCA^\38S4F@F/HT)N.(.*:'P0'1/YKEC(U^ M6+J5:ZG/";*TQ>S>&/ZMC#FO"C#;]#;Y:&32G[#X+U;SHA;Y8C47J_F45M-2 MUXDR1K@T^B"]H-#G951CUM2#A+96J1[*N,<$N"3+#XGC+[N)I,L7RW11"VFQ M3(ME>BK+9 !KD69F8Z$5-93+3/XH"DS'W'I"3!19;_84@7FVGF:Y=KO48I4N M:A$M5FFQ2D_I+VT"=\3 N1%^C&U$GPK>KYXFJAZ1;U^LS$4MBL7*+%;FJ:R, M*5TPI*,@]]]5(K7>A>Q>T6QZAX"AO(MKE'!QJ: M;.2WSI"#!J$3B 6:@P7[$#L9V^I.&6/5DC/PO5=^A!O&9FS!UV-4-61-P1X- M2H>VY:C7D=LDG@'C!HR"AAMU/*5!GO1],OREE9KN M1%(M76!3[0=K\$?2H&_6[W;-?H,AEV8A61O3UNA&!7O']RMTY4V>0*@9!?[B MZ43T?HXRGWD/\2BQ'S)UK3JF9FXUE3;<.U8(C.5E[FICHLBV6H^]#5E'($T0 MSI[8^IUOB+DUZ=>LYZQ4&O&HU6*JBD,GS";[JN;"UI&2UK6C/>(E72>W1+ M3)S',RTX=MVKEYYP_?%H)Q6J81ZB.ZXSYMT^Z/'YVT!+29 5^D]C5 6YP+@I M*6U3!<8^6J3V2M@%=!#VO(]H6P]:;YDE;>81LCQI.#>FW/ MWC:LOB4S55*@TOU^:9=:(HHEHOCH(XKC[M2QT&NM8JHG=&.?K>&.6]&7!.A% M3?QB219+\I0)4"5<7P$$"R$Z53 5H48A&F'VBHS.0LEW$+:!@4T83O%A8="C M(+:L^1)P;;:\$#?- M?:WB1F5=[D^Q83Q]!S)S-UVS#]U:,K#(-_&K5^ R5CIJ2V%XTHO%8EW4 ELL MUF*Q+L5BH:IC%JM-#*3)A5(NK:DXO.G_+M;EHA;#8ET6Z_)4UN5F.&G0Q5BU M5$PR/;'%5%S4S"ZF8C$53PDGZ2M1*%$'9%)C>HCK]%$46M/>ZF*6>W:.<7:Q M51>UM!9;]?^S]Z7-;1Q)VG^EP[OSKA0!TB1UCWPG1P-= M(-IJ=,-]$,+\^C?/.AH-DI(/ %1MQ(Y%LH_JJJPGL_)X,F+5-K$J+UOVK AM M.)(%!Z&I( ENO.IW _H$.+FOI+_/=I_T-R)Y1/*(Y/<%R?_Z=99IW9L!#>LZ MT6MH,J_"QAUA8XYH(^_61HC(&I%U6S:R;4>*YB^E@Q-S(Z=U3DQ^C9L\"#$X M5!DZRD=HV2E)B- 2H6578I9>AH7M"T),K\2)J*D37D\ZO\X5R65M:<"FJM>( M.[LB)A%W(NYL"W>TB7._H49%]3%4L@4G)=CH\V8M_RK:+[NU[!%'(HYL"T>4 M3TP21+%BD!O/@MDA%?--BX766C\OYZ';+IP.QA@B8\9T=8$G]BFOQ&FEA 2>L?#[NZH99RA2-[CF'Q[=F MDDIG"0+F MQK3"HUUQ_<"D32W!-IH 83_@IZ0)AFUNC:JY;UA[#&3PL_E-#XAQ-\<)\F@7!(;4A/'X,. EG?1TIMZMTZ):\JH4)I7,="V)02Z&O"90 M IFIK\R-FV$/F!=.0W\6VH#*$FEGO>G&38O;)2TV3#XO&5SW*^ (WHO/J?/F M0W!A6$Q$>7,?%SF[R7SNBSM-._7:M=DPN.0YMX)*@_&6W7R,/06FU*;D.L^P MKQ/:KU5)K%!!FV^+<]R]7AJ3>W0F]*G5M#6PD[NFO5TPZ?E^GZB46JT@@4U> MRA[WO(9%VI438DGA5P^W4P_:J-@AX*,V#2/HXT+83V5CTED8*RSFC$+9R/=P M$M,3 HNWC<@3FN6H:];KS9INLF$:D,@H=&G VE'QK&QT0%937K4S77[&X"=,YLRR\+0,;KDJ/\/C"Y M\CM#W:?)-RSXE\'\3%IO_HC(!"> VT%S<5X9V%/!Q3C6"MW73$UT59L4"5+< M3.-"(Q6*>K)OV;L\N%0WA4PT$Q.-0^R&D8/DP27KFUAW0Y;;.9KF-6PK)7"! M 9P<';\X3%YU-9I!\PHS;(.%)S*G5'F)DF9FBBG\-#7"_@*H# :1S>3U2Q1' MP@&!S)0UDH7YBZ_+4]5.#G35SJM8O)P'D[\0FXC\;&5_14/LD& E. M7^9-JU^,V8LMN(M(1G"6K.FVJ>R2\$9IGW1^:P,+#7);T*)?F=*&)M#$"XBF ME%DKS:Y=[R:<'8\$#&0'-S\SZ9BT1G]E\-2!S4C\5#[FT+NMG+A/13W25A4A MF<\RQ0),$C5E8=@DFRBZ- TTO&NJQ*?F+X%>0'(K2:L,BUYYX(T=><+V<5X+ M,5?N/WAIO&6E-Q#W.H@W4@+,QVE!M"*P#!D,K\['V.EO#&!$AKS'CI8F."F8 M'6XY#%GMX+:F>4OKTM'H.3-%I)ST+4G.YN;-G%*Z6:4*,0'>&F[@19%.#&.[ M0_3]-3")4X]HG]BAWN4=(4'MVH3BO@"X0-K%= (6([P5[0)+?T<, M; UO$%.S*D536W0PH#-;(0KV@-$UGK*[4AZ+#AX5'TV+#PBGR6 A]I1@+UL% M",]:(%.HWRU#:P35_(6;B28AM)M%%9)QX+D,*(UH;>O>L_3YY[N?/K^'"FC= MG[I%/XMW:,<]M&XV<&^\R2IH3,/[UO/VXL8"J7=7FX_B5*M)';"MXU%9#A([ M^@[>_=6(IWWKTL(1^@^K"*1P@3.QK$Y!C\NGU16L^K=([ O& MYUNFA<9!G*+> 3F%9[^D1S9T?G6C]Z2$J1\"P5 =3^9E3XIR,4I[8Q9A4HLY MI$@%$%_PJUX*V&T23H<\&0B;XR0% M>*!6J\;EI K[(/\ #P=Q.F!5;+\\F$5\QM ,]7>E/56 %L73?#"T5N#[06F*-(:8[" M,(7I_SP=LZ%VR )IM$"[] 3]6X!WSWI8ZHO%$)[:ME\2:D]M8=5J+'R :SBJII M%%C3CWCB/$RN314B,O&YZ/G)XH3!-L7VBGKG:CGLRHC)#E^\?PI:_,Y.FJS MY '>@W]]B*I7&QX0%3_")[WKJJ+U22B9X.B;:HF,\[-\(<)/OS[^!K6TMP;> MW*-XXY+ZHM#F1/&.OX8SU8%LF'7)2!Z\?O/#0X#GNE[!+"W36O2\V! @,7"L MIF,S>L1(*:7H,8)38HW_)L(FVW?#%[&1)V.+JFEU$)L$;<]%J*>^<2/^LRM1 ML1P_X75&YR_&DB3,KKTR"(8)P'R?<;HN@1ODXU %!$Q\Z6Q=X(XM)EDP7R2[P]GS2^.;ESS6R>>2S_-C;6Y?<"($R.L5:M7"WZI!<[F #H5BF"XIST3 MG&CY83K0#I".!SH%GONV9_K3Q/2@=D3>XR2GC@WI9$;+LJBK*>Q?F5Z\PYK\ M38;7EH;FA>0$C%E6 MMJPBV-5$PUF:VDW8M$-S?4UR>N- QU/>K)OYY"OJF6 WZ'$TH.$W+\'NQB"P M[)OC$0659)-ER=1D"/,\$+C\WQ^]>'[X!.R8HB ;UXK/OQ\_>N'^D"QA8,<+^37@S<\5[.R-N0IL3D*,#,8( 2 S0WU;T6,10>>F:)7COU>%*N% MI7T/LW+6"=_#/ZMQDYS"-S]@ _7X&?T=?O-08CVP$O#?!@^2[H..7SP^?#[T M02V17W#2N8'N L.%ND+7,1G+HP7@TZI)@6J7-QU5>6G@@X04;^ZFU MOKU1WW#]T9]EGGV"DOA60K.HN)R--Z,VF$:/@T]8=>4Y9X*'JSF(#S[_*2E@"S<%=TX: M5YGOSSD_/TU^)%QFOQ?8Q-0]")3,, [7SQ MXTB3F*!!#%I&Y14J-A0[G!"1X7 18L.8F- >$]J_@(3VS*#W:!0<:1$[@ERV M6'BW4\L;\2+BQ;;PHL4$-W3A%"DZ7/!?Z%M0V"C@V-RA:YWR^\"*8W8_[A+3 M2@ 9>9:U2<8KYSPTQ2 M2#J18?EZ-']W2O8CF$8PW9;YRQ0E!Q^,65ABFH@1N[>D$2,B1FP+(RCMO,T; M[4D.(#&OHAMMYY8T8D3$B"W:$6E1^-5RT]P4F<3F.,&:JEBIQ+4JHWVQ6TL= ML2-BQ]9<\%@/*S[XIJNO35X0=QQ1KUVM M10\PVFE72G(AEGR.L!P/0&G%!7G,S-C5(RFA4NS:4V-BP6X)5D2JB%0[ M@51MAT5=L0G(SBUH1(B($-M+)^"@R#Y,?O/+: MJ@YR-X3J@HT[87"@]A;XH(EEB>F10Q#K"_V^EM:6?B,18A@3ME(B> A::!!Q M,-S';*AK?Q_FR]RS%7ZSN4*=:("4]("K>)BNSXD!3 Y6+6-G$?8.A)75S$_G M"MV%W&."K/%DUR^12X(Z$"R8&"0TW8EPJVDZ92M=,F4T_+UEWEEDOV_SMC"9 M_FZD+%U5DRL+ 1K\NX&R05U^$001,3= UE"2!,N24)49J[LY.04@3>9 MFO@$Y35^*J*[NC'YOZBS /*NY]=YD<#KTX)+P86K; Z21JS[9FZ(D!\>/JES M?'@!8J:''GP"C!>72K@5POX#\"^4>Z49@REHS?,4E=M1PCJJ6;8-%#8LW:8P@N82;P%W/YH[+=[SDK1-#[ MA#J1^%#D[$9&$9=K&VB8NG?3BKYBZ#)\5D@*.//FCT1$? M>PY3+QU%C+#3,LBB7A+J()2W R=O[CVPYUMIZ](2EWN#/%7"Y<-<(B!XS72E MB!!TD> >'.264<0FE:X\3B5(7M$JH.BZ,:$WE;D8B0P<\3093Y/W_S3YZM7+LU-+&P1*2WI$DCXK""?8.>Z, MZ ?OTO7KW,'JQ=TH((JI$5-D6JB"?_<+ U6#Z@MEV=I[\F-8? M N,CHL5.+6Y$BX@6VT*+'X7\[R4S,/Y/QZVF?DQ+.(%28<'EJFG-/'GG'UX> M7%R^8:D]?O3X^9._GQP=/8HVR&X)0425B"K;0I4WDTFW2,7%<\E)@GC.^=ZD M13M+3K-Y7J*7?+UU:0RX[]RZ1R")0+(M(#F#+X27EWD*%@HV-":3I)HJDER: MFDB+PU;!]SL8_YT-3?F!*22YS^<+(VT?_-!W55($TH8C)+JG.,6Q$;-W1-LF"D9'@;Y_3D^EID"^Y-3>%(86W#E2HYG<(0'PUTI][C' M^#(BMG0L0Q=Z+CU3.+RC 0\7W;!Q?AM"H4:J&TF]M<^%1-0DQ,;]X6V+UMZ' MAX0$^ZW;#S>EV^ M8>MK Q_L>/.44Y9.CILV.8-U[0!.SDC+G4Y:4BC>3]BB!^G;"4&P15JZ#%K8 M8,*>=_E0&X@4AAL/?2TJL"H;[LV9\D?D0=N!#>R'G)G2\9B--1AM))AJE;TV" MQ6S\1!VOG=*[__=OCYY_\Q(!\JI.YXTD)_86"I>F0Y(-TV #5T0%2IZBWF(S MT-^F;&SC+$YMK*1EK=^1D1,'>]ET!.Y#N90J/-0AR [I6OR#^8(I]5539*8-TIU:W6;JPP%U>#QB>M.:X)MKHUW%Y5S";;KX6U M<^IY(*[EV6;2>26,H\3DM%\&$XGP$>.Z2K/>GM9VD8NJR+D_\73@;OA2M'$TJ]M'M/3'=_6XP[N(R2=$K06%_=@ MV#5RK2MX>VD",TQ[X*"L^FU7M8M/$&!'%,&>C_ Z>-;5+*D[^&/Z@6Q'_ZNO MNCSCTC7>NY2;Y5/($5@Z8Y,S7GG+!@W&6NI#[3I/J[8.Z&U[F@\P#6!<>G7CE3WHIWQZ:+."VJ.QSO# M1GK?IG61ITP#A910+!)A:*?Q6[(]\/Z-S_OZV>,G#U4!P7'"I(7JIT613HQM M>]5_YLO<%GZ+()[RCQ>PBO !=*+?>-,A !8B/6P%^8W5@I0;%PH[6SHD >I: M)CTJ$(L)Z'.O[58SZEDR7CXSOP^3)VU2.NST0W/(W;$ 4/@]AML% GA6"S6& M^N_A002 O?.R;[#0^3:N!@QJ.V?,[],D7-/>NUK*CW"L8>HE?Q;K#(R\M9> MM^^"__Y&4;Z3;0N6/"QQW@#T@UV'#D58'GK[(L6Y'BG\DKB2=0OB!P F;?DL M(D[!9C28>PJP5&/%@ H>"LF0E0QZCMQJ5%P"1@A $C5Z=2&1&3LR0>H+-'L7 M6@CM3&ON%'?#;D:8'Z'FX!ZT54D]<:G"AKN2>J47H.*,[8%*3@UNT2NX (+V M(T H=J-\>)B\(8I4;XO< BL\D/4%B0FM,5H3HS7W/UH#5A^511A15UW!/GJT M(1#3%!G%;RFEUFQGY"4Y8@.*"+AP8MB417V97J=Y@3@1,TUV2D(BY$3(V1;D M.-/.?$0[)2>(W3H4; M84 2/\_RQ8OQ1DPUC&=T1LI"6.-$E@A2NR)3$:0B2&T+I*1(E] !1C(QZ@8; M.,6+#U)=$'@B+"B"A3X =G_ N?:@:]#Y"JTD V5&8479$YT96PXZ^J M!'F=7&;09&8F'Y!1!*E=:H"KL<&,$.>.&CKU'=[1N-K78,RG1@0DFZ&BI,E) MC=F3&:?#Y.S@ YUQY5'?,$M..D&V$XTYNIG=5\8A2^7S251#FWAIG%!S %@X M8383>'GAGX""A#,T)BEFM 51=,RO[3#ZN.=D0D*K=7Y^.I)<[S7*%?H[@ DG MR01%CD6:9TE6+6DE3LO2?)0$"#V'@6Q^6K3[S F^OGR-7ZBAK&-#OVQ B3)= M7L+!NPISV?*/]'8M[(9?TK>YT+7/'R6Y56,%**:1:JHBLT;7^>EA\A[YD>>< MM]$:?X?>-DLD>Y3>SCY_RN.X;:#"?6.!-[FEIY6B-BXQ1E8GV-9&^(#H4+U: MF/7#-*>3H* 7\%![%CY,SC].S*(EP"FJ)=&@K9W#'YSA3;KB- ME!5>EC9"L M"94L*/6(PPF^K;*68@HB+.:%7:9G_BS\J,YBO2(4;8/^E M!(>&\NML2AQ7Y5#N!]-8AJ560^-L#K&&+214PXJ2:\X5O@4 \>I@_)+-E'9@ ML0H3+4A&R7#S'K/2"<]>Y85+SI*81M)P3;]:TQXXC>3C;94(TA,V"S/QRTL$ M(SDQ)1P4R0GJ,$#],^PK1*AK>G+"P1;*O>S(UIMVA9#+N=6Z;;%ELKF(AAGB M*NLCW: ) AB66;=9S?I 9I)/UL(4K&@2,)D]=A ML:/)A+"0\OQ3_D;XUTU;\)ZDAI^B"&EA%![]1IY](A\=0LE0]A4O;A !O-6> MT<1#@K+A[#+9N[!QB\Z-1JLKT8WF)W*1%]_E>_G1Q) WL4DR-BUL@JMR&^*% M5!UV"1N1Q*[ C.\TE#8:N6_%41HVOD WP626FVM,)VR]_#A_0+<,0"95GOJA M1-N8<((K)?B$@9RR?JD-,<XX3,TGC6O.BJ/I*6 AX=F@;2A8 5B9.N) M0-.,C9C9F)**A0T/CA_R$-?J>ATPBJ3JGA@;^@)Z/0KW@Q-Y1#/))5J4@'[ M,A,$6'J-TJ7J,Y8S/,SCC@'Q-\$)01^L\RC#]D22#A\/'LE; 7QFPU7)@^,Y M3'YF#EA21^PGH--7[IV^^C" 95.>(7]QX5Q#:W MA\,-U=*VC%<4-V%&UE^P MKBSP! U0+0Z.TI51AQ!!LVOGL;4CEEG[%09#>I6UK [+1QH=F3O(H3'#[@26 M0,M,Z^6P>BX79;@E+PUSC_H?IW;;HLXQ!YI-'S&1A&EWW3+RBE[4,(+QV:($ M&O1*R&C)@V:-$_^M;K)3J5#%*IU%3I1F-'.^578.R#QI\'@-VJ UNL^$-5=G M=)VBV5'F[GN2] 5:L!F;'%@(G9<=N0NHEE_<3Z7U%^GY&POR:)+1J%/[A)B+ MO4?XWA)UM)[_Y-P:($5KY/'#=WM^J.EZE7Y(/>R7'B'@:/D2%4V/5T/BYFQQ M*L7L-P@PG&!(XJ4%*ZICNB;L1C7M&BHOM!SQB"/X#5F=+KG,1Z;,,P2;_F&( MM\BWEQ=A72A6I(!9TBLKE61(:POXFYK_R95L]T!2U-L'XU6R_TG9B M+Q$QWUKFYJ"6Y;N7;]\]#$J4\#?B=FX"%S-5^<+TEP3H:"IHPP'9!%IAIW3C M5M6(G89X(IP,<&-#@0)">+:.?+DX@,8Y<.! ME\*6/2&IMCDCWO?PGJ'46AR$4" 4:.=**U<<<,5,WW:WXTD"'6BR<4 6Z6[O M\^AF*6&DRE?JE<$RBRPL,+)&UD@ZJI'"EZBQ^QMHCNMT0I0*;!9C8S;\"/:C M84 '8*./$ZW.1 @)2TO9X,D+9O%=226(!R9Y>8VV+/ @:.M^1@M!0-6*TA$((5'JCDN5?) M"(, 2X3XM&%U6#92R\[6[]@U;* N [ Z'?6PT (YB=I3GJ.CD4BE )G,0]>OKX&[("8^^.7YV^,2N$JP/ MK\Q548V]5>!=J+Z$9I8O0-S:I9&$=ABA#A8T8,_KH+HQ)=)MI:A5I,M^ M&3Q\+1PVJ.R3KE9P:.R+,0+&]5R-*Q^3T6A):$L3D*D]ISURZ,_:1,4/;5)A M.I]D."C'&YP*@0OVAV-?HX:M;BI-6II K\/3:HW1H?UM&UB('*,8HUM+1@)W MP'?@&V'4,BT,#4$%?.\O/%. J :;+E#'%WA$,TD7!@EXZ/Q YYMJCKM](I_D M<05PR=5(_/=F&90#@C1RI16&XY@CP#=^L)?,%06"85(,?H:+M,'E5;U>W,]N M 1EK?_4Y@BT0UI7.\T5-&M!>E48M]HC=2'&AW$-?!@#1ZLD9[2EV?Y$KH.3N M1"V7OQ&I4D/V,8V->6&D*<)AV"TQ.+;6'Q[:_'M/0_JG>QG4&_#Q,:HWC_6B\5O MJ36.Y=:E6+1<;1T46_^A9=9]8X7>.EA:[<=[8D)L3(B-";%?1$)LK+".D!,A M)T+.GPTYNUUA'3%J5T0J8E3$J&UAU&X56$=,VA41BI@4,6EK1[587QTQ*F)4 MQ*A=QJB]JZ^.Y=5_4GGU_:GTE:1":BW@98JY:/G)T='3KX^/'W]]?H;)'A/L M>U%>)?.\P5P9/[,AE?X 5,70Y@TQPN,?@X<]^?KD!3ZKHJX1*=43S>?(J8[] M=33E(DC6XA .AK)^#*+97I<"SN.VR4]N!)K:-Z\V!*,/;WXP-4C R7$=3FJ5 M(NI^XI(E>SFJ.@@3-AFR 7U-QY*D3;98#I,@Y?.Z*C"9L5YI0I#-)SBK,IM# M2[GN:B0A[3X67SB_]HVSL=8 R=LE ]]G[\4F"8YLGNRL34;9C?DLN\U%@,%- MD'2J^<>,N>D!E;90KF,X>8+ATH@DGPM;OP-C NB1EV*=ETA4H*FUFGAF2VAR M%24LC.DURQG;]FZ8^N^1$8RD%X^\0BX*\SO%:5AJ10[6!^ P7[T\Y8PMVFU> M8'E<<>'$5,$B,V;.P6M26MR;@#*KW Q90=ESK.1R &P ,L;\0FF&Q[DVKGG% M4-N3D18)&)\]P.N P;GY5(#Z'>6MGV(V-4AS2D]OI'R-\Q4=?T *&%#-*==8 M^K)16)TGG.14 EGX9![^Y=FE7\6*16&-5QSGQH-IKYJ;")\,$#.I\[&S*^R% MM,@T .I=T6O"QQ(F)A(J::D<$*' J+P/.U(4!B#3M9@,KB[OP6')Q2.MJ&L2 M,DN/O@EV)[80@=\>?X-#9%H'C_1]07W_6DS7G:V:'%2/U,ET36]P3J)'7' G M*VGOL\GW*+!8KRQEMQ;^K+[YM@ )2<2\%=,,C+34\I2>^ >4*S[LK&P32LXXY28EM!_8EG9%EQNZ MB7G=_M;16#)$_$E ]2CSL^]IF&_=9UDC1G69O[BTG1)R"B^,M&A#GRT)B#U? M4"?0S/S6@;#1&E!QY[BC7<.>MA4&!4(3>A&>TIQZ#BKK6N21F0)F:(LDU=L@%+0;LI3LB'29 MUIE??Y78WEU"5S-!\Y8:>MI9H1 MKS-A8NUAI:2"^18@M3'*L3-4:%^F96@VP4!:6VV&4M;R&' )I:-H5]O7CH;' M=>MH$%]%"O@4YY=TUD/5;3?V[\*C"M$68)8[K#'6DB2P*#0S^AL4^5*ZH34F M_Q?Q0TQ@1 578,![09G.B24")" MN 4O9[/3[@Q3VADVU[OW:35@\!%>@=^< M2872#]IJRNYC[1S^XCC[>^J+KLN'M5WJ3RZT/46SI=$%FY,A. MC$Z85 [U&L]YS^.= ?^@XB+X.6^NJIJWXPBV&+RML?L0B["XN:SH :\A7GAH MH3:'KD_8I$-73J&>'2K[<'T%DWX+S8KA1(^/^*-%7E/.4LD>"E:NFDKYOU._ M\M:1-,[TSQRPOSUM=<\3J!_%!.K[E4 ]$%\.JW6IH7-E6^9=>\1['JX4JX$F MI$Z!]MI_LGO*TO:!VI]\P*JIB>A?) @P=R&"V6U/1= !G"D*O)GM=XFM7"R^ M&4D#;W8>.(^3G")=(7?0)G; PAYMZIHMZ[+GGH#W;#V-Z!1_9ND43CW5RP1$ M3 &B:CH@K/3U-#O\\?AC:;+(4*$J7BT+Q+(<8N]1%RDQP?3KWODT2^TTI>7D35).C%U1U6:CHV?D.H'K/&V MI-3G$B5$["VNX,-"HX9N2[&*&"TA^-*Q]:GV&'J6'B-G Y]-Y=_"H".5"VC- MH)593G0:TG9VF/P8D!S-L7DJA5WD), LEK!*9':,+)V(ZW#O;R!VN=&'TL$' M!PF!F1 MQJC4^'M9?@?F0T?S4)7VU)ZA?96#48;F"@M -<'FS"DO!1EV+((+N T$0L@K M "^< .$RFKJNL*&M$S#+ Z3BIQULA?GL,'FGT"/TU>KK76 X,<( 7Y'Z$NO&2GKU]/^S^7 M[QZ._)C= ,,,UU#1CF2$X<4S,)M9P[Z8O'3')/FPW'C#K JY$!X]$M1&6/!! M X!/.1;31KP6(PL:XEOGMB W'U1G8@M :=.*K; E5/Z-18 W0->;*5Z+0)FPZ9OHO$FS_& M8K,]F/OF(TRB-TAB=$A5,VM3\&9DE:PX41K?M<)&JO H$-65$ J2VV#0Q:*Z M11A &=,+Y?H(3Q%Z@I P*9-3[''\\F<.V%G^-;+.R%FF&A:NF[JY)?NHL9N) M3"H;IX0]6DURLC$\C@3&;I]\S\F:$QD5#:__.2[Z%9DZ ^ZX/3\K_*36)&FG M'KTJKP!O,(_.HW?5.L;[JPAX/\_;()E1H!]?N)22-]J=AB9=UQUF70MPEZG: M_=;0Q#@G[6[)1R+C.K- A68BOS]E41$^(R&\;!&RB0 9#QT!/.G)7]KC(=!Z9\?IJT-,YI@Q3+9 MWF[O !0+955>6OX2FS!O5K(K.,QG^%S@D2*094*2/^*/7N-+'C$+(,;*_&8& MC'OR@V9"WYLTP' M*%3$51V$U.!X@SH,_H"\,HUZ;WODK2ID06H/O@+@F@)+$^NTL.<&Q?J!0Q,# MSLCETTC4D7\:B1MVKM,V2VXG!1 M18S=+)-#$Y+7ZJV?RD%TWPWY'WTIZ%GM?7M7/$XW8;_+A+3&L3-O BNBRC8Z&N^)*MX/_G$:5VI?21D2'W8:?R(* J\I!5, M.2[0TZV6V),\*/(:XFTA/JRT"3"?5+ ]F\N\DZM%*DQ7D8PRYF,SO$9HQ=F\O/[8V79>$Q#* MM: I#(Q.0EO^<<04#[ZW+#,V-T)$%%E+Q?V[0#-KQ!,JYK8$;R54R_YB2?YP M\5K-B!LZW]_-R7G/@C*/]S0HL]MV^GJ$9ANC./4\SJ%Q;_)@-^:,=^J.S6O7 M\<"ZA:7?P[JCG&\M6:T.>L=7]I '^Y52&R@JI"I7"I[EC#UP%/&]>$% 6AUZ M2"K+#KVNN4/H9P\.'.\]1]B=(Q"*XSC3PP&-(;+@'0M>MH>[P'5=$L=ZTQ[83$5+ MG%ZLE&\R]XC'Y\:T82J:>OTR@P+ATGO)&!N'Y_^Q277:F9\4 1/M-?Z=6FTV M3TS T#+9.@2DD :;[)RRJ[YG[Y.Y1H%3@K"SQ'Y[Q-9YD7M)5GXTPZY?^SG-2IS;YZG==H)9^NX M"SSV0EOGSG, CC>LG8/87GIPF$RB>\&?7HUV]S+ZV3FQ]#:6YT7V-HPC2J=X M)B>]:1JM2WS[>R2B^\L*/6/E<*P2T[+-#_X[GWP8IY,/!"Q= M:[-I0;_.\C'5>PU1AZH3DF&P%<8H]%]@,0S14]/?T#\5NR ;%$M9!4L%N*_^OQ8XX.E#:_ ]2M,=B6I59@)P9*1 M^)5@Q!M+ZO(ZKPI2,&U@5'+01CK[H%W"U\%T1:Z=G0*/J(VB-MJ6-E)8LZ46 M+FEB"F=-H]5.:.CVRV)>T05G?,'II!VQ):QZ:UAM.>6TP-:'):LC#.VD7'#) M7;OECUA5)B.8LGKB0@F7(Z*Q._T0KYR#O3]XB*"!8KD,GB:Z@@)[;B#S] ,5 MJLIU='80W2#GKY8H.!PG!)=.DD*DY6N"&/UY7>287989JZ+B\]H\;5Z]*+.6I]U8=U6GCZ5--DJ$H#_>6LTI& M_84WVCI>B5%C%R!8*!D#K7Y72W^G\,DLNWUIC$INIS I*KFHY+:EY+[G H + MK89-WE:U[0J','L:-HH[Y7:AQR]>/$T>?'_Q]O34=IF9<+\HASVJ+9TG2/4? M'(3,I&,.A*29S$"G2)6O^+160X<*:=BKAPN.<'S@5,] .S720XM5IO>$>4H) MG)(6U@H_A:C.WWT:,3(&0NR;SR-P\3R>2")81[".8/T)8(UX2WF!V!HL<\P@ M%L5=FNM[I'VHBNIJ11AW#M9D-9=N=F?:[%GN$U _.3IZ8:L5\EH[E6HW;-L, M*XCK2$$2,V$%!1[8,5*RIY5W(?00<5M/92G%W%/QV7F74?8[O'16$?.-EQ+) M8W2EE)IUK:J&LRJ=.2XLA'/^,V>D&L^[AA$.85\FK)11>:G#HT"M<)(8=14< MN1ZD-'M\OF@:,?4_Y1VV6YE'6A-VR?:/FJZ\0 LDJ/VGJ>?!5 TT1[,-$3F% M749/7?B81*/,@M6,6FBG0"-JH:B%=B%*X[/+8&O;LJ<#;'90\E;*I+U^VW2\ MP)ZG&<'"&>(]^C3\].73-, M3L!RE3U!)>,TR>KNBE)YA(UVG*,:S2>:YBJ% U*FUG@%#]Q^V7%6_G1X>9B\ M-!@K46X4^1!\T/<=O#JY5/WD*P'2,WS>D,-)X]5 NG:^\$"0-VZ>ZY52/]#B M!(HO<:EP5DU:25$"_=-@Z*Q:8$)-6_-/BRJ#.:0?V-DYRU$!I70;'/)TOCZ1 M+/>>Y?4^V?V\WJA_]TC_?E&:@^%K8U."L8'O*H4G].3HY&2D6'/W5[ !CLW> M\3FSJJ&*!BTA7Y: FMB G7MZ(]TK 3,UP3:(?#-39#WZ*'<@RN<(_FB1\_NE MS6DTCG=+(J-Q'(WC;4'<>G9ED2X3-#GAV]DM,DT0GFR=VAA[3*D]S;%D39K1 MA[7YP0>-#M*C^^%G+\^2&D^AW3<0C\SGXZYNV*I&'WL+)EYV@.;I"NW,J@[K M"RW=/'%E*L[)J-QKU:"6Y'VBRR@M3:++[.4*U0S)FU>6"M0O?[0=!CQN=N7. M (O87&-M2N\R^@$ MG00&O4FVK#?XH-QS"^;UI)NCTVDB)15T$Y_3LAR3[SAVSAN&&9%"[DPTM?DC MP?8N;>[PHC9($\GR0&[3V*1HYV UZNFHI[?IQ#J#KX0!E'F*W4&:#HOGWPJ0 M84CDP=G96Q?>;JOJ@U=E\D_ ;E1;QR,\JAP1;5*"-T@:YP7#D5X M+Y_(RZ4:3$C FQN U>O @^:$ICC/X"I*EE* Y7 V:7 +P-Y(10_P@#A5R-(! MT>]L$#IL-)/RL%K#'T2)RNS2PYNP)5V"#I')3(,Q>>,XV]@G19_H7^J1CWLC M9(9.N9H)R*SZYX(NHB"R:MA2D6M).F@4K?,DM45Q=FI1@>&5"HTA*<^U)IBY M-H6LA.@<4H&NV,4KH%RN%>A@_IV6[ZON81\D?9"K JSFV&QD$JPPS4C9 M',2/3'X#0O@3Y^LIG:::#([YZWQ4(9:R;5PJQ52X46NDY> MCMYLW5BT'=VB@Q;*,Z&OM&POR#H#3S/E=5Y7I3[9,\-J[$TV'R449N76 '!O MH5N*BZ@FU <@"-R9B2$6FEZ!W&'R2D38F6U!$1CWIZ$=X#H-" _+I,9TG!6' M*UM3:V7DV+1+W"U^2-8:^+U8K1?29YLFD0ZK5M(>(L4^N]4P\46#V++<)=8X6@EP_R;8%9CV6F!T*!3';Z 6.O M;<\%E]VY;0&.Q!7"G=HF=!ASZ!48LQCUOWOCX<("NM_P+KT"FY8;9MEV=R#> M-9;Z>ZC(7^>8LSPP@$'A68]9?(CR%:2"\F6%5:I>5%*.UYHK#F?C2R4Y"J&T M(_)1[S/XA*DKI 7!(6(W7O4SG;UNKDJ^2^WF/@#,19\)GQ.NE22+VL^$.<&I MI?5FR'%]A=A+0(00JV2 $L*OD^7<;O4#=)B^MO3*_[F(V2?P\8!LJ!7!4 +\ MY[88" :MY,-W:"I0\WF]ZU&BNKG5+@!!_>J@IALH/UUC2 \UXAUXN7>\FOM[ MKSI;F_9=JP)*YK!7\F/-8GK/ABA%D MS$!B!>J&N%\F.1;:# M#8W;R.;4,FUXLUG(7G3D#G),XJ,^G96.'QTFE]V8^<:9@@[+)!8%=K:I,9LI M[^8-4Q7:M#.3L>[AKP@9()F.@4)&QT\M/2W\\(*):S]2PQ"KLGMWNPGC8P?. M'*V'-T14J+"6W*#N)9A?) 3X!F)($[RV[(K$08$L8.2XHY,$8[O!9 =D\C"< M&$%,%(A#TVDCC>B\]![!_4!^NW70TWM]C>AI-ARS M@K,;<(G^ R+V9RY>59#WQ9:ZS-&VQ8:,8'A,6K8M^HC]*TC 1!EQS@ M:]M< M$":^*(S.O3W%N2N]A YUU(DG_K,:-2YH]?F:+ MLO$JRD 2V&97B0B<)A?Q4P'EW%L;^4"% MXJ7>.B\44I57Y#G .;CG_'M/=S]/)S9%^I1QS$&82:")"G]*7 RV>PGHL%18 M%:2GASOHKI "2KV0&-2D-K ?8Y& M&.?YY1)0/ /@;9-_=IGS!;VNB.FT=!?!T-X#P&!7H8Y<)-JT9?WUW.QE@E1S MDU0]DPUV:.6>!"9E@C=/_8JZ(O6(K#J&J:/SEDP;:\UX#H$ O=B-.)>6ADYC M>N](V/F"@8),7<.'R:?FZ_S),A.LUW,?6VG%>*'@FTX7."&V1"!Y@JFF&)N$ M"=NQ3^H6E*&$HPP%SGJI,C.AU=JQ@=\HX2B576D+GEEG[]@'C+MVQT9$>Y2R MI%MM.$4I(I)]W ,DJJ^4AJ:6-_BVG;YC7XS LV-#V@<XM# M6J&"4H[TN(NN0T,IDWQJ];OOZ $6;6BUJ$>B3]A)QPVCK6,#R:>%-TY/R578 M5_60;2+^7_0QES KY%.04^>.S2468+EC')/@:UBHM2UFZ&"A&]&=%P-K''LW ME76%,U3VO;E#!T$7.US+VW+=C*6*SA%S3EHARF3.*4?&>9=>CGMP,@QH.7AZ M?-><+M50W!>9$[.*LH2&?"A)DY>^+*=R^,16$N]I_^C#U4E'#I4K.'9>46R< M77.<\F3YKURZ6>7G8<%!\F\8KD^F>8-6'EJMMB./I"A7GI?F=%'#.4X<:I;, M3+";A= "D\)6L?Y(8X4LM#-'B#\^D)OT\\EW-3H]\$ M[4;X*AC[.U/D9NJ=C.'Z =^FMJ08\FAJ3P!N )<-SYM-;W !1^< LCG?[,^S M#S@E/QK[!KZ_> N##E">S/]E#[]2?+@Q].S=Y@58JUH"JJ .'9% MBF=P7C/[6LHDY,(@S['U:\>9Y\U NIZ J'NPJ>WS"5ZF^4>2-7IFM\A(6)E? M%<%3?&.$-GB4I]9P.GM(MI!UA;+C7K&PD+/4<@+9_I.XV]"IY'%@4%5?I:6LR]Z[KG[6?H4RP6[S M>9F50\[ ,#9#VQMC$"%B:31O(/I%2I05T!SG5R*#T[4D 8__E5^#/$FH+<( M-3,XN_YQKF78>BL_WKS#BH=;6KEIP";#;'V:AKYUCP-M;SR6:';<)^S7;M2U M[H4?,\PTJA;*.!DT/K)=WP)"+_9%NZF; +J7F$.DGCYM 8I3SNT]V5W0"ADW MXH._#!I#D+;K7B*TE3>B17?N1=<"*@U9N_<]*$@V,@?$4B9K"<+"FNXU[G*, M+">+?$$IZKCK=!:5+E0\"9@'J&D__DH=)J<,?B/I=\B"0C/.TJ(,FP-" UAB M(^0WK3[OS&#;:;\>,7Z^)K8T$L$;I.0P^;Y:HK/)9@Q@?C4*AC3]<0$J$ 7_ M>=68E/1=A%J^BF#-?<8&^22;VQ^BNM\;$WZK#M238+_?<*UA'NP.0*YQC?@C M(6RWH%3\N9>3 0\'5",T%HTXU.)OW_45Y<6)2$I.BC?9 26NMRK" V@^8F\S M=B70Y;Y08T#:BZ!/4ZE(=K9;*.N1]ONO2YV.N?A;',D7GHLOE#B< HW5;G1^ M,!ZY!(?^F4 "B=B:1+D_8^GM3JUZA)$((]N"D=MMV8TGGO733,25G1*#B"L1 M5[:%*\0NCA5T>.S!4TJWL#VF6T-,4USC)QSB4N3'#2KJC%VB)I*$[)8 1$2) MB+(]2V6.J2Y8>T)1=NU8R'$UZ=M*A6!3S$R>D 71.5B#T1>[:%/>*51Z I#3IYN8?NNH^^\9WT'%.XRUDJ0LU. M24:$F@@UVX(:8:;@R"!9+-IZ79FD_++EJO2HJ,3>L?6(->:,Y-/@6:G MY"("302:;0&-Y $F:08'*6JO4TM&.V;767*@KI%42S]<'WGA=F[E(Y1$*-D6 ME&@JGH426US(J;E^8OZ4CT!WRPFZSU1:%U/,#ZE?86(29X?E4\L>!P8FIAUM"A%R MAG573CC%DGF8;&ITT\$JY]RY&Q[8C&Z@2Z#4)QSQ0&[D/:NV?K:GU=:_(YGX M$V;ZCU,*VQC%N[SYT&!IA](08X[S)5-1PMZXO8KH]N3?;6=L-VTU^4!YZ)83 MZYIHN0J&_8#-3:^?P2C1GAQ(B45F$]S[2-M@#4XN/9=WI=RHF5B]A.:32XVP MH"O/A%]P,M-Q8$(DT7L73>716GFE=4S^+)FJ)T9!AHA .4@ MXL;7(T<2Q:I-%J%GIR0E0D^$GJV92V59==;9V$^B&Z^0'5N*TSW78 20G5KO M"" 10'8$0&S!O"L;*E<;R@"D8(#/:MI. ^Y03A_Q-$[0L927UU5QC0G 82TT M=@'HF7Q%<$0?DF"@U MDV:&W"97L1Q@QY8YXD;$C6WA1C\(AE8']8'%!H1ITU23G.*^9(!@YZ>2J@2( M!:E;(,0L:Q3$K%JB5P:+D=(R+5;_4A/&W4,T8..F*DPS,4("-*FH,6&NS)E> MTDS0NRHBUDX)6$2LB%A;.Y))QQH]4A%5*?IRO"(F,'+*26Z:-3I>\O1H<62+ M/52X[[383M1 AHVGR0S+I*K:"ZFY\@1\]W4>J[IW3HXB,$5@VA8P>0T)J?,F M!=$C/NS47_D072*F[)8(1$R)F+*] M(/C*]@EV+6\D55B09)8OV-F"%WO!J)H3_]"GDIN86K-C0A!1):+*ME"E#?L, M4.#)M9=+)Q3\\>R8L&5,-%)VXD\]*DS*7I',EI2JM*GC@"U3LG:*?= -/4.' MNAI'/-HI\8EX%/%HV[$B@ G;^C(Q39O/J:,TA8JH1+O,Q,@9KY"91IB?.-$W M("675&C@395=$'%@VMDR@2KIRF3.K+#43 MH ?GM5R\J!J*+D5K9K?D*0)4!*AM 127_@PQCA)US$BJ)>%$U")G>(7DU)CQ M@L5"60Z')PTXK9'&BF=FVF&.3$2U^1;,TF[QO0H]8G]W3]RYB4<+AW9 MOV\HCGP"?\IE7,!52 (OH$ZD]L,V)A/7SU+L1I,T.4Q 6@MS1_C.@ M\/]^+R;G.,\_WM./,'J#>G97' MGSR.B]*F?$MC= (H,6.]1,U1;YOS)NDE>-+-=!L'A2I&!DL#$,P81>! M*1(X3I;8"PPF?RQ<+=C]1&DR[;/0-;,THD#S.NR4M0?2/A_>0Q M-8;:RQ0H6_6\KP[$$WV8G'J%5YD!3)O#1?3T/)A#?BBI9-7''7F\&X![M-_@ MP^%Z;@:1FZ =W2:@^AVML7C#_ZE=FRY-#;M:T[LS,[9T80T92^ZSTSF&#,@N M2YL90X60KV+7)I9=UU8.+X+=62UY3?TEI&:B<%O5$R=\^YZW6<(F6-(JA%KQ MI1]@4B8SDW4%-A=)5Y9 6YI5E9@#6\ O1CHK2((+LT^F*??'JPW+M%$3!>;) M9+P9PG8DO@4&IB)LRT9[D;"'U$=7W4EYXQN?ZC 9N8TTLFG_U-!1>R;9]DQ# M#9S>^.NM,H)_S8"&*+1X^NU'IM.QC"03NBD6,7UEU!"BO-J@6NC^$0 M&#PJ+6#1$%*N<>JEEU2"SDG MX#$%4*MQNA2&! .H*\YHE'Y=65Z0!YWGWQ/$S2+$IQ 6%CT-Z5O5"DAE=1VT M6A<:-F"CST65=9C\;(;:N)GR"AM_"LLS"[\0CS'Y%[>:U(O6_UK" )N\YN?A M/(1:0#K*X?-1&Z747JYTLE&-"T'X&]NX[3A4OS,38L#&9IV\)8927>WN--<$ M-1MM(C9N\/JUT^"]Z7KWLY'.3KIOB&0<]JBTE6,MYAI;+[H:#I?2W7HT>%XW M\T51K4;$23WHQUI\2,3 $Y 1%&SD;!E)'HUE5/(;,6]'16^!P9H'V(U5RVUR8V8>A!2//OK_7#P^02]XH;E>L=P.TDW\%?0&Z/J5D2 MS.H[R^>27'[_AK<_?23^1M)G7ED5>*&NHG=NND]EN@$,+LK)H3T$\6$#;O*& M;CY:BAD\*DH/RQ_R.1R>?EH<\#]>5LM26UD*CQ6/"R91MR703WQ4Z%DL:6>'Q]3AUR5-#5EF. M+D%:<#&:J$V6KRG0H7A'18$Z@16MB/2F](<1!OUJ,'W70(X,(L##V\!03JPW M*_A!E^_=E/R.VT07@217G@-7<^K9%P(_6@< VNQY4QC9"PNPO2N2U;2V0"*K M8_\I3AV:S# SEQ= =L6>FTM^DV#/&;^N@7%'3$&ZR-,G.QE[-::76@U4/M,A5F36U?UB5C@[YP5Y"!#MI$$?O$U. MOA1"Y(]<%T*V#8O\ ^YW%3R<(O] Z@Y9.ED3DR+M$ 5;KN@"GFD=B:Z"+AU, M%=H&A)D4.+*.P (5]W7>Y *5:A98U2CG1NM@@+]WM7K7.!+8_RCT=(0;"X:T M:5?=LQ#,BST-P>RV:EB/OFQC%#\;]9L[5RJ>Y\I)C?LQ$Q\ZQW:O*W)!.8^H MYRM'_PIU#%9OAVLJ3!XF^ /MX(D$-5=W\$WO@4HZ7?\P0J*U24T*P'6,8$TH MM9TFQ?E"M!$'Z:,E!APR&ZJGSL7"1Y.4S66N+7:.1'Q7(7X!TFR.17+H@9=I/4Y!4QV\^5B8E;." MCTZ2!^M_>^A,]- \#CI0N^.13V>)0@@#,"RLWIE1E+T>0O'?K__O\GRM+W:# MF2N@3N;JLIJGJ%)+#>NQ?8S^Y"QO)J!1Z$2)KBW?QXB^9!Z<%_.?5#7,.BX5 M&_CTR$6-)OT$O0\]IP_-<4X7Z3PWO>DEQXYN2>X7A\*T-A[[(+=IZ59V\V/_ M.<]I26J8=NV$3C JD7CO0%K!GGDB@IAR+ZSG]IW-;Y((GQ<-#)W],ME\EQ6-"*L68D2POA2O]8/5@_CAFO7>TAAWZ M Y*VMHTO^03+RO7QT>/-6YL$V8^8S')RNEAW2P_IG*#"D*=3(9'$5LZ ;+A; M>C/D@O6\D\UDQG:K]]P/9;4LL*J'!X/44!C?QH0 "EUHC3.#EPT0>H/DG;(T M=H^1;9U0XBH')A 8[-2U7O>B_H(.0RVG'L$PU+%!$1Q\ZV%RZH]CCLNK85[= MOOAD<6>)DL&H\O)UYE+FD39&$&#P?.[ M$ A/P39A(WN_S^AK 3?2!KCP3@]0W+-TN$]I89Y4.P$(W) CSTV#WD4ZG& W MK#PCV9:+0:@[4!$KF734:(!$'F5B_T4;4MX^(UU$UG@P&V[/'0:;K+.^G6.7 M^^Z+3)-:R2^$#!?C W#1$LY%N'1L#M"&[S_W\!. UB4\J'5H<"41UE@5<+X( M@YR55U]V/NVK8%]?HZ,V]56*?&?U"5,4)'B^ZFK4G:--WTA!F/!#/VWD8T[E M:21G:[RRD62,'/,G7 '&&5QR$0E/DTSS>K[W-@\!F>01KTFC2R&]XY2._/09 ME#)8)E/75.F&D6RT;P JQFF3#X7@&ZQ)F=L8[]C8(<%-\[RAOV>4-("1F, .BL'LH*'R!"-PMUA5O&'# M?^(DYP/JIW_NNM5*R[T% 4DK<:<-/1@S/>KV<_87/L>"B^]/_*0MAK/M1@.& M!F:+HT]4O9]IHV?7WX=D^ZUV;?::7D/-P[W#/7^<)HWHJ9??JX&[I-(>Y.3, M]!S;-89;&GJ/')9'CF9L.#K;3VAATF;/D'83Q:=I3W,T\/[)7H=QWK.HJ"3/ M#?9SH1K3MIABAV<)2D_4'*Q^6EQ0#&(1QE6#,!D_BJ+) M NDDO_V>VVMP#OX1YNODZ.CYJ!?./G73?PE'WHQ.0=]6>,!]\.KT\MN''&#) M$OP!+X$CYEL-0;^NX+#U]MOD^/'!\$+W$)+TI,@V.P?8]KB&/Z M%O:)6\,S3,'["2MHSEP%S8,+ZV-ZBZ=Y=Q_?A\Q[J-L*4Z\"'1?G7$V2K MR.$-\-?![SVC"R:LN!X_.SHX.1KQF$E5>&/!3?B&]O.;!6/$@]/+,[GGX6'R M$R;=).Y7B#@8T:7ZT:Y!.5ZDZ,1"5.*AV#H:33!FU-1,0 !/6%G/&[BV-7)O M7A\,R__#P4V#XZH--SI?\,R2CYHS(?N%3*0+60EJ 'U:&(V?<^HYYBP6PDPX!RDURZO'R/OLQ&XLNF*JAU&"B1M"#73S,SIAT-:Z>UL=H, M^+8V])2TX;5$KZ@5BD57+ZI&,D76)X9N<,\MJVNI8Z2T$30WV$_J&Y.^C^M$9898L7UKYZ-%3=]1D%77E@?]2IP,JOZ:# M Y$4)I+Y/_).J;ADMEC%:GXIOD:+@TZ\MU=7QE-Q_#$]#H&:R^%\^H&BNNQ(8J<5 2^+R% M'T=52>0:,057? ]>Q F_^+(1+0N?+OPX$Q7%8PQ59]&H4L_:8;P0O)C>KZN$8Y@:FH\K]D$\7 VQ7E.J]=/ M)??+Q_M\*V$^>G^Z-JZ&)R!__?[:<4B[U'S_-,@@&=*R0T#' DWN?I"&AM^S!LQ #SA1.4QDNQ_BB6ALXW2S6Q9&%WA+P;;6W=? M@S_HJ-&K%T ,A&M>@D%%LO'H>(15+2]&'&G$F%]+M@Z%B.!+J)1ERGD]'RGW MIECQZ?O1\>&3!):FP$_>1*)$V2C^OWW,4&&!F_.7D\O3B)/[Q*'*%4 M:8/UV6)FBMZVZ,8G$UI-=HV(R*8BO1OIR\EO"P(E7*K-&[TIG0Z[^ZT1S?^'WK5MM)<*&14 M MG543.>3B7/!"OC0%YGP1!F5J,6W.-$'G&?$AG!=<86Z MEDMBY0F7O\/AH9QP+BQ5ZVGP;L]!F4@&L*L).GPI@YB3#LCMP($4PX5TFK.K MH9/!N\8K)(^AXQO5(KIEE$1>8GP)\NC!'NHF)I1J4I"\ZS B[U7M22_JBU4"/AL^Q3T.&6410S]FS8+=&)6!2Q:%M8Q.4MIJR>RZ# MI\SXG#FOKN5$;.]13!3#K@G1CQR58T/G:7'QTR!YB,(V-?R1$1QW2I8C.$9P MW"8XV@0J^5-]5L*"8PP-XG#\@'5' M2P3&G9+C"(P1&+<%C&G?,1L84A,EEE_6F*U8:AJ1G@IAV'BF'+B'RYJ9K9\! M,RW+CEG.B; =^>J,:843K9];'Q%JIP0J(E1$J!TPW>:VE#$= I&US-ZT!!J%WJ)8PQX6:!22B;[W7,6//)[_.I%15*YDJ MV*"%ZL.XRY3SZJ"/YL!Y4IA(A'(NM"CI2(\TFTP0UZ***S"(6U"IFSIO%%9D ML<;^P-8GSVIC#E8FY0B?+;-2T@(B2,"6*NZ:$28LYD3U+8P$)8A"@G]WE"D\ M:/_,)A_0JW?&RBS#Q<*6AA(^^^26SQX)28!+ZH%AEU525.454J=3+^6W'#'!ANL0MS,K4E M9\1-N;'N;&Q*@XUQTQM+?/=A[GYF[HV@_;8B$8CM@:W$\V94BL68RB6@;3TY M>J2^9EOB]YV0LI]YWMT?TJ6RKO3OYY:>[E(AZZ4J3.%W'_G-;5WG MC=8VTQ MSD3\Y4J:ON.@CI_\S>_4A*4;EH!.>G86U"@;!B]W(:/AS$BS3;Z(Z48 QFA_ MHNY%QWB%H-%RUQ/DJM'NBX/9U?A4=MB;K$\8$ZB&]W2@LC0+G [N*F%];CY2 M\:5 .W]\,H5+4^G$)Y"@]/N6-5^Y>!Q/"C7Y&'P>=MPX .V"A<'KC_;:N >E MG.OFT!Y7N9X5:3YGO8JCF9>.N5+(N=TR4S8+ML]6])"Z2;(IKM.\H,,LSB1W MNX?'--,5JE&DZIEVI#'J[ 9GE:H5/#-Z56*M%'8)4PK7KUR3,<@"!)I5MYK MB%0G5KX.5+XJ,[SRT$L3"E[<&]=48!)6JF"*QO4Z>+_.^9YW5'MZLONIO?NJ MI'>%.+'/UQ/(>J#(CQ\_N:LA,-I\RI(MJCS\?]MLV,7^_O][R$D8/9'1$QD]D??7$_E)VIZX<$Q]S4ULV7"F_@LI[GIMA>Q? MU6NL1JBTJ'-J=Z9TJ[]U@'6C3S8E0@(5@;!& TG]XY/[/O+1<(,X/ ;[/[(/ M% ]9%;8!2/D E07,X_[U>'ZHD+$1@U)%;JX]YF^<"6231#XW2:ZFLQ!^FU+2 M6DIU[J]1I\QLR[G;J (6*')?<<'/G2).N=L3FUD*1C3Y MI2DSB#M(IF)MRF ;1[B( 2XAPK15@)GW%K5/&[(A_63U'HA&E-PIH8XH&5%R MVT=YZ6$@K3"I9>,=LCG$S^@AS JAD'&H?QYU"(E@"B=_QZZ4MO8T[>(T%=?Y ML3= GM\:1&W!UYM>8"NL,PTP#:NJP^@@,9]R'F[?3J'XV25;1O+M>==0ZA/!\0:GU&-'" MU"C;]K774F/$E9O2:WB]EY'F[6N>+/I-)C.*"F%"<-O5I?2]S6MI/2X4\W", MX.[O^'=,U,.RK%:Z\#JVHJ'V2ON=8'7[LE L#OL,WK@^MB<;_- ^F]R[1)NQ46<[>#$YMC!=CBZZJJME.R.*_]K@>P:Z6:F14N0? M<%<'R;ZWB-B-GW")S5/0UI'9VB"Z=Y)).Z)/D4D8O4S2D'A*>Y:@-T/8MNH] MAR30P99<=2G&7HUDP*U-!+W;OH8J72B+>@XV%]E='G]7*YGJ:RM!:3F:R H& MYHU-.'X/>'W"QOG,79+DV7]]=?'^_,=?CK_]Y:?7[\XOW_SPO^YO4/4"6U]6? MU]SFKUSRDU_>OGOS]OS=^XOS8(E/)&_[UF5VM]^+=7U#:,'9)B:9F33[K:/F M*FS'O/M___;H^35ZTG1Z-GCX^2!H< 8&T,3C47W%^D8!UIA M0U$\.U #0ML&[.3H^"DW:A>;CZC_X'!,B2<\BJDX\S9\LU^=:%/LJ78 7X?/ MEH&/^V-__&+TXOFFL?/=:?9K.C'.DSD\AJ" )?'MSY=[8!^H_LL+JU:RLND M4HIKU_[9E2;A)FG/N:F.-G['F^XT,\J9C&^P'\*O4A6,%7+CXV?&-*Z'3 MQ9V[N;J3ZOM@?%+LY4_92(OE:$:U(56KTZA/\_J7A3,43,;/QB8WT71+99T_ MV6@H71ER-UNGRL:'C] ,:#K\O!Q_:==1'HP+Y]M -IVMQ([*_:%1^8=LV*29 M8UP0[ "J!!$,H%;5IQTF?!5YRJ<=N=)5+V!FVZS"7"Z><"PS EP]2^NB:GR8 M ,6ZWYG=KZI@;7+TW<^EK!.FG,I[DF=WL!_.0+SRUO59.ZNH/;*A]@JB:W!J M;7]*N "+D#-"XE>VR?LE'G%MW]2W(%')Q<4HN8!?\BH_9^$%J3GEHLEWU#/^ MOE_?+#^7>G/Z!Y=79^_O+B]7>70ZZ<+8S1L_(>J96WB5&Y MMR?ID^YZ<>)]^OVP#4L FVNQK9Z/G'W%-?$IYKDU7@0T "DH-"M%E20(-BM7_':=*"5JXS:>L&?_#L>H-/=B*]OM'[S0[9Q M9'@C&:^<='\ZO#Q,7F+"FYAYEU]QLMTEJ@]\IE \=%M66_P*UNFH MMFF&OG]U?(1CK-/%*O@\U#(?J-=V02G6]8JNQ]S$M.0E^;4K:;+P+;F9VG69 M=K7$M/U%:V")49DW29;.TROU:(*,UJ59V2QL,*R:PV!3P*I4]=__[8C^#S?$ M&[0\"TN;('843SFUW,ZH:)L,;I@\JI DIV!;=XXMLNGF<_RJ7[OLBMI_]DQ+ M-A3A&?[CZZZP*4GY1UDK^,TIDM'->& [P M97+!,9JBQ_2J$ZK0)C%^RR-Y71V"T?OHR8O1\=$)A\AX+H^?#U_Z[,4)G%:> MVVB:?0O]\&3#34^?CQX_.PD^Z"S8B%RYC_,MSR-)ESGG HP,9DVD__+L4@4: M'4]3JJ7@9E)CTRZ-*1-LSOSA^W_1J(Z/CO#?A[=#ZYW-QE!@MXBT[U5N+>4$ M@%;5E=D-X-+W\EJHH>,JK('(5"#QMTBCHN'F-_]'P_VD99+#5LRAUD=_X MU7H\?HM>UL8F9OZ(J9)XF1T8)= MI7&%$E!'R)O07R4*CDO-##:LI]?*/#?I%.LIZW'ED3_@-SQZ0MO[[##!KWWV M37+R[/B!>;A&72 O$BTA/ HPY,'[IP_=4C)7!PPI6#_;>(G]_3)&)TQWF;MS ML H6YA.$9L-'T3G7$W0ZORO:B]IU2F)*^5^!COB/3=KA<[2 J$2^DROB!9!! M9SYZS!/W9!"77XP>G3P;'9\\\7"_ 0C'.QX]WG#'HT>@+9X%=SP;)<>7*4@9^M ;V4LN!Y%=KW.#IY"&Q6C2S3_10J& MWTQZGL W'Q#Z 110^=P#SNYN;MY[N*0#> >6N0$$I:C5MEU&;\L1,;$ 5M8.(EX2- +@ZT3_/R3#>HXIY\CYNS9CE$H/ M7UQ6RQ$1M2!*9/!QZ"S5&8+'R=SP'.BG;,TQQN\R0T%/U.1NF[C1V)SYY:QG^2RUIXVA@LA,DNZ5ZX@_ M9./X=>(TSKDN3PKFF"N6UW,*Y<%J=/"=$R>=C0/%M57%HLTQ&F=4XVHYLY 6 M;:2L/3AUY(W-Y":/: SQS1IXUBW\@F;('3?[)&MO^,/&:9/;NE-4(E<5%3KX MNXY2TKA%4=[,X9R!;*9E4N<+0W[/J[HBRA;TI9GKNK+6/DQND4IX00\;BFW: MW0..6?"G'-VN1-K6R'*,D>L+IQ(9_J::!C*IL$PV5::1Q@2:D""A6&D1L?%4 M$6]SSKM3,=./X=.?^[8E;^':,!. Y]H1%6/5( P'^_ X@#ZX' MS@]%?.AC0:V;E(XFZ##4]@!VO* 2Y;CWGTVW"%TEB,#/G_SM&]Q!!S,&X..3 MH[]]*%NH@'H$:\1X$[36N\%WI@#4;.O5Y[J=?&^3\@*,Q*_3E0V; MB_"H6_TQ(]][\T=YA&YQ\ER4XKQBAGT*+-@IL,["!8 _(P9^]-UFST9/GST8GCX_9CN!CCYY3A(%<[GY?$]$;_)WQ$5Z* M6/?@[?O3;Q_:F<1YND5]"$<>/((/M8V"7W-GO<-40*1EG2']AX(\:Y8 I5-" M=_P7&BH]+9 W@WYNQ3+\9C*-P)!:H>U#:6842>;#P4*J-$/>U=^_&P8?T;_! MJTJZETZT-]:QS4I(,@[6M-# \I)U.>4MC)"!]]:F57<&64+$)P/K(2TM MV0XFSF;09O=4+7P>\M\611L ^3Z.(_K8H364RRB@><]#V(_W-(0]/+$[ QPW MH.861U6BK^%V7-_B".]F$=W)4MOI[P2<^R<<3-A,.SEB;P,:1%[U<*"-&:_( M.O3_B,MA2W;!MT5]J(X>>1[:M]\*-(9#"!YB^T< M8%5-V6C<^1TH+NGO<\D'3C4>%AWV?;@F2Z"K.2V6...UTQC9=YA>WZ?[U8,J MS L6&5#S,67AL#;(=5X5J76O""MGDQP?/1@_9!?[T8/TH:[9^4?A;SZ=B#W[ MKH,CZO'1^.#)T#5KCHT_/$WBKC:*K:8@?]F8"@NJDN(BZ4Q4]TYW[*J2U6ZJ)A%P/Z!C3LI,]GKZWM M^$&5+B!@L.__EV0'CGI8-T*S\7-5%]D2G8.7< *"$YF?3&-%,+5.!VKL*:3E M\/_Y-0N8VJ>N$\4?D,6"JT,DB.OK,QHR N^^9(.2FQP_]L3UTFT9?+ OF<3Q M_@+#76C1<.!B"NLYR1%ZLPYO&L&H?\5];$KXLME<#_,P07P>C^ETYR9[-9"B?/-+FB@IML,&=D7JE!+"Y:R33FD]^M MB"$^=)#\:P[J4J/ZTN9[.VB12._),2S>RGIBR=>[ML?YEGP*9^8LYVR5C0]F M$*GZB/F"$7/3!Z"$R@>;K.^ZOS2+ED7_J?^L3Q#^ZZKHRA9PO5AYK_F#E-.+ MK2LGZPX_5&*%#(>/P+(&"7'_42#X^.3)_"7 M?@K8YF-H%::@O=!4?L1+W<7D>>9=2S/L'9 5#8DN6T)X_'F*OS9^XE;8",G4/5)< M.]4\4S9KPY08^W)R2?/ )+CTO=2DZ*!;)!/RS:&7PONTJ026;1X--DPBSV9: M@.+(5G[>#Z$IA=#PN[P8\] 7V'#^$Y46-T39BZ^YZ9GU+?[^X)+;M;_/\XD7 M%-1;;,*I9#Z?QP;W9O*RJ]7PX1?PJF&MUU50DSKDC.+2T@D5*F"EJE2O@M"V M^]ZJ0H-WTJ*# W8P!)IL_*_]:J5,!@UUS?89/@T]@F 3!83'LONF2DV 9T9* MG^SX,L"(=N7WXT3?%DJ-&@^<_)26BA/$SBS.-7&.V4O$GR^AC8#F2BJ$R3&' M[%,_F@PV?RF^]V&//,;TF<>/-0[#-&^*H6,_SL-WY%E<]<':-2!8WC;)E*5U MY]FE/!>,TB$3=BUK2=@V8;O<5I5EC.ZX3SBK3XNB1HDFQ6A&!>"WU'H+#$T- M'3ZP*,W^29H1VKYQMK \,YCS4G%2"(8,&3"(!DSKL#A1P*OEF=I:'N_<0^N+ ME5XMV.DW5TWM2<7(XU]^O'A]_LOEZ:OS]__WR\N+R[,?WES^]"ZLRWU\U[I< M?%;"STJ\9]V+0HS7DE+)],+WW,G]9(^_O#O_[N+R_;O3U^\OB=SAS>M? MSO_G)Q]CGMRA.I,?F, #$_= .?-?)OSOY-[D\OSLIW<7 M?Q2]P!97XQ\_,HG)A2N(W6\0?M/G5;'1?LZ>Q(1W# ]G:@>__K_+<^^@VZSF M,/\),78=??/Z?]^]H7\>?R-I NS!S*G1GN1C4CM+-/P>7+Q]\W"("0;?I6Y% M%F9VL#P^3-Z"F<3-WBFID-J6MDS)0'FH^A(AFW'E_W=C0]IM*^,?WPMO#^4OJ3G)9)05"VM4$,2A..G(8$/W%[31 R)D:W,2"9%10X:Y@-: M8/HI.N<&90_EZ-^/'[TX?/I4*97FE/#-U]*-#?MDO;OP:52F <>&<5U]4'() MI==MX)31B0^YA TV2XOI>C]?.3ITI39'U(QC]M17V->R[,CEV.^O"\=F9$,H M+>DOY2;QW,@U>RSX+Y6\:K\%_F?)]BVI_S)G9B.THLRP]ZZDWQ!!14I!8\&J-7$=U)BL=\B^9X4M+5F M7$,' A$XFB/%1O+$"SD:GHB)/Q$+G AVQ-M0%3VB-IH\9K/#_;JFI@4 KM\ERKI(WR](U&#^3 /6WMC^V_)UN_3$M4XXYZ .Y;:-T M@0_:2G-54?5QY1A)[CO%R-,].KKN#^[L!HG()1DO;TU->PJWZ7=UNIC="__2 M>RJFPI@+HM85?E<"6YHXGC"?*24(@]N:RJ8*L8DUZ;A.XMKX-I;'A+EF-/)A M9_#,HN[3G$/F5"BV3NM)U2-CP-B2SEL4R'0'+N[$N"3^<+!@F[]SE))H[-XF M3XZ.""?1:VX 'S/ST44RY9KO35JT,PH\(;(NR-]-EW(>[\!W-C.L^A+,X^D; M&YA-+=,O#38$Y^ UC8MG#-,;V+Q8.+&R81NQ,[!G.U%VEEE5-TQ\"O8K/$3\ M_FRN\'/6Q];@H/-&1L6-?J0X'GW3QJH#=#]/.$:DGFK%>.Q.T;^^7PX4ZF2CAK+O*&BKE^EBI7#3^Q91UM#%1_&L8T7BAWZ%HW% M;-*L3#?GCB@8GD6#SRE7W\C!46K%*)9TPK.I;AW#CU1J9Z44#V$59\KDM5>2 M1K];"?% T>MK#BKZJD-BM9P)82GRP"/ZBX-G=] 1=_&OBZNO$@I>_==77X'%W^)_ E;ZIR>/%A^_D;K$ MDZT:ZMO?D>?!/Y0UW$AG7S@FMT#2=]Z M1?_WC8S@ )LZT#SH+][1,AX=/GOB_?(]3E;XJV_=C/*@'CT]?":CNOOLRX]V M%.%RX"^VN"]N[,ZPO8D^IKWQAT_T0$XU3^VQ3JVL F9#CNO\KYEN&!4:B?_U MU9859AM3__SP47_F/R.,=4>A]RWU38OSO+5/PJ"M+\>7!4<[/.<1DR(F14R*F+1+97M?5R7((J/[,DSYIE2,OS,%3 YW?_6/?T>B<:]U M;VY++;@Q^,>;FZW_Z4K'US!?^)KNBR:Z:9D<%\T7HJTPTV];"BIJHPA6.[40 M$:QV>]$ K)Y$L/H"P>I+FN (0KN]:-A08^L@=%?M'<$J@E4$JR\:K)Y%L-JY M9=D=L(K'P AJ^[9HR-:]=5"+8!7!:A<6(H+5;B\:$A='L/H2P[T;-\F?5->Z M,RULF#7[K*H7A\D#I-9[^*6D!.W,$MRHL[>:>:+* 2=U4#/\%5BU,^OT[SNW M1,]\#?[YB^1I=&KS\T.CH\.CHYU;NK](T>_,,GQ9Z:;[,>U1M^S, M.D7=LH^K=OSL\>&3K;FWHFZ)NF5GISWJEIU9IZA;]G'5CI\_.WP1SRW;7H:H M6W9OVJ-NV9EUBKIE'U?M^-GSPR=;*R6)NB7JEIV=]JA;=F:=HF[9QU7#>,N3 MK>6Q1MT2=';TZBWE[ MG[P&?E^F!]]=OCW[[+R]/VT)HJ[?BN1_:6CTV:K\3UL!4N5?MJ;^?5EW<6_L MQ"DP:H:H&?9Y&:)FV,%%>?'B\.2SW8-Q:T3%<&^G/4I_5 Q?L&(X/GI^^.RS MDQ+BWHB:X=Y.>Y3^J!F^9,UP\N+P^6>'?>+>B)KAWDY[E/ZH&;YHS7!\^"QJ MAFTO0]0,NS?M4?JC9OB2-<.3IXR-JAGL[ M[5'ZHV;X@C7#R?')X9/CG5N9[>T-GFJ=Z9L6Y:_('ONZ3<>%@=]F^?6G?7SP MK7_[%!'SAS/P2GS!\\70+AAZI=][]5/%_'-G\YW!?KW)95K *ZII\E-9FZN\ M:4UMLN323+HZ;W/3W/!]3V_]OB>D,[>X<5_#WPYO^(3CW5ZCMUT]F:4-+Q!F MZ;4K;VF2\2II9R:Y:)K.U$E:9LGI=)H7>=K"$NJ]]7U<0D_;A%VG:5%/PHWN M_WS+(F_G$Y\^D^^;U?J!B_3*'(QKDWXX2*?P?7]/BV6Z:KY*OMXA@-OMW9/D MV7]]=?'^_,=?GOYR>?[#^=G[\Y>_O+IX??KZ[.+TAU]>GKX__>H?^'?^SJ>' M\KW8DUT_UGM_WH*\33"!5IZ5V&5HD\'.:Y$WR6P=3,\WA;WF9Y&V3P+?DM0&P&J]& MA$O-K.J*+!F;!$2:+H-'_MJ5DS:ORF29MS-"L@WO:5KX!>8G-_0PO+*L6I@7 M^!>\IH+G38HN^__LO7MSVSBR-OY54-YDWZ2*T>@N.=E)53:3S.:\.Y,Y<>:= MVM\_IR@2LKA#D3J\V/%^^E]W ^!%%UM6; LB>ZMV8DF\ 'BZ^VDT&@WU_M_< M)%-(?OKDB$]PH_HTI7M_<2/0+'S67_\R[?9IB0\B$1FYXDP9D M "ZZDN)%N@DVA;^"&(/8!#FS53T#X MRYE,5&L&/4?@ ?=.,:2U-\_<$'H.[5I(F:G7N=2(74^!_T[IOQ/Z[Y@>"W^, MQ,*%9LVDC(0/S;E"9)-X*>(<*"N'0=TM7V7W=W'X$Q@^[5.2BZD+,O]XUCT3 MG@Q#]+M!48K/VE.GS[6&OG;S+'ZCRSF#/QVZJU2^-G^\$=J?[W9UA&%C/\2C MQSWTYH=I9S(N"T_KX:W5GB9#LG(3&-C=4\ Z*7_/Y,/:D,@3(=+K].P"9(/. M=TT/I_M,#Q\4&F@)(GY3#;6N.P]!B3?A>/1*E:/P$GK'XDWGF##Q85)PWU?S4B]J*7A5C)^ M?P(>>;U#>XX$D$6J\P1X67O4Q%,Q^2DFQIZZ[#,,M\-P3O/X=N\8MA0:UA [ M8&!^8.EO+0S,#]9"PQIB!PS,#RS]K86!^<%::%A#[("!^8&EO[4P,#]8"PUK M2$OR/*Q!X(N\DE$N[5O"9HIN<.: -3#L*A=[/ 28G<_>#LZ[3G]TM,1,U@[+ MC11S TL_VPW$@Q-[#T,S>TE!OZ8V<\&5J'3=NTPU8C MQ=S TL_GSJC+W'!L'&PU4LP-+/W,#>WDAO&Y,^X>K60.*\<#9P-\ M;WK& U14;Q(L[^,TPXV[R?>E"CP,*M]32[U)H-B;P+1/?:&6FS4KH#JOE8OZ M+K0:[1ST^CWGO'MP,L(#F3V[JD19 \YQ=8LIR1XLF)).'RJFI#TIJ3=PSL=, M25:"PY3$6# E-04JIJ3]X#N?.N?3'C.2C=@P(S$6S$A-@8H9:3_X)B-G.!@P M(]F(#3,28\&,U!2HF)'V3$&<.KU^EQG)1FQ:4(FB-^A,[ ;AYR1.4[%*XGF0 MV9>-Q1FB1TJ"N_-(JY9;*BMP.M_O]+&6>P#CJ3,8'>P"<*9ILW6(*88IAG%B MBODNBID,G$&?][D=&P=+=8@IABF&<6**^2Z*Z4^<\?G!2VM,,[#KC09.=W)P/B%33+-UB"F&*89Q8HKY'NR&/6#J?.<'1N'32L(7; P/S TM]:&)@? MSMX.)LYHS-7:C@V#I1K"_,#2WUX8F!^ 'P;.I,_SAV/#8*F&,#^P]+<7!N:' ML[?]GC.8]JV#AC7D."4&:@D"?/#0A1O*U!&7,I*)&U(Z@>LO@RA(,ZQ'<"7Y M?"@;8+(W\8G/ASH-J/A\J#VGD]V1,^T=["_P 5'-U2VF)'NP8$HZ?:B8DO8] ML&CLC+M3IB0;P6%*8BR8DIH"%5/2OD'5[!@2CI]J)B2]H-O"HQT^/E)S$BGD(_RO0E"3YV/ MTAMT)G8C\S7.W%#$&P=B'"N%B[V'$\ATW.=4+'8O3@/+/4_.8O_CSER6\="9 M'F]O!#L@]BH?DYH]6#"IM0!+)K6'(K7>R.F.CU90BDG-7N5C4K,'"R:U%F#) MI/90^32CB=.?'&V7(I.:OVA,G(F8Z'SY)K5N;H/BY%RRV6%3CMZ2ZTVQ5X<3YVAI.#TVOX.+H'PN&E?0@PNS"[ M,$[,+M_#+L.>,QD>;3\CLPNS"ULM9I?3PXG991]VZ9\[(YZ['!T'9A>V6LPN M)X03L\M>[#)PNM.C[7QG=F%V8:O%[')Z.#&[[,,NX[XS.'P'&+/+8[#+<:JG M/&*BA>6#_RG*9"+3C([LB;.%3$00>?%2BA>Z8,I+1T0RLRX3C3T /F^LO3#P MB7S WZ/O.38DT.FAF;9I+8)OJ4P,#7@U,X9GP^M@Z9M&L+4P#:IE8)O M*0Q,#6K6<'@Q9=80IH83'7%+;5+;!-]2&)@:B!JFW;%UT+1-0Y@:V":U4O M MA8&I :AAX$S/>:WAV# \0*K PQR'\W0'K5B."%5IB",!=\! Y4&Z6$(C13P7 MOIP=G#7 )[79PRM\4AM#Q2>U[0O?M-_K'_N 2J[J9*%N,279@P53TNE#Q93$ ME-0 <)B2& NFI&9 Q93$E-0 <)B2& NFI&9 Q92TY_I>S^F/#U[?8T:R,A^$ MR:@%%H[)Z&2@8C+B^5$#P'F8LT&X9,5WI9S,)%PG3:V*S/TF#SXZTX.K5''JZ;%GH4POS3);3"^G@1/3RUZG@TR=X8#9 MY=@X,+NPU6)V.2&OT1B/K MP&-V.3H"S"[,+HP3L\OWL,MX[/3'S"['QH%+?MB&R&])?!6D01P)N/1!,C X M4=,>UN%$38:*$S7W@Z_GC,Z/=O8QIVG:JUE,2/9@P81T^E Q(>T'WX3WL-D) M#-,18\%TU!2HF([VG1\-#S^@D0FIN9K%A&0/%DQ(IP\5$]*^A#3N#YB0;(2& M"8FQ8$)J"E1,2/L24F]\\(EC3$AM*/1Q6_:)'^>S4(I^YP&YJ3?H3.Q&YE>9 MB3!.CU;PXQ9GX3$ .3D]L25/[LX,Q]O :Z4W\'JTXTUW.1L[+6:K%.]H>RB8RYC+FHDE!J:RYF#)5-9@*NLYDPE3F97@,)59 0-3 M67.P9"IK+I6-)\YPT&,JLQ$>;B6&2Q M\.+E,HX0N:8.@J)V]5_H7^S]N8A#D(O4$3,W#3SA1K[P@S#/I&]AFG,+Q=;2 MW-DU9VPK/;,S]E#.V!.E0#\NDLUVQ@:=PT^H>*P<:7;%;#V:EXG,%@O(1,9$ MQD163<'MC(=,9#9"PT1F!0Q,9,W!DHFLR436/SC[EHF,B8R)C(GL9+!D(FLR MD?7Z3&0V0L-$9@4,3&3-P9*)K+E$!H/!H44KH7F =*53*R%D.2(7F*&4BCR5 MO@@B3$U:Y1D,V?8\G::.0BU?*:IF<*E<+97(Q6GC]F!E7;XQ>V'-P9)=L0?" M=]!UIMV!,YT<'%C@]/'FZA_SFCU8,*^U $OFM8?CM>ZHYYR/>5N4E?@PKS$6 MS&NMP9)Y[8'P[9\[P_X0N.W@^#GS6G/UCWG-'BR8UUJ )?/:0_':U!E.1TZW M>_"!9\QKS=4_YC5[L&!>:P&6S&L/Q6MC9S3M.=/S+O/:[?@H# P$MZ'U%,>F M_4"U@.!;/[BZ7^=K?7U^']FK-@=>J=^LBA(I['X\ZYX)3X8AH@,X%Y\U[O2Y MUM#7;I[%;S3R,.JANTKE:_/'&Z&EHPLM/=N:Z_5$\KD]W6O/TTPK%L2#7V7R M$":DO:SP_Q:&_TXA,]S$B#PH-M 0& K#I3<\*G):![X?R&.P] M OH>[G>@:6MP^Y=TDU1\@';YXB?IR>5,)@K+0<_9H6F/CF#!S4_!N7;@L/]! MI:UE'EN!8@ZR&9J"@_IG%DP@>]V#JONVFZ/ZW=ZY;=/$HQZO;0/*YC*@XNJLJFT8'GM<8OX[%0VO=S6T.%_$40B6\1YZD9^ MZ@CYS9,@BN5!8[Z;N4<[W'2W 21N>[(DK[T0>.QLFJTI&\>#0*=LM(8^+,U[ MY52,&E<42C(\VY,W'JWXX@B.,>28"'8G$A0^EETA?OXXC<&!<__-T- MWC[%+-A3UWV&89]MJJT>Y>) MI="PAM@! _,#2W]K86!^L!8:UA [8&!^8.EO+0S,#]9"PQIB!PS,#RS]K86! M^<%::%A#6I+<80T"[]UT04?B'_-\\@!&'9J;VK60S:3UFZ_'(V<,NSQK.#8,MMHHI@:6?J:&=E+# M=.)T!TP-QX;AH7(#'BU9H_&Y 1>+.(%K9;(4070ETVSY/8D!G,W'N4JG#,/! M9,V)?(^(2F_2=X;]@XO,LW8TW$@Q-[#T,S>TDQOZO8'3G_:LPZ9MVF&KD6)N M8.EG;F@I-_3'SG!\\#$"K!T--U+,#2S]S TMY8;!T#D?\;SAV#C8:J28&UCZ MF1O:R0V][M@9#X;68=,V[>#* <=&X(\X^1-Z+CQW%61N:%^^#-,TIRE93-.< MP_>(J Q&/68&EG[FAI9RPV3J=,^Y".6Q<;#52#$WL/0S-[23&_K# ML=,?]JW#IFW:P44#CHW USAS0^&FJ>12 1:(OQW#WC(KQ*E[-J(R')\[X\/7 M?5@[&FZDF!M8^ID;VLH- Z?7.[CH&VM'PXT4G!. &M'PXT4LP-1\>!2P4< M&X%_QM!M.D? E[/,OB099FG.3;*8I3ES[S$+^HR[SJ#;M0Z;MFF'K4:*N8&E MG[FAI=PPZCN#\X.+O;%V--Q(,3>P]#,WM)0;AB.GVSOXX#'6CH8;*>8&EG[F MAI9RPV#J](8<4SHV#K8:*>8&EG[FAI9RP[DS86HX.@Q<*.#8"*A" 6D6>W\N MXM"72?I_A/S?/,AN[,N88<+F1"6+"9O3^![U%.FQ,Q@=7-J'M:/A1HJY@:6? MN:&EW# <.4-.\3XZ#K8:*>8&EG[FAK9RP[G3F_"\X=@XV&JDF!M8^ID;VLL- M73Y%^N@XV&JDF!M8^ID;6LH-@Z$S.N=Y0XF#&FLSU+>A\A0) C]D[BR4\*T? M7-VO\[6^/J_T[1Q^K+YQRU/Q&=/5-DG?]E0]#K,X].\MR@<.F C\'\\^??WP MR_],_N>7=[^^^_G#+Q]^_7KQ/S]]NGC_^\7%I\^__@]\^\]_77RZ^)^/9V_Q M2M7A24?\#40J,AVN-"+(0.H]&)KR@7_]R[3?F[RY$.5SQ;M??Q+FV>+S1_'Q MTZ_O?GW_Z=T_Q?O/O_[TZ:NYYLN'B]__^94N^?S;AR_O\(>+O_V +W][R["/ M[QSV4:<_?'[47(I%D(IW492[H?@B5W&2B2#RPMR'1N"(]5&3DFLW\5^%/<^G+!),UI)/2-/A/RVDA[\',01_AC"7_!+%M/35TGL MYUX67 79#;X1;TC=$%X";?:D S=49O)JYJ9PKQ3D\<"D3@4^D9Q3?^'*)G_%)>*7N7.5):3Z?!UX HU/TUG/3!3PJ M=",/>DV/PV_F87Q=N3%8@N'5??5@F(6W<*-+N % 1FD83EH.;0UR=P@ M#@;L!R$5^+%(>. MI":&@3%O6[HW8@8O6:W"0/JJ7:!1?\I,)$'Z)\A5E()874%+HS1+)D' M I] XU&RXQEPH!(B]2.VPTW3?+E2D@4T*$$2<13EJ>J@S)9!A%PU24(?NXM< RTID%O':-3 M^JOK( S7OU,ZD:Y_#0,J(W_CZQ4(Q\:78 1 DE;0Z(V?9)H%RVT_K.(,N^26 M[0%)U;_A8 >@1-6?L,^1Q&$'>.!#(N.Y@S_$^(&4R4V0$:M#TA'O0A"!_'(A MKB6,(\!.=[L9/6_-',Q#^ 0CK(7R-E2@@2!R<"TV!.4^D6+==%>\0Y1BF51Y MN->O\W+U\QVD>AS3/I[J_BT2T\&5>RE?S1+I_OG*G4/_7KOAM7N3GHD?OM\? MV:^3>S@KVUGSB .YZ600;#GHDP6 ;8*>UOS&%@XB0%ULGPA<#JU$7P MH(PO:(FD:(?.LE9I_Y*X5OP&#J R!9\<\0FP4A]Z[SJ[F[WFVW]!#^"CPL2R MKB*-A;?IH))LU&>0X\5-(>7H\&A-TWZX;X3,LB[J68-MK=)"ACJ_=)5_JBVB M#X-?6,<@+&8IK+[W45_%$-=26WGXN>)=HZ',5S30:)3)O;U%"8 KJCJP1CNE M*G3NGFKOX8U9,-=&,@QA;H;CX !)]7DB=P>D"'T MNB(5B_ 5TE%\I:9=)HB@9E PFU=.'PCB_P+8.FP2!G,RC# =#$B,,- @26C( MQ?,621P%'OP>1!TE-NJ_T,B%"\^#1LD0G#-?12#BY5(F*)HP.CZ][$)&_W%% MN@*91?%*'72*90S.@(_IZF-%F M.( 4*J%@!*A-AAJ@ A5E:Y6QHC:JP 1XK:$+BK7 ,0.5BN0US'?-,!5/=G2+ M/R^CP%5>*ERR2@*9NS7U1PD-H?4[;@'23Q-XH&P6@^ZW=&"K\9/ 4547X+4AI(;:3P77H\,>95P!1G"X45 M/K@4G0 #/5E5FVZCG=,PVH5U43I?VL+PQLR'?X](HB^0MBF>^@LX.OUN;P1B MAD$9,E7!%<4BX7F O)EIP[V=BX[X&,?*TOZ4Y)?BG;\$(2);0L;TXT_O7J*( M((U3K'Q38E"$[Y2:FL9^+8TX63'2S9E4NE_VT+UR@Y!">NC#J+EUJ2Q*-,"F M!"CIO\)+ES-X+W2]JQ0X$N]R[$@8N/JB=_DEZ@MG^ MF\+]:9Y@X%U3KTQ2BA,KFPM-GCAH!NA=U%97Q:3! Y3^9A.*!8P<9!QM0@B^ MH*,'#>]69N0B3U;@>MOW-"\)@*Q%ITA05.%A\+KSVU]'C_X;R&!],H]J.!T] M?P,V4+Y:*"WL]<%U!&',L&LZ%(O;J#%J.!F^@7E OGJK:/FO?YD.I_TW\.I% MX"U, ^H4OTT$.N(KK5_,<)T(E O7'HIX#HZ,$2-2.E(X)9S0W\C5^J%6F6@- MRDTQ-(U>P T@GY(9->,#;0$7)E".>4;;EHNG@P1)5\%>/&>./AL]9I6H M_7>?39V=R+"I.RUHV-19CMI_#]C4V8D,F[K3@H9-G>6H_?>039V=R+"I.RUH MV-19CIJ*U4W9U%F'#)NZTX*&39WEJ*E8'9LZ^Y!A4W=:T+"ILQPU%:MC4VRJ@]VK$&CV74=HWV>6>TSW@_ MX 9^*GY!I2[X3(EC8V'?D2L#=M1HK)@>6?R:&]Y##N#*Q#IG7*8:N18G)@^6=R:"TY M3'L<5CH^"K8:*28'EG\FA]:2PZ3;&5N'3.N4PU8CQ>3 \L_DT%YR..\1P/N%LI>.C8$O]N%I=I<.J9C8*ET]87"VB.G)N M^'V%F!ZS)MD^53+;KE!68#78NZAIRVFI-SI\;W8CZYS: \VIEW5F,)B3&"OF MI$,XZ>!B4LQ)#58MYB2+P&!.:@!6S$G[G4H6%.8C"8DYJ#%7/2_IS$N>!V0L.:@Z>-];F?"V.GA^G,]"*?J=%M'3USAS0Y'(*QGETL9R MD08C'-RM-N\V$-M)8[869'T:*)M-<>-I9W@L>'=1W$Z[V2ZU.VX]ZENF76WD M-7N+@S.A,:$QH1783J:'QQ&9T!IL0YG0+ *#"8T)C0EMOT.9^H:H8T[/28T*Z%A0F,PF-"8T)C0[D5H(YZA60H-$QJ#P83&A,:$=J^= M:=W)X4=G,:,UV(@RHUD$!C,:,QHSVKYICAQSM!,:)C0&@PF-"8T)[5XQQP'' M'"V%A@F-P6!"8T)C0KM?S+%[^#&4S&@--J+,:!:!P8S&C,:,MA^C]89<_6HO M;'I'-Z&ZO.,/F0NC ]_ZP=7].E_MZZC3'SZ_NT.JZWASM47P5OUR:HN&[\>S M[IGP9!@B0 !U\5E#3Y]K;7WMYEG\1H,/ Q^ZJU2^-G^\$5I NMWG"N>-RI9W MBNC#U" =]#K#X:&UERL&Q(-?9?(0%N0^R#T)N<-X0_P#8=+\" MOT\ 5A6 61SZ.VW,=!\;4G!Y>6;[#&G(:AZ^U9R;PU ML(&A.WC9@0T=&SHV='8:N@%[=!N&;L*&SCI8V-"=%C36&3J>NFX:NBD;.NM@ M84-W6M!89^AXZKIIZ [>T\2&[@FUZ;"CMA[O/#NU0-'0X?\;6JV:]OO2BQ,W M"^+H-0RO3,( [CY[^T4=NB7F"73X;S_@;6]WV<#>U 8C.)YT1AO -=C O0@B M 4\- ;GTI77'0H+Q8Z/VU.<'/KE1VS+:QUE(_;UST1&I&\K4N@R;)]($:Z"P M+\>IUZ4X@"WY2<>!I3\\WLD/K!N6)W/2S)^'G:6_?-!Y^!,5U:.AMLHI@:6_I92 \>3!OU>Y^!,$E:.AMLH MI@:6_I92 P>4!OWQ\0[E9.6P+-/F ?;]-@F63YB%$E'"C1M^WY+U8R9O[)-+ MV')UL@.J[MXY[NTFI>'H\$6.1N:#6H/,J>>^,Q9,2 S5V@R(">DN_$:CPPL@ M,B$U5[.8D.S!@@FI 5!U]RYWT&Y"&@^8D.Q$A@F)L6!":@Q4'++;DY!&AR>? M,2$U5[.8D.S!@@FI 5!QR&Y/0OJ./91,2*>0[/ P=?BW)SL<]?22X\#R-<[< M4"2JEHB-&4&G?(8)Y]QMG4\]+I3-YK=S/F723F3L.))KRX2KA:1F;_(WLUDC MV*S7M!.YCK1YM3\]WN95IC-[32C3F3U8,)TUGLX&/#E[J%U5!Y]1P7367!/* M=&8/%DQGC:K.L=T9J\)93JS!PNFL\;3&0<;'X;.SKM,9W=! MHX;?C/YM0#U%:L@/F0NC ]_ZP=6VSF-7>_W5-CFM=G;4Z0^?'U/T+H+(DR+. M$X%_K+"RA".NI5BX5U+,@\B%;WWZ/5Y)==1+*E9) -V"UHIL ;)XN1#R?_,@ MNQ%NY M?SC)])TA:2M^!9"7Q-7VD!&Z*-P MEZ E&=Z-K??<5:#225+XZ,$0+^ ),RDCD:?POBP6:;Y:Q0G(^D+"ZZ]D&*^6 MLGS"A8S^XT+78S_W,M6M?WSL=?%R4($;A[XQ(^>&:2R6K@]_U1H51%BQ MLSP(41?IX70$A1%6>2'HT5?L0 "C@56DM=:ZX,?@/ M023D'"Z$5@81=>?W*,!!O"$: I_5DV.(_Y8[VTK/N M;JJ#B%W+,,1_X0X8;^DFWD*+1CFJ+[[\]2^#Z9N?7N)[]0]ZC.&++)$N] W' M5G@@8U'@B94+SP.]@9:1&#HHLF%.8PB=0%CHSS" JZ%A&Y1%7Q\KONW2$P'5^ZE?#6#$?[SE3N'_KUV MPVOW)CT3/]S/C!_>R:IAO9_Q/.)(UHZ_.F([TGRV#-(45: C/H%2(FNCF,_S MA!1&1@O76'6M9<8@.&*5)RDHN[9C0GZ#3N&SP+ZCCN1@*0+H38SF&(PZ&A\1 M0==F>1I$,J5?"B.8+4!+P2M >[ *)2JV"QH%;<%WFUN(4);N#6AR'*=D:!(W M@#_0&=&UC.; "WCA(@!;@=+H;QCZ]23.Y M! FZ -N;N&'EE^*5A&R>H-<'MP*8ER$X?L2?Y55$)T1Z9"R!9H!;8GS[#]AB MD D?ODOU6^@VP/$RD;*@%=<0%HF&!$8AEL-.Z>N]!1C_CC(:ZK_P4FP>$6TB M25)]16'P>F2*!4 C0B06&B%DL@CM/0T,T92+[)2'&)%@];NV^VG:H:GU:HF5#=^8CC$X,8_-N M/I?*6R ;25) 4O*Y<')OZ>[X)*S)3()Z@E:2C49QGL=A2$XXNMTT#*2U*)H> M>H?:?P6Y02T#4$*#S'GCW&=(#! 15:BY^6]RD M,/< H_3N&F>\2'HX-N\\G""9JW#"\INVM25'LPQ4(*X0M]#F4>\)U_%:O93M/FO?YGV M>Y,W.($%40Z0Q4#6RVD3>$=@.!$Z!TJ]%L$K5(M(1'P@EO*V"TRY MOD,Y8P*?\6I.(B" M_MG15W]>1H%KZ.X:W19/.0BAFT?>@AR S5FG@@FH/4P*7*3K'3.TR)N5(L8D5LI58@+"#5$NP<7>&!>$TG>^@KT M%_UBM)322+,Q,!AS)&FG [I4;A.Z,@F]X M9U*3.?74'-1;C26X^(L@I%:4TP$5YP)?XBI.J%WU9_A:5-7#-L??+T097N\9 M :^-K&I+;*S4'N.'K]J-8B%4ABQH^JR%R=%VIVR7-B_*-E=& TD"A1D:Y(8W MZ&)3! N\ZR5,=T6@1*!L%5BJ)74;!3$"8YFF2%1D#A5FF?0641S&ES=X,0T& M]$]%2N%905+203%2JQ@L4""5G*"]5&W#Z0>H\\W:**I&W52:6;B%OKQ")E33 M>MUDC*Y&<:9"H\CIGAUJ=J[=9I7$]_BY,^"3PVRNJOHE2"X^,X49E)7\C8Y*G%%B:IJ"O#X'3*<;A=BY7C( MA*:;E5X8 T0R R/Y3F81$.9[& 3XYQ\YV%+X]^] A.)]$H-W27]>+ (9*D/T M?S$Z FX%J1CZ9DDPRS-%=#I4CQ,WJ0*LRD*@#,+@U <>%(#"\X@7&8$TVVRH M"A2L]TU9.M(\4@W\"M1F)D$P,)R@E4I%@,+P#N-IIA-72J+-V-\B)E%. 7^0 MD4A>NONC"\1HFD)MD%HIU RSB9#MV;VI?-\B4^%7/YO^-R0[ZBL;M0 M097W&%01OX T7M(HGK;[\+G&M=H;C]& @0RY&-M),0: LZS?J=KOG!P]%=&]"JS4#5^)@9(LT!D]'23\LH)>"BCRVQQ4XL+^NIF-9 5 MM<#AGD'[EU)'!H%N,/A;P(#V^16:57)=@&R")=IA;-?_YJA[:FEA7L[;1 MUY@L&XN:M_^Q0J1K/%ID^:C :F69K$J?JH_$EH,*6YKH@!Y?#\4K5"%4O'8. M(X1KX'!W*BLA9^O&:H]5;?NG'CK5"13]2S4/Z+U)T?E**3JG/>_8GDRE5E'0 MC<+.ZR0,C%A@OH5>(L>TBDH^DPHG5)=2,*LIT+E.E;0JDRU5Y'"H? ]E1-5* M70*N&'A\&1I']6"3%%);$%%A3Q5Q)%\J&8[?L'PJEEVH/852P_XS@C JQ!%\=85/ WA7%O(V!IBAB]_ MA3$D4$A_\^59="3 M-Z*;&D79J&L9J/?-F@4KD>1!9E2 W._:[96T6KTX'6" P\R+S0R:O-9BUEQ] MZ@HN6248QM#/2N0*LU[!P47)!B4JEH!U*QQGE"[,F4H0+3,/F%+PVP5.U:!') M#./W%'_S/)SHI'J=C:8TQY=O2VXH:!/#0GQ%AE'$^;)HP2 M;^]"$72J+AJ[WH*L(+8Y ]=$+8B0X2H284[8AKSSE.C&XA]QJM+?/ZJ$^T"> MN-/U:6L\M C9TD+J1F)!-0*F9I4+,R[S8EQ4L&Y+<@+E()C569"YK!0F/9^C MD),B4CW#T*GI&::;I#JG#X2[B'9N>S\TO?C]9R#$E?BM?%C5XI.SI2:$NYZ% M-G5)3DRJC9NQ9WHMQY@YTC& \%7=8R@,'B CHQ35*Y*7,9B0TF-=%NL'] 2* M;W_(P2;*(N]W)FMJ!^_$51R<_A>C(V8![4PJ&E@-OU/,O8Y>@=+ZC;K7<82) M 2N,,F?%&AWZM[%/XX9-+;9L8!LQ%CS#%%!CA(QE6WO^"=L#(-F?8G!K,_%! MY?CADLD?<1+ZUX$/+J5>2?Q96<,O%+J-Q7LSI8&!_$>09G$"TQ/\\<1-"';^ MNNB\649=T+85LP!"R[[/>M-.OX@OS.^.6_1QV)[1IK[[W%:?8ZB-6;^X-$<: MH;Q']8F83@*_:\4(?!Q%[9M]U;174&-EB0R4QT_0+\?UU"*_9/=:5*WIGXM5 M7G!@!/@ :K7$J:ZIFI?3EI[JH<9JJ4T1=@I>"^:.E[XPKG<4J]JT=N57YJVU M2RMO4!W8ZD(A+B8W7:WIE&FR*@4.AY4LF1^3D=#YL;6=4Y2]9W2#_ =:Y%CO MZ>;K<5T&S6 )S@P,?7TXB_4=7RWSNQ6_1P<6JY/*2UR%B6@K1KBV2EX$H,N= M8>$'Y+C>*<)T4+]2I-_!>?0LZ6ZGV4]]A2B.8,96Q M0RN!*FD(["^XA'HNJ]Z?2@.X4\D]!OX)EIB2$^!;8=Y8#J%:Q=LB,"> MS&S?*2\9A_XWG=[CB.I,\+]R_[*<=O^>DIQ]T.ML#;#'I2]1)!;Y0>KEM-M) M!44HYRI(52R7]@#1VKT.E&FO94MZ.GD%,[+JE!BL%MPCVK%. >/R:90:J-=_ ME7]%2^1D(T'0U1Z-+5E1;@F?SCT,:\F*+B60[\B/Q=:^ V,.0(L7-#/]^=V[ MWUZJ-$#UUB*(K13GSM:7[IOR3VD^;59EE0C]NQ HEN)H\L8QX.LFE+Q*S?,R4(B $;R MJT.G)5\]S[26%IH1/KJO[ 0,2,-7@7N\"MRH56#C)V"Z8^&Y**JDK-0@!FU5 M.Y\QS6ZY4N;+K D7VWIB-:UR<;\"IBYJH^(%B9Y%7NHS!EEK]+< M!M62?""P#:A\I3TH=PUX;I+EZD8H M9UIU3*=Q@"_G9;G:E4\MI.S5 (Q0HJY6AJ[4=I42JZZ@Y/C* .E M%XP4?9B M?0M4\22GVE.DE1GH!O+*[$-#U_GREF(8V MA$2I:RZBM>K,_68B_.AI$G_@@['@1H83SR)81K2#35"[]W K1IQ)E<-FMF/M MS61IK.8/,(W7><6ID:*[3#$-IB9B'%05X=MZ2X5>-K.[TFK:\C\*/< UB9I5 MKZ#C;,"C-L0H#;B30V@$41JUS&"X BRFFN&0B+DU"52%*&HY;=N8"<,J,2:< M4ZS2ERDT8J8D!J;74O0M6TUV=J=%U.(.9V\O\N7254EH5<=SBV=J6QV!C;:L=^_47-"R5GTA MG_7T4R>^E&<>G?!\+E(R_%\NB$IRHSZH2-=4^27O:3ODC5J^U1$M7(&NF%ST M8WPW\<6[B_=BW!V#(;O+@IDP)EGW]T7PG3CH?0Z< Y,L8[P+R,L8."*0 M.'W,DM@DV(JES!:QCUY,&,@BQT,_4Z<::X]'%<&@.9.*,:/;L;$IP^PV5[X$ M"BQQBPY-SR1@JE:ZT+7?/83J@]HL1PM=Q8ZA8JBN*5, IJ*X&D+/+R9SQDES M_7_#D.C-W]5=P+/*#'#'!B -7S%3+P)@%?RJ+1K= [POI7.EH>K4[JW7!P-K M^WN]Z^0PT"CBR@'YG%O\-O(=T!NH3/ ![[ITTLX5?=-_RN"I24BDLAP):,2E MMN3ERH1Y H4RP6=)2;R"K-A!IO:2SV"JJF,4LSRCJQ&: +I @W\5!]Y:A%5E M%5;!+!/CT$L&CSPD2?9D<(6S@R*2X5*,CG97%<#F*E9@KC5[!&L^Y!C7G*M?*2 4]8\M4Z1(C7P;HV//R)"VU M535/17)U#I=!85V1+V.T1)AF W)1O&;-B!7=6,(4-$^4Y-53FLU<0\6MJO*B MXKRI*O>"J<42W=[$V&=JU:U1WI,3!LRRE7P#&+P2;5JSWP)W M-<'4/"U.ZA)99 "F:G%>M) 2\BC^BZ"HN;AKFZCB MOKKUTZ93^6= -V3V<.$/RWL0ZRHSFLA+<"9#*F,VUU8W*39'XS*@SC5(3"6* MRB[AKQ5]*+:/Q12L(JK3.YNR/(G4;NI ;3K/T).,HZT.S,>/QH'19/=5R3GE M6V2;'(M;G;-76M]O*I11[C;655O(^U%[N]-*>1'ROQ'E,V0-%(. \^%OW^.WJ@TK:T/OGJ\Z-C[7"RM#-;;I_ M A,C5'93JJ^RNA5'6UW45$H54QKL[SX7LYN#8A!*S78%(O3,OYAJG^H8F<\ 'RHM\95TCMWI[47&R6,8T:R#%)NM*+FAE U4$IDYM MQZ#-O8I8RTV]Q?[DPI<01AA,<)?BYKYA)\Q"T>2%]HT26W%Y \M&X=2%UD4Z MH& I,6.Q[]BO1!>*0 8]0P45"GK'%.)O>F14,FV2HF Y^B] M>ZGVPXE_BCP/L.>@\C Z,-U+5-Y 69XS5*.LEY(PZ1G] ZIP3>W5-5J,J^>@ MV0(CCC%WE9L;I51 3=%< ^IP8FW@A+*0KP+:$F%DJ[*-N5JM$9XJ/9<"*?!]0G>5RM?FCS?"G"@ C*#>D*R5P0?Q*1ZC+E:2LEF,?FLM^CM6 MI!],?JJ"^W_6)/?_W+:*OJ7R_^-V>=]&/MDR_).W!"=/_7$URK0#A!,2J+U7 M8L[>%G&"LJQE8*@&,380NB;"+81!S+1!2UW,F!"*(HOBK.Q[E7&.W$ MUDW>13?5=8Q=:Q54U4QE"11G&ZA<#;U*EE46Z^A M"]=>>(N8ZC%0_U_A,B]>L(Q]&:XG2E6[4\\XI:H#5 P \'L58I5LM1FP*-%/ M2^9I@&6M9$)'1&C-T^-21<$,DM+(H+KI&2\UI1!1)VGC-BZ_ZYH01580KF 6 M5=RJ"=)J<#9?1UEI<7I+)]VTV)"L5E:#]05ZM6.1RD!5[$OQZJ7,8'B5.('O M-T-3?>H+W%_WDJ1JTH54U9/F5-,>#X)456PQ\[2Z,4^!7ZVZ+M?4J2KL"D*5 M]U%]2E$PGHZ5?K-,1L]:P4U:+Q4PGP> MZ;I!947&M>VFE11V([A;VF3V,M(63+,5]49GXB^D.5VS&-2.^%04]A Z(YK. M/=V^[97*3V'>-Z7BT?SQ6%908'H_8EKG%Q@Q37I &EG)(7-PWH"SL)58>>_"C=8\# MKJIV!2/Y%3J^+Z1?%Z8WDA;5VQ8G"VQ:=R4MA3/T%NM,TH% QS*@W,7 ME:W0^CAZ>,%%YL[GU9VW?\]#3,"*Q(N+=W]_*7J]+IX>@E)"*$''\?S'V#P\;NH=YV923 MFA>CT_W$5?%LS2!U/[3$VC>7>FL]B+C5&[I MRP[9*F^O-?23.9,3GY"JS#@U835UPE;Y# 2F?IHGY4;IP:/@+DU"MS:9N,K6RJ/@+'8L&H.,A MFK7'Z3/^4,+*\R WRN.1*R)HYXB^,7UP:(Y^]HE6H(WIRW[S]?+<,#H_J0@A MN)7H@O(>-UA]IZ=O++&98/TA-\_RQOF^E@(* MJ\K&>9VP_B[596>*E[L>&!?5DQ/.+V'KAQQ)&TI2_,@8=<#@JN65>=I#OD74Q>S]K 9KB8+ MJ5D+?P)TWW_XK*,%N,V5#HNAD(VJ,4&TH_(24[AD(^!_ ME^E.Y:[&FF4ZCIW?A?UY#?LJTL:9!JB-ON*L*0MQZKVLEKNHQIQIXI-N)<:: MJZZ^TOO*J\)0V8GF5O>\XP%I^L!MLB@XC-^4J7$!KT3*5U2/?$OME:^UTL^Z MA2J$I0O3D.P:XY.HN2/5)\!P)%XZZ(STJ:SU.M(T8'KT''U,/>T^C;0!U/7] M:D5RMHQ-M=M41("Z:PX5+3M\VZ)844R7VI.N2?CLIK+Z]@N(A!3O838=XS37 M!!*,'V^,-1O+NP_)F) MXJLPOPXWH1$I5D;7&;YPE=6[-J?[ZE%!J@88]7$M%'@JKKA!+U07\G" USQHL4 MO^&&^MO7_(6)(6"[P0ZIHJ6W/I#V(/NZ# #*F/1R=5I2\.T5F-1LH2J95$O1 MZ<-1S,DY>$[UMOCQC0K@ZYA'L99UPODUGU2=WJ_NM]/.J/FCXM"IZBVJ8$^E M"C%I/(AGG&""E%D(Q@!LE1CT%&5GW6=\RI:BPT*==&E>AYH!EE*GRR@ITVL9 M171:EX<)5')!A-E;E\H;D&3;T&4%CX5*"ZZH8HHJA5"CC**K^%+5Y([X>]WL MJF&F/A7!9?.*@LU5G;QT?15".^5*58RY<\IZB3J\I4Y+RD08TZE$::"VV)HL M%[.D'WAYF-WH6GPYLD1X4^S1-\>0Z%B6KE+L5(M@H*].A8@KZ\AE86GM.F([ M:-%X+GU:P\"W$U#;1DO7K[SC7'N"L3SZM"C*<7MKR'SNU0A<]0RK:TZ%8!2R M(+\%J;*Z:;["T:>DP@0K4VB[O*45ITY&[VX!QS&'XI@AIK2U0EY1%%4]=WB+ M6J-^\>OG?Z8OU3'*YU-PV?6)14Y9+OY9;W!>_B"N71."T,5!Y^#GZN-S2#", MAP3*B=&J(E:KCAS#UP0W?;J^AK@G-8RS"*3*:-O$BC,X%(C*+A.95OU^;Z! M.@:GW^V/"U^QTNBMU\/%W8XH$@(B55(DN(SPGCIB&X%;7#F@NTRS$G/6,BJ3 MA[54RSX!I@Q]40:Y?E()]D$?S')'P]1L MD([UT"9/\8=3RI0ZGY,60XO<"[(#=-A>[6EJ=4#W+(]H;0:?@^N'46GW:5I. M)U+6WDFMK!UULF/-@5+#?+0[*,+Z#!5UUM66@VA.W?Q4%K\$/1DM;1[HW"LT:7-S%I4ZG,/!5Y&&58X: M@^:;?@OL,FU[Z+X!+QGD *>/:C;=H>][;\2[S5':<8NYHPSSZF*)T"[ AG[S:_!IO=7+*HHSU50(J@%:MN;R^$$M<0D:Q*MVJ M]I=*+C4'Z>(Z@@IFN5O=(4I>KYRAMY=<&R&EHI3*SAFA^J\\DNK00L(1MV;@ M6:DZ:\9,,]=IK$PDJ,RTP=3?\7XB,2J7'2V"69#M,A]FR&JO_4=\C>ZB678N MCH)7-.!4S^>I*EYEU7I?G4YWC!<>N2C_-Y>% JU%WXKG8/*PJI&J24A?3=5/ M\PR+=YF#8+"^:J?IBZ1#7B1MUB(IN-QI[*R=QFO<,Z/%;N%V"3HX03F9N\PA M%O2--)N;H[XI?R[3!L*R!5)JOYE9U9(MM;.B_%++6DW;%7"$DXH'%6W8X53N MQBDHO'UU!&N1-FBR0^L#0%)"AA]+/9-)5M$L\E 4WG0HAQ$?Q83K5+#>#'U" M]O>[]TU8Y?[#[-D$$J]X)CA<,Y#0>:"B1-4HH!HG/$]$3_NJ/ZI:VS!H1=I9 MP6!U1J2,]=)-@6\BJL!)<3;Z"FW#"BMSQGE:30[MB+]+S]5;E4P!VQ"FAKJT MON9/U;;:YAXUO\<=>>1W0&/B4)521UNDVT:1+7.4!(T*[XJO5#[U(ZQD+7%:93"3;: MV(&I4A0O W2ORK,D=KQHJ_M\UV9B==;-$F1HH0^UI[A8$&V>POUK7+Z93M&Y MJX^*]XEF+H3T4&JL' EQ2 M!" \Q32 ,P/-Y:4RQWG*B/4I"Y*LM^I4<7JDW?F1O\9Q=>A]"^EL[$%,%!I M^M)D3M<6%"[S@,Y,6I_KR+#8$E1-N_PYC&'*AU$3L(P!/N"?\?4K:!QD M7OS\Z9]?/[W4BE0M$]*N__NJ-5.!E' 69'AO,["A.\XNJELN5=\4)27K]@>[+ N?UV^J7A@D.HTDQ->1GQ7 M.]WS)W.ZI][0=>*G=?^A\];7SI0NF#=$$:^LRVTY9PIK6PN?CH?6GC\=[OV? M6D;&S/6!U&:XX0@#PTY1M=W$CZ]A'K#0=>"9;]+W_@TR._E M_KP\@2^HKA^N$C =26".XRW*YV?7\/^;E;(IQ5$-K]<.,HKS#)27)LG;SC2B M%"K:UCR39&=4*+1\9[9(XOQR41Q^H]\/W<' Z$71&%5&P)3^QZFN/F(OBQU] MB$: (5;ESMRCC=43>%3T70U9:9OP/"U,(-"],=_K1%*=I%A$+F.5(H9;O]$" M)\#N7G$ $UC(A<2H8E)9??/-(SOB-UW>K 0!CQ!YA>V[J1X*M38"U0%0E59J MESYA!T_=0Z84C0TU46'\,C,;HYLJ1KSE,+C4G.ZD=GKN=1A<5$F,J9SHMG& MFZ% ?7=YUMO:!EJ<,J\PR4P=E[I4HN'J%%^E-GQ15_2<4#%V:&F](!Z?'&EJZ^C M2BP250"/,ULM=*88+=\K*X/L0(.NKL?CQI0MKC5E&7PK#E;$.\WS;I2CEE1[ M&JCU:CT94;=@U@JE6-#NYN)$]&*KH3)09AQH#AA$1?:&\DB]F_)LRT1M7W33 MB@:KBF4JZ)&5\8(P1JXH'F%V.J,6)'K;>1$F50.((,7/.$%J?CXD]?;S-5$J2F'[JPY"D\N$DGK> Q7+IQQ0R)UL'Q9ZRIM.W^&$^(,[?5 M&E@56SP4D*)-56%4WDK1;#4)ZHB/ZLPYQYAPVB>K6C/+;TA=S3R((AO:R"LK M3 W?XQ!)T^%M3@,&4P&3&T<74RKCOBKFKJI,1#I$8X(P-0W=A)MFD65"B@FU MX12P&'5L>[%'MN$+HZ/37!B]NZ1J2]=%<&?NUK'DJ?&U9HP;] M<:=K69N*G0QPI6U-LZP]9G:%:\1(X.O+'"-'UV_ I5_+VFZ=K<5E(=O:I-,A MSBUKET-13U7\*KRQ#DFJZT33AFVSA8U-1479MW*3319GE Q@JO:'8;EQP*U7 M^3*U&M1TQ;*AT,%LRUJU'98]D@GM3H)XKP][:,0BYA]%WTLC!)*1.J$E1Y!D(EK[%<[*:'.Y5VT)[A*YDL MI.N#48IO7-Q?K)?54D>D7N*N=/*2.:]CX_AP=;81U2>]U/%JLP&SB.EA.4.3 M!V=J!3G%]BL\ D45-:5MOHM@M:(=>MB3(DE!]4N]194N-BN]I[Z$\H>L%&R\ M3#"?3[58;4U3P(=4>'5-&E09#XKDZJ_44D7M(47@EZHTK"=U8>H\!5'+?3^; MH7! L")P[-S$IU4*1,94SC>L M#>R6H<9D6%P JH[H6G:[WCY:UT'=?PQS5W;+E4"?<&K;YV)'^0>M]Z=MV#_3 M81.F3T7=LTKMYR]__!Q1[@1* M'R8'.$7VOK.[5%S1-?+A@C1]V&W+QRFG_,7L!L;>_00:&,:T5']W8>4"^Q(N M#8')OU>9MNLRLH/65W7X:TN2B-N-4]0+JFRUB/P["]FF1>G?HB&F[M!FV\BB M%05.C*E*8S2BF/M F3@Z>02NP+5L.8?G8X/]"2^S+5N19%,C'F@ESIA4/C3U'&D);K/,Q<\EBP2-JJJ"B3QO/L MFI2F+/NARKX4S7)J&5;DZ92;&\JZ[,765R^K=+;L7#&P*LM?3760P6>T040: M]EJ?_F2Q>4SQ6!DM, .EJ&9,7ILBFS5HU#KIVC*W.6PB-G_I16Z=?(+"HTJM M9<9<5!Y,XUF'Q+RK(;72+Y0A_KEBB-_5#/$>6FXL]?'55R>%X!([%4[6E8;4 M:]=>6#?2BI;P.6L\5+::IO-5M3'L5>Y'*7WX[6J#&Z--_;#RO".G4@*JW"-0 M2=@V]6PIZR&'&VFC59Y@$D71OD(E%0)%S]8SK6B1W\4D\@WR(>?1Q$OK7N/&=) KG).6]I>:DIKXH;DI-?)4\4NRRK6P^T8OJ MI!E8[I VX;TK?@]ORL7JI>M+VKN/!!70.9]8I+'8YX*MI?E'9="F!WB\+VFZ. M3R;XN]^L]_]2\TK)VJ)-59>)'.G:FXKG5W9;DI5UU+.=FC>I M=G,7$2EC73<:9PK5J3DZ'I^EMN707@&3IAEJB<>G7GQX;PKUZA!:2<&5!Y2U MRR[<9.9&,GWU^5LH;VAK(66@=?MJ.^/F[R\=O0$A5EF!,>[]ETG)(VCVED&^ M3(O '6Z1*@O6[G#AU;8'MWYDD4Y]W2#.>_J=E01*H]F%=3$EYINOOWM#Z MAF7EC4\S*\_R,-2F5W^<HXO27GRGXV-W.W$G$"4K.J5WO&^?( 5K M5X&;%Y5;JJN.4K%_F@YM79]U51]%FXOT$RHG**J=H<5)K$LL"5.Z&O2CV3:B MRJWB-\4F9[*8IQR$I?F$V1BN!0V(Y%>9G;:@ M%[EJ >X2N%[7+%:5>(W ;/Q E*=+?9;%RRLO>%7=I:'W\YH-@M4%AQ.6JM^P M4GAJJL&7I;!//<3_5:W*5OI6J]NQRY95+JELZ_DW./FI'WC%?I]B'PYN.\!X MWPQ+N-.2ZEKE6G.>HIE*5HZ;J)R%F6'IZ&^YFNCM4UF9TCO*"2GNE K#6PIB M5US8+26"L2CPR[5RFQ26V"C<7*V?=+I"W_A2#?4J#6YAL\P2Z%X%&_2F33I) M0+CKTK?M!M(JM0LSC_0[ BK]\$=Q:H39UZ=*/VPOG*#W\VVK"U$MTUK6AHAI MQ:N(9ZX5C7A5+1I!KD-Y!'+YWIWU))P["TJ@2C]0-8FR$)>ZW=13P??>LO"X MS^&&=NOD%TDQJ\KYUT!-49R;59335LJ/-'FG'E8*ZJQJ/71@BBW%KW$FU42M M[XA=ZQ@:B;.W%_ERB85W,#&H$DFICB)6\@J*#4)4,QW?03;A/:@+_.Z3@_.Q M"&U?E)6K0.Q^GR-^IA2: MWZC<)@V)^N(7ZO7MT^$G"';XP17^H]:#9K0L\.-9]TQXX*I!T_!TG>+S"M<( M].=:0U^[>1:_47>_0G9S5ZE\;?[ VL1^MG@]A8:>TN]R?6\(Y\?%BW2_RJ03/?:E/N0T$!+T%;\>#8^*V!:!KX?RD>$R7SU M]W),%7+]4>=\>#MT9M!: ]NME+A#T1X=0:UHS]_ S#R3K]"F8]^N$W>UADQC M<&#+QM"P+E@TX/!IO+\RW D.ZP?KQ^,-^ ]Z>L*3%,N!8E*W&9IBNM*W8;K2 MZ]4H"$=XZUR%YS,57-7>I:+ M#1,NR%+2Q=%-TX/%=!H#S/X!!>C9+1"]__BQ^_'](VB3#C <9?B?(%/A!>VE MBO/4C?STY:%4\FBCOXU='F#POV^LK5E5?KQAW\/Q?0H;Q3C=@5-WOTG*?=8( M$FS,0S _@W>GDK$.60 #4PQ3#./$%--$\)ABK("!*88IAG%BBFDB>*VGF,," MEH\6_G^L@*4U"%1*@A]CV8M9WK)A;YD!>F8? HJ_VTW/@_.NTQ^-[ .G9>IA MJY5B30=\['8_N@:9ERV)*( M^ #;&IL$R]J1=\<*?W__AL8F@6+O4L0^2>\M-VMV0'5WC0->]4/\>OV><]X] M.*SX0';/KIT+UH!S7.5B3K('"^:D!D#%G+0G)_4&,&5E3K(2'.8DQH(YJ3%0 M,2?M>5*6^W,LP3E(^V!K;Q^7/[ M5*7U>S3L@($MUM$A8(NUF1+18XMU; S88MDS[&RQ;(?M1?\EFZP2!#709IQO M@^0ILK5^R%R03OC6#Z[NU_E:7Y_?1\"JS3GXE:-.?_B\.BA!!D+E?:>@'U"P M#JV/Z<$F1F=O.ZJS^G(11%XBW53Z(HO%L\%YMS,0T-@PB"/X3>!Q@V*>Q$OX M;3KI#-3-]0NFCG"CXD&XC_;9H-.M7>F(.!&]YX[PX97PHO*MJ1O"F, ]V4** M"QG]QQ7I39K)92KHT! I?H] +WQQD;D97.E&:&.C+(#&^\+UXU6&+=GR +P_ M0.L5N7B)&V(LXD^9I1WQ=5%V'"_;V0AQ[:9BGB?P?2+\)( QP^M7;I*)V8V( M\T3(;S#@?M$3P,F3VYMNAA.[@,_%IP1N&,)SYO-4TA/AQ0!3*!+IYUZFQ]B] MDHE[*44J83"C2[%* D^FG;_]@%B_W2&V**2]_FI;O-4JN35[K[5 .D+%C7ZC M?$$:*_7%+RJ0M*=XK^WH7A/S7K_7.=\AYKW>L-,5=TKXI'P "??DN7ZS^N_7 M19"6-Q#:20!(P' :'7#%,QC\RIM*>439\: ')),PXOG<];(<9 +3*%$PX-?E M"@8URE)H6BJN03+P7U=X"Q@GHX3CXNF)#-U,]9X>[D8>W.(:W9D'R5*L\@3N M3O'5RV60+?'I'5%-WQ2^K YC?SSM#'<,8W\RV+ D.(S%(ZB)HW*H:13[]5&L MO9NZMY()NB2NZF)B9 9NO:R$&YUZ0\?GSXO6X<"YB?H>YBZF96O@R;*9<$'U MT=NQQ#&]3I"__?B:1C2(H&E9G-R8-Z_A]-UJOM-)6U?\/0W!_3CSP:>1$]V_ M16(ZN(*Q>#4#$/Y\YJIZK#/FA\/.Q*Z# MS*V;6S]Y,DK7+D"J@VS388K5L$=O:,/II,-^I\NGD]9Q^Y=TDU1\H+G*3]*3 MRYE,%):#GL.'EEJ'%YM AH9UYO2 F73.AP^(#:O18ZM1F]5C5UY<:R<]M@+% MW&\S-,7T9VS#[*=WWCF?WC^_N]W3(XS1'GT6U&8J.K:%.TA-V 2R"6P,KK@0 M=G03R)-:>TUE:S3!BB%G7; 3& [PG!):K$8<"&H24,>>)C$T#Y[^_VBSH&F- MJ7@2M ^L[Y8 S;$+57(DB"-!)XL=V\!3A_6YB.=[YQN??G>_QID;MJB_7[[O MF#OFN!/FN-;8,*:F1L)JB7O.(25[3=R="M4:96$;V$A8V3UO=']M<<^9X^SG M.(Y$G2K5,9-A\8>%&UW*%MEV2Z8O;3;9EI4"UBO?1QG^>^SM/G3\7U YDSA/ MWU,. >$SXNX'A\G";[S+'3.,'3 PPS##,$[,,,W#CAG&#AB889AA&"=FF.9AQPQC M!PS,,,PPC!,S3/.P8X8Y+-_BT;*P'BO?PAH$RH,[ M3I-GY6B[C6HC-;"K>F17=<"NZK$Q8'O$P]Y>Z6=7U494>EUG-)I:!TW;E,.6 M;=,/_VCGV%CT_%DUH!SZB>4-1Z+@^)@[3B2 MS!K@P/<]NG5CJ\56JX58L"-]^E"Q([T??/WQV!EW#XZ],=6,Q9@>9H6('^;LBS>=.OSL\.M.T7&6.LR'WMH5H/\YGH13] MS@.ZROU)9S"R&YJO<>:&(MXH[WVLY(U;)C./@=#)*8XMB31W'AQQ&WBM]!ML M355[&B2;[5.,A\ZT?[2]&;M\]9T&LU5Z=UP;RGQVDKLX'L0HMBEZ=WZ\K2!L M_MC\,1;LSK,[S^[\P[CSO9'3'1^M*A#SF;TVE/F,W?DVN//3'KOS5@+#YH^Q M8'>>W7EVY_0UJKN_U367=;O/CRU[\,IF]^>BD^ MF#5^]---+S=Q/'O;40.B;RQR T00>8ET4^F++!;/1N>=KH".A4$(>"Z>];J=L;G*$7$B^OWG^M7JOU\7LKSCVDW% M*@D QA+X><2&U%])+QG(5W? RW.:!02&;H9-'8EDS2.(JDVW'MQE.8A)3UX M<9JEU)11I2MT41A$@:>WZ%>JF)=C@7<-.Q-S5^=O/^"HOMTA1"@RO?YJFX&U M2HIT@8*?*P4*WM4*%(@7%S^36+R[OSR9.W<)U* [ZDQW2%1_/"Z%9;=(#0PA^[_ MWKGHP,?E4B9> )#_1ST.QW_]_4:JX7$9Z$\7@9P# M2M++";K/\WG@R<2I#GOB@FP[^"^ #"JA2E+X 3X0!&#A)OXU\).!3(M]98R! MML#H7$NX!AJ20>-A)./Y/)69F,&82O.J4%YJB8JAW0F,>SR7::K>D\KD"MJ6 MUE3R7LHUO5.YND?5K)J2T'TP-+%"[C7X'3(!DR/APD\85)!I)CY%(!#2$<47 M6M\<\9D&4/TN7NBO7SK0],P1_XQ3&, (KD8;EP?I@@P7#.E/-8]$YX,,;SD09>*S]KKHL^UAKYV M\RQ^H_TN\'E"=Y7*U^:/-T*'B+HZLWPC&_&)TD%'D\[XT*T[CQ*&.MU)]4/M M-AC<1GN70:^'\IC9,'W1YUS:[96V8': MOV ZD(H/T"Z<#WAR.9.)0G+0;K/1Z-0;:=XFOW=,9C 7SK,4."_=4 M UZS< >I"9M -H&-P167O-@$MM $MD;"3\]RL6&";KY?N-'EKK,+GLXTV53% MRPY@;"G LE.;5'SA**-_CV7.0X?_11");!'GJ1OYZ4OK,DVWD4N3$D!/.$^[ M53G8MN+4W6^.TNXL:UO!:WVI-3M@8(IABF&R?Y8YT&TR@X=7!7B\1!0--YNEAX[ MW7[7/FA:IARVVBBF!I9^IH:64L/0F4YZ]D'3,N6PU48Q-;#T,S6TE!IZ3F]X M\!DMK!R6A?9.+171&@"*T)XNY61?L)M9FM<8V@L#4_79VQ>]KG,^.'@>QSKR M0#APKCI;I58*OJTP,#DH=V@O#$S9F'T_.C\X^YXUI.$:POS TM]>&)@? MSMY.QKO.M&#]:+M^,#NP]+<7!F:'L[=3W@Q4P4"-LQGFVQ!YBGC?#YD["R5\ MZP=7]^M\K:_/[R-?U>8<_,I1IS]\7AV4( .A\KY3S@_9BOM)5=G#XXU,3S:Q M.GO;49U>*\Z'_R323:4OLE@\&W>Z IH>8F PB 2>ERCF2;P4SX:=\[5?IHY8 M)0$,$715N*EP!3PW#S,1SX4;%0_&J^,<8XQ7\-HEC)VX"63HB\3-9.=O/V"[ MW^Z @>^UU]M,T=V8O%!;XN^+Q@ZU7(-#;#>ZX-NX("?AH?CD2VD<)=QD@7_ M<3-\ ESBRUDF_"#UP/YE<(.OO@G2-'[ M_9[X-<%?$KD$_'/\)\HJ;W@% M(QTO@XAPG;DAXIEVQ!]XAX<%?WT0)6PL/A#O>];MC#?$$M_X;%->I_@O"0U^ MIZ4FNXX%<-\2^RZO@CA/H?/8*KA&^GK8]."!Y:@W?*.#;@+"/)]+C]H/HT@' MB:5&SK>/HVX0VJ#4""])?A*H6X&=O86XQF\C/_:+?,J!%THROF>1BB MJYDK67/#,+Y6QE))YM+]=YP$V0W*'S+DYM.@3U]1,$FB<>RVC%C=A/BJZQ4= M,(-6'2ILP2J)YP%9=!"\_RC5P5:8Z]-\E@9^X*)"[)+YRK2A?ASANA;LJ17W M\^,>/(HTU?U;)*:#*_=2OIK!$/WYRIU#_UZ[X;5[DYZ)'RQQ5FE@IWL/;/4X MN_N.]*'#NFE7CM&*]\"M\&6JG!U4OW])-TG%AP@)[B?IR>5,)FJL!ST'K901 M>BO:/[6J-60?;1NBR=W,/-Y;4X[#RK6!I/M\],&(0%[GT,(D!"<$+OPBKR30 MG"/>@UN.$EU\\7.";MIO9-T))O7%+]3KVT?H">R7GN;3K%\?)_'C6?=,>#+$ M WH]X-7BLPZ>T.=:0U^[>1:_T8=1>'$8NJM4OC9_O!$JQ#+MZKCO1D[1H^=Y MZ1RB(3EY?+2\5G=T+7NK.S;W5ECGZD=IN/RF;+ MQM"P+AQMP'N=P71_9;C/,BGK!^O'XRR)\G3%=J"8U&V&IIBN]&V8KO3Z-0K" M$=XZ5^'Y3 577"+B:4N++=Q!:L(FT%(3..B,V 3>WP3NVJ;,)K#))K U$GX* MEJM_9_R@=8;I/:66'-TT/5A,IS' V%]30048CC+\3Y!^\((2#N,\=2,_M;&^ M^2:[-&F7AZT[!;31/!:3S&V'??T2 %+:Q#0FX;L*X?,+,]5J!\? MAF?V(:#XN]WT/)A.G/[TX'JOK!X-MU),#BS]K20'%3]L.3GTQ\YXPD<['1L' M6ZT4DP-+?RO)@6<.9V_'76?<&]F'38DNS!@BFI 5#Q-&G/:=(0 M*.G@!3:FI%.(K#YFQ3@_SK&X-WB #\=.O4%G8CF* M+8M!]ZV$5 .OE3Z%M>NM3P-EH_V-_F3@#/I'R^C9Y7#LM)BM4CQ[ZF(QH3&A M-0=+"PEMS]WI3&AW$EI_XHS/!TQH-H+#A,98,*&U@M!XAO9 V Y'SGAP\"(E M\]DI1(0MKOIY*L%?U6;[%K[:N"5F6QWIHZ;#K%/15IIY@B+2UL VZ3VW3U5: MOU'##AC88AT=@LTS.]AB==EB'1L#MECV#+ME%HM]K,U4+C98)01JF,THWP;( M4TS/?\A\JLTY^)4CFLY7!B7(0*B\[Q3S XK6H>TQ M/=C$Z.QM1W567RZ"R$NDFTI?9+%X-IA..@,!C0V#.(+?!!XY*.9)O(3?^N/. M1-U5[TW=$$8%[LH64ES( MZ#^N2&_23"X%G1PBQ>\1*(8O+C(W@PO="$ULE 70>E^X?KS*L"E;[D_Q 0%: MK\C%:]P08Q%_RBP5UPN90-\SL7!]L0C2+$X"SPW#&S&3$H8O#OV.^+HHAPL'*33,QN1)PG0GX#7/RBNP"G)[=W4(]ZYV\_ M()1O=T@ERF"OO]H64;5*+,WN:BUOCE!!H=\H(Y# 5%_\HJ)$>TKOVI[M-2GN M]8:=[@XI/C_?^&F+_/9&Y55*=$?/]:O5?[^"T)2W(/RK) H8#R-A+OPF&%G M6'E9*4J(N@=]('&",<_GKI?E";1_E<1^[F7PZW(%PQK!)?!P)317<9@O9?E> MD-%J?N7:*/0G@YVZW.]/.I.[AV$XZHQKP]#OUH>A]GIHIRM6,D&/P;V4%7SH MWLM*--"IMW72>UXT$#ON)OK[KOE^LC;Z=I(V9Y5KTEGL]325J+&$7R$DS'%;P$&@6HQ.L&Q0@@]3V1:1YF MQD*XJU4BO<"MFJ??.Q<=X<=AZ(*=R!-P!?;6]>F=NMX]JJ+75)?N\Z47)]3] MU^!"R20,X.ZSMY]!1.!;Z/J';RL9I3*]O?=/0/G:V2#?0WO*/YYUSX0G0_3E M/6AL\5F[^-"U"Y#J(-MT+$)9&A89TX/F$GG_!Z;X.^3J\5JQ.?&/U'Z56LG M/;8"Q=QO,S3%]&=LP^RG=]XY/R"7N-W3(PSX'7T6U&8J.K:%.TA-V 2R"6P, MKKB@TUE:S3!BB%G7; 3& [PG!):K$8<"&H24,>>)C$T#YYE_FBS MH&F-J7@2M ^L[Y8 S;&+(G(DB"-!)XL=V\!3A_6YB.?K:9\-[N[7.'/#%O7W MR_<=J<8<=\(-[J\M[CES MG/TN7[*,-_C[W=AX[_"RJK M$>>I&_GI2_L*/&T)BC5G\&VM/[?'A(_K!!X?I\E^<_-VEYNW%#LNM6D'#(_# M+SSLS#!-P(D9YG2Q8X:Q P9F&&88QHD9IGG8,9"#U ^N- MD14P*#YGNK80&M80.V!@?F#I;RT,S _60L,:8@<,S \L_:V%@?G!6FA80^R M@?F!I;^U,# _6 L-:X@=,# _L/2W%@;F!VNA80UI7'F&WJ SL1N$+S*5;N(M MA!OYPI=7,HQ72WEXF1+.$^0P-6QR]<$.9.N)21C)Q0UHB=?UE$ 5IAMNLKXY]3L]W' ?3; 6R)9]C MGP-?6F[KK(!JLO?Q/.WV&/KCL3/N3H]^AHU-QY-9 \ZIGU#6>"P.BH.UXT@R M:X ;GQ\<*SNI$[JL&7"V6HP%.])-@8H=Z3T=Z=ZY,^GUF6K:HS-,->P@-P"X M\>3X#C)/_ZVV;CS&[" S5.P@?P]\P[$S/1\?G6E:KC+'V9![VT*T'^>S4(I^ MYP%=Y?ZD,QC9#-Y&C_*RSOS%Y2Q6A$ZCO9297'W$EBFRB0? @T:CT;=!;'E: M4&CO?:CBC6]0^W%83='[L_QH+#>0[G.9RO9@V]T]/- M7NDU=.:ST_6AS&<&R7_3/S/(;6/PH!?8@ND Y\Z[OUV+[_PKC]OHW?YX91^9*=AMG_."\6- M0=/L5^K_%B)=Z+O]:=YW6WOS_:]_:?4_?'JK769K_!BG9V]9Q/'L8T,))/WB MK#9 HWNTI]Z.HQL M=@X'RAO8'VYN;O4JG.M]?&[)OKU-'L=@M* ME^FC:0P:O9<5LMU=5DAC62'=:#N-G"O27'-:1DYUX!JI+OAS\>MS[03A:S,1 MS.\*UT3)=!J$,=XZ2$)45M#4!*3R>^.F ;].)B($!?0TSTI\>ZSGY.:)NQ2G M(!Z+$-XF&(DH@K' QY$([UT;Y#P?>3]O.*P;?FV\E)XK/8;W!]^O[%=T&)WY-H:VM&=E$F4'RYH$9BTCO^" M4H$UJ@8:CANK$8^MT'D -LT>G=II9S[F^;W4"X-\O7ALXW<6WCVSX"6#[2Y8 M_/QFZXT\Y^(V,?+^BT;>/*B%+QBK_)XC[""4+_X>HB<1@@<6<.$5ID9$%&M7 M/FB@T+79!ZG=Z]JU1$#]77N3?OQ6AZ''NO8EB$" /ER-;C=QH['TXR#23V*H M?/6W,+AW$2]I&^E];JU'+&)[3M#[C"'69HN67?J&+GZ[456?'4K?;QQF+SBU M[L2[(9C!CW?6"-[OO>4]6$_1F?;+@42?!HXRCDQ#[U_/FF>:+3S,3]J@3;/? MT[!=_KXPT/=6$@HUVZN]I.4J@"Q:1.&9I5]4V'FZX8Q@(%;;I,7._Y#*X(\+2% MAH?;E\ 7/%PI,V$7R"[P9'#%A4]V@35T@;71\./S7.R8X#4OQI9_M^[\B_VY M)DJ=X&@ 0Z6)SUIK2A,,!Q'_%BN=9>7_QO6U>!PDD>4[T5MRYI/E7P:M^OCP8,3#%,,8P34\PI@L<40P(&IABF&,:) M*>84P:L]Q1SF^.N])RS)(##;Z^7*35GDSDQ@MC_4J2*UXOL#@'%X_6F MZ;;>[QGTH*F9<5#U44P-K/U,#36EAI9N=-OTH*F9<5#U44P-K/U,#36E!D/O M-4N?],/&02RW=W3%B&00F.7VTC97]-+=3-.\RE!?&)BKSSZ^,9IZNUDZQ\!/F@>[) G-A'F!G9*=59\JC P-P WM <#>LC4 MS$#>X82OFK*[:5-V,6O*[HN87O*;"9O7'.H+ Q,V9OJX8H, #*4G<\P- M)^:4:J;X5&%@;L"*C6:7*S8.C0)5"V%^8.VO+PS,#S!W,'6SQ1N!#@U#!>D^ MKN8K*_S%,Q33M%^LSE"DE@9GQN;5A_K"P(Q]]K'777=\ ]M'W>V#V8&UO[XP M,#M@OJ_=9'XX- I4+83Y@;6_OC P/YQ]?--M-^DA4S,#697M^R6VAIZ 3QWW M?KL77WC/G[=YK[RIEGYDIV&V?\[+PXU!H>Q7RK?,9MPKU6@/SSC*WJ0(T]G' MAGKII?Y\^$\HK$@X6AQH/[4; PV&[F%6T/4U/#11&X7!1/NIU3"7_M+3M6GH M@HC@534KTBP-[IMXL1:,-,N?W1BO#A),,-[#8R<@.^W)%9ZCA58L&G_[!"\V:!&'L_L>* M\0YPB2.&L>:XD0VN+X8O..H3-XH2R[>%9@=1',$M/4!-C@YO,OLKW !_-YNF MH7T-8A&="+"J)/8J+8F]G)7$?A7QIA@_4U6K/0!.<]#@"O@%P0=QPM!@T+YF M)V$H?/M)G4!EV1*O.\OU(PF2%T21B'3Y,R*P_!>E+OB74$P _P3_\>/<$]Z! MI(.)ZTM$8-[5_X#1M[_CJ@2CA8O"%^[Z?F"B>!3U27X0CD91!V+ZLH M_BM5"#]+=2A^"#0@P0E*0MR[01*!*'",<(UP4B&FH@0WLO@:A=>U0E#MT4C8 M\FU IO)HL2C3^M5230>$#BG*5%G:0>BJKP)-VV/M 3_UG<2.M6$2N;Z(3D7- M4P6_M1ZW]V#9LM',AZ%2@X[T5^H(:,6R2^LUM.LDOP U]X: 9Q0%MBMU^%5TR2<0?*[XB1 *URY'=A MW"*6@Y!?M+11XGD8]>LX&,J'E184CF(;!R)7^'13O/\ITDCP5FG"AK%@?U#+\0#H&"3P%=_S6+ JV_7^./7X%Y,AL"* M8/UM*7#\(TRY1/@ -A +4,AD"!X0[@,/0?.";_U/XF.$871T[$4?!@_P>:2^ M);\/I@B8:B/+=CV)[9E&0SN/M4_"5B_4,G2\S2"5K@/>(AKK\K\:/!P$Z4D! M2D\(!)V+)F!2Z0D["QX# M28"A:T,4^F@$M\!!@B/">ZS3,ABG!\0>R[O[H-J: 1,.4.O.1P!&B#"D3*3HSPWZ"U$-/,H)<%?\;6M,G2:XROD.&G-U MWM4&S'VP[BF&BAA2R6&"VH!PO 23):"5=P'^^_VO?VGU/WS"Y]V%UD193AJ% MX=]MSX4[@3P@5K,\H,C/:N0+1A"D4M8BX#(7%!+P4880SMP^D'V42"*74Y\1 M@H+C0&U-QX(BE%J?P/-@0*#$P->>]0!?!-%)L[F)W+J*J79 MF3;A]"J[#AC"@7L@A2X)$)4*!P"D@L[2NK=<#QTH#B21GMFRD:[59T 4"N<8 MHT<5-(_@&VC^,XCL-)Y9]"0PF?&<+!+UQ1WX7OC1G4QA/IF123I>^.[,(F?4 M; TEI>)C4GW,ZPN@CY'U'<:&VLU8/@OG2NNU)QVEGDY,I=XJ_R.)PQ'26F$ MH 1/R.AQ$.;=P_M4\1SW/E,]E;G&-*C*H"JAJ4-K?CUKGFDVV"XF6N'KL]_3 MU*S\/9S]\T+)T>C-=2WJV4#&M(90:7DSRKLSQKH\EJ]7[ MO,']UY+%_==SN=(5R?/=OO*F@ZS:+Q0GOX<:R5__TC?-[H?D4&NE MN^S]SSZJ2'-%XG$>/\U#HEPR$[W3C/125_@[,"5"/?H*N* EG88(+GL\=)OC8O_ZE,RC@)%;3"^F&?)RRJ=^>-)QMX^S$L]QTMA.D"PBK M)A]RI3X?&>&/<(\0)NZ)9X6Z-G>A,)KYHZ2'5(]2]YBM"ZE)_0/FA3S,_UR79A$6WC-584*ML %M ]KIAT;3D.V6SRN MVE;ZS326'8?9"TZM._%N"-/F'^^L$;S?>\M[L)ZB,^V7 ZV0,V$Q83%AG0IA M[1_G5*Q',Z#5E)ZEYI#$[E76;2&O*E(A*O_!D@Y2IL>]FWWVHR<;#6"W:J;5)=!9IAE8N!T1J M944+PN55GBQYBTF.6:H$\]G"'ON!%V V]X7U@FSY,;L5>R522L1>B;W2(5,@ MCK@+A5H(E857P2C-IF:K6FF5Q9;)6O8RI)2"O0Q[F4-YF:RP$<*6D8>%,.E\ M*K?CP(\#"%BPC,9[TGPA'.5-L*[1MM*L*%Z;OX(]#"F%8 _#'N90'@9= _H$ M6;F738'RE2PKRO P61/BWZ*G"/%)RL1L]+?Q7IIN;,OK8['K(SE/TD'@ZZ'G0P5G6 GPT[FD+D7B%/".S'? MB3.5-6R+R5V8-:G2$LNY!\!2K5G"2Q?)&$P"9PDW5N:RG8(\WFBY5[+=;LLFAHYUAFE-[B061XI\E^>^S"[UAP M>8=CQ]FS[0DK5$,#64SAJV!$JE);EI3+/24H"KF_=L4;X>C33Z.Q%0JY+W($ M;FYQ0T8FSKD4BVG -+A6A.GE-WD-A8YL$%J8;BZ=IE@09AZ4H+5^)YKS7>M#H7PYXHK9/8# MU/!>;GE] FRCA>U":8UM)%:]:;HSQ/*B0"&81TWN#E,^13H@N4%G_FVU20DL MSQ-A&KO(173<-R,7U8MFH]Y_81O2;">0U%<CGUKRM4(18U+;XF? M;0F1VRCDIA.E--)OZ2I6G&VS4WM7'L8 .4Y*ZCJ0M5]P<@>Y#M M^FY8BT6FK^G$=$@=/^QI!%DCOC8M0/)"EAT(5O3*DI#TEV97J\&K$AH8"4;> MOYX98'\93A/7<3QQB),)6D9C\ )VF=1J@]O_8>BD7?K8(B?K *"P;!GZ&DO; M.8)[;2U' X>B_:P[2J*VS$,5*.8@RM#,.,BD0$&#.6PHW97W*UM&D#4V?T1 M.\\R34H<1/Q[Z.GZ1B[_!4ED^4[TMFR.88=GT+1W(7PR9SM0/?QD W:IU1D< M1''J5X'329]@0Q2XNIUA0Q4&IA>F%\:)Z>7$@&-ZH0$#TPO3"^/$]')BP#&] ME$M2[FPU8%=)2C((?!7IR2.XX<-UU$E;;Q(\U,?U2Z\ K%[&'XBAT#MJ?I-IZF;9H<<,'4S#2Y:9TZH MI>(S)Y"#Y$U'[S77[9YERV!*.%6),R60@($I@1PD;XRV;O9:Y("IFVF\/>GR M/?K9O"MYCF8UV3Q>?>/E!8:!N;IJ7%JFWFHUR>'"YD$#!B8'UO[:PE![[[/K6[[-57O$+(&& MV&OOD$C 4'NZ;IEZ<\!+&@:AY,#FP]M<7AMJ30T_O==KD8&'KH $#YBT=[;/EW0@NM M6&B!GQ[W[@4/!RO[>_U)IJ=M1%06+38YMZKF_HX$5/V*H#KID,'L'&QAD.2Q M8V2 .?93M1D+YB*&BKEHF[UH9J?TYF0F(Y([EIF':N#.!BKFH4W*)=NE M%]B8AHXAL?K:3/=SB54G2(:>T,Q&?6@)3S]Q?3L45B2T-XY0/[V%SV1655>Y M5?%GX@(\,/Q(LWQ'"T44AZX="T?^_5"K%L]$$DNC*WB9'ICT'7BU#$)+= M5O8#XTF')T9;;W=Z!_:7FSO+6MG<8?TG M]>=MU"X_G-*/[#3,]L]YH;@Q:)K]2O7?0J07F-']79UOKC MW6C-/H$WT.*QT)Z$%4::\/%,[D_"%I.A"-636X:NF4UC(/_;E[> 'WHZ)J:G M I\MO"==FX8N $"U9Q$:'$@[^K#J+T@BF!H3A+B8/%3&+D;.!&6%_]D-%OS M\<%HVX/YX-5P6]W\!?F'-K1;N-O+4LF_X[.O*.5GR=IG=30Y0#-+V,/=+=L& M9Q1', I;N/=H%/(ES*4Q+WUM&HJIY3HJG1_ 2$+- IG$2@*M^9=3K-5_X=W@ MZZKZ&I 5(3YK!%^3 Y.B73FVJ?4D!R8'8MMA J_BN=;0]90T\)G+.O$0HI=S M@@7+[$SO6G/<5'7:=DJ%MXJTYNG M5++]"K0&K+^[N=:TM]&:5N%E5IO!4RKCYJX4I5=4E$68I%*T&VWUK6S,6X#W M"@#,;L-8>.Y+*'0W%.MOJ-EJ+4DLEM-KP M0_64W2F_4(D]-M0L >/_=:%=@>-0>?]VW,Q:*KI&X:B MJUK @__P(S="]S4/!,&D,O--V2&*)P#-S$1UM&,OP4F:-DU"N!@M&BUT8L40 M+V:\$XW!=;\#79SD[H).#:ZBT69DSQR8V-O_)Y M/0-H\[CZ06AC:_-Q #5L>BD*Q!8"0L]1&$SD4"++6Y3Q4^:44[$JI]R:SQ'T MG-^=2UO&M:FT\6XSZ:371ZSC:6]/(#^#%ND\TVPV/A11]/KX87'KCV6 G]^@USVQ=]C6V7UI/>@IYL+"TB M^M1OM'>F3AO?>*9V6[SQH=6SW6AMK9YKHM(C"XUD2/(M#.Y=1TUXYNTFMT^- MR9M-A=J5)C+;-AK$Q]K2?GE7DM.?M1DP?XULS^W"A*,+"1D4\PF01^ M.L>"KXG)U N>1#HO:75R4WS0*_Q>G-U=/(K0=M5T*OM:>J-@BNR99I)@VK/T MYTQ#M2D$6'G>!D)>>G'K47MPX_$X\##\PAFDZ^#^_J$86]XH_V@UD47/%(TM MF(7!+6-/R$ HSZ];P-";IP8V0:&_*Q0&N7!B1R"4%9%AY!1D QGU=B6CA634 M/H2T&*T]X^?Z&\^M4S\U!%U_G=?;QL7!QR&@FEB>=CWTW#MK+H\+D+BKF/:9 M%^QNX\3P&)^4%#VK^EWW_ 5S3.$A@&'*Q#M33BM/O2KXVFZ;9 MJ(PV#W7XFO8/"^P&#;XC8T:9@9(S>[!(*TMOWX5"^F2HY+["M6&4+O@OG(0A 82&4U+4+,!>XH^]:ZL;I M0@Z@ 4+S$5/XRO\DOI#C4X&1[Z2?_\-ZDACHDG;@$W!V +;E^V@A4^MI%G@N M#CB?>-6SO)]<20KP;^UZ /^L_+W'+^;=FY&T]#,7'1 M/!)0/>7\@]"]DZ^D'OH&/[M\!"<9X=M_2[_P]D7Q_F3DEP<+ ATL3["+?XRVI523 .SK/ZA6,:S(-0BM\2E6E8"%]W>@9"]JUWCJ5%>)@Y+*?_!G!Y3W\A"PI3FQP;INSH(T' <^>Y M28QEY1TE5'"%++Z1;BJ=.@":-S%\H.XC)3"W1]='WRJIZ00XX#RY2T#G :;V M2E]EV;CL\Y33HF5RG.M$,+^=0KX-^(9!$4447%S5,!2C'_LGF%]QAE M+8;$"_JOI)33?PB"%E89A 47IYKMP[ @Y+C/"J96JG_AH0O+[Q"EPQ_]0IS^ MPJ":N:*MV5.!>T&?9/"6/K]P[V-'=ZWRHZ'9N4EV?O89"B_S:"@FT'(CC1Y0 MN O1<&L^O9!&(=&6T6YJ'@O@S;XJ%S33Z@>Y##F;OLY7JXQ>>^GFZI9& 9,3 M*RHPZU!4\_I_@#Y^\)8WUM)''Q(=PC8H%;6-!+OLQ\^:.DN@F8S/4.@T%9E M3_UOVN8K&GZMY9S7;&4XWLU?A^_ MA- "NL?ZS:;]#?9;%(I-# 2]!>_GAG] MLQE.$]=Q/'&(EE^=3J/9WJSM5VUP^Z;"794%Q?(OF5)<8V([AVZOIR30 &#S M3EZUI1RJ0#'Y4(9F1C[F&8%VDX-&T]Q^D6\RSS8B1X[K :N)K;4NB][3'+P ML,<\,>S88QX[K&WTF!WVF$3A88]Y8MBQQSQV6/\1A&)YHMZ93]39B]*#C,HA MYFOM,%VQJXWX29P?9NQ&YJ\2\:Y+;5;6HS;P M[9T4R'295M7^:5O$?)^Q?!EP5L%/KM/X_NCC&$LU=]FGGUOL'[;%OIPTUKQ! M?J^G-\W2)WRS=9RXDV)N8.UG;J@G-[3TIG&PPU/8-HB[*&8&UGYFAGHR@]%K MZ\TF<\.A<:#JI)@;6/N9&^K)#7_]2]\T3+:.P^- TTDQ-[#V,SF#MKRT,3 ]G'XVFWFH9Y*!A"Z$! _,#:W]M M86!^ 'XP=+-\#1E;R&E;"/,#:W]]86!^./MHZJT!T\.A4:#27:""$R%."99O MV;F;%9005 /-:PZ$."5DZ!8 ;M+]K.:^C014_85F=J]"ZZ0#!&.@-UOF@;T> MK39U9+ YK&DQ(]'!@AGI^*%B1MKP,&J]WRQ=$<&$=+J6Q81$!PLFI..'B@EI M,_@ZNFDP(9&$A@F)L6!".A6HF) V):0F$Q)-:)B0& LFI%.!B@GI*%I2,"4= M0Y^*YXI/G" 9>D(S&Q6RD]%J]&@CJ_=8SJCB W3&6/!=,9TQG2V.9WU!WJG<[!V5LQG='TH\QD=+)C/F,^8 MSS:;GIF<;:2)#=,98\%TQG3&='8F2*RS#PG*VMK2R UZ/1N]\LS_)MH=V, MA8BU\Q"^>"A.>"._2#6QM:]T"S_20N%I_KIC-UII#VX\5A+?!M^1\]MQ<+1@O#. M\MW_J*O@-VWD^B ^U_(T< "Q+T+Y75V+$GNL61'(+DSL. GAN^I2@=^*ID)] M)PFG020TD)@;NR">>&S%VD.0>(X:U5 (7Q,1VI,;C?$F\.UX+&;?#$;:R+)= MSXUA3/X=_#YZ-TPAC22D5@Y2?'8 7P\U>"N0(XS,\KPGS8>+@@?\J^=.7'S1 M]/Y10_L,G[H^REN^-0CIS@K13VH(]<1W1ZZM_I)K2*3#92-X3!QH7X-8:#U= M^QLX13_3I1RT,'+/M0&QBV "SU;CM'Q'NX!KX#$"Q"M &?'K'W5\8;QCA+=& M05SDX?D\0^,&Y)&^,^+H^MHWP$>[NM*U*_B#TH8^W@W^&&GGO@^2T+Z+:1#& MC6C9^D MN@13$0+F:'1X<2BA1![2(B64XX55@7W'+O C7&.-1L+&@0R? M-'N,1"7'@)X=/#]8M*=YXEYXZ*E_;]PTED;7T&['<\<0#/\MT"5(6@P2Y*U[ MN%1ZQ-17(,FZDCRF),_)$,KR868 7_TRP-7?$(6#I 8&PK&FOBS\2%6=R,[/-/EE_!MQ#@VN$+ MD;"34$$'OXU!+)H- 94;:W\":8,^-;1S^:=G8KVQY:@'X\,*(X#O_M3M--KJ MBP 1#-77,4B*W"B-J^9?GX"HGS)E1W6!]\7/HS&\YCM0S\G"Z^#-C9[YPMTM M#'2 VP)Y.X!E(L(TK@0]5,,.(":3MN0'4O?_-1>R*(BP.,HTN@3SD6'O2#AH M7Q#^N7XD(U0'Q RC0>-[$E8(8:D#GZZ6JAS16'BI-.&!H(:@LKXVM/P?\JVM MZ30,0--@Q/"0GPRS86CIVVLPD#7W58,$%E\Y1H!::I.,-Y>-/(+7!1&"KTFD M*J*N+SHAZ9J4+#'&'L&M<>B@!PE8PR@3UY(+!#,)\=3.AO;?P0-H>ZC#0VPK MB41A .AZE3L".U_4"!2O]"=2(8?"DX8C7Q?ODG>D*P;M*H'DC%#B[P3R8X%? MP*\%"Z.1LX70DM%Z.NU(<(IS/YM *.N3(1;>)T'*P*D0B!VL0UXYG^( !C"= M4;>6;L0'K4U%4!AP]CZ(V/AIBM..&,;M:<;/J:=?03:I!N((9&@.XX2!!*"[ MTEW[R!1J>C2;N*%E6QHJ62C'.)F"J]=0/1(YS9G/#N8O$LUF![L*"O<0N'Q. M[>TB"4/I.RX?4[D>?Q #S(*8Z2EWY*P]!*/Q$Y$+^5%A0-D@O!#*_L!<423( MXG'D.D+JT>^^C('DO% I/5X*;QL N4GUR+DP6XG4S5V9\P1,#)0&HG4G\. 277Y\F82!'$KN5?X77MP! MXIYBPA-@%J$'GX"Y.4"-,#9TFWHANGMA=-*#*M>62",/A1V RX%@02*'812 M<0>4HV3C!5&DAH_HS Q+PC4/H)"@+62U*8">_E7F(=((Y$T*X%OI&V?/!#-' M\EH>^$>^K; J=,M .>MM,&$NP;?1Z MN<32+.Y6.11PFOZ3W!#;^Q!)H:-<,2A?)/'>SS+J4[;Y(.;$(?P[&)TT(G3> M!, #?+JU;M2_KM]+W&X?9"TY! M5N^&$%/\>&>-X/W>6]Z#]12=:;\0REVOIHD#"K*8Q#C,.&3,XEO*Q^:\G'87 M!@_2+![ .\@4J^LK>L#P,<*4%:J[-"F8.,UBJ"SHQK@I2K/0^%%Q;CZS)S7[ M?3GW9G=>^@;#6)NA?3LXC M'J,D3&.!^2I#L")2D>^G5.*(P_9_J"GF]VPFFOX^3T,>??!^Y6O_D_@"8XZN M=(=N%"6@ #(+TIF':'=WN)84RPDS*,84-,.:H%ZA#AF-7N=GM$:(>V)7I?%] M%[1%YCYDV&TV32/-;ZO_8BYP9+EA.I]/9PQK[P%3ZF<3!?I"0E-..*2>CL#+ M!.$L]$?/G7_&2%BXX/?"R):_M3 RR1]I_E/F/E3^0:YMR#>:3 *TV\#^H=SA M[!(5E"]]WQ$O?A\N\7!1998-*0Q_)I]<0EB]33:%43&E?+,M4!@F<>;^,P>> M+*RK!I&KLB8RT33R@@>YCKG:O^/F]V_?OLB?S[_G5R+[FRY$SNZJ MS>\J%R3S=_X_[=/Y[7D5*X\'-P#)#($'7@VCJ1>C3WV6!<)_!<*8"BD1N/+.Q602W/I; I[2SD=[GUTP/DR' MC5P/DQ*8U<%TUH:%%"BW&\0ABEJ*/N,0HT@M*',Z),8$5K>5 MZ3[O,>M1EKGQ(\E40-_*>/9YC9O5.\O!GGW,]/2WP H=N38.8:2:MB EW&#H M/X8OBC!:HHPC1.I0CWP^?5!:?[:IX)VZOBI%5!/Q*Y2P]6549!IX6 MP(0F=[GR;N GCA6+FOJ&K#[22APW6\ZQ;%O%=^CV%]S&XK#//N;#S=1A+,Y1 M"\YAQ=T*/N?91\IBGUAF7B+7<;'*)]J(4TL][0W* \-W,ADR M*JZ2/7/;PK.S]<)GQZ"_ZO66P_V%&<)\7K"4!E$E+I-I*,98=@<*@NMYTHGV=Y]L5P)BUP'2.=5<3C4*@5R-ERMDJSKUN0U#%MY27. M;/UC84KS!I[G96NPJIX\5!6+EISO9+BF@EK0Y>>&O7)>E6E%8QNPYK?<1!>S M*KR"O::*^5]IQ21Z:3OOI>?C#3,OO4YY=3!?+.$!.K!#5Y;$+&P? %C6ON S MY)56R>;YXYVDE+M0)5I":R(>@O#'-L;SO.'"V[3>5G:[- ,]?,H$/G'C6,BT MX,T4%4>6'5TO[NY06GT+LSD')G'J6U&$J>LW%]U"*UWL%*@*FUE M%*-GN=;5=KRQRUQEWXO^8QCO)(L+0&)]#2;O)R07DJF MK.632BA3LLPFK@GXID@=LTPY,.]&XUFBDDV_EF..5Y/##J(!7$ /9,H7V4[N M[[+F$^1T%^%$U[*RN[ _:<>?I-+E[PW^%Z>I6[^R+)KVBN<_1:N_6)6KY$O M%LA,[%AE2?:153/S>227'),H4AY"KM&U<\O=+RU3Y%V>6B!69 1C]^7*6[8' M*,Y\L.(,3ZUBP]_1=[&=5Y6-VDW^Z3RYG@.!^_Z=T'Z-XQ(E,E 6;LU3P\AKOMKA5./>2>26_=*YC%KY" M3/U\9D=F5=3&.%RDMK2I6@;+1?DC7,$.YPMEB),!>&CH MR/3K;%QRUVNZ#RZ_%=*S'J+9\CYH#PQ>[A\($R^M H.W3+S%9,;-_/MXQ6S' M4"ZWD=U2OM0+%<;L8C=+T8.*.XG<;K&A"FMN*OC5.@&VY3N@BC-<%5C:[1A[ M@LS_FFIBMO%3FWJ6 ABFWCANI3OJB:"-P5#NU\5:P<"7RH2;?T/Y;&N(FX$? MQD(63N'W#NE0L (E5/F[V>09%3B[1)^--"T(%&&(O4_ P83POFGI77I)F;DV M;E!=V'N[>B*_E")D(RIK1$A_J:*F*G] ]9OQ?VI&*GL4V,))0E6&F.[VF&_J M6*>HAW^;C4QES8NB6U%!B:/8#-V/?.&&=H,=D'(7SX0F'D&#?!F_(=UH,185 M#W$BH6OBW@75LT6NRY!T41,U0<2AS"MA9XG$PPE/Q66I8EHJ]9>])E;QIAMY MTD798J(QW6_M+.QC 7G(_7;H81R!::]Y7*YCEN]!@*^!?Y<>@NHF/)<&GCA&VF"](J\[NME KGMH\_".N'G"Z(1X@0 MTW++$R]C[!Q1&>.+CR3#6,]8W %'AR4IS;6Y-A">CG5(L61\S1?V'!GW(N6.GW;#>UD@I[ 3GNA M%%IJI(^&VR*M@)GG(MOA+'.56ZEY:4YBW!F"1['2;!MVVERU MZ)JF2R#HFEKA+.9:.6^0:^*/Z0O,MG&MR/NL6']>&3]B9XE72$AYXRB-VZ?I M3EX5\"]%^6_):U0@XF- MD!M28V%G$DS\;&!2)G\F;K;A$V9'.GXK!W]A9*G6I]H@Y6;GVIS,(WL5R62! MRC8[^]DYKU[[RUJ@R;(B4#C<@@::Y,W96-_"&V'C(=P$G"J,Q%VJR4*^!%T> M1)(Z.JA_"WNFR6@&63RKM&0Q5.X*SSPU)3I\4983K:K*&<[%$$8W;$ MGPGN#A_.7SW7OPFSO&[ZWG*YS(K3P/HNS56BUF)OIWPN=^9V@X4 &!^,[P^# M16=YXKIY8MLR+G"-!3L]G3PW'GM5$S^(/B/G2DGR5T\[*=!0CSY*P*H46BCG5QJ_8L%:-/-)8 MY2UVPPR\>[7PIHFT[[YJN^=YPK^3><&4!H KI..67EH\:O].G+N4=FE M#+-2.6"N$0C5J]/R5%-.24Y809[+-&1QR"'S_K'U0_AJ#_?#./#$K"&%I3K$ MZK(I\_RMTTG1:IN09J"GDRLY,=(B%2B+Y7=>?0/,Q/CY5'E1T8)YS5BJETR+ MU.M KWR,Y@*80OUS%IV]P\(#V< ?].UZ"#H.@8XVN_)8!4SVD;LH#A41F/%P M7ARZV08!4T+>W:*.U$VUPDV;N\J_.5H:6H//0=>!D74DIPS8NA)FI![,Q$9EM17+#G>6)65O4T%$9 MIGLWREJ!BKE>!YE>S^__,$9_B]W_8+Z/0?U-N%UYNO M'19&+9VYRJ>GZ[A8DY*F(^2<),VLJ^9.4\^R@1+L) )]Q-5A 9KEZ-K8C1 . M]-_ROOKL3FIHD8T+N&D:0]AC'U3A3E[N^GYPGVL(NWJS0AS$\MHY[+)C^4\# M8][>M5%8DF.#?2F4G3=9R[0@UQ(1(Q,YVY3-D%U)Q%:\9MD_WZ!RKMSW.??^ MO!G(6'EU$&#)8B7$&X/9_*)X%HPM+H?+>H54Y57-Y[-/GAEK?N>I+(FRO"=< M#\*$WI+=8/#GJE*#)/0U3_F$_-#D&X 0LR'F DIYV(5,WXU&6!**[2O7U8S( M.HCYJ\U26W.35C58!<-6YR<4"@ZD7&<%%6H1'1OH'[$>_VT8:K]\/'><,+>. MGZK.+-)?+>"E!<\EZ:CLC9\F)65N)KN'#-K3RHKE0/;%7J$X<<#4^HHRF&PE M=F6E\BS_])*M9XE MXULH0M"QK P-' D'I\.I0:YPP=DRHHS%E#N>F>[VAK?LJ.T8U!^Y)$$1;]$O^#&6EL\8/YU'(!9 M7018P15I7[Y\.^(7NP&F^9\ UX O(!"!RWW7.N+7^2R&88*U!&8'Y[IF\PC5 MG,SB3-;W2A[AYV0=@9;WO&4S,Y@KV"_DVLUFLS]O_I-,%V(<^1[]SL\?L$?V MN[%Z#<,$@7JT_GMY:<_?CO_B:? M%LK_.ICN '1_/5,O.KOKT+)_W(5X^MF[V7H#_M^'= 3O/#&*I1RR#[Y+B)N- M7B?WX2T*:_&CW^8258/J]AK]=%2;2S_]=3:*13CP@P/Z[SF\?_LE=L@(VFAT M=B'H%7&+$JVQE$[!2',8NOL1-XP*XXU?S\RSF>@GKN-XXB"B;S4ZRZ(OX5LW MU/KU[11S$==&N:Z2B!2.GUUC"P<$Y.YAGV7\2A8?]%'#75*9W]%[DX&=?&UHO^XO/G MYN>+(TO=OB#]/:P@G,M]SV7I8V="WU_:Y!BSY[L3^YP+4*@KB6 ?KHEQ>@$G M,T_;Y:'*T7B(8ZF"Q1D[$EDPAH$9AJ+8F6&. R=FF./%KO8,4VX*>6S5/V0 MN$C[DUBOFDR>P!H\%?VG(?;:NR$:,$@F9Z*F" U;" D8F!]8^^L+ _,#66AJ M;R&GMA9HM!H]VAA@@P8W_\ MF_N(?_\_*)Z\9J[-*7). #(,'(20"$(ZRT'(^;WE>M@!Z',0 MWD!P<"/L))3M\C^)83S_+2TGV=74V^B9>ML<5!:/L/6?N/4S]['VUQ<&YKX2 MW-?=*?>5GXJ;1DLW^P9S'S45XZ7OPV-PGIT;)P].OD=KU>6!4'@^K.<%#[*) M*/;P=X)D&(\2+W?4W$C[:6LWT2^&R-ECP$U\2A^2#>O[;%3E ^2Y)^@->BN] MP GCJVQ,_5>6.)1 K.C8JT-LI5N?(]8WVP7$\!RSPAE8\MWP?CIH,AY9B2?# M>$_T\JT<6'.:N[XP<&!=(K#N%?QOP==^%?&.,TA]4^^WN'B#G#I1M73F.=;^ M^L+ /%>"Y_K5\5SY;%&_J7<[7+A!3IVX<./P&%S-#YBFESSE@(-SUO6%@0.. M$@''8#G@R!S<$\09NYI(#PR]T^-*#'+J0]6RF==8^^L+ _/:]KS6;I;GM?(3 MYX&I-UL=YC5JZD.ERN+U)_*)P*/X(GXQ)V$(]%J-F5-)>K M!K'7''1QVG9$)0^XR5$6-7=Y-* R-SUXA .>[0(>8SG@27WKI7*MY[YSC7Y5 M'?RPXX7R@=YO][#5:'=H@W :QY5644N!ECA/+K_/1-,>!$Q]-LXNXIM ? M<2\9@K9IZLV.R4LEU!2(JO$S-S(W,D[,C7OEQD(_Q;W,[N$6>K_#Y7'D%(A* M&<'NIO+$ ?@6!E,1QD^R3 #/*)ABVT39K(%>)I8C%MX35%\8N&BQ1+Q1Z N3 M.;QO'MSZW'"YPK=M,KS7/EI MMF'J_2:=572V]-HLF!,'X!I,T8KAU35/6)'@Y7(J=D!#[+5W1S1@X,"C1.!1 M:",W\W5?T-5)-*Y'OT=")OIW-<,V#;U381\Y-O43-W4F.M;^^L+ 1 ?0]$W# M)(A-[4V$%X#W.S656\,/NR6<>9J8V&OOA&C P#Q=8D):Z/>:VT3V-?#M'1^) MU]);A#9JLXD3-W$F.-;^^L+ !%>"X K]14L0W"N.H-?[G2;S&S4UHK+$N^=^ M;,11^2ZB.'3M6#B:;47C0V6;N"7,,61EN27,T4#%+6%V$]MT"CUFYQ[T ASH MN2__P5HVT )XX=?-Z'/MU2H\G*4B;\W-7PBZ!&92.E@PDYX 5,RD.V+20O/2 MJICTA;.5NTUFTN/0*2I+[\^D#/!T>$]HX"2JX]2CZ:U&MDW[+E Y.ENADN5\ ML4/)<^#5,A3ZB1Z,F_6:J01)#I,6PJ1"#UJUCK*S)FW=@=YM5W>>S:X:S:YU M\;7R%&0;N3,#DW'=S,#,P,S KV#@-=U2=]8*KMO2#8-.,Q9FX&,H:]CW]H"\ M'(>!Y[P2D;+B_^):0]=S8S<]1RZ* _O'&,8CPDCNH.E]D$WCXB=ZF66NK"30 MWI9C':HX%0(>#F:.!KO:US;2@($9AAF&<6*&.4'L:L\PO M]KP"D_?\U;S[A MI)K*&GJ"7XF"VYLP2X5(G[OY)JDJI>&YEZN"^*?^VX\.=C:[>;%?7 M5HS-^\2]+),;:S^3&Y/;9N16."2Q#+F5+\DU6WJG6=V> O8O-HNJNB1S&/ M#A/A\,(H*3N@(?;:NR,:,'#(42+D*)Q7F3JZW(Z#'4^I.TU]P(. MS!U'Z= C=QQEJ+CCZ*ZBG=4';^UO0M_2.X,>F54$[CU*USDPI]+!@CGU!*!B M3MT1IZX^ZZN2_$&NN,P8,&T>A0*=_HK\T73GKC!%P&L6)Y8LWZ"39,W=%@V< M-FOZR3'+5C%+MW"&U_Y2 +VFWC4,7NZ@ID14'0#S(_,CX\3\N%=^+)S,M;]R M@*ZIMXTV\R,U):)2#K"[>3UQ +X$\-:Q""=@5<.87H*5 Q7>\%-?&+CXL$28 M43C9"GW<+;BX3^#A7G5L]H8[UIMZJUE=Z2$;^8D;.5,<:W]]86"**T%QA:.C MRE!<^=FTT3'UUJ"ZZ30;.;'I--UEAD:39WXN;.9,?:7U\8 MF.P^R@-<38+8U-Y$:K$7G#@J:B.X-YO(\E9P8@!1S>3RMK6C@8JWK>UH5EQH M*+N\;6T/Z\_ZH,6[P8]#P7@W.&/!M'HR4#&M[HA6"TU3R]+J*WJUZWV33JMV MIM5C6 ;?H5$74MH;_(IA,W'@B\!!WRW>D48(@A&^#C6IOO@:QT+IOZ66?N:[QP.LS MW-.',D[#> 9>W,_>]%TD['?NX[NQZ\!0WZ_X.C1E5>V,Z M8CIBG)B.=DI'O2;3$2W,J*R]UW;Z>A,']H]QX(%?B>1.E]X'3?R9N/$3O3PD MQPB\SZB^,/!6/++0L(60@('Y@;6_OC P/Y"%IO86BYT=@*LRO\18?"R6]C<<;A2%]!H MZN0U@CE X"\W=B+T%ELX8AEZ"NK!$4'JT6V>GS0&GIPFEIPMK*P5-J"0W_6J=-9J%1'IAI-5E>I>' M"]+OM-MZJ[N)(T&$2KQ?8=&H%!);VV.)D186"H4U\!P9R[E3B8YE\U8H M+9-,%Q0V7^+FR^3%VE]?&)B\2I!7H1IJ._):V>(K1UZK,DS4]*;VYLN5\?O& MX!Q>':W!\K2IY3HP2,VVIFYL>?36XCBHX"70^L+ 046)H**P_#GW=]_ W5WY M%\K9Y6*-777U[II=O;UR]9&:IK'!DX"!Z8ZUO[XP,-V5H+M"'>_]$ P8.2#Z^V3XB*=3"YER?/(CT(N_XKGSP@^(+>+^O(KX>W5J/ M95:LI::\6\C^&W1.\&!#3[6I]#$0S' GYEIKIOA486"&*\-PA?T3E3+,7-N-#WQ*/1_L23I+_3PV?&@( M(:@6#@UY%5H< 2U&0(5]@]]%;+F^<"ZMT WF0.]U M^V26'_C(RBZKH,IF0X63,EUP)(I^5"4 M7.@KMRTEE]^Y8+8[>KM/IV"0*?D8F@@\D]EP@F3H"0V<26W(664U/-<:NIX; MN]BVU7=VD.78X?I/#5&CNJBP/0C"6BJ;*(9"W\/7<7/Y MO$>[V](-8U4O?>;FYQ1-*5.F2\^IW3[2'K_$%D@'/G7<^^U>?N%=?][&B/+# M66/I-MQ5A"^;>OE!5)["& O-LK$O@^4_@6K"7V+,8X3PL:^Y\#IWH>R:&,9: M,-+BL8@$6J9TG'('R[$NV$HK!_OK!&\WWO+>[">HC/M%[*BWVX0J?B&0 M;B[ZL MG+^*^S#0+H)P6M#AXWTK2<07UU]OKK]L:23>9S]\T-(XI=E,6P<4%A[V%"EU MS4:S7;8RH(0VOAPLU7>^G.4NVB8I0 H>8UTXV]\DG*T4&A@)'@'[ZYD!]I?A M-'$=QQ.'F!"W.IMN9*@-;/\GK##2+F%"I MP(HK0.P!V0/6V 38LYTDK.#9>@?W;)1*\&G 0O\X 96=.-UJHN_B7OB)H+=[ M2O+2Z10)^'_GY>,&X"G&ZPK@6X.F;G:J*X#G=LPG[LV91)E$ M">#$)'J,J&U/HH5J],I)M)^1:/E*]5:_IYO] 9,H-7VCZLV91)E$">#$)'J, MJ&U/HH53YRLGT5Y&HKWR)&IV]6ZOS21*3=^(=;1Y37'?*<%R$41RHU?XNG3[ MX Y M.\^Z&Z:A#YKTV\YP2[_#>PHF6#I8,,$>/U1,L#LBV%Y5!%M!1MXP6OJ@RP1[ M'+K&!,M8,,&>"E1,L#LBV'Y5!%M!MG[0UP=]@_GU*%2M!C7Q1JO1HPW"W\,@ MBK1I&(SK D0U:00S=[+;UE.3TBZ@*8(9DA&2=FR+TR M9.&H](T9LH(DN&GV].Z SLFLS)#$2M9WF/ FCD!Z_(!_IXG'J? C$9%;I^1X MY5 K^37W121@D.%(O:,-HLBP@=" @>F!M;^V,# ]4$6P&#$P/K/VUA8'I M@2HR;" G5]M*'('O(A)6:(_E49N.N!=>,,5C2.EEP9FR>?&AMC P99=87C2+ MG;.4LSOWG4]S5W>IUCAV7K3:&>CRU E>;Z2E6$1-G@F/M;^^,##AE2"\%8<6 ME":\"FI0VWV]W>'&RN04BZC),^&Q]M<7!B:\$H2WXH"!TH1711?DGM[I\JY$ MSVR/1.^HU)?O._%/OZ'R;1!;GA94UFBB&H0X,"*]1KY)MRR. MG(X#R\TZ:G%H57UH53B)8M;N)PVBHMVO#W3;>M^D4QK(411=#\+,3 <+9N8: M8,G,?"AF+IRIL"4S5["8T#(Z>K-+9Y<:,S-=#\+,3 <+9N8:8,G,?"!F-@MG M.6S)S%6L/'1ZNMFK;N6!F?D85AX(-[&FO\CP!0]M'(7!)%MH"'SN9'UX2Z A M=CYYXRAPXI,W7H;NS?8!3>'HC5E <^7;P42@ZWS-,D DU>;=I@=2=_5VK[KE M .[/5Y%BO:6' +,ELR7CQ&RY5[8L=)+;FBV?3\UOQY9M0^^UJSNXBMF2V?)( M)4[4"S-;'@=.S)8[8DIUMO#E^7O,#E.7/A7 M8'NAB&+-E19);J63 Q=N#%9?&+@78(DE^D(OP"O_'CP<]O]384?F\W9>W=[5 MFR9W 22G4D2-G:F.M;^^,##5E:"Z0MNWJ8^VO M+PQ,=26HKM!TK1S55='<73>Z;:8Z:BI5@T)KX@C,BM@L0QT%N[R?1&3I>8WMBOUE+QB<+ ]%:&W@J-M+:BMPJ2Q0-]T*33))R- MG&N.#R_\ZW@LPK3@6'N3)HO?ZIHO8GJK*!QT\.)5;6'@H*-$T-$J]@A#A_2\TXYKWX/H)#K M)X#(]:Q%_F_2F:KK;M&57C["\ 8U[?"IZM83"*(@S#>"0-Y*'<5G36VG/DW M3;W9KRX>XA7V0\_]F79/RYTS[1X'3DR[.Z'=%=VH#D2[E7:>[NOM%K,N.05E MUF5OSJQ[1#@QZ^Z$=5-]G)&]"AL.G.A M1 XO0JLDXZ=M@^=5C1:2T.BM,+A M-^&+D;O[[MF&WAE4=UP'GW)]NDZ"N94.%LRMQP\5<^N.N'5%,[$2W/I"(G]& MH+UNG^GS*#2)Z9.Q8/H\%:B8/G=$GRN:E96@STIJ\-M-YM;C4+,:%.8;K4:/ M-@A?1:QY0<2U^(?7?AIBY_*$H\")RQ-V4IY0:$L'_G'3([&KK9YOZ=U^ERL* MJ.D4U_&Q V:B/"*9+]+_/D$>'$ M/+D3GBQT9MN")RNM4._JW4YUF7'FR=.I4-]A_INX\%6_R&3 MX>_)K5QR\,*]LNH+ [?'HXH,&P@-&)@>6/MK"P/3 U5DV$!HP,#TP-I?6QB8 M'J@BPP;"%:][!^%B;/EW\$!7MJ" ^_J:G82A\.TG58OMR;8SFN7\.XGB";P MO20Y\SFO3=06!N;S[7?HM%7<=V[G_O%\ MYAZ_BOAZ=&L]?@M"^8LF7-$S\4@,)_A*/=6:X?:6^P:E9$;S5P M(-$8C/==+,()7'HOE&%'NN:+THET[J-%AXRYCQ9#Q7VT=I2E+YR.L2ZT.K^W M7 _#(AA$!+',C;"3T(U=$1T@+]\RJMN RRVW3M>?, W3P8)I^/BA8AK>$0T7 M3EHX* UOVE7:;)I,PT>AD4S#C 73\*E Q32\JY6&PJD,!^7AK=<6S&:;"?DH M=+."!8?7+O[P.9&%OM2V7'' !8=@3:..0ZW4<0AU!*O[FW0>XQCK.+#EAQZW>I"JXK(@$,K@@Z%B9H.%DS4-<"2B?I01%TX MNF*G1+WIHH31I=.N\"&N+40+1\H$50M@%?+ MH.HG:RZQ7F/,[ZV&H0:@;- 13)#M%,Q4S%IXDE M4S%3\4HJ+C1;?!45KU^6R%.QT3B"XDJF8J9B,C P%9\.EDS%3,4KJ;C05.,=9%EH85HQESGBKB^2MZZ'LDH\SJ)HQA\-H!8T3),\[DJEX^MIMYOMO1^ MC^M;CD,!R3;N9MZFXNN9MT\'2^;M@_%VH>WD+GA[_9K-B[S=[!CZH&LP;Q^% M C)O,Q;,V[7!DGG[8+Q=Z$*Y"]Y>O\#S/&^; [UMMH&[Z9_+08VWE9)E.O:< M.N[4O:2+/[_(_F?PJ>/>;_?R"^_Z\S;&E1_.&@]@PUU%^+(+*#^(JB5\.Q:: M9>.BA>4_@6K"7V)X/JB:9OF:"Z]S%UJ>!KH7X]I./!:10-.4N_(L7-88N;[E MVRY'D/\]-T@ZVM@?I.\W#K,7G )G MO!N&POKQSAK!^[VWO ?K"3CG%[*BWVX0J?B&@>=L+?KRF\+NPT"[",)IP5*/ M^*TN\F[I9N:,T&_=Q(']8PR#$6'TU[_T3:/W0;O\,W'CIQ-Z_S>N#PXZ2"*( MJ")=$X^V@-A!QF@:",5Z6XF_DH/M%NTB96))S&DL(\,Q6W@>1BM +K/?TSA( M_KXPEO=6$@; M:M/+T=GQ3OAV)OQF8]!=EGT%DBZ8\KK N+=)8'QB,H<-0: U9]=/8>BU!AM7"$(#LU1H@:H=Y1 & M@N(J_+;'@==[?45V5HH.SE!U9IY#.[12AL(>CSW><<)Z/@%H8O9X-?1X=1(P M94?%?@@K6ZRI>\ R2DX.L,,B)6!V6,11^R1&KNT>/G)BAT778?&4D1W;T:%V MY=O!1&AOO@11=.ASO'EBR&Z+!A#LMHBC-F])S/Z*V*)QO-/3I=<:R/X79ZJ="#PMC]6J=MHN'[-T]?7S\P;$^UK;U1[7<1 M6ZXOG$LK] 'CZ*79JM2X=QN2K6D:NM'O,MF2T\G255+,L\RS)VX;S+/'B5L) MGFWO;TH[;_8F^R4M=$I2]:N;4N^<7[N]/G,K.3UD;F5N96YE;CTEW+:GULZK MJ/55.5ZS/=";K393(SDUJJH >V>[%'95@$T'@LM'$=IN)+1@!.:'50KPFF"9 M6C!%(SE8)R$.7HC)G9T3#1PV/)RUMO''NAKJ[LH Y"J*$N%\2D*0]3<1NH&C M2JOE'Z^5"\QTV@:\H=MJZU[S9[>-IJ5A3?L04[<@S"#LO[7&0=F MT%(S^-Z&!/I/RTL$(?YIYZ"Z7;[L4D[F5(E-WS1,>N"PD=# @4F"];_..#!) M,$E0 H*DD3!)L/[7&0C:L7"R"\ SE*YEY8TXI[<1I^Z^BP0.',24JF7M%?L! M/U?+^GWF#.5EYP]6Z/P]#**(9CUKOZ4;9G5E.NQ$3MR),(FR_M<9!R;1UZ>+ MV4A.W$B8)%C_ZXP#DP23!"4@2!H)DP3K?YUQ8))@DJ $!$DC89)@_:\S#DP2 M3!*4@"!I)$P2K/]UQH%)@DF"$A#<9O+ $*A*%.W!C<=CX3E8_Z'%UJ,6#$'P M%G>:)&(7).3._HD&#DSB+YPBL:X\KWBNL+P&NW!\#L);Z_%?Z 8##\4.'\B_ M_F9%PL'Z.N%'TA_2+,XS6GIS4%TK;?8A5>EIZ5,FF#Y/S&W73O6)XL#TR=NX M*0%!TDB8)%C_ZXP#D\0+XQM%*>>Y9.K7>9(A6O&ZXP#1RKE.B:VM^J8>)FZ1'G1M]0A?@-_2+1E M8J^EF]WJCF%C+W+B7H19E/6_SC@PB_+V1$I D#02)@G6_SKCP"11YH2=7F>; M$W;63K1HU&1N=%Y/6^\.>CSW(J>Z1-T*TRKK?YUQ8%KEN1(\D5I=$I6]RHE[%695UO\ZX\"LRE,O2D"0-!(F"=;_.N/ ),$D00D( MDD;"),'Z7V<?ZA\W/<5;MJ/6MJM)$[C59_IQO67\HC1%[3&]:PNU?_N[L(,[7]Y%;N6F49>XT=YOLZL;G39O_B:G MYD1=$%,PZW^=<6 *YGD:)2!(&@F3!.M_G7%@DF"2H 0$22-ADF#]KS,.3!)E MDGG])J%D'J?@:N8XN/_BGB'X*F+-"R+NKTA ^4G(G9T0#1PX>N&M>92 (&DD M3!*L_W7&@4F"28(2$"2-A$F"];_..#!),$E0 H*DD3!)L/[7&0QY?K"N;1"']"+-FZ<*Y7JW8;+9*VNWNWT MN1<(.;5\2PX"9DM6_3KCP&S)4RI*0) T$B8)UO\ZX\ D46Y*99:=4O%\J![V M_O;U%8.OK>%<* _4AD'HB#"3;A1XKJ.I"S7Y1E,K!#&>,B37\5B$LDMB*,;" MC]Q[\:JRPFKP41$(PT.U0M]X'IQ,5J&KE4?Y%?J9\7UWP5\?7HUGK\%H3RW-$X M#MUA$EM#3]P&WZ0KJZKUOFTGD\2#*YUU ]IZE\.\=*?3I=/NB[E\-YL;F,;K M0 U,X\>#%=/X[FB\O3\:9\(]:>=10?7LT?7;S,MP&'C.:^$H*_O?+,_R;;B? M%6N?A"T#7*UEZ!J:&KG"A MYT;8.SQ:B'8ZR]&.["\>72=Q%%L^@E%1&@(^G03^31S8/W+IAN6@Y^KKY^?V M#'TT!WJOU=,[78-W"Y%3/Z*^@\F5R96!8G+=^_D>W0*W(ON-858DPDAQY5[) M5684YIMNFTRAY)2,J(=@"F4*9:"80O=.H;V]4>BY\]()]:5/Q>HT^[II@I)U)LPW3+=,E!,M_M?_.[OC6^?Z;3[^H929J>G]]O5+90SXQZ\"(W)]L1\ M.)/MD0#%9+LCLAWL;W*[50WXZ_G7T,VVR>Q+3DF9?=FI,_L>%5#,OCO)+ ^: MKR+?5^6#S?9 -WK,C_34J.@##M/T>.]EVW0@.'>"J33A8*19M@U2C4$2FJQ& MM$)'>_,UB(76.MAF-HYDB,F=G10-'/@0AL-W,V$C(6XD3!*L_W7&@4F"28(2 M$"2-A$F"];_..#!),$E0 H*DD3!)L/[7&07?B2L_?X'KV^[4$Y>CD;#CZU&6KO]_"8S,';FVA;_MO$:TG[5- MZC^_R7'0[9'IEL0NA;A+84IE_:\S#DRI/.^B! 1)(V&28/VO,PY,$J7F7>:A MYUT\:3IRG:NJ-O'H6LK2@>#R482V&PFL3;1ERR5XS<#^H2E;C,@5\'*PPH73 M=<:!@Y5276$'A:-LY.:(JRA*A/,I"3$@$:$;.*I9K/SCM7*!F8MT=MG9;GT@ M\V+_V'9/[W6Y%0\]+27J09A!6?_KC ,SZ.MSPFPD)VXD3!*L_W7&@4FB5$ZX M<-+8FEG6/RTO$;N<9)T[+_0^?3YSO-&F]Y8^Z'5YWD5.;8FZ%*94UO\ZX\"4 MRO,N2D"0-!(F"=;_.N/ ),$D00D(DD;"),'Z7V<>*!^-6F)SCE%J] M' %WD=PS!&BGEF\7*S63*?P8"D]8JHPS%%$%TAY_>9,Y27G3]8H?/W,(@BFL6<\'JZV:ONE"?V(B?N M19A%6?_KC .S*&_PIP0$22-ADF#]KS,.3!),$I2 (&DD3!*L_W7&@4F"28(2 M$"2-A$F"];_..#!),$E0 H*DD3!)L/[7&0=@ 8@66X]:, 3!6]QGD8A=D) [^R<:.#")PYN^*5&?URO4Y\EKL W'YR"\ MM1[_A6XP\%#L\('\ZV]6)!PLL!-^5.5I.U6W6NSK1K.Z1M+L0ZK2T[?D(&#Z M9-6O,PY,G[R/FQ(0)(V$28+UO\XX,$F\,,=:LY&[OSS%.G?^G40QSH:B[\*# MB9%S&^QWIG7N[+[?HJ'WVB;/OLAI,,^^V*'75/6)XL#$RK,O2D"0-!(F"=;_ M.N/ ),$D00D(DD;"),'Z7V<@&^TG1<6+ME'W"V]=7;7+#Q1TT7(3A MAIJ83+W@28CTPVD2VF/LP#CU+)]=&WU"%^ W](M=NBT=2;[29W6R2GJD3="-,HZW^=<6 :Y9V-E( @:21,$JS_ M=<:!2:+$Z3PP?=GF=)ZU,ZTC*N?LZ!V3YU[T5)>H6V%:9?VO,PY,JSSWH@0$ M22-ADF#]KS,.3!),$I2 (&DD3!*L_W7&@4FB5(+.W'6"CM-J]7(&W(=SSQ!( M8]2&6%^-%9VS FMRE9UQX B%MR92 H*DD3!)L/[7&0]<6*DGZ M7=C!G2_O(O.E1U2WV.KJW59U&59V02?N@IB"6?_KC -3,,_3* %!TDB8)%C_ MZXP#DP23!"4@2!H)DP3K?YUQ8)(HE#B?@21%4=9/)=Q);K M"^?2"GU +]JT0#V22O5NPV6R]D"']^%>(.34\BTY")@M6?7KC .S)4^I* %! MTDB8)%C_ZXP#DT2Y*56W[)2*YT/UL/<*#KI^;0WG0GF@-@Q"1X29=*/ BU>5%5:#CXI &!ZJ%?K&\^!DDJN7 M=R.*5?=%6]H8KM..> Z\+6\CR\J[/;8NIJ5:@L&T= )8,2TQ+9T$.DQ+# ;3 MTJE@Q;3$M'02Z# M,1A,2Z>"%=,2T]))H,.TQ& P+9T*5DQ+.^OFU5LNII$K M]1?YA?IY;,YK,2D+P&^69_DVW,^*M4_"EG&MUC)T#BY$78,CQ8BG<%RI".[BD?721S%EH]@5)1]@$\G@7\3 M!_:/7)9A.>"Y^OKYN9U"'UM-W>RV]$ZKRWN$R*D?4=_!Y,KDRD QN>X[BV T M"]R*[#>&69$((\65>R77Q6Q"A:=S,(6>N(=@"F4*9:"80O=.H<;>*/3<>>E< M^M)G874ZIMXU3*9;<@I)U)LPW3+=,E!,MWOO V68>^/;9_KKOKZ-5*O9U9M] M9EQZ.LE]==F',]D>%5!,MCLBV];^)K=;E7Z_GG\-O=GK,?N24U)F7W;JS+Y' M!12S[VXRR^U7D>^K\L%FNZ.W^RWF1W)J5%79]L[V?.RJ;)L.!)>/(K3=2&C! M"'L;3\"8([1,+9BBD1RLNS%',,3DSLZ)!@Y\Y$*IRFNC<(J=#$"NHB@1SJ&V2;T@;;UFCWS;[>,ZM+OK,'.7$/P@S* M^E]G')A!2\W@"V<6K2'0?UI>(@CQY]*F;N9)S3SEQG\*9J-A+B1,$FP M_M<9!R8))@E*0) T$B8)UO\ZX\ D42H[5V@U7&5VKL*<6G7;.=@34"M7/;HN MPW0@0$/%1L.%CW-BVSS8=]' M@:.8?;%#KVFJD\4!R96GGU1 H*DD3!)L/[7&0M_G7%@KBS%E1U*7+F/JM:NWFFWF5;)J2Y1M\*TROI?9QR85KFY M#B4@2!H)DP3K?YUQ8))@DJ $!$DC89)@_:\S#DP2I1)TW5TGZ*I+JW4XK49. MX;@=Z<$AD,:H#;',' M;9W7FY J^.4+A0OLZX\ 1"N_0I 0$22-ADF#]KS,. M3!),$I2 (&DD3!*L_W7&@4FB5*ZS]\PN_MM@376@W LW7-[$_UW\F;@1R/]& MA/>N+522]+NP@SM?WD7F2X^H;K%M\&$()-6N6<(OHI8 M\X*H],'JO.WBQ,K]V0G1P(&C%]Z;1PD(DD;"),'Z7V<K6R=AG5*67;\E!P'3)JE]G')@N M>4Y%"0B21L(DP?I?9QR8)$K-J5K-LG,JGA#5Q. K./'[M56<"P6"VC ('1%F MTHT"SW4T=:$FWVAJA2#&4X;D.AZ+4/9)#,58^)%[+UY56%@-/BH$87BHUN@; MSX.32:Y>WHTH5MT7;6ECN$X[Y#GPQKR-+"OO]MBZF)9J"0;3T@E@Q;3$M'02 MZ# M,1A,2Z>"%=,2T]))H,.TQ& P+9T*5DQ+3$LG@0[3$H/!M'0J6#$M[:J? M%Q;!+%;3R)7ZB_Q"_;RXYJN(KT>WUN.W(,3;G\=QZ Z3V!IZXC;X)CU95;WW M;3N9)!YH6K,GPF,]H<09FZ$7BV'):\$_/7! @414R# < )6N>_LO,*@ %@J1( MBA2+1)Z8TQ9O0"$S*W]9>;U-0N=/S:^Q:&)=?_VRKCCI \!#M].IM7M-8ZJ2 M5ME>*^&"E0[#>269P7"^5V;^Q3@^,I(?STG2*0$Y0NT$SG-U]-;R^=)>.+'L&NS?J$-)K]6J=!I_%3T1* M&=N9&8SMC.V,[0?NX-5[-7!?TQKYY0W .HUAK=\;,+R?AJ >K4TR(SLC^[DR MDY&=D5U#]O[K'=NW*A!8"_::'[[99C0_#>%D-#>##XSF9\1,1O/S1?/MP7SP M(C!_D>>\U>S5VEV.BN\D6\VC0X"J'_B5ZDK@7==[V.[A"\_ZB_9LO5E2N..* M_>O #T7T_ 9>=I^UR?Q$WT9*X#T2\6XB+-O!!MEV\ 32!Y\DF/P?P=N!Y<'C MW$>V;X%X)58XML#DC05N/E*': 5;8R^P \>#+\6I 1U?+-)H=\IWUE!^]ZNV M=^$G7K79*MY%?ZVMPQP&#QOJ^291^H S^U[41Y&P_ZS;8WB^][;_:#_%;ZQ? M7T[=S1[RP%M)+Z/9EO2[TOFK>(A"ZRJ,9B7A/]VG(EB^NOEZ>_/[]:?+N\^? M_G5[!__\\?GKW>V_KBYO_^^_OOQ^\X_;-Q^N=(V0':1C5!E7=CRQOOCA8WP^ M=/GPU@M %X;SV [<^-U>])+^&.OUGX(U0CEE&/SM30-L(N'["/V@QK/7RJB@ MUX75O;?G2?B;,BL TGU[%HOWZ1^_6#UJ[E\#M( MV//VSS&UN0G]"9H7K6,.%REMEE7VZ& 3>W2OC("5P&,#)YJPVU*N3#W7]<4Q MBM_;W8OA9L7OK[!KS&#;/X4=Q=9G6)>;5;=*5K:;M17;ZN ,?-5Q26;P8?/: M[U>BOGDP8RJCCK S&'"> YR6"7C3;%QT=O":5AN1UK158."I@C[;:9NPPF.% M=Z)\!84W8(7'"N^Y+7#>'&!%=O)\!476/[HB,ZFUG!EL,:6MW.K<$NEJ.![Y MAXV'GZ\N'2M@B@7BU38B,&&!,U M.&JRW#$36IA-Q*;A9K:!47ENS+K7/.DP%QA=S*,ZH\LIL(G1Y619Q^AB!!<8 M71A=F$V,+F?&NLJCRVYNR\.-TCF0V](4!GP5B>6'\<[.R<,%9QC@CS/EJTKJ M9^<2W(,Q0$)WI9%YATX8P\7BV6]1./82G,'UH@%;6W6H:C;:M=Z@9\P@+M[D M+VQ>P=C&V':Z7&!L,Y IVV-;I[$KM@U2;!OLH?OBL-9J=!G:#!,GAC:&M@J* M/4.;@4S9 =J:NT);/X6V_LNAK=VK];K[ZRO,>_P T%:17%93:'_I_GL>)[*7 M21):D8"]Z'B^L +E+<9W\6\'TU[GL7 M+^"<5P,XQU$MY@(;*2?'&=X?1G"! ML8%EOZ)<8&PPE3.\/XS@ F,#RWY%N<#88"IG*K\_SBY;M-F^Z!O-@T]B%@G' ML\G%;P>N94_#*/'^2V^8YS1GV.90146YP+"]_1B63FLQ)*GK._C;%_C'9>!> M:FKO)3FFFZ7?U+J]_0U+XWU_UON>,8]EOZI<8,S; ?/:^\>\];FGF^7EU :# M/F.>8=)EZ+YGS&/9KRH7&/-VP+S._C%O?5+J9I,X:]T&8YYITE6!WJK&NYWU M;8CS]?)D4U_8L;#L.!8)IYL>?6>80?6JZRU2X*'*'RO:[V; M\4VJ\WY'E7>)&N_@GN=VK=7>GT7"._ZL=SRC'<&;2:+?-8PQO$ M""XP.+#L5Y0+# X,#J:P@5-HC\V#VR1T_JR/;*R;=\+I3 2Q]&N*G_BW,,_? MS]#-49:*PE:;P#I\WVZSUAAQ0-4V@#-WJ#',L M^U7E L/<#C#7WP?,[2-5ME?K[3%*QUO]K+4"XR .R!@MS08[! (N ?O=+/6ZC("FB9PC("L M>RLH]H9R@1%P%P0LS0\[! (^,VLLA[GF_D8_\VXW9H@8)SKO3OYO4?C@Q;B7 MX:O66YPC]B"B)RL$CY2UC@G*0A-&3>6$3MC$X6%51+K"-L8.-T5VT,:Y3W48J M[Q-HO(-G'C=KG2Z'I$V3)4-W.2,\@L;M4:C2XC MG&&R9.@N9X1CV:\J%QCA=D"X4G>G;1%N#RTOVK7AH,,(9Y@L<1/EX_/@:QC4 M'3N>6!YLP$C$"7=/-F4SF$'UJJLD([C AL<.AD>IWU:QFNF+%]B! ^2^"F,J M:[URHV<]H)[>W _]VJ#/;J?>>^;Y7[FS.7=>? C MB 00^;_"M>YM+XBMMWX8QR)^9\EN%W"GP'+F420"Y\FB:\K=P[V7C[Y;S*!Z MU766$5Q@>V6'HN!>UG(C"][DJ_#MJ0C!0?B=5>(/U5*@'KY0:O,/U^"^> M_*>-]^LV.#9NF#AQ7TG6K!44>T.YP/BVPWF\=6!XV[ 1QH9%/LW!@$'0,)DS M5!LP$K+L5Y4+C(2[G/3:!X;"31MH](=#!CG#Q(F;*Q^5_%<3.[B'.WB!%/?)\+_$$MU8^*0CD,-E9P?O M>M"J-;O[Z]_/&Y\334^2X(9JVHJ)O:%<8+S;!>^6M(E_*=[MH=M!LU5K-;GK MH&GRQ8#'JK:"8F\H%QCP=@&\)5WC7PIX>VAST&S7!IQ@:IQ\G7>"J?D^YK3? M-6>0GACH<:3KK+G IL2=OZ+IH>F\/;3HWE]M)F]JGF!^D@0W5(M6 M3.P-Y0)CV0X-"DH-XE\ 9?ML1@#'Z,[^)H[RSC_KG<^HQ[)?52XPZNUR@BOU MAW\![.W#:]RKM89]ACO#!&L/7F/.3'X!_;]%8F9[;CJ.338C").)B%0_W$1U M*3 OO,(6"0>U*LH%MDAVL$CZI<[]98M$J<-/8BQ ^;F?I5:\#-P;5(F7I D/ MGL' ^0V;87;;309Y R3*ZS"K%63 ,9R@6V-[9/[^JWGSM !C\ M6/:KR@4&OUT.VQOT@-H>_?;0%:-5Z^WQY,U;GZMY3I+@ANK:BHF]H5Q@Q-L% M\3;H K4]XFWJ3AX,]Y<8Q+O;&'SUW@8\EOVJ'.]-$:U\S M_#AK^65NYF@N7,OW[)'G>PGW639@'YA!]:IK(R.XP";(#B;(!DVZE-[[/5=[ M!V^ T6S76HTN![H-$R]#-SZ#'LM^5;G H+=#>'6P02.H;5%OP\;,VDF[PYE< MIHD2IR>S5JV@V!O*!<:V[0]T@PTZ/&T+;?MHOMRJM7K[&]G'&]\LO_)+_?P% M)[(U"B-71"F!X]#W7$M^T:+'FMG8EOB\G#Y.D0?(* M/#JUG6-*7&P=:U*Z55O'&<$I:=SLA5GG; #M<+C?H/T7:=>O8: ZW._)M;U= M&G6K-FCMKR_'GI3[YIJ]2BKD:+G5#+GF*W*&W%/A%$/N@7P.FW; V@%Q-^TE M/>PQEIZ$=!U7-S"@&L,*!M23YQ0#ZH$ ==.F6CL ZJ:-1GH=0&[X M:_OP.\V+AMD^_*\BL1P[GECS6+B6%UAAVA'(P@WU<-04(!I7YMH)>O0"U_B\('SQ7NQZ]L<9F8)-YMU9?37J?A*/3=ES%C5\KCMK7&?O@86^,HG%I>\"#B/<4MN/O>6:4 ;&([ M54EI&VB2ML\AK*N\B6)9G"!T871A=G$Z')FK&-T,8(+C"Z,+LPF1I7LVG2;S8!O\\B9V#'<(QQ;\22,$MD]13HPI[!>;ME]]#UA!M6KKIF, MX )W>-LETEH:&_+-?B+==A=>.O^9>Y&X?+ ]'^>%? FC6]L7M\*91Q2V^21& MR<';=[>:S5JCT3,FS,I:X,A94 Q^9E&]6F)O*!<8_'8!O]+ BKV"WQY&1K:: M[5J_94Z.$6L!!C]6NY45>T.YP."W _@-2W,K]@I^^Q@?.>C7AFUSBF)8"U0W ME]84VG^+0D<(5^72QK!5#N">YM T!\Z8"VRD[)\S@U:S91YK>(,8P04&!Y;] MBG*!P8'!P10V&+E!&!Q8]JO*!0:'[;L>#TNC"U//R9![O?$ZV/0L&%/V:L(TPT/#$F;>F\,?0R%_EU9017& # M90<#I319<-% N0SO!FO#L4>/@&WVZFU#>I-R,K :&7 0,BR7U4N,!#N M (2E@7\' <)])..V!K6V00W_6!D8K0P8"%GVJ\H%!L(=@+ TJ.\@0+B/Q-QA MH];N-!D(#1.Y?7FQ.3MW1P;D@22+O <[$; ;IS,[>#(OQL,&"D?6*LH% M-E!V*1G*IM\%#U'X/M=VU\$WJ>NNI*H[N$^Z7^LV&AQ%-TRB=JZ*98@[*^5: M,;$WE L,<9Q3; H;C-P@# XL^U7E H,#@X,I;# C];;@H:S\=,U"\]M9%,Y$ ME#Q9=N!:XC]S;X:'?IZ":@"?#(W_/3.%D!OB&\.I8D/\%S'KG(V%'9REI;'C MI?Y*WY1>_>;#S2X#]W.J6@_N/VW7.OV6,?%;GEQJ8JM!QEGSM3?C[*EPBG'V M4#A;FA6^+YS=0\KPH 8+9IP]! M,I([M7:+KO-"\:7:.9\E4DEF/'$W3U/WBN<*W1DVJW ;2S M<#\]4&W!L:)E;"29'U/>9 0N6U$GP@F;\IQ?SQ MZ4 MD-'Z% 3/E)*%E1KF4'U6=$*.0M]]&4=V)3_N6&OLAX^J6_C8"^S V4^<@KO! MG54VP"964[4UEQ%LVM BJK2U8RCK*E^M: 87&%T879A-C"YGQCI&%R.XP.C" MZ,)L8G0Y,]95'EVX/?2K,N /+_"F\ZF5V#^M1R^93$(?"6'-;- 786"-Q,3V MQ]AQ14QG?O@D8#5P42L0B15/[$A8L4@27[RD^PIW4SNK6&+E59@17.!N:ML7 ME+4;Y0F(JJ#LN_#M1+AWX9W]\Q^YGL1!%Z@%/]JQ<+'3M AB&^_U"NU2&MW] ME9>Q,N!VTR=)<$.U;\7$WE N, ;N@H'EX8<'P< ]9!,W:_W._EJ&L3)@##Q) M@ANJ?2LF]H9R@3%P%PPLSST\" :NS]'-@6XXW-]D0][OQC0-X?[@>^T/KD:3 MR@Q<+X[G=N (=%T[X70*VSY.0N=/*PES5S;W5S. ;^9&XKAXZ20XQ?W5#E2; MU%TW_?E:*=B;,5D^\0]XY.@:W@@2[P'G0B\WB+ 16PQ?\^?(S%M4R3H5T:\WN_GJ%<$NVLU4UC,_&L(+Q^>0YQ?A\('PNC_,X'C[OP9T_K'6&/8;G M4Y!5AF=F!7"*X?E \%R> G(\>-Y#-Y!FJP:G<,;G4Q!64_+JN:WY1FW- M]]DNA#NO&0/9W'F-6&'*CU).0/&Z4RJQ@ MN*X(*QFNCP77FTXAV1JN]Q"YZ-?ZW0ZC]2D('J,ULX+1NB*L9+0^$EHW-QU" MLC5:[R.0T:PUA]S7_"0DSY2^YEQJH7/E\W@LG(2Z OUT)G9P+ZS(3H0E_XZQ M<1#&.&HRTB'^,_> 2U@^9=F!:T4B3B+/281+GW,6B0$<-30W@6VQLV$EVV+' MLL5*(V:D^KX9?U;*^SOH[IL S3/\_\^YNOZ>:6K\X#)PBV]HW\Q24CYY\2R, M;?_O(%4S^ 6\1G/."^;"O9F)R'YQK4=NR+6Z^[/B.!WE;%42 [TQK&"@/W]6 M,M ?JVU%L]2^T'2D7Q][B4F2ZT7('S#DGX+T[MP%BM'^_"&"T?YL6,EH?ZQC M?:E/H^E@OVFW*_@%8_PIR"Q7F9C*&:PR\0(G$G8LX(]7B,9P9HPQ6,^9,'KQTI=FI=0R:3,$&G+'* MB2'?&%8PY)\_*QGRCP7YI3Z:)D'^'LI?!K56RYP&Y8SXQNHF1GQC6,&(?_ZL M9,0_%N*7.G.:A/C[**&I==I<07,2PFM*!A[[Z,([N2_\KX M.IC5E@"/33,T-Z;:^LL(-FUH6U7:;C*4=14;5&8J%QA=&%V838PN9\8Z1A(,2L8I<^#4XS2 M!T+ITO0@^:&9K#:?7J[5;YD\I6 DB55)& MQDXI8(@W!!P8XAGB&>)WA_C2)")S(-Z8U :&^+/%%89X8UC!$,\0SQ!_ (@O MC2 R!^*-R8M@B#^!B,O!@KWGW>_F=CZ;^6(*J[)]RX5=ZH?Q/,*9T&,94!G[ MX:/E!7+?P2XR+AC/I:,&M!VLO$UE*)O*AA4;32?"NLJ7CIK!!4871A=F$Z/+ MF;&.T<4(+C"Z,+HPFQA=SHQUE4<7SAH_/E&_AX-*0^FM2FW>H-;^!*OTJ7F$B::W='G#P]A0$ MC/.SF!4,IPRG#*?+X;0T/'Q;.-W#M,]F;=#9WWQOAM.SU>$,I\:P@N&4X93A MM 2GI<'E^0^ MYT'9 M%8RCC*.,H\MQ=,EPY'W@Z*8M2KK#_RD><-8QJQ@+&,L8RP[C&>[E7JV@X(Q'O)H)2OZ]A_M)U!( MO[Y< C=[R .+I]Z295O2[XP8H,B"]#F.MHJO M#'N@JC&8@UKNC#&9'X*VWW M!)]/V]-?LCU]F^UI4K02%[_.IR+R'!VJ2_,:;Z)[._#^:R-^YM>&%Y>!^RT" M+1(D]/)FG-TLO]Y:,/"+]=\K0 -)\A9Z*Y6 J 6^J98["F M>6%]P;_)6,)ZG8_SV M$'"M%#"PCK;THC=H3]IY]P"X=((\,0.I!K$<[IO'( MT2R,2 Z]P/K#"^"9P\2V@ I_V)$SD6JNV:A9K4:CA[(+RYR/P52;$VJY\#KZ M4V!54Q ^ /D>$.+H'V\Z\^'V:!Y84^%Z8/*!%?C@.?#$."$"J9J $D^H*@K( M'(AY!.;.O?PFF*EHA>$BO00$UG^"7SG(E7M<7>G7SB0* ]@G,]L++JS;^2@6 M_YG#9_Y336<@/7-!&P.^@7N8=!! M\!B!9Y< >#NQ/[I4W (Q!,J"(,.^2*Z)%!-*: $.)1:H"JQO0WH$XEYRG#IV MC?WP$3@;A5,+Z]YH*\47UJ=YA"S#:SX).[($/+4+]';$-"-RNXE4;@Z+M\YN M:V3]5/G/,2-CA.4O ,^)8UF^1>&#!V3_^/0#KGP=W$C^!/>7N%5A>XE7 M)$*W<5%.8BK2 +V<'(!*2N-T4E#H]HC>>H_"^LNP4U(0\G0&WMQW [M'*L M600/$(%R@VO!J?U^@N\\T"<^G)_)$*&TG/_,O>3)B@5L?9++&I[&H_ 1R0RL M D0 =>"*46+9]Y&@'TKN>W$\Q]N3\(33:1BHG!Y8OP<7_QH^D.2@P'124+%F M<+8'T C'8T%J"DF&W_Z?>2#PFUUYST=83"*"Q:_7+'CL1^'[^*_^L][:G\DE M!@\B2CQ$1[#// !$>1ITYZB+K5767Z?9+3AJ/@$IKH,8;"\DQ1]V@G1[^B=H MVC4BJ.2X^-O+GU[\+[SF32"^A7 :O14/(O@"TO%-1&AJW](RK_*%HSW[:2[N M'N'#)_E?^.T?1.8E6N-#J]%JIB*K'NQ#08PH M/_#=!EY/DH!R ^^!!> $1! MVT.@I8&2 O2\5R*&+(//;&?B"30[X.-19KR-_BW(&LE-#O@7#&)!9HF49! = MD"C,WT138CY#"+1!?NYC4!CP$_P=BE_-NA>!4IQ6/!_C1L=?1$BGN<)$O/V* MU>/?8.#0_@MB>1)8_D0QKO3)&@F$*)0(L$YMS\>UPF\ %\'PB4%N0!G0KL$+ MS*+0G3L)K!),!C@@HP4%W\,KVM&3O*E*4+6 %)'MP170"T;?\%/7 @JU-X9G M@HT(V(M7>X*O *U^0I9S$*U7GV^MO-^]0&N.)'>5R6=#%N$- NFV0KWCN M*\T]#GV?%'RAZ2OH51#W"+9 Y$H;?9G0/>L=@]V3V9_CIDUHZ MDAUX0'L6B_?I'[]9RMG<:*A63&O3@N67I9"4GX_$E/QJQUH);II6[S?-K[:""2 TK UBH5=@]4)1C_I&#"3O-"]I9_"C>FC=>KH\0&3UA'"W=7K4QH! M\4U=[PMPZUH=%Z^E-2/-N=2:6W]Z7RU!=(S/O3WMYD6O_*#J= [\QM@5_!K- M]M1$T>5%&3EDR%.[J!IM3SCH9N>>3%B<,*9V4IZ+DC>'WW:'O^%7%K4]Q6U+ M45NV?=CV8=OG?&V?S'D'1WC %72%A*1OU-%..5WQ'=#@H)I\GUZ$\P2.4@&9 M +F1L.P@%@E7B"GI"MVU-8L$:*@H*[!#I;7N^*C">ZO +!5S;QFMU:JP%V7J?L M&5YAXUULA@^G&MJZ#G)/[BJ?AAT\ZZQ=]&/4+-#+SD39QRB\JUT>$^$3)CL@ MT;87I-^A#R>ACR'.FO0C_ M]2<86B[^=J9:GNJ^9'FG"VGQR/_JP:)(.,)[@#50U$FW\NT9O/H)ST%(M;W- MWRI%0/=D\Z]FQX+-#Z>;SAJ;'X\U\)P945%H,_M>H>-&)KZFRTX]_T!3TKV% M# IJCO(02ED6XQU?0%[^G**1#]^E*RW=(-K(M5M7"PY+V=!WOO["/,P*,8: M.-X,]I]-C[:)HPMVKR@0KKN><.D4Q>]P0T('5SVV?;^!^^"HI*RW,,VK7VY$ M]LOZ8.S*2&RK=S*1V%ZJOB2%ED9BJ3$UZ.9[+T8>N^NM(HKD!+K2WV&7]M<0 M\#*[\F4JX=]2 3=VZQ;!H-6Z*$O;AALWGH-]*87P6:161S+T*M87W8K9@:V MXV_Q'10"BW)2W\DHO*S]1!,YL7#G_"*A'#UU=@!6AQ0"^)9J M8[YFJY1\<0OZ.*)D/>?I9BRM+<_Y9C_A)\=G\F(60RRF7AV?GW(2<=/ ^=5& MXTCA6)/H4LQ4:LJ>,\!33(*3CCQ!X7;\6?I=2^8S]4I)$HN65!(F("T%'VGF M@J;D&"U#9='+F,=8I4E1DX?N%YM>)3^S;GHAD[Z*Y&:.OC,W=!,:ZV MZWJ])5EKZ5Z^D,?G(M-6YV^7C!-M NJE' V QX[0QP23>!]9V5D>BGN9Y,OX ME^L$R;]&/^PVWWG:<3KW3;@[K@TZK4>_T>KU^IRMZS7%O=5JWV5D:+SE1)Z;=)]IZ3!/MJQ%]^,%QCV)/][R%3ZY_-)CDER(@M2 M6R\\..WLF+O-"K&LB?T@K)% :RD26"3HIL,^(I=2$Q^]9)(._U A/@1^S.*2 MJ66(*/"YF"5YRLN/B]L+ZRW^5^K_OU]>?E. _?R2E(=J><*6HQT[DTD8B]0Y MM4;YH_;-/1LZ .0]ALF:@RT$.O9F_(])"$]U\Q@(-_O="_*-%[T?]5@XZ %Y M!!J#N+WY@$D^947]2*NP0EP&V%;Y.BZL2["@R/)1A7D+=-%3DG(&"]^; KV! M[LMU_\+K,R[/:QE>GH>RK-!/5O?H0+P% JZ#T%;';G<'K7Z],QR.ZIWQ&"XP M'/7J':?5'([[W>'8:;Q9@RWE$+VXQ_W[7Q1.,^RH/'#>Q'> M1_9L D*.[@3T>^(#P3EV%JK96'A,=>2CPP) 93LJ?UH\V/YSV,-)*,6J:M,GL6\H#QQH]F1SO P-]>L_)XCP M=G[XJ"+%FF0@C>4/:EF*O!VD,G!!UG6$$9G%ZCMDF"L %*98/X._PO1W>MNV ML+;/QYQ?U'KT".0 SY:=/CH>!YUR#4J:?K]J(RC1$KHXH8QC,"0K3PFSITCM M+TV:IV73Y?OI/?B@22J;.B"CE-5JO)KH%'>?OM#_@H0U4Y#6>I+ MMR+XKYU9WR#I<%GR=:>6I;^!-_%Y+JSO90U)FEV*H*II M':%' ?VKKAMIY<'R:>R>7]=Z>)^%OS^7A#5:FX;U2 MQYUN_Z(\JX"@QI+?6]-6;8=F$,_WW#FFTC6CSUV[W.?NF PIG3=6=44:;-(5 M::^L@95@_M3?WC1A]QV_?5JG<=$H-_HO\"ZE6F7X]D\*SGQ>WG;@Z,W&7J.) MF!E\V'PDQM1S75]4#WA,Y=/KLX8A: <(:KUY/3:M;L/:O.@O=/!<"C\,47J8 M$HY01]YPU4:B8VNXG;8)JT!6@6?#5YPARRJ056"%MP"KMO/D*S9!/[IJV]20 MJ+(*W&U$Y\&&^$K_Q&NTE#]6@%&+_Q@W0EFBT_E2W_SQXBO1Y4B#%YA/.I\: MFUD"IDQA.0[SMBV_:Y>JD:_" .TAF>SPW8O_S.OMUK4MB*,D*][^>Y; 8OM4 M0:'"ZS]N\Q+NA9M\?/HH F>""1%ZQ3(6,LC ^ M2&%\\ R,MQG&39-WAG&&!X;Q4^(3P_@A8+Q4J%\]&%\]QW4!QIL,XZ;)^R]+ M@AO[G=>Z0SGNKPM5%Z=<(O5[B/))E5!V' M5,IX7K'DT8XRZJ'JJ"'^AGHAJ M^K"8+Q%P<5^V;:9Z/YQ34Z/><'(XHUY]CL7G:@Q=6G*W50>2;JD_ZA>X&^S. M*QRX%CA/=UK5^V7@TDM?EKY5O@A9DS)+3 M*&5]'MX)IZPY$SNX%ZJ%%JQ&C,I9CS_+. M$VMO./'B)(QH3*:L-TU+"U4)=3I?:N$J^6JGP/\)MAK!.03W8G'5I4HZZW$B MTI&;>?>HT(&GCF4-KJPHIJIMQ>:,64F^/2S;_?<\3J3Q F)1!RQ&7642L"2;=1!Z>S1E<(#^SB4'4%P=4H"I!8Y372-(AHB4QGU8RJ M(-.">Y%,+!!%7BI]=,7K=]19M%@.G?T(VX3-RP]>9)#BJ23"3O,6VJ76D:M! MY>]P&QR]F?/C1?,G\S9=ZSIENFLGD5KY,$G%_]VH4)H3LS\JK':I%>9'YN1H MK)D_L2$Y!B3E+Q&+TAR8_1%D]>&D*!:-):,R-Z1#8=!H'X D:TN)2))MJI+R MT!0BJ1&]C=#&>F(1$U^L"C93 B^2_U*?M.?9_7T?.J L_>NFK[R2,B@U]MD7 M,790!:O;4K^6*NAL<>S8CAR;*X(U#5FW4@0GWMSC+FTEFZ!)0WT6EG7.H+YH M@:UL%6VN[WT4/DI#6MFW(!!C'[NRY U2,MTBK\-36$.9&]E MLNCQ@Y(BG@B7'HNFQ8*(@M7Z,6T00L,EU$FC>/^L)4[QMMGT9VSS@U<0P;VD M&O GO9.=#0%/;>@ Q5^->=[.L5!JK/0C%C?CSW%"C66W[*;T;#^1;E/V7QNX MHVYK)%KU?K?9K'>ZKJC;C99;'XU:MCWJ-MK#_O)6'B?@;O@AVS)F)#Q]%X-T M%MCIT*$5?2M?WC>SX&F#&UV2M-KI;.-8M="B0QTIE#]!FZ5D5J-JX_E4M=&6 MO6BDLB,'PE0>U>6!+;_M!@Z3P,UZJCWAXU";[XM">UKM88M+TM;\[[DK>_; M&L8^K&N;1:2-08%&TUAV&\<>7#B)%TDNN^VXX7R4C.=^YIB0_LE'.P)FP]E4 M&UHM/Z&!+'79T @?$ Q2^EA^Z@I@/2Q$N@*0"E,\Z_Y7OH%^5'49+WB 18;1 MDZ6ZP:57R%Y:*[MNKO0MGUG?S?;I]]W=9J]MM,4=K?;?K-N)7L!D.<'[[UVG'/3P7 '7@@QT6!L)WQ,/,I8T$F1N@T%);<>>-+!!#SK8T'[6.G)J@W7IX92!U$^* M_:-SK*)Q$^H;"%;Z/:G%9"#M]+@X@6Y1@:^V-)_/E+\"0QM.I/!7]8)4!6*@ M\2.)82$U2!)N2!+PI;0K?@1J0%WBG;J-^45K=)M.CE#VVRS$\ZY']F(\'_T[ M->;2\Q(>RE!6BK1S).WPC$F6E2>;7N+TLIJ<8886)=@FF7FGJ3WIB9MBWT5T MYZ\X3=)5X!R;3@N$QRLT[(5]E*WH,2E^.JI?Y%BXRB2&W\WQM$GQXKCH M$TSC9Z*P6KS2%&[^E#;#',-&5L2C,2%XF"S?8,%U$J_SG0R)0NA/DCJ)'ED^ M?Y =AT=V\.=>)L)U2B?2*[@54$^N_-E)0AO$'%H7Y=R7?,I/L,O\LDY9NVV[ MZN6.P6S5G;6+3IYG'0#!3*#G0,B0*@J(0*23VMTL\! MAX4P]J3_A:2#AN,M;+:3=\,MC[AGP\CP9$A^FD+D-:X5_4CH:PN#0$CAHL,R M[L25TY@Z[9,97+8X?&GIX#*:855;I=!U[4WGW,S;2;:?B&9V1,XO-&E&."B+ MS!_X)9Q\QYZ:A(PMJS-?H,Z+TFPFL'1"/.1BN 7O"5H=M"^>DP6I=E+&6=Y M<0GDA@"D6*[[08.?N+Q?2_ J^BXETJSHJ4V4P>%HQ&+]DSDJ"WA0T Q@9T;( M>=F%&5;AR+0*%]M$>Z,Y&,A$VUC@K(^$,@YP'E9,@WQ]L1Q4"S=+/ Q#Q$OO M551OJKLX*K+[D#RY4@!%YKP@.8HI,TRVSE:7S'ME+RZ^EGMRE??*HCZ^">K9 M6B$?IN3$R6R>="&YGDUOF">>4*('3O*FO &T*.SHY >,WM%9B,R79X8%I)VQ M"U@\+&C+TC$C'1V0==7^_!/'G@'G[R8 DCCC^7D]^EHYO^DB=ZJ_?7:FP0[4 M[3:J1=W5@=N#4+=9+>JNC@,_2]T@7)+ _MP;FLK6>]7+! OKK]*QL67506=? M50?FL><9U:*5$VQ-M%+RV=D0[1F-\1*BE7+5SH9HSR@"?21T.6/P^3=^44[+ MQ5D4BV>Y;"8*?(^FOZKO/>\DT3)N*-]$/V44<]"2%UDWN1_5 (10LS1!-AP! M1WPXAFTO&V3CFF/>M"M&WA?8-YL@\$$ MY2A^CIJT !I?PEXE!(]SX=JFT/N M)NBQ*5ADA_ H>[2L@,$FGT$I/37SQY[!$5T?=IBY\D+RH<4T+UT-Z0+>8;#3 M%0^>(ZQT-&&:T>+AS//1/"%?25XGATG1CU8BG$D0^N$]7<$+@O A'8[GBAG" M,=(:[O.G(#].C%Y5OX;NHD1Y5X$+\&H6>2+!J=+9%9]HIOO,]_*$I?OP040! MI>I$XG[NI[=2SJ>L= 1^.L^B;Q0A4K$7F=%$%Y2W)9]5EC,9"!FV#4=4!V5G M5D'J/0SNBYXI+\X>,Y'SQKS()0\;A7KG8YM2")7_*9YC\%B@\PFN3NXJQT;' M41SZHH["+.?UU>7XQOS[9R"+Z%^S _0&!R&%KB/BPLH\V8PW2!41H63&Y5Q6 MN-QBDIKD],RW,68?A#()55IT^&V<:EB\.^6,4F;F\INJ9;LXFS&<88I I//6 MM>@:J6BABL$L5V*XS+*;2?%>G)/H3&S49P*V8^(Y.$TRD@LBE_KJYQ^A8#CH M2!S/,2(D'UBX(%1C6HOOGX&\9%L,8UI(!XK*./-(*P96;E<]Q1:#"LIY^[3Q M=EXGF\2,[.L9!^P'V_.)V<"?[,U$!34T61@]Z>*]9>YOJ>G1%]N+_I_MS\7- M.(O)Y\$B54E$HDB*L)S#4EIE1VILS^RF;+ MO@A@5:SBU? -KC(QZ($:Y M4H.GM<:(Y1CX5HN8RI@ICI/?;LN477WPF)>!B_]\SA^V\C7W5VD" /VA4>:T M-XJ.')18Y)+Q!?IY O?P,58,CUI,T(%S&& Q)O])O(8M%7GPD!1(E:%[NZHY'C#!J]0=MYLP:RRX&FI9#]/1/'=9!>/23/Z4+H<]+W-0Q4'>GSCMGGKK7\W8*_57O8 MF_$G^:B:CWH]N&U/CI(__Z3(\0S6+^OIL1K[(RRYBX4L<1"!]>TY2FXI+ZNL_-.Y4^^.2FL M6^$H+\-IHV;AU.O;<0P[6\@&#_E!UXJSIZ7"Y-2#68?+US'WMAC:T*XC^[>M MO!)Y;.KD-L)C,79PI!=901UY9VWRL"MG57ZM&JTR.V=G_=NH.85<(D5T2+_. M:1E9PX:\>\9%FBP>%A8:RQ/]XG$>UZWZ9:2=@;2C_:HC/:XJ$I@4C-M9NQ1\ MB7P!=*EF*[M.)#(7!-!!H])"+=/2-2^]4V'1S99\:.UVH*/"G''N G,*E:.% M6OW<4P)//DT#*YF+&TE?ICF&&]##OE",HK7S6"HO>L"O#W1]E/0A3/GQ[I"-+R.P9NK&8J>LLN+/.],2(J(G*9SD#+1>K-:!9B MNQ794V#M/5KK[E%HE;?8W*J69H@G8HJWBQ"IU9ZI*9JII@BX=8&@U.]!!FN! M$*J)WC;=_4X]1G2)L.Q[059JH!$=:0$J3(D=UJ#XX:,,RU%0A\*V1&^]/5A& M^K0BEYPD$JQQ3P@[P@V9AXM!-M#%@X6WLJL$[!8OGF0]#2E"3G<%T?;BS$1, MUW5A?8-M[LVGL?46V]*2/_V=W,FRCP.L\"WZU#&^]\["Z+?L8N:-,U6:&A'9 MPZ* Z'TA<>E/'KJ+\G:58%#9R(FZ(B"6/L$RIR*9A+"=/WD/H [0GT^^(_6I M$I]T!]\'M#ZJ;T#2H![XOK)[&_Y*&9_DMRH0$S\$]4-M?[5%SL#N&I-A@^8V M&:MH6;%2)E(,B^*;@&B#[2ZOH816 M.EBUD)@LBAI[48RTJ:F_PKG2&1= D?*=%^XI._MB#Q\G#X=3@ALTXP MDKV))JAE+0KD30J7RRZEZ@RU'@:I,,FOT0^T/0+K2AM2J8T'8@V, WXL9IV5 MJ97+*?8OD.E-4L)(XFU5!HI[-94OV"[2I-"75?PID0K-3#(^,X/=EIU,E+CJ M59Z8AE/H )CO0WWGY:0;IUE0N64K#UY*'^3FF$9NN)<7D:V3ADKU9F"%UEU: MPRYX.NTTHTX FKF,EDNI$-4+*5D26*"J3Y4&=](,C'/652PN>UHZG2 M45'=ATP%Z!@"9LAF(IAWFO?37:7A-PIE9*2C76M>H?+>4@UYSC\^Q:4/=SKKG6"8'2YTO2H6K/2D[ MY*_%@((C86U"+JKT!S0LTS1+M:E1&5#??PFG&?[@*3IK.R#QAE3,EH>R08$7 MJM;MNY1=?,[;B3>;@=X$?OQ?6!D<;._1/.=,KY0PQ*^4-'1T.?$C7.'!)NF# MR>,+FOBJ?3N=CSP9;G(S=X/NBTB]!FLG_U0IJZ5[!EDMFR2EK,MJ&;F]EMMP M^_6>:XMZ9S0>U(>N:->=<4\_!<^Q\FV M:5;TLC2"[4%?&3-*;K%_5UK83)V [X768B]OR*RURK-5K5"AI"3O'@PG4C^9 MA//[25YKA*F"U,2FMOQFB.7:'9+'<,7%X_(L##(@M8>0;K09=JRB,QG05KIG MO$2ZC\88;:*.[*&O:K&F'BKK^S!T9;4'M697M:D+F0_R+M@'2HX1RGQ@>8YL M\6#B)7HABE#K8S\-[20O3A2C)&Y6R&HM9?5IL<=SR,*?V#L M81Z3DPW^MV3?;6>J]4I#*?+*TO@NLET!-AIURRQ7GEZFG9;@1/-)]*QG4\;$7>YH(( .=BP4I-*K"I>Y@<5@\ MX-J![3^A=M(\JR/;A:/0")41G)9CS0VKLFX>PP@CN^0MST;1@>2!EG+4CZ3+ M*#_R9)=(4WUF=H)=V50/L-37H5P[L W^,[?S,65V@:)6!V:5F&S+/(MYP0JIT2F M*O#W G<+33S 9:WLU-DK]8%=N3-^T#5_]\;K2DGB*/F.&H#2#>'%'U[@3>?3 MU?TB%OMUN/,H[==1M.*O_M47;J?O=,=U9S#LUCOM9J<^& ^HFWZGTQV/[>ZX M]^8#)2^5.GB"E;.:!J6ZTCW3P/ZY,PT^C(&%2\]WF])#.D&7-#Y?(-&%]?M2 MP5S(O\!=L""4,F:4R22E6$D/O1X]T80RS]8@^;7",4HP3+QV- M&5%4I99G-\AHB-RKJ_TH:YX$I4I!WYIBC@YSG,RH$$FYI3T4)")A7D=F80=KI MU\7Q$2K%#'6"# 9@()%J!\9@>\9I'GJF7?+GT(H1]3 G18RS1_=B/=]5K@O; M4N1Z#[Z!P:4$.^)B!!B3/[*LO9I*CBGFML@8L_#HT7&D8/X0VLJ1ZK,9Z&C\ MLKJ:#)'C6I>F(-.*TO8/S_5Z6Q$?*A75TH;*MYLJ,M@U0+A+?R]='E2=06U! MO)=;3;4\)08L"O0)B)DF3M*7>)/4,/!Y05! Z;M M/.2.VHG](*12UF+JWO+\G.?GR16F)Z%-.(_0WKK.-C#-6%J^LEII[2G0Y<2[>K M.W?$4A8HZ%& FBT^&Z%$6<5GE-6F[&%)1UZ,N9A94E*Q>9L] M1^_4Z*GP(WL.XJ_:I6C34FGC !JXFF1BIB>-R@X23".;JU0J;:=I,V.H:1E* MY,*RLKD"CR04E)R8)IE \_&LF)$=2?*Y>3 M1:M'-N.27\B50?ZE-.A+F69R Z1S&6DMONU-2](O)1^?H[3;]%KY4-XLI1V;ARD'8L'8E$6C,7"P_]XVWTF[R,[,5>6KP$B:*]*>&C> M4W0!4&(R+*\NEU?'Y=7E>(P<0).TA>[R##*)N#Y9G8EV.L)[CF"GC[V\ *=0 MR]9M_)*1I:#RY49#GP0EI((.2'QY,LJ&\F15M)HB?%J>%55((X4(XM MX*)/9H!6GEM0D"IY6,N7TG!:)9U<6)=60'K6U^BPXD;K[(;*YZ+T3C\79:-4 MDG6Y*.WFR(83S;@^=!IVO>-V>W7;&8IZ=]#H]=I]>SBTQ=JIK/LY#"V7E2,* MARFC1+=,*L>]32=IR["1J*:M9WN/3*F74.9M^/S33B'Z6ZIY+P/W6JGDSU)O M[YJ+_)).]RL>94D/AST^R@OFNFS_*$L**O?X*+WT47I;/\K774;4&+9)M5[6&1L[Z#'#B %28-B*!H:M)ZT",6Q9?[5GT'XZ./8UEIA\'G6H !44Y*/@LQ[E]S/ M/1==(Z7%9@6]?N9J5+E6M.Z_^^&(.D@G=G!/DV-_#Q_KN&KE='_[]^O?[Z[? MJ=.@6J7TU*2'0)7QFL:Z5ZV@U-5^&@*B*MIY,78'D_,*M ;F:OP!51=FPR8I M;J^>MU U&3QICMB\,T3F[57+QN=6!>KYG;(+8NTG+$8/VF\V6+X<)KO2H432 M4P:#*A^JET/D"_3)!.YW;-MRVF&>F^>ZTN3M]6379LTQ&R<@$>A[$E&> /:? M.7I\L91VEB@'5Y[#0IDOV=!7Z>\*"]=9[B::+S;J =VD]5$J=\Y:U>M(%MJ1 M*UUJ".=)YIC[*G2B;<7LP56NCG(O24OL6;))3SD5/:FZIBSM)^LU&E]'9AX=)![3NL!1LE@?7_28[:P'NK T!54[]3HA#--;*D:C]2=:INEH^UE'UBW&$:1 M98AIW^UL\E$]/9;1Y_ISDEJJ2UL(KPJ75)4\:@P0#FA0@V!JA6R_&H5@'1E) MMIUL[@*91O+TB\HF_W%&GH1"0WI&8?91/N&&>EMEC!F+-*:H6C#$-(@=GS[V M:*(X=5&1,8\@'<.-#[NE@BBY/VZ!>^(CTN=*(\\-&8+D,D!O-ZP#:[8=<7*.(HU"= QX9-0%>T.6M;Y9+++W *_57V?8KBC MFWWMY>_7.ZF.7__(95SZ7EX#5X>!P#FTE9)6T?B.^%#B2GE MN#!>=VW: M2^'9U&ZNJ:0:6TO"4Z1(\VFH\R-I,LV=A'99C)M1?5F5N\2+R@QTY5DT([H. M5!=F=#'*PW,^8F@IXS^&V/?K[9?+VX_OU*%I^1=_S*C-*,C&CW?6U_"";E%O M##>0D;) 6&_OPADH49"%=^^M:SVE';CV68FO17K455M<=4/65J>D*LVE*A12 MN2%-6H-;_0_ QXF94Y@<9CN#^!;!%+Y(W\:D7:,(;,3@^6)$B:L^5+CTU+R MJ"@M'&FI+1'G'E MM#4]"*Q?4A:3/LF$W&)""R:7:"X#_=B^='5Z*A-=#O_(\EM+-:L:-RG;O^BC MI;P0E0U2&%^U5STMX MPX67CI?FP\1+0M](V338K^PI]:7,DL(?8B)O1(W6X+W,$[&8])*G&BTRA(31 MHXQ@UY)Y"FG2"_ICJ"P"GJLNG4\+_3"+A1/X1(E*O5D0;"WO<$K:G/IX)1K= MTIZ9Q1'2\R5[8!E5B]UD9>O.?, =!AP>\("[Z)\G8\K]?;'9J YVA::=4*REO9]ID M^C[""0#SQ/.S+)J/O@V6R:TSP99_ZNIU;/%(/:%#%Z>HIBW9R-V*"4)/LFI> MCG:5ZZ*ND"A9CP*V-ORKN51T3RH7EAHM+#"B1O[](.WB M0-?"XV1ZA70!;^?QG#IAX+?H[)DAQ;O:RE(].)*O,O-3S-(>NMB4/!N803@F MXQJH1+,:BLHG:/5//T%KH_RJ=0E: ]L=C.V&4Q]U[6:]T^RWZH-Q4]1[=KO0+/*5[7QEG43A&) L 6GI+7OP8J43LBO4Y$ $ M%6:3;7?F(UF2D48&:6B"ZI"IWPDLRS&H6N6SQRA&=MDS"40O)WK9F"+UCW>E M0VLV?(-.>-1B.7?#2!L;?Y"?;0G,OJ6_0E>@9KPN,ZFLU*3")X 3@12/M1*\RH09O/L3P)LWL2/TW(?(^![)\OD!* MKSE-N4;_,T"DUL1$,W5 1NW4BL]ZJIZZL?)91O>T^<6I,P5$ WY8SV5A<:R( M+,W014NUWI;]HK(!6UDL3"NQ23O@%L)SRC(AF?.I E:45X<6B12@HE"GUA5I MD,QQ@,=56SY4WJN04@;P.NE8%?TY5[LKLXP#6"=:VEG=!S7Z!%,ZE:TLYG?J MPK&]2S)G4U(JY*8X?QG(B#PV=D>>-%>U2"R<3]7L)("AV MB[D@<=IV?V&XQO/-)U:9REHU==X_3K>:TS/1ZBXAI0Z&RR,PE[FG_.-3_A7E M6;Q$\Y[^\__DC;_1\IK/CWVC']T]S80^Z2^?!4>:&2?=QM]O?^S8:B2<1UJW M$+TWR#EM#G0(DMZ,%PY[TI19NADHJ)&*BE;R9CL33SQD/J*LGBT+B]I^H6F@ M@ZV2874EK:@V8RQ6.DFV.8O2[@KA26D#J?E5&LY%6?5TDJ,]Y"2JG78USP M"!7D49L[8J=$I.*QZ%ZHH0-$=J3,3RETMI46"RYQO9?!7DJU6OA",XLGS1K] M _6?=65'?FC%GO17HRM5NO8R^/ M@6$RCW12U59]3U8G(HG4OM&(5)-SL-3R1R)YQ.1RPLOWQ&]J]T.*-^A5C/?"7VOOY":!&@(:3\HJM MO@M3EK#'B>=+]UR>F8T3+OUY(2<:'R=_CK0MZ5Z>@HK]UR^H\*2IB9]J9!SN M Y@*1D'>$]E=O?Z4"909NLK7$2S$3K,C87%HL3Q)/4O-C\*QYVK 5[&G?3JT M-E^H%RSW1]66/].BB!&8X50LFRR?M1*9-[U0=]LR!;4TU1[V6IXH]2T*@Q ; MB9!:WW?]RM+\TX$,$CF-47_0Z "D]<>=>J9GKUI7L M4?Z['*VKTO[:K=Z[]]8?FDF'\%/X)NR,I9=C!O7A#./*J%"86VW-]A)?*7R:.5JI MZ(5RO% KD?*?CV 7YEEOY (/@KF=:YV1 "FAJ<$4H,YK))O==,2U'_)W"& M,R5KX%HOGL[F3NH:V["B=0U AO5FJV;8\DPCE]X^-4N>[S0 16\]+"@;/ZD3 MAV'K-HV.FK&&6*N3U;@61W<3.$3@/C%L70)S8P,R?])H@ZQJ5LFY6?4-50RD MLWZE=PCNH*)#U -/%@/2\4_:<9B;C5/"Y73E['P([%IL_&D'TK_L3=-X4SX9 M8'4;W<7>N7B8Q?1/&:J6N4VR8:[V''IPX#$0$;G(T:Z4:15J\$=>6%TLI\;, M*CB6VW("JF&\5,8KJF##5B;-[EAJ-UG!,4LM4[NXB\=P00QQS3""O/;I,*0 MD_P#&'&E)J$=RA'6[LJ34*O5<)Q&KUF?0&=9'K7&W[G1%=] 9V,.N M6,B6UH[%F-L')MYOI^,;:U^DPQF?.7)FHU_7S(5MK3PB/N]'.^HTQ$)L[\KJ M-7JG[1.\":0;054>RA>R_'"P,,A0U=_B>]@60P..6)44IR39H( XG?-)P&ZNNJ9K%JS(P64TF1\Q(K68O28O\3J@G\6"Q M++0$":M)J)IT%]K=I-69BE2P/!RD2_E7J=FK^J.GE6LR%5BX*G*2%_V.M 8[ M2_H"+$L-3?-#=/[I*^INP;S"<&1BU47AM\71LV!^_"@^.E4 $A5]7U4NIC-\ M=8L_3>/3ND<"OXO2J2KVTGKJ]#*(R1[6-B"L%YHJT.2=Q9 1YCG$)%Z(;2OF M#U-188J;RA4#)X40:\V6N(MU9N9)XEA ,<6GR0YFT^;NL(79\0O&3F:I06O MG*M62]/&]2?$DH0 IR9DO=QH1A0FGJ>EZS)W$#-OTF%%N*LW5/12F17N2\48*N*JN+1>"R"%$$,GG0S[KLE6O# MB]1>91[U2WWN5L<+/Z.EFD+9'3)V$ULIS5W*ZQ*^A-&:H*2>.9U_)VL_(;M/ M@)+L-(:KTYJ>M<;ZG730_-TJSNC9@#0<09%_W4C")>7X@RPV;I>M (DO-@*& M3U7K;^F,%,YC>-SXW?MR_&2M#94_U<[AA*-OH#P^ <_@>@_X3T):9(1*,/K; MFP9P5/@^Z \L@LI>SS!S2+TN//E[>YZ$O\E?UW$PLSV+Q?OTC]\ !-QD\GX( M!B+1+8GHOS23#6SNO[V1A,LN.K*=/W' 7.#6%5)]H?_[32V@[HMQ0G1-W_A. MQ&E<]+O:FW=(_.);'W,.R35UVA?MCEK6YNQ4+[-E%,U@?,,,_O[UU\0UAM3- MB\$!"%TZ<11MFYS4@XUJ7O=)%&W9B MWD[XY3%#61F>\&5@_&<<2S5RW/BG?G5$;A)74 M\7G 2HJ5%!M1K)_*6^-7=8A^]:-TX=RL/ 8IAL MQ:JEQ2HCYJR=3I)M"Q'SHZNH35&_RJILYR/^U9:ZHD*)+(:3*&LH,)G4+<,^,,I91?#(Y/@\81!A$F$D, M(B?+* :1X_. 081!A)G$('*RC*HVB!PM=^C5'8M+"'[49DAZH6@->Y2:EU9W M$&PWA@^F)OJ^CD(RA@U_,8\#$KN?Y8(6(Z0*[7V$"(UARYH9#EX<=EK-_H_; M3X4A#LW%XN94T7W/]-Q7D5S-(XSFK>_WTE^5KV?#D4G:' MP:>4TQ6OLAX:N _GKCP*[;EX& M[B5V6J(VN;U&+V\8,L"&(3O!>;/6Z3":&[=S3,451G,6?D9S1O/-T+Q],FC^ M(@SM#6K]=H=!U#2!K7*6KS%,^!8)''R83G>67^IKG5Y[;U8);_@SW_",=BS\ ME64#H]V;#V^WA[O2-)*7P1U[[4'X:2O4=2#O]'L,XZ;MEG?F<8 1G.6^LFQ@ M!-_EO-H[-0!_D:.^6QON,76-58IY?GI.FG]!TGPVYY\/I+!(3T ,X2<8/ MXYU=])R/P/D(S 8V>OU6EQ.H%IHK;SB9_A[[ST;L7DWE0V,/SM]-S\GM :.L:<+\CC/NC?'DNV+L.=[. MG6\X5^&\@N05TT2FLH%-GEU,GD%CT>3Y+A+;"X3[V8X"H'2L:;Y/4O$=W%?? MZO9K@\[^SOJ\]X_MK6?,.R]E6S&Y-Y4-C'D[>.L'I99O+X(\=M#KT#WL<2Z@ M<5O$5/7%V,W"7UDV,';O=%XM-;,S'+SWXY5O=7NU09^AU3@)7N:7_S7!)DSP MKNL]?""6H?QYP9R,MF6DP =OS9;M;?W)NQ>MSB_;/&Q!^4G)^3J?@M'HY#NJ M7:XWO74FPIW[XF:\;B<$[M7$#NY%?!WHW_$"QYOY(KZ#A7_T0^?/8^^^(>X^ M^D,ZI@3LJADJUF@NMI3+,C.,D22L<$SO>%/8H0F^LMUP1MH7_H>?7(4!3?V@8$=AIJCU:,<6_&\<^G[X&%MO M/?Q%.(^! _$[FC@*!$6Q1WV$NT"-$OG;FP;(@?!QRK(#/,M>*T5"KPML>&_/ MD_ W-8@$R.S;LUB\3__XS9+J9MA0%N3K5[44 E^;3@,^S(2.4S2L]CBZ_&C$ M-V;WKY]IWFR8,-2\V[X8/+-3*C?4_)-P"*>LMBECS7FJ4!4*)$WE@!%$K]QP MP PH6B;@1+.WV0RZRH"$LL#-VR?51@LS>*#;O[Q56+V='L]2!\,_//0D&#A/ MD-7<\7G :NX4N,23@T^ 2?L:\VRYBB M5%6A'UN1<(3W@-7@-2L0!F9XTE0P)(T7W/ M]-Q7D3P_UQ?KO9?URMVH(="@4>MU]S?!GG?YF2M;AC@6?H8XAKC-(*ZS)X@[ MD=ZX5[;OR(Z!/X!_T=K.N$LZXNX,XOU!K MZNMYWB"^MP;W.\-YJ]9M\H!:XW9.E;.,C6'"=0";,0DC3\3FA<;8KCK?@"2S M@8VK QA7O47C*E5P3V!3'SM;]P/2NO,U=>C-PL_)5E R/W3I/Q!N<-W0?U[V?3^#3( M;C)T[#@6R\&>^ MX1GM6/@KRP9&NQW0;MC8+]J=B%?A:*G_G"MHXK8Q5:4QGK/P5Y8-C.>[Q .& MS4H"^FN'"0;#-L.X:;ME69S@UP0K7N!=UWM8]N#XF,W6;)G:T!^T>]'J_&+. MDUX'E@V;*R+9MAZ]9&*IX1PU"W:WY7JQXX?Q/!+8"1_?\:8@ ]07WU;3.RSX M'WYR%0;4NPNM80LV:B(W,G[U9B8BVHJQ]6C'%OQO'/I^^!A;;SW\<3B/85_' M[ZB%.!!7T9A(KGJ#_>T-G# /D-'NMI)9>%UCRWIXGX6^JLQA0W+=G ML7B?_O&;)65[V%"F4:4'PU718C!A&IPQBF#]E))FPX0Q)=WVQ>"9G5*Y,27_ M%'9D?89EN=8GX9#Y(5G9;M8LM$../K>$VP96( M23Q,_&195VU@-X,'^M%EY>:I]DYQ3!ZTR#Q+!\C]PT,GD(&]G5G-'9\'K.9. M@4ML<)\ D]C@/EG651N)CN9),RA(8R!;JA:O,9@/1I]T.%:C'78N8^N[F(51 M(ER.SK#RVDQYG?&^8'5VDFQ3B4+6I#6Q M@WMQ=!VU*?A769=5I[^V&1S(M7PW5,Q^D29(1GG_GT2LY]YA5W MWJH(&QA0&%"83PPHI\\K!A0CV," PH#"?&) .7U>51Y0JE.\9PP35+,-\Y+O M&-;/-^71&#;PZ&0CV;)]ZZ368NLDI=>^1.'T"FZ"5\**EZMY#.01T>>?CC]' M#F S)?B?>V?_?*83<*/9:+ZLA6![T*^U!D/N/F2:O)FJC1D#6?@9 QD#-\/ M]F$Q\$3:";ZP/_ ^4+Y7:S5;C/*F[2A3\891GH6?49Y1?C.4[S#*[[-I\,OQ MOEEK]/N,]J;MK"HG.1O#A*LPIA3GZ&51!DX>X$ GLX$-,",,L.ZB 89*[F;\ M]S!T8S T;D7TX#DBO@U]]^ 1A6:S71OVNCSWV#2Q,G7+,]ZQ\%>6#8QWN^!= M;R]X=R)^A:-'#Q#1.YW]#0YFI7;F2HT1G86_LFQ@1-\%T?M50O37B13D -YM M[6]*\!GJ+[D/TFVP;L>\1BR@,&(P9=O7^13DRUFE05#@%KU7"<1J]7'XV'XWIG MT!G61ZUQM^YT17?0&=C#KK#?K+M0=_@ONHY4O/ %X5XF"Q^V5Z+;@FP2VP<; ML_V9MCA;2,4+JU&L[\()[P,O[7&WA-?X:+UGG\RPV9_IXWFQ%) M"*QP! Q4 SOG>/2D 9\@\E,:YVF3."">R)&ACHKNQY8="2N&'\9C3[@UN)CG M3*S0<>;P&7V5KD/+@XO"I>A"H9].%[T*IS,[>/K?_VL EL)OL76/5H"5A):7 MQ/EM+N0ND/_5'F,J;!Q5ZN* 4;R:/45<5[>)/5=U-M+O9(F?,\!;N@=000!^ M6UX [SK4+PR/R=EZ(T O^BVMZF*-+)S>(%BPEH"M4_O?8>0E3TBR&&R(&%D( M]LI2WM 7@&BS2,3P1&3[@"'BPS_ ;638+ K=.0B)G= %9J$GN>%-9[Y-OP!F MP(>3,)YY"9@O%JQB*EPPK'QK;#N>#YL.%Z$S+)/5. WD6O,97,>!SWTA!])* M88+;.\+%V;5@U5GV/)G P_V7[IJ*9K;Z6%LACJ0%ZLNMD IH*@0D*?C=7!K/ M3A#P\2(QM;T )3X3!"08;7!L%3:.PNE2L7"].(F\T9PX(0T!?!/8EOA/2+R< MV\B69>R&[?LH?!__S:X&RRI(9"I;'@H-[&S8]< WVWV@%LNHI(*"G-56JQZI MGI20$N=1_"?>+.V)IH0)[U=0/7<3D)T%[:=4)RP''G5F/Y':@Y7%H&8\U(I* MC4;B'@X:\$"D4:76C2R/;@9:"?80T!EH &_.8Z$O(;ZP[K3]X(8@'D&("\4' MHR-E+-,H UQ!.S'=_RA'I._C.'0\(KZC8 ,OV"3IA(\$.PK:5DK"*+74IK\A\/'D^T.8F(@K* @0RDA)17Y=2 M+>%8,3 N\>S1CN!)DJ>"A9+:IKCC1D(W9D"F\()!K)2YOHND*D/!>!L+87V% MS2%W=?]=<8/-Z'R/2@I$ G[] (8$X%N N@TAC_8=D,V3UT(6: MBAC9,:Q+VB >0.[]/2J"1%@^4,&G?3N;1V!\Q*)HYGQ3^BXJ6FT1DC$0).NT M[1;7=9$=VW0;/_73J'.<9O+W2Q&63UZ<+A-^>3-6!M<='E;O0+@^^J'SY_KD M@F'JKAA*=X6('7N&AX5H+I:>\T]S_]P1^W&P/5F*-+T^LR]2QHV>K'N!>G$V M>:H5Y,$:>;Y/V\5U(P4,NJ5AO241"^]!;@*XE3@BMEKY8.AUP6*OP?S*/Q-->; G6W/8O$^_>,W2WIJA@WEWC_6')9N M_Z)SS/D?I^OVWE?3[S:/7UG?"[S9,*$9>*=Q\4RWZ(F)_@ MJ(^^=,G*=K-V],;@W/"[LJ!B*EL87LQAA&&C)IH7_4T:N3'^:'S%XP_#3(7U MV4[;A">"L0H\&[YBP@JK0%:!%=X"K-K.DZ^@VOI'5VT\7>P4"^^5_^%\$[9_ M!!Y&\&C.6&Q>^BDAU/E2W]1T>6X$OZ>F2(=C46,S0X!+'K8K>1@_JU SIB]0(0*5.D1//VZ7Q>5W:3#8ZM4:>VPP>(95!JSV&6V/3G9&6T;; M<^#;]F@[- 5M]]'.M]6L]0=GVV-$TM.(325,]<8U0NH4L3V38H\5YT5Q2M_P:!C_BO+70'F("O4ZMU6D;,X7 R/0(8V36 MO"0QAFK3]#]#]N0:V+/0)W[V+0-9LY M=V%B^\<> [C&G#H$5TYNOY@26-VV#*[ O$K:6Z>;[+$75K(M5K#%#CPB>D]5 M#,-&K=4U9W3A*N-J)3)42L$<%RP8N,WA!0,W S<#]V& NS1:>._ O8^"B$&_ MUAH,&;A/0@@9N)D7#-P,W S@US=G.N&I />)CBQ\ MEACZL\NQ#EOLN0WGXIW]Q+IOM(MPG-+GGS/A>C1X F>X?/XIIC.:EI*2:-GP MCVZC-(Q5J8[OZ32H;R*B[1TXXB8;P?)9#6V!1X.OW(QO:0*]3&#=SB1.>(A'/_61A]%(Z;LKU8L>N^R(8)J-*"-LZH\X",L/QL#Y(O@'CZ#*Z\6VE7M='876CG2M_G\O.$7 MW^DVL:/D$W"-<@=:C5:CWFC6"^YL#4[KL7#>N_/H$2 J%L&;#R!FUI.PHT75 MBU._:+882LA;KT!L)+\,)F X-A$A7S6D4:*);./-I^&U"[94K\+',UT,_X=+27Q26X"V&IWXN63 MD)9-66WWY"S77M^UP6;JU1O#\:C>Z8Z;=;LS<.OCULCNCD8]=]0!U/M?BD55W)#\N8;G#.Q8W+HT@UGZ6C-R]LK:]!I+4Z^.S.4 MO@FL_[%!/T1/5K-FH8 4<=!&B@@Y=S" 1=F9Z )!Y!3YE%(UJS!O45L6Z4$' M[B8E5PU>S(>3_F?N 09;.-"-AN?)(;5284LU*#6\[]DC-3V3=+%/EY.P2G_G MLWM!K0JI,U<#:JECCMQ>-S,:H!OFBT" 4Q%_""+BO MT=)JVE8BZ116/7GS(<^KRQ"4/HFST6RV3W9,/!&B. 1TNWUPFD/M5@F]E*U, MWN>QIR8DTZ5I8K8U%<"9HCFW*0CD:%>PU7(@=X6=Q.KPQ M-S2R^[Z5UY 5[>4'6Q@6*7QIM]+%;.=/^YYNF/\,KC'+3FDB.Z6IH:E(I9J^ MA06(.RF5&2PL2A_)+JOCHG9Z]'R?C*U R$FT*RVC%>?UE9VZ%X5X0Z'>;L[] MOF6XV6BH;3J)TB>< 6OJHTC8?];M,3S@>]M_M)_B-]:ONSLNMGO*#;T66UF MZTS(SK#A],:]=GT\'/3K'=&'YV\XC7K;L=O=WKC?%XYXLVXEA[)]5LB/,2IP MV;CDXZ\*1)?\M7AFHA&]^1$/O0%2@=2D*I *SYJ ,H$S-JH>J;H='Z[AC>$= M.8L=U*OV':6:U31F=4(K_J2H_6P_#@LJ< (;(Z;3XA*EAWK)%6B9@"ZFK^>V M"NG 3/G)9[E0]I&9[-!M@LQ24D^DF6KAPD>ZZ89LTZ87%V;#JCFRN:=E*LTH M=9F9_43FD17BY/#B />I6XXS5D^.%@<&1C=RI^R@><'=/>SK- M090]7"H>6PX\+OD\;YV)<.>^N!FOLT,#]VJ"9FU\'>C? 0)Z,U_$FYP_7\?V MW7CV\KE9KOJA=87%*CV<($;*_I,CM5%ZX3>+6U7M8OCD+UL'Y9JEOFC%TQ2% MIV[&/V*!0;AUQZG7/#!I<;UN%KSKO?G0ZER4:X9!(_E^BB+KU-QN!"QU2BD2 M\'=U@R?32=>[*-=PI:0KZ6,7%\ XWQ"H&^_^]51Y_#$>)HL\]79EET M^A>M [1WW22:>>[3R]:TU.UWJD5SPZ:3 ?:4&+#277'Z+/FH=+J=F+<5>)CB M\7G ZHC5T2NR1#.>K4^[5T^S3F*==$8T9YW$)A*K(^/:LLOS\=&:E9G*E6-T MC4-$8$:<"'+P9&^-;9^$0\Y=JRU=J(.C=]RJ,J*P[C*'$:R[3&=;$NKINJRT M*J:TJD1@5D:FLVTA$GUTC612XU(S.&30 ;Z:,>_4DW6+"1SOS?-F50Y5#*"Y M(;-DF4GKF-0NP#TSREA&\4'D^#Q@%&$4828QBIPNHQA%CL\#1A%&$682H\CI M,JK:*'*T@4BO[5HTIB!R>5FR>;UC#X/LQK#!W,[+W#3YN!R0R%WM?L?_^W\- M6LT6;X_C\\%,+<7@P-+/X%!1<-B^;42I5>BN?3>PC:&(T[&_:3-#_:VL,NY5 M6QMB>Y>=.O"W.K5^OVE, WY6/88C ,O2S\#+P/OAL#;/JV&5PRC9Z9(*IS+ M:@P/;F1?TGF$>=1Z#SCS8C%LW9QQ"(S9P";. 4R_YVKN2FJ^9Z;@ M+INAE]L7S>;^IMOR/C[S?EO[IL8-C=!79+DT6WAUWC0;3;*(^),$]^*Z]&.!/[M7GP>PA/37.N MU@Q*,2^$Q'8.1^ZJRP:V"[AM9.*N2MC>,B@]:^S,_>)^?^3YG ME&/IKRX;&.7>?'B[-"OH:[T0%"&RV&T-72*B4R%K(D= M+^9;QRCM5C@>>XZP2$9JUJ,=B4DXC^'/2,3"CIR)!;L(=LF#\,,9[C9K;#MJ M,]-'XC]SCSZXL'Z7EWWTDHF%3G2XY=AJMJPIK&\"+R*X<0R_B@0L,H$[.-BG MW[5 M8":L$9J F",$P!K%JP8WXV$#[O753GBXN=,!'@3O A>X#X ^M$E;.!C M9"/UZKX7X.5B#V[Z("*ZCOP]+NM"BHK\KTXD6^H.21CY?0<^ A+CFV_C.5(# M/O5^PAUG]A,IGW=6+&8V$%;X3]8X"J?P;,'J'\-[4UQL).SL8=X55O37@H3J MVK54-_,[D%.(8L3R9H;JZ"[\_#,1@6N$EJ4_R&OXX9)D8G&N_+!&+-*%U==D M*1)3VPM0<#.I(D%*)G9@K297UO\R>(C"I;3ZGE[X#JY[,[X"4J$Z?^9@: ?W M(CT2_@$_G\ZGKWX(S$FJ8U8]%LY[=QX]PR? MQM*LMY1F< M@NJW[P61#FD67P;N)R^6.OX[+#N^0\O@#JCXT0^=/]>'/19%2(!!.$.K(9J+ ME6>"L[$C'A5-+5L259-O:0:X*6$MA$*)SXB5H>^'CS'-\]V,1JMMT3*)MB"* M;B#"0M 61$,=!4"-"_K;FP9(@/!QEKH#,IZ]5A8VO2[8S>_M>1+^IH8- ;M\ M>Q:+]^D?OUG2#A\VE!OE];,YY +ZK6<'LNLSORLSA>?U.=&ZZ V8$6;'I$1;J?H=(+N(]N$/,H-MJ<.:U!P*YXWQ>:0^I'KJ[\A]T+GGP[C"F0,AO3%B4(.W#,5Y0N@E[J.T'/T343.L^57 MP\7RJWQD1KWUYD/_HE%*3?O%N*W,N6D;Y*:MCGR7:OF690MDK0O^L)-Y!/\: M'>T^X@Y?G9/T5U2]Z8,6A>G-AXFPIHJR,B-IH8?I0@C<>NMAFELXC^W C=^] M_^NO>/$/'!AGF^_H1L;QZYAK$[6H0MSL3U9F5F9+\Q]9E]\O+"T91QFX_N#[=K :%,7/M4DC5(2 M"C !/!!=.4>GUNQ1 R#E M!(SB'PHP ;P/0SD_G+P/.OY4EPWD?>SD?90:,6WE?8P#QH[G?QB=PXW&)?57 MS_^@Z,<>_D=+.4^<_ \Z %67#>1_[.1_&/OX'Y_].#B>^]$QJ'FCGX/9LU$5ZD=MS M@P;VV+Z/46L-!LJ$7C:R&WF;7G';<8WQ&+W5Z*G-AT<_,EUYMSB9.*'<:6'O M$(WZ?% T/*!*FTGBTXDZ39+#4W!X.KLZ/$?S2KH[,_O33 M@H_>3/"W8]YN+K>@HRB/BL+W1HD SRJ'R/9C;$1F- X(ONI'&[[A\%4O0A;$ M;&%SN7,=*%;X2=5DE:(!ATT"0ZOX5TE?2MD6,*=AY57[6=N[66N:UZ<.UM%" M2:W:H*U.*&F9)[74[%.#WYT;_/87- \ D;OUPTCI)K[*:/M#/)VZ?(!QFCVS M@'B:XPG5<\0(]I7M>:DO;S6O_@D6S%N06R#!,' 4\Q^OX-*? N2F/KSG[/R* M94?:)UB6K9P64 ?>*J?(5&5+Y?)B"C-"2>B@N>4TMUP=!E2CE%3Q\%W&NR6'AP>+__)N.%S/[)LI6^8=M M>=$?+7-D- >C7KUG]JUZV]3U>K_7;-;U=K_=Z78Z;=WH5BB!,#1=T[.8%HX9 MN]@<0DE4\73$.DAU.S2=6'P;,_%'GU\O? MFNZ+.0M?:;]N9])VWV6!.W/,R)F.5E MLLQ6ISOJ]>"@^VK5@[;6[FKDG-0(-JJ9&:E6G%%-'E"(4?4(%X48KR?$>'$5 M#&IP8'Z8ZEOE77KYB8+DIPSAV3.$)@]%*A>& MIAQAQ:+_E *D3L![9/A*TZ"+F17.COO1[S+UBLLZ>MQ*VS?L4("K5I[0'.0E9,GA2("RA:FG:E1K.\]:1$+ M)IH_EZHX@'=RK?5KJBB1*@33"(.L6>P:,RJ%,L M=8H]_+WRPN72_U/GAE[O>JD,,]=SV]$O2NU TL)6_M5N9&+O6458,/E$V["&-5 M^329 CQ0$C"HS0.U>5"' 0JAR057=UU$ M_4FH60.)+#8^"OQ2N2;=(*'*@TJ6EBM;-$#Y_NWR_:W5^?YOY@R//N'1.\>W M:H->4YFTOX)ZKGJ&/]>.^ZH3YXQI7_V(:3T>-AC% ;]<:K/(=-P00P08-;CU M)U/3F_WO__1!Y=Z%Z:":R<2)N#XUTC;FFU5&E""3GN5,L;0WT"8XO=BTGV&=YA/SXU # M$OZ 1^-[\-/IBPK/@;?RT[L[$Z^2$#=DT0MC7O*,J1E$#KX*@WE^.89GFQ%K M<":+*I>(66//^4\,+(E#QC@QPQDO"'PP.5A!KPUG M^0])/QK\9%.L,AZ&$9#=,5WTO-'EBUU7-B\89?XZF5)E)9],*9E2!4QIJVA* M?R\?B#.K%<;3J1](ZP0&)1+FR_,3^\3M'D8&\+R=?0VHZ8S OX.3/H8DB@?4 M?6"40+# M)2*S!3]2&JU%<;:&]N@GH5UX1_D%M7PR0GPRE"X_J>-,H9__!P&KA.. M8:EA(7O8+MS7_((+^,+?_QE?\)5%O!,]#ZE_8\$#/F!%:D*F-M+,QH=9^N/? MDCUSVMS\=,+2I^\XA/!_U[_PXN8%#\S%]3\'P#7F6;.%3\LG +XS;!X#7J9\ M[,J,9Q.L9RF/">+.8%AP/',&5O,>_:?R"BU">RV,9VD\B MYP"#I@4GB!"D91/Q114.487KW,7/"S'LS\_$&[-9++#@7*!-S2G&_3VL_ ^F M_%B!AQ,\Q8@-CDW8QQ##]#E)?W&BL5,X-1FKI!V^;YDRF(Z?">,1(+W#"W-+ MC@32*F!IQ'GQW@MO+FP45)*_W=;B$(M]8*&!7.9WI<91T/I#(6XB[2?BQ( M,RXV0D/><09;A.E L3TDL8/\ <\<-:B6:/)2S2W='9\?W[W2G\MV? 8_LS)7 MR^79O]EHG?-.8$,.J-=;CZ;-B7\DW+U\X; M]3J;$^Q?<4-Y9=BP*$$"0]%>7#000NYR2 M2_.1SUH=8YRY.N:#?Z"SMMZK&>TNS65734$4M5V$W"3]U64#(3<=[=3A@Y(J M0@!!TE]=-A! ['*TZU]R I1.8I4S-73C\^1,N)V?1;A7YI,JOZCRB]A WH]Z MQV-2D>M6$0((DO[JLH$ 8I?C\8 RG[FG9">!;W@0.,C)VZBUVU1OK)RJ*&K% M",-)^JO+!L)P.N2IPP:<4[<(DM3A!4'2Y;.*(.E8L0"=$KZ%X((\UWR%8\T#?MN)'':8 MDNNV4>NUVLK47)/[H*X=)/=!'5Z0^W#YK"+W@4ZT5\ <@B3B!4'2=;"*(.E8 M)UKCLK/;= EM%?K)O"JW+?MQT.7:4;C@-BOMQH]M9GSZ$>FJYG7,&;:RF5GSCRH-IKFF2QS+U; M"DZ5LG'GQ2OR'=3A!?D.Y#N0[W 4WZ&ME.]PY-J&/?O!&;6V0<[#96@".0_$ M"W(>R'D@Y^%2;M$3GJEK0PG/U.$%X1GA&>'940[#'87+(O8ZNQI&N];K]^GL MNJ7@"N%,9'.5&)^BK.'7R 3JP%]MYWF[S1?V^LLV2IE?#KQ2OIDO1/+N+Z^: MH W,=9$[P.?T=\EW_GMAH6_-./+?2K MY,S+U=!W[:4"VM]$0'>5Q@^F:WH6T\Q0\T?:1V9Q"O*IPW3 MWM5.:2O*.VJZK@8;"&$(88A/A##7QSM"̌ A#"$-\(H2Y/MX1PJC!!D(8 M0ACB$R',]?&.$.9L[1FKFPW[ O\VTV#!/UBDC8"D.(APYS&$Q\OR$^S3M-3J MWO:L-EYO?U&SJU37HB-W/%S;$)O;^"_;FE,6:*^=W5.?5/%$U1C$!O*# MU#LCDXI9,:NVXP1B)/T5Y<-!.)TRE.'#TJJ" $$27]UV4 L:[[" MJ>8!O^U$#CM,R;6NUSHM=6JNR7U0UPZ2^Z .+\A]N'Q6D?M )]HK8 Y!$O&" M(.DZ6$60=*P3K7[9V6TZ@!+:JW43>%7JV_;CHFP[=UTY]_B$@W"2O+F"-VG2MFX\^(5^0[J\()\!_(=R'!G =R'B[E%CWAF;HVE/!,'5X0GA&>$9X=Y3#<5K@L M8K^S:[M;ZS6[=';=4G"%<":RN4J,3U'6\&MD G7@K[;S7-A\D8@/W%SH.],"L-?7C5! MO9CK(KMA^>GO MU#UB2TD[I\F#97O)0L^X#CX'&]>RS,(@\7>@ZL&6N 5M!)",?#_"-@X"+KX^ M_B',Q"OMY\1]ZYHHE:Z=GB!S#]#A K;L& M>!2-&:((1WVE<1]=/7 MJ-\I5(M_$D]:CA>;_,2RA*YZ?R%A%WFNDLY#W[6W%NA=I>;6!PH%D8.FX(%Y M#E@F+%X/I6.\N:3D-R24^HRZ< /<'FD?F<5/J%I+KVEP2AW4N ",X%"+*A$S M_!#^9<5Y_./X1S:,[KPP"F*4M3LX@ <@=]]!QAXB%+1O M++#@'\RG#<[GQ6?QX[CW'/CW'OOF.U[TP)Z9]]EY9O*9@FLY/B+_/L;L\07^ M<2;^"]_-#NN#^D:@]R RAI[00>[LO?9BAMJ? MM@_@E(;8%7>3!EH4($,IEM-)I:.+Q09&HQRNT4#+7?BA(8[5XK^/165#RMD, MS;+C@>F5YGAHA@[7U@D?DJ=-@;#SDGA5\ M%>VY PX)/))7:F@&8L"Z+L@ATYOQ#'GO75@^:J*5 M7.(0F]-IX/\$*X\@#@^#9X,"31F8]&?PD\T@F,'13S,G?HP?!YC7(E]^,/?( MB43QAK94D_NE_ 6B6'9#\N;9!/,.QOZS'SS PA_QYV-I =;Z0)G;>W)! CB1,W]$4Q/R-(#QCQ+,I*# MVY3L6'O-0P8H/&EG',PUAS$7/8)[X@EO76 MC"/_W;I8PV!IJ.%$-V#WZBF\U-/8)UETN?4'Y^]R<12&E*!O63JOOU$@ZY"L M@95@O.@OKW0PT F?)HYMN^P<;17:O49[#>\2JE6&;TD00_ OB60L4;&CL^ZD MG>S58,!UM;&_8DTA\+DLUJ3@8[PZ'9N6UR@V=ZINJS8XW4S@%(A'H/FC]17O M^=8/H[-WW:DR_)[;JN]D&LCLD]F_&K[^%:-B%3+YOZ>AO@IM^F_P9E"9"NWX MKQC;)6@G:*^P:2?(ODZ^$F178-/5@^S?>.;U[)BM4A-<-1A#V'XA/"%LOWB^ MWCP]!>S)C%B%##\6S&J\8I:,OW+,V3QEFK\0=,).!C*%>A;RG[3F4%QP,Y9*-5I1E$\;=ENI=B<517EWHC NL8$01D6R$\):[Z,SUV4G MN:V)5Q@_8-^U]=WFLE*"Q]F4Y6<#"$.:/7U5![F-I^#V:D9S<+!A &0PKMQN M$UR2]!-<$EQN!)>]\C3ZU7!I6?$D=K%]+[\]DUTIP8N"'QBLD#V:/T^(H1E0 MMGH$DJH)I*K6FD"2I)] LIH@N>?D5-*.*S=2A TD_80-U<2&[0]0:^.-V4FF M>)12,<[8/MS043(4BF5(%;XXJ'Z&]-:?3%A@.::K37>*5-2D>M6$0((DO[JLH$ 8I>3 MU-K@XS'RID<*.K8/=SV#C(5B:5,%YE->72XUF/J!&3'X4W3V1O5[#*>\;G51 MI=ACD[;F%;=L2K"JV'5B+VZ1JU1PE9KGS=-*:_T5C/6!*\[:1JW3[RM3$$9? M"ZL(HS=CW^OM0;I[*)#&89M*@/3ARKD(HH\IK&\(G55@@Z(FG]#Y8EA%Z'RD M$W1_;;S[.*4!1XUS]UH$T)NNC'YFN M%IY]<.L*)^IT/%%8550I==IV6'J!>97TLG;N1W/N,18'X21Y8(7PB'[$BH,] MF]08-<,PE"FW7.9*+06#2MF4\^(#8;4ZO""L)JPFK#X*5G=.76^PP=UR72>$ MO@AQ(X0F7A!"$T(30A^SVJ!WZFJ#4Y8+$$ K62Y V$S83-A,V%PI;-Z^UF!M MI'N'6H.](]QM0YV& I<"ST*H$IE:)7ZGJ!7X-4(1@K_:SO-[SDN4%L>+3<', MN3]D$MGJM_^PO.@/8TN:%4CTRS8ZF-\%O!(7C"*&ZY MLMUKM-?P+J%:9?CVD5F\?E#PKZ77-/ -^DM4[.BL.VDC(#48L'DQ7V4A1U5& M$?BHS)H4?(Q7"M3BZ\V=3M#5!J>T:DMZ_E78,Q:HG;WLOLKP>VZKOI-I(+-/ M9O]J^,I3BA4R^5GVM$*;_AN\&52F0CO&ZK5S]Q(E:%<2VBMCV@FRKY.O!-D5 MV'3U(!NKV<[>_UNM6_!J,(:P_4)X0MA^\7R]>7H*V),9L0H9_L^F$VC_,-V8 MD?%7CCFJ]#]9:F9D"O5:6YUD+8JTA[/W.UENZVGDFZH%WY4JYE:43QM6=%>[ M6EM1WM&D-#780 A#"$-\(H2Y/MX1PJC!!D(80ACB$R',]?&.$$8--A#"$,(0 MGPAAKH]WA#"[I<6.EGW?/RVFMQH]M9EPZT\F++ OON0\81^^QO,/$H,:;?T)9FDX[ZNSU[N!P[?G) M8%RYW2:X).DGN*PF7/[O__0-W2#M.#\?U#12A TD_80-U<2&[9NL]P\V!^6 M(]VW.6!EIZA!DPY0J@GDV<:V$SXJ1O:*"3[AHXI^^<9JGZ<$&.30HS* MB:0J]P8/T&?UZK*FP=0/P-.%/T5*SDX_!E\N3EU4*>O8Y'I^Q2V;$JPJ5D_M MQ2WRE0J^4NN\:5EIK;^"L/=K;;O[ MZ$>FJX5[=]P]XBC2T_%$8551I;9GVR[W!>95TLM2M9+P-)PD#ZS@@;6/F&+? MRY6"[]5:[;8R]87+7*FE8% IFZ+>I!K":L6,/&$U835AM3+7K@G/U+6AA&?J M\(+PC/",\.PXV?G>J;/SZ]/KAJ[.I6^":"5O@A,Z$SI?)R\)G:\6G;<&YT'S M"+GYO2/">HLBPML*G!"J1*96B=\I7[/>8G2XGBQR9FY@!RX M>=V8+M+'_/8[#:/]RSE5[+MT1K4GT_%"S0\T%]Q26,$H\"=:-&9:"**L^2/- M26M30LWT;,V'?P3K-C9ALVR"Q2G!3',F4],)^(=JFC."#\YJ&FBNF:AA'594 MYX_,LN4:2)H6,'@$.,GP'O%H^,'R)TQ[S7Y.F1>R-S7-8Y%FAO@/<1 PNZ$] MPOHL/XQP?;GG@;FUM1?XI,TB%DP<#QX[-$/X+RR%[VD*FCIR+# =L%3\B3-2 MF[!H[,OGFA/0._[DH$@CW'SZ)TDM^&Z>/K!)_IXI"QS?#K5IP$($3"/X),?'!]Z\=J2S=HZDV=_R!,'@-3-D6<"6*V4.\O M1= E2T4BD N-X"30T4$VV-H(!XL_XV#Q$+F._+OU09Z]&8]Z]MZ%:\1X...D ME1Q YJ8"SI_XD5F\7$L#3-"0Q-H+ \DW45YZ\\8-7HIU#9,*]2J3XRRL 5XNY+F(!H$KZNT09_GMAH6_-./+? M29P!&^^:TY"]37YXIPDLZC5E(ZI2 =.)P+#;;0S6E$HN/Q7E_"\+-3PXA -6 MW:-1=Y03;:O0W M+#NN#-O2\A,-ZT^6:-;167;2OE)J$'ZE*3L5P4DV1#O3UAIAO>"@@E"TV;,W'F2V!%'AW:IO>]9 MKT5LA:J6G4"4P)3!?A$8'J9?-L>3-?>;]L(3/&PSL_J MQP320;]#0*J:Q*G5(V"O_-HUL24)(YBCB 5I\$"+QD#TI[$V/F#W MD/4UL4O](E'JP:0XJXR-4PCD(FWG(JT=?K[,1;I!XPL>TJ.PNI_!Z**S%)XH M]%!KMP;*%X-2IZ7S&Q7"8G5X05A\!:PB+#X6%J\=GKLM%I\@H?5D4SCG&'4OW9@*+M87;QX0 =$ _51GJ!VT3W7!6*Q](]U^JD?^BBZ^%] MKF-.&=S/M>H9-<-0OYNT:A=>JP@0!-;J\(+ FL":P/HX8+UVH--N72GV ^FV M<;A$1%5 6O6N%%G[@'/<&U_>P*"D _6F-FQR^Y'V,K B_Q@=HL]';SHZ,T* M^M-%YF@1!?(W?[:U-[LR.R$'=@TH=@.@9@#*-P,XU)6S2_0_KS7?*>@];_-O M@2S#P#D-#])[L5T5[L6VFHT6W8LMLBWI["+8U])K=#U6P>NQEP A5ZPDEXXO M56.-TNT8-HU?5!N7\&A$4*2&A3M+PYF=U(1,()G J^$K=N\E$ZB@-T[-:H[4 MT==\2?O*GJT,BR[3*T9VNDQ_+0E:2KYNEWPMS>M),TY@*;\DAO(KB^Y'WUG( M@N?CI5V-;JW5.5S9.=V7OW*C35A)6*D GP@K+Y-OVV-E_]!8N?O@G%:OUNY0 MDS;EA(IZRRC)EL^.YX1CG%'C^S8UD%&")ZK>A*9+ZQ?#*KJT?BQ79[#4U4E, MZ5_1DIXD+M#MU SC<'WTZ#KZ]9H*0EAU>$$(>P6L(H0]#L)VFZ59O'LC[.[1 MA$Z[UND?[E(R(>PEA!BHX!$"MT?TI+F_Y$I9> \(EZ$9Q2?G?US12.8^6Z\VV;& R#I(= M3LTG5A\&S/Q1YU-XWIKNBSD+7VF_GJMA#IH.QXM-;HBRECFM_A^VY45_F%V] MHQO-4;W=[QCU]G XJ@_-4;/>Z@RZACDR38/IKU9TWBE5/W\+_"D+HMDW%ZAU MX]F?_A,[4VS>6]V>.PE)--.SM90>-7A;1#UX+JV! O7@N;[D,O7@H1X\U(-' M8=I3#YZ+9=1EX4O56$,-*"Z>K]2#Y_QJ1#UX+I=W9 (OGJ_4@T=1;YQZ\!PG MC/.;">IO8GI(8TD\4;U\(K474#4;3YGVB\BT4Q9]NRQZ:6C9TF347P,_7'49 M0#Y@Z?<_S!YG4W;STPF3CZ;_](5'"?>KD.O4>BWJ3:"<1*IJ\0EH"6@5X!,! M[67R;7N@;:L%M+N7P!FU?H\:YBDGD:HT :INA.'6GTSCB 59?(%7+X7^*'HQ M Z;>/6OR@<[4B:#BADD--@@_A]R8[=R8SAG=F,3 'C1N,*@-FH>[6$=6X\JM M!F$F27]UV4"8N0MFED8MJX&9NX< ^K5>1R?,5$TRJ* \9/_ M")0(?J:)/^=7!#7(7GE[I 8;R(O9Q8O9_-KJX;V8U*["QSY+JWJ(PW^KUA_T M*9>AFG"J:C@(-DGZJ\L&@LU=8+,TOT<9V-QC$%!MT*1:.^6$DTH SLV!WY@9 MLK'OVIHSF0;^,T.]/-OH'W)D%"-[Y>V1&FP@1V871Z8TG>>$CDQJ5^]R9O40 M 8!VS3"ZE,E033I5M1R$FR3]U64#X>8.N*F79NZH@YN[1P -_7#!<[)3P*0?7N@0Z]UMKD/B?OT-]5JGTR.P M5$V@J+9!2;;\QL+PK79C6?$D=LV(V:!STP#42HS/Q3X(YL0/(N>__ ^42%&! M::I&YRF1#X%++QM- \'XM&0F!+T,>WYR_1&%5 M$,/VXZ'+-*-Q0#!6OVXAT5@>L4@G.-0TC^T\)O(8DXN/R"/%M4;5;,#VDX<+ MS*ND1[7SV*NS)W4.PLJK]K:V=[8V[RSYE1TOAJ'7>EUU6D$L\Z"6&OY*V8_S M8@'ALCJ\(%PF7"9]#"2JT])J&_C+_;Y\_ M"7[H:2]FJ/UI>U-1:@ZW29!TC2O?U)OZ8I^^DQJ([JOW[4;9:]> -2[\4-MA M+T:I8<_^>^DG>RG;P<)>6HWR*+ID+YQ'.VRG=(5^_^WTDNWT5F\'K.$*U@0L MG#+XXS-S9PUN- IV(=M#JU]"H@=KS.S89?>C&\L*8F;_YIA#QW4BAX6/:&L> M8>T?7-_ZL9V0,5C\%#T!>.9",XUF0N^OM1.):9*:/_1=>VNKL:N)D!31& 0_#D&(PC=+3. )K"[:?T1L9)%$T+^\ H6SF.LB1@+:IK]+].6_%Q;Z MUHPC_YW$7\ ^UYR&[&WRPSM-8'2O*6O82Z'U$SD)YRX1K.R94-5" T'O>:?L M%L@R#)S3\ !6!3OVT#JG_)@XMNVRHDC%+G MRT^3J>O/&/LN;&4N$7,;!\$1+V*VNK6F0M= J'>%XC:;H)*@4@$^$51>)M^V MA\I20\0]H7*/-D_=6F]PN)Z(!)6*M7E2N(FSXAQ(3_V!/V)A"%IANMJ([7[4 MIT:5%YGF)).D.!MH'NOT\!^W(_$EY= 7D7PVR M5]X,J<$&7 M#01RNX!6N%>% <^ G/LBM-'PWGOU=FKU/TNH=_>"MT]A$ M]>1*59TGQ"/IKRX;"/%V0;S!,1!OG\2VWJ3$MG)R18GM(;E/N6CE1456- M"<1(^JO+!@*Q74"L- U@%Q!;>&0F$%-:5"@W?6X.)*?B%S. ST'HM3\["$R/=L,\):9'5O1/Z6UX];/=(]^JUKO]2DDKYI8J:KR M!'@D_=5E P'>+H!7:F%V ,#;)P=MM-296DXJKU@.6HU)=,JP)3F"^]&8!><* M2:DZGDX535$E/+C)[(N*&S4U6%7LU;H7N\C7*?@ZI5YI]V@XRR-WCWRJ[]5: M;76NNVUD(!08 5]%(T'8J@XO"%NO@%6$K&-YY]R]?VQ#P+Q/VC$UJN'\8!>X07?W!]Z\<:?[2I-_6< M8\I MJ=H:4"/Q#=AW\R^B;+E_&%;7O2'8;:[PXXQK _LD5%O=_51O=_L]NJZ MV3)-9IG#?J^W4)20,OWI(M.UB%:2_T/?M;>V3;L*2J^AY4C,6_L5B(SL6K*Q MKM(;NY^RP,1]:+\Q,]QS(YV&T?[EG'AQYVG+E*;;*C8MX]M%G@(#&7+U&WS> MMU>HAM0U_L4;++1[XM][G$W9S4\G_ ,?^YW9+[YOWX]&CL5NG@+&/_*%388L M6*1;>42QS8A-X.7C&4-+_.K]%]XY$C[G--,;OT?&>%[YF M:BXN4#.3E^,[-',Z#?R? %41"@*V]5?O_QY[3'(2/_\>^ +JYMHR"NJ9X*-?WT<^H$''L^PMJ/ MSP8AM)(?:X1V!ALUC'F1U5Z<: P$ Q>,]T8%Z'2UJ3D3!A5X4A!1[4];NW[M M4G7L',T^QQ& X!=8PB2>?)-O_AAO<._T*+)<[Z1>8_?5>Z.Q0&K!A+KP0PW( M9H'.A2ARH.([T*:S2IB6$>;.^^QXIOLOX"RH.W[TD063<].IO91.4JI >NPX MX+0"(SG"+6@HG2AD^!=A'\%D3AH: ,9'9O&7HWIV5QE6>#XLU<'-&G= MDYBT2R.ZT1@LMX_@KBPVB=RP8?8X,XWB&%IT;XK']E=+#ZC==F^UKXU.RT;0W^RGU!O89XTV]HY> "=Q!7TEWP M)@D4\,\_)ESD\ 2"X6M 3_@]G,.\=)FID4P-*!I4^ 3\,6*X4/Q4" _5T,G3 MS+ L*F!!QPZ<49QPN2/;*5W3Y:PI>K#Z)8D J* 0@>Z*0YQMSO(N<8LSW"B= MY!IY7H(WLXW]T#9W,OHUO:>O]C'V.MX-DD./WDM.=Q@?$IHAE,5?$9?H ME)R_0^K' Q>4$RL(L$@HB.35.@59CB/])=Z4[X4)GMA7;S_R@+$P%KTH,I1B MK?:1F_/1$FQJK(CXZ<9EA_PZK1.$_#Z;%B:69N)#B2#<>RQC>+O9%PR'']8& M4&[BISB,D-GMK<)^'E!\)->2PX$7>.K8C\/D^)19MY5&J5VFW*?1B('M?&8' M"#D=BF@Y+1%T$T!J"&TI$7!]V*U3JHW>TAJ?:?> 0&+KPM%8%#(6YV/IL$4@ M&'#$';K.$P]^@@C!P7?O(%RG5!0E]H@-TKV(6T5LCWY\^G6:G58S^:%P7FJN M=!;T9K,&JRF["^ +"*7*X@//,MS W>I\<(G'E9:+V)K#T1&MTN.+OW-8=\-< M!#]TH$#!'S/;(\\?:[6O?[*@]Z$)])D-@QB=;>$'SMF=D^A>*5%S.MTKT*W7 M-!+WS\!10AQ$.R4PL*R&:PU0MW3D/1G\[[GQ M3&SZM84)N*(#D!(;;;+^>JQ?)%: MH7YLBX*M515?[=ZHUV^UA_4VZ%B]S8;=^J Y-.K=?G=HV^VN.=!'%UKQ50C\ MG6T524LSAC^Q*C/D%,P+W.-2FHI]9J+V ^=5\?@P MSR4>AA%\T.$Y?K#(()GX(O1T>"97?@U<'##Q(\<2].+16/BG9\>&'9HKP'_3 M_FJ;I:X6)(M=PU^NYNX&,EV$\>#\^D%G%M,,XU\ MU_5?0NTUSU>"TPI,"-^\+8<^5QJY; EG,+[P2JP?$ O'7UP MP,ST=UFWS7\O+/2M&4?^.UFY;0%=S&G(WB8_O--$=7>O*5N)EBYCGZB\_-Q= MWBI[E4C5IC."WO/E_%A0.0R=H%:ST=JPF\G2 M^SU%MWEO?#5\%:5F M9 *5\\9I;OQQPC@?TGSX!]/%5+IZ_5!I8M"9.P8OA0[JMZ-2I^#=V42]= HE M'*6KC%L]>)UJK+RG6;>JZ$(:I"]\O9(#3;0".!=O(S2_!P%*+]T-"8#^! MP-T#U4:MU2K?)%1/^BIO!,Z38U?CQH0R;/D];^_\E!KBK79^DM:W1S_W&PN[)M$L7Q7%[@T!K0IL4-5Z M$]!>#*L(:(\&M.6."@< V@-$%_1:OZE.&1P![<9 >YXJ@%71A@H.?OWDV0>H M\:=AO.J *PWC58F7-(SW>IVHK7VH7FFRP0%*(OUH?MECV;G)N?_MTQ^_W7W]?WJQ]^_8#(MC#4*Q]71\ M>2A:^UHLB$S'2_JLRZ__[__TP:R]"\6W'!;('L(!^T_LX".3KTW$)-!TQFL< M6./"E/2PT&CWAD]_32<#RYDZ@^(TAK%I+WTN#GQTHCWFR/9*_?._R6=GG:#Y M/-.OP(;'%^8^LR] _/&J +1\$G;0OQ_E6NIGP^(X[3.IRTV]7#UUM+MBU*MF MQPR;-1M-H]G0/LOID[SIL9@4LX;, ;/0 -N:J<'^@R>V(T%+S9WOO&?8I!_, M/CO!)*'N;,:YTJD10#']N^G)Z2M&4]P?2X;V M.*&D8VY,QI_^3_1BWUH:B_/5'L1*4F')I/!F@O,5^+QB;X-I&9]QF#7[S7EF M]IT'SMR3 W!\$X8L"C_,OIC_]H-;UPQ#+J3R*_/OWESKM]]U9^M=/[[X%[_K M[O:[Q@DF%[_OWM;[_NS'P<5ON[_]MF$KBFT;SC<+CF+[_R'!KVQ2+CI.8IP# M,\'02@?/ TKP\0C<4PAQ3O9R:%+;F?\-..#AK)SK\.9Q1MD7.0VPV5TUH,Q+ MAX7C!(Z A1%W-5Q)CPQVN8>/S_EBSGQP$>$8+QP9Q-\OS'9 ++5/=BP&>O"G M?67I')#\LDW+ M8F&8NE+RS/ #3O':&/X/GRT7;0/J1\*K?_'@M^%,K)F__J^_B>'J 3.Y@J,L M8V/(P'1K&@YR\/R)8XEQ)"QPIF,&_P*2'CS[,1QA9B'X8#AEB<<;PAI0T7)C MGJ^>PGIJ6ASBSS9#E>:KG?AV[/(!Z\)F&QJ?2BR6'VA,&<9 + M =/83WAFB'J%RXCF3F)\NAX*BL9/8L.Z?$9C^="47JE0)F'-C6=_9,_,]:?< MVF4N\JV/-+&B1_\;"U#&!-FAIS$ M#.?*,2E3.'/-E4-K<%B;RV4R^;(-YC' (ZY@;O8.\/RU(A2@=SR;$N38__BZ-%TBW M/O!GILMGU@S-4,QOQV\\H6;#,^%I0$W4?_'!&=(O"07(/PDVS7V,RP,P*WTJ M'SJ/-L(4YUJ/15H(&,Q7G-F<9!P2<_@D-N!:?@/R2)W35R;>/K>D9'9=>1GI M!_CHV1"'\-ALY'C$ MEB/8\A/8J L7DET,Q]ML[E.R:Y%IPGB^',^TXRRH=?.?].;2 5#YZD+Q84'< MY_6?YYC]YU7A_06IH>-N>=-%'CR[5YI'>*Z58-#=Z+[+ MC2%4Q]$9X?& "C(&-X>$G@VZ.>4R4\^9'9K>D7/[O_W0& MF87@^?XP!PO9 7Q*I3_?Q6./@#;P MA>\8^N&?@E^^B/V<"XONOGY>B49&:U:#&F7.J1YWNJ)U/3L34[#A!9 MDU1].)>K3TNWYKN MBSD+7VF_GJ-P<,5H\=;@#QMGB[=[HUZ_U1[6VTVC66^S8;<^: Z->K??'=IV MNVL.]-'"\>C) W1CU!ET6G:]WV>M>GO0-^M#PS;JG59K9(+@V\-!#Z!A0S810UUA%GX. ]<)QR8H3,$N+.BX[EL_1)>WCQR_ MOO%X]@/_*NR9_],^&:53G:3;NC0P\$.KN9WW4NNW6F6K(\C',Y+^9.*C PVT MTOP7$>('BGA,$#Y-QMY]N\<*LC &EB8![,5!49'>E65Z\%K+#,=HWD2&%O_5 MSN(9&%#FD?3=HB;%8IJOOG<++[OTR,ER?A"E!^O!QOP]=GGPI[NESD(TZ?%QZH&9-8SY9/E*/5*[1.F6NRA/J!+P8^C8+$@[ M,EYTH5(^,CQ84ZM43.R:VC1PGL%4NK/ZF+DXU59\+_(!\ !!GS2?AW% \+VG ML):D?_D[EGQUY'A@<%%K9%8=MX#*@[7(5LPO+/@>Z%B$X@H;B5CA6L+C./#C MI_'ZBPEALAH[]\[(CWAUT"Y&;5#0SDQ<"M(B>^ \B*U\F-UF>_D*6]F]"5W! M0/578> <75=L%#V+@15!^ZC(_<"'E3(O%?O MHQ=_@0NW1$1"$2:XF>VEXM!LT"E MF_3A9Y605F-!,FF)A*#B9R191F)18&'^ .O%1B-PE,&7PDM*LKXJ9U1^LL!R ML%##P4*.:4+^"7P7M'P4!]QFX/V+,$JN'*RP&/PV4S[4G%20Y!WJ"&_%S-U@ M*M9X9%N$52^L4TF]_JRHA!>/U+1A'"$-YF2JAKLR+5[]L&(#F]^J*CJLRT2] MIDV8&?)_ \* &89__"__8 A+W2D4/C#FZK47:?AW6#3L#W[[(M]_@PZ<>/LM MO'S;IA4%@>TU!BOB1.!!N:Q(HT0*.(NX8\7O\4AA*]1K%2F&=.+"# #F1#[^ ME=\' F8Y@:A9Q3 =_/?)1]L $NQ*V52#L/W#Q]Z-;L71^_3;,B+DW#?45 M2C^O&>BAA:L)33 Y,( NV2.&@,J;V6A^$WB<$I;.4!*[/3VXKW4VFN0RXJ:"("-D;G M&*R">%YINXD= 0YBT3*>H-!TK3!M0 13XTX;:K>3T 6X40SGKW'"CDPS?28^)NHTM"D\*4#=L,%>6>+;*"3/#D]Y M\+5.D#580^W L\"3Q$L)\$KX--IR(*PHWYZ*FN6U)^<+\?@MV/]EN_F?425X MO3/:/FLZ*+ZWLL.."\#EN3@;@X2%+5 0T"9SG (4Z#D3 :H@U M^%CSF E/T?M"M8]9R*,-XMDS;F'#&$[!X.]%>$?Y!91)1AP C(=< ?CK1W$4 M\\+.*5:VX,]A6JP[,6WAA_!'%3XB2\ #L*: \4,07- D4 U0;;XZ>"2GP) Q M;Y5/O,2.E_(O>#4V$Z"D/008<3,(9O!';NH/[1-OO^Y2?/@ ZRZEO]:NVRN[ M\F6@6B*3HKP4@=@4:T4,7YR#3;*O_0LV2G>PA(DPOYL#%$@V:ZZ/G <8(SD/H1O);Y19VB+&3RI;YK\YR5YJ* M,13+":QX@I2Q&+_X5$I(\,-0@"80] M O0:?F,[D$476IL,2?'F\ G?#A:_S MG@R!#Y"-%3O>"%5)WIIQ36>""Q6G+">PZWR)XFTR-9LXT_/=)B)FC3W?]9]D M:5 6 V4A*_,U:V4!!A]T'*]]N?RRQ93A$F69C_F3E_E,?=R,@[K.?51^FU_@ M@BSY*9[<0#+ J^+F/[O$PL^;<+X7Q]-"HXO$@;*9K-OGA8[,,F-<.QY(GWWW M&5$%293X1N8LPZ G0-$PFA,O<:KFZQ1G1HXX^*(9BP3RX+K;J(0EG2FX-/EBX-L.9=!.DO#J8 M?3>C.$3M21LBY-^ 6B5?4$M#GN!PY%^"ST:4XJ<3=%A&L0N'KQ"T&$O>DF,] M; *<)OM$(K]:#V//=28.>$@KCAKC'"'RE(9'P[&5'_XL3(E@V9_L.P/;+496 M4J,!'IN/AUU9N(QJ%\YS&8]OF&(Q-3R1)H='C!P+:B2G5BS1*OJ=0^8Z[%D^ M,?7^RKG -73Q,/Z#_BV^5USU$:>STGZ!A+PP$7AY92J--BN%,CRO2Y3->6E_C4U^)XVMZ"VPUDG^NB#>G1V@S##TX72/U.5VE)^ YL@;?2>AS9E.FK>YZO7^OR$#GF-JKP45X"MO:CP('432URQOP D38J"/&(*;LK2/ M7W(%FKL9(E&.G5HVX0 A$KSZ=^QQ*N);'#9*&99E[/+#IC<3S8G)@;H^1$: M9#KP6+:;$ MZ_YW;#_Q>_CY"/Q=&BW(7%A\?!"[220^='Y*/L%?)BP:^W;BN7!Q"!A;QI3T M:PEW>'V_%',@%R^NX8L4KA->++)Y(-[C702:80C!LY,](+^C-[H:#_^]E^^*KW9Q)\/XG,K8V>P$99>KK H*&J6:$CLSO+VA>>/@?A2F JBOD8,$Q.X_,U_#OG%KD13\!&P M1>V?YC/[9^!@-8"P1X+-6$Z(]0 DG&65O@=%4+FW,(L4Y58&/Z918M/@S1K MWFR9'CYOB/DQ_RDP80W<%1:1IRCI$P1Z/03!!.DRN$3E2?-/$01[PC"EM+9Q MN&K720.*;^![.V$:M?L2NY&#'TL7A[DXL.+R2&_*,!'F!%W&3T_PD)O;VT^_ M??I^\_@)=@[F [L_ 09A%Z5Y+O&3 *>)#V==,,GX6DGGT!QAWB,8(B9CS4,H M#]2M#M?KVX:&N^V]TXR>_IJ]69#3Y"^2", 9PI>\\/NC-QDK3=["%F,2>?[5 M$BH%#(2#R35FPK0)[3[%&,W<0FB6;(JWP\P).L^')F9>0FJ&#O#!8 X<_KP, M%G8Q_Q(+Q3?Y,2^QQ "6K;8@7&>A01[46D:OIAN=G,$/P7;C-UKM)=]HM0 F M>H5O]&J:;L#+.O!_/?G"9; !'X1#R!+8,(S%+VWWFS4X=Q0H<55&/'5S>GDW M)TD9A/%05E:;VK]]!\@2)C4'690=I> %]0-DKFST4WDK?![%MU:*VL-3N-*B MC\YYX9K@X(U%K>48]ESGEE!>R=5>6ZB&R=X'M ]><@36-P\RSSEFP M,(IM?KF7W_'EBY+ZE=1V)5::1]HP!XWG"ND&I)%UGM?AG@#L3CH!;[AG/0&/ MEM?YE"B&CCF_CNR_U-+(%@9E,#:24 @>)VDC:)#01(9%Y;>P=]\0+^%P!F*2 M'0PSD_7SX*+([]H)Y2:\\9#,&-0T9Z0AJF S]U^8&X MK@DJXN=.'(F=PXWY<83'*?@GQP+^\LZ=H63'$%M[.Z*/%3\""2/) ZEFF,5' M\ZC(38(KLA] L'SYD%!S'I1+Q2S9C#CE97M[$2H<,%&9F21G3*S'L/ASTF,6 MMU4R>=Y?6LZT^$3.FV_AE@'HF:BIEO'Z,(-)>%M*3GG^^[\PGA:"-MP:]SN_ MO$-MJH^%,=:-YB_O>/$A0*0,2O(>#='X_WZ%)[R7)Z.:U*1GEK.N(J6372V5 M2]2& 9QJ0WE3"UOEISW)N'D41(:UW_"/AVD9?*6\S0.@O*W,3CD?!C MANXB4"JM\#1$:4(Q4X%U7R^F$R6^NCSF\=11E#XQ%/Q:=LY9')_DH+D11,[! MX(G&9MSG:#-(PDD+#),,*BT*)"41#7">6'K7RPI\I9"6*EYW$!^YRZ_U-+/<&5\LC5C(]<3'W0"3J>;#5D48U8BZ0.0IFNX;Y\M&] MC["*%Q-%1H3+8B\4GCH\:FV8JY8/BATJT-8HA+F+:IQD$SXFC2KX];,H+4\O MJQ5(,Y)9%%](S$@MIG NN05_F3O\OOB)V@!G$_[.^?$\]'TW7X:-2TI84HX: M3\$)$&]$;I0C^L+*.'AIQX+M\@I9CNPLB;7#ZYX=L%82*?.'#B3[(];+@'G\ MH=WSO+7V^O>';X_W;U*:XX$9O[B]WO]#1W6PW9(R4O?8WTP5::H.+A,VQHW5I_T*D9 M_287BUZMT^_5C+8N7&D1!4B.[;)T2W[[,>!%&?#OPB^ EZ)6O/[V>//A32IV M*%2+'&QT\@6:"S4+$[!?%)58Y6^=UL>1]7!8;I'X*29W;GCW;X*ZO=A.E]7%X- MO8$1E<^-BFY:+&K#^%E+'M-XIB*.^)4"#*NEA3OB?(KMKOQ0=NNO5L:]?_D9 M]YT3YI?IC:_0B_.>$60D((VC+3\A)#EW)7<2XI496^TU2AM>.E7E;;O2&Y# MP_W+D7 LH/<[5!ZA9=Y M+%2;IOL= Q?L;$.O4$UJ;'M&Y:>)E/U*;ZU0R>2A=ZST< M'BF4'8_*&B;!1?UR7F^E:O 4.Y[U"_)DC=$9 8N7YM>)-;NO;OY,K!WLJ+NZ M[/4R3T9X!HF?8K"_1BN?S+__X9IC>*/VS<=.7]HW[ F0#F2+G$ $01Y$7B%- M8\21R:&==_40%X8L[+ZER7 C#XJ83JY,-IH+"257M[,+1+E+3XG/_NSXKIDF MX1[$[<%0TYNOAV_D[=C7YIM$OS[]%+T5M!M+1GR^QR !>G-8[RSZ3"ED=?": MVDT=K%!Z6"*WFC4A1SI@;:<38N* IQYR;1T"S<> -R?)7.?QI'AK$75%''Q9 MHBGK/Y++9O [6.XL^8[(-6&98U+'E+POF1N4BX;-OP!%%>SE/[BT!0Q3S.)Z MV#_]P+5?,./\@(W6&PL<)JXZJ&GS,:_$5.7+NU,Y-]-L#.^:B%=E&19L\B86 M*,7)61%3GD76%^KZ=JRK1A% RBT0@MHB-WESN5BH'IK>SNG$0Z:@^."\^.-' M] '68F%$2U32C$!61-,-.X[XQ>(8%LA[>,#.QI/$QP-*B8Z3E@S.BWAV)&JC MI:5)FP$5->COL0T+^ >/<=Z.Q^80;%4Z!&MA[M-/'&^9XA$%$3+^NM8$R;H- MT*!G450H.K&DDRPS6R4K#9=V-!P,YCH:)KFI&WP4$D=TIUW7\ZHO>U[A#^6D MA1T'MCE[]=[0Y]L1@MC,TG($7O8@SM%B^->&OVDJ2&\O:O&W[;V3 M!_!Z7E"D'Q,[S?7USK,:VNOD']\D65!NNXI#L$#5%B3GB)51_3DT0YTDNY)%8;\Q.)S5P\_<_ MAF8@;@5(RLM<%)("$-D59X@I '/2G(FW2^*\%)VA,BY)<?5OTD'&%ET+ Y[=OJ @V.,8SL'8E9Z7T$%AYA=%6I$Z?^49D-F\&Y*T:RV%J9:S@%_H MV9CV_!H$5A7"*L'>"(YSY+;$"5L:_!7MIVI::Z%I>QSC4U\LZ@'%P2@ M6XB3V597$VJ%\5[SE2O+3GFM=LF$?F3#"-#,G=4'Y@CW61FI\W8X%*; M'/0;VF^^]U3G[;60K'OU%CCG3O1&K_.+ENLIC.<=!Q"'=[V675:S?\2_:G]C M&/G ?_HG;^N&U7AI_>.%M^SD(SM$P5IWWLCQ ]'6W89[S=)$0Y28.WZ+'HW! M9]-BFX[<*'XS=5/N/?8-[ZD\8)[F,WC,W\341\'+N8[1'V/V^ +_.!/_A>_F MZM";W053?7*]C#O-52W,S:%QEGK!BE-P2H5"%>:NE?+4Q[1>Y9ZN2">B%E*S ? 28W? MJN*QEY< #Y->W06% M0 "4["*3]N@.>(8#3^@CYZ=H+,\13CBPV=CN)#PP-6<\O;IN>,=Q)E MN1^)H+ECR5$2YV?RO.M6=M9@>\)9&^F]@6&T]?JPV;'K;=,RZL/.H%?7FY8^ MZ-I#-K(9EI5,G+H8]LM=P^A(UQ47S>?U,'=?R^5==9JUUO#^TFB%:W7S=:HY8%OYEFT]IC;J<8EMJT,8C MPH^\H6*G;ET,&P>[C5A;$]UAQ&BF_*59$?OKIL?1TE%4D,*Q4WR MF@S03^%=/_G]>A>G]2VKGCR?0&_G\92Z?'Z3I,0A!XAD7UET/[J3I,"A*1O< MH3NU?[ET1$NWNV!.MF(\2V?&K.]G> G-;3^AO=G!]>XM*Y>@]66/?)%_G?101:9*FG%7-XJ/7_ Y%U!MAYPW&OVMV:" M&'4L1B KSPIPXAJM7F\!Q;-IQ8LB\\N/$8/5QXC#+DCD @N O6?&XA),//RW;#)EVECMQ@_3 M\51FIWU+-"44M,YJ^'"QD9P5-&\WYJR%S%[)X8%2!T1)5)CTA^(Y'V"I'R2G M?LPW%$<4R16EO]LF#K2:,-L1K)]BP0;/I15]3ZQL?9: M%*-A^E6\C0=!YA_TAK>;XE4&)L8JDN%NO/])J@5+,G[99'1>%!)A(2!>0UFN M)'$4%)!37Q.'SMN@,:@3,A8OP/'7^S.S$B#!*+CIUS M227N5?^)G[D7'K%%=@O],&Y)%@! >7W\@@ .M1.F?FOS7HJ_%=GZG=ELP@6& M2\!&B? PB+YC(2$7"?CEBQAZI93TY,S\H+_57OX!_.ND\#^''/QF4 (< MW+0:4==FY0V+NS%>3%_)<.:,KRO=^ M+1[."O'YWZ?\DE-"ZF+-#3^$3DW>I5@6]->29L@61N/%]+\:_C*NK0G.%)B, M9,:_#'/7_/ AHB'EQL^I:6:T\$/,%?<\B@64A0>*4^R3SV?RCN 7O.2$B0IY MMZUPB%["G>2*/^?&BB%]H M) H.W_^<[Q02\O%^0S703//92]N:_*G1H=Q=U MKB=GSON<*Y#@Q=AY"Q+>A9_PM8_^]W0YW-"I[*66"GX6A'!S%FQQ*%=P0M2< M9JRP:]K4C4,YU-GF4AM[.'POJX6(?#'NDOU,)YMRI2Q+6H[%XG)$H=+722V7 M53)YY"2SB^^<)WBM"@:)$&B!:-995/F MN47S3R83MY?:I3O> 7VA_HO9'IS0\A[I%&^=\%G!'[\-"Y8&_$Q M[AZ(;MPY<+!]UX5#HA0#[HILG271^RL*E#)O,7Q(UZ%L95+S4(D1(2;P@_#L M"MS.W082 X=XY1D_[@-'%EQ_D0)K)W7]211RSC#GL#(GMND 6C%\ED6EZ*LI M3+BB)IN7+F,)N: ]CWM.>^P^9 MNY3ND%>\LTA4VLF1GS**45N8<5H<.9;42:Z#RT!R;CMY]R0+[1BS>LF \@<7OJO@>F^]+_,@=.'%S:P[PLL>D MW^5G)\!1*W:3>S'B@)6(37&8+!A3!TAM!K(\([56XNYP>IMC+$9GY(=XYNDP M8J88T+!BL?.[1"@%\&5>VD0^AVI2W'$S.UCTS3.(R96XQ)>"]8MTXFVR3 7- M?+$@HV4T!BL*4$7KAOR,CN$L5[13%HEE@I66 8%@+[,90@!*G):3OO"0S\_Z MJ5GE X:BM#@N%..66#2/&2,1[N5/E;99#(R5+TS'':]R#Q=MRD_N/<\+[6NN M#TD%$Q_2 O\"#/NOO .?N([LYY1YH2C,31NB++"FR>?X.5!CHY&\KUNHQ]VE M]-]8D[[-E_Y_2EZK=/5_NW 4Z#:,LGS_DM$[:3#)3UI ^^))[SHQ:4$M'>Q: MX,7V]M)8D.T<,9R<_9G?QQ,E:E^9^K9P46E:8@H%=8H#OG,*6H1O=%*M%+Y% M4:2T#.E4^V&*20^S5= M6Y%'^()$'MQ\C WQ5IZ;8DR'9UK4IE^ M>?I%6AN^+.T4@OH.AZ*;\?W!^/[!M QBD,E#)\^I-Z M+#(V0_:U;,H!.1_FTUUWO+-1\G3F3O7=*;;ZS>KVUJ@@XR9"W M7KW7>T:MLZ @6#TU.8TGI8S JPHHA..$XPKPB7#\,OFV/8ZO:PUP33C>)QR_ M-D-UJ*#(T2*+5Q\4^=W+JCN34OYSQ>7)KU*,[)6W1FJP0?A.U7:-7F_O&ZUI MO).S?!^EX;MP!VF/0$>SUNXN:EFLFBI4S"*]48\#!,4D^-5E T'Q3E"\IMW8 M]4'Q/K&*6JM9'I>DGBI4S"*].7_IAAKW;Y3A2#YT4;CH?:ZPGJH7="X1PD^1 M+%I5!E@IVZ8JJXI)H[W811Y9T2-;,/=&]8X&9PR/U'JMB_>T3&J/6;.J'_1>C" :(TQ[S;;OLQ M=H@Q&@=T!/16HZG$[U_P>.UEV M&E9>M8>WO8-7:N^,?M.C])LNW)/;(X[3;=9:!ZP#/M@UZ$VAJ%(63;TF$>0I MJ 8QY"F0IT">PAZ>0JO4^?:*/(4]JG Z1JTU:).GL$N'(CT1[+-U*)*1GU]Y M0U[X*_;G37@INS^?JY'UXO[3I?$"Q^P_/3>^98_FTYL13/7>TZ4&\=1XFAI/ M4^-IY3/;@M[S:',+9!D&SFEX0!VG5>^[1AVG+Z'GW25 R!4KR:7C2]580^U7 M+YZOU''Z_&I$':IRD>MIA5UNZG5]''B-1_SDY&UW$#5="AT:9"W M>O77U.F!FEDJP"=J9GF9?-L^%9TFP3!1-=_),LN'B?15TBCBNS"NC_X_T+3> MCVY3PWK/[>H%I+"7Y^-VSE^WC-J@?;@N$M3P\LI!A[">L%X!/A'67R;?ML=Z M@[#^4+5JA/5J*H4JS:W5J)Y1ABT\-G.0?E'GSWM>$U_4OV) '2,49Q5UC#A6 MQXA6:QM_+75O[J29Q7X2E^R<[=,Z2N\-E+]&0,TCSMIMFQR!2T 7<@0NAE7D M"!S-$6A7VA'8XT8A.0(7HQ:*]_JF+E)[=I$Z8JM/Z@VA4+B9>D-4)P%'O2$. MGZ1;,T$MYW$5!\W>CQ['\Q[@)7M]>]3AZ+5>MZM,;NY2VDA4$G/:$&_>NNO(.5*)Y%$:O1+NFD$7842J(QKS;E",)JS%!62U(29N_ M03;7F(HZ49TA;M[I-3IK\DN5[$1UJLN\C59;K42Y2M?D]:8*]^3;S49SPQ1L M9:[!_XN90:A]@G79&K6ENH3[\9> )U>L,)<.-E5CC6*M6O1&;]]^.Y7#*&I+ M=7XU.GG=:=["45LJLG75L774EHILW5H5(!M&-DQ5I0(;UCN[#5.IB%@-MBC? M@D^&'*ZWZ. 6_HR9T=AT2ZD5]>H1."Q=+S,NN)J'*G7.RZ+F9DX!5>%L5X73 MFZ_"FY%"F@666?*F5^5(4) M0F="9P7X1.A\F7S;'IW[EXO._02=]ZAO)71648Q5A0E"9T)G!?A$Z'R9?-L> MG0>7B\Z]!)U[A,[797Y4Z39;W8Q#7M-QQ(^='P*D7H\L(K <(]7=K[99!R*J:_*IJ6PA92?JKRP9"UEV0U;A M9#U F+Y;:[8/UR.*;(MB8?K#-.TZ=R,;9=BR,'9?&!(7GKLOJ&H];U31'U6R MC30U@$R WJMV3U<9N!8 MG3AIJLOY[1'!N#J\(!B_ E81C!\+QMN7!>.KTQ 95@\.F,,GI+Y>DT-(K0XO M"*FO@%6$U,="ZM* +K61>G5:(T/J?HN0^C)$5I5;!ZO2&=4WT,[1$JD61L8 M'64J3RYE.ED5\8:P7QU>$/83]A/V'P?[-VFV>'[L/\!U#L#^UJ!-V'\1A;"]R00_%/G6#\V,@.)3T%)6IOB?-@*M9=3O- O4_R;E MXQN^"RASRU?Q@(M0D.)W7S\#,'4;K5Z)U-J4!8+"#>T1R"O$%6]Z)03?2.U M@3:C;X&F^A*)?LR>K4C)!I!4. 9KI+G=:>AE&DM);@BY%O\%RXAPC1\HVCQP M26T@: TB$(T-JO,VC M?XI]W ?6VCD.QXB( @^_M-_8B>:(9,! M+F&9_'7R0W+I*MC,/:UDZ>K30B9^^@D4=:3U3/\QY9Q^5:SCQE@VCS+1Y MZYO8@(!9#%9O[V)42V7KWP+?8LP./P?^Y$[>Y(#4A# SBP5C_&C^8&@8GQA\*!#V.+61*W$PU$S/+KPFM;O M55YX!*XX+S0"IS=DH&S 7SF0S7;<,.W]& M(^MX5L!PA=RXP_? $N:?()2:/WM/M>X4@/HV?47B_G#7&!<> M^.4+X,XDGA3U[=)T>HE#!4S:D]K=0U/;_'GYU-[ @MZ$4F,*ONF$@=(E+HQI M<0<*CYX6N ]P"#5K:[6[H-%@FC&2@F=2 :#2[9+@JC&^56%6\,OX'7A@\F;X M(KI4X"_#EYQG$U4Y%,;?PW5*QWL'N]\K2,U-ZL*%C_Z-=#1-]YOIV'?>K3EU MP&WCSO:-9TL.Y+SN\"N+T/.^''#0C49S%3B MR@""0OC$4O..#GFE\\[J2# MSR;\9L=6XEZ;*;VU*1"\SK&)DUS##X@7\M S+T(=FB[OKQ&.050;(AX%.T'2 M.UYLB@!B(0B5\;U5;IGW+6 CAKOEQ]%'X-X'=_6Y=$'%$P/23C&,'<1L80 0 MPTUZ?[HHKKTHZ)4?1;MM/&K7X-.@H>4D34OIHG'"+ FLX;ZZ:[=U]L :8 &8 M$9 U)PJ34QRX+$,7A".)KM7F@ERVYL=1&(%4H_W;X8A6"N)GV 0G,B1J&H-" MJC-[ T_^(1Z&CNV8P>P!=%D^)H\/=]_N,W/0UG6]F?R@SX/$B@C]>[U3,YK] M6K.] $.RTU+>$$Q3>>%VOJ%],JVQ^"Q^=.Z?N4W(?QUXLP.)2T,U'84 M;6BX#V$?73_,Q8?G#[!+!!ZMZU=PA'&Q H%UO:;AJFL:^L89G_.* 1E;((1 M_U7LUUX8K-B,P1J 1;9XS,1*Y'PW9G=+?<07@/V_*B/YC>Z0SLWJ#>Z@^;]7;/:M7[[;99MP?=EF$-FFR@=R[5"=&;#>%O MU#E)N2HQ\"11S59R:] J./0/%OBD,2)DSBY_A]-.\,SLSW[P.8[B@"7QG4"0#O\[\EW7?PG? M[I6*W2O[BWEHK!S@("4R^7]Y!;;>8JZ+N7K AO1W607 ?R\L]"V"USM9!V#! MGLQIR-XF/[S31*U ORE;"Y>N+IZO<*??;+3F&QXO195]*A.H]FU!L^E^_R2T M+UGH964B_4W*1 [*!5@):!FP 0 TXW]-1U/B#4J8\PFO6HJPS6#SWL] M#_00SIRM0_Q6AY)KJO'/Q1WE&5K4CXF<*);N!PZ6FAZ*K3EFD=?:Y^)PW7W@L#>N/9WU/SR?_A M=S2>&R=Z2DU)UB5ZC-J@U:YU]'*UDGHR28-PU)I7?^UNSO=\8N!)U'GYHR1% M<&S'YZ1AVVMBFZK1\LJ;+S78P#T;#IL,G7]&4L\G/2RR]0UO7-/ M'-@]:7!-[%(U:$ 3!RZ&59U-DSCD*6WI*;5V\Y0^2:O+/YKV$ "3>V#?2*_I M7;W6;1^N_RS-#[@$A^F(%155'A]@;5I)JF"YQ>FZ"%Y%4HQZ"*JD?JKR!U)W%_%#X@%F+8_ MC=+'Z6U-W-R#KV#)I?/,M)L7_%S^P? I_BNLLY;VNT&Z0*;E+[[GC MC86-A+ IQ2QYX(HGP6\F0 D+)HZ'8L!OOVXB'_AX]G/J!*9H@ ?;'C$'4;JF M60C2KLO_18,SEL]E=<),V=_3CR/^L/3Z'CP\C).K^6$-/N2Z2 *@37[$6_)J M>8!KK#!0&]Q"/KN%^CW'CE3K=M"FTD2F0SI4&^C(9S\.(L8\8<52(U;4FK;> MW#8"UN^T:WJW[)4M$WQ^OS_KAU@XYB>B5M.F;BQZQ7K<='#9$\\+V,2$KWM/ MFOEL.BZ_JID+$4AE6J!$-7G_E#<= V2.@;0E/I_@2;OXR@YAO'K'4*&)_"VG5X,NP0'[+%C[/9/-#6[07XLV( MQ0UC?%Y>"+CE3/I'.;S1QQ+Y@0>]=I*=<&#U8C[V4FX4A/SO)OPID(VI=-PC MPW8F,V8&C7EO]QHM8]X?08CDJ)9PE,.'B;*5N%"%PJ\:/-L#EDW.C2+(^_%4([\[&3 12=NQ-^1M[):>K'HJ7A(<$[8N"2"P)G( M'1<1K,(;E[1 M]E;E_0E=AK"9_ARP[D E0\F@H&6BUPCFQU\L]7_29#)Z&6^ M&3WGF_,Q\83>CYW93Z /8?M%X,P)$)(]% MW%V E7_),ULL>4_'W&)O=8(JO=@;SD7?E.[=Q9^>H_\_/2-G\]C;=3 MV6[S]]-J4QK%H@$U"+;CPI;!"?]B,8^[+5<[D,SY2]I,97N3E QX4\9D,Y/P M_6K/+?.VL@\N;"=D:18\PJY.-(EUDHU(QNBYSO.^!&:M9[/@'-N6=IS_\DYI"J_3^3.[WLK0G1N'M:K%%;@9,_K' QI+4-G NOD7J9 M-0(&_?\R!D6P3.JV-NQ0CUQDBBL [(ZY1PD\4-X\6;M[2=5NGBY"#@?,TPY M*C)/N>YX*X/#.]EE;FC>P16;!2 @<#DV]KBB%[1P3EKXK_ M_)$\;>)!'-%J\C0Y2"^2WC3?*''/6PC; 6\RGK&#PZ4/N1I3>*S=OH:\CMZR M'V.6Q))Y6TH6B@ORK;!0M4T_O^E1+S 6?)\?;X7U-A4@X]L75B.[RO-(/_\; MD.2W[S_SCL'_!*/87"W8?-1 MX-]AL+R?);MTV$'"UD>$E#(5Y;8!=I%3/KPA]SAS%@NEBX2)AY^$F+B)W0#S M S;?G7,+L![FD?XR>6KG/F1"\U*+DAJDW)MD#[#>7F2?Q(FPBUV%<(YV/%@6 MFTV#O&RRD5]86;@U *L5@\=P[WUGLU_^RN#E4!HF3[[T^7.M#-PF&+ ^Z?NN M0F\16SC)EB2QNV)LR@A,0NY9#S?LVTI-KWOVE39T>8\E^ICNEL1/[^ A/_JP MJ'[DCO_@)%)9T[]=O1J'1M*K49GJ;#)6G=[0<92>H4S4WLB8CGO#P7B@68IA M3!QS?Z_&!EB86Y"4^9SSVSH.N!G1378+:_G/IJBYZ6 XM2Q[R'IL,IKV#-4$U6%PE>&8#4QFZ"/%=JX./4EA MS;M@M\@ASFZ1FD;M(NLZ=SPT.M2"U-\N MDK,#-25$Q2=Y\B!H&DLRU# R!QO?*HJ=.G6-1$@W]76-W-ZD'ZXT:,@23_DQG$6;SVI*?#_^A!-)X*Z]^5H9!=+TX&+^TIH$%@? M.UH7G"C -!C( MAD7=*=')<6=C1&@02%-TZ^-QHF+,^8%O2T!>#^W$N@L#>3VEO!YS&= M#YFQA'_<.3^0>3NZK RKJQN_)CN"!L5R*DTCKL6F?>2NHNYGC[SP64^8\[PZ':'N&234! M(4719,74*2"$3=9_J3\65$%M:IL0.>@UK8[CU3VGI'RQ:INPPAJ\H#DEC8%J M<'3Q<+>=LA(^F7UQGVP5J(+?K=L\-<-)&UKR0-'0Q+%H: H%M_ 6&!^H];;P M[6FHUKN6C235>C+ )+X5XZD;@G+7> M%.QI692A\]8)!PSD]I2J];:U]M=ZEW>1;&4@FX/J*KW)"N&I]$;0A;A-B)RW MTKO^ML1MP@IKZ((JO1L#%55ZGRT2I7>PTON$G)VBR0-SU_3,6IF&2KTIMH6P MOOA J;>-;U-#I=ZU'K>C4F_,.%&I]WG!)2'MB);)I4\H9-=*GFJ M&X'J2[VIZ*EE<9#.VR0<,%#VKY2OT_2VWL^'GQ( MT"!PRX?>BS@1K_'^\NV[^-_@@84+%@JE@M_AVQ^0"T3;LN["0"Y0N0*HBIM\ MKVSGAR $RPG__0QV\\O:;N+R@S3+DBW+IN@/-E%&4.'470>(SKHA 0)KO*%C MQ@@K#.3SE K[5-3?^^)GW"G64S<"=-8-(2A88PR=MTXX M8""WIURHY_(]M"]^UNV4C)AB6;)*L2!\LHX@%D2GW>BT6T.QPAJ\H--NC8&* M3KN=+18U[.!IM_).VD"SY"&BT7-TVJT)T:U#SMLD6(X\)FG]LSL$^=7%>01N MB' 07>?PP1IT.>*LU2'HR)]#A.619^_$+GJ\KGGB4#467 M%:6ZW..Y9M'M)9J:+%8BM)G,'A+O2WALKV(N6O#IQ'VX$5ARX7+]I9. F8 + M$@E[B/%:W/7A]A&+\8Q-EAY+Y79+\'-R%]V"J#S ON:.W_P.7N.-![\\(-@[ M-AIT%? ^^DSJIT*5K.X1F?I&":1MH"L4R2 MDRX3F!\0: GV>Y)81>D+N'J1Y$:2PXNY>&5F=,W!+22]&\):: 7R\@2WY*+# ME9V#F2K?;U=@#GFPD*L7*.KJYU1QQ<\;#WKM+./@=:JZH#:>LXC8=?:/UU*B MWD,E38]N[30NM"4<*'V]=/0Q1YEC^"T+J^#,YOI!586#RX?NSP+(,?L- 8E] M# E4"@T\"2P$8&->(0@_:EK?/"[ZV!G44GY,P/N\C*/8\?GBU1X'NX2SA ," MLFD$S2%HU+YJ/Z_1:O&:_Z]X #9)UO[V@87.?>DSDJ0=;=<.8HK++OA06*/* MLE2D'EU**&(%9E\VL;ZM2KKM)V6I^UC@]J&%KJ&PVL-K&/;PJK)!0'M33IW! M+$G>),@%4WP:1 Y:_1AL[%](9LG[VI](RQ"$V*BU# M[D:0,XFCZ6V+%*_JA@(H4C1V. MIGYU W\H&QKYD>B$L:I4TF5/*;0)@6SR^3T?L5;?B/-+>RIHUA]K^4[G#1$* M&,AA*97[T:KV6,0 RM5(\7^&010=]E6L;&J?57@DN*++YE!!,Q*<3 1N$T$$ M2=*/>3-/W%CW9GYO&JCXQCXJQ)/E4T'[Z5.[NK&,OJ42/V*31:R&FO@13>-M M6G<2]Y8N.QE[##"03X@6&M*0CIR208- EMI@Z;ZC='*C:648:!"@0@R"@D/AL2.V,01 MJZTFBD1SH(76G<2]I,6-/'B%&5(H?2RGN!19U N^"V/&*G%#9[_L=?51E MH,C#"JM;R&H@2^=4,_7DI)&U;8(ER_&,'7_,/*^^ RRG3WMJ$RQX<]#'C'/J MN&%# =7PZ.%;W?:;RB20C*H]IP]!.&5NO S7OM/9CL=8\D"O[B1O168?UQ R M-,)96Z->8F,\)IY4!.6YFF-IMA RK:;:TY)6P\J35CM8]TQI*\/LVSIQ;B.D M%(6Q)^+%@\7+<\()#%*,#F)!!((6&W)+FX47Z=)YLT:-.P247TB\HW(L?&E5 M:LQ:2RZ;1N4T "<:E7.>=FF#FD?E%$X":?)@,)2'ED9U,MC$#ZGI(%XEV<>; MRZ'*4JQI&U5!.2IG9Y)&[YM$B.C$#ZMM)D)$Y'.>43GESQ]9JJQJU, %G2QB.7]T\4P2&@1H4@XV#<"Q M[)TW1"A@('^E5.JG\DG0A2?EV%GAL5TX"Z2;\E"A23GHY!"IB2"").G'O)TF7O MF+$GCQ C*H5/I>B5GV$^?5+.?M_OZ),JZD V*(""3SZQG%2A23DT*0<_+'AS MT#0IIQE0T:2<\R60*I\Q6'A23OD,DSJ4==- 4_U+C6)I4@YZ&*B7,EYL:%). M8Z Z+6FEXYZ4<_C$C=&W\)Q()8."WM@3\>+!@B;E( *#% ,/%D0@:+$AM[19 M>)$NG3=KU+A#0/F%Q#LIQ\:75J6^K+7DLFE23@-PHDDYYVF7=L[^KL=,RBE^ MS$@>:$/9,JBC*SKQ0VHZB%=)]O'F9E%/^_)&FRK99 M77==LA#(,DDT*>?4HT8T*0>+!N!8]LX;(A0PD+]2(O5C*Y4?HBX\*6>8%1X/ MBS>;,V3%JJZ=#IF(=IL((DB2?LQ[>>+&NO?R>[- [23:E-.A=2=Q)V/?61C()T0+#6E(1P[)H$& )N74C0#581 ,1-;5 M-CJSE>URC(HGY91/7MB:+5L:U>NBDS.:E$-&MY."3S6(&%$Y+6]A8IZ4*G4HK/2SS[I)S]OM_1 M)U4,33:'-$P1G7QB.:E"DW)H4@Y^6/#FH&E23C.@HDDYYTL@5>XY%9Z4<\+Q MF*$M#Y7J1@E2IUB4:2>BX_;8>%(1E =KJ"?Y9;-6%NY1.0?S5J;9K["J@PQ* MZXT]$2\>+&A4#B(P2#'P8$$$@A8;N? MG7[RJXMW?LZPKF3K 1>A@HQ80'RR,'[U0"9ZL=D!(IJ.)S MHZL=SE,X[Z3*IF'*JHVG-&>?X[67*LCF$)-WCLE)2U#6PA[8Y9='IJLD>T3R MR48Y\&=G=S>E;^.9@$?F [UI)Y+%@L3.1-.14.1L=S?G!1E\7I!>\[P@4BED M*D7$0WYKLZ$J?K#KG+&A0J>Y2A_B4I6A;%ODQ39#0K$<[=H;J.Y:ISZ'"Z43 M2<&TNMP<-=QM9'7!L8DX2K(AQ6D[R48)M"H2:)5/\'Z_MKUG2J"IJB5;EHZF MC)S.MN,V'<2L)/V88PG4Q;[NL,'>=-?PC.Q8;;K+,/L5!@K(*+3<-A,EHAEF MU/F,U>#J9M!73\Q8D:JT3%4Z1A3D/6)$I7C2:7<\9?2RQSAZV6/<3#JIY\HZ M64-9M4WR);$)(Y8S8)1?>F 1;-SDC3Q3$,*/"S:&7TAQP%%JZRHD\>(@IQ*C*@4SZ?5$'VYO;\/V;T3LTL=\K)D6Q^2 MK[E?6!.!S.3QD.A>(MWV*N8)'_ATXC[<9+!]6LX9[#2*+<;&N_]41#'SCU?Z MEH.^9A2Z:]5+?#=CDI-IF^1FZL9E?5P# DU\\^6/!=)==OB:_MC/7@&NPI>]Z^]/*;Y7I' M9F]Y^-W&7A#Q;R>W3E)NZX?-MZ+<_;#IU\%2L-![XE],WGGCF1_3373/27;1 MTCT &??$/<22;D$CO@ +/EF&_)K\%D_,"0$SN-%DE11,Q#7+#(K_VN))X1^6 M] BO\_>3(@YZ\6'>+Q#%/_F+[1N(('[Y#E;E RS*21,=M:L;S>H/U2W[+Y^Z M(L4'15QR1>QL1>Q=*Z+W-6MK182\G+@HE3$EQI4,ZZRP68?!#F%SOZ4AH-N#8 M76!_0KE4XMYE<*R6_:5BJ?T#5P$0I2!A<4*7T MC$O[B8<)U^,/Y_I+\;+'1;2X4Z=JFTY>_N><&UC>U:S:Z5-5/?5:9V'VA@NP ME;U1R)R_>LX47O#:\1Z=)[#!:$\-:3 M[]P/_,8]P$1KOG@ WINGC;3)5ZYP=["F;SSX7C$3RD!C%EQX0R"]72@>*:PH M-BD993YWLU,*%3ZU4'&QH))82VGT],P%E_-=XI\[Q(_@\G.O?AIX7O 879^T MLSMI,\FWM3SF(,H:DP/WOUT!4?'!R'SK#R^_^CD-%HB?-Q[TVEG&P>OTN#YL MZ3UG$;'K[!^OI32DH"AI+'BKAO7L=<7)$^A*7S-KG*33V$AU-PJJ,0OP5\G@F+N3B(3A4I WZ]I$#XSMG M[I)]-<9S8&3IRAT4JP^TU._NC XA/6:=$!*A@,97VSL^JLOF"P=(H"L& =4 MH"Y3IT(8O,@K+^H*@7)1Q=".LV"=<0>R;'V"5YJS1^JC$6K8M8M\@P: 5)43 M1_I%^H46I+JYBE2%5(5 (BIJ+70484#"-+0KPJ\J1$7H02(J:BQTI%^4^6X8 M)BA@H)TJ$O/59>N$ X.$_8G<\2%#VD$\@0B%VE/7G8'A*YL[KK__7 'I0\?U M@9BA?@S(;\**#&D'\00B%$@3.HT!\0169$@[B"<0H4":T&D,B">P(M-M[: < M*CY,4,! W)UK7Z%AZ-:CJMV*DR>3\H@PT*D%&2=,*%#B[E(PO(6/>5/8I>-) M=RRJJK:+]1?T8D'%"BP(9)W*DR%;A#)XC MZF]?.RP;4W/%WTW8. C%8(SK9"*:"W]]=9.-OY#$_(L39^A6@^ I/:-;;/R: MPT?42SK?2[K^EOE$2V3'&@)-[7%[LETYJ'YV_61$XB\8-*DSRTY,WTC8GKO2 MV P<38W ZB-T1D7(LC42MM2R\?F(M>]ACO6GR8Z1'2,[1G:,/+3FXG5\<@'> M[ !B;S]\T#Z\O519?@7+OV.UZQF9NY%'Z$5LW'-_]&:@(H45IS/T M10WYPU3A0Z ![U?W!__]!U[V[ :^M/3=^"N;_G;U_<\?H]!SHQEL0:(KR9W\ M=I48R8%Q)?G.'!9F&?7N'6=Q_8U_YXT3L]94K3U>9K+-:4C3*_ *_7YJXGG>\L? M1C4,0[>5/],G.>%!WCQM/\KM#S?ZTW\( _&3^B_&G^Q/35&'JJ:K5]*$C5U8 MQ>BWJX^?/EQ)?*V=^+A]/?\4%$[O%I[K$;!8:F M6M^_O=OG*9OF3D]Y5)&GO.TA9S7%:37QQI^\8;#FO"GI&P\M^ZS;^VU:/[2]I^T\&;:+L'ZYJJ7+-A-M$P)'5"WI0$"ZUA^H MZ[(EP^X;1LTGH"_MLZ&!#&G/$]JQX("A>*?P3CE>^\J.!MTL.]).":8,55E7 MC,K\+C)-[39-1,SU2/_%VNRB0>*(NB+UZL;JVP-R8DE7.LP4I2.+Y+^B#1R: M%M4%E?)WM:L;0^\;.CFTV/0!*5L029/T=Q@&8NI293MZ-\MV3HDTJ8.A; Q, M(F9LXH_4-!$QD_33[IDXN4S9S9#*;H[>+6M]E7;+Z.2?>@'5C< 1534&T(9IG:;)B+F.MOY4%7-1E4-WQ3VC5.K:DA76J8K'6,*M.?UR'\M7U5SWN-X MS:ZJ.>3O B4,K+YEDT.+31^0L@61-$E_AV$@IBY557.9MM'HJFI.BC0---G4 M-2)F;.*/U#01,9/TT^Z9.+G$[ME6J*JFR&ZYNJH:,DO(JFJH5\T9JVH&0!^F MWM>'ZZH:R^S;*AWSQ:(T*):=;!<.&,BO*E55L_N ;^NK:HR3>M7H\E!7J%@9 MF_@C-4U$S-2K!HM7:^I7-W9?L\B))5WI,%/0:3N4L)Q657/>TW;-KJHYY.]J M5S>6TA]45U5#9JK=;$$D3=+?81B(J4M5U5RF*S*ZJII3(DWJ8" /ARH1,S;Q M1VJ:B)A)^FGW3)QE\9$BECDW\LO6HV2FBR(5WI"F_,Z1*O MM0")]>,6PW)$J8T)G&(;?5U9E]H,K?Y J_GL;]ZIJ@W'/!PTWW.'C3N$#$W" M0P35YIS/D^#JJA^WKXIG]X'BUE?Q#$Z)K9B*; _Q'"4^RI[EF89L&CD"G7,$ M-DI[RD'1^1(@@X^K4DXM 2*=:IE.$?-4&^RL"):7O>9"T'35M7=W8=M_$<_B?#!IVLB':KQ\)BJFU "J*J9VM7NDR_:;1U2N=%%-3 M![+)=Y;D"#1 )\@1($> M(3V_^W!ZK0**(TJH([>[P_[1/,-40HLS88.E45- M@B7HA:3UJ2PJ5Q9E ?NH?<.HMBJJ&AQW.FX=A!%O27J_4G1&!0^!1D <1 MEILNX'GQ[*I_N*^R:O>A\M975IFG1(%DTS!EU1Z@*9'?YR#NY2LR>^1.=!:+ MW=551X+1^>JJP=6-V=>&Y*0C@@V%5A'[5!M?K0B6G?'5\M!TU7\^HK[JO"=, MFUU?=BO6:/W EL6)">4!RAZ5B=5J>E4YW6L7$#P^Q;%# ^.776/S:=TH6L*2^;!DXV ^#_ST*:=A,)?X@SHK RDE3-!/ MGN2>^6",/>])>H WA/W.,I2>F //*OZ4WV/BQ.*N8BWZ!Z!6-?Q8?UF&T1(^ MDN)@$Z_-]13O"FNU8*'8 OIC)@EB3%8M_6/^*T#M[?O/DNM+_W+"\8Q?T.Q+ M=_#;/7\+BR]%R]%_V#C>OHXH4+1>1X(,77_)X6+A W!6]MWL">,94,K]3&(. MW-19+$#EN7D3,'*!Y:CUI8]3R=EXD#GC8@SR(@00?I(>W7CF)B(6 Q:2Y\ZY MP$0+X+^I"P^0_A(>7G+N0\;F &2R6HDDY=\FN_M:(;)/.#SCY%WA]52/ MKN>!XDEC_J'GL4E?6HG_CC6">P/?"B]@+:TKC<@!,DP>=^GSAUEIP"8*L"+. MHQ-.)$>HJ7@]!O297%[H@%#7$6-^_@$;K@\?MY?IN0[D)7Z\#+E#P6&0\^O' MEV^OR([3"SK^)%6$%-,X *I*T,@,((N7H9\!D#Y)3BERIFW!/;GDVB%<$N[E M2#$L-N//S#\.(G!Z)+[0/Z0 7$[X_:? G>* *O[C> M'P@EC;('$ZLH7GK[85+\9/!DP5N>B*?P=ZYK7A6=>\?U@0G65]Y>3D$"OVXX M4.M]A3[<#B:"XD^6L ^8[O;AUTZ%\"F$2W'+E?$6_.P'-WZZXZ;M#J3ZC0>_ M/[!5X%*LJ(J:\^-9-'86?",8+ME.I['9WQ:N1%.NCPY%SQ&UWLLU07<7.YP\RV2(*ADR_+;E0(P@@WEFQ(0S=7/Z79' M_+SQH-?@P@2OTPT/;#8\9Q&QZ^P?KZ5D4V0K:=_VK4,9]64V!E;?V&HG?Y;Z MKN[&]/:GE?KZ9=9^:TNV;T-L'[,AKA0%>!).%SR2L4)D#A3CL5H04?O6UDST M%D.29+\28(+I'@6I$8[+=#?'@<5!(U4C!F2DR$C5"DD6FT^@22/T^/2$;!4Y M5 A0(%M5)R2W]_H'N5$84" K52I9 M<#)F9,Q: ]L'QPT1.-4H6X#C0(@IJ8Y-]W4R.;&%V&XK#E_P0\YNG]5>^.$_\(W'J\/U_EV[\ M]-&/XG#)/XP^QS,6WLT;ETB+GOWM$B:CJ0?[CKU^/7; M]W4C$K-H2S+=&,B# 9YQ 75G:-"(,U9;1$1-LG]NV:^MG]A+%$P,6[9UV%#9 MW8+\O&3[K'V8*)CBI5(\WJQE+Z^I"(%IM48[7Y1+0D^T2T1+3[ MB#9/KNK@N+Z;()>59[@[8)T"#P-?G32K3%F GS!,_#Q)G\H?0 '&:1W2^ M9>^\1<(! [E%I2+\]N6"#B*X$'WTOXC&C^?R@:RL5:%5--)O#&U9KW#T")F< MEIL<(ER2?L0A".+:VD,0>V/]6EVT6UO ?S\O:UE(&3L:!+;"T^E(H]+QZ:;EZ]$@01E[@H%8^_#9M!(!ZN'E M=LI_B)(XO %J6Y=53:4D/3:QWG? DKBV:T:^8X)/U7$H83DM-+U[@O4%"!=G M:-H<]H=XIE23Z4'. $2\)/U$O$2\1Y:EF[67I2<!.7QW11Z[B%PP&5FA:8N#V4_033B7CH+003?'M8@%4%92G\T" MIM7L?5H2P[@XCR_A$7!F,&RU/R 2;X;4HV /8G(\6)">X,6&Z+QA@)$RG364 MW[@J_OQ"XFU&;^'+=5'KO5H2C-2,O@DX*=2,_ARM:H9U],<];S/ZP@%Y2U-D MVZ!R1'3BC-46$5&3[*.-JE,Q(MX ^NY^N2UM1K\K:F[9?JM:P9??F*?V,H6Q66G9']098GH&;TE57W4S-Z+*J 8]D[ M;Y%PP$!N4:D(?VU=<<_E ]E979Y=--(_,&W9&E S>G1BC=7D$.&2]",.01#7 MUAZ"V!OKW]V$H,W-Z/?S,N_X8_>5ZL;0DNEI.0,0\9+T=Q<&8E^\V'1>13I2 MQHX& 6I&CP4)RM@3#,3:![$ITQZFMMZX^ +4ZM"4-<;A _>Y"0UG&\(5"_WN:.>-F4S M"I=O5(LYJ< GW ZK.W5/;0-1)AJ(X-O#&J0B*,OEJ4/MA?,4NT,GK6TX?S!) M8:M]"\_)-;)0Z-F#F!P/%J0G>+$A.F\88*1,9PWE-ZY2/[^0>!O.V_AR7=1> MKY8$(S6<;P)."C6L'CQO2ZK"I["/3(YR$T.$2Y)/^(0!'%M[2&(?;%^5>E8V]D>I S !$O27]W82#VQ8M-YU6D(X7L:!"@EO-8D*",/<% K'T0 MFS(-8FIK@(LO0*UK ]G6JQO-1C:G[DXP1+8ML_(=$WPJCT,)RVFQ:;5S+>C:=$-63"I-1R?K M6$K3J1\]]:-O$#YX,Y?4C[XA4+W.;DD*EJPBF)O>'%[G5(8C\63/P8!Q)WUR4GDH(IAZBM2Y (8?+? M51XI^?'49%+3FCRVPKN\Q"F0O7F&CIMO'#@=F1,BU[-0OF>HK([C^@]A<,9( MT?N4@^X"?OP64:Y''2JR/L13+$K';9%;(J)IDGVT\1YJPEQ[:&=O7L:HA6I1 M968&P[Y176:&S U1+5$MR3Y1;4>I=B.+HFW3ZR53*#5M<(_/HNA#>:A6U]>Q MA08HD>9,F _)_27R):]B9^0Q^'3B/MQDL'T"F00!*;88&^_^4Q&MWGP\> 0N MU:Z_%,JTSQB-X3XLS#^$JFT^5/[GW&.7?\ZJ05%5(TV/S,+L#1?@/?=&(7/^ MZCE3>,%KQWMTGL#%?U4+&L_ 6%M"W=#^G(S]^,^1K4XL933J:TUM&_+@4<)0TA1V=!.O]%XO7?\I_P1G0\9_^\3<;:/,U M_'4PGP=^FAQT8O&=";\U?#^]2U]Z\:&"W&FM7U_QI42SH'R]D#W2,]2$VR$! M"'SMQUX@0%R 93\2M"C[6H+;&HI^]MZ[L[O"^MI'6]_\+NE2^R+P<@SI_7SA M!4^,2<(/DKXLP_$,EDSZXCG^@5D557O>)ORU'D3EPG?/H&CBM6TG3)>Z& BD=+WGL2UGP" M\!X%HRQ%R]%_8.? BS, 5<<'0O?@3N.0VV%N(O['@8_"IX3[5?YDS!G/I"?F MA(F9YD( QB-X<"?PY R<,)<_&4MO&TF/;CSC%P\6BR",N40\\=LML@=9O_.+ MEB>>P2[@?B8MG*B*C=M7L)3G$T![9^8QW7[U-%[%MB5K/Z4K#K2] FV<>]\-V5APG??< MN1N+WT7]?(W+]Y7 <5E(;,H*W5VTDJ()I,3^R^6M#&J#RLH6,XWXPI_T\_2M M$#BQP%]8R+<39\0M:R/T(H#V#@"3U4^7U@O 2/!UADW[#FMTP<'9CN!#6)MXEM)\#F714;&?[0W6 M>\7>/"- SCM:-G$ M8'47?.\8+MG.?<21>\7:.?T6%'4.S_C$\136V$F71WH$5PW^;PJV,GB,K@L7 MW56S6X1;\B@"#_$(TDK*:'Z[4@ PYGD\T@*^X^KG-#8C?MYXT&MG&0>OTR*< M,;R3LXC8=?:/UU(2P;&5-&J_5?)YH=I<4^LK6MD3'7LC&:=$FYJ;W:GJB,T M%1['Y( $(O8QX50.I0#5XV*>@!U!E<$/=*Z MS40U&[A26D(6D"Q@:W#E<3RR@&0!NZL!9-G:B2M8-JMVRX:IX0$.6-!W.TBC M$^VMW[Z%%^>9*L?+TMCP_RQ\J&_\XX'S#(,V(X'W0 ,=\6\ 3L/CO (Z%E&P MNLNJO+IK;7+3.J]E/ M">.?" QWY48V])095S'/4%4TV=3SS'!&>>B C1!1= M]ZH313<")Z+H\U!T=3.8:Z/H%^HH#XU<'EJR;A%%HQ-DI$:(*)HHFG BBKXL M153F(;/PK3^-'_(@XHHLL0J*8A#TT%S70)LBJX MK0I1*@E_9V$@2BU%J;L'/"&GU/(1?5559,4@2D4GNDBM"E$J"7]G82!*+46I M6A,IM7P$WM)ES<0STYB,"M7_(T$@#< ?;,B'+T]%'@]E![L* WD\I3P>1%U: MRX7H2\SF,U79-*@T$)WX(K4L1*LD_)V%@6BU%*U6UWNZ'EHM'IV7%4V7AU9U M\7FR+.VV+$2K)/R=A8%HM12M[AX.T!Q:+1RAMW633IIC%%ZJD:\;@=7\&ZZI MH3M:)O-B>* ^RI?/2S^[?"!6L(P M<1GW1PP7KKF&_N@APZ8\, RJ4L FO%@M._$I"3_Q*?'I47QJ-8U/]Q?0'\VG M WF@J<2GV(07JV4G/B7A)SXE/CV*3^VF\>G^ZOFC^=20S:%%?+I?>!,!S>3S MD"A?(D+_2DRKA4_Y\-H,MG2L<;'%V'CW4\;H[AI1;"]VV9)=M\S/*RAJ+$I' MWYW0>Y+>_V#AV(U8=. ]S!??H_9)R\(\2,$BR2 L0O;@!LL(WN^>YP+9!.Q> M-@E=4Q1+XA9$?B[^6'&Z5Q,^+,'AP M)TQB6>8BN:,T ^ 8_Q.XDN 0_F7FI2/:6;K&\! /+.)/DSVHZ\,OP:2!+15I MCQ!^#3+,OS(6P\XE,8^]+]W-6,BD1_Z?$DG7W4W*RDQD_YP\^*<@?9/-).P+ M8[Y?2IWRZ>;<1C\&L-S,+Y-?-G9W*;GTJ[Y8?%7%J^X^/7[I5WTQ(;[UJGZP M@VE?^F"M.VEJT(FE;-RNI*NRQ 5,_->6''_"_V%)0);C6:(UT7+TGU0='5"S M1>I)I-HZ8]Y$&CT)_>5KY_A/?>EVDC7B\YYD/JR=6X?G$W[%?;,[VC*_ E=4 M^'9AS\O8.KOX)0S&C$VB#V$P_YB>6?SS-R']BM/]GMJ7%#]Y)> M'MTCIXC4[GG'K=,*EWG'XYL6E!)7:>Q$,Q"K,8/GG, _/(>+*@C;,[&5N8E? M@"#"]SPN8W-P'&,^FV;,.W-.)/A2,C)IRL(0?G9]N$B>"X2L.2O1E!:..P$: M[HV=A1O#ST["0JF6\)OW#U"[BMQ'R7A6\'M/("_EH6^VUW*W-C<2 42&:?N MR-1Q0[[A6#)N=:(-[R9S:;AGD:Y/)*0BQ3RS;<*BK;^Q]H#>?_OR15I&L,5( M7!\/=C"];V-P8N!KJ4?#[RU66)H'$^8)#R3_5"[<]+*L&W''C(T.$K MT_-!+X!WQ4:"I9 $N3U;$4>9T'T_.G6&A7!Q;C P,LE?QSXXA;@S(VNY M,3?\P"?BP]RMYHP[8W!YU_.D$3SD>.8RT.]^9MO3+N/!%XM9<@8[W 6/<(1+EOREZ\-^ M_#9>/^Z?8S_^4TU$<1IPAYB+A;.^?T*?RTC8HDQ*,]%9+_GU\VV8V+;!1^E= M$UG*+U1VYWKV:WSGR+?UXFAPTA7YMRMP'L?,XS,1Q_"&JY_3_;CX>>-!KYUE M'+Q.>RK#KMES%A&[SO[Q6DIV[;:21E_KFD1OZ'W%1#7OO+OAXBPB;VNH -EB M>"13$_-#2E5E/:5T[DXF'JLC!C,I/<^9]NM#=(>13L[ M@#1V^4!%KI&E\_ L%.G3%2ISD$K9_O2B = FE0_717TB_2+UP@$15A M0(%4A4 B*FHE=!1_JQ\#8AH,*!#3- D8IK&0M=MID'69_)<84XT9^#?_^ G M;OB)"1;.13/))UZQB+&1Y#;[MR?>?'1ZK48 DO3:!?@!C7+\RI<_>U5^^*WG M_NC-@!J8?YV>V3.N;@9]Z]=7_)O4%*%NP+"VNR';1;8+G^T:<-LU(-N% [ & MV:YV:P[9,XRH'&'/3+)GB #K; D3&@16>_N'P'-B<9B_$>GC-F%0'9F<#P(B MDQUD8@&9J#\E\/WC;[:F:J^3'P;:3R=23--CQVA@;%!)3.N7G6P:?IMF7]T8 MQDZ;II)-0P)C@VQ:N_6)K!Q&5(ZP:K!I9M1:A M[-UV[N0$#]DY9&$" MJB$HB\ [EP]U\B?2OUWF3?#%S9% <,7;3?"):=I!\%#(/"4YB)38?F[CF636/3_6/WB$VQBRQ6>T+Q M-R1 D#Z@@('XM0R_[AZ>W#1^M3)^W9K"3/R*760[6QZ67\@:C_3S*;BENUXW MK6@"R9ICS>EVWO3@@*&X*Q/R>[7*D\&*#:D("AB('DCVNRK[1 ]XL2$500'# MX> HJ0.I0Z=@H-@H8G ZKR-4Y]GL/M!-JQC"O,NC>L^Z,V@OGB

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�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�/YBFL^#P M((BB1#:\U'OV_G_]QSO\COZ5KH?_IGX:2/@0+N)H7WYO-=NMX;]>M@\;<"'\ M?*!_?W>@[_C/_7UQ^4&<1N%"QJF,Q>)EH]EH-UX2OX]S_>S462 MK@+Y]V>I_)[NNX$_"=_$_F2:OIVY\<0/]X=1FD:S-\VY^2:-YO0GW>&'G@S3 M-\W_>CN.PG0_\?^??--JP:_TY]B=^<'JS<"?R41PB8KW)8'UQX,/=S]X/ M^IW+Z]Z@=W4I.I=GXKK[N=/O\)\?^MWNI^[EX-T!/NQ]"3AW L76K1JH/'O_ MW^$PF;_=?!Q_9$GJCUO_PN!/?43B\*%&WKB6LY=/A?1 MF<12SN .L9?BE?_]M^-VN_EVY[,T]ZL3H_M;;Y\+>!;AK_2$'Z:1JZ9A5G\(HR8)8^ MK":68SBB<"0%'!&^(U_:V!VER9M[H(?Z\-Y[(W%[2ZV7(*INM:W:+.2^X=MI M%'!3K3608UA<\YBXK,%SQ,/6J[? )6;S(%H1EA-*(A8JNH(O@@#8B&<1E$)C MS4A:FI/CRZJLC!A^[_>[Y5;_KP-&!(@"H &S!U;B#1S++TLP-X+>% M#%T\.#PT5XOD1$Q!3U>U%@[JSP<#C_PY*K,+B5G3DZ=1-*QC0-EF73-TU89=KCR5)55A, M_G)$R>&*UT L3=)/P" S4*K'&2 H(*L7C3)P?4_ M0PK<,!&A',DD09$;P1-DXL? &$EMG.";>T?/]V?P)"2V$'A$ M3$P&&94$8KN?M8HNO+I"PW=LNUNS07?A^H%F;HJ)@(!G5"WIB0[NQ(73#??E M=] $WS2T 4>XA!S(\T"EH(J*VZ?7Z(?:NFKYOEWVK!%7B6:,L=#KA]8TWXH M)3)%_!C+?V>@X2*_QR6C)K3.JMU8LAB2WP%_4C_A@UQ&\3?^RB?_P9I2O=J$ MA6NG8Y\"O&P\]I'3KJ\$,H;RU=U2BD3$E^V!"/@;N^ UIT9["[?W6ZO:LO%VZ2]B6" M7WJ?W8D\ ?3Z1K^TD^0B,PTA.RGC0:?1.,I"O] M#N ,B)[H)_5L;(J0(CB"T1%NFH)Z!NP#40Q>=3T!/_4,IH#A<%$F5R*P[LH#++C 1_J.+\ MSL83*4J"PCE?L7B3+FP2%&Z48_[S*F?O"'@K/VI]1;=<#MRWYZNW;!: ?'\! MYDHHT5(,.,G6!1S)P@5+B#D$]KRQ0I?"$%\ MAOU,NG2FBJ1Z&(M ?.E+8)$9@L@C>FN]/CYB63U#1G%G['EM(,I?4HFH3 Z3U!"]";Q-6336LMEDX;HT(Y M(,AU&:%;[;JZXZQ>K0),I) M6VY:;IR[^6V:);\-AMIC_=(YB+3](.]LSD9H=1-YF2MTN1YVNL1WM\ M[NR__BMJFWNC^],>3V0HQWZ:^T)NNL'F;>JF#DE*!,]<$HQ(ZXG=41K%MHY( MDBL!H]1;D\=@;$S]P&BEK JLOB:IRJ:U,JGNW3ACRJKN+#X MQV'E[7GW1W<]BUI.#;6(:T*G*AMNLT/ TB=RLE)4M:OYEGNA-A'RSFX5O3YT MJ0"1;B1(= M-\!VP[6VN^.)-63H%&PPU/TSN 06,; &X9%RZMR%P/0DF%VJU MD9XF@_&^%0\AA8WHN6B<$*&1#;L-A#GL.-RADGZ2N5*9 MB?T5 /X XQDO;DPVN&TXXYQ<#Y_=U6@J1]_>XB>"-2!9AP28)[ZZVMKM?H>3 M3JH=0H^"6V^)>&R!?Q6S+L*]"J"@ B41NGBK*ABPF:0&2,M8.MS5_ M"FG1G!5;C(%;E) KG11UH(?KT#^)+L)I? /^6Q8V &&@0X?S@C$XPWXH3(4B M#!MJ@.BE%]"^:AE*$%;+MEB2SU(Y,W7(GWS%*/7T2VY#(@;V?XY0[D5)KQ== M'-Z[C+40M&P;BZ\J((8L/DF4*8%J\C/"VDRU?&"/&6' MO]%I886L;-8#"U\-83-D-5M)/'"5#P2XB%CT&">U'X/6M?>B^1R3PI-25OB: M! ")MI0H3BJ-P&(0J2IV:L(?=A;C') Y4_F4E9LC7;LZ8GFW$&5.[D"J:>R/ M5'1F8^#2LG85T;:"J=]@8;V-A=-K., MY4@RYJND5PPG@N(&/_WOUM$KYV6SV6@>.TKFV($>3 @A/V92C<8%_2JE\X^5 M\TB)(7\VDYX/WY'"MUG@%?9SC0)!+=7LB)0T=-+ JL()$.[(3:8BR&: 3!EP M%.+[[GP>^#E=:[W+T1DN8S\&T]5H:KC6(IT7BS0>A_]FYRC]BYNC]+?$[U,5 M&??$1PG6]W0$&D]EI'YLR_$ CBBQ,=L$V*?T%.)?,2R]Q% E,Z[$SAA'WP4P M1$0%3US-0A_4'G&2>1-@?'V0'N$(!)@JSAJE*D3YLABBO'5X\NJDWUG+,%G/ M/O5 F1JE2#GN2D6B*Y5-E>4,FI>?S=AI4_"*5YQI[X(9[R?.B\\JXHTR*5IX?Y*XTPRVK[<2)1Y*L_@1Y(JAOMK=_ALP< MEJ^7[+! PYM+$K@E_X]QX3'RD45W+/C:VFJS2*V7I4?U)8_%"N(K)(HT2IVC(H MUZG82)\')(BLQEBI@ M,(H29#AWCPHI++@I?(U/+'FT])EM\PO$LNR6*Q*\.;/FZTZN]'HZ=ZWTQJ*Y M54"",!*!RQP1+,DS8'&S(?SUHJ6?N@*UL61.T5=P+&Q:\HZ966&(7KM"67]5 M!I]*;2=?J5D<67Y ]_S //3IJCJG_/:"("AL3D?XL6X),^WA&WR:LT'HD$;" M1H;]$(N4\T,@4E:A6.LP A]0P#-I#(5<8RV)%.65O?4/@!5OR0JX)2MN-UNO MQ4D4@F6FW"!5?/E$CMPLD9O3$Z,1H!L ')8NBV+=#489XC83_!S=?^@]&^(K MK2P;6@=<+#'@HY"GJT/TBL,16UG+9#17&4S!*)-P^16:16Q]45G)X (X9E J M@R8IQ?IS/PV_!72< L0NHQ19MXE1D(<$@#.)R(F(?CN5FUFLR.5EVA3@E':H M4J8+Q*BO**U*T>VVK3/W0(T/8^)K]9".$:5_SD>D%*S$Q: )1DSWG_Z2Q9$&P3=!MPHHP("B%C M5#GL%@FZP"1'A#&^D"4),">)!>JPJ@1#=E8PSR10J,89:*I@C=)Z!PUK@4@" MK#E71Q"VE>!S^I1A 12 0MW[MG4$CN+ I+?>$$,K*78,JB3#S"[I2:Y_-TTG MBBVU;BY1Y U FD;(&X,Y'$5/- XR+.44@DM*+KY7G+6 PLYP-@KJY_,@=(X M"NRK37D_F07Y'DNPLSIN2&1S7&*\OI^JFB9J:D!9N28_W=/.9!G$6;.P*P;AH%+NPB MB9 R*'KI<27V"G, )KS%*2+>2"7IY$BX0U^X/Z?1_:5#@X_$4)7OD4;*GD-B=UN'Y":A<,>NA>17S+26YXH,F M&%&7W>DJ;RHZQ/4Z.E?5*O0V+IIR]ZAH&4IBO>,Q)5BHS#_34OHCK'0'3L9DP,B M^(09JG;PP9UA@01<%"7TK(3KC]@1[V@3$#1VC'?D.I0CT-:BW60A?71 >?N. M:E6LHIE4R[1G=^<; 4#@BCN20T$;J!DM/->^2CMJLF2-,J9 G*G_@B_)8T6: M+9&*H?-UK!H:]54=Q,QEPX\0AJYG!=;2;CD!G&)[P)E-\P6=$:XU6F[LM-GF MU'YAY=94M5ME3S$63G*0#4"3T+LRM/@=I61343(%9 (W+7L)<@T-R-@I6,*Q MG&6A:01)2:I ^?RG<@)O!EO-<$34;#VG-5L/X$_-5F2A,XN!L43':.!0>;.L MV6H1_8,(F"M*C*1 :C9)U6S5-<1"[BN)G.2;3QX\-]5)%$/2"DPH>11E,0G* M8G$;Z26C5>T8D.'Q=5L8PK)F:ZHG7A;944?W_A!Z*/+TCR M[.FC0SM[VA&';?&E<=TX;8!&V#IZ]1;_VWPKVLUF$Y0!V)C\=^.MZ,QD[(]@ M&:Q]G_F):YJ%PZ/+C^2'5#RWU6XU6_EC68.8\K-*:=ZO7A2?VGZ]\:FO[&=V M)A+7-XI]TW476SGF/OJU];9?5X'@J-VR % )S..C(S9CJD']&LRS:O"V7A_; M#^]20%?YRPN32,'L@:Y-22<44N< M-LX;_4;N)[;/&RLMSPEO:7^?I.>C:+N0J#97+-(^&OY<6.X1'1#_D9_\N>O' MXL(=.?S;Y=QRJ1#U(Q&U_IHUV5AHL<]$P 9LI@B1[LA8JM9 M!OW7*/X&S+'C83#(!$+[$M;!?04OH]0'%#74ONTU&HU$D6W4#'C$;+''7!2' MOLMH;?&;FJT6C^-CE)$@6P,_;*.!)-G@EH *^JWVZ\-F\9BM_>;^YS!SAEXR4_]E,$9NW^21PMP_U^-,06NYH/K7/7BG=]B!;*GDW7 M7XG;>-EH.RA3]1-P\J4J7I8S;"NCE1 W@H*5A8MRY(IAXVQ0)<(7!T; MK]E6*GUX3T==8,]VB@9FVI"^%C-'T8>P?K#MPDT4Y+#&&K M'\:QFX%L@(?$#>.>CQBT]4]*/WT^BR,/B!:K7HD]85 )K#B>U M(V4R;G+D4X&*/,L#VXUXOC0NFV07O,,\-QDF&.U?Y;&/>1;ZY+XQW_CA'UDX M4IWP 8PP2U[/=8F_XEC&_.0*E*H=\:*LDC0UXD M$Y5ZS E4?*4NGV%UZ]8CJFY_:.T7C>8O/C1_UT.S.$$66B+5$+0.K2(G($W* MTXZB%0=^BZU)JHLJD)7D10+\')#1;W]"-X@Z',9=3F-)1K9R9U'2=:? 3>OC5XHQN>TA6=;%7ZK"+F0UJ/,N& M^J%)'&7S0DO<3:2S7H]$!<>/Y%06MS\4N]>P:MK#V=6J\;VJ0:)8_4T9]+ES MKU@NMHS]-)5AD=;*]4B%X]UR7G_!!,9#3$U]2F)\Y$F,#Y+G[)R@_9(3M.MB MG^P!JZS0PV^EKO]J1XCN6*!#"7ES_/(OKEU@M"Y>3U;H =KDQ-7AL?9QLVU2 MG+C"(5=223T%X?O33+U?C_I[BYUUH"W5_"&4;^')J5#-'40RC;+ TU-"] 4R)R "2UA4ZM][.NRUVZIOKML MJ%()>AG +. >!9#O"&4L^0W%WBL%2\XTKT97;FVSB+Y)X:>;FVTN_60J$^OB MM<8?>6.S#,>"R ;P*%CT]_4_9B;+VO? UJGY!HM-AAZ^:;9%//&K"$^#\R M8MP>T.3>JW1*6[3\I;?K%0W[^1\WF?ICT<=_/$>TCN%])[&/XV(^N_&W);9I MZTMOB<&24RJ;..V(UX?-HY=O>3:+ZP=OU%,:_)3_$\I%'#5&$:QZPX GGKMG M0YCA6JXE=>!43%^34!?H+R)N<$(EKZ"IQ#)=E1H8%9H1V6V 4=";'A%17-'S M:ZUU0Z%RWBU>J=72%ZJ$X''H!3LW->K^LWOZ9=#[K2LZI_]S>?7UHGOVH7LM M!A\[ Y'_]K%S+4ZZW4O1.?NM=]T]$U?GHG-Y)GK7XKSSJ7?1Z_3%U][@(]S7 M%9_[5W!1[^KR&B\[[5STSJ_ZE[V...W]UKL0IU=G77'=/1W %:+U\K#MB*\? M>Z#F\[/SJXN+JZ_7N&L &!X_]U8;3TD:[ O\P"KQ;']V?JL=IONV( M#]W+;K]S(?K=BV[GNBO.K@ .EU=X!H,N 'IP)4XO.KU/ZF00S*?][EEO<-47 M\'^^K7?Y07SN] >_Y[?CD>(%UU^N/P/(\3G=?_:N!Z)W*3["Z<%/'[M].,3? MX)-Z\*#WJ8LGIXX?'HK?ZI7AL>,:'-$[I\=?BI/?X5F?U+/@-,&^/P.4 ;SY MU!ET^[W.Q<7OHG-^#@L U+%>>]T=#"ZZG[J7@QQ[SKHGA4W!';2GAJI=^HD8 M\6MH]Z2+(.]\[?3I%*X[O;,"S3@V77;[78!^]Y^?^]WK:X#RUPY\#11T^;OH M]SY\'%Q;%W_J_,ZG,L#;OER>X6$!K7WM7ES@O_0-W7HUH-,9= 9?!ETZK=.K M3Y^ 7"\Z7X%,>Y>GO<\772+OZQZ0/U!_EX[W ;:\>'7O+2\NHW#_S$_0!SY1 MXBN?S*P^C[D(4SN_/U,/FY1SC"],AD B\E'.3W.B_K0)O'8PN[?QJAJ2Y^E' M.6*$NN,(X$/I.9A04^CLYY"BE)<8ZXX\?JPGT]#[K!+DRDIB76:<5Q339&;L M'%>L+Z9R6VS.BI>H&9V. '-]&D9!-*&8I1ZK [?YI%QQ%D] /\YC?T'#$LI) M!E.=5F4W5GD%9Z3@PM6D[ _D;DFL\*D>/02?%(>)SR+JA:*:G6$[%UW'!/N, MAS[WP,#+)]AX6 T%HGJF1Z'A[>Q0/[KW80C;&-0N8S_ &,CBL#2CW6Z>62PER=WBC)KHRY2L3_!B70Z"CU7:6$@+'CZI,>MN+W877+' M1T"@#*YW'E:_EI=/HG 4P^_B9YT" J-W+B%Q4U:N&:))Q4;&ZV*\!58K69CT6I4MRI M7Z8XZ<(/:=R;SCZ$UWCHK!R!1$ZL48X^>S$K922^L&9'8:1RS=:%4*O9DM85 MF)HM4#5#I!8J>1G"@KI0\T(?G(/A^,?UU!3]0BW'#6-"EM2$-V6UU(!?&;AH MPN788]V/X1RT=K$7)K53LF>\TRB[0/7T80L.;%!@2\C0=,\Q+")SE]0LJM!H MJ-1!TYB_905?A3]7EB7H!LH69,[%5J/ND>&/L5W64%(?J*0XP%--FW#SA>IU M6LO, X5JTU46!C=\=,H!#WO0(/?3\CF_@P/JJ/-S)VM5T8,%FV"[E<+F+-,E M]^P",R5.."=YK1%H]?11LWYJ_5J.]Y0C0WNC,O!@*=P- M#$$&ASR25$ 3^ZI>9S3*...8*YKRKIDYV$SK=%ZBI@'Z$=B*+[EF,J N .C% MX"39/)U\6\L 4QB@:BE-8C]LQGNNII.HD*&C YG\K-) U_*4V55560*9CI4=1?MCV9HJUUN=' MRP6&T%RZM'<@,; =C=V KCZ#Y:KMHVF*74[1,.VQ'=,LDMLY$E10FJILIB'" MUY.:95#+?V^;0L [UWWU<,(>]Z=48P!&*>9$N@8[G/(V-# +:%,]#*QBZ)>9 MX%5F';G;S[3\,[L@Y:($#8(!,3F$BGT (;451!R*,2Z4FW1=:_&DBWR_IG+;ZBJ,'1I:;VE@K7I=4]VP/X0#I]B& MQ'1 M8E PD9Q"DTQT!!N2MGA2G5$2&M>N5)(-E%2\?RM5)*-S^?Y:@,*"M*9U52VZL0V=JMU$@>(8J=+1K8SZ MB/!(QM)*FW?$E]!';D@W)+H+!^N$V' 7"^E'+K98U6$+GN&AA816ZQ*%4DEA M^!YB>Y1S3M7:(R>#?'4/,+Z_.BF=2(OYO,LPJE9<.#\-) M8\2HA)R#*IU?F8L8@2HWMBTWLZUD[$.T49(H6# O1.=K4-!KW7R!.K?8C"X+ M998B+EI!6!-)2C MV^P)"W:H"=*83/Q\ZV'GG<[ZJ'/E275QUV(<9=1404S3=)Z\.3A8+I<-UXL; M43PY2( \DP-E$QV@6R YR+=#2__75SELS+UQ@WK&V2"UV,]LQ@.QZ!C(<>)J M=8F*'JR[#-A@Y3IZ.D97AZ00ZF$AM];RQ+ BB.HEISGG&;"DG:BV'$K,*^T2 M;RDQ4&F?..^ QMZI>5MRX=JOVZREH&H3I_2WGI9\F^%_H(*@"9D7+V@G3VZI M^3/T9--\/QQZ"BI9QD[N683)\NPKX<(2NG6IU=$DP^E%R/^+S!WGJ7+^-YRP MY7]2N&EK'O1N=A%AKV=E+1<2(Q (^HO6H6ETG;NK2DH;SP:%(U)C71U*_9], M8E\B ;,ED&\>] \,E@\#73[C%2U^SL@(\REKU*ED1=GO)=VCH]^LWD&G[JB! M5Q&NI)3*N]:7Q-9N,:\%2\]LIX5#78!9[/*K'E3$^^@IXOT4\;Z]PO04WWYO M\51FC;ZQ\@L2U&I\S5,H;(9B\>CJV=,U"X:]JMEZ4%K5;$E1;,O.NBVN[&G& MO(Q0EFU%%)]8Y\K)<:ZO6BR!,DD3R/6\S)B=Y1LE==Q:N\R%^-?*U?FU;YWY]HG/QG)('!# M&665"3"#DH@>14' %1?:MM\ZB]EPA0T3A^WYPMS1,]82GBMCK1G&>C2SK1W0 M"G)O+I47JX@WAR.5QX#'4.L)T-045)60V 6X1J+FB[UY'O2N2UCS$%5R(]M9 M8Y0;>X#VK0=PP_GY*-X]]CK8H^.Q?Y1'8%7GN%34UUZ,(C)P;2R1T[<9BPZ(D0L\WP9>TB>:I"& MF1$LZ5777,M;5,S"46T[5VIZ,-;MP%VAG$2IKZTI;*"2<"AZAX[3R2OMAAGFV.3Y:)&^H" L;]K64*>2L!:ED(@4+/1 X5:P2DI) M8?89^XD9(4ZY76YHRC[R(+&^.'6_(=%'$ZDRI S^HK6@=YM@T9@YC(<>%'QQ M[X) YD8-RW/+;Z N. M]^(XT=0ER8+HRIA!,7:3Y,WL"5XM\U"C7M8>T,9,QA,+\3$/X_E. 4\=X:'8 M-$\=K0[REY5+W'_EK%/V#8VN&G(>;D;/5;MU-3<%<4S7X MQ=8U1"_/V=<(NJZ'VKT+BJ;W6OL5G.N)64))A9"MPN(MJL\N8HV8G54HRZJ- M2IVHZM-Q:!@>I;EP.:GI+9=CKM9 *B=TYBUD1V:4$^L-][OI7I'RBN* PT-2.6?(5%W>_*2,S[V3EX3)-8L4C. M0:6U]$*JFH8O/W"3D&H/8$$88"%6:BUC7GIF6%5%V0T4D:R&$0 M+:G $_:X7^R>QR^'KZV)"B4/\Y:Y*1RBU[KB!IHRV;JAE#K$ZEO)]D9SMODT M1CM!M<@CAJH43,^(4-LO-^;Q=;MW57P-C\$8\;B8)5O2-C&>3.E[6U[4$.=9 MC,"?4;"P(@N@=5R?;^=]Y=3[YUPI#*(IF()E3 M]M53B2W7^-0#+H.GZ2CP$4=6!])*A5YSQMFE5G3H>]^?&[,C!Q'%=XL7:\\F M 9>'>X]5K3RJ$"7,_U>3VDB.2MXA+0R8-5V0+"=>3L@E1VDW1( MC"7)B, .PJ3/B@A"2[?6]UQ=U;AA:7&J^HZ56Y!E^E2#',1E<=)KMWV52Z# MXH/Z^7P^B00ASMGB/N!&H<<5)6Y83Q\3;>9$7-ACSB@[5AEE+W]U M+B#7?3#:)K";E)A*C'(5+ ^))YZIBF,<[60B M+6$GIU8C29"SG/ZX.,'2U M(TZV_P.4#^)W.=ZS'VB!GW06O^XX@;;U"#;&WN<'E&[RZBG=Y"G=Y"G=Y%[J MI+W,&"+V[49#2BGI'Y@QJ6KLASM M!Q$;MEBN2OCDUO INL#EDG" ;]/)*AFZMT[#Q2?0^4CSOCO'[4;8C#?,%,%1I758#A!U.\/FV88C%#DJE7NIUP7IGYPT46[O79_UL MR.?F+J-B26LO6'6@-6&08)B!,AHFB R:+##U=Y//B)V<@)S):"KA 9)U*51, MU! O2CN;@,1 11RKOW!*8XXL59 ;14$4O_D;F/21S8.;Q-[K%A>G4C4J:RJV MYCKEGN3XYV<9^Y$GND"VK$ZNL3B50TWEX+5+JZAM^L3XJ:_(K1=H"2A32PGR M-:/J//:JA,K'3%C*A9JYS21T!4;-]E5[P(/LEYCJSU%="\P4ZB98[PU=52)1 ML[77'KCM9JMF*WI=L_74[<00U>NVIKJU5G,#=.6O*0O(A-$8$,"170& ]!/C M8R8NP\8+:"3,;C#9N,3%*V=Y_<*=*A?[0^.Q][Q); MO%]VKZ_%5VP_?G7.03Z>.<%)/FR081,'KR)]8B@YG\?DXEA=7=8;'V%> R<^ MA[ <92H6^RGC6]V4 H!#"2KL]K2$G^&N^6EO]/P%_#)?*,_O!4ESUAJ7&E3QK46 M^P[A%X^ZZ>##>?//A#CY<'IU<=7_^[._G=/_GN5^.%H1.\@1*OJ+/CVTV7CU MTOIR@* K?G62PY=7>'C8>%ERWMUX%+:7'O\NG@U^<7>0>K\>)*\:QT?W#D3E1&G2_WZE*_NL,^B>O1'_P-;=H,Z\>I=D\W65XQA A3&[?7U< M;>"5(-!2; FG)#X>U_MT^NX GO#>$>UFN_G3^83-%'[5T?X0YO%+Q WSCVUP MU C\8,E#'"0'XBS*)J(38)M$/QU-[\;-GA2&)X7AKZ$P:(+'[3\N:G\B]"=" M_TD@^>G$#;2].?%C9V_- T>:PV:C^5CN#9^Y/5F]HQUR?G=R?T8GC#!S? ^O/P2:6MR>'431OY M,2KL$[AWUI ?$K0OW9FLKS!X?(&1)RE0TX.I'UMZD@)/4N">H#W "0WU$P,/ M%M[B]/QJC;,?4/HM?,?)N#?W'+B_M&#;E[]C:O)?NQ/",?;9>.J&\">[(;P[ M&$;>"ILB'$S360 ?_C]02P,$% @ UH994"J^-E$V P >1@ ! !N M=G)O+65X,C$Q7SDN:'1M[5G=4^(P$']WYOZ'6$??VK2 7P69.5'1.P1'<&[N MZ28E 3*3)ITT4O&OOZ0M*"<"YRG,J2\M^Y'L[F\WFYU2V3QIU3H_KT[!>>>R M :YNCAL7-6#9$/XHUB \Z9QD@I+C>J C$8^IHH(C!N%ITP+60*G(AS!)$B<:#E3(2I )$1,'*VQ5OVQ4#"]]$X3-6U'%B/[!AU+8Y*[@>;\.':VD M17 LJ\"Q]J9M@V8=U 0?$JF(!,-=QW4*3O$ V+91" 0>Z?=&)0*Q&C%R9"ER MIVS$:)_[DO8'JAPBV:?<#H12(O3=:,)1(DK)= 7EF'#EN]OEGN#*3HA9ZP>" MX8P1TWOB>T8])7LHI&SD=VA(8M D";@6(>*YJG'$YT*&B&6;*P-@3S,TEY-, M:X@D1=HBR!6MZNG=@ 94@8+G>!485=\TJ#^CLJH[/(BC:(O2//!X928O>4YAU\AUA> 9\H)3*,T1Z^5[!X_D,#.26]+. MZ(BTTT4+#'/_-886> ;^++;%^.XB,G),F#,+X=GDOU;2QIAVS=!BFMT%[^K3+R3*&!*T9!]Q>I_2,PIQ MC,$@\[V8HC<%5P;+HGLBO_L,8FW!* :>WBF_,E.N-PVK(1GEQ,X-/Q(_S<,# M\#DCG0U\U]G7]^&\8E@&^3QK.:+_E(R=+6_/74N[\196_6<:7Y[&[+# =$S4 MO&QH_#BCXU0)@^-ZK=5H71]96[6S,_>L9KUM+U]EXK/QZ9+H?HH8:"/)YISE MU0 Q]\[XFPOO/>>MG5!U3R1#'*]Y[%USR39H2!7!*[Z!7JU&WT]:;KC) _BN MNSX6X7)%^9Y/Z'297JD1:"CLK+U=?7;7)7+W]3;6BHRBC]E;ZT23? 3J87#^ MV5C7G9,\&XN&\^6CG?7]^"6XYQ_H*S#_(^ W4$L#!!0 ( -:&65 [?V>K M^P( "D( 1 ;G9R;RUE>#(S,5\Q,"YH=&W-56UOTT@0_HYT_V&(! *I M]OHE:5/7%PDM=;;I.'7WVSL5+14=TC B2_VSLO. MS#-O&S\?WR39W[,4_LH^7,/LX]OK20(]A[%/8<+8.!NW@K[K^9!I+AMAA)*\ M9"R=]J!7&%-'C.UV.W<7NDIO6#9GA:G*/BN5:M#-3=X;_?$LMKS#'WEN_T:8 M$ND@MUHY>!>$_F??XY1]8$\W! R M1VDB[\7%6DGC[-#>C9:JS%O&FE>BW$>9J+"!*>Y@KBHN6UDCOF#D6U,M:0.) MI-(5+UOCQF9P30SB2FRUMEP+3AZA4^R-TKM"+(6!('3]F-6CIT&M*$S4CU % M_8>P#O13N#H85T@U$_S)\#OH75@_A"BV_ <8Z-DIOI M(IUF<',)D^DXG:7T(7*>7DT663I/Q\<6?9,D-Q^GV82:XG(R_Q SZV'T*%L/ M]E\# ME_E1.K32IA,'YV=GPY/N'/J#\^[LGP;>:7?VSH?^_3D8#LX.UEK2\_N#UZ#6 M-"DTZ#2_NG8MJ6XU14XX#.04(3G'I;[E>@_!X 3(C$?BDC#(S1&Y380J1:N^ M%I++E> EE?H>H75K-7&]QI416Y38--:;L)-"2\O:,%J5H&B+?&6CC81\G<"N M$*L">%TCUTV;4M&TJ?$]Y[W[$SOL/U9(;_12+IOZXG?Q:.W[0?UXCPY_LS$* MT)P'M=>.$6L8S+18X8Z:1!?JML%$J1JIM-?7LWBI@8T67,([>JI.(*'%2IZD MX*WDFY[\UU)\YX/R"TOQ\US&K'M/8]8]W/\ 4$L#!!0 ( -:&65"J4W95 M"P@ .0\ 0 ;G9R;RUE>#,Q,5\W+FAT;>V;[7/:1A/ OW>F_\.53#/V M#"#DEZ8#)#,4<,(TM3,.[O,\GSJ'M()K3CKU[@2F?WUW[P3&-G9PZT[R /Y@ MN/?=E?:GW3O1_JYWT1W^[T.?O1O^\IY]N/KI_:#+*K4@^,]Q-PAZPYYO.*DW M0C;4/#/""I5Q&03]\PJK3*S-FT$PF\WJL^.ZTN-@>!E,;"I/ JF4@7ILX\J; M;[]I4YW[!![3IQ56 G[)IEK5X/HX#'][5<=.V!0LVMK!HO=WM1H[?\NZ*IN" MMJ#9]+3>J!_5CW]DM1IU&*EXCI_?M'-F[%S"ZXJ%:UOC4HRSIA;CB6VE7(]% M5ALI:U7:;.3+&JMR5W0C1!9#9IN-[UN)RFQM!C2V.5(R]A4)3X6<-X7'J\[YD TOMD>ICWBY+@?# M0?\C7KKNN\[YVS[K=(?L\NH]5H7'G5IX[[TL/J_%\:*9/XW M[^4GZ%O:JM3C'YE@4&6].OL9A)VPMUH9@VM6681T0DV8G7#;] K'8LJ+\L)F?D@M4E+RW$!S\:7% M9B*V$]04C>)6T/0O9M-R931I93&)[WI:/SKYOC6;" LU6IIL,-,\KVQ^C7Y8 M>XF^X#5I4_U"]B\H1UAO!]3TANX ?)S%]R_&LUCYV41^@JWPSF<3/@6F82I@ M!C'>Z\*P3I857+)+R)6V3&7L#&=F8:/V,U,)SH9/>7QZZ[S>6MH$_VGZ1\Z MG^@G>V_916\YVFIO^8D;]!%TB'3./N%-(R$>0]4[C?;>$BN<(E.613B8BXSQ M;,Z*S.H"4&EN(<7'';D19RF64!C)$AYAE68JQ4#1*M_O7H<,(C"&ZSEU2?DG MP'57YC18%Z,PN*0DV] :U"$2.BI2[);A<)0$O8CAO1]-F"GHW\WX&6@H)R$% M4F$D1NSHB.AB^0'*(G( T;XZBJ1C5Q" >C3*:KYIA#X8]&&[+<;R;8 "6 MB Q=C[SXQM6J2 7LCLUZI5UD)!*GE!R_1[*(<4YTYQ6_JB(*A)9SEJ,W$D@( M,%+>D*)T4G-G:811['+]*O4H)'9 /"CT8;><;I2RNH( LQ#FGK1;3(&]RW]>CI.GN?S7[-_#6\[P\L6/1^&KEBD]N,P3 MZ4&IDD1@\< <.D\9,*[!^23ZF*!;&X5B8.@V%V9"(ZA;BG$"Q0I4CH6)I#(% MCJ,(0BOIG3/7*H(8JPT[0%^, 9W;.US_.IKP; RL@P_GRT)BC_"8U\+3 _!2 MA*>Q+_FBH.V)S$.!YF?T!%]AA?==DF7CA9);"R6X$.EYER#8@Y*-YJY3X4:/ 4 AE M,4J*F%LGZ,B(6*"=2 'ATRH7U&4T4V$HU7'@-RXO]IC<)4R.MA63&X=;]VBY M>:"V,301M%,1$PNY49GC!3?(4=H<(D!R'2]@A?@4?"2DL'-*!]E0GFAEK%"%^G !NFVD,&6:E$LF)+9 3DJE+D5E/ M1T2WR#'VW/-QS\<=XF.T/7SLH]"%B[4('I D$%DQ1;EKGV!K&C+Z[? MBW(XQ($8]QF_XS52A7U8@DVB6[[L#;2=EWQ^7YR-%AN%CO#@+8'RM&CR/='V M1-L=HL7;0[2>A\5]Z-#A7[EIYEK6DNT)<1XENRJ*"DUH6><2?$)9'F(>:=_]1^;:,_1G0?+Z.Y1G#NZ-GGB!I.I- MS$$AT"H6;L(/&$\9BM?PDTR[(![\40@4W]&MR")WBGFX/UK81U"[ [IM.EKH2,EH M]TH@R.BPD(X=(P%(GC*O6V[QSX!_HD3-[QZY5,WM>[D7J!8O-#R)9^5NO#^J M71.F\!@'&EA&*0^RK]PMPR$(,.1#U6>+!E-%4Z1H;U38*5-&AVM?_=A','N. M[1C'MFCOOX,)7Z(QZ*DB5<#%:<@E]SIE";"JSY=$-E5R"I0T97Q&KK)SF"D"WI9]NBTRHX: M1XT[OUCY6S_/>3I(G@?6&[+ZY#%4WX87+ZQJE2(LC.#.P%FC_NHTM^Q%P_VU MUGG>PT8KBZ2H*]^V(E6LN_B/F?49;XS !/=_YK."G,#;[8G&(]6WW7)KK;8U MVG4G I*7+\(?&JW^-40%'07XXH7/JQ_5-OP_T_;@@S]"Q#\C?'?P%02P,$% @ UH994'2C''\>" /3T !$ M !N=G)O+65X,S$R7S$Q+FAT;>U;;7,B-Q+^GJK[#PI;V;*K@&&PG:2P=ZL( MQFOJ]O"6%]'%-MZ%Q,DF !\ 22VINT?]S-/2 MS,6WES>=P2\?NN1Z\)_WY,/=3^]['5*I1=%_3SI1=#FX# VG]49,!H8J*YS0 MBLHHZO8KI#)V+F]%T70ZK4]/ZMJ,HL%M-':9/(VDUI;7F6.5M__ZY@+K_"^G M#'^=<)+#'S4QNL;O3^+FKW%NU?CN/-7*U:8<^[:&6K)0D=),R%EK(#)N29]/R:W.J IM M5OR/MV(<*A11D9;2)J,R#.[0@RE40*WB06I"C: P(RD%*V^[]V,Q%(ZX8];';N;OM#7K=CZ3[<^>Z MW7_7)>W.@-S>O8>J^*1=BT^/VL>DW;\D\=EE*#TR__,7/8/"+ MD4DY,_BT,A\DB)[5FZ??G4_'PO$:3HU.F!J:5YZY(M^OO2!?\0I<8/UR_Y0;7@Z"!F3"2N#4$&(0/&X,!MJ< M)UY!'#<'U30#,X%F@U.&LU4W'$)^KT/^9 ]"GI-4* @JC,]E$%4AWD$"V:'N( M[[V.[]/=B>_!@V!X_>K'9OS#N2TCN,S:\!:HTU1 \<@>^TCI$6JXCTF(,8%+ M&Y0BW.(R%W:,/5 L P: + #+3-A$:EM /^0&1LL0G+G1"6=0;%A(DXA-:B\^.>- B/F.A%(H"MP94 404K0NRB M+AM/E#Z8*(6)T,['" (2F""T]AT5OLX2?JV&-C]_/A0/(/BGZ'%$CW<&!2^Y M!9T!#'Q.\&6DJF*ZDM#";MX%\X8A!]0I9PJ9B"X,# !T8R*L)S$@Q94?![?* MEO1GE4(9+JF'L3(564)1M:17V"B "H$N5DO!J/.*#JU@ OR$!HB0,'E2IW"D MPF(2XX'?^HS'4QYM.2CD@&)AIYP"?B:%I,C4P"ROQ#(9@AXAM5K-".'?D*,@ MD"GHS]G>DZ<#3.X33 YW%28WIEM/T')SHK8Q: +03@1#+*16*X\7U *.XK8/ M B0U; Y6 )^"#H44;H;IX+II$;H]KGG("JC[0'1EV\@3W_O2H+PP.4"F]>EK MD@#\> 7\!M*(*\A*)2 GM/ <(1E%"N4".@)TBQRXYP$?#_BX1_B8[ X^=D'I MPG,M! ^>ICQQ8@)A;]=L/"UR[0VX8RBNWXOR< @=@??9L.,UU(5[7H--V"U= M2'/N6GF M6]8BVQ8\#Y-=G22%06A9R2S7C)IIZZ >GP2"L6P" _U64/^LV]$S75+ 2&!@ MCZ1+Q1- +G\BB8>5_DP_Z'4 "?LLC7X!==.T<\_ELA M0'V/;H5*_"GF\>%HX<"@]@?H=NEHH2TEP=TK 4"&AX5X[)@(#LA3YG6++?XI MIY\P40N[1SY5\_M>_M&H^0,-6^%9N1L?CFK7T!3*H*/E"Y;R+/:5NV70!0 , M\*$:LD4+J:(M,O W&.R-*=GAVD<_#@SF@&-[AF,[M/??AH0O-4!ZJH JW/,T MP"7_H&0)8-60+PDUT7+",6E2=%0^[VE*:L>S7.H9A];I6 <^1Q_ (\#9BV24 M]<\#S3_RW8I+<'2+7/&A*? QV.99E30;S<;ZMT6V>S5F>R!Y&;#>$*M/'T'U M [@*C65T14'D$:1G@C')*V0K/Y5%M,V7'SH.*Y;N:=3/U@/M>GT\YLX5*?TU MU\0?V)-&_0<8D;QJ^,_Y.IAX&#,R,5\V+FAT;>U9;6_;-A#^7F#_X:J@:0I8 MKTZRUG8#N+:3!NWB(E:Q]=- 2W1$@"(UBK;C_?H=]>(ZKMTE;=:\K/X@B>3Q M>/?P[N%)[CSM#WOAIP\#>!O^]AX^?'SS_K0'ENVZOS=[KML/^^7 ON/Y$"HB M%<,BMQSIN+?W4MN'L!'I2S*C25,'LP/&< MP&F^!-LV F,9+_#^I)-!KA>Q"M!2[2'0[)>J""7LLM99IR\N6 M/5IF1;.8P41,A6YYS]H3*;0]IV9N:RQY7'9,2,KXHA6RE.9P1N=P+E,BRK&< M_4U;OE%5-HTA+2%52GBI7!L )]B!O8*64C.B&,$5H1*TC@:7"1LS#^4=PO 8PK<#&'7/ MWW3/!B-[^,?[P2?H]D(S$GA>L.;VMV7B#9RJ *F,_2X_3P5$4@@:&3*'.=,) MZ(1"5X@IX7!.,ZDTR D:A/2,M*LR!_:,Q.[.RR#PVCV99D0LBI;??@&HY!AU M@^_9[P!7+[1-6!ZAM@4E"BAZ'4.?1C0=4[6[XQ]Z[:;?0!S]5PT@.0IS%%A: M,J+15.%1@Z 0$.G!". ;RY_G'3! 1,71K MVWQ%\\S@.J,<6[$$2J($$JKH> $X0;,)]F=3E4]Q3T!+6&&- KJ,-"0 M6&8:P5F=7G"Z@&Q7;:**U@>-$M\J@C=D,B@Q];7$Z MT19V:3+F%,92Q52]MCP+;>4\STC$Q,6RG9$XKMMUW)=3[$AR3K*7:X,I!I MV/&*7WM3'FX'K6H:1XOV511-QZ;-_QJLMQ@8;NY^^993GN0K-.26Z-T00@/ MC\/OCA)K';MO1NT1!=66=^2;LLV]]G$O4PP/F@Q/&KIT5):.OM@0!+7726E" M<6)85R,C97',Z8\+CILS]W?1P?^(4;_\\/,@*?5N /P2O$=%' 4YEN&P_ I8 M-E=H\OZ<('=SK*ZPZ^>*WM3Q)(KD5&@L K>3[;\4[/]U>=MQJW\1.V[U;^4_ M4$L#!!0 ( -:&65"%R)MME1, !-@ 1 ;G9R;RUE>#0V7S8P-RYH M=&WM/&MSW#:2W[=J_P-6N5LU+DNUD)<55LBS;JG,LGS2YW'[: DEP!A%) MT XH]E??]T-@ 1',[+\N$11Y"I+FB$(-/K] H[^\O+\9/K/]Z?LS?3'M^S] M3R_>GIVPG>%X_//^R7C\:5D5:JBA?C\>F[';8SM[8^&(^7 MR^5HN3]2>C:>7HSGMBR>C NEC!AE-MMY_N<_'>%W]%OP#'];:0L!?U0+K8;B M^LFS?SV;?#>"4?!L'!X>C_$DEVHDE?NF9'_%@>[N_ F?5P*7.:@ M4KKDA1^!H(1O:'J+.,SA"_BV$F[4@FO)84WF!^X\/[V>RT1:0/NSHW']?/.N M4H!3Z,_;EH7IYO MV/3-*;LX?7UV.;TX?C?]]IOO]W:_.[QDEZM3=GPRQ<>[_]A_\M6Q^F5(_(JL M\^TWN\\FAVO[^Z3=[$Y&DZ=W9G]\&U:M$E-_T:K[H^^?WB,T'ANFL7VG@[8WF1O,H E06.!(M+UB,UYQF .EA;#MC/TG MOH""L3^K%*!HQ$"+8SE%@:G8%[AM10^('2R M2A4NR@GF& .>X#-]?:# E,QX>TG[ YG/ZXJP :[$(0^V,@K( W;G0S_B^6R M@)F6TL[7!1)A;>7L!"@DC8&]#3IX[%RBW+:FVI&NYMJ.V,\"$)["WCF\O5(- M@J(%=^BX#7<#&N$003 @6+RN"QB>%(+56BTD F*"$GDM*J%A>R<1I=[R9:MC MK%_FI8 YN18]C+]\??*V)1=P,N-9YET\0#:R-DWX!U8NNWOWUH\EA9H=HDZY%.V]^Q^Z\YSU![=-E._3:TS#(GG>^\?Z% S%!10V.(:D<4"[]'0URN?N M'5ZJ24&A)T#O?9(TW>"_>T:A4]31X:FQZ*>16L#_M)"64'*AO0[ M80VU,B\*!NH&7":R9J6TUKW#W1M>H=&T;D&@,5B$HLG0L.(S47@?"\9F8.Y2 MJ[09,>2B^#6PJ611YWP!AK0IFP*TW(( PYDH7D1C<]N& M<-C#+\"N8&D]P'[6B#M(D\/&:&K:MQ\:S7]6M;IXX(Q GDM2QPO1XN,NZ]9J MZ4@3K0/_83^-!5-<$?("C$2RI821X&)H\:&1VM' \BM!W@$'M'!"2 _[9.+Q MCS"F;ZBV>@&W.1P#8 -@$! @A#F:4 LD&-)<=0M_Q-$ ;^(:@#6(/N"]IB0. M#- 68@9J!99(A<#9G.T-Y&"%Y(DL +\UC=#CH!LBA"P3RQ )7 ;F5Q(4 D9$B+'=2A@\$!D L(27"#7JF06M "1 M$7^#QX1K)(KKK,?5"")^0=@HP/U<<%G0/G((81Q3DD@L )P :B&!2S)/L R\ M)%4T3EXT<)+;;E/?OL/ EWX,7"X0I$XEUE%W,+[DB)5<2-HJQ1/0S0,BY@O)>A)(HXM-^: MTW&#L"U42IJF@55I&C?8R.H*84/ZQQ+89_%UF$8,8YZP1"PFG*8!O@7JB=:% M_1CSK\4V0$RB3O-Y!7YS]@[%2 $CM!3MJFM(=Q*]%+1::\X# M'^:-;;1X4(8<0A9G#[U*[+%F%Q?%BB[U^=@,E:O0J32 /;3K/F["X#-(\D;J M?AH"O[^WGO@%Y7I\\'5!W/> G/ CSBJPK#_L_.OX].S\I[?O)=-QJ8Q;A$!:H&E+*ZX*E !0WJ0Y'& MEAI]]N 3$M@P%WKY-ZRC$WYR_H'M:J\X2"_$9$)UT 3_T_@OSE"QH[%*A%T* M,!I-9XTB%%M:+\0^#FL?G]19 .?'H=-0.MT3B#BB]0"86I8K>S MG9)2:]*DJJG\RN&UM,W=4$BXMLY-) :&2 3% BW;/BAE/UV7!D]E9$A)ANZC M\M,969?TDBF$4;TX"^)J4448AO"](K+$H8A[Y-G3!.1CD$$^$K#I$)0%P +B M+U40GHL&/(_=)T^0SWGE7!HC 74(#]TUIYZEX@=S]!50 ,8G%+]@)@$ M[5;P_L")"5L-ADE3#F!3#O+TO]DEFA:UK*@4JQ<2XM%U0_#@V.(8'./AE%\) M!8$:.Z4XV?2J05@J0A2>?Z0P18-<7>H!\=.E*M=K:BUF"H^9S\I=WJGV"?'S M>JZ4PFOP8@M,T*9]]9:7"0H/,<_2\8%,\_=!(UZ!%WK9!_[84 MO/).FB53!W^#[!Q^=#3 =+TB" 'H-F^TA!#_$#]I4:H%;S-GL/>F3%Q&#>"A M9%N40#6A2ETK\,0I:X3[="%+M/MHX]*N;9"R/RF5O:69(PQN="8HJ1=CAB;O M9?XP8=%NP!6.R&90*=WE="#"3'"K$AN _)XI#;+V?;_H<&/9$GD3*8T@HQN+ MB:52-B4C$41Z@GA<"8O!;BI:A>4KVN7O@-R MN!B.RN:IPI320E#M@9!7:T1UR"-"G)*)#PU*7SLBD9BF7E_8%5T*HWPBSRW5 M%>@AM# XS AQ%5R*73PL!(X'-B\@. M5V=B?*1\ 5H;Y Q7WO U=?6]761&HC@D]D8].1: M@J@7*^3@IC*JD*FT;@V0/Y@PVI]RS1^Z23&AB7M4C24>\ 4IP[,%D)7[=&U+ M'U]R,Z*=%D/FE#=&M%#ZW:P/G%"Z_(1OGQ&:V$WWG]-&*?$?7==R/QQ>2]U0L#Y>OR6:8K M#-T@-:E#DJ^0G$R]?*&2Q9HH#X0<;:; @U-*%Z[T3REX61[ MW1XI*GA&N'86%TCT/FC\!Z2-/J9E\&-"#BKW& .I1S^/>@NR!I.;ZZG5.&7: M6VX:P>D+6OW:^DA)9%M <2Y@YV%BOP!%#SSVMIQGI%WCA(>-6ER8=Z5: M8F",1#71T,I#?3K^_3:EK985,X573SVT=A$)MCUATMHYGRHA)$2^IT]IU& = M'KQ#] (Y:T@]/B)N.GA@6F2#I$& G#9: \#@O+ON'E]"IT*(.V@ 02)[ TP. MXCF]N#TA5/4V]M518T^_%_#3_0CO/#JEZTIA M;?Z#/+:U=<"=!Q)2AQFAR:U$BH%T6@%1G[UCS]XMC4)QV]X7;ZV-4*.&VPJS M.KK/(\$S]BT>M%-JPN\ZO_(M'O*('0.R%ARL6+K"D&<+&U*ZAN85V*+OW65^ MIS4@Y"W0@MN^ZE/U8/'ZN'MU8/]^]O];!- M;H6GIM.>4S\&<70(G3.233 MYC(S[._)0BDT)*]#=Z-79;XXZEQ=44(D(.IDA014L>4 M,2JECP.,/!PB<"!5.3H2U%HJ'1I[@E%L(YLMN$!_HL%(,\.Y!VSWZ5]Q>BK4 M4-5H[10@Q3]])R5&P%V8S+>F&0H#]0R=7FH I^YD\@0A6A:#KK,Y)KC+,;<\ MG7E?!(^['_S=ET;L[C&)@2,Y$DFI>E"DBZ^Y9C%!K75%B)\L'NCBRJN M%Z&?W&,LGS&X)<$8#D3TT_!A41]%?F8EZE?IS_U5L^H^[0$;>QL.<)",G %\ M9=7EL7YTIXZ^W+CFDTI[\C#, ,!XY+("IF=&/$ M#SN%R"WZVI9@2I0&"'[8F>P YHO"U!RC\_9SC8>Z_.? :.X5])(+7AMQ$/Y M"]OSYJW&'QF>9J25@1%WPB1NJ&-#,')6#'%IY*2EYO7=8X%G7_T^DU@*_K8F M!G];%YDXF#@:V^Q7W/!FN=T"\?]7!>0WA>3;;ZXQ>708.=N;:?#[X::;R-VB MCW>>]U5#?!RS=65 2Y :+-2*%ZXBOUD!W4 A_-#X W4$_ ;U\:A$'I7(HQ+Y M77#3)RH1+":C3O#'3LA_ ?][IE3&=H@*S*!66F7*MOW?8W=LG8T9V4R!=U/?[N\G.4T;]K4^O2593B M:WNDSW2NUO)J=#K%G]3 \PSN*J84+,2GY^\^UA)'75>; %4)2 ,ZHVH7753F"S^"+:F)ONL@345>+N M'K"V<*<98"JZDJ#'SE5H^#'(;.2Z-=CSZ8^];^+6C8=)D.XH9+VS+G0TIK_? M""W4*BE28"A,>R,IK<5C-5YTJ?&PNSPTU&/CO'A/>1!8).$EO$EOMP,#HN+Q MX;M.*%IA^QIGGWY#!3^E6DD9M8<6O:+3.DTBDOEC9E_?/-#=15V_:[]$@J8Z MT7*96Z7TI94>ETU37= N,WJ?#UI"O@XCDF M0U"X!5WY@BH"+]J:!7[]& P#NH2,87O^;$[EU]3=0";I6A?D;[!@ U\$#>5> M?ZO(>K9VQ%XU&H4=:])K%7C*^[IK5$B>MU\^Y0VG-YC!T$&,YIN<_4V5L6[ M(Y)4G/JM>LJ.QO[F_*.QOZ+__P!02P$"% ,4 " #6AEE0/DZN4B-6 #4 M9@ %@ @ $ 9S%Q:#-M-&(R8S1F,# P,# Q+FIP9U!+ M 0(4 Q0 ( -:&65 5C?9;D5@ *UP 6 " 5=6 !G M,7%H,VTT8C)C-&8P,# P,#(N:G!G4$L! A0#% @ UH994"'!?8TI( M>R, !8 ( !'*\ &C4 5 " 3EN M 0!N=G)O+3$P:U\R,#$Y,3(S,2YH=&U02P$"% ,4 " #6AEE08UENI,0; M "O0 $ $0 @ '$U@4 ;G9R;RTR,#$Y,3(S,2YX&UL4$L! A0#% @ UH994*$ YW380@ 4QP% M !4 ( !3 @& &YV&UL4$L! A0# M% @ UH994'*DE-<8*@ ^S8! !0 ( !DF,' &YV1@ ! ( !A[L' &YV#(S,5\Q,"YH=&U02P$"% ,4 " #6AEE0JE-V M50L( #D/ $ @ $5P@< ;G9R;RUE>#,Q,5\W+FAT;5!+ M 0(4 Q0 ( -:&65!THQQ_'@@ #T] 1 " 4[*!P!N M=G)O+65X,S$R7S$Q+FAT;5!+ 0(4 Q0 ( -:&65"GI_[5_00 !X= 0 M " 9O2!P!N=G)O+65X,S(Q7S8N:'1M4$L! A0#% @ MUH994(7(FVV5$P $V !$ ( !QM<' &YV XML 51 R37.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Revenue - Cumulative Effect of Changes to Consolidated Balance Sheet (Detail) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Jan. 01, 2018
Dec. 31, 2017
Revenue Initial Application Period Cumulative Effect Transition [Line Items]        
Accounts receivable, net $ 82,833 $ 80,656   $ 67,287
Prepaid expenses and other current assets 9,838 6,621   6,463
Accumulated other comprehensive loss (313) (1,077)   (1,242)
Accumulated deficit $ (409,768) (306,082)   $ (257,844)
ASC 606 [Member]        
Revenue Initial Application Period Cumulative Effect Transition [Line Items]        
Accounts receivable, net     $ 68,734  
Prepaid expenses and other current assets     5,987  
Accumulated other comprehensive loss     (1,238)  
Accumulated deficit     (256,877)  
Adjustments Due to ASC 606 [Member] | ASC 606 [Member]        
Revenue Initial Application Period Cumulative Effect Transition [Line Items]        
Accounts receivable, net   2,514 1,447  
Prepaid expenses and other current assets   $ (893) (476)  
Accumulated other comprehensive loss     4  
Accumulated deficit     $ 967  

XML 52 R33.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Formation and Business of the Company - Additional Information (Detail) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 12 Months Ended
Jun. 30, 2016
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Formation and Business of the Company [Line Items]                        
Net loss   $ 13,742 $ 17,847 $ 28,021 $ 44,076 $ 9,607 $ 11,265 $ 10,620 $ 17,713 $ 103,686 $ 49,205 $ 36,658
Cash used in operations                   50,225 5,708 14,273
Accumulated deficit   $ 409,768       $ 306,082       $ 409,768 $ 306,082 $ 257,844
1.75% Convertible Senior Notes due 2021 [Member]                        
Formation and Business of the Company [Line Items]                        
Debt instrument due year 2021                 2021    
XML 53 R52.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Balance Sheet Components - Summary of Gross Unrealized Gains and Unrealized Losses of Investment Securities Excluding Investments in Money Market Funds (Detail) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost $ 172,222 $ 231,344
Gross Unrealized Holding Gains 211  
Gross Unrealized Holding Losses (4) (210)
Aggregate Fair Value 172,429 231,134
Agency Bonds [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 17,209  
Gross Unrealized Holding Gains 37  
Aggregate Fair Value 17,246  
Commercial Paper [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 12,425 119,692
Gross Unrealized Holding Gains 24  
Gross Unrealized Holding Losses   (90)
Aggregate Fair Value 12,449 119,602
Corporate Notes [Member]    
Schedule of Available-for-sale Securities [Line Items]    
Amortized Cost 142,588 111,652
Gross Unrealized Holding Gains 150  
Gross Unrealized Holding Losses (4) (120)
Aggregate Fair Value $ 142,734 $ 111,532
XML 54 R56.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Balance Sheet Components - Additional Information (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Property Plant And Equipment [Abstract]      
Depreciation and amortization expense $ 4,563 $ 3,887 $ 2,507
XML 55 R3.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Statement Of Financial Position [Abstract]    
Accounts receivable, allowance for doubtful accounts $ 797 $ 824
Preferred stock, par value $ 0.001 $ 0.001
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 290,000,000 290,000,000
Common stock, shares issued 31,544,361 30,263,536
Common stock, shares outstanding 31,544,361 30,263,536
XML 56 R79.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes - Income Tax Expense by Applying Statutory Federal Income Tax Rate (Detail)
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Income Tax Disclosure [Abstract]      
Tax at statutory federal rate 21.00% 21.00% 34.00%
State tax, net of federal benefit (0.10%) (0.40%) (0.40%)
Foreign rate differential (0.70%) (1.00%) 0.50%
Tax credits 3.00% 2.80% 4.50%
Excess tax benefits related to stock-based compensation 3.80% 2.00% 21.50%
Effect of Tax Cuts and Jobs Act of 2017     (121.10%)
Change in valuation allowance (26.40%) (21.20%) 61.40%
Other (2.20%) (4.90%) (4.40%)
Total (1.60%) (1.70%) (4.00%)
XML 57 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Formation and Business of the Company
 12 Months Ended
Dec. 31, 2019
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Formation and Business of the Company

1. Formation and Business of the Company

The Company was incorporated in Minnesota on March 10, 2006 to manufacture and market innovative active implantable medical devices for the treatment of neurological disorders initially focusing on the treatment of chronic pain. Subsequently, the Company was reincorporated in Delaware on October 4, 2006 and relocated to California.

Since inception, the Company has incurred net losses and negative cash flows from operations. During the year ended December 31, 2019, the Company incurred a net loss of $103.7 million and used $50.2 million of cash in operations. At December 31, 2019, the Company had an accumulated deficit of $409.8 million and does not expect to experience positive cash flows from operations in the immediate future. The Company has financed operations to date primarily through private placements of equity securities, borrowings under a debt agreement, the issuance of common stock in its November 2014 initial public offering and its June 2015 underwritten public offering, as well as its June 2016 underwritten public offering of convertible senior notes due in 2021. The Company’s ability to continue to meet its obligations and to achieve its business objectives for the foreseeable future is dependent upon, amongst other things, generating sufficient revenues and its ability to continue to control expenses to meet its obligations as they become due. Failure to increase sales of its products, manage discretionary expenditures or raise additional financing, if required, may adversely impact the Company’s ability to achieve its intended business objectives.

Public Offerings

In November 2014, the Company completed its initial public offering (IPO) of shares of its common stock and as a result, the following transactions were recorded in the Company’s consolidated financial statements during the fourth quarter of 2014:

 

•

the sale of 8,050,000 shares of common stock, including 1,050,000 from the exercise by the underwriters of their overallotment option, at an offering price of $18.00 per share, for net proceeds of $131.6 million, after deducting the underwriters’ discounts, commissions and offering costs paid by us; and

 

•

immediately prior to the completion of the IPO, all the outstanding shares of the Company’s redeemable convertible preferred stock and convertible preferred stock were converted into 15,208,048 shares of common stock.

In June 2015, the Company completed an underwritten public offering of its common stock, which included shares of its common stock held by certain of its stockholders, and issued 2,470,587 shares of common stock, including 705,882 shares issued pursuant to the exercise in full by the underwriters of their option to purchase additional shares.  The Company received cash proceeds of approximately $118.4 million, net of underwriting discounts and commissions and offering costs paid by the Company.

In June 2016, the Company issued $150.0 million aggregate principal amount of 1.75% convertible senior notes due 2021 in a registered underwritten public offering and an additional $22.5 million aggregate principal amount of such notes pursuant to the exercise in full of the over-allotment options of the underwriters (the 2021 Notes). The interest rates are fixed at 1.75% per annum and are payable semi-annually in arrears on June 1 and December 1 of each year, commencing on December 1, 2016.  The total net proceeds from the debt offering, after deducting transaction costs, were approximately $166.2 million.
XML 58 R85.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Net Loss Per Share - Additional Information (Detail)
Dec. 31, 2019
$ / shares
1.75% Convertible Senior Notes due 2021 [Member]  
Earnings Per Share Diluted [Line Items]  
Convertible notes, conversion price $ 96.37
XML 59 R75.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Detail) - USD ($)
$ in Thousands
 1 Months Ended 12 Months Ended
Mar. 31, 2019
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Stock-based compensation expense   $ 41,697 $ 36,637 $ 26,143
Stock Options [Member]        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Stock-based compensation expense   10,312 13,765 13,412
Restricted Stock Units [Member]        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Stock-based compensation expense $ 1,600 28,845 21,006 11,197
Employee Stock Purchase Plan [Member]        
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]        
Stock-based compensation expense   $ 2,540 $ 1,866 $ 1,534
XML 60 R71.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation - Schedule of Employee Stock Purchase Plan Activity (Detail) - ESPP [Member] - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Additional shares reserved 302,635 297,375 288,868
Shares issued 164,960 110,040 73,262
Shares available for future issuance 1,161,645 1,023,970 836,635
Employee contributions for shares issued $ 6,544 $ 5,521 $ 4,697
XML 61 R81.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes - Additional Information (Detail) - USD ($)
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Income Taxes [Line Items]        
Increase in valuation allowance $ 31,100,000 $ 12,600,000    
Unrecognized tax benefits 7,383,000 5,200,000 $ 4,233,000 $ 3,384,000
Accrued interest and penalties 0 0 $ 0  
Research and Development Credit Carryforwards [Member] | California state [Member]        
Income Taxes [Line Items]        
Tax credit carry forwards 9,200,000      
Federal [Member]        
Income Taxes [Line Items]        
Net operating loss carryforward $ 398,500,000 139,500,000    
Net operating loss expiration date 2026      
Federal [Member] | Research and Development Credit Carryforwards [Member]        
Income Taxes [Line Items]        
Tax credit carry forwards $ 13,700,000      
State and Local Jurisdiction [Member]        
Income Taxes [Line Items]        
Net operating loss carryforward $ 194,800,000 $ 22,100,000    
Net operating loss expiration date 2020      
XML 62 R47.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Lease Accounting - Supplemental Lease Cost Information (Detail)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
USD ($)
Leases [Abstract]  
Operating lease cost $ 4,936
XML 63 R43.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Lease Accounting - Additional Information (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Jan. 01, 2019
Lessee Lease Description [Line Items]    
Operating lease assets $ 21,533  
Operating lease liabilities 23,943  
ASC 842 [Member]    
Lessee Lease Description [Line Items]    
Operating lease assets 24,800 $ 24,771
Operating lease liabilities $ 26,200  
Existence of option to extend the lease true  
Option to extend the lease term, description As of December 31, 2019, the Company has leases with remaining terms of less than 3 year to 6 years, some of which may include options to extend the lease term for up to 5 years.  
ASC 842 [Member] | Minimum [Member]    
Lessee Lease Description [Line Items]    
Lease term 12 months  
Operating lease, remaining term 3 years  
ASC 842 [Member] | Maximum [Member]    
Lessee Lease Description [Line Items]    
Operating lease, remaining term 6 years  
Options to extend the lease term 5 years  
XML 64 R60.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Long-term Debt - Additional Information (Detail) - 1.75% Convertible Senior Notes due 2021 [Member]
 1 Months Ended 12 Months Ended
Jun. 30, 2016
USD ($)
d
$ / shares
shares
Dec. 31, 2019
Debt Instrument [Line Items]    
Aggregate principal amount of convertible senior notes $ 150,000,000.0  
Debt instrument interest rate 1.75% 1.75%
Debt instrument due year 2021-06  
Additional aggregate principal amount of convertible senior notes $ 22,500,000  
Debt instrument frequency of payment   semi-annually in arrears on June 1 and December 1 of each year, commencing on December 1, 2016
Net proceeds from the debt offering after deducting transaction costs 166,200,000  
Convertible notes principal amount $ 1,000  
Convertible notes, shares issued | shares 10.3770  
Convertible notes, type of equity security issued   common stock
Convertible notes, conversion price | $ / shares $ 96.37  
Debt instrument convertible, percentage of conversion price 130.00%  
Percentage of repurchase price, which is equal to principal amount of convertible notes 100.00%  
Debt instrument combination settlement $ 1,000  
Debt conversion, converted instrument amount $ 32,900,000  
Debt instrument, effective interest rate 6.29%  
Debt issuance costs attributable to the liability and equity component, total amount $ 6,200,000  
Debt issuance costs attributable to the liability component $ 5,000,000.0  
Number of shares purchased under convertible note hedge transactions | shares 1,800,000  
Purchase price of the shares issued under convertible note hedge transactions | $ / shares $ 96.37  
Total cost of the convertible note hedge transactions $ 45,100,000  
Proceeds from issuance of warrants 33,100,000  
Net cost of reduction to additional paid-in capital $ 12,000,000.0  
Warrant [Member]    
Debt Instrument [Line Items]    
Number of shares issued for warrants under convertible note hedge transactions | shares 1,800,000  
Purchase price of the shares issued under convertible note hedge transactions | $ / shares $ 127.28  
130% for Applicable Conversion Price [Member]    
Debt Instrument [Line Items]    
Debt instrument convertible trading days | d 20  
Debt instrument convertible consecutive trading days | d 30  
98% Applicable Conversion Price [Member]    
Debt Instrument [Line Items]    
Debt instrument convertible trading days | d 5  
Debt instrument convertible consecutive trading days | d 10  
Maximum [Member]    
Debt Instrument [Line Items]    
Percentage of closing sale price of common stock 98.00%  
Maximum [Member] | Warrant [Member]    
Debt Instrument [Line Items]    
Overall conversion price | $ / shares $ 127.28  
Minimum [Member] | Warrant [Member]    
Debt Instrument [Line Items]    
Overall conversion price | $ / shares $ 96.37  
XML 65 R64.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Convertible Preferred Stock - Additional Information (Detail) - shares
Nov. 11, 2014
Dec. 31, 2019
Dec. 31, 2018
Nov. 10, 2014
Class of Stock [Line Items]        
Convertible preferred stock outstanding   0 0 15,208,048
IPO [Member]        
Class of Stock [Line Items]        
Convertible preferred stock converted to common stock 15,208,048      
Common Stock [Member]        
Class of Stock [Line Items]        
Common stock shares issued for each convertible preferred stock 1      
XML 66 R68.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation - Summary of Activity under Stock Plans (Detail) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Exercise Price And Additional Disclosures [Abstract]        
Number of Options, Outstanding Beginning balances 2,529,740 2,559,972 2,821,227  
Number of Options, Options granted 244,075 236,900 503,690  
Number of Options, Options exercised (828,722) (247,768) (707,410)  
Number of Options, Options cancelled (298,908) (19,364) (57,535)  
Number of Options, Outstanding Ending balances 1,646,185 2,529,740 2,559,972 2,821,227
Number of Options, Options exercisable 1,117,773      
Number of Options, Options vested, exercisable or expected to vest 1,612,455      
Weighted Average Exercise Price, Beginning balances $ 46.72 $ 43.62 $ 29.85  
Weighted Average Exercise Price, Options granted 56.71 47.96 74.71  
Weighted Average Exercise Price, Options exercised 34.52 16.05 10.59  
Weighted Average Exercise Price, Options cancelled 66.22 44.70 46.83  
Weighted Average Exercise Price, Ending balances 50.80 $ 46.72 $ 43.62 $ 29.85
Weighted Average Exercise Price, Options exercisable 46.70      
Weighted Average Exercise Price, Options vested, exercisable or expected to vest $ 50.66      
Options Outstanding, Weighted-Average Remaining Contractual Term 6 years 3 months 18 days 6 years 8 months 12 days 7 years 3 months 18 days 7 years 4 months 24 days
Options exercisable, Weighted-Average Remaining Contractual Term 5 years 1 month 6 days      
Options vested, exercisable or expected to vest, Weighted Average Remaining Contractual Term 6 years 2 months 12 days      
Options Outstanding, Aggregate Intrinsic Value $ 109,870 $ 21,866 $ 71,120 $ 123,425
Options exercised, Aggregate Intrinsic Value 42,695 $ 15,468 $ 50,971  
Options exercisable, Aggregate Intrinsic Value 79,186      
Options vested, exercisable or expected to vest, Aggregate Intrinsic Value $ 107,839      
XML 67 R22.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Summary of Significant Accounting Policies (Tables)
 12 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
Schedule of Revenue by Major Customers by Geographic Area The United States is the only country that accounts for 10% or more of the revenue during the periods presented:

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

United States

 

 

84

%

 

 

83

%

 

 

81

%

 
XML 68 R26.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Balance Sheet Components (Tables)
 12 Months Ended
Dec. 31, 2019
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Summary of Gross Unrealized Gains and Unrealized Losses of Investment Securities Excluding Investments in Money Market Funds The following is a summary of the gross unrealized gains and unrealized losses on the Company’s investment securities (in thousands):

 

 

 

December 31, 2019

 

 

 

Amortized

Cost

 

 

Gross

Unrealized

Holding

Gains

 

 

Gross

Unrealized

Holding

Losses

 

 

Aggregate

Fair Value

 

Investment Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Agency bonds

 

$

17,209

 

 

$

37

 

 

$

—

 

 

$

17,246

 

Commercial paper

 

 

12,425

 

 

 

24

 

 

 

—

 

 

 

12,449

 

Corporate notes

 

 

142,588

 

 

 

150

 

 

 

(4

)

 

 

142,734

 

Total securities

 

$

172,222

 

 

$

211

 

 

$

(4

)

 

$

172,429

 

 

 

 

December 31, 2018

 

 

 

Amortized

Cost

 

 

Gross

Unrealized

Holding

Gains

 

 

Gross

Unrealized

Holding

Losses

 

 

Aggregate

Fair Value

 

Investment Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

$

119,692

 

 

$

—

 

 

$

(90

)

 

$

119,602

 

Corporate notes

 

 

111,652

 

 

 

—

 

 

 

(120

)

 

 

111,532

 

Total securities

 

$

231,344

 

 

$

—

 

 

$

(210

)

 

$

231,134

 
Summary of Contractual Maturities of Investment Securities

The amortized costs and estimated fair values of the Company’s available-for-sale securities by contractual maturities as of December 31, 2019 were as follows (in thousands):

 

 

 

Amortized Cost

 

 

Fair Value

 

Amounts maturing within one year

 

$

156,783

 

 

$

156,985

 

Amounts after one year through five years

 

 

15,439

 

 

 

15,444

 

Total investment securities

 

$

172,222

 

 

$

172,429

 
Components of Inventories

Inventories (in thousands)

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Raw materials

 

$

26,354

 

 

$

37,453

 

Finished goods

 

 

65,225

 

 

 

54,582

 

Total inventories

 

$

91,579

 

 

$

92,035

 
Schedule of Property and Equipment, Net and Depreciation and Amortization Expense

Property and Equipment, Net (in thousands)

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Laboratory equipment

 

$

5,733

 

 

$

2,874

 

Computer equipment and software

 

 

9,909

 

 

 

8,751

 

Furniture and fixtures

 

 

3,898

 

 

 

3,903

 

Leasehold improvements

 

 

4,226

 

 

 

4,218

 

Construction in process

 

 

1,006

 

 

 

1,811

 

Total

 

 

24,772

 

 

 

21,557

 

Less: Accumulated depreciation and amortization

 

 

(13,006

)

 

 

(8,756

)

Property and equipment, net

 

$

11,766

 

 

$

12,801

 
Summary of Accrued Liabilities

Accrued Liabilities (in thousands)

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Accrued payroll and related expenses

 

$

36,056

 

 

$

26,792

 

Accrued professional fees

 

 

1,633

 

 

 

1,595

 

Accrued taxes

 

 

2,353

 

 

 

2,506

 

Accrued clinical and research expenses

 

 

2,157

 

 

 

1,105

 

Accrued interest

 

 

243

 

 

 

243

 

Accrued warranty

 

 

1,178

 

 

 

1,236

 

Accrued other

 

 

7,346

 

 

 

5,313

 

Total accrued liabilities

 

$

50,966

 

 

$

38,790

 
XML 69 R35.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Summary of Significant Accounting Policies - Additional Information (Detail)
 1 Months Ended 12 Months Ended
Jun. 30, 2016
Dec. 31, 2019
USD ($)
Subsidiary
Business
Customer
Dec. 31, 2018
USD ($)
Customer
Dec. 31, 2017
USD ($)
Customer
Dec. 31, 2016
USD ($)
Summary Of Significant Accounting Policies [Line Items]          
Number of wholly owned subsidiaries | Subsidiary   4      
Number of business activities | Business   1      
Net unrealized foreign currency transaction gains (losses)   $ 1,000,000.0 $ (600,000) $ 800,000  
Realized foreign currency transaction gains (losses)   (1,600,000) (400,000) 500,000  
Cash held in foreign banks   12,100,000 4,100,000    
Money market funds   52,400,000 15,600,000    
Restricted cash   956,000 606,000    
Write down of inventory   1,600,000 2,000,000.0 4,000,000.0  
Impairment charges   $ 0      
Interest or penalties recognized     $ 0 $ 0 $ 0
Employee stock purchase plan offering period   6 months 6 months    
RSU's [Member]          
Summary Of Significant Accounting Policies [Line Items]          
Vesting term   4 years      
Performance Based RSUs [Member]          
Summary Of Significant Accounting Policies [Line Items]          
Dividend Yield   0.00%      
Minimum [Member]          
Summary Of Significant Accounting Policies [Line Items]          
Estimated useful life of property and equipment   3 years      
Maximum [Member]          
Summary Of Significant Accounting Policies [Line Items]          
Estimated useful life of property and equipment   5 years      
Certificates of Deposit [Member]          
Summary Of Significant Accounting Policies [Line Items]          
Restricted cash   $ 600,000 $ 600,000    
Collateralizing Payment Charges Related to Credit Cards [Member]          
Summary Of Significant Accounting Policies [Line Items]          
Restricted cash     $ 400,000    
Customer Concentration Risk [Member] | Revenue [Member]          
Summary Of Significant Accounting Policies [Line Items]          
Concentration risk, percentage   10.00% 10.00% 10.00%  
Number of customers accounted 10% or more concentration risk | Customer   0 0 0  
Credit Concentration Risk [Member] | Accounts Receivable [Member]          
Summary Of Significant Accounting Policies [Line Items]          
Concentration risk, percentage   10.00% 10.00%    
Number of customers accounted 10% or more concentration risk | Customer   0 0    
1.75% Convertible Senior Notes due 2021 [Member]          
Summary Of Significant Accounting Policies [Line Items]          
Debt instrument due year 2021 2021      
XML 70 R31.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Net Loss Per Share (Tables)
 12 Months Ended
Dec. 31, 2019
Earnings Per Share [Abstract]  
Computation of Basic and Diluted Net Loss per Share

The following table summarizes the computation of basic and diluted net loss per share (in thousands, except share and per share data):

 

 

 

 

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Net loss

 

$

(103,686

)

 

$

(49,205

)

 

$

(36,658

)

Weighted average shares outstanding

 

 

30,803,872

 

 

 

30,051,961

 

 

 

29,424,360

 

Less: weighted average shares subject to repurchase

 

 

—

 

 

 

—

 

 

 

(306

)

Weighted average shares used to compute basic and

   diluted net loss per share

 

 

30,803,872

 

 

 

30,051,961

 

 

 

29,424,054

 

Net loss per share, basic and diluted

 

$

(3.37

)

 

$

(1.64

)

 

$

(1.25

)
Computation of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Shares

The following potentially dilutive securities outstanding at the end of the periods presented have been excluded from the computation of diluted shares outstanding:

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Unreleased restricted stock

 

 

1,288,332

 

 

 

1,010,123

 

 

 

720,840

 

Options to purchase common stock

 

 

1,646,185

 

 

 

2,529,740

 

 

 

2,559,972

 

Convertible senior notes

 

 

1,790,033

 

 

 

1,790,033

 

 

 

1,790,033

 

Warrants related to the issuance of convertible senior notes

 

 

1,790,033

 

 

 

1,790,033

 

 

 

1,790,033

 

Total

 

 

6,514,583

 

 

 

7,119,929

 

 

 

6,860,878

 
XML 71 R39.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Revenue - Impact of Adoption on Consolidated Statement of Operations (Detail) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Disaggregation Of Revenue [Line Items]                      
Revenue $ 114,374 $ 100,162 $ 93,571 $ 82,148 $ 107,944 $ 95,630 $ 96,080 $ 87,635 $ 390,255 $ 387,289 $ 326,674
Cost of revenue                 $ 121,905 113,965 $ 98,981
Balance Without ASC 606 Adoption [Member] | ASC 606 [Member]                      
Disaggregation Of Revenue [Line Items]                      
Revenue                   386,212  
Cost of revenue                   113,441  
Adjustments Due to ASC 606 [Member] | ASC 606 [Member]                      
Disaggregation Of Revenue [Line Items]                      
Revenue                   1,077  
Cost of revenue                   $ 524  
XML 72 R12.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Balance Sheet Components
 12 Months Ended
Dec. 31, 2019
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Balance Sheet Components

6. Balance Sheet Components

Investments

The fair value of the Company’s cash equivalents and short-term investments approximates their respective carrying amounts due to their short-term maturity. The following is a summary of the gross unrealized gains and unrealized losses on the Company’s investment securities (in thousands):

 

 

 

December 31, 2019

 

 

 

Amortized

Cost

 

 

Gross

Unrealized

Holding

Gains

 

 

Gross

Unrealized

Holding

Losses

 

 

Aggregate

Fair Value

 

Investment Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Agency bonds

 

$

17,209

 

 

$

37

 

 

$

—

 

 

$

17,246

 

Commercial paper

 

 

12,425

 

 

 

24

 

 

 

—

 

 

 

12,449

 

Corporate notes

 

 

142,588

 

 

 

150

 

 

 

(4

)

 

 

142,734

 

Total securities

 

$

172,222

 

 

$

211

 

 

$

(4

)

 

$

172,429

 

 

 

 

December 31, 2018

 

 

 

Amortized

Cost

 

 

Gross

Unrealized

Holding

Gains

 

 

Gross

Unrealized

Holding

Losses

 

 

Aggregate

Fair Value

 

Investment Securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Commercial paper

 

$

119,692

 

 

$

—

 

 

$

(90

)

 

$

119,602

 

Corporate notes

 

 

111,652

 

 

 

—

 

 

 

(120

)

 

 

111,532

 

Total securities

 

$

231,344

 

 

$

—

 

 

$

(210

)

 

$

231,134

 

Realized gains or losses from the sale of investments and other-than-temporary impairments, if any, on available-for-sale securities are reported in other income (expense), net as incurred. The cost of securities sold was determined based on the specific identification method. The amount of realized gains and realized losses on investments for the periods presented have not been material.

The amortized costs and estimated fair values of the Company’s available-for-sale securities by contractual maturities as of December 31, 2019 were as follows (in thousands):

 

 

 

Amortized Cost

 

 

Fair Value

 

Amounts maturing within one year

 

$

156,783

 

 

$

156,985

 

Amounts after one year through five years

 

 

15,439

 

 

 

15,444

 

Total investment securities

 

$

172,222

 

 

$

172,429

 

 

Inventories (in thousands)

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Raw materials

 

$

26,354

 

 

$

37,453

 

Finished goods

 

 

65,225

 

 

 

54,582

 

Total inventories

 

$

91,579

 

 

$

92,035

 

 

Property and Equipment, Net (in thousands)

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Laboratory equipment

 

$

5,733

 

 

$

2,874

 

Computer equipment and software

 

 

9,909

 

 

 

8,751

 

Furniture and fixtures

 

 

3,898

 

 

 

3,903

 

Leasehold improvements

 

 

4,226

 

 

 

4,218

 

Construction in process

 

 

1,006

 

 

 

1,811

 

Total

 

 

24,772

 

 

 

21,557

 

Less: Accumulated depreciation and amortization

 

 

(13,006

)

 

 

(8,756

)

Property and equipment, net

 

$

11,766

 

 

$

12,801

 

 

Depreciation and amortization expense for the years ended December 31, 2019, 2018 and 2017 was $4.6 million, $3.9 million and $2.5 million, respectively.

Accrued Liabilities (in thousands)

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Accrued payroll and related expenses

 

$

36,056

 

 

$

26,792

 

Accrued professional fees

 

 

1,633

 

 

 

1,595

 

Accrued taxes

 

 

2,353

 

 

 

2,506

 

Accrued clinical and research expenses

 

 

2,157

 

 

 

1,105

 

Accrued interest

 

 

243

 

 

 

243

 

Accrued warranty

 

 

1,178

 

 

 

1,236

 

Accrued other

 

 

7,346

 

 

 

5,313

 

Total accrued liabilities

 

$

50,966

 

 

$

38,790

 
XML 73 R16.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation
 12 Months Ended
Dec. 31, 2019
Equity [Abstract]  
Stock-Based Compensation

10. Stock-Based Compensation

Common stock reserved for future issuance as of December 31, 2019 was as follows:

 

 

 

December 31,

 

 

 

2019

 

Outstanding stock options and restricted stock units

 

 

2,934,517

 

Reserved for grants of future stock options and restricted stock units

 

 

3,680,784

 

Reserved for employee stock purchase plan

 

 

1,161,645

 

Total common stock reserved for future issuance

 

 

7,776,946

 

 

Stock Plans

The Company’s Board of Directors (Board) and stockholders previously approved the 2007 Stock Option Plan (the 2007 Plan). In October 2014, the Board adopted the 2014 Equity Incentive Award Plan (the 2014 Plan and, together with the 2007 Plan, the Stock Plans).  As of the effective date of the 2014 Plan, the Company suspended the 2007 Plan and no additional awards may be granted under the 2007 Plan. Any shares of common stock covered by awards granted under the 2007 Plan that terminate after the effective date of the 2014 Plan by expiration, forfeiture, cancellation or other means without the issuance of such shares, will be added to the 2014 Plan reserve.

Under the 2014 Plan, 1,854,166 shares of common stock were initially reserved for issuance, plus the number of shares remaining available for future awards under the 2007 Plan, as of the pricing of the IPO. The number of shares initially reserved for issuance under the 2014 Plan is subject to increase by (i) the number of shares represented by awards outstanding under the 2007 Plan that are forfeited or lapse unexercised and which following the pricing date are not issued under the 2007 Plan, and (ii) an annual increase on January 1 of each year.

Under the 2014 Plan, the Company may grant awards such as incentive stock options, nonstatutory stock options, restricted stock units and stock appreciation rights. Incentive stock options (ISO) may be granted only to Company employees (including directors who are also employees). Nonqualified stock options (NSO) may be granted to Company employees, directors and consultants.

Stock Options

Options under the 2014 Plan may be granted for periods of up to ten years and at prices no less than 100% of the estimated fair market value of the shares on the date of grant as determined by the Board, provided, however, that the exercise price of an ISO or an NSO granted to a 10% stockholder shall not be less than 110% of the estimated fair market value of the shares on the date of grant. Upon the exercise of options, the Company issues new common stock from its authorized shares. The vesting provisions of individual options vary but are generally over four years, with the exception of performance based stock options.

Pursuant to the 2014 Plan, the Company granted performance based stock options to the Company’s former CEO in March 2016. This performance based stock option award is subject to the CEO’s continued service to the Company through each applicable vesting date. If a performance metric is not met within the time limits specified in the award agreements, the shares subject to vesting under the vesting tranche for that performance metric will be cancelled.  Upon the former CEO’s resignation from the Company in March 2019, the unvested shares subject to this award as of the separation date have been cancelled.

A summary of shares available for grant under the Stock Plans is as follows:

 

 

Shares Available

 

 

 

for Grant

 

Balance at December 31, 2016

 

 

2,202,239

 

Additional shares reserved

 

 

1,155,474

 

Shares forfeited for tax

 

 

13,094

 

Options and restricted stock granted

 

 

(1,002,063

)

Options and restricted stock cancelled

 

 

97,502

 

Balance at December 31, 2017

 

 

2,466,246

 

Additional shares reserved

 

 

1,189,502

 

Shares forfeited for tax

 

 

28,107

 

Options and restricted stock granted

 

 

(805,653

)

Options and restricted stock cancelled

 

 

102,560

 

Balance at December 31, 2018

 

 

2,980,762

 

Additional shares reserved

 

 

1,210,541

 

Allowance for PSU for overperformance

 

 

(277,778

)

Shares forfeited for tax

 

 

38,696

 

Options and restricted stock granted

 

 

(1,077,178

)

Options and restricted stock cancelled

 

 

527,963

 

Balance at December 31, 2019

 

 

3,403,006

 

A summary of stock option activity under the Stock Plans is as follows:

 

 

 

Options Outstanding

 

 

Weighted Average

 

 

 

 

 

 

Number of

 

 

Weighted Average

 

 

Remaining

 

Aggregate

 

 

 

Options

 

 

Exercise Price

 

 

Contractual Term

 

Intrinsic Value

 

 

 

 

 

 

 

 

 

 

 

(in years)

 

(in thousands)

 

Outstanding at December 31, 2016

 

 

2,821,227

 

 

$

29.85

 

 

7.4

 

$

123,425

 

Options granted

 

 

503,690

 

 

$

74.71

 

 

 

 

 

 

 

Options exercised

 

 

(707,410

)

 

$

10.59

 

 

 

 

$

50,971

 

Options cancelled

 

 

(57,535

)

 

$

46.83

 

 

 

 

 

 

 

Outstanding at December 31, 2017

 

 

2,559,972

 

 

$

43.62

 

 

7.3

 

$

71,120

 

Options granted

 

 

236,900

 

 

$

47.96

 

 

 

 

 

 

 

Options exercised

 

 

(247,768

)

 

$

16.05

 

 

 

 

$

15,468

 

Options cancelled

 

 

(19,364

)

 

$

44.70

 

 

 

 

 

 

 

Outstanding at December 31, 2018

 

 

2,529,740

 

 

$

46.72

 

 

6.7

 

$

21,866

 

Options granted

 

 

244,075

 

 

$

56.71

 

 

 

 

 

 

 

Options exercised

 

 

(828,722

)

 

$

34.52

 

 

 

 

$

42,695

 

Options cancelled

 

 

(298,908

)

 

$

66.22

 

 

 

 

 

 

 

Outstanding at December 31, 2019

 

 

1,646,185

 

 

$

50.80

 

 

6.3

 

$

109,870

 

Options exercisable as of December 31, 2019

 

 

1,117,773

 

 

$

46.70

 

 

5.1

 

$

79,186

 

Options vested, exercisable or expected to

   vest as of December 31, 2019

 

 

1,612,455

 

 

$

50.66

 

 

6.2

 

$

107,839

 

 

The aggregate intrinsic value of options exercised is the difference between the estimated fair market value of the Company’s common stock at the date of exercise and the exercise price for in-the-money options. The aggregate intrinsic value of outstanding options is the difference between the closing price as of the date outstanding and the exercise price of the underlying stock options. The weighted-average grant-date fair value of options granted during the years ended December 31, 2019, 2018 and 2017 was $27.91, $23.27 and $32.35 per share, respectively. The total fair value of options vested during the years ended December 31, 2019, 2018 and 2017 was approximately $8.3 million, $14.0 million and $13.3 million, respectively, based on the grant date fair value.

The options outstanding and vested under the Stock Plans by exercise price, at December 31, 2019, were as follows:

 

 

 

Options Outstanding

 

 

Options Vested

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number

 

 

Contractual Term

 

Weighted Average

 

 

Number

 

 

Weighted Average

 

Exercise Price

 

Outstanding

 

 

(in years)

 

Exercise Price

 

 

Exercisable

 

 

Exercise Price

 

$1.44 — $18.00

 

 

334,087

 

 

3.79

 

$

10.25

 

 

 

334,087

 

 

$

10.25

 

$32.51 — $48.44

 

 

391,304

 

 

7.85

 

$

43.43

 

 

 

159,456

 

 

$

42.13

 

$49.94 — $63.23

 

 

365,966

 

 

4.45

 

$

57.78

 

 

 

352,632

 

 

$

57.73

 

$63.39 — $76.81

 

 

393,930

 

 

8.27

 

$

70.58

 

 

 

155,991

 

 

$

73.09

 

$84.30 — $97.52

 

 

160,898

 

 

7.07

 

$

88.62

 

 

 

115,607

 

 

$

89.07

 

$1.44 — $97.52

 

 

1,646,185

 

 

6.29

 

$

50.80

 

 

 

1,117,773

 

 

$

46.70

 

 

Restricted Stock Units

In 2015, the Company began granting restricted stock units (RSUs) under the 2014 Plan.  Holders of RSUs do not have stockholder rights.  Upon the release of RSUs, the Company issues new common stock from its authorized shares. RSUs generally vest four years from the date of grant.

Pursuant to the 2014 Plan, the Company granted performance based RSUs to the former CEO in March 2016. The performance based RSUs are subject to the former CEO’s continued service to the Company through each applicable vesting date. If a performance metric is not met within the time limits specified in the RSU agreement, the shares subject to vesting under the vesting tranche for that performance metric will be cancelled. Upon the former CEO’s resignation from the Company in March 2019, the unvested shares subject to this award as of the separation date have been cancelled.

In March 2019, the Company granted RSUs to the current CEO, subject to his continued service to the company and based on the total shareholder return of the Company’s common stock price compared to a targeted composite index over a three-year period.  The number of shares to be issued upon vesting of these RSUs range from 0 to 3.5 times the target number of shares granted, depending on the Company’s performance against the targeted composite index.

A summary of RSUs activity under the Stock Plans was as follows:

 

 

 

Number of

 

 

Weighted Average

 

 

Aggregate

 

 

 

Restricted

 

 

Grant Date

 

 

Intrinsic Value

 

 

 

Stock Units

 

 

Fair Value

 

 

(in thousands)

 

Outstanding at December 31, 2016

 

 

345,555

 

 

$

70.39

 

 

$

25,108

 

Restricted stock granted

 

 

498,373

 

 

$

82.60

 

 

 

 

 

Restricted stock released

 

 

(83,121

)

 

$

69.90

 

 

$

1,175

 

Restricted stock cancelled

 

 

(39,967

)

 

$

81.57

 

 

 

 

 

Outstanding at December 31, 2017

 

 

720,840

 

 

$

78.26

 

 

$

49,767

 

Restricted stock granted

 

 

568,753

 

 

$

68.09

 

 

 

 

 

Restricted stock released

 

 

(196,274

)

 

$

77.43

 

 

$

968

 

Restricted stock cancelled

 

 

(83,196

)

 

$

81.73

 

 

 

 

 

Outstanding at December 31, 2018

 

 

1,010,123

 

 

$

72.41

 

 

$

39,284

 

Restricted stock granted

 

 

833,103

 

 

$

59.56

 

 

 

 

 

Restricted stock released

 

 

(325,839

)

 

$

70.69

 

 

$

4,064

 

Restricted stock cancelled

 

 

(229,055

)

 

$

70.23

 

 

 

 

 

Outstanding at December 31, 2019

 

 

1,288,332

 

 

$

64.92

 

 

$

151,431

 

Restricted stock expected to vest as of

   December 31, 2019

 

 

1,190,393

 

 

$

59.42

 

 

$

139,919

 

 

The aggregate intrinsic value of RSUs released is calculated using the fair market value of the Company’s common stock at the date of release. The aggregate intrinsic value of outstanding RSUs is calculated based on the closing price of the Company’s common stock as of the date outstanding.

2014 Employee Stock Purchase Plan

In October 2014, the Board adopted the 2014 Employee Stock Purchase Plan (the ESPP). A total of 196,666 shares of common stock were initially available for future issuance under the 2014 Employee Stock Purchase Plan, subject to an annual increase on January 1 of each year. The ESPP provides eligible employees with an opportunity to purchase shares of the Company’s common stock through payroll deductions of up to 15% of their eligible compensation, subject to plan limitations.  Under the ESPP, the purchase price of the Company stock is equal to 85% of the lower of its fair market value at the start and end of a six-month purchase period.

A summary of ESPP activity was as follows:

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Additional shares reserved

 

 

302,635

 

 

 

297,375

 

 

 

288,868

 

Shares issued

 

 

164,960

 

 

 

110,040

 

 

 

73,262

 

Shares available for future issuance

 

 

1,161,645

 

 

 

1,023,970

 

 

 

836,635

 

Employee contributions for shares issued (in thousands)

 

$

6,544

 

 

$

5,521

 

 

$

4,697

 

 

Early Exercises

Stock options previously granted under the 2007 Plan allowed the Board of Directors to grant awards to provide employee option holders the right to elect to exercise unvested options in exchange for restricted common stock. There were no unvested shares at December 31, 2019, 2018 and 2017 which were subject to a repurchase right held by the Company. Additionally, as of December 31, 2019 and 2018, there was no cash received related to unvested shares, respectively. Amounts recorded are transferred into common stock and additional paid-in-capital as the shares vest.

Employee Stock-Based Compensation

The Company estimated the fair value of stock options granted to employees and shares purchased by employees under the ESPP using the Black-Scholes option valuation model. The fair value is amortized on a straight-line basis over the requisite service period of the awards, with the exception of performance based stock options whose fair value is recorded as expenses based on the probability that the performance metrics will be achieved. The following assumptions were used in estimating the fair value:

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Stock Options:

 

 

 

 

 

 

 

 

 

 

 

 

Expected term (in years)

 

5.7

 

 

5.5

 

 

5.5

 

Expected volatility

 

51% — 52%

 

 

44% — 51%

 

 

44% — 46%

 

Risk-free interest rate

 

1.4% — 2.6%

 

 

2.3% — 2.9%

 

 

1.8% — 2.2%

 

Dividend Yield

 

0%

 

 

 

0%

 

 

 

0%

 

ESPP:

 

 

 

 

 

 

 

 

 

 

 

 

Expected term (in years)

 

0.5

 

 

0.5

 

 

0.5

 

Expected volatility

 

48% — 61%

 

 

44% — 57%

 

 

36% — 37%

 

Risk-free interest rate

 

1.6% — 2.4%

 

 

2.1% — 2.5%

 

 

1.0% — 1.4%

 

Dividend Yield

 

0%

 

 

 

0%

 

 

0%

 

 

Expected Term. The expected term of stock-based awards represents the weighted-average period that the stock-based awards are expected to remain outstanding. The Company has historically opted to use the “simplified method” for estimating the expected term of the awards, whereby the expected term equals the arithmetic average of

the vesting term and the original contractual term of the awards.  Starting in late 2016, the Company started to utilize its own historical data for the calculation of expected term.

Expected Volatility. The Company has historically determined the share price volatility for stock-based awards based on an analysis of the historical volatilities of a peer group of publicly traded medical device companies.  Starting in late 2016, the Company has started to incorporate its own stock trading volatility with those of its peer group for the calculation of volatility.  In evaluating similarity, the Company considered factors such as industry, stage of life cycle and size.

Risk-Free Interest Rate. The risk-free interest rate is based on the U.S. Treasury yield in effect at the time of the grant for zero-coupon U.S. Treasury notes with remaining terms similar to the expected term of the stock-based awards.

Dividend Rate. The expected dividend was assumed to be zero as the Company has never paid dividends and has no current plans to do so.

Expected Forfeiture Rate. The Company is required to estimate forfeitures at the time of grant, and revise those estimates in subsequent periods if actual forfeitures differ from those estimates. The Company uses historical data to estimate pre-vesting option forfeitures and record stock-based compensation expense only for those awards that are expected to vest. To the extent actual forfeitures differ from the estimates, the difference will be recorded as a cumulative adjustment in the period that the estimates are revised.

The Company accounts for RSUs at their fair value, based on the closing market price of the Company’s common stock on the grant date. The fair value is amortized on a straight-line basis over the requisite service period of the awards, which is generally the vesting term of four years.

In 2016, the Company granted performance based RSUs to its former CEO that only vest upon the achievement of specific operational performance criteria.  The stock-based compensation for these performance based RSUs are recognized as expenses when it is determined that achieving the performance metrics are probable. Upon the former CEO’s resignation from the Company in March 2019, the unvested shares subject to this award as of the separation date have been cancelled.

In connection with the former CEO’s resignation in March 2019, the Company amended the terms of his then vested nonqualified stock options such that they remain exercisable through the second anniversary of his separation date.  This modification resulted in a charge of $1.6 million in stock-based compensation.  

In 2019, the Company granted performance based RSUs to its current CEO that only vest based on the total shareholder return of the Company common stock price relative to that of a specified targeted index.  The fair value of these performance based RSUs is based on the Monte Carlo simulation model using the following assumptions:

 

 

 

Years Ended December 31,

 

 

 

2019

 

Index volatility

 

36%

 

Company volatility

 

45%

 

Risk-free interest rate

 

2.4%

 

Correlation with index

 

0.28

 

Dividend Yield

 

0%

 

 

A summary of pre-tax stock-based compensation expense by line items in the consolidated statements of operations was as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Cost of revenue

 

$

3,061

 

 

$

2,656

 

 

$

1,878

 

Research and development

 

 

6,323

 

 

 

5,871

 

 

 

4,601

 

Sales, general and administrative

 

 

32,313

 

 

 

28,110

 

 

 

19,664

 

Total stock-based compensation expense

 

$

41,697

 

 

$

36,637

 

 

$

26,143

 

 

A summary of pre-tax stock-based compensation expense by category was as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Stock options

 

$

10,312

 

 

$

13,765

 

 

$

13,412

 

Restricted stock units

 

 

28,845

 

 

 

21,006

 

 

 

11,197

 

Employee stock purchase plan

 

 

2,540

 

 

 

1,866

 

 

 

1,534

 

Total stock-based compensation expense

 

$

41,697

 

 

$

36,637

 

 

$

26,143

 

 

As of December 31, 2019, total stock-based compensation expense not yet recognized, net of estimated forfeitures, were as follows:

 

 

 

Unrecognized

 

 

Weighted-Average

 

 

 

Compensation

 

 

Amortization Period

 

 

 

(in thousands)

 

 

(in years)

 

Stock options

 

$

14,720

 

 

 

2.7

 

Restricted stock units

 

 

62,680

 

 

 

2.6

 

Employee stock purchase plan

 

 

1,262

 

 

 

0.4

 
XML 74 R1.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Document and Entity Information - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2019
Feb. 14, 2020
Jun. 28, 2019
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Dec. 31, 2019    
Document Fiscal Year Focus 2019    
Document Fiscal Period Focus FY    
Trading Symbol NVRO    
Entity Registrant Name NEVRO CORP.    
Entity Central Index Key 0001444380    
Current Fiscal Year End Date --12-31    
Entity Well-known Seasoned Issuer Yes    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Filer Category Large Accelerated Filer    
Entity Small Business false    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Common Stock, Shares Outstanding   31,820,724  
Entity Public Float     $ 1,923
Entity Interactive Data Current Yes    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Security Exchange Name NYSE    
Entity File Number 001-36715    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 56-2568057    
Entity Address, Address Line One 1800 Bridge Parkway    
Entity Address, City or Town Redwood City    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 94065    
City Area Code 650    
Local Phone Number 251-0005    
Document Annual Report true    
Document Transition Report false    
Documents Incorporated by Reference [Text Block] Portions of the registrant’s Proxy Statement for the registrant’s 2020 Annual Meeting of Stockholders are incorporated by reference into Part III of this Form 10-K to the extent stated herein. The Proxy Statement will be filed within 120 days of the registrant’s fiscal year ended December 31, 2019.    
XML 75 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Beginning balances at Dec. 31, 2016 $ 249,034 $ 29 $ 470,869 $ (221,186) $ (678)
Beginning balances, shares at Dec. 31, 2016   28,886,862      
Exercise of common stock options $ 7,493 $ 1 7,492    
Exercise of common stock options, shares 707,410 707,410      
Issuance of common stock upon release of restricted stock units   83,121      
Shares withheld for tax obligations $ (991)   (991)    
Shares withheld for tax obligations, shares   (13,094)      
Issuance of common stock under employee stock purchase plan 4,697   4,697    
Issuance of common stock under employee stock purchase plan, shares   73,262      
Vesting of early exercised stock options 7   7    
Stock based compensation 26,154   26,154    
Net loss (36,658)     (36,658)  
Other comprehensive loss (564)       (564)
Ending balances at Dec. 31, 2017 249,172 $ 30 508,228 (257,844) (1,242)
Ending balances, shares at Dec. 31, 2017   29,737,561      
Adoption of accounting standard 967     967  
Exercise of common stock options $ 3,976   3,976    
Exercise of common stock options, shares 247,768 247,768      
Issuance of common stock upon release of restricted stock units   196,274      
Shares withheld for tax obligations $ (1,742)   (1,742)    
Shares withheld for tax obligations, shares   (28,107)      
Issuance of common stock under employee stock purchase plan 5,520   5,520    
Issuance of common stock under employee stock purchase plan, shares   110,040      
Stock based compensation 36,630   36,630    
Net loss (49,205)     (49,205)  
Other comprehensive loss 165       165
Ending balances at Dec. 31, 2018 245,483 $ 30 552,612 (306,082) (1,077)
Ending balances, shares at Dec. 31, 2018   30,263,536      
Exercise of common stock options $ 28,607 $ 1 28,606    
Exercise of common stock options, shares 828,722 828,722      
Issuance of common stock upon release of restricted stock units   325,839      
Shares withheld for tax obligations $ (3,057)   (3,057)    
Shares withheld for tax obligations, shares   (38,696)      
Issuance of common stock under employee stock purchase plan 6,545 $ 1 6,544    
Issuance of common stock under employee stock purchase plan, shares   164,960      
Stock based compensation 41,696   41,696    
Net loss (103,686)     (103,686)  
Other comprehensive loss 764       764
Ending balances at Dec. 31, 2019 $ 216,352 $ 32 $ 626,401 $ (409,768) $ (313)
Ending balances, shares at Dec. 31, 2019   31,544,361      
XML 76 R87.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Selected Quarterly Financial Information - Schedule of Selected Quarterly Financial Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Quarterly Financial Information Disclosure [Abstract]                      
Total revenue $ 114,374 $ 100,162 $ 93,571 $ 82,148 $ 107,944 $ 95,630 $ 96,080 $ 87,635 $ 390,255 $ 387,289 $ 326,674
Gross profit 81,258 69,940 63,943 53,209 76,154 67,248 67,921 62,001 268,350 273,324 227,693
Loss from operations (11,681) (15,984) (26,560) (42,254) (8,603) (9,237) (8,201) (15,702) (96,479) (41,743) (29,579)
Net loss $ (13,742) $ (17,847) $ (28,021) $ (44,076) $ (9,607) $ (11,265) $ (10,620) $ (17,713) $ (103,686) $ (49,205) $ (36,658)
Net loss per share, basic and diluted $ (0.44) $ (0.58) $ (0.91) $ (1.45) $ (0.32) $ (0.37) $ (0.35) $ (0.59) $ (3.37) $ (1.64) $ (1.25)
Shares used in computing net loss per common share, basic and diluted 31,233,416 30,929,938 30,677,567 30,363,623 30,214,454 30,123,188 30,028,985 29,836,277 30,803,872 30,051,961 29,424,054
EXCEL 77 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 78 R77.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes - Components of Loss before Income Taxes (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Income Tax Disclosure [Abstract]      
Domestic $ (106,010) $ (52,755) $ (39,370)
Foreign 3,923 4,318 4,120
Loss before income taxes $ (102,087) $ (48,437) $ (35,250)

XML 79 R9.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Revenue
 12 Months Ended
Dec. 31, 2019
Revenue From Contract With Customer [Abstract]  
Revenue

3. Revenue

Adoption of ASC 606

On January 1, 2018, the Company adopted the new accounting standard ASC 606, Revenue from Contracts with Customers, using the modified retrospective method applied to contracts which were not completed as of that date.  Results for reporting periods beginning after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 605, Revenue Recognition. Under ASC 606, assuming all other revenue recognition criteria have been met, the Company will recognize revenue earlier for arrangements where the Company has satisfied its performance obligations but has not issued invoices.  These amounts are recorded as unbilled receivables, which are included in accounts receivable on the consolidated balance sheet, as the Company has an unconditional right to payment at the end of the applicable period.  

The Company recognized the cumulative effect of initially applying ASC 606 as an adjustment to the opening balance of accumulated deficit.  The cumulative effect of the changes made to the consolidated balance sheet as of January 1, 2018 for the adoption of ASC 606 were as follows (in thousands):

 

 

 

Balance at

 

 

Adjustments Due

 

 

Balance at

 

 

 

December 31, 2017

 

 

to ASC 606

 

 

January 1, 2018

 

Balance Sheet:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable, net

 

$

67,287

 

 

$

1,447

 

 

$

68,734

 

Prepaid expenses and other current assets

 

 

6,463

 

 

 

(476

)

 

 

5,987

 

Accumulated other comprehensive loss

 

 

(1,242

)

 

 

4

 

 

 

(1,238

)

Accumulated deficit

 

 

(257,844

)

 

 

967

 

 

 

(256,877

)

 

In accordance with ASC 606, the disclosure of the impact of adoption on the Consolidated Balance Sheet was as follows (in thousands):

 

 

December 31, 2018

 

 

 

Balance

 

 

Balance Without

 

 

 

 

 

 

 

As Reported

 

 

ASC 606 Adoption

 

 

Effect of Change

 

Balance Sheet:

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable, net

 

$

80,656

 

 

$

78,142

 

 

$

2,514

 

Inventories

 

 

92,035

 

 

 

92,126

 

 

 

(91

)

Prepaid expenses and other current assets

 

 

6,621

 

 

 

7,514

 

 

 

(893

)

In accordance with ASC 606, the disclosure of the impact of adoption on the Consolidated Statements of Operations was as follows (in thousands):

 

 

Year Ended December 31, 2018

 

 

 

 

 

 

 

Balance Without

 

 

 

 

 

 

 

Balance As Reported

 

 

ASC 606 Adoption

 

 

Effect of Change

 

Statement of Operations:

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

387,289

 

 

$

386,212

 

 

$

1,077

 

Cost of revenue

 

 

113,965

 

 

 

113,441

 

 

 

524

 

 

Revenue Recognition

Revenue is recognized when obligations under the terms of a contract with customers are satisfied, which occurs with the transfer of control of the Company’s goods to its customers.  Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods.

For a majority of sales, where the Company’s sales representative delivers its product at the point of implantation at hospitals or medical facilities, the Company recognizes revenue upon completion of the procedure and authorization, which represents the point in time when control transfers to the customers.

For the remaining sales, which are sent from the Company’s distribution centers directly to hospitals and medical facilities, as well as distributor sales, where product is ordered in advance of an implantation, the transfer of control occurs at the time of shipment of the product.  These customers are obligated to pay within specified terms regardless of when or if they ever sell or use the products. The Company does not offer rights of return or price protection. To the extent the Company has a post-delivery obligation, such as programming devices that have been delivered as part of a direct-ship order, the Company defers revenue and the associated cost of goods sold associated with the post-delivery obligation only if the amounts are deemed material.

Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The expected costs associated with warranty obligations continue to be recognized as expense when the products are sold (see Note 7). The Company periodically provides incentive offers, in the form of rebates, to customers based on their aggregate levels of purchases.  Product revenue is recorded net of such incentive offers.

The following table presents revenue by geography, based on the billing address of the customer (in thousands):

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

United States

 

$

326,012

 

 

$

321,781

 

 

$

263,462

 

International

 

 

64,243

 

 

 

65,508

 

 

 

63,212

 

Total revenue

 

$

390,255

 

 

$

387,289

 

 

$

326,674

 

 

Practical Expedients and Exemptions

The Company recognizes revenue upon the transfer of control of the product and there are no material future performance obligations beyond such transfer.  As a result, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company does not capitalize incremental costs when the amortization period of the asset is less than a year.
XML 80 R73.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation - Schedule of Fair Value of Performance Based RUSs based on Monte Carlo Simulation Model (Detail) - Performance Based RSUs [Member]
 12 Months Ended
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Index volatility 36.00%
Company volatility 45.00%
Risk-free interest rate 2.40%
Correlation with index 0.28%
Dividend Yield 0.00%
XML 81 R83.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Net Loss Per Share - Computation of Basic and Diluted Net Loss per Share (Detail) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Earnings Per Share [Abstract]                      
Net loss $ (13,742) $ (17,847) $ (28,021) $ (44,076) $ (9,607) $ (11,265) $ (10,620) $ (17,713) $ (103,686) $ (49,205) $ (36,658)
Weighted average shares outstanding                 30,803,872 30,051,961 29,424,360
Less: weighted average shares subject to repurchase                     (306)
Weighted average shares used to compute basic and diluted net loss per share 31,233,416 30,929,938 30,677,567 30,363,623 30,214,454 30,123,188 30,028,985 29,836,277 30,803,872 30,051,961 29,424,054
Net loss per share, basic and diluted $ (0.44) $ (0.58) $ (0.91) $ (1.45) $ (0.32) $ (0.37) $ (0.35) $ (0.59) $ (3.37) $ (1.64) $ (1.25)
XML 82 R58.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Commitments and Contingencies - Additional Information (Detail)
 1 Months Ended 12 Months Ended
Aug. 01, 2019
May 31, 2015
USD ($)
Jul. 31, 2017
USD ($)
Apr. 30, 2017
ft²
Feb. 28, 2017
USD ($)
Dec. 31, 2016
USD ($)
ft²
Mar. 31, 2015
USD ($)
ft²
Nov. 30, 2014
USD ($)
shares
Aug. 31, 2014
Dec. 31, 2019
USD ($)
ConvertibleNote
Patent
Dec. 31, 2018
USD ($)
Dec. 31, 2017
USD ($)
Dec. 09, 2016
Patent
Other Commitments [Line Items]                          
Standard product warranty, description                   limited one- to five-year warranty      
Retainer fees                   $ 59,017,000 $ 48,459,000 $ 37,560,000  
Contingent consideration payment secured by convertible notes                   8,500,000      
Additional contingent consideration payment secured by convertible notes                   $ 3,000,000.0      
Number of secured convertible notes | ConvertibleNote                   2      
Secured convertible note, measured at amortized cost                   $ 7,900,000      
Value of certain rights measured at cost                   1,000,000.0      
Contingent liabilities                   $ 0 0    
Litigation amendment period 21 days                        
Boston Scientific Corporation [Member]                          
Other Commitments [Line Items]                          
Patent infringement lawsuit allegation against number of patents | Patent                   8     10
Indemnification Agreement [Member]                          
Other Commitments [Line Items]                          
Contingent liabilities                   $ 0      
Patent Infringement [Member]                          
Other Commitments [Line Items]                          
Contingent liabilities                   0      
Service Agreement [Member]                          
Other Commitments [Line Items]                          
2020                   2,500,000      
2021                   2,500,000      
2022                   2,500,000      
2023                   2,500,000      
2024                   2,500,000      
Licensing Agreements [Member]                          
Other Commitments [Line Items]                          
Annual royalty payment                   $ 3,200,000 $ 3,100,000 $ 2,500,000  
License agreement commitment amount     $ 300,000                    
License agreement expiration year     2022                    
Licensing Agreements [Member] | Mayo And VGL [Member]                          
Other Commitments [Line Items]                          
License agreement, terms                   The agreement will terminate upon the last to expire patent application, unless terminated earlier. The agreement can be terminated any time after three years from March 2006 by Mayo or VGL.      
Licensing Agreements [Member] | Mayo Foundation [Member]                          
Other Commitments [Line Items]                          
Retainer fees                   $ 40,000      
Common stock, shares issued | shares               20,833          
Noncash research and development expense               $ 500,000          
Licensing Agreements [Member] | Mayo Foundation [Member] | Minimum [Member]                          
Other Commitments [Line Items]                          
Annual royalty payment                   200,000      
Supply Agreements [Member]                          
Other Commitments [Line Items]                          
Purchase commitment, amount due in 2020                   6,200,000      
Purchase commitments for inventory related charge                   $ 3,600,000      
Redwood Office Agreement [Member]                          
Other Commitments [Line Items]                          
Lease agreement, commencement period                   2015-03      
Area of office space | ft²             50,740            
Lease agreement, effective date             Jun. 30, 2015            
Lease agreement, expiration period             2022-05            
Lease expense, payment due             $ 2,000,000.0            
Annual lease expense payable in final year of lease term             $ 2,400,000            
Redwood Office Agreement Additional Expansion Premises [Member]                          
Other Commitments [Line Items]                          
Area of office space | ft²       8,171                  
Redwood Office Agreement Additional Expansion Premises [Member] | Amendment 1 [Member]                          
Other Commitments [Line Items]                          
Area of office space | ft²           49,980              
Lease expense, payment due           $ 1,200,000              
Annual lease expense payable in final year of lease term           $ 2,900,000              
Commencement date description                   The lease for the Expansion Premises commenced on June 1, 2018.      
Lease commencement date           Jun. 01, 2018              
Lease agreement, expiration date           May 31, 2025              
Redwood Office Agreement Additional Expansion Premises [Member] | Amendment 2 [Member]                          
Other Commitments [Line Items]                          
Lease agreement, effective date       May 31, 2017                  
Lease agreement, expiration date       Jun. 01, 2018                  
Facility Lease Agreement, Original [Member]                          
Other Commitments [Line Items]                          
Lease agreement, commencement period                 2014-08        
Lease agreement, effective date                 Aug. 21, 2014        
Lease agreement, expiration date                 May 31, 2015        
Lease agreement, lease expense   $ 100,000                      
Facility Lease Agreement, Extended [Member]                          
Other Commitments [Line Items]                          
Lease agreement, commencement period             2015-03            
Lease agreement, expiration period             2017-02            
Lease agreement, lease expense         $ 300,000                
Non-cancellable Facility Lease [Member]                          
Other Commitments [Line Items]                          
Lease agreement, effective date         Mar. 01, 2017                
Lease agreement, expiration date         Feb. 28, 2022                
Lease agreement, lease expense         $ 400,000                
XML 83 R50.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Fair Value Measurements - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Millions
 1 Months Ended 12 Months Ended
Jun. 30, 2016
Dec. 31, 2019
1.75% Convertible Senior Notes due 2021 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt instrument interest rate 1.75% 1.75%
Debt instrument due year 2021 2021
Fair value of notes   $ 232.6
Fair Value Measurements Recurring [Member] | Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Net asset value of market funds   $ 1
XML 84 R54.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Balance Sheet Components - Components of Inventories (Detail) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Inventory Disclosure [Abstract]    
Raw materials $ 26,354 $ 37,453
Finished goods 65,225 54,582
Total inventories $ 91,579 $ 92,035
XML 85 R62.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Long-term Debt - Net Carrying Amount of Equity Component of Convertible Debt (Detail) - 1.75% Convertible Senior Notes due 2021 [Member] - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Jun. 30, 2016
Debt Instrument [Line Items]      
Net carrying amount     $ 32,900
Debt, Equity Component [Member]      
Debt Instrument [Line Items]      
Debt discount related to value of conversion option $ 32,945 $ 32,945  
Debt issuance cost (1,179) (1,179)  
Net carrying amount $ 31,766 $ 31,766  
XML 86 R66.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation - Additional Information (Detail) - USD ($)
 1 Months Ended 12 Months Ended
Mar. 31, 2019
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Oct. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Common stock reserved for future issuance   7,776,946      
Weighted-average grant-date fair value of options granted   $ 27.91 $ 23.27 $ 32.35  
Fair value of options vested   $ 8,300,000 $ 14,000,000.0 $ 13,300,000  
Employee stock purchase plan offering period   6 months 6 months    
Stock options unvested shares   0 0 0  
Cash received from unvested shares   $ 0 $ 0    
Stock-based compensation expense   $ 41,697,000 $ 36,637,000 $ 26,143,000  
Employee Stock [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Option purchase price, percentage of fair value     85.00%    
Number of shares available for sale         196,666
Maximum employee subscription rate     15.00%    
Performance Based RSUs [Member] | CEO [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Targeted composite index period 3 years        
RSU's [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting term   4 years      
Stock-based compensation expense $ 1,600,000 $ 28,845,000 $ 21,006,000 $ 11,197,000  
Maximum [Member] | Performance Based RSUs [Member] | CEO [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Targeted number of shares granted ratio 350.00%        
Minimum [Member] | Performance Based RSUs [Member] | CEO [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Targeted number of shares granted ratio 0.00%        
2007 Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Additional awards authorized under plan   0      
2014 Plan [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Common stock reserved for future issuance         1,854,166
Plan modification description   The number of shares initially reserved for issuance under the 2014 Plan is subject to increase by (i) the number of shares represented by awards outstanding under the 2007 Plan that are forfeited or lapse unexercised and which following the pricing date are not issued under the 2007 Plan, and (ii) an annual increase on January 1 of each year.      
2014 Plan [Member] | ISO [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Percentage of shareholder granted option   10.00%      
2014 Plan [Member] | NSO [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Percentage of shareholder granted option   10.00%      
2014 Plan [Member] | Share-based Compensation Award, Tranche One [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Vesting term   4 years      
2014 Plan [Member] | Maximum [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Stock options expiration period   10 years      
Option purchase price, percentage of fair value   110.00%      
2014 Plan [Member] | Minimum [Member]          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Option purchase price, percentage of fair value   100.00%      
XML 87 R45.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Lease Accounting - Schedule of Weighted Average Lease Terms and Discounts Rates (Detail)
Dec. 31, 2019
Leases [Abstract]  
Weighted-average remaining lease term 5 years 3 months 21 days
Weighted-average discount rate 7.00%
XML 88 R41.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Revenue - Additional Information (Detail)
 12 Months Ended
Dec. 31, 2019
Revenue From Contract With Customer [Abstract]  
Unsatisfied performance obligations description The Company recognizes revenue upon the transfer of control of the product and there are no material future performance obligations beyond such transfer.  As a result, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company does not capitalize incremental costs when the amortization period of the asset is less than a year.
XML 89 R49.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Lease Accounting - Schedule of Supplemental Cash Flow Information Related to Lease (Detail)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
USD ($)
Cash paid for amounts included in the measurement of lease liabilities:  
Operating cash flow from operating leases $ 3,970
XML 90 R28.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Long-term Debt (Tables)
 12 Months Ended
Dec. 31, 2019
Debt Instrument [Line Items]  
Interest Expense Recognized Related to Convertible Notes

The following table sets forth the interest expense recognized related to the 2021 Notes (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Contractual interest expense

 

$

3,019

 

 

$

3,019

 

 

$

3,019

 

Amortization of debt discount

 

 

6,843

 

 

 

6,432

 

 

 

6,046

 

Amortization of debt issuance costs

 

 

1,063

 

 

 

943

 

 

 

833

 

Total interest expense related to the 2021 Notes

 

$

10,925

 

 

$

10,394

 

 

$

9,898

 
Debt, Liability Component [Member]  
Debt Instrument [Line Items]  
Net Carrying Amount of Convertible Debt

The net carrying amount of the liability component of the 2021 Notes was as follows (in thousands):

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Principal

 

$

172,500

 

 

$

172,500

 

Unamortized discount

 

 

(10,462

)

 

 

(17,305

)

Unamortized issuance cost

 

 

(1,738

)

 

 

(2,801

)

Net carrying amount

 

$

160,300

 

 

$

152,394

 
Debt, Equity Component [Member]  
Debt Instrument [Line Items]  
Net Carrying Amount of Convertible Debt

The net carrying amount of the equity component of the 2021 Notes was as follows (in thousands):

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Debt discount related to value of conversion option

 

$

32,945

 

 

$

32,945

 

Debt issuance cost

 

 

(1,179

)

 

 

(1,179

)

Net carrying amount

 

$

31,766

 

 

$

31,766

 
XML 91 R20.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Selected Quarterly Financial Information
 12 Months Ended
Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract]  
Selected Quarterly Financial Information

14. Selected Quarterly Financial Information (Unaudited)

 

 

 

Three Months Ended

 

 

 

December 31,

 

 

September 30,

 

 

June 30,

 

 

March 31,

 

 

 

2019

 

 

2019

 

 

2019

 

 

2019

 

 

 

(in thousands, except per share data)

 

Total revenue

 

$

114,374

 

 

$

100,162

 

 

$

93,571

 

 

$

82,148

 

Gross profit

 

$

81,258

 

 

$

69,940

 

 

$

63,943

 

 

$

53,209

 

Loss from operations

 

$

(11,681

)

 

$

(15,984

)

 

$

(26,560

)

 

$

(42,254

)

Net loss

 

$

(13,742

)

 

$

(17,847

)

 

$

(28,021

)

 

$

(44,076

)

Net loss per share, basic and diluted

 

$

(0.44

)

 

$

(0.58

)

 

$

(0.91

)

 

$

(1.45

)

Shares used in computing net loss per common

   share, basic and diluted

 

 

31,233,416

 

 

 

30,929,938

 

 

 

30,677,567

 

 

 

30,363,623

 

 

 

 

Three Months Ended

 

 

 

December 31,

 

 

September 30,

 

 

June 30,

 

 

March 31,

 

 

 

2018

 

 

2018

 

 

2018

 

 

2018

 

 

 

(in thousands, except per share data)

 

Total revenue

 

$

107,944

 

 

$

95,630

 

 

$

96,080

 

 

$

87,635

 

Gross profit

 

$

76,154

 

 

$

67,248

 

 

$

67,921

 

 

$

62,001

 

Loss from operations

 

$

(8,603

)

 

$

(9,237

)

 

$

(8,201

)

 

$

(15,702

)

Net loss

 

$

(9,607

)

 

$

(11,265

)

 

$

(10,620

)

 

$

(17,713

)

Net loss per share, basic and diluted

 

$

(0.32

)

 

$

(0.37

)

 

$

(0.35

)

 

$

(0.59

)

Shares used in computing net loss per common

   share, basic and diluted

 

 

30,214,454

 

 

 

30,123,188

 

 

 

30,028,985

 

 

 

29,836,277

 

 
XML 92 R24.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Lease Accounting (Tables)
 12 Months Ended
Dec. 31, 2019
Schedule of Weighted Average Lease Terms and Discounts Rates

The weighted average lease terms and discounts rates are as follows:

 

 

 

December 31, 2019

 

Operating Lease Term and Discount Rate

 

 

 

 

Weighted-average remaining lease term

 

5.31 years

 

Weighted-average discount rate

 

7.0%

 
Schedule of Maturity of Lease Liabilities

As of December 31, 2019, the maturity of lease liabilities are as follows (in thousands):

 

 

 

Operating Leases

 

2020

 

$

4,924

 

2021

 

 

5,073

 

2022

 

 

5,258

 

2023

 

 

5,522

 

2024

 

 

5,687

 

Thereafter

 

 

2,399

 

Total lease payments

 

 

28,863

 

Less: Interest

 

 

(4,920

)

Present value of lease liabilities

 

$

23,943

 
Supplemental Lease Cost Information

Supplemental lease cost information are as follows (in thousands):

 

 

 

Year Ended

 

 

 

December 31, 2019

 

Operating lease cost

 

$

4,936

 
Schedule Of Operating Lease Assets and Liabilities

Supplemental balance sheet information are as follows (in thousands):

 

 

 

December 31, 2019

 

Operating Leases:

 

 

 

 

Operating lease assets

 

$

21,533

 

 

 

 

 

 

Other current liabilities

 

$

3,498

 

Long term operating lease liabilities

 

 

20,445

 

Total operating lease liabilities

 

$

23,943

 
Schedule of Supplemental Cash Flow Information Related to Lease

Supplemental cash flow information are as follows (in thousands):

 

 

 

Year Ended

 

 

 

December 31, 2019

 

Cash paid for amounts included in the measurement of lease liabilities:

 

 

 

 

Operating cash flow from operating leases

 

$

3,970

 
ASC 842 [Member]  
Schedule of Impact of Changes Made to the Consolidated Balance Sheet from the Adoption of ASC 842

Adoption of the new lease standard resulted in the recording of operating lease assets of $24.8 million and operating lease liabilities of $26.2 million.  The impact of the changes made to the consolidated balance sheet as of January 1, 2019 from the adoption of ASC 842 were as follows (in thousands):

 

 

 

Balance at

 

 

Adjustments Due

 

 

Balance at

 

 

 

December 31, 2018

 

 

to ASC 842

 

 

January 1, 2019

 

Balance Sheet:

 

 

 

 

 

 

 

 

 

 

 

 

Operating lease assets

 

$

—

 

 

$

24,771

 

 

$

24,771

 

Other current liabilities

 

 

119

 

 

 

2,389

 

 

 

2,508

 

Long-term operating lease liabilities

 

 

—

 

 

 

23,805

 

 

 

23,805

 

Other long-term liabilities

 

 

2,825

 

 

 

(1,423

)

 

 

1,402

 
XML 94 R63.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Long-term Debt - Interest Expense Recognized Related to Convertible Notes (Detail) - 1.75% Convertible Senior Notes due 2021 [Member] - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Debt Instrument [Line Items]      
Contractual interest expense $ 3,019 $ 3,019 $ 3,019
Amortization of debt discount 6,843 6,432 6,046
Amortization of debt issuance costs 1,063 943 833
Total interest expense related to the 2021 Notes $ 10,925 $ 10,394 $ 9,898
XML 95 R67.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation - Summary of Shares Available for Grant (Detail) - shares
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Stock Options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares Available for Grant, Beginning balances 2,980,762 2,466,246 2,202,239
Shares Available for Grant, Additional shares reserved 1,210,541 1,189,502 1,155,474
Shares Available for Grant, Allowance for PSU for over performance (277,778)    
Shares Available for Grant, Shares forfeited for tax 38,696 28,107 13,094
Shares Available for Grant, Ending balances 3,403,006 2,980,762 2,466,246
Employee Stock Option and Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares Available for Grant, Options and other than options granted (1,077,178) (805,653) (1,002,063)
Shares Available for Grant, Options and other than options forfeited or cancelled 527,963 102,560 97,502
XML 96 R48.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Lease Accounting - Summary of Operating Lease Assets and Liabilities (Detail)
$ in Thousands
Dec. 31, 2019
USD ($)
Operating Leases:  
Operating lease assets $ 21,533
Other current liabilities 3,498
Long term operating lease liabilities 20,445
Total operating lease liabilities $ 23,943
XML 97 R44.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Lease Accounting - Schedule of Impact of Changes Made to the Consolidated Balance Sheet from the Adoption of ASC 842 (Detail) - USD ($)
$ in Thousands
Dec. 31, 2019
Jan. 01, 2019
Dec. 31, 2018
Lessee Lease Description [Line Items]      
Operating lease assets $ 21,533    
Other current liabilities 3,597   $ 119
Long-term operating lease liabilities 20,445    
Other long-term liabilities 1,937   $ 2,825
ASC 842 [Member]      
Lessee Lease Description [Line Items]      
Operating lease assets $ 24,800 $ 24,771  
Other current liabilities   2,508  
Long-term operating lease liabilities   23,805  
Other long-term liabilities   1,402  
Adjustments due to ASC 842 [Member] | ASC 842 [Member]      
Lessee Lease Description [Line Items]      
Operating lease assets   24,771  
Other current liabilities   2,389  
Long-term operating lease liabilities   23,805  
Other long-term liabilities   $ (1,423)  
XML 98 R40.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Revenue - Summary of Revenue by Geography on Billing Address of Customer (Detail) - USD ($)
$ in Thousands
 3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Disaggregation Of Revenue [Line Items]                      
Total revenue $ 114,374 $ 100,162 $ 93,571 $ 82,148 $ 107,944 $ 95,630 $ 96,080 $ 87,635 $ 390,255 $ 387,289 $ 326,674
United States [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 326,012 321,781 263,462
International [Member]                      
Disaggregation Of Revenue [Line Items]                      
Total revenue                 $ 64,243 $ 65,508 $ 63,212
XML 99 R21.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Summary of Significant Accounting Policies (Policies)
 12 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation

These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (U.S. GAAP). The consolidated financial statements include the Company’s accounts and those of its four wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated.
Segments

Segments

The chief operating decision maker for the Company is the Chief Executive Officer. The Chief Executive Officer reviews financial information presented on a consolidated basis, accompanied only by information about revenue by geographic region, for purposes of allocating resources and evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level, other than revenue. Accordingly, the Company has determined that it has a single reportable and operating segment structure. The Company and its Chief Executive Officer evaluate performance based primarily on revenue in the geographic locations in which the Company operates. 

Until 2015, the Company had derived most of its revenue from sales to customers in Australia and Europe.  In May 2015, the U.S. Food and Drug Administration (FDA) approved the Company’s premarket approval (PMA) application to market Senza in the United States and the Company launched sales in the United States in 2015. Revenue by geography is based on the billing address of the customer. The United States is the only country that accounts for 10% or more of the revenue during the periods presented:

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

United States

 

 

84

%

 

 

83

%

 

 

81

%

 

Long-lived assets and operating income outside the United States are not material; therefore, disclosures have been limited to revenue.
Foreign Currency Translation

Foreign Currency Translation

The Company’s consolidated financial statements are prepared in U.S. dollars (USD). Its foreign subsidiaries use their local currency as their functional currency and maintain their records in the local currency. Accordingly, the assets and liabilities of these subsidiaries are translated into USD using the current exchange rates in effect at the balance sheet date and equity accounts are translated into USD using historical rates. Revenues and expenses are translated using the monthly average exchange rates during the period when the transaction occurs. The resulting foreign currency translation adjustments from this process are recorded in accumulated other comprehensive income (loss) in the consolidated balance sheets. Unrealized foreign exchange gains and losses from the remeasurement of assets and liabilities denominated in currencies other than the functional currency of the reporting entity are recorded in other income (expense), net. The Company recorded net unrealized foreign currency transaction gains of $1.0 million during the year ended December 31, 2019, losses of $0.6 million during the year ended December 31, 2018 and gains of $0.8 million during the year ended December 31, 2017. Additionally, realized gains and losses resulting from transactions denominated in currencies other than the local currency are recorded in other income (expense), net. The Company recorded realized foreign currency transaction losses of $1.6 million during the year ended December 31, 2019, losses of $0.4 million during the year ended December 31, 2018 and gains of $0.5 million during the year ended December 31, 2017.

To the extent that the Company’s international operations grow, the effect of fluctuations in currency rates will become greater, and the Company will continue to reassess its approach to managing this risk. In addition, currency fluctuations or a weakening U.S. dollar can increase the costs of the Company’s international expansion. To date, the Company has not entered into any foreign currency hedging contracts. Based on its current international structure, the Company does not plan on engaging in hedging activities in the near future.
Use of Estimates

Use of Estimates

The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant accounting estimates and management judgments reflected in the consolidated financial statements include items such as allowances for doubtful accounts; warranty obligations; stock-based compensation; depreciation and amortization lives; inventory valuation; valuation

of investments and accounting for income taxes. Estimates are based on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.
Concentration of Credit Risk and Other Risks and Uncertainties

Concentration of Credit Risk and Other Risks and Uncertainties

Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents and investments. The majority of the Company’s cash is held by one financial institution in the United States in excess of federally insured limits. The Company maintained investments in money market funds that were not federally insured during the years ended December 31, 2019 and 2018, and held cash in foreign banks of approximately $12.1 million and $4.1 million at December 31, 2019 and 2018, respectively, that was not federally insured. The Company has not experienced any losses on its deposits of cash and cash equivalents.

The Company’s convertible note hedge transactions, entered into in connection with the 2021 Notes, subject the Company to credit risk such that the counterparties may be unable to fulfill the terms of the transactions.  The associated risk is mitigated by limiting the counterparties to major financial institutions.

In the international markets in which the Company participates, the Company uses both a direct sales force and distributors to sell its products, while in the United States the Company utilizes a direct sales force. The Company performs ongoing credit evaluations of some of its direct customers and distributors, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.

There were no customers that accounted for 10% or more of the Company’s revenue for each of the years ended December 31, 2019, 2018 and 2017.  Additionally, there were no customers that accounted for 10% or more of the Company’s accounts receivable balance as of December 31, 2019 and 2018.

The Company is subject to risks common to medical device companies including, but not limited to, new technological innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, product liability, uncertainty of market acceptance of products and the need to obtain additional financing. The Company is dependent on third party manufacturers and suppliers, in some cases sole- or single-source suppliers.

There can be no assurance that the Company’s products or services will continue to be accepted in the marketplace, nor can there be any assurance that any future products or services can be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that such products or services will be successfully marketed, if at all.

The Company expects to incur operating losses in the near term and may need to obtain additional financing. There can be no assurance that such financing will be available or will be at terms acceptable by the Company.
Fair Value of Financial Instruments

Fair Value of Financial Instruments

Carrying amounts of certain of the Company’s financial instruments, including cash equivalents, short term investments, accounts receivable, accounts payable and accrued liabilities approximate fair value due to their relatively short maturities.
Cash and Cash Equivalents

Cash and Cash Equivalents

The Company considers all highly liquid investments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents. Cash and cash equivalents include money market funds in the amount of $52.4 million and $15.6 million as of December 31, 2019 and 2018, respectively. At December 31, 2019 and 2018, the Company’s cash equivalents were held in institutions in the United States and include deposits in a money market fund which were unrestricted as to withdrawal or use.
Restricted Cash

Restricted Cash

Restricted cash as of December 31, 2019 and 2018 includes certificates of deposit of $0.6 million representing collateral for the Company’s Redwood City, CA building lease pursuant to an agreement dated March 5, 2015.  Restricted cash as of December 31, 2019 additionally includes certificates of deposit of $0.4 million collateralizing payment of charges related to the Company’s credit cards.
Investment Securities

Investment Securities

The Company classifies its investment securities as available-for-sale. The Company classifies these investment securities as short-term or long-term based on the nature of the investment, its maturity date and its availability for use in current operations. Those investments with original maturities greater than three months at the date of purchase and remaining maturities of less than 12 months are considered short-term investments. Those investments with remaining maturities greater than 12 months are also classified as short-term investments as management considers them to be available for current operations if needed. The Company’s investment securities are recorded at fair value based on the fair value hierarchy.  Money market funds are classified within Level 1 of the fair value hierarchy, and commercial paper and corporate notes are classified within Level 2 of the fair value hierarchy. Unrealized gains and losses, deemed temporary in nature, are reported as a separate component of accumulated other comprehensive income (loss).

A decline in the fair value of any security below cost that is deemed other than temporary results in a charge to earnings and the corresponding establishment of a new cost basis for the security. Premiums (discounts) are amortized (accreted) over the life of the related security as an adjustment to yield using the straight-line interest method. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of securities sold.
Inventories

Inventories

Inventories are stated at the lower of cost or net realizable value. Cost is determined using the standard cost method which approximates the first-in, first-out basis. Net realizable value is determined as the prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company regularly reviews inventory quantities compared to forecasted sales to record a provision for excess and obsolete inventory when appropriate. Inventory write-downs are recorded for excess and obsolete inventory. The Company estimates forecasted sales by considering product acceptance in the marketplace, customer demand, historical sales, product obsolescence and technological innovations.

The Company’s policy is to write down inventory that has become obsolete, inventory that has a cost basis in excess of its expected lower of cost or net realizable value, and inventory in excess of expected requirements. The estimate of excess quantities is judgmental and primarily dependent on the Company’s estimates of future demand for a particular product. If the estimate of future demand is inaccurate based on actual sales, the Company may increase the write-down for excess inventory for that component and record a charge to inventory impairment in the accompanying consolidated statements of operations and comprehensive loss. The Company periodically evaluates the carrying value of inventory on hand for potential excess amount over demand using the same lower of cost or net realizable value approach as that has been used to value the inventory. The Company also periodically evaluates inventory quantities in consideration of actual loss experience. As a result of these evaluations, for the year ended December 31, 2019, the Company recognized total write-downs of $1.6 million for its inventories.  For the years ended December 31, 2018 and 2017, the Company recognized total write-downs of $2.0 million and $4.0 million for its inventories. The Company’s estimation of the future demand for a particular component of the Company’s products may vary and may result in changes in estimates in any particular period.
Shipping and Handling Costs

Shipping and Handling Costs

Shipping and handling costs are expensed as incurred and are included in cost of revenue.
Revenue Recognition

Revenue Recognition

The Company has revenue arrangements that generally consist of a single performance obligation, although, in some instances, revenue arrangements may consist of two performance obligations. The Company recognizes revenue at the point in time when it transfers control of promised goods to its customers.  Revenue is measured as the amount of consideration it expects to receive in exchange for transferring goods.

See Note 3 for further discussion on Revenue Recognition.

Adoption of ASC 606

On January 1, 2018, the Company adopted the new accounting standard ASC 606, Revenue from Contracts with Customers, using the modified retrospective method applied to contracts which were not completed as of that date.  Results for reporting periods beginning after January 1, 2018 are presented under ASC 606, while prior period amounts are not adjusted and continue to be reported in accordance with the Company’s historic accounting under ASC 605, Revenue Recognition. Under ASC 606, assuming all other revenue recognition criteria have been met, the Company will recognize revenue earlier for arrangements where the Company has satisfied its performance obligations but has not issued invoices.  These amounts are recorded as unbilled receivables, which are included in accounts receivable on the consolidated balance sheet, as the Company has an unconditional right to payment at the end of the applicable period.  

Revenue Recognition

Revenue is recognized when obligations under the terms of a contract with customers are satisfied, which occurs with the transfer of control of the Company’s goods to its customers.  Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring the goods.

For a majority of sales, where the Company’s sales representative delivers its product at the point of implantation at hospitals or medical facilities, the Company recognizes revenue upon completion of the procedure and authorization, which represents the point in time when control transfers to the customers.

For the remaining sales, which are sent from the Company’s distribution centers directly to hospitals and medical facilities, as well as distributor sales, where product is ordered in advance of an implantation, the transfer of control occurs at the time of shipment of the product.  These customers are obligated to pay within specified terms regardless of when or if they ever sell or use the products. The Company does not offer rights of return or price protection. To the extent the Company has a post-delivery obligation, such as programming devices that have been delivered as part of a direct-ship order, the Company defers revenue and the associated cost of goods sold associated with the post-delivery obligation only if the amounts are deemed material.

Sales, value add, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The expected costs associated with warranty obligations continue to be recognized as expense when the products are sold (see Note 7). The Company periodically provides incentive offers, in the form of rebates, to customers based on their aggregate levels of purchases.  Product revenue is recorded net of such incentive offers.

Practical Expedients and Exemptions

The Company recognizes revenue upon the transfer of control of the product and there are no material future performance obligations beyond such transfer.  As a result, the Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which it recognizes revenue at the amount to which it has the right to invoice for services performed. The Company does not capitalize incremental costs when the amortization period of the asset is less than a year.
Allowance for Doubtful Accounts

Allowance for Doubtful Accounts

The Company makes estimates of the collectability of accounts receivable. In doing so, the Company analyzes historical bad debt trends, customer credit worthiness, current economic trends and changes in customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts.
Property and Equipment

Property and Equipment

Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation of property and equipment, other than leasehold improvements, is computed using the straight-line method over the assets’ estimated useful lives of three to five years. Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the life of the lease. Upon retirement or sale, the cost and related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is reflected in operations. Maintenance and repairs are charged to operations as incurred.
Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group might not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net cash flows to the related asset group’s carrying value. If an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. There were no impairment charges, or changes in estimated useful lives, recorded through December 31, 2019.
Income Taxes

Income Taxes

The Company records income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s consolidated financial statements or income tax returns. In estimating future tax consequences, expected future events other than enactments or changes in the tax law or rates are considered. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized.

The Company operates in various tax jurisdictions and is subject to audit by various tax authorities. To date, taxes paid have been predominantly due to income taxes in foreign and state jurisdictions in which we conduct business. The Company provides for tax contingencies whenever it is deemed probable that a tax asset has been impaired or a tax liability has been incurred for events such as tax claims or changes in tax laws. Tax contingencies are based upon their technical merits, relative tax law, and the specific facts and circumstances as of each reporting period. Changes in facts and circumstances could result in material changes to the amounts recorded for such tax contingencies.

The Company records uncertain tax positions on the basis of a two-step process whereby (1) a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. The Company’s policy is to recognize interest and penalties related to income taxes as a component of income tax expense. A nominal amount of interest and penalties have been recognized in the

statements of operations and comprehensive loss in 2019. No interest or penalties related to income taxes have been recognized in the statements of operations and comprehensive loss in 2018 and 2017.

On December 22, 2017, the 2017 Tax Cuts and Jobs Act (the 2017 Tax Act) was enacted into law.  The recorded impact for the effects of the 2017 Tax Act is based on the Company’s current knowledge, assumptions and interpretations of available guidance.  The Company elected to account for Global Intangible Low-Tax Income (GILTI) as a current period expense when incurred.  The Company will continue to monitor the issuance of additional regulatory or accounting guidance and record any necessary adjustments in the period for which additional guidance is issued.
Other Comprehensive Income (Loss)

Other Comprehensive Income (Loss)

Other comprehensive income (loss) represents all changes in stockholders’ equity except those resulting from distributions to stockholders. The Company’s unrealized gains on short-term available-for-sale investment securities and foreign currency translation adjustments represent the components of other comprehensive income (loss) that are excluded from the reported net loss and are presented in the consolidated statements of operations and comprehensive loss.
Research and Development

Research and Development

Research and development expenses, including new product development, regulatory compliance, and clinical research, are charged to operations as incurred in the consolidated statements of operations and comprehensive loss. Such costs include personnel-related costs, including stock-based compensation, supplies, services, depreciation, allocated facilities and information services, clinical trial and related clinical manufacturing expenses, fees paid to investigative sites, and other indirect costs.
Stock-Based Compensation

Stock-Based Compensation

The Company accounts for stock-based compensation arrangements with employees in accordance with Accounting Standards Codification (ASC) 718, Compensation—Stock Compensation. ASC 718 requires the recognition of compensation expense, using a fair value-based method, for costs related to all share-based payments including stock options.

In March 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-09, Stock Compensation (Topic 718): Improvements to Employee Shared-Based Payment Accounting, which the Company adopted on January 1, 2017.  Under ASU 2016-09, entities are permitted to make an accounting policy election to either estimate forfeitures on share-based payment awards, as previously required, or to recognize forfeitures as they occur. The Company has elected to continue to estimate forfeitures expected to occur to determine the amount of compensation cost recognized in each period.  ASU 2016-09 also requires that entities recognize, on a prospective basis, all excess tax benefits and tax deficiencies as income tax expense or benefit in the income statement as discrete items in the reporting period in which they occur. The adoption did not result in a cumulative-effect adjustment to accumulated deficit as of January 1, 2017 using the modified retrospective method. Additionally, under ASU 2016-09, excess tax benefits are classified as an operating activity in the statement of cash flows. The Company has elected the presentation of excess tax benefits in the statement of cash flows using the prospective transition method.

The Company’s determination of the fair value of stock options, other than performance-based awards, on the date of grant utilizes the Black-Scholes option-pricing model, and is impacted by its common stock price as well as changes in assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the expected term that options will remain outstanding, the expected common stock price volatility over the term of the option awards, risk-free interest rates and expected dividends.

The fair value of stock options is recognized over the period during which an optionee is required to provide services in exchange for the option award, known as the requisite service period (usually the vesting period), on a straight-line basis. Stock-based compensation expense recognized at fair value includes the impact of estimated

forfeitures. The Company estimates future forfeitures at the date of grant and revises the estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

The Company estimates the fair value of the rights to purchase shares by employees under the Employee Stock Purchase Plan using the Black-Scholes option pricing formula. The Employee Stock Purchase Plan provides for consecutive six-month offering periods and the Company uses its own historical volatility data in the valuation.

Equity instruments issued to non-employees are recorded at their fair value on the measurement date and are subject to periodic adjustments as the underlying equity instruments vest. The fair value of options granted to consultants is expensed when vested. The non-employee stock-based compensation expense was not material for all periods presented.

The Company accounts for stock-based compensation for the restricted stock units at their fair value, based on the closing market price of the Company’s common stock on the grant date.  These costs are recognized on a straight-line basis over the requisite service period, which is generally the vesting term of four years.

The Company also issues stock options and restricted stock units with vesting based upon achievement of specific operational performance criteria. The fair value for these performance-based awards is recognized over the period during which the goals are to be achieved.  Stock-based compensation expense recognized at fair value includes the impact of estimated probability that the goals would be achieved, which is assessed prior to the requisite service period for the specific goals.

The Company additionally grants restricted stock units with vesting based on its stock price performance compared to a specified target composite index over a certain period.  The fair value of these grants is determined by using the Monte Carlo simulation model, which is based on a discounted cash flow approach, and requires inputs such as expected volatility of our stock price, expected volatility of the targeted composite index, correlation between the changes in our stock price and the target composite index, risk-free interest rate and expected dividends.  The expected volatility of our stock and the target composite index is based on the historical data. Correlation is based on the historical relationship between our stock price and the target composite index. The risk-free interest rate is based upon the treasury yield consistent with the vesting term of the grant. The expected dividend yield is zero. Stock-based compensation for these restricted stock units is recognized over the specified performance measurement period.

Upon adoption of ASU 2016-09 as described above, excess tax benefits or deficiencies from share-based award activity are reflected in the consolidated statements of operations as a component of the provision for income taxes, whereas they were previously recognized as additional paid-in capital.
Net Loss per Share of Common Stock

Net Loss per Share of Common Stock

Basic net loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, restricted stock units and common stock options are considered to be potentially dilutive securities. Because the Company has reported a net loss in all periods presented, diluted net loss per common share is the same as basic net loss per common share for those periods.
Recent Accounting Pronouncements

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires the measurement and recognition of expected credit losses for financial assets held. The FASB has also issued several updates to ASU 2016-13.  These ASU’s are effective for public entities for annual periods beginning after December 15, 2019, with early adoption permitted. The Company has not determined the potential effects of the guidance on its consolidated financial statements.

In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This ASU eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences related to changes in ownership of equity method investments and foreign subsidiaries. ASU 2019-12 also simplifies aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU 2019-12 is effective for public entities for annual periods beginning after December 15, 2020, with early adoption permitted. The Company has not determined the potential effects of the guidance on its consolidated financial statements.
Adoption of ASC 842

Adoption of ASC 842

On January 1, 2019, the Company adopted the new accounting standard ASC 842, Leases, which requires entities to recognize assets and liabilities for leases with lease terms of more than 12 months on the balance sheet.  

The Company adopted the new lease standard using the transition method that allowed entities to initially apply ASC 842 at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption (the optional transition method). The Company elected the package of transitional practical expedients, such that, for leases existing prior to the adoption of ASC 842, the Company will not need to

reassess whether contracts are leases, will retain historical lease classification and historical initial direct costs classification. The Company also elected the hindsight practical expedient to determine the lease term for existing leases.  Operating lease assets and operating lease liabilities are recognized based on the present value of minimum lease payments over the remaining lease term.  The Company uses its incremental borrowing rate based on information available when determining the lease liabilities.  Lease cost is recognized on a straight-line basis over the expected lease term.
XML 100 R25.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Fair Value Measurements (Tables)
 12 Months Ended
Dec. 31, 2019
Fair Value Disclosures [Abstract]  
Financial Instruments Measured at Fair Value on Recurring Basis The following table sets forth the Company’s financial instruments that were measured at fair value on a recurring basis, by level, within the fair value hierarchy (in thousands):

 

Balance as of December 31, 2019

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds (i)

 

$

52,359

 

 

$

—

 

 

$

—

 

 

$

52,359

 

Agency bonds (iii)

 

 

—

 

 

 

17,246

 

 

 

—

 

 

 

17,246

 

Commercial paper (iii)

 

 

—

 

 

 

12,449

 

 

 

—

 

 

 

12,449

 

Corporate notes (iii)

 

 

—

 

 

 

142,734

 

 

 

—

 

 

 

142,734

 

Total assets

 

$

52,359

 

 

$

172,429

 

 

$

—

 

 

$

224,788

 

 

Balance as of December 31, 2018

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

Assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Money market funds (i)

 

$

15,572

 

 

$

—

 

 

$

—

 

 

$

15,572

 

Commercial paper (ii)

 

 

—

 

 

 

119,602

 

 

 

—

 

 

 

119,602

 

Corporate notes (ii)

 

 

—

 

 

 

111,532

 

 

 

—

 

 

 

111,532

 

Total assets

 

$

15,572

 

 

$

231,134

 

 

$

—

 

 

$

246,706

 

 

(i)

Included in cash and cash equivalents on the consolidated balance sheets.

(ii)

Included in either cash and cash equivalents or short-term investments on the consolidated balance sheets.

(iii)

Included in short-term investments on the consolidated balance sheets.
XML 101 R29.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation (Tables)
 12 Months Ended
Dec. 31, 2019
Summary of Common Stock Reserved for Future Issuance

Common stock reserved for future issuance as of December 31, 2019 was as follows:

 

 

 

December 31,

 

 

 

2019

 

Outstanding stock options and restricted stock units

 

 

2,934,517

 

Reserved for grants of future stock options and restricted stock units

 

 

3,680,784

 

Reserved for employee stock purchase plan

 

 

1,161,645

 

Total common stock reserved for future issuance

 

 

7,776,946

 
Summary of Shares Available for Grant

A summary of shares available for grant under the Stock Plans is as follows:

 

 

Shares Available

 

 

 

for Grant

 

Balance at December 31, 2016

 

 

2,202,239

 

Additional shares reserved

 

 

1,155,474

 

Shares forfeited for tax

 

 

13,094

 

Options and restricted stock granted

 

 

(1,002,063

)

Options and restricted stock cancelled

 

 

97,502

 

Balance at December 31, 2017

 

 

2,466,246

 

Additional shares reserved

 

 

1,189,502

 

Shares forfeited for tax

 

 

28,107

 

Options and restricted stock granted

 

 

(805,653

)

Options and restricted stock cancelled

 

 

102,560

 

Balance at December 31, 2018

 

 

2,980,762

 

Additional shares reserved

 

 

1,210,541

 

Allowance for PSU for overperformance

 

 

(277,778

)

Shares forfeited for tax

 

 

38,696

 

Options and restricted stock granted

 

 

(1,077,178

)

Options and restricted stock cancelled

 

 

527,963

 

Balance at December 31, 2019

 

 

3,403,006

 
Summary of Activity under Stock Plans

A summary of stock option activity under the Stock Plans is as follows:

 

 

 

Options Outstanding

 

 

Weighted Average

 

 

 

 

 

 

Number of

 

 

Weighted Average

 

 

Remaining

 

Aggregate

 

 

 

Options

 

 

Exercise Price

 

 

Contractual Term

 

Intrinsic Value

 

 

 

 

 

 

 

 

 

 

 

(in years)

 

(in thousands)

 

Outstanding at December 31, 2016

 

 

2,821,227

 

 

$

29.85

 

 

7.4

 

$

123,425

 

Options granted

 

 

503,690

 

 

$

74.71

 

 

 

 

 

 

 

Options exercised

 

 

(707,410

)

 

$

10.59

 

 

 

 

$

50,971

 

Options cancelled

 

 

(57,535

)

 

$

46.83

 

 

 

 

 

 

 

Outstanding at December 31, 2017

 

 

2,559,972

 

 

$

43.62

 

 

7.3

 

$

71,120

 

Options granted

 

 

236,900

 

 

$

47.96

 

 

 

 

 

 

 

Options exercised

 

 

(247,768

)

 

$

16.05

 

 

 

 

$

15,468

 

Options cancelled

 

 

(19,364

)

 

$

44.70

 

 

 

 

 

 

 

Outstanding at December 31, 2018

 

 

2,529,740

 

 

$

46.72

 

 

6.7

 

$

21,866

 

Options granted

 

 

244,075

 

 

$

56.71

 

 

 

 

 

 

 

Options exercised

 

 

(828,722

)

 

$

34.52

 

 

 

 

$

42,695

 

Options cancelled

 

 

(298,908

)

 

$

66.22

 

 

 

 

 

 

 

Outstanding at December 31, 2019

 

 

1,646,185

 

 

$

50.80

 

 

6.3

 

$

109,870

 

Options exercisable as of December 31, 2019

 

 

1,117,773

 

 

$

46.70

 

 

5.1

 

$

79,186

 

Options vested, exercisable or expected to

   vest as of December 31, 2019

 

 

1,612,455

 

 

$

50.66

 

 

6.2

 

$

107,839

 
Summary of Options Outstanding and Vested under Stock Plans by Exercise Price

The options outstanding and vested under the Stock Plans by exercise price, at December 31, 2019, were as follows:

 

 

 

Options Outstanding

 

 

Options Vested

 

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number

 

 

Contractual Term

 

Weighted Average

 

 

Number

 

 

Weighted Average

 

Exercise Price

 

Outstanding

 

 

(in years)

 

Exercise Price

 

 

Exercisable

 

 

Exercise Price

 

$1.44 — $18.00

 

 

334,087

 

 

3.79

 

$

10.25

 

 

 

334,087

 

 

$

10.25

 

$32.51 — $48.44

 

 

391,304

 

 

7.85

 

$

43.43

 

 

 

159,456

 

 

$

42.13

 

$49.94 — $63.23

 

 

365,966

 

 

4.45

 

$

57.78

 

 

 

352,632

 

 

$

57.73

 

$63.39 — $76.81

 

 

393,930

 

 

8.27

 

$

70.58

 

 

 

155,991

 

 

$

73.09

 

$84.30 — $97.52

 

 

160,898

 

 

7.07

 

$

88.62

 

 

 

115,607

 

 

$

89.07

 

$1.44 — $97.52

 

 

1,646,185

 

 

6.29

 

$

50.80

 

 

 

1,117,773

 

 

$

46.70

 
Summary of Restricted Stock Units under the Stock Plan

A summary of RSUs activity under the Stock Plans was as follows:

 

 

 

Number of

 

 

Weighted Average

 

 

Aggregate

 

 

 

Restricted

 

 

Grant Date

 

 

Intrinsic Value

 

 

 

Stock Units

 

 

Fair Value

 

 

(in thousands)

 

Outstanding at December 31, 2016

 

 

345,555

 

 

$

70.39

 

 

$

25,108

 

Restricted stock granted

 

 

498,373

 

 

$

82.60

 

 

 

 

 

Restricted stock released

 

 

(83,121

)

 

$

69.90

 

 

$

1,175

 

Restricted stock cancelled

 

 

(39,967

)

 

$

81.57

 

 

 

 

 

Outstanding at December 31, 2017

 

 

720,840

 

 

$

78.26

 

 

$

49,767

 

Restricted stock granted

 

 

568,753

 

 

$

68.09

 

 

 

 

 

Restricted stock released

 

 

(196,274

)

 

$

77.43

 

 

$

968

 

Restricted stock cancelled

 

 

(83,196

)

 

$

81.73

 

 

 

 

 

Outstanding at December 31, 2018

 

 

1,010,123

 

 

$

72.41

 

 

$

39,284

 

Restricted stock granted

 

 

833,103

 

 

$

59.56

 

 

 

 

 

Restricted stock released

 

 

(325,839

)

 

$

70.69

 

 

$

4,064

 

Restricted stock cancelled

 

 

(229,055

)

 

$

70.23

 

 

 

 

 

Outstanding at December 31, 2019

 

 

1,288,332

 

 

$

64.92

 

 

$

151,431

 

Restricted stock expected to vest as of

   December 31, 2019

 

 

1,190,393

 

 

$

59.42

 

 

$

139,919

 
Schedule of Employee Stock Purchase Plan Activity

A summary of ESPP activity was as follows:

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Additional shares reserved

 

 

302,635

 

 

 

297,375

 

 

 

288,868

 

Shares issued

 

 

164,960

 

 

 

110,040

 

 

 

73,262

 

Shares available for future issuance

 

 

1,161,645

 

 

 

1,023,970

 

 

 

836,635

 

Employee contributions for shares issued (in thousands)

 

$

6,544

 

 

$

5,521

 

 

$

4,697

 
Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation and Monte Carlo Simulation Model The following assumptions were used in estimating the fair value:

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Stock Options:

 

 

 

 

 

 

 

 

 

 

 

 

Expected term (in years)

 

5.7

 

 

5.5

 

 

5.5

 

Expected volatility

 

51% — 52%

 

 

44% — 51%

 

 

44% — 46%

 

Risk-free interest rate

 

1.4% — 2.6%

 

 

2.3% — 2.9%

 

 

1.8% — 2.2%

 

Dividend Yield

 

0%

 

 

 

0%

 

 

 

0%

 

ESPP:

 

 

 

 

 

 

 

 

 

 

 

 

Expected term (in years)

 

0.5

 

 

0.5

 

 

0.5

 

Expected volatility

 

48% — 61%

 

 

44% — 57%

 

 

36% — 37%

 

Risk-free interest rate

 

1.6% — 2.4%

 

 

2.1% — 2.5%

 

 

1.0% — 1.4%

 

Dividend Yield

 

0%

 

 

 

0%

 

 

0%

 
Summary of Stock-Based Compensation Expense by Line Items in Consolidated Statements of Operations

A summary of pre-tax stock-based compensation expense by line items in the consolidated statements of operations was as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Cost of revenue

 

$

3,061

 

 

$

2,656

 

 

$

1,878

 

Research and development

 

 

6,323

 

 

 

5,871

 

 

 

4,601

 

Sales, general and administrative

 

 

32,313

 

 

 

28,110

 

 

 

19,664

 

Total stock-based compensation expense

 

$

41,697

 

 

$

36,637

 

 

$

26,143

 
Summary of Stock-Based Compensation Expense

 

A summary of pre-tax stock-based compensation expense by category was as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Stock options

 

$

10,312

 

 

$

13,765

 

 

$

13,412

 

Restricted stock units

 

 

28,845

 

 

 

21,006

 

 

 

11,197

 

Employee stock purchase plan

 

 

2,540

 

 

 

1,866

 

 

 

1,534

 

Total stock-based compensation expense

 

$

41,697

 

 

$

36,637

 

 

$

26,143

 
Summary of Stock-Based Compensation Expense Not Yet Recognized

As of December 31, 2019, total stock-based compensation expense not yet recognized, net of estimated forfeitures, were as follows:

 

 

 

Unrecognized

 

 

Weighted-Average

 

 

 

Compensation

 

 

Amortization Period

 

 

 

(in thousands)

 

 

(in years)

 

Stock options

 

$

14,720

 

 

 

2.7

 

Restricted stock units

 

 

62,680

 

 

 

2.6

 

Employee stock purchase plan

 

 

1,262

 

 

 

0.4

 
Performance Based RSUs [Member]  
Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation and Monte Carlo Simulation Model The fair value of these performance based RSUs is based on the Monte Carlo simulation model using the following assumptions:

 

 

Years Ended December 31,

 

 

 

2019

 

Index volatility

 

36%

 

Company volatility

 

45%

 

Risk-free interest rate

 

2.4%

 

Correlation with index

 

0.28

 

Dividend Yield

 

0%

 

 
XML 102 R38.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Revenue - Impact of Adoption on Consolidated Balance Sheet (Detail) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Jan. 01, 2018
Dec. 31, 2017
Disaggregation Of Revenue [Line Items]        
Accounts receivable, net $ 82,833 $ 80,656   $ 67,287
Inventories 91,579 92,035    
Prepaid expenses and other current assets $ 9,838 6,621   $ 6,463
ASC 606 [Member]        
Disaggregation Of Revenue [Line Items]        
Accounts receivable, net     $ 68,734  
Prepaid expenses and other current assets     5,987  
Balance Without ASC 606 Adoption [Member] | ASC 606 [Member]        
Disaggregation Of Revenue [Line Items]        
Accounts receivable, net   78,142    
Inventories   92,126    
Prepaid expenses and other current assets   7,514    
Adjustments Due to ASC 606 [Member] | ASC 606 [Member]        
Disaggregation Of Revenue [Line Items]        
Accounts receivable, net   2,514 1,447  
Inventories   (91)    
Prepaid expenses and other current assets   $ (893) $ (476)  
XML 103 R34.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Formation and Business of the Company - Additional Information - Public Offering (Detail) - USD ($)
 1 Months Ended 12 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Nov. 30, 2014
Dec. 31, 2019
Subsidiary, Sale of Stock [Line Items]        
Net proceeds from common stock   $ 118,400,000 $ 131,600,000  
1.75% Convertible Senior Notes due 2021 [Member]        
Subsidiary, Sale of Stock [Line Items]        
Aggregate principal amount of convertible senior notes $ 150,000,000.0      
Debt instrument interest rate 1.75%     1.75%
Debt instrument due year 2021     2021
Additional aggregate principal amount of convertible senior notes $ 22,500,000      
Debt instrument frequency of payment       semi-annually in arrears on June 1 and December 1 of each year, commencing on December 1, 2016
Net proceeds from the debt offering after deducting transaction costs $ 166,200,000      
Common Stock [Member]        
Subsidiary, Sale of Stock [Line Items]        
Common stock, shares issued   2,470,587    
IPO [Member]        
Subsidiary, Sale of Stock [Line Items]        
Common stock, shares issued     8,050,000  
Common stock, shares issued price per share     $ 18.00  
IPO [Member] | Common Stock [Member]        
Subsidiary, Sale of Stock [Line Items]        
Shares issued upon conversion of redeemable convertible preferred stock and convertible preferred stock     15,208,048  
Over Allotment Option [Member]        
Subsidiary, Sale of Stock [Line Items]        
Common stock, shares issued   705,882 1,050,000  
XML 104 R30.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes (Tables)
 12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Components of Loss before Income Taxes

The components of the Company’s income / (loss) before income taxes were as follows:

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

 

 

(in thousands)

 

Domestic

 

$

(106,010

)

 

$

(52,755

)

 

$

(39,370

)

Foreign

 

 

3,923

 

 

 

4,318

 

 

 

4,120

 

Total loss before income taxes

 

$

(102,087

)

 

$

(48,437

)

 

$

(35,250

)
Components of Expense/(Benefit) for Income Taxes

The components of the expense / (benefit) for income taxes are as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Current:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

(103

)

 

$

—

 

 

$

—

 

State

 

 

187

 

 

 

220

 

 

 

170

 

Foreign

 

 

1,644

 

 

 

1,477

 

 

 

1,238

 

Total current income tax expense / (benefit)

 

 

1,728

 

 

 

1,697

 

 

 

1,408

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

 

—

 

 

 

—

 

 

 

—

 

State

 

 

—

 

 

 

—

 

 

 

—

 

Foreign

 

 

(129

)

 

 

(929

)

 

 

—

 

Total deferred income tax expense / (benefit)

 

 

(129

)

 

 

(929

)

 

 

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total income tax expense / (benefit)

 

$

1,599

 

 

$

768

 

 

$

1,408

 
Income Tax Expense by Applying Statutory Federal Income Tax Rate

Income tax expense differs from the amount computed by applying the statutory federal income tax rate as follows:

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Tax at statutory federal rate

 

 

21.0

%

 

 

21.0

%

 

 

34.0

%

State tax, net of federal benefit

 

 

(0.1

)%

 

 

(0.4

)%

 

 

(0.4

)%

Foreign rate differential

 

 

(0.7

)%

 

 

(1.0

)%

 

 

0.5

%

Tax credits

 

 

3.0

%

 

 

2.8

%

 

 

4.5

%

Excess tax benefits related to stock-based compensation

 

 

3.8

%

 

 

2.0

%

 

 

21.5

%

Effect of Tax Cuts and Jobs Act of 2017

 

 

—

%

 

 

—

%

 

 

(121.1

)%

Change in valuation allowance

 

 

(26.4

)%

 

 

(21.2

)%

 

 

61.4

%

Other

 

 

(2.2

)%

 

 

(4.9

)%

 

 

(4.4

)%

Total

 

 

(1.6

)%

 

 

(1.7

)%

 

 

(4.0

)%
Tax Effects of Temporary Differences and Carryforwards that Give Rise to Significant Portions of Deferred Tax Assets and Liabilities

The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities are as follows:

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

 

 

(in thousands)

 

Net operating loss carryforwards

 

$

94,680

 

 

$

68,552

 

Tax credits

 

 

17,095

 

 

 

12,451

 

Depreciation

 

 

463

 

 

 

339

 

Stock-based compensation

 

 

9,372

 

 

 

10,770

 

Accruals and reserves

 

 

9,569

 

 

 

7,507

 

Lease liabilities

 

 

5,887

 

 

 

—

 

Other

 

 

1,096

 

 

 

2,057

 

Deferred tax assets

 

 

138,162

 

 

 

101,676

 

 

 

 

 

 

 

 

 

 

Right of use asset

 

 

(5,294

)

 

 

—

 

Deferred tax liabilities

 

 

(5,294

)

 

 

—

 

 

 

 

 

 

 

 

 

 

Valuation allowance

 

 

(131,807

)

 

 

(100,747

)

 

 

 

 

 

 

 

 

 

Net deferred tax assets

 

$

1,061

 

 

$

929

 
Summary of Unrecognized Tax Benefits The following table summarizes the activity related to UTBs (in thousands):

 

Balance at December 31, 2016

 

$

3,384

 

Increases related to current year tax provisions

 

 

790

 

Increases related to prior year tax provisions

 

 

193

 

Decreases related to prior year tax provisions

 

 

(134

)

Balance at December 31, 2017

 

 

4,233

 

Increases related to current year tax provisions

 

 

893

 

Increases related to prior year tax provisions

 

 

80

 

Decreases related to prior year tax provisions

 

 

(6

)

Balance at December 31, 2018

 

 

5,200

 

Increases related to current year tax provisions

 

 

1,611

 

Increases related to prior year tax provisions

 

 

572

 

Decreases related to prior year tax provisions

 

 

—

 

Balance at December 31, 2019

 

$

7,383

 
XML 105 R13.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Commitments and Contingencies
 12 Months Ended
Dec. 31, 2019
Commitments And Contingencies Disclosure [Abstract]  
Commitments and Contingencies

7. Commitments and Contingencies

Operating Leases

In March 2015, the Company entered into a lease agreement for approximately 50,740 square feet of office space located in Redwood City, California for a period beginning in June 2015 through May 2022 with initial annual payments of approximately $2.0 million, increasing to $2.4 million annually during the final year of the lease term. In December 2016, the Company entered into an amendment for an additional approximately 49,980 square feet of office space adjacent to the premises under the original lease (the Expansion Premises), with initial annual payments of $1.2 million, increasing to $2.9 million in the final year of the amended lease term.  The lease for the Expansion Premises commenced on June 1, 2018.   The amendment also extends the lease term for the original premises to terminate on the same date as the amended lease, which is May 31, 2025.  In April 2017, the Company entered into a second amendment to the lease for a temporary space of 8,171 square feet for a period beginning in May 2017 and which ended on June 1, 2018, the Commencement Date of the Expansion Premises.

In August 2014, the Company entered into a new facility lease for warehouse space beginning on August 21, 2014 through May 31, 2015, under which it was obligated to pay approximately $100,000 in lease payments over the term of the lease. In March 2015, the Company extended the warehouse lease through February 2017 under which it was obligated to pay approximately $0.3 million in lease payments over the remaining term of the lease.

In February 2017, the Company entered into a separate non-cancellable facility lease for warehouse space beginning March 1, 2017 through February 28, 2022, under which the Company is obligated to pay approximately $0.4 million in lease payments over the term of the lease.

See Note 4 for further discussion on Lease Accounting.

Warranty Obligations

The Company warrants that its products will operate substantially in conformity with product specifications and provides a limited one- to five-year warranty.  Activities related to warranty obligations were as follows (in thousands):

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Beginning Balance

 

$

1,236

 

 

$

708

 

Provision for warranty

 

 

1,942

 

 

 

2,334

 

Utilization

 

 

(2,000

)

 

 

(1,806

)

Ending Balance

 

$

1,178

 

 

$

1,236

 

 

Supply Agreements

The Company has entered into supply agreements with certain of the Company’s suppliers that required certain minimum annual purchase agreements.  As of December 31, 2019, the Company had minimum annual purchase commitments of $6.2 million due in 2020. For the year ended December 31, 2019, the Company recorded a charge of $3.6 million related to the cancellation of firm purchase commitments for inventory related items.

The Company also entered into a service agreement in January 2020 for which it is committed to pay $2.5 million annually in each of the next five years.

License Agreements

In March 2006, the Company entered into an amended and restated license agreement with the Mayo Foundation for Medical Education and Research (Mayo) and Venturi Group LLC (VGL), which provides the Company access to the certain know how and licensed patents owned by Mayo and VGL for treatment of central, autonomic and peripheral nervous system disorders, including pain, using devices to modulate nerve signaling. The licenses granted are exclusive and the Company has the right to sub-license. The agreement will terminate upon the last to expire patent application, unless terminated earlier. The agreement can be terminated any time after three years from March 2006 by Mayo or VGL.

Per terms of the license, the Company is required to pay royalties based on the greater of earned royalty or minimum royalty. The earned royalty will be based on a percentage of net sales of licensed products either by the Company or the sub-licensee. The minimum royalty payment will be based on royalty periods as defined in the agreement.

In March 2011, the Company entered into a Phase II License Agreement with Mayo which provides the Company access to the certain know how and licensed patents owned by Mayo. The licenses granted are exclusive and the Company has the right to sub-license. The agreement will terminate upon the last to expire patent application, unless terminated earlier.

Per terms of the license, the Company is required to:

 

•

Pay a retainer fee of $40,000 per annum starting March 2011 and ending February 2013;

 

•

Pay royalties based on the greater of earned royalty or minimum royalty. The earned royalty is based on a percentage of net sales of licensed products either by the Company or the sub-licensee. The minimum annual royalty payment is $200,000.

Royalties paid during the years ended December 31, 2019, 2018 and 2017 were $3.2 million, $3.1 million and $2.5 million, respectively.

In November 2014, the Company issued Mayo 20,833 shares of common stock owed in connection with the IPO pursuant to the terms of the license, and recorded noncash research and development expense of $0.5 million for the fair value of the shares on the date of issuance.

In July 2017, the Company entered into a license agreement for which it is committed to pay $0.3 million over the remaining term of this license agreement, which ends in 2022.

Contingent Consideration

In February 2019, the Company entered into an agreement with a privately-held company to, among other things, provide the privately-held company financing in the form of a secured convertible note.  Through December 31, 2019, the Company has provided financing totaling $8.5 million in the form of two secured convertible notes. The Company has the obligation to provide additional funding of up to $3.0 million in the form of an additional secured convertible note and takes effect only after the Company exercises its option to make a further investment in the privately-held company that is based on certain development targets.  The agreement additionally provides the Company with the exclusive right, but not the obligation, to acquire the privately-held company.  As of December 31, 2019, the value of the secured convertible notes, measured at amortized cost, is $7.9 million, while the value of certain rights in relation to the agreement, measured at cost and monitored for impairment on an ongoing basis, is $1.0 million.  These amounts are reported in Other Assets on the Condensed Consolidated Balance Sheet.  The accretion of amortized cost is recorded in Interest Income, while any changes in value from impairment assessment are recorded in Other Income (Expense) in the Consolidated Statements of Operations and Comprehensive Income.  The Company concluded that the privately-held company is a variable interest entity; however, the Company is not the primary beneficiary as it does not retain power to direct the activities that most significantly impact its economic performance.

Contingencies

From time to time, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. There have been no contingent liabilities requiring accrual at December 31, 2019 and 2018.

Indemnification

The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, including, among other circumstances, in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to the Company’s technology. The term of these indemnification agreements is generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future, but have not yet been made.

The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has director and officer insurance coverage that reduces the Company’s exposure and enables the Company to recover a portion of any future amounts paid. The Company believes the estimated fair value of these indemnification agreements in excess of applicable insurance coverage is minimal.

The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. No liability associated with such indemnifications has been recorded to date.

Legal Matters

On November 28, 2016, the Company filed a lawsuit for patent infringement against Boston Scientific Corporation and Boston Scientific Neuromodulation Corporation (collectively, Boston Scientific). The lawsuit, filed in the U.S. District Court for the Northern District of California (the Court), asserts that Boston Scientific is infringing seven of the Company’s patents covering inventions relating to the Senza system and HF10 therapy. The lawsuit seeks preliminary and permanent injunctive relief against further infringement as well as damages and attorney’s fees. On July 24, 2018, the Court issued an order on claim construction and summary judgment.  In the order, the Court ruled that six asserted method claims in three of the Company’s asserted patents were patent eligible and not invalid as indefinite.  Specifically, the claims upheld in the ruling were claims 11, 21 and 23 of U.S. Patent No. 8,359,102; claim 18 of U.S. Patent No. 8,792,988; and claims 1 and 5 of U.S. Patent No. 8,768,472.  Collectively, these six claims cover methods for delivering SCS therapy at frequencies between 1.5 kHz and 100 kHz.

The Court, however, found that Boston Scientific is not currently infringing the six upheld method claims.  Specifically, the Court found that Boston Scientific's sale of the Spectra WaveWriter systems for commercial use in the United States does not infringe the upheld method claims because the Spectra WaveWriter systems cannot be programmed to generate signals above 1.2 kHz.  With regard to the use of the Spectra WaveWriter and the Precision with MultiWave systems in patients that have completed the ACCELERATE clinical trial, the Court found such use to fall within the safe harbor provision of 35 U.S.C. § 271(e).  The Court further held that 35 U.S.C. § 271(f) does not apply to method claims, and therefore the sale of the Precision with MultiWave systems in Europe does not infringe the upheld method claims.  The Court also found that the asserted system claims in four of the Company's asserted patents were invalid as indefinite.  Specifically, the Court invalidated claims 18, 34, and 55 of U.S. Patent No. 9,327,125; claims 5 and 34 of U.S. Patent No. 9,333,357; claims 7, 12, 35, 37, and 58 of U.S. Patent No. 8,712,533; and claims 1 and 22 of U.S. Patent No. 9,480,842.  

On July 27, 2018, the parties submitted a joint statement to the Court wherein Boston Scientific asserted to the Court that, with respect to whether any U.S. launch of a high-rate product (such as the Precision with MultiWave and Spectra WaveWriter models used in the ACCELERATE study or any other system that is programmable at any frequency in the range 1.5 to 100 kHz) is imminent, Boston Scientific, as of now, has not decided whether to launch such a product; has not established a timeline for when such a decision might be made, if ever; and has not determined what frequencies would be enabled if it were to decide to launch such a product in the future. Boston Scientific further confirmed its public statements that the ACCELERATE study had been extended into 2019, with an estimated study completion date between April 2019 and November 2019.  On the basis of the foregoing, the parties agreed to dismissal on ripeness grounds of Nevro’s declaratory judgment claims without prejudice, each side to bear its own fees and costs as to these claims, and jointly requested that the Court enter such a dismissal. The dismissal was thereafter entered as a court order on July 31, 2018.  The Company and Boston Scientific are each appealing portions of the Court’s July 24th ruling, and have submitted their respective appeal briefs and replies to the U.S. Court of Appeals for the Federal Circuit.  The appeal was heard on December 2, 2019. The Company is awaiting the ruling from the appeals court.

On December 9, 2016, Boston Scientific filed a patent infringement lawsuit alleging the Company’s manufacture, use and sale of the Senza system infringes ten of Boston Scientific’s patents covering spinal cord stimulation technology related to stimulation leads, rechargeable batteries and telemetry. The lawsuit, filed in the U.S. District Court for the District of Delaware, seeks unspecified damages and attorney’s fees, as well as preliminary and permanent injunctive relief against further infringement. During this litigation, Boston Scientific unilaterally dismissed their assertions with regard to two of the ten patents.  In relation to this lawsuit, the Company filed petitions for inter partes review at the U.S. Patent and Trademark Office (USPTO) against all the eight remaining patents asserted by Boston Scientific.  As a result of those petitions, in February 2019, all of the asserted claims of Boston Scientific’s U.S. Patent Nos. 6,895,280 and 7,587,241 were found invalid by the Patent Trial and Appeal Board (PTAB) at the USPTO. Boston Scientific has appealed these rulings.  The Company and Boston Scientific have submitted their respective appeal briefs and replies to the U.S. Court of Appeals for the Federal Circuit, and are awaiting a hearing date. This patent infringement lawsuit has been stayed pending completion of the inter partes proceedings since June 2018. As of this time, the Company is unable to determine an outcome or potential range of loss.

On April 27, 2018, Boston Scientific filed a second patent lawsuit alleging patent infringement, theft of trade secrets and tortious interference with contract. The lawsuit, filed in the U.S. District Court for the District of Delaware, seeks unspecified damages and attorney’s fees, as well as preliminary and permanent injunctive relief against further infringement. In relation to this lawsuit, the Company filed petitions for inter partes review at the U.S. Patent and Trademark Office USPTO against seven of the nine patents asserted by Boston Scientific. In January 2020, the PTAB initiated inter partes reviews in all seven of the challenged patents. As of this time, the Company is unable to determine an outcome or potential range of loss.

On August 23, 2018, the Oklahoma Police Pension and Retirement System filed a putative securities class action complaint against the Company and certain individual officers alleging violations of Sections 10(b) and 20(a) of the Exchange Act, and Rule 10b-5 of the Exchange Act.  The lawsuit, filed in the U.S. District Court for the Northern District of California, seeks unspecified damages and attorneys’ fees based on alleged misleading statements or omissions by the Company and the individual officers regarding the Company’s rights in technology underlying the Senza SCS systems and the termination of the Company’s former Vice President of Worldwide Sales. On November 3, 2018, a related shareholder derivative lawsuit was filed in the United States District Court for the Northern District of California seeking unspecified damages, injunctive relief and attorneys’ fees based on alleged violations of Section 14(a) of the Securities and Exchange Act of 1934, breach of fiduciary duties, unjust enrichment and waste of corporate assets. On August 1, 2019, U.S. District Judge Vince Chhabria granted the Company’s motion to dismiss the pending securities class action complaint, with leave to file an amended complaint within 21 days of the order. The plaintiffs did not file an amended complaint, and on August 23, 2019, the securities class action was dismissed.  On September 6, 2019, the related shareholder derivative lawsuit was voluntarily dismissed

On February 14, 2019, the Company filed a lawsuit for patent infringement against Stimwave Technologies, Inc. (Stimwave) asserting that Stimwave is infringing the Company’s patents covering inventions related to its HF10 therapy and the Senza system, as well as a claim for false advertising under the Lanham Action Section 43(a), 15 U.S.C. § 1125(a).  In relation to this lawsuit, on July 24, 2019, the court granted Nevro's motion for preliminary injunction, and has issued an order barring Stimwave, and all affiliated persons and entities, from infringing patent claims covering frequencies between 3 kHz and 10 kHz by programming Stimwave's SCS systems to deliver its recently introduced high-frequency, paresthesia-free SCS therapy.  Per Nevro's request, the court order does not enjoin Stimwave from providing follow-up care and programming for any patients who were already programmed with such high frequency therapy.  On July 25, 2019, Stimwave filed a Notice of Appeal to the U.S. Court of Appeals for the Federal Circuit.  The Company and Stimwave have submitted their respective appeal briefs and replies to the appellate court, and are awaiting a hearing date. During the appeal, the litigation in the District of Delaware will continue on the merits.

As of December 31, 2019, the Company did not record a liability, as an outcome or potential loss range cannot be reasonably determined. 

The Company is and may from time to time continue to be involved in various legal proceedings to defend its intellectual property, including several pending European patent oppositions at the European Patent Office (EPO) initiated by the Company’s competitors Medtronic and Boston Scientific and an entitlement action filed by Boston Scientific in Germany.  In addition, the Company is and may from time to time also be involved in various legal proceedings of a character normally incident to the ordinary course of business, such as product liability and professional liability matters, which the Company does not deem to be material to its business and consolidated financial statements at this stage.

XML 106 R17.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes
 12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Income Taxes

11. Income Taxes

The components of the Company’s income / (loss) before income taxes were as follows:

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

 

 

(in thousands)

 

Domestic

 

$

(106,010

)

 

$

(52,755

)

 

$

(39,370

)

Foreign

 

 

3,923

 

 

 

4,318

 

 

 

4,120

 

Total loss before income taxes

 

$

(102,087

)

 

$

(48,437

)

 

$

(35,250

)

 

The components of the expense / (benefit) for income taxes are as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Current:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

(103

)

 

$

—

 

 

$

—

 

State

 

 

187

 

 

 

220

 

 

 

170

 

Foreign

 

 

1,644

 

 

 

1,477

 

 

 

1,238

 

Total current income tax expense / (benefit)

 

 

1,728

 

 

 

1,697

 

 

 

1,408

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Deferred:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

 

—

 

 

 

—

 

 

 

—

 

State

 

 

—

 

 

 

—

 

 

 

—

 

Foreign

 

 

(129

)

 

 

(929

)

 

 

—

 

Total deferred income tax expense / (benefit)

 

 

(129

)

 

 

(929

)

 

 

—

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total income tax expense / (benefit)

 

$

1,599

 

 

$

768

 

 

$

1,408

 

 

Income tax expense differs from the amount computed by applying the statutory federal income tax rate as follows:

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Tax at statutory federal rate

 

 

21.0

%

 

 

21.0

%

 

 

34.0

%

State tax, net of federal benefit

 

 

(0.1

)%

 

 

(0.4

)%

 

 

(0.4

)%

Foreign rate differential

 

 

(0.7

)%

 

 

(1.0

)%

 

 

0.5

%

Tax credits

 

 

3.0

%

 

 

2.8

%

 

 

4.5

%

Excess tax benefits related to stock-based compensation

 

 

3.8

%

 

 

2.0

%

 

 

21.5

%

Effect of Tax Cuts and Jobs Act of 2017

 

 

—

%

 

 

—

%

 

 

(121.1

)%

Change in valuation allowance

 

 

(26.4

)%

 

 

(21.2

)%

 

 

61.4

%

Other

 

 

(2.2

)%

 

 

(4.9

)%

 

 

(4.4

)%

Total

 

 

(1.6

)%

 

 

(1.7

)%

 

 

(4.0

)%

 

The tax effects of temporary differences and carryforwards that give rise to significant portions of deferred tax assets and liabilities are as follows:

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

 

 

(in thousands)

 

Net operating loss carryforwards

 

$

94,680

 

 

$

68,552

 

Tax credits

 

 

17,095

 

 

 

12,451

 

Depreciation

 

 

463

 

 

 

339

 

Stock-based compensation

 

 

9,372

 

 

 

10,770

 

Accruals and reserves

 

 

9,569

 

 

 

7,507

 

Lease liabilities

 

 

5,887

 

 

 

—

 

Other

 

 

1,096

 

 

 

2,057

 

Deferred tax assets

 

 

138,162

 

 

 

101,676

 

 

 

 

 

 

 

 

 

 

Right of use asset

 

 

(5,294

)

 

 

—

 

Deferred tax liabilities

 

 

(5,294

)

 

 

—

 

 

 

 

 

 

 

 

 

 

Valuation allowance

 

 

(131,807

)

 

 

(100,747

)

 

 

 

 

 

 

 

 

 

Net deferred tax assets

 

$

1,061

 

 

$

929

 

Realization of deferred tax assets is dependent upon future earnings, if any, the timing and amount of which are uncertain. Accordingly, substantially all of the net deferred tax assets have been offset by a valuation allowance. The valuation allowance increased by $31.1 million and $12.6 million for the years ended December 31, 2019 and 2018, respectively.

As of December 31, 2019, the Company had federal net operating loss carryforwards (NOLs) of approximately $398.5 million, of which $139.5 million was generated in fiscal year 2018 and thereafter, which can be carried forward indefinitely under the 2017 Tax Act, as well as state NOLs of approximately $194.8 million, of which $22.1 million may be carried forward indefinitely. If not utilized, the remaining federal NOLs will begin to expire in 2026, and the remaining state NOLs will begin to expire in 2020.

As of December 31, 2019, the Company had research and development credit carryforwards of approximately $13.7 million and $9.2 million for federal and California state income tax purposes, respectively. The federal credit carryforward begins expiring in 2026, and the state credits carry forward indefinitely.

Under Section 382 of the Internal Revenue Code of 1986, as amended, the Company’s ability to utilize NOLs or other tax attributes such as research tax credits, in any taxable year may be limited if the Company experiences, or has experienced, a Section 382 “ownership change.” A Section 382 “ownership change” generally occurs if one or more stockholders or groups of stockholders, who own at least 5% of the Company’s stock, increase their ownership by a greater than 50 percentage point change (by value) over a rolling three-year period. Similar rules may apply under state tax laws. As a result of the Company’s June 2015 underwritten public offering, the Company experienced a Section 382 “ownership change.”  The Company currently estimates that this “ownership change” will not inhibit its ability to utilize its NOLs. However, the Company may, in the future, experience one or more additional Section 382 “ownership changes” as a result of subsequent changes in its stock ownership, some of which changes are outside the Company’s control.  If so, the Company may not be able to utilize a material portion of its NOLs and tax credits, even if the Company achieves profitability.

The Company had unrecognized tax benefits (UTBs) of approximately $7.4 million as of December 31, 2019. The following table summarizes the activity related to UTBs (in thousands):

 

Balance at December 31, 2016

 

$

3,384

 

Increases related to current year tax provisions

 

 

790

 

Increases related to prior year tax provisions

 

 

193

 

Decreases related to prior year tax provisions

 

 

(134

)

Balance at December 31, 2017

 

 

4,233

 

Increases related to current year tax provisions

 

 

893

 

Increases related to prior year tax provisions

 

 

80

 

Decreases related to prior year tax provisions

 

 

(6

)

Balance at December 31, 2018

 

 

5,200

 

Increases related to current year tax provisions

 

 

1,611

 

Increases related to prior year tax provisions

 

 

572

 

Decreases related to prior year tax provisions

 

 

—

 

Balance at December 31, 2019

 

$

7,383

 

 

If these UTBs were recognized, approximately $7.4 million would affect the effective tax rate before consideration of the valuation allowance. The Company does not expect any material changes to the estimated amount of liability associated with its uncertain tax positions within the next twelve months.

In accordance with ASC 740, Income Taxes, the Company is classifying interest and penalties as a component of tax expense. There was a nominal amount of interest and penalties accrued at December 31, 2019.  There were no interest or penalties accrued at December 31, 2018 and December 31, 2017.

The Company files U.S. federal and state income tax and foreign income tax returns with varying statues of limitations. The Company’s U.S. federal and state tax years from inception in 2006 will remain open to examination

due to the carryover of the unused NOLs and tax credits. The Company does not have any tax audits or other proceedings pending.
XML 107 R86.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Employee Benefit Plan - Additional Information (Detail) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Compensation And Retirement Disclosure [Abstract]      
Expense for matching contributions $ 3.1 $ 2.5 $ 2.2
XML 108 R76.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation - Summary of Stock-Based Compensation Expense Not Yet Recognized (Detail)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
USD ($)
Stock Options [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized Compensation $ 14,720
Weighted-Average Amortization Period (in years) 2 years 8 months 12 days
Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized Compensation $ 62,680
Weighted-Average Amortization Period (in years) 2 years 7 months 6 days
Employee Stock Purchase Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized Compensation $ 1,262
Weighted-Average Amortization Period (in years) 4 months 24 days
XML 109 R72.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation - Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation Model (Detail)
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Stock Options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected term (in years) 5 years 8 months 12 days 5 years 6 months 5 years 6 months
Expected volatility, minimum 51.00% 44.00% 44.00%
Expected volatility, maximum 52.00% 51.00% 46.00%
Risk-free interest rate, minimum 1.40% 2.30% 1.80%
Risk-free interest rate, maximum 2.60% 2.90% 2.20%
Dividend Yield 0.00% 0.00% 0.00%
ESPP [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Expected term (in years) 6 months 6 months 6 months
Expected volatility, minimum 48.00% 44.00% 36.00%
Expected volatility, maximum 61.00% 57.00% 37.00%
Risk-free interest rate, minimum 1.60% 2.10% 1.00%
Risk-free interest rate, maximum 2.40% 2.50% 1.40%
Dividend Yield 0.00% 0.00% 0.00%
XML 110 R8.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Summary of Significant Accounting Policies
 12 Months Ended
Dec. 31, 2019
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Basis of Presentation

These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the U.S. (U.S. GAAP). The consolidated financial statements include the Company’s accounts and those of its four wholly owned subsidiaries. All intercompany accounts and transactions have been eliminated.

Segments

The chief operating decision maker for the Company is the Chief Executive Officer. The Chief Executive Officer reviews financial information presented on a consolidated basis, accompanied only by information about revenue by geographic region, for purposes of allocating resources and evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level, other than revenue. Accordingly, the Company has determined that it has a single reportable and operating segment structure. The Company and its Chief Executive Officer evaluate performance based primarily on revenue in the geographic locations in which the Company operates. 

Until 2015, the Company had derived most of its revenue from sales to customers in Australia and Europe.  In May 2015, the U.S. Food and Drug Administration (FDA) approved the Company’s premarket approval (PMA) application to market Senza in the United States and the Company launched sales in the United States in 2015. Revenue by geography is based on the billing address of the customer. The United States is the only country that accounts for 10% or more of the revenue during the periods presented:

 

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

United States

 

 

84

%

 

 

83

%

 

 

81

%

 

Long-lived assets and operating income outside the United States are not material; therefore, disclosures have been limited to revenue.

Foreign Currency Translation

The Company’s consolidated financial statements are prepared in U.S. dollars (USD). Its foreign subsidiaries use their local currency as their functional currency and maintain their records in the local currency. Accordingly, the assets and liabilities of these subsidiaries are translated into USD using the current exchange rates in effect at the balance sheet date and equity accounts are translated into USD using historical rates. Revenues and expenses are translated using the monthly average exchange rates during the period when the transaction occurs. The resulting foreign currency translation adjustments from this process are recorded in accumulated other comprehensive income (loss) in the consolidated balance sheets. Unrealized foreign exchange gains and losses from the remeasurement of assets and liabilities denominated in currencies other than the functional currency of the reporting entity are recorded in other income (expense), net. The Company recorded net unrealized foreign currency transaction gains of $1.0 million during the year ended December 31, 2019, losses of $0.6 million during the year ended December 31, 2018 and gains of $0.8 million during the year ended December 31, 2017. Additionally, realized gains and losses resulting from transactions denominated in currencies other than the local currency are recorded in other income (expense), net. The Company recorded realized foreign currency transaction losses of $1.6 million during the year ended December 31, 2019, losses of $0.4 million during the year ended December 31, 2018 and gains of $0.5 million during the year ended December 31, 2017.

To the extent that the Company’s international operations grow, the effect of fluctuations in currency rates will become greater, and the Company will continue to reassess its approach to managing this risk. In addition, currency fluctuations or a weakening U.S. dollar can increase the costs of the Company’s international expansion. To date, the Company has not entered into any foreign currency hedging contracts. Based on its current international structure, the Company does not plan on engaging in hedging activities in the near future.

Use of Estimates

The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Significant accounting estimates and management judgments reflected in the consolidated financial statements include items such as allowances for doubtful accounts; warranty obligations; stock-based compensation; depreciation and amortization lives; inventory valuation; valuation

of investments and accounting for income taxes. Estimates are based on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.

Concentration of Credit Risk and Other Risks and Uncertainties

Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash, cash equivalents and investments. The majority of the Company’s cash is held by one financial institution in the United States in excess of federally insured limits. The Company maintained investments in money market funds that were not federally insured during the years ended December 31, 2019 and 2018, and held cash in foreign banks of approximately $12.1 million and $4.1 million at December 31, 2019 and 2018, respectively, that was not federally insured. The Company has not experienced any losses on its deposits of cash and cash equivalents.

The Company’s convertible note hedge transactions, entered into in connection with the 2021 Notes, subject the Company to credit risk such that the counterparties may be unable to fulfill the terms of the transactions.  The associated risk is mitigated by limiting the counterparties to major financial institutions.

In the international markets in which the Company participates, the Company uses both a direct sales force and distributors to sell its products, while in the United States the Company utilizes a direct sales force. The Company performs ongoing credit evaluations of some of its direct customers and distributors, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.

There were no customers that accounted for 10% or more of the Company’s revenue for each of the years ended December 31, 2019, 2018 and 2017.  Additionally, there were no customers that accounted for 10% or more of the Company’s accounts receivable balance as of December 31, 2019 and 2018.

The Company is subject to risks common to medical device companies including, but not limited to, new technological innovations, dependence on key personnel, protection of proprietary technology, compliance with government regulations, product liability, uncertainty of market acceptance of products and the need to obtain additional financing. The Company is dependent on third party manufacturers and suppliers, in some cases sole- or single-source suppliers.

There can be no assurance that the Company’s products or services will continue to be accepted in the marketplace, nor can there be any assurance that any future products or services can be developed or manufactured at an acceptable cost and with appropriate performance characteristics, or that such products or services will be successfully marketed, if at all.

The Company expects to incur operating losses in the near term and may need to obtain additional financing. There can be no assurance that such financing will be available or will be at terms acceptable by the Company.

Fair Value of Financial Instruments

Carrying amounts of certain of the Company’s financial instruments, including cash equivalents, short term investments, accounts receivable, accounts payable and accrued liabilities approximate fair value due to their relatively short maturities.

Cash and Cash Equivalents

The Company considers all highly liquid investments purchased with an original maturity of three months or less at the date of purchase to be cash equivalents. Cash and cash equivalents include money market funds in the amount of $52.4 million and $15.6 million as of December 31, 2019 and 2018, respectively. At December 31, 2019 and 2018, the Company’s cash equivalents were held in institutions in the United States and include deposits in a money market fund which were unrestricted as to withdrawal or use.

Restricted Cash

Restricted cash as of December 31, 2019 and 2018 includes certificates of deposit of $0.6 million representing collateral for the Company’s Redwood City, CA building lease pursuant to an agreement dated March 5, 2015.  Restricted cash as of December 31, 2019 additionally includes certificates of deposit of $0.4 million collateralizing payment of charges related to the Company’s credit cards.

Investment Securities

The Company classifies its investment securities as available-for-sale. The Company classifies these investment securities as short-term or long-term based on the nature of the investment, its maturity date and its availability for use in current operations. Those investments with original maturities greater than three months at the date of purchase and remaining maturities of less than 12 months are considered short-term investments. Those investments with remaining maturities greater than 12 months are also classified as short-term investments as management considers them to be available for current operations if needed. The Company’s investment securities are recorded at fair value based on the fair value hierarchy.  Money market funds are classified within Level 1 of the fair value hierarchy, and commercial paper and corporate notes are classified within Level 2 of the fair value hierarchy. Unrealized gains and losses, deemed temporary in nature, are reported as a separate component of accumulated other comprehensive income (loss).

A decline in the fair value of any security below cost that is deemed other than temporary results in a charge to earnings and the corresponding establishment of a new cost basis for the security. Premiums (discounts) are amortized (accreted) over the life of the related security as an adjustment to yield using the straight-line interest method. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification method for determining the cost of securities sold.

Inventories

Inventories are stated at the lower of cost or net realizable value. Cost is determined using the standard cost method which approximates the first-in, first-out basis. Net realizable value is determined as the prices in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company regularly reviews inventory quantities compared to forecasted sales to record a provision for excess and obsolete inventory when appropriate. Inventory write-downs are recorded for excess and obsolete inventory. The Company estimates forecasted sales by considering product acceptance in the marketplace, customer demand, historical sales, product obsolescence and technological innovations.

The Company’s policy is to write down inventory that has become obsolete, inventory that has a cost basis in excess of its expected lower of cost or net realizable value, and inventory in excess of expected requirements. The estimate of excess quantities is judgmental and primarily dependent on the Company’s estimates of future demand for a particular product. If the estimate of future demand is inaccurate based on actual sales, the Company may increase the write-down for excess inventory for that component and record a charge to inventory impairment in the accompanying consolidated statements of operations and comprehensive loss. The Company periodically evaluates the carrying value of inventory on hand for potential excess amount over demand using the same lower of cost or net realizable value approach as that has been used to value the inventory. The Company also periodically evaluates inventory quantities in consideration of actual loss experience. As a result of these evaluations, for the year ended December 31, 2019, the Company recognized total write-downs of $1.6 million for its inventories.  For the years ended December 31, 2018 and 2017, the Company recognized total write-downs of $2.0 million and $4.0 million for its inventories. The Company’s estimation of the future demand for a particular component of the Company’s products may vary and may result in changes in estimates in any particular period.

Shipping and Handling Costs

Shipping and handling costs are expensed as incurred and are included in cost of revenue.

Revenue Recognition

The Company has revenue arrangements that generally consist of a single performance obligation, although, in some instances, revenue arrangements may consist of two performance obligations. The Company recognizes revenue at the point in time when it transfers control of promised goods to its customers.  Revenue is measured as the amount of consideration it expects to receive in exchange for transferring goods.

See Note 3 for further discussion on Revenue Recognition.

Allowance for Doubtful Accounts

The Company makes estimates of the collectability of accounts receivable. In doing so, the Company analyzes historical bad debt trends, customer credit worthiness, current economic trends and changes in customer payment patterns when evaluating the adequacy of the allowance for doubtful accounts.

Property and Equipment

Property and equipment are stated at cost less accumulated depreciation and amortization. Depreciation of property and equipment, other than leasehold improvements, is computed using the straight-line method over the assets’ estimated useful lives of three to five years. Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the life of the lease. Upon retirement or sale, the cost and related accumulated depreciation are removed from the consolidated balance sheet and the resulting gain or loss is reflected in operations. Maintenance and repairs are charged to operations as incurred.

Impairment of Long-Lived Assets

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group might not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net cash flows to the related asset group’s carrying value. If an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. There were no impairment charges, or changes in estimated useful lives, recorded through December 31, 2019.

Income Taxes

The Company records income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s consolidated financial statements or income tax returns. In estimating future tax consequences, expected future events other than enactments or changes in the tax law or rates are considered. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized.

The Company operates in various tax jurisdictions and is subject to audit by various tax authorities. To date, taxes paid have been predominantly due to income taxes in foreign and state jurisdictions in which we conduct business. The Company provides for tax contingencies whenever it is deemed probable that a tax asset has been impaired or a tax liability has been incurred for events such as tax claims or changes in tax laws. Tax contingencies are based upon their technical merits, relative tax law, and the specific facts and circumstances as of each reporting period. Changes in facts and circumstances could result in material changes to the amounts recorded for such tax contingencies.

The Company records uncertain tax positions on the basis of a two-step process whereby (1) a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. The Company’s policy is to recognize interest and penalties related to income taxes as a component of income tax expense. A nominal amount of interest and penalties have been recognized in the

statements of operations and comprehensive loss in 2019. No interest or penalties related to income taxes have been recognized in the statements of operations and comprehensive loss in 2018 and 2017.

On December 22, 2017, the 2017 Tax Cuts and Jobs Act (the 2017 Tax Act) was enacted into law.  The recorded impact for the effects of the 2017 Tax Act is based on the Company’s current knowledge, assumptions and interpretations of available guidance.  The Company elected to account for Global Intangible Low-Tax Income (GILTI) as a current period expense when incurred.  The Company will continue to monitor the issuance of additional regulatory or accounting guidance and record any necessary adjustments in the period for which additional guidance is issued.

Other Comprehensive Income (Loss)

Other comprehensive income (loss) represents all changes in stockholders’ equity except those resulting from distributions to stockholders. The Company’s unrealized gains on short-term available-for-sale investment securities and foreign currency translation adjustments represent the components of other comprehensive income (loss) that are excluded from the reported net loss and are presented in the consolidated statements of operations and comprehensive loss.

Research and Development

Research and development expenses, including new product development, regulatory compliance, and clinical research, are charged to operations as incurred in the consolidated statements of operations and comprehensive loss. Such costs include personnel-related costs, including stock-based compensation, supplies, services, depreciation, allocated facilities and information services, clinical trial and related clinical manufacturing expenses, fees paid to investigative sites, and other indirect costs.

Stock-Based Compensation

The Company accounts for stock-based compensation arrangements with employees in accordance with Accounting Standards Codification (ASC) 718, Compensation—Stock Compensation. ASC 718 requires the recognition of compensation expense, using a fair value-based method, for costs related to all share-based payments including stock options.

In March 2016, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2016-09, Stock Compensation (Topic 718): Improvements to Employee Shared-Based Payment Accounting, which the Company adopted on January 1, 2017.  Under ASU 2016-09, entities are permitted to make an accounting policy election to either estimate forfeitures on share-based payment awards, as previously required, or to recognize forfeitures as they occur. The Company has elected to continue to estimate forfeitures expected to occur to determine the amount of compensation cost recognized in each period.  ASU 2016-09 also requires that entities recognize, on a prospective basis, all excess tax benefits and tax deficiencies as income tax expense or benefit in the income statement as discrete items in the reporting period in which they occur. The adoption did not result in a cumulative-effect adjustment to accumulated deficit as of January 1, 2017 using the modified retrospective method. Additionally, under ASU 2016-09, excess tax benefits are classified as an operating activity in the statement of cash flows. The Company has elected the presentation of excess tax benefits in the statement of cash flows using the prospective transition method.

The Company’s determination of the fair value of stock options, other than performance-based awards, on the date of grant utilizes the Black-Scholes option-pricing model, and is impacted by its common stock price as well as changes in assumptions regarding a number of highly complex and subjective variables. These variables include, but are not limited to, the expected term that options will remain outstanding, the expected common stock price volatility over the term of the option awards, risk-free interest rates and expected dividends.

The fair value of stock options is recognized over the period during which an optionee is required to provide services in exchange for the option award, known as the requisite service period (usually the vesting period), on a straight-line basis. Stock-based compensation expense recognized at fair value includes the impact of estimated

forfeitures. The Company estimates future forfeitures at the date of grant and revises the estimates, if necessary, in subsequent periods if actual forfeitures differ from those estimates.

The Company estimates the fair value of the rights to purchase shares by employees under the Employee Stock Purchase Plan using the Black-Scholes option pricing formula. The Employee Stock Purchase Plan provides for consecutive six-month offering periods and the Company uses its own historical volatility data in the valuation.

Equity instruments issued to non-employees are recorded at their fair value on the measurement date and are subject to periodic adjustments as the underlying equity instruments vest. The fair value of options granted to consultants is expensed when vested. The non-employee stock-based compensation expense was not material for all periods presented.

The Company accounts for stock-based compensation for the restricted stock units at their fair value, based on the closing market price of the Company’s common stock on the grant date.  These costs are recognized on a straight-line basis over the requisite service period, which is generally the vesting term of four years.

The Company also issues stock options and restricted stock units with vesting based upon achievement of specific operational performance criteria. The fair value for these performance-based awards is recognized over the period during which the goals are to be achieved.  Stock-based compensation expense recognized at fair value includes the impact of estimated probability that the goals would be achieved, which is assessed prior to the requisite service period for the specific goals.

The Company additionally grants restricted stock units with vesting based on its stock price performance compared to a specified target composite index over a certain period.  The fair value of these grants is determined by using the Monte Carlo simulation model, which is based on a discounted cash flow approach, and requires inputs such as expected volatility of our stock price, expected volatility of the targeted composite index, correlation between the changes in our stock price and the target composite index, risk-free interest rate and expected dividends.  The expected volatility of our stock and the target composite index is based on the historical data. Correlation is based on the historical relationship between our stock price and the target composite index. The risk-free interest rate is based upon the treasury yield consistent with the vesting term of the grant. The expected dividend yield is zero. Stock-based compensation for these restricted stock units is recognized over the specified performance measurement period.

Upon adoption of ASU 2016-09 as described above, excess tax benefits or deficiencies from share-based award activity are reflected in the consolidated statements of operations as a component of the provision for income taxes, whereas they were previously recognized as additional paid-in capital.

Net Loss per Share of Common Stock

Basic net loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net loss per share is computed by dividing net loss by the weighted-average number of common shares and potentially dilutive securities outstanding for the period. For purposes of the diluted net loss per share calculation, restricted stock units and common stock options are considered to be potentially dilutive securities. Because the Company has reported a net loss in all periods presented, diluted net loss per common share is the same as basic net loss per common share for those periods.

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which requires the measurement and recognition of expected credit losses for financial assets held. The FASB has also issued several updates to ASU 2016-13.  These ASU’s are effective for public entities for annual periods beginning after December 15, 2019, with early adoption permitted. The Company has not determined the potential effects of the guidance on its consolidated financial statements.

In December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes. This ASU eliminates certain exceptions related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences related to changes in ownership of equity method investments and foreign subsidiaries. ASU 2019-12 also simplifies aspects of accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill. ASU 2019-12 is effective for public entities for annual periods beginning after December 15, 2020, with early adoption permitted. The Company has not determined the potential effects of the guidance on its consolidated financial statements.
XML 111 R82.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes - Summary of Unrecognized Tax Benefits (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Income Tax Disclosure [Abstract]      
Beginning balance $ 5,200 $ 4,233 $ 3,384
Increases related to current year tax provisions 1,611 893 790
Increases related to prior year tax provisions 572 80 193
Decreases related to prior year tax provisions   (6) (134)
Ending balance $ 7,383 $ 5,200 $ 4,233
XML 112 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Income Statement [Abstract]      
Revenue $ 390,255 $ 387,289 $ 326,674
Cost of revenue 121,905 113,965 98,981
Gross profit 268,350 273,324 227,693
Operating expenses      
Research and development 59,017 48,459 37,560
Sales, general and administrative 305,812 266,608 219,712
Total operating expenses 364,829 315,067 257,272
Loss from operations (96,479) (41,743) (29,579)
Interest income 6,020 4,871 3,164
Interest expense (10,931) (10,401) (9,902)
Other income (expense), net (697) (1,164) 1,067
Loss before income taxes (102,087) (48,437) (35,250)
Provision for income taxes 1,599 768 1,408
Net loss (103,686) (49,205) (36,658)
Other comprehensive loss:      
Changes in foreign currency translation adjustment 449 (37) (360)
Changes in unrealized gains (losses) on short-term investments, net 315 202 (204)
Net change in other comprehensive loss 764 165 (564)
Comprehensive loss $ (102,922) $ (49,040) $ (37,222)
Net loss per share, basic and diluted $ (3.37) $ (1.64) $ (1.25)
Weighted average number of common shares used to compute basic and diluted net loss per share 30,803,872 30,051,961 29,424,054
XML 114 R51.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Fair Value Measurements - Financial Instruments Measured at Fair Value on Recurring Basis (Detail) - Fair Value Measurements Recurring [Member] - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets $ 224,788 $ 246,706
Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 52,359 15,572
Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 172,429 231,134
Money Market Funds [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets [1] 52,359 15,572
Money Market Funds [Member] | Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets [1] 52,359 15,572
Bonds [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets [2] 17,246  
Bonds [Member] | Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets [2] 17,246  
Commercial Paper [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 12,449 [2] 119,602 [3]
Commercial Paper [Member] | Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 12,449 [2] 119,602 [3]
Corporate Notes [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 142,734 [2] 111,532 [3]
Corporate Notes [Member] | Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets $ 142,734 [2] $ 111,532 [3]
[1] Included in cash and cash equivalents on the consolidated balance sheets.
[2] Included in short-term investments on the consolidated balance sheets.
[3] Included in either cash and cash equivalents or short-term investments on the consolidated balance sheets.
XML 115 R55.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Balance Sheet Components - Schedule of Property and Equipment, Net (Detail) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 24,772 $ 21,557
Less: Accumulated depreciation and amortization (13,006) (8,756)
Property and equipment, net 11,766 12,801
Laboratory Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 5,733 2,874
Computer Equipment and Software [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 9,909 8,751
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 3,898 3,903
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross 4,226 4,218
Construction in Process [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, gross $ 1,006 $ 1,811
JSON 116 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "nvro-10k_20191231.htm": { "axisCustom": 0, "axisStandard": 35, "contextCount": 257, "dts": { "calculationLink": { "local": [ "nvro-20191231_cal.xml" ] }, "definitionLink": { "local": [ "nvro-20191231_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "nvro-10k_20191231.htm" ] }, "labelLink": { "local": [ "nvro-20191231_lab.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-doc-2019-01-31.xml", "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "nvro-20191231_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-ref-2019-01-31.xml", "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "nvro-20191231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "https://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-parts-codification-2019-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 699, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2019-01-31": 62, "http://www.nevro.com/20191231": 8, "http://xbrl.sec.gov/dei/2019-01-31": 6, "total": 76 }, "keyCustom": 70, "keyStandard": 447, "memberCustom": 31, "memberStandard": 53, "nsprefix": "nvro", "nsuri": "http://www.nevro.com/20191231", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100090 - Disclosure - Lease Accounting", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccounting", "shortName": "Lease Accounting", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100100 - Disclosure - Fair Value Measurements", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100110 - Disclosure - Balance Sheet Components", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponents", "shortName": "Balance Sheet Components", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100120 - Disclosure - Commitments and Contingencies", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100130 - Disclosure - Long-term Debt", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebt", "shortName": "Long-term Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100140 - Disclosure - Convertible Preferred Stock", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureConvertiblePreferredStock", "shortName": "Convertible Preferred Stock", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100150 - Disclosure - Stock-Based Compensation", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensation", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100160 - Disclosure - Income Taxes", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100170 - Disclosure - Net Loss Per Share", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShare", "shortName": "Net Loss Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100180 - Disclosure - Employee Benefit Plan", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureEmployeeBenefitPlan", "shortName": "Employee Benefit Plan", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010 - Statement - Consolidated Balance Sheets", "role": "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100190 - Disclosure - Selected Quarterly Financial Information", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureSelectedQuarterlyFinancialInformation", "shortName": "Selected Quarterly Financial Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:QuarterlyFinancialInformationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100200 - Disclosure - Summary of Significant Accounting Policies (Policies)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "p", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100210 - Disclosure - Summary of Significant Accounting Policies (Tables)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100220 - Disclosure - Revenue (Tables)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "nvro:ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100230 - Disclosure - Lease Accounting (Tables)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingTables", "shortName": "Lease Accounting (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "nvro:ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100240 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "p", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100250 - Disclosure - Balance Sheet Components (Tables)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsTables", "shortName": "Balance Sheet Components (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100260 - Disclosure - Commitments and Contingencies (Tables)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables", "shortName": "Commitments and Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "nvro:InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100270 - Disclosure - Long-term Debt (Tables)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtTables", "shortName": "Long-term Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "nvro:InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "nvro:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100280 - Disclosure - Stock-Based Compensation (Tables)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationTables", "shortName": "Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "nvro:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100020 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100290 - Disclosure - Income Taxes (Tables)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTables", "shortName": "Income Taxes (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100300 - Disclosure - Net Loss Per Share (Tables)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareTables", "shortName": "Net Loss Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:QuarterlyFinancialInformationTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100310 - Disclosure - Selected Quarterly Financial Information (Tables)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureSelectedQuarterlyFinancialInformationTables", "shortName": "Selected Quarterly Financial Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:QuarterlyFinancialInformationTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "us-gaap:QuarterlyFinancialInformationTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191001_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100320 - Disclosure - Formation and Business of the Company - Additional Information (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail", "shortName": "Formation and Business of the Company - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R34": { "firstAnchor": { "ancestors": [ "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20150601_20150630", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100330 - Disclosure - Formation and Business of the Company - Additional Information - Public Offering (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail", "shortName": "Formation and Business of the Company - Additional Information - Public Offering (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20150601_20150630", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "INF", "first": true, "lang": null, "name": "nvro:NumberOfWhollyOwnedSubsidiaries", "reportCount": 1, "unique": true, "unitRef": "U_nvroSubsidiary", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100340 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "shortName": "Summary of Significant Accounting Policies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "INF", "first": true, "lang": null, "name": "nvro:NumberOfWhollyOwnedSubsidiaries", "reportCount": 1, "unique": true, "unitRef": "U_nvroSubsidiary", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_srtStatementGeographicalAxis_countryUS_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapGeographicConcentrationRiskMember_20190101_20191231", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100350 - Disclosure - Summary of Significant Accounting Policies - Schedule of Revenue by Major Customers by Geographic Area (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueByMajorCustomersByGeographicAreaDetail", "shortName": "Summary of Significant Accounting Policies - Schedule of Revenue by Major Customers by Geographic Area (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:SegmentReportingPolicyPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_srtStatementGeographicalAxis_countryUS_us-gaapConcentrationRiskByBenchmarkAxis_us-gaapSalesRevenueNetMember_us-gaapConcentrationRiskByTypeAxis_us-gaapGeographicConcentrationRiskMember_20190101_20191231", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ConcentrationRiskPercentage1", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100360 - Disclosure - Revenue - Cumulative Effect of Changes to Consolidated Balance Sheet (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueCumulativeEffectOfChangesToConsolidatedBalanceSheetDetail", "shortName": "Revenue - Cumulative Effect of Changes to Consolidated Balance Sheet (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20171231", "decimals": "-3", "lang": null, "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100370 - Disclosure - Revenue - Impact of Adoption on Consolidated Balance Sheet (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedBalanceSheetDetail", "shortName": "Revenue - Impact of Adoption on Consolidated Balance Sheet (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_us-gaapInitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaapCalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member_20181231", "decimals": "-3", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "us-gaap:QuarterlyFinancialInformationTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191001_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100380 - Disclosure - Revenue - Impact of Adoption on Consolidated Statement of Operations (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedStatementOfOperationsDetail", "shortName": "Revenue - Impact of Adoption on Consolidated Statement of Operations (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201409Member_us-gaapInitialApplicationPeriodCumulativeEffectTransitionAxis_us-gaapCalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member_20180101_20181231", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100030 - Statement - Consolidated Statements of Operations and Comprehensive Loss", "role": "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss", "shortName": "Consolidated Statements of Operations and Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-3", "lang": null, "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "us-gaap:QuarterlyFinancialInformationTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191001_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100390 - Disclosure - Revenue - Summary of Revenue by Geography on Billing Address of Customer (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail", "shortName": "Revenue - Summary of Revenue by Geography on Billing Address of Customer (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_srtStatementGeographicalAxis_countryUS_20190101_20191231", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100400 - Disclosure - Revenue - Additional Information (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail", "shortName": "Revenue - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2020-01-01_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100410 - Disclosure - Revenue - Additional Information (Detail1)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail1", "shortName": "Revenue - Additional Information (Detail1)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapRevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_2020-01-01_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100420 - Disclosure - Lease Accounting - Additional Information (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingAdditionalInformationDetail", "shortName": "Lease Accounting - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_20191231", "decimals": "-5", "lang": null, "name": "us-gaap:OperatingLeaseLiability", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100430 - Disclosure - Lease Accounting - Schedule of Impact of Changes Made to the Consolidated Balance Sheet from the Adoption of ASC 842 (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfImpactOfChangesMadeToConsolidatedBalanceSheetFromAdoptionOfASC842Detail", "shortName": "Lease Accounting - Schedule of Impact of Changes Made to the Consolidated Balance Sheet from the Adoption of ASC 842 (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapAdjustmentsForNewAccountingPronouncementsAxis_us-gaapAccountingStandardsUpdate201602Member_20190101", "decimals": "-3", "lang": null, "name": "us-gaap:OtherLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "nvro:ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100440 - Disclosure - Lease Accounting - Schedule of Weighted Average Lease Terms and Discounts Rates (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesDetail", "shortName": "Lease Accounting - Schedule of Weighted Average Lease Terms and Discounts Rates (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "nvro:ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100450 - Disclosure - Lease Accounting - Schedule of Maturity of Lease Liabilities (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfMaturityOfLeaseLiabilitiesDetail", "shortName": "Lease Accounting - Schedule of Maturity of Lease Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100460 - Disclosure - Lease Accounting - Supplemental Lease Cost Information (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingSupplementalLeaseCostInformationDetail", "shortName": "Lease Accounting - Supplemental Lease Cost Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100470 - Disclosure - Lease Accounting - Summary of Operating Lease Assets and Liabilities (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail", "shortName": "Lease Accounting - Summary of Operating Lease Assets and Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "lang": null, "name": "us-gaap:OperatingLeaseLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "nvro:ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100480 - Disclosure - Lease Accounting - Schedule of Supplemental Cash Flow Information Related to Lease (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetail", "shortName": "Lease Accounting - Schedule of Supplemental Cash Flow Information Related to Lease (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "nvro:ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20161231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040 - Statement - Consolidated Statements of Stockholders' Equity", "role": "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity", "shortName": "Consolidated Statements of Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20161231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160630", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage", "reportCount": 1, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100490 - Disclosure - Fair Value Measurements - Additional Information (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail", "shortName": "Fair Value Measurements - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20191231", "decimals": "-5", "lang": null, "name": "us-gaap:DebtInstrumentFairValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100500 - Disclosure - Fair Value Measurements - Financial Instruments Measured at Fair Value on Recurring Basis (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail", "shortName": "Fair Value Measurements - Financial Instruments Measured at Fair Value on Recurring Basis (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapFairValueByMeasurementFrequencyAxis_us-gaapFairValueMeasurementsRecurringMember_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100510 - Disclosure - Balance Sheet Components - Summary of Gross Unrealized Gains and Unrealized Losses of Investment Securities Excluding Investments in Money Market Funds (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail", "shortName": "Balance Sheet Components - Summary of Gross Unrealized Gains and Unrealized Losses of Investment Securities Excluding Investments in Money Market Funds (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "lang": null, "name": "us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100520 - Disclosure - Balance Sheet Components - Summary of Contractual Maturities of Investment Securities (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail", "shortName": "Balance Sheet Components - Summary of Contractual Maturities of Investment Securities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100530 - Disclosure - Balance Sheet Components - Components of Inventories (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail", "shortName": "Balance Sheet Components - Components of Inventories (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsNetOfReserves", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100540 - Disclosure - Balance Sheet Components - Schedule of Property and Equipment, Net (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail", "shortName": "Balance Sheet Components - Schedule of Property and Equipment, Net (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DepreciationDepletionAndAmortization", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100550 - Disclosure - Balance Sheet Components - Additional Information (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail", "shortName": "Balance Sheet Components - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": null }, "R57": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100560 - Disclosure - Balance Sheet Components - Summary of Accrued Liabilities (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail", "shortName": "Balance Sheet Components - Summary of Accrued Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StandardProductWarrantyDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100570 - Disclosure - Commitments and Contingencies - Additional Information (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "shortName": "Commitments and Contingencies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StandardProductWarrantyDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20181231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StandardProductWarrantyAccrualCurrent", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100580 - Disclosure - Commitments and Contingencies - Schedule of Activities Related to Warranty Obligations (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfActivitiesRelatedToWarrantyObligationsDetail", "shortName": "Commitments and Contingencies - Schedule of Activities Related to Warranty Obligations (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-3", "lang": null, "name": "us-gaap:StandardProductWarrantyAccrualWarrantiesIssued", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050 - Statement - Consolidated Statements of Cash Flows", "role": "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "p", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160630", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100590 - Disclosure - Long-term Debt - Additional Information (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail", "shortName": "Long-term Debt - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160601_20160630", "decimals": null, "lang": "en-US", "name": "nvro:DebtInstrumentMaturityMonthAndYear", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160630", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredFinanceCostsNoncurrentGross", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100600 - Disclosure - Long-term Debt - Net Carrying Amount of Liability Component of Convertible Debt (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail", "shortName": "Long-term Debt - Net Carrying Amount of Liability Component of Convertible Debt (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_nvroDebtLiabilityComponentMember_20191231", "decimals": "-3", "lang": null, "name": "us-gaap:DebtInstrumentCarryingAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20160630", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100610 - Disclosure - Long-term Debt - Net Carrying Amount of Equity Component of Convertible Debt (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail", "shortName": "Long-term Debt - Net Carrying Amount of Equity Component of Convertible Debt (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ConvertibleDebtTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_us-gaapLongtermDebtTypeAxis_nvroDebtEquityComponentMember_20191231", "decimals": "-3", "lang": null, "name": "nvro:DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "nvro:InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20190101_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InterestExpenseDebtExcludingAmortization", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100620 - Disclosure - Long-term Debt - Interest Expense Recognized Related to Convertible Notes (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail", "shortName": "Long-term Debt - Interest Expense Recognized Related to Convertible Notes (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "nvro:InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapDebtInstrumentAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20190101_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InterestExpenseDebtExcludingAmortization", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesIssued", "us-gaap:PreferredStockSharesIssued", "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesOutstanding", "reportCount": 1, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100630 - Disclosure - Convertible Preferred Stock - Additional Information (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail", "shortName": "Convertible Preferred Stock - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:PreferredStockTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20141110", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockSharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "nvro:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "INF", "first": true, "lang": null, "name": "nvro:CommonStockOptionsAndRestrictedStockUnitsOutstanding", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100640 - Disclosure - Stock-Based Compensation - Summary of Common Stock Reserved for Future Issuance (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail", "shortName": "Stock-Based Compensation - Summary of Common Stock Reserved for Future Issuance (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "nvro:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "INF", "first": true, "lang": null, "name": "nvro:CommonStockOptionsAndRestrictedStockUnitsOutstanding", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "nvro:ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100650 - Disclosure - Stock-Based Compensation - Additional Information (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail", "shortName": "Stock-Based Compensation - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "2", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20181231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "reportCount": 1, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100660 - Disclosure - Stock-Based Compensation - Summary of Shares Available for Grant (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail", "shortName": "Stock-Based Compensation - Summary of Shares Available for Grant (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20161231", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20181231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100670 - Disclosure - Stock-Based Compensation - Summary of Activity under Stock Plans (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail", "shortName": "Stock-Based Compensation - Summary of Activity under Stock Plans (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20191231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100680 - Disclosure - Stock-Based Compensation - Summary of Options Outstanding and Vested Under Stock Plans by Exercise Price (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail", "shortName": "Stock-Based Compensation - Summary of Options Outstanding and Vested Under Stock Plans by Exercise Price (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis_nvroRange1Member_20191231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100060 - Disclosure - Formation and Business of the Company", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompany", "shortName": "Formation and Business of the Company", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20181231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100690 - Disclosure - Stock-Based Compensation - Summary of Restricted Stock Units Under Stock Plan (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail", "shortName": "Stock-Based Compensation - Summary of Restricted Stock Units Under Stock Plan (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapAwardTypeAxis_us-gaapRestrictedStockUnitsRSUMember_20161231", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100700 - Disclosure - Stock-Based Compensation - Schedule of Employee Stock Purchase Plan Activity (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail", "shortName": "Stock-Based Compensation - Schedule of Employee Stock Purchase Plan Activity (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapAwardTypeAxis_nvroEmployeeStockPurchasePlanMember_20190101_20191231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100710 - Disclosure - Stock-Based Compensation - Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation Model (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail", "shortName": "Stock-Based Compensation - Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation Model (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceBasedRestrictedStockUnitsRSUMember_20190101_20191231", "decimals": "2", "first": true, "lang": null, "name": "nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100720 - Disclosure - Stock-Based Compensation - Schedule of Fair Value of Performance Based RUSs based on Monte Carlo Simulation Model (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail", "shortName": "Stock-Based Compensation - Schedule of Fair Value of Performance Based RUSs based on Monte Carlo Simulation Model (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapAwardTypeAxis_nvroPerformanceBasedRestrictedStockUnitsRSUMember_20190101_20191231", "decimals": "2", "first": true, "lang": null, "name": "nvro:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100730 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense by Line Items in Consolidated Statements of Operations (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail", "shortName": "Stock-Based Compensation - Summary of Stock-Based Compensation Expense by Line Items in Consolidated Statements of Operations (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapIncomeStatementLocationAxis_us-gaapCostOfSalesMember_20190101_20191231", "decimals": "-3", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100740 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail", "shortName": "Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20190101_20191231", "decimals": "-3", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100750 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense Not Yet Recognized (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail", "shortName": "Stock-Based Compensation - Summary of Stock-Based Compensation Expense Not Yet Recognized (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapAwardTypeAxis_us-gaapEmployeeStockOptionMember_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100760 - Disclosure - Income Taxes - Components of Loss before Income Taxes (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail", "shortName": "Income Taxes - Components of Loss before Income Taxes (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100770 - Disclosure - Income Taxes - Components of Expense/(Benefit) for Income Taxes (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail", "shortName": "Income Taxes - Components of Expense/(Benefit) for Income Taxes (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CurrentFederalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100780 - Disclosure - Income Taxes - Income Tax Expense by Applying Statutory Federal Income Tax Rate (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail", "shortName": "Income Taxes - Income Tax Expense by Applying Statutory Federal Income Tax Rate (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "U_xbrlipure", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100070 - Disclosure - Summary of Significant Accounting Policies", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100790 - Disclosure - Income Taxes - Tax Effects of Temporary Differences and Carryforwards That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail", "shortName": "Income Taxes - Tax Effects of Temporary Differences and Carryforwards That Give Rise to Significant Portions of Deferred Tax Assets and Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100800 - Disclosure - Income Taxes - Additional Information (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail", "shortName": "Income Taxes - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20181231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100810 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail", "shortName": "Income Taxes - Summary of Unrecognized Tax Benefits (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-3", "lang": null, "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "us-gaap:QuarterlyFinancialInformationTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191001_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100820 - Disclosure - Net Loss Per Share - Computation of Basic and Diluted Net Loss per Share (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail", "shortName": "Net Loss Per Share - Computation of Basic and Diluted Net Loss per Share (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "0", "lang": null, "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100830 - Disclosure - Net Loss Per Share - Computation of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Shares (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail", "shortName": "Net Loss Per Share - Computation of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Shares (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapLongtermDebtTypeAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20191231", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100840 - Disclosure - Net Loss Per Share - Additional Information (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail", "shortName": "Net Loss Per Share - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:EarningsPerShareTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_us-gaapLongtermDebtTypeAxis_nvroOnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember_20191231", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentConvertibleConversionPrice1", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD_xbrlishares", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100850 - Disclosure - Employee Benefit Plan - Additional Information (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureEmployeeBenefitPlanAdditionalInformationDetail", "shortName": "Employee Benefit Plan - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "us-gaap:QuarterlyFinancialInformationTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191001_20191231", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100860 - Disclosure - Selected Quarterly Financial Information - Schedule of Selected Quarterly Financial Information (Detail)", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureSelectedQuarterlyFinancialInformationScheduleOfSelectedQuarterlyFinancialInformationDetail", "shortName": "Selected Quarterly Financial Information - Schedule of Selected Quarterly Financial Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:ScheduleOfQuarterlyFinancialInformationTableTextBlock", "us-gaap:QuarterlyFinancialInformationTextBlock", "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20191001_20191231", "decimals": "-3", "lang": null, "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100080 - Disclosure - Revenue", "role": "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenue", "shortName": "Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "nvro-10k_20191231.htm", "contextRef": "C_0001444380_20190101_20191231", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 87, "tag": { "country_US": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "UNITED STATES", "terseLabel": "United States [Member]" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueByMajorCustomersByGeographicAreaDetail" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r462" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report", "terseLabel": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r461" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r459" ], "lang": { "en-US": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated By Reference [Text Block]", "terseLabel": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r463" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r463" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r463" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r464" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float", "terseLabel": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r463" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r463" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r463" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r463" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers", "terseLabel": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well Known Seasoned Issuer", "terseLabel": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r458" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r460" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "nvro_AccruedClinicalAndResearchExpensesCurrent": { "auth_ref": [], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail": { "order": 10040.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for clinical and research expenses. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Clinical And Research Expenses Current", "terseLabel": "Accrued clinical and research expenses" } } }, "localname": "AccruedClinicalAndResearchExpensesCurrent", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "nvro_AdditionalContingentConsiderationPaymentSecuredByConvertibleNotes": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Additional contingent consideration payment secured by convertible notes.", "label": "Additional Contingent Consideration Payment Secured By Convertible Notes", "terseLabel": "Additional contingent consideration payment secured by convertible notes" } } }, "localname": "AdditionalContingentConsiderationPaymentSecuredByConvertibleNotes", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "nvro_AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Adjustments to additional paid in capital hedge and warrant transactions net cost.", "label": "Adjustments To Additional Paid In Capital Hedge And Warrant Transactions Net Cost", "terseLabel": "Net cost of reduction to additional paid-in capital" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalHedgeAndWarrantTransactionsNetCost", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "nvro_AmortizationOfOperatingLeaseAsset": { "auth_ref": [], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10140.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amortization of operating lease asset.", "label": "Amortization Of Operating Lease Asset", "terseLabel": "Amortization of operating lease assets" } } }, "localname": "AmortizationOfOperatingLeaseAsset", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "nvro_BostonScientificCorporationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boston scientific corporation.", "label": "Boston Scientific Corporation [Member]", "terseLabel": "Boston Scientific Corporation [Member]" } } }, "localname": "BostonScientificCorporationMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cash paid for amounts included in the measurement of lease liabilities abstract.", "label": "Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:" } } }, "localname": "CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetail" ], "xbrltype": "stringItemType" }, "nvro_CollateralizingPaymentChargesRelatedToCreditCardsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Collateralizing payment charges related to credit cards.", "label": "Collateralizing Payment Charges Related To Credit Cards [Member]", "terseLabel": "Collateralizing Payment Charges Related to Credit Cards [Member]" } } }, "localname": "CollateralizingPaymentChargesRelatedToCreditCardsMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_CommonStockOptionsAndRestrictedStockUnitsOutstanding": { "auth_ref": [], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail": { "order": 10010.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Common stock options and restricted stock units outstanding.", "label": "Common Stock Options And Restricted Stock Units Outstanding", "terseLabel": "Outstanding stock options and restricted stock units" } } }, "localname": "CommonStockOptionsAndRestrictedStockUnitsOutstanding", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail" ], "xbrltype": "sharesItemType" }, "nvro_CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan": { "auth_ref": [], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail": { "order": 10030.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Common stock reserved for future issuance under employee stock purchase plan.", "label": "Common Stock Reserved For Future Issuance Under Employee Stock Purchase Plan", "terseLabel": "Reserved for employee stock purchase plan" } } }, "localname": "CommonStockReservedForFutureIssuanceUnderEmployeeStockPurchasePlan", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail" ], "xbrltype": "sharesItemType" }, "nvro_CommonStockReservedForFutureIssuanceUnderStockOptionAndRestrictedStockUnitGrants": { "auth_ref": [], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail": { "order": 10020.0, "parentTag": "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Common stock reserved for future issuance under stock option and restricted stock unit grants.", "label": "Common Stock Reserved For Future Issuance Under Stock Option And Restricted Stock Unit Grants", "terseLabel": "Reserved for grants of future stock options and restricted stock units" } } }, "localname": "CommonStockReservedForFutureIssuanceUnderStockOptionAndRestrictedStockUnitGrants", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail" ], "xbrltype": "sharesItemType" }, "nvro_ConcentrationRiskNumberOfCustomersExceedingThreshold": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Concentration risk number of customers exceeding threshold", "label": "Concentration Risk Number Of Customers Exceeding Threshold", "terseLabel": "Number of customers accounted 10% or more concentration risk" } } }, "localname": "ConcentrationRiskNumberOfCustomersExceedingThreshold", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "nvro_ContingentConsiderationPaymentSecuredByConvertibleNotes": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Contingent consideration payment secured by convertible notes.", "label": "Contingent Consideration Payment Secured By Convertible Notes", "terseLabel": "Contingent consideration payment secured by convertible notes" } } }, "localname": "ContingentConsiderationPaymentSecuredByConvertibleNotes", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "nvro_ConversionPricePerShare": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Conversion price per share.", "label": "Conversion Price Per Share", "terseLabel": "Overall conversion price" } } }, "localname": "ConversionPricePerShare", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "nvro_DebtEquityComponentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt equity component.", "label": "Debt Equity Component [Member]", "terseLabel": "Debt, Equity Component [Member]" } } }, "localname": "DebtEquityComponentMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtTables" ], "xbrltype": "domainItemType" }, "nvro_DebtInstrumentAdditionalAggregatePrincipalAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Debt instrument additional aggregate principal amount.", "label": "Debt Instrument Additional Aggregate Principal Amount", "terseLabel": "Additional aggregate principal amount of convertible senior notes" } } }, "localname": "DebtInstrumentAdditionalAggregatePrincipalAmount", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "nvro_DebtInstrumentConversionsSettlementAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Debt instrument conversions settlement amount.", "label": "Debt Instrument Conversions Settlement Amount", "terseLabel": "Debt instrument combination settlement" } } }, "localname": "DebtInstrumentConversionsSettlementAmount", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "nvro_DebtInstrumentConvertibleEquityComponentIssuanceCost": { "auth_ref": [], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail": { "order": 10020.0, "parentTag": "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Debt instrument convertible equity component issuance cost.", "label": "Debt Instrument Convertible Equity Component Issuance Cost", "negatedLabel": "Debt issuance cost" } } }, "localname": "DebtInstrumentConvertibleEquityComponentIssuanceCost", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail" ], "xbrltype": "monetaryItemType" }, "nvro_DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption": { "auth_ref": [], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail": { "order": 10010.0, "parentTag": "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Debt instrument convertible equity discount related to value of conversion option.", "label": "Debt Instrument Convertible Equity Discount Related To Value Of Conversion Option", "terseLabel": "Debt discount related to value of conversion option" } } }, "localname": "DebtInstrumentConvertibleEquityDiscountRelatedToValueOfConversionOption", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail" ], "xbrltype": "monetaryItemType" }, "nvro_DebtInstrumentMaturityMonthAndYear": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The month and year (YYYY-MM) that the debt instrument maturity is due.", "label": "Debt Instrument Maturity Month And Year", "terseLabel": "Debt instrument due year" } } }, "localname": "DebtInstrumentMaturityMonthAndYear", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "gYearMonthItemType" }, "nvro_DebtInstrumentMaturityYear": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt instrument maturity year.", "label": "Debt Instrument Maturity Year", "terseLabel": "Debt instrument due year" } } }, "localname": "DebtInstrumentMaturityYear", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "gYearItemType" }, "nvro_DebtLiabilityComponentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt liability component.", "label": "Debt Liability Component [Member]", "terseLabel": "Debt, Liability Component [Member]" } } }, "localname": "DebtLiabilityComponentMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtTables" ], "xbrltype": "domainItemType" }, "nvro_DeferredTaxAssetsDepreciation": { "auth_ref": [], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 10070.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Deferred tax assets depreciation.", "label": "Deferred Tax Assets Depreciation", "terseLabel": "Depreciation" } } }, "localname": "DeferredTaxAssetsDepreciation", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "nvro_DeferredTaxAssetsLeaseLiabilities": { "auth_ref": [], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 10100.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Deferred tax assets lease liabilities.", "label": "Deferred Tax Assets Lease Liabilities", "terseLabel": "Lease liabilities" } } }, "localname": "DeferredTaxAssetsLeaseLiabilities", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "nvro_DeferredTaxLiabilitiesRightOfUseAsset": { "auth_ref": [], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 10020.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Deferred tax liabilities right of use asset.", "label": "Deferred Tax Liabilities Right Of Use Asset", "negatedLabel": "Right of use asset" } } }, "localname": "DeferredTaxLiabilitiesRightOfUseAsset", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "nvro_EmployeeStockOptionAndRestrictedStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Employee stock option and restricted stock.", "label": "Employee Stock Option And Restricted Stock [Member]", "terseLabel": "Employee Stock Option and Restricted Stock [Member]" } } }, "localname": "EmployeeStockOptionAndRestrictedStockMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail" ], "xbrltype": "domainItemType" }, "nvro_EmployeeStockPurchasePlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Employee Stock Purchase Plan [Member]", "label": "Employee Stock Purchase Plan [Member]", "terseLabel": "ESPP [Member]", "verboseLabel": "Employee Stock Purchase Plan [Member]" } } }, "localname": "EmployeeStockPurchasePlanMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail" ], "xbrltype": "domainItemType" }, "nvro_EmployeeStockPurchasePlanOfferingPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Employee stock purchase plan offering period.", "label": "Employee Stock Purchase Plan Offering Period", "terseLabel": "Employee stock purchase plan offering period", "verboseLabel": "Employee stock purchase plan offering period" } } }, "localname": "EmployeeStockPurchasePlanOfferingPeriod", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "nvro_FacilityLeaseAgreementOneMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Facility lease agreement one.", "label": "Facility Lease Agreement One [Member]", "terseLabel": "Facility Lease Agreement, Original [Member]" } } }, "localname": "FacilityLeaseAgreementOneMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_FacilityLeaseAgreementThreeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Facility lease agreement three.", "label": "Facility Lease Agreement Three [Member]", "terseLabel": "Non-cancellable Facility Lease [Member]" } } }, "localname": "FacilityLeaseAgreementThreeMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_FacilityLeaseAgreementTwoMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Facility lease agreement two.", "label": "Facility Lease Agreement Two [Member]", "terseLabel": "Facility Lease Agreement, Extended [Member]" } } }, "localname": "FacilityLeaseAgreementTwoMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_FederalAndStateNetOperatingLossCarryForwardsExpirationYear": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Federal and state net operating loss carry forwards expiration year.", "label": "Federal And State Net Operating Loss Carry Forwards Expiration Year", "terseLabel": "Net operating loss expiration date" } } }, "localname": "FederalAndStateNetOperatingLossCarryForwardsExpirationYear", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "gYearItemType" }, "nvro_FirstAmendmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "First amendment.", "label": "First Amendment [Member]", "terseLabel": "Amendment 1 [Member]" } } }, "localname": "FirstAmendmentMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_IncentiveStockOptionsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Incentive Stock Options.", "label": "Incentive Stock Options [Member]", "terseLabel": "ISO [Member]" } } }, "localname": "IncentiveStockOptionsMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_IncomeTaxesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Income taxes.", "label": "Income Taxes [Line Items]", "terseLabel": "Income Taxes [Line Items]" } } }, "localname": "IncomeTaxesLineItems", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "nvro_IncomeTaxesTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Income taxes.", "label": "Income Taxes [Table]", "terseLabel": "Income Taxes [Table]" } } }, "localname": "IncomeTaxesTable", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "nvro_InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Interest expense recognized related to convertible notes.", "label": "Interest Expense Recognized Related To Convertible Notes Table [Text Block]", "terseLabel": "Interest Expense Recognized Related to Convertible Notes" } } }, "localname": "InterestExpenseRecognizedRelatedToConvertibleNotesTableTextBlock", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "nvro_InventoryWriteDownCashAndNonCash": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Inventory write down cash and non cash.", "label": "Inventory Write Down Cash And Non Cash", "verboseLabel": "Write down of inventory" } } }, "localname": "InventoryWriteDownCashAndNonCash", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "nvro_InvestmentInPrivateCompany": { "auth_ref": [], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10100.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Investment in private company.", "label": "Investment In Private Company", "negatedLabel": "Investment in private company" } } }, "localname": "InvestmentInPrivateCompany", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "nvro_LeaseCommencementDateDescription": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lease commencement date description.", "label": "Lease Commencement Date Description", "terseLabel": "Commencement date description" } } }, "localname": "LeaseCommencementDateDescription", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "nvro_LeaseCommencementPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lease commencement period.", "label": "Lease Commencement Period", "terseLabel": "Lease agreement, commencement period" } } }, "localname": "LeaseCommencementPeriod", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "gYearMonthItemType" }, "nvro_LeaseEffectiveDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lease effective date.", "label": "Lease Effective Date", "terseLabel": "Lease agreement, effective date" } } }, "localname": "LeaseEffectiveDate", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "nvro_LesseeOperatingLeaseRemainingTermOfContract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Lessee operating lease remaining term of contract.", "label": "Lessee Operating Lease Remaining Term Of Contract", "terseLabel": "Operating lease, remaining term" } } }, "localname": "LesseeOperatingLeaseRemainingTermOfContract", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "nvro_LicenseAgreementCommitmentAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "License agreement commitment amount.", "label": "License Agreement Commitment Amount", "terseLabel": "License agreement commitment amount" } } }, "localname": "LicenseAgreementCommitmentAmount", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "nvro_LicenseAgreementExpirationYear": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "License agreement expiration year.", "label": "License Agreement Expiration Year", "terseLabel": "License agreement expiration year" } } }, "localname": "LicenseAgreementExpirationYear", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "gYearItemType" }, "nvro_LitigationAmendmentPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Litigation amendment period.", "label": "Litigation Amendment Period", "terseLabel": "Litigation amendment period" } } }, "localname": "LitigationAmendmentPeriod", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "nvro_MayoAndVglMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Mayo And VGL.", "label": "Mayo And Vgl [Member]", "terseLabel": "Mayo And VGL [Member]" } } }, "localname": "MayoAndVglMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_MayoFoundationMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Mayo Foundation.", "label": "Mayo Foundation [Member]", "terseLabel": "Mayo Foundation [Member]" } } }, "localname": "MayoFoundationMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_MoneyMarketFundsNetAssetValuePerShare": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Money market funds net asset value per share.", "label": "Money Market Funds Net Asset Value Per Share", "terseLabel": "Net asset value of market funds" } } }, "localname": "MoneyMarketFundsNetAssetValuePerShare", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "nvro_NinetyEightPercentApplicableConversionPriceMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Ninety eight percent applicable conversion price.", "label": "Ninety Eight Percent Applicable Conversion Price [Member]", "terseLabel": "98% Applicable Conversion Price [Member]" } } }, "localname": "NinetyEightPercentApplicableConversionPriceMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_NonCashResearchAndDevelopmentExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Noncash research and development expense.", "label": "Non Cash Research And Development Expense", "verboseLabel": "Noncash research and development expense" } } }, "localname": "NonCashResearchAndDevelopmentExpense", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "nvro_NonQualifiedStockOptionsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Non Qualified Stock Options.", "label": "Non Qualified Stock Options [Member]", "terseLabel": "NSO [Member]" } } }, "localname": "NonQualifiedStockOptionsMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_NoteHedgesNumberOfSharesContractedToBuy": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Note hedges number of shares contracted to buy.", "label": "Note Hedges Number Of Shares Contracted To Buy", "terseLabel": "Number of shares purchased under convertible note hedge transactions" } } }, "localname": "NoteHedgesNumberOfSharesContractedToBuy", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "nvro_NoteHedgesTransactionCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Note hedges transaction costs.", "label": "Note Hedges Transaction Costs", "terseLabel": "Total cost of the convertible note hedge transactions" } } }, "localname": "NoteHedgesTransactionCosts", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "nvro_NumberOfSecuredConvertibleNotes": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of secured convertible notes.", "label": "Number Of Secured Convertible Notes", "terseLabel": "Number of secured convertible notes" } } }, "localname": "NumberOfSecuredConvertibleNotes", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "nvro_NumberOfWhollyOwnedSubsidiaries": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of wholly owned subsidiaries.", "label": "Number Of Wholly Owned Subsidiaries", "terseLabel": "Number of wholly owned subsidiaries" } } }, "localname": "NumberOfWhollyOwnedSubsidiaries", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "nvro_OneHundredThirtyPercentApplicableConversionPriceMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "One hundred thirty percent applicable conversion price.", "label": "One Hundred Thirty Percent Applicable Conversion Price [Member]", "terseLabel": "130% for Applicable Conversion Price [Member]" } } }, "localname": "OneHundredThirtyPercentApplicableConversionPriceMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "One point seven five percent senior convertible note due twenty twenty one.", "label": "One Point Seven Five Percent Senior Convertible Note Due Twenty Twenty One [Member]", "terseLabel": "1.75% Convertible Senior Notes due 2021 [Member]" } } }, "localname": "OnePointSevenFivePercentSeniorConvertibleNoteDueTwentyTwentyOneMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_OperatingLeaseAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Operating lease assets and liabilities abstract.", "label": "Operating Lease Assets And Liabilities [Abstract]", "terseLabel": "Operating Leases:" } } }, "localname": "OperatingLeaseAssetsAndLiabilitiesAbstract", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "nvro_OperatingLeasesExpirationDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Operating leases expiration date.", "label": "Operating Leases Expiration Date", "terseLabel": "Lease agreement, expiration period" } } }, "localname": "OperatingLeasesExpirationDate", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "gYearMonthItemType" }, "nvro_OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Operating leases future minimum payments due in final year of lease term.", "label": "Operating Leases Future Minimum Payments Due In Final Year Of Lease Term", "terseLabel": "Annual lease expense payable in final year of lease term" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueInFinalYearOfLeaseTerm", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Organization consolidation and presentation of financial statements.", "label": "Organization Consolidation And Presentation Of Financial Statements [Line Items]", "terseLabel": "Formation and Business of the Company [Line Items]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsLineItems", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "nvro_OrganizationConsolidationAndPresentationOfFinancialStatementsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Organization consolidation and presentation of financial statements.", "label": "Organization Consolidation And Presentation Of Financial Statements [Table]", "terseLabel": "Organization Consolidation And Presentation Of Financial Statements [Table]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsTable", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "nvro_PatentInfringementLawsuitAllegationAgainstNumberOfPatents": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Patent infringement lawsuit allegation against number of patents.", "label": "Patent Infringement Lawsuit Allegation Against Number Of Patents", "terseLabel": "Patent infringement lawsuit allegation against number of patents" } } }, "localname": "PatentInfringementLawsuitAllegationAgainstNumberOfPatents", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "nvro_PatentInfringementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Patent infringement.", "label": "Patent Infringement [Member]", "terseLabel": "Patent Infringement [Member]" } } }, "localname": "PatentInfringementMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage of principal amount of convertible notes is equal to repurchase price.", "label": "Percentage Of Principal Amount Of Convertible Notes Is Equal To Repurchase Price", "terseLabel": "Percentage of repurchase price, which is equal to principal amount of convertible notes" } } }, "localname": "PercentageOfPrincipalAmountOfConvertibleNotesIsEqualToRepurchasePrice", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "nvro_PercentageOfShareholderOptionsGranted": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage of shareholder options granted.", "label": "Percentage Of Shareholder Options Granted", "terseLabel": "Percentage of shareholder granted option" } } }, "localname": "PercentageOfShareholderOptionsGranted", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "nvro_PerformanceBasedRestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Performance Based Restricted Stock Units RSU.", "label": "Performance Based Restricted Stock Units R S U [Member]", "terseLabel": "Performance Based RSUs [Member]" } } }, "localname": "PerformanceBasedRestrictedStockUnitsRSUMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationTables", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_PurchasePricePerCommonStock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Purchase price per common stock.", "label": "Purchase Price Per Common Stock", "terseLabel": "Purchase price of the shares issued under convertible note hedge transactions" } } }, "localname": "PurchasePricePerCommonStock", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "nvro_Range1Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Range 1 [Member]", "label": "Range1 [Member]", "terseLabel": "$1.44 \u2014 $18.00 [Member]" } } }, "localname": "Range1Member", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" ], "xbrltype": "domainItemType" }, "nvro_Range2Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Range 2 [Member]", "label": "Range2 [Member]", "terseLabel": "$32.51 \u2014 $48.44 [Member]" } } }, "localname": "Range2Member", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" ], "xbrltype": "domainItemType" }, "nvro_Range3Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Range 3 [Member]", "label": "Range3 [Member]", "terseLabel": "$49.94 \u2014 $63.23 [Member]" } } }, "localname": "Range3Member", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" ], "xbrltype": "domainItemType" }, "nvro_Range4Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Range 4 [Member]", "label": "Range4 [Member]", "terseLabel": "$63.39 \u2014 $76.81 [Member]" } } }, "localname": "Range4Member", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" ], "xbrltype": "domainItemType" }, "nvro_Range5Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Range 5 [Member]", "label": "Range5 [Member]", "terseLabel": "$84.30 \u2014 $97.52 [Member]" } } }, "localname": "Range5Member", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" ], "xbrltype": "domainItemType" }, "nvro_Range6Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Range 6 [Member]", "label": "Range6 [Member]", "terseLabel": "$1.44 \u2014 $97.52 [Member]" } } }, "localname": "Range6Member", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" ], "xbrltype": "domainItemType" }, "nvro_RedwoodOfficeAgreementAdditionalExpansionPremisesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Redwood office agreement additional expansion premises.", "label": "Redwood Office Agreement Additional Expansion Premises [Member]", "terseLabel": "Redwood Office Agreement Additional Expansion Premises [Member]" } } }, "localname": "RedwoodOfficeAgreementAdditionalExpansionPremisesMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_RedwoodOfficeAgreementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Redwood office agreement.", "label": "Redwood Office Agreement [Member]", "terseLabel": "Redwood Office Agreement [Member]" } } }, "localname": "RedwoodOfficeAgreementMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Revenue recognition shipping and handling costs.", "label": "Revenue Recognition Shipping And Handling Costs Policy [Text Block]", "terseLabel": "Shipping and Handling Costs" } } }, "localname": "RevenueRecognitionShippingAndHandlingCostsPolicyTextBlock", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "nvro_ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of cash flow information related to operating lease.", "label": "Schedule Of Cash Flow Information Related To Operating Lease Tables [Text Block]", "terseLabel": "Schedule of Supplemental Cash Flow Information Related to Lease" } } }, "localname": "ScheduleOfCashFlowInformationRelatedToOperatingLeaseTablesTextBlock", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingTables" ], "xbrltype": "textBlockItemType" }, "nvro_ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of common stock reserved for future issuance.", "label": "Schedule Of Common Stock Reserved For Future Issuance Table [Text Block]", "terseLabel": "Summary of Common Stock Reserved for Future Issuance" } } }, "localname": "ScheduleOfCommonStockReservedForFutureIssuanceTableTextBlock", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "nvro_ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of operating lease assets and operating lease liabilities.", "label": "Schedule Of Operating Lease Assets And Operating Lease Liabilities Table [Text Block]", "terseLabel": "Schedule Of Operating Lease Assets and Liabilities" } } }, "localname": "ScheduleOfOperatingLeaseAssetsAndOperatingLeaseLiabilitiesTableTextBlock", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingTables" ], "xbrltype": "textBlockItemType" }, "nvro_ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of weighted average lease terms and discounts rates.", "label": "Schedule Of Weighted Average Lease Terms And Discounts Rates Table [Text Block]", "terseLabel": "Schedule of Weighted Average Lease Terms and Discounts Rates" } } }, "localname": "ScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesTableTextBlock", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingTables" ], "xbrltype": "textBlockItemType" }, "nvro_SecondAmendmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Second amendment.", "label": "Second Amendment [Member]", "terseLabel": "Amendment 2 [Member]" } } }, "localname": "SecondAmendmentMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Secured convertible note receivable measured at amortized cost.", "label": "Secured Convertible Note Receivable Measured At Amortized Cost", "terseLabel": "Secured convertible note, measured at amortized cost" } } }, "localname": "SecuredConvertibleNoteReceivableMeasuredAtAmortizedCost", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "nvro_ServiceAgreementCommitmentAmountYearFive": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Service agreement commitment amount year five.", "label": "Service Agreement Commitment Amount Year Five", "terseLabel": "2024" } } }, "localname": "ServiceAgreementCommitmentAmountYearFive", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "nvro_ServiceAgreementCommitmentAmountYearFour": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Service agreement commitment amount year four.", "label": "Service Agreement Commitment Amount Year Four", "terseLabel": "2023" } } }, "localname": "ServiceAgreementCommitmentAmountYearFour", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "nvro_ServiceAgreementCommitmentAmountYearOne": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Service agreement commitment amount year one.", "label": "Service Agreement Commitment Amount Year One", "terseLabel": "2020" } } }, "localname": "ServiceAgreementCommitmentAmountYearOne", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "nvro_ServiceAgreementCommitmentAmountYearThree": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Service agreement commitment amount year three.", "label": "Service Agreement Commitment Amount Year Three", "terseLabel": "2022" } } }, "localname": "ServiceAgreementCommitmentAmountYearThree", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "nvro_ServiceAgreementCommitmentAmountYearTwo": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Service agreement commitment amount year two.", "label": "Service Agreement Commitment Amount Year Two", "terseLabel": "2021" } } }, "localname": "ServiceAgreementCommitmentAmountYearTwo", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share based compensation arrangement by share based payment award equity instruments options and other than options forfeited and expirations in period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options And Other Than Options Forfeited And Expirations In Period", "verboseLabel": "Shares Available for Grant, Options and other than options forfeited or cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsForfeitedAndExpirationsInPeriod", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail" ], "xbrltype": "sharesItemType" }, "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share based compensation arrangement by share based payment award equity instruments options and other than options grants in period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options And Other Than Options Grants In Period", "negatedLabel": "Shares Available for Grant, Options and other than options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOptionsAndOtherThanOptionsGrantsInPeriod", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail" ], "xbrltype": "sharesItemType" }, "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options expected to vest.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest", "terseLabel": "Number of Restricted Stock Units, Restricted stock expected to vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVest", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail" ], "xbrltype": "sharesItemType" }, "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award, equity instruments other than options, shares expected to vest, weighted average grant date fair value.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Expected To Vest Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value, Restricted stock expected to vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExpectedToVestWeightedAverageGrantDateFairValue", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail" ], "xbrltype": "perShareItemType" }, "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share based compensation arrangement by share based payment award fair value assumptions correlation wirh index rate.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Correlation With Index Rate", "terseLabel": "Correlation with index" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsCorrelationWithIndexRate", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail" ], "xbrltype": "percentItemType" }, "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share based compensation arrangement by share based payment award fair value assumptions index volatility rate.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Index Volatility Rate", "terseLabel": "Index volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsIndexVolatilityRate", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail" ], "xbrltype": "percentItemType" }, "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share based compensation arrangement by share-based payment award, fair value assumptions volatility rate.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Volatility Rate", "terseLabel": "Company volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRate", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail" ], "xbrltype": "percentItemType" }, "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of allowance for PSU for over performance.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Allowance For P S U For Over Performance", "negatedLabel": "Shares Available for Grant, Allowance for PSU for over performance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAllowanceForPSUForOverPerformance", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail" ], "xbrltype": "sharesItemType" }, "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share based compensation arrangement by share based payment award number of shares forfeited for tax.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Forfeited For Tax", "verboseLabel": "Shares Available for Grant, Shares forfeited for tax" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesForfeitedForTax", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail" ], "xbrltype": "sharesItemType" }, "nvro_ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Share based compensation arrangement by share based payment award value issued in period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Value Issued In Period", "verboseLabel": "Employee contributions for shares issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardValueIssuedInPeriod", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail" ], "xbrltype": "monetaryItemType" }, "nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sharebased compensation arrangement by sharebased payment award equity instruments other than options aggregate intrinsic value expected to vest.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Expected To Vest", "terseLabel": "Aggregate Intrinsic Value, Expected to vest" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueExpectedToVest", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail" ], "xbrltype": "monetaryItemType" }, "nvro_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share-based compensation arrangement by share-based payment award, options outstanding, weighted average exercise price, and additional disclosures.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Exercise Price And Additional Disclosures [Abstract]" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceAndAdditionalDisclosuresAbstract", "nsuri": "http://www.nevro.com/20191231", "xbrltype": "stringItemType" }, "nvro_SummaryOfSignificantAccountingPoliciesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Extended line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Summary Of Significant Accounting Policies [Line Items]", "terseLabel": "Summary Of Significant Accounting Policies [Line Items]" } } }, "localname": "SummaryOfSignificantAccountingPoliciesLineItems", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "nvro_SummaryOfSignificantAccountingPoliciesTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A summary of information pertaining to the \"Summary Of Significant Accounting Policies\" disclosure as a whole for which no other established GAAP taxonomy identified hypercube is available.\"", "label": "Summary Of Significant Accounting Policies [Table]", "terseLabel": "Summary Of Significant Accounting Policies [Table]" } } }, "localname": "SummaryOfSignificantAccountingPoliciesTable", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "nvro_SupplyAgreementsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Supply Agreements [Member]", "label": "Supply Agreements [Member]", "terseLabel": "Supply Agreements [Member]" } } }, "localname": "SupplyAgreementsMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_TargetedCompositeIndexPeriod": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Targeted composite index period.", "label": "Targeted Composite Index Period", "terseLabel": "Targeted composite index period" } } }, "localname": "TargetedCompositeIndexPeriod", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "nvro_TargetedNumberOfSharesGrantedRatio": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Targeted number of shares granted ratio.", "label": "Targeted Number Of Shares Granted Ratio", "terseLabel": "Targeted number of shares granted ratio" } } }, "localname": "TargetedNumberOfSharesGrantedRatio", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "nvro_TwoThousandFourteenEquityIncentivePlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2014 Equity Incentive Plan.", "label": "Two Thousand Fourteen Equity Incentive Plan [Member]", "terseLabel": "2014 Plan [Member]" } } }, "localname": "TwoThousandFourteenEquityIncentivePlanMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_TwoThousandSevenPlanMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "2007 Plan.", "label": "Two Thousand Seven Plan [Member]", "terseLabel": "2007 Plan [Member]" } } }, "localname": "TwoThousandSevenPlanMember", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "nvro_UnrealizedGainsAndLossesOnForeignCurrencyTranslation": { "auth_ref": [], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10200.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Unrealized gains and losses on foreign currency translation.", "label": "Unrealized Gains And Losses On Foreign Currency Translation", "negatedLabel": "Unrealized gains (losses) on foreign currency transactions" } } }, "localname": "UnrealizedGainsAndLossesOnForeignCurrencyTranslation", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "nvro_ValueOfCertainRightsMeasuredAtCost": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Value of certain rights measured at cost.", "label": "Value Of Certain Rights Measured At Cost", "terseLabel": "Value of certain rights measured at cost" } } }, "localname": "ValueOfCertainRightsMeasuredAtCost", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "nvro_VestingOfEarlyExercisedStockOptions": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount related to shares of stock that were vested over the period per the terms of the related stock option agreements.", "label": "Vesting Of Early Exercised Stock Options", "terseLabel": "Vesting of early-exercised stock options" } } }, "localname": "VestingOfEarlyExercisedStockOptions", "nsuri": "http://www.nevro.com/20191231", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r169" ], "lang": { "en-US": { "role": { "label": "Chief Executive Officer [Member]", "terseLabel": "CEO [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_CounterpartyNameAxis": { "auth_ref": [ "r59", "r115" ], "lang": { "en-US": { "role": { "label": "Counterparty Name [Axis]", "terseLabel": "Counterparty Name" } } }, "localname": "CounterpartyNameAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Range [Axis]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Range [Member]", "terseLabel": "Statistical Measurement" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RepurchaseAgreementCounterpartyNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Repurchase Agreement Counterparty Name [Domain]", "terseLabel": "Counterparty Name" } } }, "localname": "RepurchaseAgreementCounterpartyNameDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RestatementAdjustmentMember": { "auth_ref": [ "r125", "r127", "r128", "r129" ], "lang": { "en-US": { "role": { "label": "Restatement Adjustment [Member]", "terseLabel": "Adjustments due to ASC 842 [Member]" } } }, "localname": "RestatementAdjustmentMember", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfImpactOfChangesMadeToConsolidatedBalanceSheetFromAdoptionOfASC842Detail" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Restatement [Axis]", "terseLabel": "Restatement" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfImpactOfChangesMadeToConsolidatedBalanceSheetFromAdoptionOfASC842Detail" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Restatement [Domain]", "terseLabel": "Restatement" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfImpactOfChangesMadeToConsolidatedBalanceSheetFromAdoptionOfASC842Detail" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Scenario Unspecified [Domain]", "terseLabel": "Scenario" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Geographical [Domain]", "terseLabel": "Geographical" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueByMajorCustomersByGeographicAreaDetail" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r168", "r260", "r262", "r447", "r453", "r456" ], "lang": { "en-US": { "role": { "label": "Statement Geographical [Axis]", "terseLabel": "Geographical" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueByMajorCustomersByGeographicAreaDetail" ], "xbrltype": "stringItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r217", "r409" ], "lang": { "en-US": { "role": { "label": "Statement Scenario [Axis]", "terseLabel": "Scenario" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r169", "r407" ], "lang": { "en-US": { "role": { "label": "Title Of Individual [Axis]", "terseLabel": "Title of Individual" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Title Of Individual With Relationship To Entity [Domain]", "terseLabel": "Title of Individual" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingStandardsUpdate201409Member": { "auth_ref": [ "r264" ], "lang": { "en-US": { "role": { "documentation": "Accounting Standards Update 2014-09 Revenue from Contracts with Customers (Topic 606).", "label": "Accounting Standards Update201409 [Member]", "terseLabel": "ASC 606 [Member]" } } }, "localname": "AccountingStandardsUpdate201409Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueCumulativeEffectOfChangesToConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedStatementOfOperationsDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueTables" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingStandardsUpdate201602Member": { "auth_ref": [ "r392" ], "lang": { "en-US": { "role": { "documentation": "Accounting Standards Update 2016-02 Leases (Topic 842).", "label": "Accounting Standards Update201602 [Member]", "terseLabel": "ASC 842 [Member]" } } }, "localname": "AccountingStandardsUpdate201602Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfImpactOfChangesMadeToConsolidatedBalanceSheetFromAdoptionOfASC842Detail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingTables" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r44" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10130.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]", "terseLabel": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r3", "r24", "r170", "r171", "r261" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10230.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable Net Current", "terseLabel": "Accounts receivable, net of allowance for doubtful accounts of $797 and $824 at December 31, 2019 and 2018, respectively", "verboseLabel": "Accounts receivable, net" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueCumulativeEffectOfChangesToConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments": { "auth_ref": [ "r103" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10160.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Accretion Amortization Of Discounts And Premiums Investments", "negatedLabel": "Accretion of discount on short-term investments" } } }, "localname": "AccretionAmortizationOfDiscountsAndPremiumsInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r17", "r419", "r439" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail": { "order": 10030.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes Current", "terseLabel": "Accrued taxes" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r46" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10140.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities Current", "terseLabel": "Accrued liabilities", "totalLabel": "Total accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedProfessionalFeesCurrent": { "auth_ref": [ "r8", "r9", "r46" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail": { "order": 10020.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Professional Fees Current", "terseLabel": "Accrued professional fees" } } }, "localname": "AccruedProfessionalFeesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r42", "r211" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail": { "order": 10020.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation Depletion And Amortization Property Plant And Equipment", "negatedLabel": "Less: Accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r62", "r63", "r64" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10070.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income Loss Net Of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueCumulativeEffectOfChangesToConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r61", "r64", "r65", "r361" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "Accumulated Other Comprehensive Income [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r25" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10060.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid In Capital Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid In Capital [Member]", "terseLabel": "Additional Paid-In Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r124" ], "lang": { "en-US": { "role": { "documentation": "Information by new accounting pronouncement.", "label": "Adjustments For New Accounting Pronouncements [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfImpactOfChangesMadeToConsolidatedBalanceSheetFromAdoptionOfASC842Detail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingTables", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueCumulativeEffectOfChangesToConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedStatementOfOperationsDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueTables" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Adjustments Related To Tax Withholding For Share Based Compensation", "negatedLabel": "Shares withheld for tax obligations" } } }, "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) to additional paid-in capital (APIC) for recognition and exercise of award under share-based payment arrangement.", "label": "Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options", "terseLabel": "Vesting of early exercised stock options" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r273", "r275", "r312", "r313" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value", "terseLabel": "Stock based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AgencySecuritiesMember": { "auth_ref": [ "r191" ], "lang": { "en-US": { "role": { "documentation": "Securities issued by government sponsored entities.", "label": "Agency Securities [Member]", "terseLabel": "Agency Bonds [Member]" } } }, "localname": "AgencySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r275", "r305", "r311" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Allocated Share Based Compensation Expense", "terseLabel": "Stock-based compensation expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r30", "r172", "r193" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Allowance For Doubtful Accounts Receivable Current", "terseLabel": "Accounts receivable, allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r84", "r102", "r385" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail": { "order": 10020.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization Of Debt Discount Premium", "terseLabel": "Amortization of debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r77", "r102", "r387" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail": { "order": 10030.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization Of Financing Costs", "verboseLabel": "Amortization of debt issuance costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r102", "r387" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10190.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization Of Financing Costs And Discounts", "terseLabel": "Non-cash interest expense" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r137" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount", "terseLabel": "Potentially dilutive securities excluded from computation of diluted shares outstanding" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r137" ], "lang": { "en-US": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r137" ], "lang": { "en-US": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities Name [Domain]", "terseLabel": "Antidilutive Securities, Name" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AreaOfLand": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area of land held.", "label": "Area Of Land", "terseLabel": "Area of office space" } } }, "localname": "AreaOfLand", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "areaItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Arrangements And Nonarrangement Transactions [Member]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r102", "r209" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Asset Impairment Charges", "terseLabel": "Impairment charges" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r166", "r417", "r438" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r5", "r58" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10160.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r365" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets Fair Value Disclosure", "terseLabel": "Total assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": { "auth_ref": [ "r180" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail": { "order": 10010.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax", "terseLabel": "Gross Unrealized Holding Gains" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": { "auth_ref": [ "r181" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail": { "order": 10020.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax", "negatedLabel": "Gross Unrealized Holding Losses" } } }, "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": { "auth_ref": [ "r178", "r195" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Available For Sale Debt Securities Amortized Cost Basis", "totalLabel": "Amortized Cost" } } }, "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": { "auth_ref": [ "r185" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail": { "order": 10040.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost", "terseLabel": "Amortized Cost, Amounts maturing after one year through five years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue": { "auth_ref": [ "r182", "r185", "r429" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail": { "order": 10020.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Available For Sale Securities Debt Maturities After One Through Five Years Fair Value", "terseLabel": "Fair Value, Amounts after one year through five years" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": { "auth_ref": [ "r184" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail": { "order": 10030.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Available For Sale Securities Debt Maturities Within One Year Amortized Cost", "terseLabel": "Amortized Cost, Amounts maturing within one year" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": { "auth_ref": [ "r182", "r184", "r428" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail": { "order": 10010.0, "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Available For Sale Securities Debt Maturities Within One Year Fair Value", "terseLabel": "Fair Value, Amounts maturing within one year" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecurities": { "auth_ref": [ "r175", "r179", "r195" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail": { "order": 10030.0, "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Available For Sale Securities Debt Securities", "terseLabel": "Aggregate Fair Value", "totalLabel": "Fair Value, Total investment securities" } } }, "localname": "AvailableForSaleSecuritiesDebtSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfContractualMaturitiesOfInvestmentSecuritiesDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": { "auth_ref": [ "r177", "r195" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10220.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.", "label": "Available For Sale Securities Debt Securities Current", "terseLabel": "Short-term investments" } } }, "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r276", "r308" ], "lang": { "en-US": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]", "terseLabel": "Award Type" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationTables", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis Of Accounting Policy Policy [Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BondsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt security, in which the authorized issuer owes the holder a debt and is obliged to repay the principal and interest (the coupon).", "label": "Bonds [Member]", "terseLabel": "Bonds [Member]" } } }, "localname": "BondsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member": { "auth_ref": [ "r263" ], "lang": { "en-US": { "role": { "documentation": "Calculated under guidance for revenue recognition in effect prior to change to new guidance for revenue from contract with customer when using transition method for cumulative effect in period including initial date of application.", "label": "Calculated Under Revenue Guidance In Effect Before Topic606 [Member]", "terseLabel": "Balance Without ASC 606 Adoption [Member]" } } }, "localname": "CalculatedUnderRevenueGuidanceInEffectBeforeTopic606Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedStatementOfOperationsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CaliforniaFranchiseTaxBoardMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Designated tax department of the government of the state of California.", "label": "California Franchise Tax Board [Member]", "terseLabel": "California state [Member]" } } }, "localname": "CaliforniaFranchiseTaxBoardMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CapitalExpendituresIncurredButNotYetPaid": { "auth_ref": [ "r107", "r108", "r109" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.", "label": "Capital Expenditures Incurred But Not Yet Paid", "terseLabel": "Purchases of property and equipment in accounts payable" } } }, "localname": "CapitalExpendituresIncurredButNotYetPaid", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r1", "r39", "r104" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10210.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash And Cash Equivalents At Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r12", "r105", "r111" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash And Cash Equivalents Policy [Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": { "auth_ref": [ "r12", "r105", "r111", "r416" ], "lang": { "en-US": { "role": { "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.", "label": "Cash And Cash Equivalents Restricted Cash And Cash Equivalents Policy", "terseLabel": "Restricted Cash" } } }, "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents [Abstract]", "terseLabel": "Cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r98", "r104", "r110" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations", "periodEndLabel": "Cash, cash equivalents and restricted cash at end of year", "periodStartLabel": "Cash, cash equivalents and restricted cash at beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r98", "r382" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect", "totalLabel": "Net increase in cash, cash equivalents and restricted cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashUninsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.", "label": "Cash Uninsured Amount", "terseLabel": "Cash held in foreign banks" } } }, "localname": "CashUninsuredAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CertificatesOfDepositMember": { "auth_ref": [ "r431" ], "lang": { "en-US": { "role": { "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.", "label": "Certificates Of Deposit [Member]", "terseLabel": "Certificates of Deposit [Member]" } } }, "localname": "CertificatesOfDepositMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class Of Stock [Line Items]", "terseLabel": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r122" ], "lang": { "en-US": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1", "terseLabel": "Purchase price of the shares issued under convertible note hedge transactions" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r121" ], "lang": { "en-US": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights", "terseLabel": "Number of shares issued for warrants under convertible note hedge transactions" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommercialPaperMember": { "auth_ref": [ "r234" ], "lang": { "en-US": { "role": { "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.", "label": "Commercial Paper [Member]", "terseLabel": "Commercial Paper [Member]" } } }, "localname": "CommercialPaperMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r52", "r216", "r423", "r444" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10020.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments And Contingencies", "terseLabel": "Commitments and contingencies (Note 6)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments And Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r215", "r223" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments And Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r54" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock Capital Shares Reserved For Future Issuance", "terseLabel": "Common stock reserved for future issuance", "totalLabel": "Total common stock reserved for future issuance" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfCommonStockReservedForFutureIssuanceDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r23" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock Par Or Stated Value Per Share", "terseLabel": "Common stock, par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r23" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r23" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock Shares Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r23", "r246" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock Shares Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r23" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10050.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock Value", "terseLabel": "Common stock, $0.001 par value, 290,000,000 shares authorized at December 31, 2019 and 2018, respectively; 31,544,361 and 30,263,536 shares issued and outstanding at December 31, 2019 and 2018, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "auth_ref": [ "r266", "r267", "r272", "r314" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.", "label": "Compensation And Employee Benefit Plans [Text Block]", "terseLabel": "Employee Benefit Plan" } } }, "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureEmployeeBenefitPlan" ], "xbrltype": "textBlockItemType" }, "us-gaap_CompensationAndRetirementDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Compensation And Retirement Disclosure [Abstract]" } } }, "localname": "CompensationAndRetirementDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r68", "r70", "r71" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income Net Of Tax", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income Policy Policy [Text Block]", "terseLabel": "Other Comprehensive Income (Loss)" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer Equipment and Software [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r156", "r157", "r376", "r377" ], "lang": { "en-US": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.", "label": "Concentration Risk Benchmark [Domain]", "terseLabel": "Concentration Risk Benchmark" } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueByMajorCustomersByGeographicAreaDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r156", "r157", "r376", "r377", "r448" ], "lang": { "en-US": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk By Benchmark [Axis]", "terseLabel": "Concentration Risk Benchmark" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueByMajorCustomersByGeographicAreaDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r156", "r157", "r376", "r377", "r448" ], "lang": { "en-US": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk By Type [Axis]", "terseLabel": "Concentration Risk Type" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueByMajorCustomersByGeographicAreaDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r150", "r435" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk Credit Risk", "terseLabel": "Concentration of Credit Risk and Other Risks and Uncertainties" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]", "terseLabel": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueByMajorCustomersByGeographicAreaDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r156", "r157", "r376", "r377" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration Risk Percentage1", "terseLabel": "Revenue", "verboseLabel": "Concentration risk, percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueByMajorCustomersByGeographicAreaDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r153", "r156", "r157", "r158", "r376", "r378" ], "lang": { "en-US": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]", "terseLabel": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueByMajorCustomersByGeographicAreaDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r156", "r157", "r376", "r377" ], "lang": { "en-US": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.", "label": "Concentration Risk Type [Domain]", "terseLabel": "Concentration Risk Type" } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueByMajorCustomersByGeographicAreaDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConstructionInProgressMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.", "label": "Construction In Progress [Member]", "terseLabel": "Construction in Process [Member]" } } }, "localname": "ConstructionInProgressMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r107", "r108", "r109" ], "lang": { "en-US": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion Of Stock Shares Converted1", "verboseLabel": "Convertible preferred stock converted to common stock" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ConversionOfStockSharesIssued1": { "auth_ref": [ "r107", "r108", "r109" ], "lang": { "en-US": { "role": { "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion Of Stock Shares Issued1", "terseLabel": "Shares issued upon conversion of redeemable convertible preferred stock and convertible preferred stock" } } }, "localname": "ConversionOfStockSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleDebtSecuritiesMember": { "auth_ref": [ "r268" ], "lang": { "en-US": { "role": { "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.", "label": "Convertible Debt Securities [Member]", "verboseLabel": "Convertible Senior Notes [Member]" } } }, "localname": "ConvertibleDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of borrowings which can be exchanged for a specified number of another security at the option of the issuer or the holder. Disclosures include, but are not limited to, principal amount, amortized premium or discount, and amount of liability and equity components.", "label": "Convertible Debt Table [Text Block]", "terseLabel": "Net Carrying Amount of Convertible Debt" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Convertible Longterm Notes Payable Current And Noncurrent [Abstract]" } } }, "localname": "ConvertibleLongtermNotesPayableCurrentAndNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": { "auth_ref": [ "r21", "r22", "r247", "r250" ], "lang": { "en-US": { "role": { "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.", "label": "Convertible Preferred Stock Shares Issued Upon Conversion", "terseLabel": "Common stock shares issued for each convertible preferred stock" } } }, "localname": "ConvertiblePreferredStockSharesIssuedUponConversion", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CorporateNoteSecuritiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This category includes information about short-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest).", "label": "Corporate Note Securities [Member]", "terseLabel": "Corporate Notes [Member]" } } }, "localname": "CorporateNoteSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r79" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10160.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost Of Goods And Services Sold", "terseLabel": "Cost of revenue" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedStatementOfOperationsDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost Of Sales [Member]", "terseLabel": "Cost of Revenue [Member]" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CreditConcentrationRiskMember": { "auth_ref": [ "r378" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that a specified receivable or amount at risk from a counterparty under a contractual arrangement is to a specified benchmark, such as total receivables, net revenues, pretax results. Risk is the materially adverse effects of loss attributable to (a) the failure to collect a significant receivable from a major customer or group of homogeneous accounts, or (b) a failure by a counterparty to perform under terms of a contractual arrangement.", "label": "Credit Concentration Risk [Member]", "terseLabel": "Credit Concentration Risk [Member]" } } }, "localname": "CreditConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r114", "r344", "r349" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail": { "order": 10060.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Federal Tax Expense Benefit", "terseLabel": "Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentForeignTaxExpenseBenefit": { "auth_ref": [ "r120", "r346" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail": { "order": 10080.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current Foreign Tax Expense Benefit", "terseLabel": "Foreign" } } }, "localname": "CurrentForeignTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r114", "r344", "r349" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail": { "order": 10010.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense Benefit", "totalLabel": "Total current income tax expense / (benefit)" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Current Income Tax Expense Benefit Continuing Operations [Abstract]", "terseLabel": "Current:" } } }, "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r114", "r344", "r349" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail": { "order": 10070.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Current State And Local Tax Expense Benefit", "terseLabel": "State" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r154" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]", "terseLabel": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionByUniqueDescriptionAxis": { "auth_ref": [ "r107", "r109" ], "lang": { "en-US": { "role": { "documentation": "Information by description of debt issuances converted in a noncash or part noncash transaction.", "label": "Debt Conversion By Unique Description [Axis]", "terseLabel": "Debt Conversion Description" } } }, "localname": "DebtConversionByUniqueDescriptionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r107", "r109" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion Converted Instrument Amount1", "terseLabel": "Convertible notes principal amount" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r107", "r109" ], "lang": { "en-US": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Debt Conversion Converted Instrument Shares Issued1", "terseLabel": "Convertible notes, shares issued" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtConversionNameDomain": { "auth_ref": [ "r107", "r109" ], "lang": { "en-US": { "role": { "documentation": "The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion Name [Domain]", "terseLabel": "Debt Conversion, Name" } } }, "localname": "DebtConversionNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r242" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "terseLabel": "Long-term Debt" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r16", "r17", "r18", "r418", "r421", "r437" ], "lang": { "en-US": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentCarryingAmount": { "auth_ref": [ "r18", "r237", "r421", "r437" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail": { "order": 10010.0, "parentTag": "us-gaap_LongTermDebt", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.", "label": "Debt Instrument Carrying Amount", "terseLabel": "Principal" } } }, "localname": "DebtInstrumentCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent": { "auth_ref": [ "r236" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The carrying amount of the equity component of convertible debt which may be settled in cash upon conversion.", "label": "Debt Instrument Convertible Carrying Amount Of The Equity Component", "terseLabel": "Debt conversion, converted instrument amount", "totalLabel": "Net carrying amount" } } }, "localname": "DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r239" ], "lang": { "en-US": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument Convertible Conversion Price1", "terseLabel": "Convertible notes, conversion price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.", "label": "Debt Instrument Convertible Threshold Consecutive Trading Days1", "terseLabel": "Debt instrument convertible consecutive trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.", "label": "Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger", "terseLabel": "Debt instrument convertible, percentage of conversion price" } } }, "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentConvertibleThresholdTradingDays": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Threshold number of specified trading days that common stock price to conversion price of convertible debt instruments must exceed threshold percentage within a specified consecutive trading period to trigger conversion feature.", "label": "Debt Instrument Convertible Threshold Trading Days", "terseLabel": "Debt instrument convertible trading days" } } }, "localname": "DebtInstrumentConvertibleThresholdTradingDays", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "us-gaap_DebtInstrumentConvertibleTypeOfEquitySecurity": { "auth_ref": [ "r49", "r247", "r251", "r253" ], "lang": { "en-US": { "role": { "documentation": "Description of the type of equity security or securities into which conversion will be made (for example, common stock or preferred shares).", "label": "Debt Instrument Convertible Type Of Equity Security", "terseLabel": "Convertible notes, type of equity security issued" } } }, "localname": "DebtInstrumentConvertibleTypeOfEquitySecurity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r386", "r388" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument Face Amount", "terseLabel": "Aggregate principal amount of convertible senior notes" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r375" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument Fair Value", "terseLabel": "Fair value of notes" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFrequencyOfPeriodicPayment": { "auth_ref": [ "r50", "r432" ], "lang": { "en-US": { "role": { "documentation": "Description of the frequency of periodic payments (monthly, quarterly, annual).", "label": "Debt Instrument Frequency Of Periodic Payment", "terseLabel": "Debt instrument frequency of payment" } } }, "localname": "DebtInstrumentFrequencyOfPeriodicPayment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "auth_ref": [ "r48", "r240", "r386" ], "lang": { "en-US": { "role": { "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.", "label": "Debt Instrument Interest Rate Effective Percentage", "terseLabel": "Debt instrument, effective interest rate" } } }, "localname": "DebtInstrumentInterestRateEffectivePercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r48" ], "lang": { "en-US": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument Interest Rate Stated Percentage", "terseLabel": "Debt instrument interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtTables" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r50" ], "lang": { "en-US": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument Name [Domain]", "terseLabel": "Debt Instrument, Name" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r433" ], "lang": { "en-US": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument Redemption Price Percentage", "terseLabel": "Percentage of closing sale price of common stock" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r50", "r117", "r247", "r252", "r253", "r254", "r385", "r386", "r388", "r434" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Debt Instrument [Table]", "terseLabel": "Debt Instrument [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtTables" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r385", "r388" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail": { "order": 10020.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt Instrument Unamortized Discount", "negatedLabel": "Unamortized discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Debt Instruments [Abstract]" } } }, "localname": "DebtInstrumentsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": { "auth_ref": [ "r191" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Debt Securities Available For Sale Table [Text Block]", "terseLabel": "Summary of Gross Unrealized Gains and Unrealized Losses of Investment Securities Excluding Investments in Money Market Funds" } } }, "localname": "DebtSecuritiesAvailableForSaleTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r114", "r345", "r349" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail": { "order": 10030.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal Income Tax Expense Benefit", "terseLabel": "Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r43", "r387" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Deferred Finance Costs Net", "terseLabel": "Debt issuance costs attributable to the liability and equity component, total amount" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNoncurrentGross": { "auth_ref": [ "r43", "r387" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail": { "order": 10030.0, "parentTag": "us-gaap_LongTermDebt", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before accumulated amortization, of debt issuance costs classified as noncurrent. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Deferred Finance Costs Noncurrent Gross", "negatedLabel": "Unamortized issuance cost", "verboseLabel": "Debt issuance costs attributable to the liability component" } } }, "localname": "DeferredFinanceCostsNoncurrentGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r114", "r345", "r349" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail": { "order": 10050.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Foreign Income Tax Expense Benefit", "terseLabel": "Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r102", "r114", "r345", "r349" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail": { "order": 10020.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense Benefit", "totalLabel": "Total deferred income tax expense / (benefit)" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Deferred Income Tax Expense Benefit Continuing Operations [Abstract]", "terseLabel": "Deferred:" } } }, "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r19", "r20", "r335", "r420", "r436" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 10030.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Income Tax Liabilities", "negatedLabel": "Deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r114", "r345", "r349" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail": { "order": 10040.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred State And Local Income Tax Expense Benefit", "terseLabel": "State" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r336" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 10010.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets Gross", "totalLabel": "Deferred tax assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r337" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets Net", "totalLabel": "Net deferred tax assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r318", "r342", "r343" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 10050.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Deferred Tax Assets Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r320", "r342", "r343" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 10110.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Deferred Tax Assets Other", "terseLabel": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "auth_ref": [ "r340", "r342", "r343" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 10060.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.", "label": "Deferred Tax Assets Tax Credit Carryforwards", "terseLabel": "Tax credits" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r318", "r342", "r343" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 10080.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost", "terseLabel": "Stock-based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": { "auth_ref": [ "r319", "r342", "r343" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 10090.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.", "label": "Deferred Tax Assets Tax Deferred Expense Reserves And Accruals", "terseLabel": "Accruals and reserves" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r338" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail": { "order": 10040.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets Valuation Allowance", "negatedLabel": "Valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTaxEffectsOfTemporaryDifferencesAndCarryforwardsThatGiveRiseToSignificantPortionsOfDeferredTaxAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.", "label": "Defined Contribution Plan Employer Discretionary Contribution Amount", "terseLabel": "Expense for matching contributions" } } }, "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureEmployeeBenefitPlanAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r102", "r164" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10130.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation Depletion And Amortization", "terseLabel": "Depreciation and amortization", "verboseLabel": "Depreciation and amortization expense" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member": { "auth_ref": [ "r263" ], "lang": { "en-US": { "role": { "documentation": "Effect in current period from application of guidance for revenue from contract with customer compared with guidance for revenue recognition applicable prior to change when using transition method for cumulative effect in period including initial date of application.", "label": "Difference Between Revenue Guidance In Effect Before And After Topic606 [Member]", "terseLabel": "Adjustments Due to ASC 606 [Member]" } } }, "localname": "DifferenceBetweenRevenueGuidanceInEffectBeforeAndAfterTopic606Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueCumulativeEffectOfChangesToConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedStatementOfOperationsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation Of Revenue [Line Items]", "terseLabel": "Disaggregation Of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedStatementOfOperationsDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueTables" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation Of Revenue [Table]", "terseLabel": "Disaggregation Of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedStatementOfOperationsDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueTables" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r260" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation Of Revenue Table [Text Block]", "terseLabel": "Summary of Revenue by Geography on Billing Address of Customer" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Country [Member]", "terseLabel": "Federal [Member]" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r135" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share Basic And Diluted", "terseLabel": "Net loss per share, basic and diluted", "verboseLabel": "Net loss per share, basic and diluted" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSelectedQuarterlyFinancialInformationScheduleOfSelectedQuarterlyFinancialInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Earnings Per Share Diluted [Line Items]", "terseLabel": "Earnings Per Share Diluted [Line Items]" } } }, "localname": "EarningsPerShareDilutedLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r111", "r137", "r138", "r139" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share Policy [Text Block]", "terseLabel": "Net Loss per Share of Common Stock" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r141" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Net Loss Per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r382" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10040.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations", "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r119", "r325", "r326" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Continuing Operations", "totalLabel": "Total" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r325", "r326", "r348" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail": { "order": 10010.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate", "terseLabel": "Tax at statutory federal rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r325", "r326", "r348" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail": { "order": 10070.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance", "terseLabel": "Change in valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r325", "r326", "r348" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail": { "order": 10060.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.", "label": "Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate", "terseLabel": "Effect of Tax Cuts and Jobs Act of 2017" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential": { "auth_ref": [ "r325", "r326", "r348" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail": { "order": 10030.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to statutory income tax expense (benefit) outside of the country of domicile.", "label": "Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential", "terseLabel": "Foreign rate differential" } } }, "localname": "EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": { "auth_ref": [ "r325", "r326", "r348" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail": { "order": 10050.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.", "label": "Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost", "terseLabel": "Excess tax benefits related to stock-based compensation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [ "r325", "r326", "r348" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail": { "order": 10080.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation Other Adjustments", "terseLabel": "Other" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r325", "r326", "r348" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail": { "order": 10020.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "Effective Income Tax Rate Reconciliation State And Local Income Taxes", "terseLabel": "State tax, net of federal benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": { "auth_ref": [ "r325", "r326", "r348" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail": { "order": 10040.0, "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations", "weight": -1.0 } }, "lang": { "en-US": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.", "label": "Effective Income Tax Rate Reconciliation Tax Credits", "negatedLabel": "Tax credits" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesIncomeTaxExpenseByApplyingStatutoryFederalIncomeTaxRateDetail" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r46" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail": { "order": 10010.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee Related Liabilities Current", "terseLabel": "Accrued payroll and related expenses" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]", "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]" } } }, "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "auth_ref": [ "r307" ], "lang": { "en-US": { "role": { "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1", "terseLabel": "Weighted-Average Amortization Period (in years)" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail" ], "xbrltype": "durationItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r307" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options", "terseLabel": "Unrecognized Compensation" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "auth_ref": [ "r307" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.", "label": "Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options", "terseLabel": "Unrecognized Compensation" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.", "label": "Employee Stock [Member]", "terseLabel": "Employee Stock [Member]" } } }, "localname": "EmployeeStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [ "r303" ], "lang": { "en-US": { "role": { "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.", "label": "Employee Stock Option [Member]", "terseLabel": "Options to Purchase Common Stock [Member]", "verboseLabel": "Stock Options [Member]" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EquipmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tangible personal property used to produce goods and services.", "label": "Equipment [Member]", "terseLabel": "Laboratory Equipment [Member]" } } }, "localname": "EquipmentMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r246" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r365", "r366", "r367", "r371" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]", "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r365", "r366" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Fair Value Assets Measured On Recurring Basis [Text Block]", "terseLabel": "Financial Instruments Measured at Fair Value on Recurring Basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r268", "r269", "r271", "r366", "r410" ], "lang": { "en-US": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value By Fair Value Hierarchy Level [Axis]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r365", "r366", "r368", "r369", "r372" ], "lang": { "en-US": { "role": { "documentation": "Information by measurement frequency.", "label": "Fair Value By Measurement Frequency [Axis]", "terseLabel": "Measurement Frequency" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r370" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r268", "r269", "r271", "r366", "r411" ], "lang": { "en-US": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value Inputs Level1 [Member]", "terseLabel": "Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r268", "r269", "r271", "r366", "r412" ], "lang": { "en-US": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value Inputs Level2 [Member]", "terseLabel": "Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r268", "r269", "r271", "r366", "r413" ], "lang": { "en-US": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value Inputs Level3 [Member]", "terseLabel": "Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Measurement frequency.", "label": "Fair Value Measurement Frequency [Domain]", "terseLabel": "Measurement Frequency" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Measurements Fair Value Hierarchy [Domain]", "terseLabel": "Fair Value Hierarchy and NAV" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r370", "r372" ], "lang": { "en-US": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value Measurements Recurring [Member]", "terseLabel": "Fair Value Measurements Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r111", "r373", "r374" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value Of Financial Instruments Policy", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r203", "r204", "r206", "r207", "r414" ], "lang": { "en-US": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite Lived Intangible Assets By Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r203", "r205" ], "lang": { "en-US": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite Lived Intangible Assets Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossRealized": { "auth_ref": [ "r379", "r380", "r381" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of foreign currency transaction realized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain Loss Realized", "terseLabel": "Realized foreign currency transaction gains (losses)" } } }, "localname": "ForeignCurrencyTransactionGainLossRealized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": { "auth_ref": [ "r103", "r379", "r380", "r381" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain Loss Unrealized", "terseLabel": "Net unrealized foreign currency transaction gains (losses)" } } }, "localname": "ForeignCurrencyTransactionGainLossUnrealized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r111", "r381", "r383" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions And Translations Policy [Text Block]", "terseLabel": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture And Fixtures [Member]", "terseLabel": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_GeographicConcentrationRiskMember": { "auth_ref": [ "r155" ], "lang": { "en-US": { "role": { "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).", "label": "Geographic Concentration Risk [Member]", "terseLabel": "Geographic Concentration Risk [Member]" } } }, "localname": "GeographicConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueByMajorCustomersByGeographicAreaDetail" ], "xbrltype": "domainItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r78" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10110.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "terseLabel": "Gross profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSelectedQuarterlyFinancialInformationScheduleOfSelectedQuarterlyFinancialInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "I P O [Member]", "terseLabel": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r111", "r208", "r214" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Impairment Or Disposal Of Long Lived Assets Policy [Text Block]", "terseLabel": "Impairment of Long-Lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": { "auth_ref": [ "r118" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail": { "order": 10010.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.", "label": "Income Loss From Continuing Operations Before Income Taxes Domestic", "terseLabel": "Domestic" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r74", "r125", "r415", "r424", "r446" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10050.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest", "totalLabel": "Loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": { "auth_ref": [ "r118" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail": { "order": 10020.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.", "label": "Income Loss From Continuing Operations Before Income Taxes Foreign", "terseLabel": "Foreign" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfLossBeforeIncomeTaxesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r213" ], "lang": { "en-US": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r328" ], "lang": { "en-US": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityNameAxis": { "auth_ref": [ "r328" ], "lang": { "en-US": { "role": { "documentation": "Information by name of taxing authority.", "label": "Income Tax Authority Name [Axis]", "terseLabel": "Income Tax Authority, Name" } } }, "localname": "IncomeTaxAuthorityNameAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority Name [Domain]", "terseLabel": "Income Tax Authority, Name" } } }, "localname": "IncomeTaxAuthorityNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r352" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpense": { "auth_ref": [ "r327" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.", "label": "Income Tax Examination Penalties And Interest Expense", "terseLabel": "Interest or penalties recognized" } } }, "localname": "IncomeTaxExaminationPenaltiesAndInterestExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r114", "r165", "r350" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10060.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense Benefit", "terseLabel": "Provision for income taxes", "totalLabel": "Total income tax expense / (benefit)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesComponentsOfExpenseBenefitForIncomeTaxesDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r72", "r111", "r323", "r324", "r333", "r334", "r339", "r351", "r455" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax Policy [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r106" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid Net", "terseLabel": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r101" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10250.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase Decrease In Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r101" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10210.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase Decrease In Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r101" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10260.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase Decrease In Accrued Liabilities", "terseLabel": "Accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r101" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10220.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase Decrease In Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Increase Decrease In Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": { "auth_ref": [], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10270.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.", "label": "Increase Decrease In Other Noncurrent Liabilities", "terseLabel": "Other long-term liabilities" } } }, "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingAssets": { "auth_ref": [ "r101" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10240.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in operating assets classified as other.", "label": "Increase Decrease In Other Operating Assets", "negatedLabel": "Other assets" } } }, "localname": "IncreaseDecreaseInOtherOperatingAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r101" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10230.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase Decrease In Prepaid Deferred Expense And Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndemnificationGuaranteeMember": { "auth_ref": [ "r224", "r233" ], "lang": { "en-US": { "role": { "documentation": "An agreement (contract) that contingently requires the guarantor to make payments to the guaranteed party in compensation for that party's or parties' loss or injury attributable to specified events or actions, such as a patent infringement action against an entity that relied on certain representations as to ownership rights made by a software vendor.", "label": "Indemnification Guarantee [Member]", "terseLabel": "Indemnification Agreement [Member]" } } }, "localname": "IndemnificationGuaranteeMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionAxis": { "auth_ref": [ "r263" ], "lang": { "en-US": { "role": { "documentation": "Information about effect of transition method for cumulative effect in initial period of application.", "label": "Initial Application Period Cumulative Effect Transition [Axis]", "terseLabel": "Initial Application Period Cumulative Effect Transition" } } }, "localname": "InitialApplicationPeriodCumulativeEffectTransitionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueCumulativeEffectOfChangesToConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedStatementOfOperationsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InitialApplicationPeriodCumulativeEffectTransitionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Effect of transition method for cumulative effect in initial period of application.", "label": "Initial Application Period Cumulative Effect Transition [Domain]", "terseLabel": "Initial Application Period Cumulative Effect Transition" } } }, "localname": "InitialApplicationPeriodCumulativeEffectTransitionDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueCumulativeEffectOfChangesToConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedStatementOfOperationsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r73", "r163", "r384", "r387", "r426" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10090.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r84", "r241" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest Expense Debt", "totalLabel": "Total interest expense related to the 2021 Notes" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebtExcludingAmortization": { "auth_ref": [ "r86" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail": { "order": 10010.0, "parentTag": "us-gaap_InterestExpenseDebt", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.", "label": "Interest Expense Debt Excluding Amortization", "terseLabel": "Contractual interest expense" } } }, "localname": "InterestExpenseDebtExcludingAmortization", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtInterestExpenseRecognizedRelatedToConvertibleNotesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r96", "r99", "r106" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Interest Paid Net", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r9", "r10", "r46" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail": { "order": 10050.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Interest Payable Current", "terseLabel": "Accrued interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r32", "r202" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail": { "order": 10020.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory Finished Goods Net Of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryFirmPurchaseCommitmentLoss": { "auth_ref": [ "r201" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of loss recognized on firm purchase commitment for inventory.", "label": "Inventory Firm Purchase Commitment Loss", "terseLabel": "Purchase commitments for inventory related charge" } } }, "localname": "InventoryFirmPurchaseCommitmentLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r2", "r56", "r197" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10240.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory Net", "terseLabel": "Inventories", "totalLabel": "Total inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r11", "r57", "r111", "r144", "r198", "r200" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventory Policy [Text Block]", "terseLabel": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "auth_ref": [ "r33", "r202" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail": { "order": 10010.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.", "label": "Inventory Raw Materials Net Of Reserves", "terseLabel": "Raw materials" } } }, "localname": "InventoryRawMaterialsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsComponentsOfInventoriesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWriteDown": { "auth_ref": [ "r199" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10180.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.", "label": "Inventory Write Down", "terseLabel": "Write-down of inventory" } } }, "localname": "InventoryWriteDown", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r83", "r162" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10080.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income Interest", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r192" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment Policy [Text Block]", "terseLabel": "Investment Securities" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r449", "r450", "r451", "r452" ], "lang": { "en-US": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r449", "r450", "r451", "r452" ], "lang": { "en-US": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investment Type Categorization [Member]", "terseLabel": "Investments" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.", "label": "Investments Classified By Contractual Maturity Date Table [Text Block]", "terseLabel": "Summary of Contractual Maturities of Investment Securities" } } }, "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Investments Debt And Equity Securities [Abstract]" } } }, "localname": "InvestmentsDebtAndEquitySecuritiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_LeaseAndRentalExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of rent expense incurred for leased assets, including but not limited to, furniture and equipment, that is not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "Lease And Rental Expense", "terseLabel": "Lease agreement, lease expense" } } }, "localname": "LeaseAndRentalExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseArrangementTypeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by group of related lease arrangements. For example, but not limited to, leases grouped by facility or contractual terms.", "label": "Lease Arrangement Type [Axis]", "terseLabel": "Lease Arrangement, Type" } } }, "localname": "LeaseArrangementTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LeaseArrangementTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Group of related lease arrangements. For example, but not limited to, leases grouped by facility or contractual terms.", "label": "Lease Arrangement Type [Domain]", "terseLabel": "Lease Arrangement, Type" } } }, "localname": "LeaseArrangementTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r403" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease Cost Table [Text Block]", "terseLabel": "Supplemental Lease Cost Information" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseExpirationDate1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Date which lease or group of leases is set to expire, in CCYY-MM-DD format.", "label": "Lease Expiration Date1", "terseLabel": "Lease agreement, expiration date" } } }, "localname": "LeaseExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r210" ], "lang": { "en-US": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_LeasesOfLesseeDisclosureTextBlock": { "auth_ref": [ "r391" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.", "label": "Leases Of Lessee Disclosure [Text Block]", "terseLabel": "Lease Accounting" } } }, "localname": "LeasesOfLesseeDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccounting" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeLeaseDescriptionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Lessee Lease Description [Line Items]", "terseLabel": "Lessee Lease Description [Line Items]" } } }, "localname": "LesseeLeaseDescriptionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfImpactOfChangesMadeToConsolidatedBalanceSheetFromAdoptionOfASC842Detail" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeaseDescriptionTable": { "auth_ref": [ "r398" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about lessee's leases.", "label": "Lessee Lease Description [Table]", "terseLabel": "Lessee Lease Description [Table]" } } }, "localname": "LesseeLeaseDescriptionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfImpactOfChangesMadeToConsolidatedBalanceSheetFromAdoptionOfASC842Detail" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r396" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee Leases Policy [Text Block]", "terseLabel": "Adoption of ASC 842" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend": { "auth_ref": [ "r397" ], "lang": { "en-US": { "role": { "documentation": "Indicates (true false) whether lessee has option to extend operating lease.", "label": "Lessee Operating Lease Existence Of Option To Extend", "terseLabel": "Existence of option to extend the lease" } } }, "localname": "LesseeOperatingLeaseExistenceOfOptionToExtend", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingAdditionalInformationDetail" ], "xbrltype": "booleanItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r404" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "Lessee Operating Lease Liability Maturity Table [Text Block]", "terseLabel": "Schedule of Maturity of Lease Liabilities" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r404" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfMaturityOfLeaseLiabilitiesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease.", "label": "Lessee Operating Lease Liability Payments Due", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfMaturityOfLeaseLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r404" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfMaturityOfLeaseLiabilitiesDetail": { "order": 10060.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth fiscal year following latest fiscal year.", "label": "Lessee Operating Lease Liability Payments Due After Year Five", "terseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfMaturityOfLeaseLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r404" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfMaturityOfLeaseLiabilitiesDetail": { "order": 10010.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next fiscal year following latest fiscal year.", "label": "Lessee Operating Lease Liability Payments Due Next Twelve Months", "terseLabel": "2020" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfMaturityOfLeaseLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r404" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfMaturityOfLeaseLiabilitiesDetail": { "order": 10050.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth fiscal year following latest fiscal year.", "label": "Lessee Operating Lease Liability Payments Due Year Five", "terseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfMaturityOfLeaseLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r404" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfMaturityOfLeaseLiabilitiesDetail": { "order": 10040.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth fiscal year following latest fiscal year.", "label": "Lessee Operating Lease Liability Payments Due Year Four", "terseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfMaturityOfLeaseLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r404" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfMaturityOfLeaseLiabilitiesDetail": { "order": 10030.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third fiscal year following latest fiscal year.", "label": "Lessee Operating Lease Liability Payments Due Year Three", "terseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfMaturityOfLeaseLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r404" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfMaturityOfLeaseLiabilitiesDetail": { "order": 10020.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second fiscal year following latest fiscal year.", "label": "Lessee Operating Lease Liability Payments Due Year Two", "terseLabel": "2021" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfMaturityOfLeaseLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r404" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee Operating Lease Liability Undiscounted Excess Amount", "negatedLabel": "Less: Interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfMaturityOfLeaseLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseOptionToExtend": { "auth_ref": [ "r397" ], "lang": { "en-US": { "role": { "documentation": "Description of terms and conditions of option to extend lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.", "label": "Lessee Operating Lease Option To Extend", "terseLabel": "Option to extend the lease term, description" } } }, "localname": "LesseeOperatingLeaseOptionToExtend", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseRenewalTerm": { "auth_ref": [ "r397" ], "lang": { "en-US": { "role": { "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee Operating Lease Renewal Term", "terseLabel": "Options to extend the lease term" } } }, "localname": "LesseeOperatingLeaseRenewalTerm", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r397" ], "lang": { "en-US": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee Operating Lease Term Of Contract", "terseLabel": "Lease term" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r45" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10010.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r29", "r422", "r442" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities And Stockholders Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities And Stockholders Equity [Abstract]", "terseLabel": "Liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r47" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10090.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities Current [Abstract]", "terseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LicensingAgreementsMember": { "auth_ref": [ "r353" ], "lang": { "en-US": { "role": { "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).", "label": "Licensing Agreements [Member]", "terseLabel": "Licensing Agreements [Member]" } } }, "localname": "LicensingAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebt": { "auth_ref": [ "r18", "r238", "r421", "r440" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long Term Debt", "totalLabel": "Net carrying amount" } } }, "localname": "LongTermDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r50" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10100.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long Term Debt Noncurrent", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r50" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-term debt.", "label": "Longterm Debt Type [Axis]", "terseLabel": "Long-term Debt, Type" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtTables", "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r50", "r235" ], "lang": { "en-US": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Longterm Debt Type [Domain]", "terseLabel": "Long-term Debt, Type" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfEquityComponentOfConvertibleDebtDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtNetCarryingAmountOfLiabilityComponentOfConvertibleDebtDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtTables", "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LossContingenciesByNatureOfContingencyAxis": { "auth_ref": [ "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r225", "r226" ], "lang": { "en-US": { "role": { "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.", "label": "Loss Contingencies By Nature Of Contingency [Axis]", "terseLabel": "Loss Contingency Nature" } } }, "localname": "LossContingenciesByNatureOfContingencyAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyAccrualAtCarryingValue": { "auth_ref": [ "r216" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of loss contingency liability.", "label": "Loss Contingency Accrual At Carrying Value", "terseLabel": "Contingent liabilities" } } }, "localname": "LossContingencyAccrualAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingencyNatureDomain": { "auth_ref": [ "r216", "r217", "r218", "r219", "r220", "r221", "r222", "r225", "r226" ], "lang": { "en-US": { "role": { "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.", "label": "Loss Contingency Nature [Domain]", "terseLabel": "Loss Contingency, Nature" } } }, "localname": "LossContingencyNatureDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MoneyMarketFundsAtCarryingValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Investment in short-term money-market instruments (such as commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and so forth) which are highly liquid (that is, readily convertible to known amounts of cash) and so near their maturity that they present an insignificant risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify as cash equivalents by definition. Original maturity means an original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three-years ago does not become a cash equivalent when its remaining maturity is three months.", "label": "Money Market Funds At Carrying Value", "terseLabel": "Money market funds" } } }, "localname": "MoneyMarketFundsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r268" ], "lang": { "en-US": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Money Market Funds [Member]" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFairValueMeasurementsFinancialInstrumentsMeasuredAtFairValueOnRecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r98" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10030.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided By Used In Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided By Used In Financing Activities [Abstract]", "terseLabel": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r98" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10020.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided By Used In Investing Activities", "totalLabel": "Net cash provided by investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided By Used In Investing Activities [Abstract]", "terseLabel": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r98", "r100", "r103" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10010.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided By Used In Operating Activities", "negatedLabel": "Cash used in operations", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided By Used In Operating Activities [Abstract]", "terseLabel": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r66", "r69", "r75", "r103", "r138", "r425", "r445" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10010.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income Loss", "negatedLabel": "Net loss", "terseLabel": "Net loss", "totalLabel": "Net loss", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSelectedQuarterlyFinancialInformationScheduleOfSelectedQuarterlyFinancialInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementEarlyAdoptionTableTextBlock": { "auth_ref": [ "r124", "r126" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of financial statement line items and the effect of the guidance on the financial statement line items if the entity elects early adoption of accounting guidance.", "label": "New Accounting Pronouncement Early Adoption Table [Text Block]", "terseLabel": "Cumulative Effect of Changes to Consolidated Balance Sheet" } } }, "localname": "NewAccountingPronouncementEarlyAdoptionTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the quantification of the effect of adopting the new accounting standard or change in accounting principle expected by the entity to have a significant effect on the entity's financial statements.", "label": "New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification", "terseLabel": "Adoption of accounting standard" } } }, "localname": "NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements Policy Policy [Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonUsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Countries excluding the United States of America (US).", "label": "Non Us [Member]", "terseLabel": "International [Member]" } } }, "localname": "NonUsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail" ], "xbrltype": "domainItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Noncash Investing And Financing Items [Abstract]", "terseLabel": "Significant non-cash transactions" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NumberOfOperatingSegments": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.", "label": "Number Of Operating Segments", "terseLabel": "Number of business activities" } } }, "localname": "NumberOfOperatingSegments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10120.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10070.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income Loss", "terseLabel": "Loss from operations", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSelectedQuarterlyFinancialInformationScheduleOfSelectedQuarterlyFinancialInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r399", "r405" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease Cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingSupplementalLeaseCostInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r394" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease Liability", "terseLabel": "Operating lease liabilities", "totalLabel": "Total operating lease liabilities", "verboseLabel": "Present value of lease liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfMaturityOfLeaseLiabilitiesDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r394" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail": { "order": 10010.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease Liability Current", "terseLabel": "Other current liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r394" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail": { "order": 10020.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10110.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease Liability Noncurrent", "terseLabel": "Long-term operating lease liabilities", "verboseLabel": "Long term operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfImpactOfChangesMadeToConsolidatedBalanceSheetFromAdoptionOfASC842Detail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r395", "r400" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease Payments", "terseLabel": "Operating cash flow from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfSupplementalCashFlowInformationRelatedToLeaseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r393" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10180.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease Right Of Use Asset", "terseLabel": "Operating lease assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfImpactOfChangesMadeToConsolidatedBalanceSheetFromAdoptionOfASC842Detail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingSummaryOfOperatingLeaseAssetsAndLiabilitiesDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r402", "r405" ], "lang": { "en-US": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease Weighted Average Discount Rate Percent", "terseLabel": "Weighted-average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesDetail" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r401", "r405" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease Weighted Average Remaining Lease Term1", "terseLabel": "Weighted-average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfWeightedAverageLeaseTermsAndDiscountsRatesDetail" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent": { "auth_ref": [ "r389", "r390" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Operating Leases Future Minimum Payments Due Current", "terseLabel": "Lease expense, payment due" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsDueCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r340" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Net operating loss carryforward" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperationsCommencedDate1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Date the operations of the entity commenced, in CCYY-MM-DD format.", "label": "Operations Commenced Date1", "terseLabel": "Lease commencement date" } } }, "localname": "OperationsCommencedDate1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "dateItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r0", "r364" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]", "terseLabel": "Formation and Business of the Company" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompany" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r8", "r9", "r10", "r46" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail": { "order": 10070.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Accrued Liabilities Current", "terseLabel": "Accrued other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10190.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCommitmentsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Other Commitments [Line Items]", "terseLabel": "Other Commitments [Line Items]" } } }, "localname": "OtherCommitmentsLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_OtherCommitmentsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about obligations resulting from other commitments.", "label": "Other Commitments [Table]", "terseLabel": "Other Commitments [Table]" } } }, "localname": "OtherCommitmentsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r356", "r357", "r360" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10040.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities, attributable to parent entity. Excludes amounts related to other than temporary impairment (OTTI) loss.", "label": "Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent", "terseLabel": "Changes in unrealized gains (losses) on short-term investments, net" } } }, "localname": "OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r356", "r357", "r360" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10030.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.", "label": "Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent", "terseLabel": "Changes in foreign currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive Income Loss Net Of Tax Period Increase Decrease [Abstract]", "terseLabel": "Other comprehensive loss:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r67", "r70", "r356", "r357", "r360" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10020.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent", "terseLabel": "Other comprehensive loss", "totalLabel": "Net change in other comprehensive loss" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r7", "r8", "r46" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10150.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities Current", "terseLabel": "Other current liabilities" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfImpactOfChangesMadeToConsolidatedBalanceSheetFromAdoptionOfASC842Detail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r51" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10120.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities Noncurrent", "terseLabel": "Other long-term liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfImpactOfChangesMadeToConsolidatedBalanceSheetFromAdoptionOfASC842Detail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r85" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10100.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income Expense", "terseLabel": "Other income (expense), net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over Allotment Option [Member]", "terseLabel": "Over Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Payables And Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "auth_ref": [ "r95" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10050.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Payments Related To Tax Withholding For Share Based Compensation", "negatedLabel": "Minimum tax withholding paid on behalf of employees for net share settlement" } } }, "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": { "auth_ref": [ "r88", "r91", "r176" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10070.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Payments To Acquire Available For Sale Securities Debt", "negatedLabel": "Purchases of short-term investments" } } }, "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r92" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10110.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments To Acquire Property Plant And Equipment", "negatedLabel": "Purchases of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r276", "r308" ], "lang": { "en-US": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Plan name for share-based payment arrangement.", "label": "Plan Name [Domain]", "terseLabel": "Plan Name" } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PostemploymentBenefitsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Postemployment Benefits [Abstract]" } } }, "localname": "PostemploymentBenefitsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r22" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock Par Or Stated Value Per Share", "terseLabel": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r22" ], "lang": { "en-US": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r22" ], "lang": { "en-US": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r22" ], "lang": { "en-US": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding", "verboseLabel": "Convertible preferred stock outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockTextBlock": { "auth_ref": [ "r256" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.", "label": "Preferred Stock [Text Block]", "terseLabel": "Convertible Preferred Stock" } } }, "localname": "PreferredStockTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureConvertiblePreferredStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r22" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10040.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock Value", "terseLabel": "Preferred stock, $0.001 par value, 10,000,000 shares authorized at December 31, 2019 and 2018, respectively; zero shares issued and outstanding at December 31, 2019 and 2018, respectively" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r4", "r37", "r38" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10250.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense And Other Assets Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueCumulativeEffectOfChangesToConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDebtNetOfIssuanceCosts": { "auth_ref": [ "r94" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from additional borrowings, net of cash paid to third parties in connection with debt origination.", "label": "Proceeds From Debt Net Of Issuance Costs", "terseLabel": "Net proceeds from the debt offering after deducting transaction costs" } } }, "localname": "ProceedsFromDebtNetOfIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r93" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds From Issuance Initial Public Offering", "terseLabel": "Net proceeds from common stock" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": { "auth_ref": [ "r93", "r309" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.", "label": "Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans", "terseLabel": "Cash received from unvested shares" } } }, "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": { "auth_ref": [ "r93", "r309" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10060.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.", "label": "Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options", "terseLabel": "Proceeds from issuance of common stock to employees" } } }, "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r93" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds From Issuance Of Warrants", "terseLabel": "Proceeds from issuance of warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": { "auth_ref": [ "r88", "r89", "r176" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10090.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Proceeds From Sale And Maturity Of Available For Sale Securities", "terseLabel": "Proceeds from maturity of short-term investments" } } }, "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfShortTermInvestments": { "auth_ref": [ "r90" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10080.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.", "label": "Proceeds From Sale Of Short Term Investments", "terseLabel": "Proceeds from sales of short-term investments" } } }, "localname": "ProceedsFromSaleOfShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r66", "r69", "r97", "r166", "r167", "r356", "r358", "r359", "r362", "r363" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10120.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Profit Loss", "terseLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Property Plant And Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r42", "r212" ], "lang": { "en-US": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property Plant And Equipment By Type [Axis]", "terseLabel": "Property, Plant and Equipment, Type" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r41", "r210" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail": { "order": 10010.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property Plant And Equipment Gross", "terseLabel": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property Plant And Equipment [Line Items]", "terseLabel": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r13", "r14", "r212", "r443" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10170.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property Plant And Equipment Net", "terseLabel": "Property and equipment, net", "totalLabel": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r40", "r111", "r212" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, basis of assets, depreciation and depletion methods used, including composite deprecation, estimated useful lives, capitalization policy, accounting treatment for costs incurred for repairs and maintenance, capitalized interest and the method it is calculated, disposals and impairments.", "label": "Property Plant And Equipment Policy [Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r13", "r212" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property Plant And Equipment [Text Block]", "terseLabel": "Schedule of Property and Equipment, Net and Depreciation and Amortization Expense" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r13", "r210" ], "lang": { "en-US": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property Plant And Equipment Type [Domain]", "terseLabel": "Property, Plant and Equipment, Type" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Property Plant And Equipment Useful Life", "terseLabel": "Estimated useful life of property and equipment" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r76", "r194" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10170.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Provision For Doubtful Accounts", "terseLabel": "Provision for (recovery of) doubtful accounts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PurchaseObligationDueInNextTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Minimum amount of purchase arrangement maturing in the next fiscal year following the latest fiscal year. Includes, but not limited to, recorded and unrecorded purchase obligations, long-term purchase commitments, and short-term purchase commitments.", "label": "Purchase Obligation Due In Next Twelve Months", "terseLabel": "Purchase commitment, amount due in 2020" } } }, "localname": "PurchaseObligationDueInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_QuarterlyFinancialInformationDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Quarterly Financial Information Disclosure [Abstract]" } } }, "localname": "QuarterlyFinancialInformationDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_QuarterlyFinancialInformationTextBlock": { "auth_ref": [ "r147" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information.", "label": "Quarterly Financial Information [Text Block]", "terseLabel": "Selected Quarterly Financial Information" } } }, "localname": "QuarterlyFinancialInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSelectedQuarterlyFinancialInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": { "auth_ref": [ "r31", "r111", "r173" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.", "label": "Receivables Trade And Other Accounts Receivable Allowance For Doubtful Accounts Policy", "terseLabel": "Allowance for Doubtful Accounts" } } }, "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r270", "r406", "r408" ], "lang": { "en-US": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]", "terseLabel": "Related Party Transaction" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]", "terseLabel": "Related Party Transaction" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms": { "auth_ref": [ "r316", "r317" ], "lang": { "en-US": { "role": { "documentation": "Describes the terms of significant agreements under research and development arrangements accounted for as a contract to perform research and development for others (including royalty arrangements, purchase provisions, license agreements, and commitments to provide additional funding), aggregated by similar arrangements or individually if necessary to understand the effects on the financial statements.", "label": "Research And Development Arrangement Contract To Perform For Others Description And Terms", "terseLabel": "License agreement, terms" } } }, "localname": "ResearchAndDevelopmentArrangementContractToPerformForOthersDescriptionAndTerms", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r315", "r457" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10130.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research And Development Expense", "terseLabel": "Research and development", "verboseLabel": "Retainer fees" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.", "label": "Research And Development Expense [Member]", "terseLabel": "Research and Development [Member]" } } }, "localname": "ResearchAndDevelopmentExpenseMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r111", "r315" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research And Development Expense Policy", "terseLabel": "Research and Development" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchMember": { "auth_ref": [ "r341" ], "lang": { "en-US": { "role": { "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.", "label": "Research [Member]", "terseLabel": "Research and Development Credit Carryforwards [Member]" } } }, "localname": "ResearchMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis": { "auth_ref": [ "r39" ], "lang": { "en-US": { "role": { "documentation": "Information by category of cash or cash equivalent items which are restricted as to withdrawal or usage.", "label": "Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Axis]", "terseLabel": "Restricted Cash and Cash Equivalents" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash And Cash Equivalents Cash And Cash Equivalents [Member]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsNoncurrent": { "auth_ref": [ "r6", "r15", "r104", "r110", "r454" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10200.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Restricted Cash And Cash Equivalents Noncurrent", "terseLabel": "Restricted cash" } } }, "localname": "RestrictedCashAndCashEquivalentsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r137" ], "lang": { "en-US": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Unreleased Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units R S U [Member]", "terseLabel": "RSU's [Member]", "verboseLabel": "Restricted Stock Units [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r26", "r255", "r441" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10080.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings Accumulated Deficit", "negatedLabel": "Accumulated deficit", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueCumulativeEffectOfChangesToConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenue From Contract With Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r259", "r260" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10150.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue From Contract With Customer Excluding Assessed Tax", "terseLabel": "Revenue", "verboseLabel": "Total revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedStatementOfOperationsDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueSummaryOfRevenueByGeographyOnBillingAddressOfCustomerDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSelectedQuarterlyFinancialInformationScheduleOfSelectedQuarterlyFinancialInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r265" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue From Contract With Customer [Text Block]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenue Initial Application Period Cumulative Effect Transition [Abstract]" } } }, "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue Initial Application Period Cumulative Effect Transition [Line Items]", "terseLabel": "Revenue Initial Application Period Cumulative Effect Transition [Line Items]" } } }, "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueCumulativeEffectOfChangesToConsolidatedBalanceSheetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueInitialApplicationPeriodCumulativeEffectTransitionTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information when using transition method for cumulative effect in initial period of application for revenue from contract with customer.", "label": "Revenue Initial Application Period Cumulative Effect Transition [Table]", "terseLabel": "Revenue Initial Application Period Cumulative Effect Transition [Table]" } } }, "localname": "RevenueInitialApplicationPeriodCumulativeEffectTransitionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueCumulativeEffectOfChangesToConsolidatedBalanceSheetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r112", "r113" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition Policy [Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation": { "auth_ref": [ "r258" ], "lang": { "en-US": { "role": { "documentation": "Description of when remaining performance obligation is expected to be recognized as revenue.", "label": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation", "terseLabel": "Unsatisfied performance obligations description" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]", "terseLabel": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Line Items]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail1" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "auth_ref": [ "r257" ], "lang": { "en-US": { "role": { "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1", "terseLabel": "Unsatisfied performance obligations period" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail1" ], "xbrltype": "durationItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "auth_ref": [ "r257" ], "lang": { "en-US": { "role": { "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.", "label": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Start Date [Axis]", "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail1" ], "xbrltype": "stringItemType" }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.", "label": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Table]", "terseLabel": "Revenue Remaining Performance Obligation Expected Timing Of Satisfaction [Table]" } } }, "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueAdditionalInformationDetail1" ], "xbrltype": "stringItemType" }, "us-gaap_RoyaltyExpense": { "auth_ref": [ "r81" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.", "label": "Royalty Expense", "terseLabel": "Annual royalty payment" } } }, "localname": "RoyaltyExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale Of Stock Name Of Transaction [Domain]", "terseLabel": "Sale of Stock" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r156" ], "lang": { "en-US": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Sales Revenue Net [Member]", "terseLabel": "Revenue [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesScheduleOfRevenueByMajorCustomersByGeographicAreaDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "Schedule Of Accrued Liabilities Table [Text Block]", "terseLabel": "Summary of Accrued Liabilities" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r137" ], "lang": { "en-US": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]", "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r137" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block]", "terseLabel": "Computation of Potentially Dilutive Securities Outstanding Excluded from Computation of Diluted Shares" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Schedule Of Available For Sale Securities [Line Items]", "terseLabel": "Schedule of Available-for-sale Securities [Line Items]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAvailableForSaleSecuritiesTable": { "auth_ref": [ "r183", "r186", "r187", "r188", "r189", "r190", "r427", "r430" ], "lang": { "en-US": { "role": { "documentation": "Schedule of available-for-sale securities which includes, but is not limited to, changes in the cost basis and fair value, fair value and gross unrealized gain (loss), fair values by type of security, contractual maturity and classification, amortized cost basis, contracts to acquire securities to be accounted for as available-for-sale, debt maturities, transfers to trading, change in net unrealized holding gain (loss) net of tax, continuous unrealized loss position fair value, aggregate losses qualitative disclosures, other than temporary impairment (OTTI) losses or other disclosures related to available for sale securities.", "label": "Schedule Of Available For Sale Securities [Table]", "terseLabel": "Schedule Of Available For Sale Securities [Table]" } } }, "localname": "ScheduleOfAvailableForSaleSecuritiesTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfGrossUnrealizedGainsAndUnrealizedLossesOfInvestmentSecuritiesExcludingInvestmentsInMoneyMarketFundsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": { "auth_ref": [ "r304" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.", "label": "Schedule Of Compensation Cost For Share Based Payment Arrangements Allocation Of Share Based Compensation Costs By Plan Table [Text Block]", "terseLabel": "Summary of Stock-Based Compensation Expense" } } }, "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r346" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "Schedule Of Components Of Income Tax Expense Benefit Table [Text Block]", "terseLabel": "Components of Expense/(Benefit) for Income Taxes" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r138" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule Of Earnings Per Share Basic And Diluted Table [Text Block]", "terseLabel": "Computation of Basic and Diluted Net Loss per Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": { "auth_ref": [ "r80", "r132", "r133", "r134", "r136", "r140" ], "lang": { "en-US": { "role": { "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.", "label": "Schedule Of Earnings Per Share Diluted By Common Class [Table]", "terseLabel": "Schedule Of Earnings Per Share Diluted By Common Class [Table]" } } }, "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r325" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "Schedule Of Effective Income Tax Rate Reconciliation Table [Text Block]", "terseLabel": "Income Tax Expense by Applying Statutory Federal Income Tax Rate" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": { "auth_ref": [ "r275", "r304", "r311" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.", "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]", "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": { "auth_ref": [ "r275", "r304", "r311" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.", "label": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Text Block]", "terseLabel": "Summary of Stock-Based Compensation Expense by Line Items in Consolidated Statements of Operations" } } }, "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": { "auth_ref": [ "r118" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions.", "label": "Schedule Of Income Before Income Tax Domestic And Foreign Table [Text Block]", "terseLabel": "Components of Loss before Income Taxes" } } }, "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r11", "r34", "r35", "r36" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Schedule Of Inventory Current Table [Text Block]", "terseLabel": "Components of Inventories" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": { "auth_ref": [ "r124", "r126", "r142", "r143", "r146" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.", "label": "Schedule Of New Accounting Pronouncements And Changes In Accounting Principles [Text Block]", "terseLabel": "Schedule of Impact of Changes Made to the Consolidated Balance Sheet from the Adoption of ASC 842" } } }, "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingTables", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r232" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "Schedule Of Product Warranty Liability Table [Text Block]", "terseLabel": "Schedule of Activities Related to Warranty Obligations" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r42", "r212" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Schedule Of Property Plant And Equipment [Table]", "terseLabel": "Schedule Of Property Plant And Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsScheduleOfPropertyAndEquipmentNetDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfQuarterlyFinancialInformationTableTextBlock": { "auth_ref": [ "r145" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of quarterly financial data. Includes, but is not limited to, financial information for fiscal quarters, cumulative effect of a change in accounting principle and earnings per share data.", "label": "Schedule Of Quarterly Financial Information Table [Text Block]", "terseLabel": "Schedule of Selected Quarterly Financial Information" } } }, "localname": "ScheduleOfQuarterlyFinancialInformationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSelectedQuarterlyFinancialInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.", "label": "Schedule Of Revenue By Major Customers By Reporting Segments Table [Text Block]", "terseLabel": "Schedule of Revenue by Major Customers by Geographic Area" } } }, "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock": { "auth_ref": [ "r295" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the total intrinsic value of options exercised (or share units converted), share-based liabilities paid, and the total fair value of shares vested during the year.", "label": "Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value Table [Text Block]", "terseLabel": "Summary of Shares Available for Grant" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r276", "r308" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]", "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock": { "auth_ref": [ "r303" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of employee stock purchase plan activity.", "label": "Schedule Of Share Based Compensation Employee Stock Purchase Plan Activity Table [Text Block]", "terseLabel": "Schedule of Employee Stock Purchase Plan Activity" } } }, "localname": "ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": { "auth_ref": [ "r282" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.", "label": "Schedule Of Share Based Compensation Restricted Stock Units Award Activity Table [Text Block]", "terseLabel": "Summary of Restricted Stock Units under the Stock Plan" } } }, "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable": { "auth_ref": [ "r308" ], "lang": { "en-US": { "role": { "documentation": "Details comprising a table providing supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table]", "terseLabel": "Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock": { "auth_ref": [ "r308" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.", "label": "Schedule Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Text Block]", "terseLabel": "Summary of Options Outstanding and Vested under Stock Plans by Exercise Price" } } }, "localname": "ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r282", "r293", "r296" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Schedule Of Share Based Compensation Stock Options Activity Table [Text Block]", "terseLabel": "Summary of Activity under Stock Plans" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r299" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "Schedule Of Share Based Payment Award Stock Options Valuation Assumptions Table [Text Block]", "terseLabel": "Schedule of Fair Value of Employee Stock Options Using Black-Scholes Option Valuation and Monte Carlo Simulation Model" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r53", "r116", "r243", "r244", "r245", "r247", "r248", "r249", "r252", "r253", "r254", "r255" ], "lang": { "en-US": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule Of Stock By Class [Table]", "terseLabel": "Schedule Of Stock By Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock": { "auth_ref": [ "r307" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of cost not yet recognized and weighted-average period over which cost is expected to be recognized for nonvested award under share-based payment arrangement.", "label": "Schedule Of Unrecognized Compensation Cost Nonvested Awards Table [Text Block]", "terseLabel": "Summary of Stock-Based Compensation Expense Not Yet Recognized" } } }, "localname": "ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": { "auth_ref": [ "r332", "r347" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the change in unrecognized tax benefits.", "label": "Schedule Of Unrecognized Tax Benefits Roll Forward Table [Text Block]", "terseLabel": "Summary of Unrecognized Tax Benefits" } } }, "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r111" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting Policy Policy [Text Block]", "terseLabel": "Segments" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r82", "r196" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": { "order": 10140.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling General And Administrative Expense", "terseLabel": "Sales, general and administrative" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [ "r87" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling General And Administrative Expenses [Member]", "terseLabel": "Selling, General and Administrative [Member]" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseByLineItemsInConsolidatedStatementsOfOperationsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ServiceAgreementsMember": { "auth_ref": [ "r354" ], "lang": { "en-US": { "role": { "documentation": "Limited duration contract between, for example, an electricity transmission customer and an electricity transmission provider for service.", "label": "Service Agreements [Member]", "terseLabel": "Service Agreement [Member]" } } }, "localname": "ServiceAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r101" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": { "order": 10150.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share Based Compensation", "terseLabel": "Stock-based compensation expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r277" ], "lang": { "en-US": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1", "terseLabel": "Vesting term" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "auth_ref": [ "r287" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period", "negatedLabel": "Number of Restricted Stock Units, Restricted stock cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "auth_ref": [ "r291" ], "lang": { "en-US": { "role": { "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value, Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r289" ], "lang": { "en-US": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period", "terseLabel": "Number of Restricted Stock Units, Restricted stock granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r289" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r288" ], "lang": { "en-US": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number", "periodEndLabel": "Number of Restricted Stock Units, Outstanding Ending Balance", "periodStartLabel": "Number of Restricted Stock Units, Outstanding Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r288" ], "lang": { "en-US": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value", "periodEndLabel": "Weighted Average Grant Date Fair Value Outstanding, Ending Balance", "periodStartLabel": "Weighted Average Grant Date Fair Value Outstanding, Beginning Balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r290" ], "lang": { "en-US": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period", "negatedLabel": "Number of Restricted Stock Units, Restricted stock released" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r290" ], "lang": { "en-US": { "role": { "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value, Released" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r301" ], "lang": { "en-US": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate", "terseLabel": "Dividend Yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum", "terseLabel": "Expected volatility, maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum", "terseLabel": "Expected volatility, minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r302" ], "lang": { "en-US": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate", "terseLabel": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum", "terseLabel": "Risk-free interest rate, maximum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum", "terseLabel": "Risk-free interest rate, minimum" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": { "auth_ref": [ "r308" ], "lang": { "en-US": { "role": { "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Maximum Employee Subscription Rate", "terseLabel": "Maximum employee subscription rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized", "positiveVerboseLabel": "Additional shares reserved", "terseLabel": "Additional awards authorized under plan", "verboseLabel": "Shares Available for Grant, Additional shares reserved" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r308" ], "lang": { "en-US": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant", "periodEndLabel": "Shares Available for Grant, Ending balances", "periodStartLabel": "Shares Available for Grant, Beginning balances", "terseLabel": "Number of shares available for sale", "verboseLabel": "Shares available for future issuance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r285" ], "lang": { "en-US": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number", "terseLabel": "Number of Options, Options exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r285" ], "lang": { "en-US": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Options exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r295" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value", "terseLabel": "Options exercised, Aggregate Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r287" ], "lang": { "en-US": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period", "negatedLabel": "Number of Options, Options cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross", "terseLabel": "Number of Options, Options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r294" ], "lang": { "en-US": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value", "terseLabel": "Weighted-average grant-date fair value of options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r308" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value", "terseLabel": "Options Outstanding, Aggregate Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r284", "r308" ], "lang": { "en-US": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number", "periodEndLabel": "Number of Options, Outstanding Ending balances", "periodStartLabel": "Number of Options, Outstanding Beginning balances" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r283" ], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price, Ending balances", "periodStartLabel": "Weighted Average Exercise Price, Beginning balances" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [ "r296" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value", "terseLabel": "Options vested, exercisable or expected to vest, Aggregate Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [ "r297" ], "lang": { "en-US": { "role": { "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number", "terseLabel": "Number of Options, Options vested, exercisable or expected to vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r297" ], "lang": { "en-US": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Options vested, exercisable or expected to vest" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms": { "auth_ref": [ "r306" ], "lang": { "en-US": { "role": { "documentation": "Description of modification of award under share-based payment arrangement. Includes, but is not limited to, terms for expiration date, vesting rights and exercise price.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms", "terseLabel": "Plan modification description" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "auth_ref": [ "r308" ], "lang": { "en-US": { "role": { "documentation": "Number of shares issued under share-based payment arrangement.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period", "terseLabel": "Shares issued" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r274", "r279" ], "lang": { "en-US": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]", "terseLabel": "Award Type" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfEmployeeStockPurchasePlanActivityDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfPerformanceBasedRussBasedOnMonteCarloSimulationModelDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfSharesAvailableForGrantDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseNotYetRecognizedDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationTables", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Options exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Options cancelled" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Options granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share Based Compensation Award Tranche One [Member]", "terseLabel": "Share-based Compensation Award, Tranche One [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheOneMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r111", "r276", "r280" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Share Based Compensation Option And Incentive Plans Policy", "terseLabel": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r298" ], "lang": { "en-US": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Axis]", "terseLabel": "Exercise Price Range" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r303" ], "lang": { "en-US": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Domain]", "terseLabel": "Exercise Price Range" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]", "terseLabel": "Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit": { "auth_ref": [ "r303" ], "lang": { "en-US": { "role": { "documentation": "The floor of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit", "terseLabel": "Options Outstanding, Exercise Price Lower Range Limit" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r292" ], "lang": { "en-US": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options", "terseLabel": "Options Vested, Number Exercisable" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions": { "auth_ref": [ "r284" ], "lang": { "en-US": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding stock options as of the balance sheet date for all option plans in the customized range of exercise prices.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options", "terseLabel": "Number of Options Outstanding" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit": { "auth_ref": [ "r303" ], "lang": { "en-US": { "role": { "documentation": "The ceiling of a customized range of exercise prices for purposes of disclosing shares potentially issuable under outstanding stock option awards on all stock option plans and other required information pertaining to awards in the customized range.", "label": "Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit", "terseLabel": "Options Outstanding, Exercise Price Upper Range Limit" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding", "terseLabel": "Aggregate Intrinsic Value Outstanding" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Intrinsic value of vested award under share-based payment arrangement. Excludes share and unit options.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested", "terseLabel": "Aggregate Intrinsic Value, Released" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfRestrictedStockUnitsUnderStockPlanDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "auth_ref": [ "r278" ], "lang": { "en-US": { "role": { "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period", "terseLabel": "Stock options expiration period" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r300", "r310" ], "lang": { "en-US": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1", "terseLabel": "Expected term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationScheduleOfFairValueOfEmployeeStockOptionsUsingBlackScholesOptionValuationModelDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "auth_ref": [ "r308" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1", "terseLabel": "Options exercisable, Aggregate Intrinsic Value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r308" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1", "terseLabel": "Options exercisable, Weighted-Average Remaining Contractual Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares", "terseLabel": "Stock options unvested shares" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r297" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2", "terseLabel": "Options Outstanding, Weighted-Average Remaining Contractual Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r297" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1", "terseLabel": "Options vested, exercisable or expected to vest, Weighted Average Remaining Contractual Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r281" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1", "terseLabel": "Fair value of options vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Purchase price of common stock expressed as a percentage of its fair value.", "label": "Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent", "terseLabel": "Option purchase price, percentage of fair value" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [ "r285" ], "lang": { "en-US": { "role": { "documentation": "Weighted average exercise price as of the balance sheet date for those equity-based payment arrangements exercisable and outstanding.", "label": "Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1", "terseLabel": "Options Vested, Weighted Average Exercise Price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r284" ], "lang": { "en-US": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1", "terseLabel": "Options Outstanding, Weighted Average Exercise Price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r297" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2", "terseLabel": "Options Outstanding, Weighted Average Remaining Contractual Life (in Years)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsOutstandingAndVestedUnderStockPlansByExercisePriceDetail" ], "xbrltype": "durationItemType" }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "auth_ref": [ "r256", "r314" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).", "label": "Shareholders Equity And Share Based Payments [Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued Price Per Share", "terseLabel": "Common stock, shares issued price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares Outstanding", "periodEndLabel": "Ending balances, shares", "periodStartLabel": "Beginning balances, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Shares Paid For Tax Withholding For Share Based Compensation", "negatedLabel": "Shares withheld for tax obligations, shares" } } }, "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r123" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StandardProductWarrantyAccrualCurrent": { "auth_ref": [], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail": { "order": 10060.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability that is expected to be paid within one year or the normal operating cycle, if longer. Does not include the balance for the extended product warranty liability.", "label": "Standard Product Warranty Accrual Current", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "terseLabel": "Accrued warranty" } } }, "localname": "StandardProductWarrantyAccrualCurrent", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponentsSummaryOfAccruedLiabilitiesDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfActivitiesRelatedToWarrantyObligationsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrualPayments": { "auth_ref": [ "r228" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in the standard product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard product warranty. Excludes extended product warranties.", "label": "Standard Product Warranty Accrual Payments", "negatedLabel": "Utilization" } } }, "localname": "StandardProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfActivitiesRelatedToWarrantyObligationsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r229" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in the standard product warranty accrual from warranties issued. Excludes extended product warranties.", "label": "Standard Product Warranty Accrual Warranties Issued", "terseLabel": "Provision for warranty" } } }, "localname": "StandardProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfActivitiesRelatedToWarrantyObligationsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StandardProductWarrantyDescription": { "auth_ref": [ "r227", "r230" ], "lang": { "en-US": { "role": { "documentation": "Describes the nature of the product warranty, including the approximate term of the product warranty, how the product warranty arose, and the events or circumstances that would require the warrantor to perform under the product warranty.", "label": "Standard Product Warranty Description", "verboseLabel": "Standard product warranty, description" } } }, "localname": "StandardProductWarrantyDescription", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StandardProductWarrantyPolicy": { "auth_ref": [ "r111", "r231" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.", "label": "Standard Product Warranty Policy", "terseLabel": "Warranty Obligations" } } }, "localname": "StandardProductWarrantyPolicy", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State And Local Jurisdiction [Member]", "terseLabel": "State and Local Jurisdiction [Member]" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r55", "r246" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Statement Equity Components [Axis]", "terseLabel": "Equity Components" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingTables", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationTables", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement Of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement Of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement Of Stockholders Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingTables", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationTables", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": { "auth_ref": [ "r22", "r23", "r246", "r255" ], "lang": { "en-US": { "role": { "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.", "label": "Stock Issued During Period Shares Employee Stock Purchase Plans", "terseLabel": "Issuance of common stock under employee stock purchase plan, shares" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r22", "r23", "r246", "r255" ], "lang": { "en-US": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period Shares New Issues", "verboseLabel": "Common stock, shares issued" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": { "auth_ref": [ "r246", "r255" ], "lang": { "en-US": { "role": { "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.", "label": "Stock Issued During Period Shares Restricted Stock Award Gross", "terseLabel": "Issuance of common stock upon release of restricted stock units" } } }, "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r22", "r23", "r246", "r255", "r286" ], "lang": { "en-US": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Stock Issued During Period Shares Stock Options Exercised", "negatedLabel": "Number of Options, Options exercised", "terseLabel": "Exercise of common stock options, shares" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationSummaryOfActivityUnderStockPlansDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": { "auth_ref": [ "r22", "r23", "r246", "r255" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.", "label": "Stock Issued During Period Value Employee Stock Purchase Plan", "terseLabel": "Issuance of common stock under employee stock purchase plan" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r55", "r246", "r255" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period Value Stock Options Exercised", "terseLabel": "Exercise of common stock options" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r23", "r27", "r28", "r174" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets": { "order": 10030.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders Equity", "periodEndLabel": "Ending balances", "periodStartLabel": "Beginning balances", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders Equity [Abstract]", "terseLabel": "Stockholders\u2019 equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]", "terseLabel": "Subsidiary Or Equity Method Investee Sale Of Stock By Subsidiary Or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Subsidiary Sale Of Stock [Axis]", "terseLabel": "Sale of Stock" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureConvertiblePreferredStockAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary Sale Of Stock [Line Items]", "terseLabel": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureFormationAndBusinessOfCompanyAdditionalInformationPublicOfferingDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": { "auth_ref": [ "r341" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Summary Of Operating Loss Carryforwards [Text Block]", "terseLabel": "Tax Effects of Temporary Differences and Carryforwards that Give Rise to Significant Portions of Deferred Tax Assets and Liabilities" } } }, "localname": "SummaryOfOperatingLossCarryforwardsTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "auth_ref": [ "r60" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "terseLabel": "Balance Sheet Components" } } }, "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureBalanceSheetComponents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental disclosures of cash flow information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardAmount": { "auth_ref": [ "r340" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Tax Credit Carryforward Amount", "positiveLabel": "Tax credit carry forwards" } } }, "localname": "TaxCreditCarryforwardAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_TaxCreditCarryforwardAxis": { "auth_ref": [ "r341" ], "lang": { "en-US": { "role": { "documentation": "Information by specific tax credit related to an unused tax credit.", "label": "Tax Credit Carryforward [Axis]", "terseLabel": "Tax Credit Carryforward" } } }, "localname": "TaxCreditCarryforwardAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_TaxCreditCarryforwardNameDomain": { "auth_ref": [ "r341" ], "lang": { "en-US": { "role": { "documentation": "The name of the tax credit carryforward.", "label": "Tax Credit Carryforward Name [Domain]", "terseLabel": "Tax Credit Carryforward, Name" } } }, "localname": "TaxCreditCarryforwardNameDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Adoption and early adoption of sources of change to generally accepted accounting principles (GAAP) in the United States. The FASB released the FASB Accounting Standards Codification as the authoritative source of literature effective for interim and annual periods ending after September 15, 2009. As part of the Codification process, the FASB issues Accounting Standards Updates to amend the Codification but otherwise the Accounting Standards Updates are not authoritative in their own right. All previous accounting standards (such as FASB Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Emerging Issues Task Force Consensuses, other pronouncements of the FASB or other designated bodies, or other forms of GAAP are considered accounting pronouncements) were superseded upon the adoption of the Codification. For an interim period, references to the superseded standards are included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.", "label": "Type Of Adoption [Member]", "terseLabel": "Type of Adoption" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingScheduleOfImpactOfChangesMadeToConsolidatedBalanceSheetFromAdoptionOfASC842Detail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureLeaseAccountingTables", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueCumulativeEffectOfChangesToConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedBalanceSheetDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueImpactOfAdoptionOnConsolidatedStatementOfOperationsDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureRevenueTables" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r355" ], "lang": { "en-US": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Type Of Arrangement [Axis]", "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r321", "r329" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r330" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions", "negatedLabel": "Decreases related to prior year tax provisions" } } }, "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r327" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued", "terseLabel": "Accrued interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": { "auth_ref": [ "r331" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.", "label": "Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions", "terseLabel": "Increases related to current year tax provisions" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": { "auth_ref": [ "r330" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.", "label": "Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions", "terseLabel": "Increases related to prior year tax provisions" } } }, "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesSummaryOfUnrecognizedTaxBenefitsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r148", "r149", "r151", "r152", "r159", "r160", "r161" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use Of Estimates", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r322" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance Deferred Tax Asset Change In Amount", "terseLabel": "Increase in valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r308" ], "lang": { "en-US": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]", "terseLabel": "Vesting" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r308" ], "lang": { "en-US": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Domain]", "terseLabel": "Vesting" } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant [Member]", "verboseLabel": "Warrants Related to the Issuance of Convertible Senior Notes [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureLongTermDebtAdditionalInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfPotentiallyDilutiveSecuritiesOutstandingExcludedFromComputationOfDilutedSharesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number Of Share Outstanding Basic And Diluted", "terseLabel": "Weighted average number of common shares used to compute basic and diluted net loss per share", "totalLabel": "Weighted average shares used to compute basic and diluted net loss per share", "verboseLabel": "Shares used in computing net loss per common share, basic and diluted" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail", "http://www.nevro.com/20191231/taxonomy/role/DisclosureSelectedQuarterlyFinancialInformationScheduleOfSelectedQuarterlyFinancialInformationDetail", "http://www.nevro.com/20191231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation": { "auth_ref": [ "r131" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail": { "order": 10020.0, "parentTag": "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "weight": -1.0 } }, "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock subject to repurchase or cancellation determined by relating the portion of time within a reporting period that these shares have been outstanding to the total time in that period. Common stock subject to repurchase are outstanding common shares that are contingently returnable (that is, subject to recall).", "label": "Weighted Average Number Of Shares Common Stock Subject To Repurchase Or Cancellation", "negatedLabel": "Less: weighted average shares subject to repurchase" } } }, "localname": "WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r130", "r136" ], "calculation": { "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail": { "order": 10010.0, "parentTag": "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number Of Shares Outstanding Basic", "terseLabel": "Weighted average shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2019-01-31", "presentation": [ "http://www.nevro.com/20191231/taxonomy/role/DisclosureNetLossPerShareComputationOfBasicAndDilutedNetLossPerShareDetail" ], "xbrltype": "sharesItemType" } }, "unitCount": 11 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e7018-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3044-108585" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4273-108586" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4297-108586" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(iii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(d),(e))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(i)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(i)(4))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r123": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1448-109256" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e2646-109256" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1252-109256" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1278-109256" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1311-109256" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117326831&loc=d3e1337-109256" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=117327953&loc=d3e4984-109258" }, "r141": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e725-108305" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e765-108305" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=118952077&loc=d3e1280-108306" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.10-01.(b)(6))", "Topic": "270", "URI": "http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699" }, "r147": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "270", "URI": "http://asc.fasb.org/topic&trid=2126967" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4647-111522" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4428-111522" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118952595&loc=d3e4531-111522" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5074-111524" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=118936363&loc=d3e5144-111524" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26610-111562" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26853-111562" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118954083&loc=d3e26626-111562" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(aa)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27161-111563" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27198-111563" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27290-111563" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27337-111563" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27340-111563" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=118939692&loc=d3e27357-111563" }, "r191": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "http://asc.fasb.org/topic&trid=2196928" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118955202&loc=SL82895884-210446" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=119407570&loc=SL82919249-210447" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=118942338&loc=SL82898722-210454" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116846819&loc=d3e3927-108312" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4578-108314" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r215": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14326-108349" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14615-108349" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14394-108349" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14435-108349" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14453-108349" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14472-108349" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=118942415&loc=d3e14557-108349" }, "r223": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=99404985&loc=d3e10037-110241" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12021-110248" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12053-110248" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=118943654&loc=d3e12069-110248" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=118956092&loc=d3e13051-110250" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031897-161870" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6031898-161870" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=109500613&loc=SL6036836-161870" }, "r242": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r256": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130543-203045" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118956577&loc=SL49130549-203045" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=118944142&loc=SL49130690-203046-203046" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(i)(1)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=113356391&loc=SL49131195-203048" }, "r265": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r266": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "710", "URI": "http://asc.fasb.org/topic&trid=2127225" }, "r267": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "http://asc.fasb.org/topic&trid=2197446" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921" }, "r272": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116855982&loc=d3e4534-113899" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5047-113901" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)-(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(3)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=d3e5070-113901" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=116856206&loc=SL79508275-113901" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11149-113907" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=118258462&loc=d3e11178-113907" }, "r314": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23199-108380" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420387&loc=d3e23221-108380" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=117330534&loc=d3e28680-109314" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=SL37586934-109318" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32123-109318" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32247-109318" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116821951&loc=d3e32280-109318" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b),(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "217", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=117331294&loc=d3e36027-109320" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "05", "SubTopic": "30", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=65884525&loc=d3e40913-109327" }, "r352": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5419-128473" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5419-128473" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591551-111686" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116874947&loc=SL4591552-111686" }, "r364": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13279-108611" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13433-108611" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13531-108611" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=118260190&loc=d3e13537-108611" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30700-110894" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(Note 3)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=82846649&loc=d3e38371-112697" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "840", "URI": "http://asc.fasb.org/extlink&oid=77902758&loc=d3e41502-112717" }, "r391": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "840", "URI": "http://asc.fasb.org/topic&trid=2208923" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=119364159&loc=SL77916155-209984" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918643-209977" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918666-209980" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918673-209980" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918701-209980" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=118948506&loc=d3e107207-111719" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(1)(a))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116637391&loc=SL114874048-224260" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62557-112803" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(a)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=119400593&loc=d3e572229-122910" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=116637232&loc=SL114874131-224263" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=117419784&loc=SL117783719-158441" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(2)(i))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611133-123010" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12C(1)(a))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611225-123010" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611282-123010" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611379-123010" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=116631420&loc=SL116631458-115580" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "740", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r458": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r459": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r460": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r461": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r462": { "Name": "Forms 10-K, 20-F, 40-F", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d-1" }, "r463": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r464": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6801-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6812-107765" }, "r60": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "210", "URI": "http://asc.fasb.org/topic&trid=2122208" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669646-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e637-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e681-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669686-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL34724394-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669619-108580" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6904-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=SL7669625-108580" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=118930883&loc=d3e557-108580" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6911-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.21)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "8", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3151-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=118951113&loc=d3e6935-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3179-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3367-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3000-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3521-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585" } }, "version": "2.1" } XML 117 R59.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Commitments and Contingencies - Schedule of Activities Related to Warranty Obligations (Detail) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Commitments And Contingencies Disclosure [Abstract]    
Beginning Balance $ 1,236 $ 708
Provision for warranty 1,942 2,334
Utilization (2,000) (1,806)
Ending Balance $ 1,178 $ 1,236

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